
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-7201-7500*
  '("'hotspots'" "A+A" "A+G" "A-allele" "A-type" "A1" "A1-Flag" "A1-containing"
    "A1-flag" "A1066V" "A2308V" "A23187-induced" "A234T" "A242V" "A284Q"
    "A391E" "A430V-Src" "A5359G" "A5653G" "A586V" "A587S" "A748V" "A765T"
    "AAACAA" "AACA" "AACAAA" "AATC" "AAVS1" "ABT-510" "ABT-737-treated" "ACAs"
    "ACGT" "ACHMS" "ADAM-33" "ADC-23" "ADR-SCR" "ADR-siATF4" "AF488" "AFB"
    "AFs" "AG+GG" "AG06173" "AG1521" "AG876" "AGC" "AIC" "AIDS-like" "AJCC"
    "AKAP7" "AKT-IRES-GFP" "AKT-S473" "AKTKD" "AKTi-1" "ALLGene" "ALLGenes"
    "ALLmiRNA" "ALLmiRNAs" "ALM" "ALNRTSSDSALHRRR" "ALOX" "ALT-E" "AMARA"
    "AMARAASAAALARRR" "AML-like" "AMPAR" "AMPK-activators" "AMPK-α" "AMPK-α2"
    "AMPKα" "AMPKα1β1γ1" "AMPKα2" "AMPKαβγ" "AMPKβ1" "AMPKβ2" "AMPKγ1" "ANA"
    "AOAH" "AP-1-Luc" "AP-1-mediated" "AP-1-nor" "AP-1B–positive" "API-1and"
    "APL" "APRE" "APS-mica" "AR-4" "AR-ChIP" "AR-NTD" "AR-NTD-DBD" "AR-half"
    "AR-nonspecific" "AR-null" "AR-positive" "ARE-BP-1" "ARE-binding"
    "ARE-luciferase" "ARH-AP2" "ARIBE" "ARIBE-1" "ARIBE-2" "ARIC" "ARNSM"
    "AR–chip-Seq" "AS-genesis" "AS60540" "ASCO" "ASDs" "ASONDs" "ASPM"
    "AT-rich" "ATC238" "ATCC" "ATF4-proficient" "ATM-NSV" "ATM-NSVs" "ATM-SNVs"
    "ATM-levels" "ATN" "ATN-161" "ATS" "ATTTA" "AUF" "AUG" "AUTS2" "AX" "Ab7"
    "Abcam" "Abdelrahim" "Abelson" "Abraxas-null" "Ac-H3" "AcH3" "AcH4"
    "Acetyl-CoA-carboxylase-α" "Achilles" "Ackermann" "Acm" "Actinobacteria"
    "Acto-myosin-driven" "Ad-AC" "Ad-Cre" "Ad-GFP" "Ad-MEK-DN" "Ad-shAC"
    "AdNGUS24i" "AdVs" "Addenbrooke" "Adenine" "Adepoju" "Adult-born" "Affadin"
    "Affimetrix" "Affymetrix" "Africa" "African" "African-African"
    "African-American" "African-Americans" "Africans" "Ag11" "Ag3" "AgOAc"
    "Aims" "Aki1" "Akiyama" "Akt8" "Akti1" "Akt–Thr-308" "Akt–pSer-473"
    "Ala-to-Cys" "Alabama" "Alaska" "Alaskan" "Albihn" "Alexa" "Alexa-488"
    "Alexa-568" "Alexander" "Aliahmadi" "Aliprantis" "Alk4" "AllStars" "Alt-E"
    "Alternaria" "AlthoughC" "Alzheimer" "Alzheimer's" "Alzheimer’s" "Amaxa"
    "Amber10" "America" "American" "Americans" "Amplification" "Anderson"
    "Angolensin" "Ann" "Ann-V" "Antigen-purified" "Apigetrin" "Apochromat"
    "Arf-GTP" "Arf-family" "Arfl" "Arg-X-Arg-X-X-pSer" "Argentina" "Ariol"
    "Array-CGH" "ArrayExpress" "Asea" "Ashkenazi" "Asian" "Asian-Americans"
    "Asians" "Assisi" "Atf" "Atta" "Aurora" "Austen" "AutoDock"
    "Autoquestionnaire" "Avance" "Avance-series" "Aα" "Aβ" "A–E" "A–S2D"
    "A–induced" "B-4500FO2" "B-RAF-bypass" "B-RAF-homozygous"
    "B-RAF-instrinsic" "B-RAFalternative" "B-RAFamplification"
    "B-RAFamplification-driven" "B-RAFamplification-mediated" "B-RAFamplified"
    "B-RAFcopy" "B-RAFgDNA" "B-RAFgain" "B-RAFi" "B-RAFi-resistant"
    "B-RAFmelanoma" "B-RAFmetastatic" "B-RAFor" "B-RAFover-expression"
    "B-RAFresulting" "B-RAFsecondary" "B-RAFvs" "B-RAFwhich" "B-Rraf" "B-Zip"
    "B-bound" "B-form" "B-lineage" "B-lymphoma" "B-type" "B1" "B2" "B23" "B3"
    "B4" "B5" "B56γ1" "B56γ2" "B56γ3" "B6" "BALB" "BAML1" "BAPTA-AM" "BARD1β"
    "BAS" "BAS-III" "BBXB" "BCL-2-family" "BCL-2-induced" "BCR-B" "BCR-Fw-T"
    "BCR-JAK2-bearing" "BCR-JAK2-expressing" "BCR-JAK2-mediated"
    "BCR-JAK2-transduced" "BDII" "BE3" "BEN1" "BEZ235-treatment" "BG02"
    "BH3-only" "BIM-L" "BIM-S" "BIOGPS" "BJ" "BL518" "BLC-2" "BMAL" "BMDM"
    "BMH1" "BMIs" "BMPR1A-CA" "BMPR1A-CA-expressing" "BMPR1A-CA-induced"
    "BMPRI" "BMRII" "BMRPII" "BMRPRII" "BMs" "BOADICEA" "BP-100" "BPDE-DNA"
    "BPDE–DNA" "BPTES" "BR-0194" "BR-02101" "BR2082" "BRAD1" "BRCA-like"
    "BRCA-mutant" "BRCA1-IRIS-expressing" "BRCA1-IRIS-low"
    "BRCA1-IRIS-overexpressing" "BRCA1-defective" "BRCA1-like" "BRCA1or"
    "BRCA2-defective" "BSC1" "BX" "BX-912" "BXBBB" "BY4741" "BZF" "Ba" "Bacco"
    "Background" "Bacteriomatch" "Bad–Ser-112" "Bad–Ser-136" "BamH1" "Banik"
    "Baquero" "Barbareschi" "Barr" "Barrett" "Baudino" "Bax-deficient"
    "Bax-mediated" "BaxKO" "Bay11-7085" "Bay117085" "Bcl" "Bcl-xl" "BcoR"
    "BcoRL1" "BeadChips" "Beckman" "Beckwith" "Beckwith-Wiedemann" "Begg"
    "Begg's" "Belsey" "Benjamini" "Benjamini-Hochberg" "Bermuda" "Berns"
    "Bevan" "BglII" "Bhattarai" "BiGS" "Biacore" "Bie" "Bim-S" "Bio" "Bio-Rad"
    "Bio-Sciences" "Bio-technology" "BioID" "BioID-LaA" "BioMart"
    "Biochemicals" "Biolabs" "Biomax" "Biomol" "Biosystems" "Birmingham"
    "Biscardi" "Bladowska" "Blake" "Blehm" "Bloomberg" "Bmp6-deficient"
    "Boc-DON" "Boc-chemistry" "Boehringer" "Boeuef" "Boltzmann" "Bonferonni"
    "Bonferroni" "Bonferroni’s" "Boothman" "Borregaard" "Boston" "Bourdon"
    "Bowden" "Boy" "Boyden" "Braak" "Brachyury" "Bradford" "Bradham" "Bradner"
    "Brandt" "Branzei" "BrdU-incorporation" "Bristol" "Bristol-Myers" "British"
    "Brivinib" "BroLi" "Bromo-UTP" "Bronte" "Bronte-Tinkew" "Browser" "Bruker"
    "Bub" "Bub3-BD" "BubR" "BubR1TPR–KI" "BubR1–KI2" "Bugreev" "Burchardt"
    "Burdette" "Burk" "Burkitt" "Burkitt's" "Burkle" "Busselton" "BxN" "C*0602"
    "C-7α" "C-HMQC" "C-RAF-dependence" "C-allele" "C-aspartate" "C-citrate"
    "C-glucose" "C-glutamate" "C-glutamine" "C-heteronuclear" "C-lactate"
    "C-like" "C-rich" "C-terminally" "C-to-T" "C-type" "C1" "C1-epitope"
    "C11orf54" "C12orf48" "C16ORF5" "C1orf112" "C2" "C2-like" "C20orf30"
    "C2orf44" "C2orf44-ALK" "C3" "C33D4" "C3G" "C4" "C4-2B-ARE-Luc"
    "C4-2Bsip53" "C4-2Bsip53-ARE-Luc" "C4-2Bsip53-Luc" "C4-2Bsip53–ARE-Luc"
    "C4D" "C6" "C7" "C73F8" "C7α" "C8ORF30A" "C8orf30A" "CA074" "CAAAAA" "CAAT"
    "CAAX" "CAES" "CAGAGATTGC" "CAGGAA" "CAGGAG" "CAGGAT" "CAGTGATTTG"
    "CAL-101" "CANG" "CANNTG" "CARD6" "CARMA" "CARMA-BCL10-MALT1" "CARMA1–3"
    "CARMA2" "CBB" "CBM" "CBRM1" "CBX-less" "CBXs" "CCAAT-2" "CCAAT-3" "CCCH"
    "CCDN1" "CCG-2911" "CCGGAA" "CCK1" "CCK1R" "CCL153" "CCL231" "CCND-2"
    "CCP2" "CCP2-positive" "CCSD" "CCSDs" "CCSs" "CCVs" "CCl-779"
    "CD44-dependently" "CD45R" "CD8α" "CDIs" "CDKI1A" "CEM-T4" "CEMx174" "CEU"
    "CFSQSKLD" "CG+CC" "CGG" "CGHarray" "CGHarrays" "CGI" "CHC" "CHEN" "CHI3L1"
    "CHIC2" "CH–π" "CIAP" "CIM-plates" "CIMP-status" "CK2-I" "CK2-I-induced"
    "CK2-I-mediated" "CK2-I-treated" "CK2-Is" "CK2-prephosphorylation" "CK2β"
    "CKIδ" "CKRs" "CL" "CLFSYHRLRDLL" "CLIBS" "CLOCK-activation" "CLP"
    "CML-like" "CMML" "CMP-6" "CMR" "CMRPD190031" "CMRPG340381" "CMRPG360701"
    "CMRPG360851" "CMRPG371511" "CMRPG391411" "CMRPG3A0281" "CNTG" "CNV" "CNVs"
    "CORO1B" "COS-1" "COX-promoter" "CP-751,871" "CPA1" "CPT1C" "CRK-I"
    "CRM1-RanGTP-dependent" "CRMP-3" "CRPCs" "CRTCs" "CRYPTOCHROME"
    "CRYPTOCHROMES" "CRYs" "CTC" "CTDN" "CTG•CAG" "CTIF" "CTLA" "CTNNB1-CA"
    "CV" "CXL12" "CXORF39" "CXorf56" "CY61" "CYP1B" "CYR1" "Caf4" "Cahoy"
    "CalDAG" "Calc" "Calicchio" "Califano" "Cambridge" "Cappuzo" "Carlo"
    "Carpinteria" "Carraway" "CatB" "Caucasian" "Caucasians" "Cav-1"
    "Cav-1-Y14D" "Cav-1-Y14F" "Cav-1–Tyr-14" "Cav-1–dependent" "Cav-1–null"
    "Cay10444" "Cdh1-mediated" "Cdk5cKO" "Centenera" "Cepero" "ChIA" "ChIA-PET"
    "ChIP-PCR" "ChIP-PET" "ChIP-on-ChIP" "ChIP-on-Chip" "ChIP-on-chip"
    "ChIP-pull" "ChIP-qPCR" "ChIP-re-ChIP" "ChIP-sequence" "ChIP-sequnce"
    "ChIP-studies" "Chang-qin" "Cheng" "Cheon" "Cherry-SIRT1" "Cherry-p27"
    "Cheung" "Cheyette" "Chi-squared" "China1" "Chk1-mediated" "Chk1xSer-280"
    "Chk1–Ser-280" "Chk1–Ser-296" "Chk1–Ser-345" "Choi" "Chordata"
    "Chromatin-immuno" "Chung" "Ciechanover" "Cl" "Claudin-1was"
    "Cleaved-Caspase-3" "Cleaved-Caspase-6" "Clinicaltrials" "Cloninger"
    "Cloninger’s" "ClustalW" "Clv" "Clv-Csp-6" "Cno" "CoA-racemase" "CoCM-1"
    "Cochran" "Cohen" "Coil-containing" "Colgan" "Computation-based" "Concato"
    "Conclusion" "Conclusions" "Connecticut" "Coomassie" "Copy-number"
    "Cornish" "Cornish-Bowden" "Cosmosiin" "Cosmosiine" "Costanzo" "Cowland"
    "CpG-A" "CpG-A–DOTAP" "Cpt1c" "Cre-activatable" "CreP" "Crouzon"
    "Cruciferae" "Cruz" "Ct" "Ctsk" "Cucurbitaceae" "Cul1" "Cullin–RING"
    "Cultrex" "Cyclooxygenases-1" "CylcinD1" "Cytokeratin5" "Cytotrap" "Cɛ"
    "Cα" "C→A" "D-clade" "D-luciferin" "D-type" "D101A" "D10S1236" "D10S173"
    "D10S1765" "D10S190" "D10S541" "D13S317" "D150A" "D1and" "D2" "D285R" "D3"
    "D32Y" "D4GDI" "DAAM2" "DACT" "DAMP" "DAMPs" "DAVID" "DB216922" "DBIRD"
    "DBIRD-like" "DBS" "DDLPS" "DDLPS-associated" "DDLPSs" "DEA-NONOate" "DEF8"
    "DEPC2" "DFNA5" "DFP-4-AB" "DFP-4-AP" "DFP-4AB" "DFP-4AP" "DG-2"
    "DGRQRRPpSTIAEQTV" "DHT-treatment" "DIEA" "DIGS" "DIPGs" "DIV" "DLAGP5"
    "DLD1" "DLEU7" "DLR" "DLX3" "DME" "DMEM" "DNA-damage-associated"
    "DNA-protein" "DNAH3" "DNAH9" "DNAI1" "DNA–protein" "DNMaml" "DNP73"
    "DNTMT1" "DNaseI" "DNp63" "DNp73" "DNp73α" "DO1" "DOCA"
    "DOH99-TD-C-111-006" "DOTAP" "DOX" "DPP-III" "DQ021501" "DQA1" "DR-GFP"
    "DR-U2OS" "DR53" "DRB1" "DRB1*04" "DSB" "DSBs" "DSM-III-R" "DSM-IV" "DSTT"
    "DSTV" "DTC-1" "DTPL" "DTSV" "Dab2-DPF" "Dako" "DamID" "Dapper1" "Darby"
    "Dawley" "Dawson" "Dbz" "Dcx" "DeMeester" "Delta-like" "DeltaNp63alpha"
    "Deng" "Denmark" "Density-Notch" "Dews" "Dexa" "Dexa-treatment" "Dharmacon"
    "DialignTX" "Dictyostelium" "Diego" "Disabled-2" "Disse" "Dixit" "Dlg-A"
    "Dlg1" "Dll1" "Dmtf1" "Dolcetti" "Domínguez" "Donnell" "Dontu"
    "Dose-response" "Dpr" "Dreifuss" "Ds" "Ducruix" "Dufour" "Dulbecco"
    "Dulbecco's" "Dulbecco’s" "Dulloo" "Dundee" "Dunn" "Dunnett" "Dunnett's"
    "Dutch" "Dutt" "DβH" "Dβh" "D–6F" "E-box" "E-boxes"
    "E-cadherin-EGFP–expressing" "E-cadherin-EGFP–labeled" "E-cdh" "E-type"
    "E1B" "E2-dependent" "E288R" "E290R" "E2F1–3" "E2F3a" "E2F3b" "E2β" "E3-E3"
    "E3-K63" "E3-ligase" "E3-ligases" "E3-ubiquitin" "E4ORF1" "E746-A750"
    "E746-T751" "EASY-Column" "EBPdelta" "EBP–Brm" "EBP–cdk2" "EBS6" "EC1–EC2"
    "EC2–EC3" "EC50" "ECFP" "ECFP-R3B3" "ECFP-pasA" "ECFP-pasB"
    "ECM-attachment" "ECM-contact" "ECM-deprivation" "ECOP" "ED" "ED50" "EDMD"
    "EDMD1" "EDMD2" "EDMD4–6" "EDRN" "EDTA-Notch" "EFPVTC" "EGF-like"
    "EGF-rhodamine–labeled" "EGF3+1+2" "EGFP" "EGFP-MYCN" "EGFR-importinβ1"
    "EGFR–containing" "EGM-2" "EGR" "EH" "EH-domain" "EHE#1" "EHE#2" "EHEs"
    "EIIIA" "EJ5-GFP" "EKAR" "ELF-binding" "ELISAs" "ELREAT" "ENCODE" "EORTC"
    "EP-cad" "EPIYA" "EPSTI1" "ER-66" "ER-activity" "ER-coactivator"
    "ER-regulators" "ER-stress" "ER-α36" "ER-α36-mediated-estrogen" "ER-α66"
    "ERB2" "ERE-E1b-Luc" "ERE-luciferase" "ERE1" "ERE3" "ERMYC" "ERS"
    "ERα-negative" "ERβ-genes" "ERβ-positive" "ER–mitochondrial" "ESC-like"
    "ESCRT-0" "ESI-MS" "ESM" "ETFSDLWKLLPE" "ETS3" "ETS4" "ETS5" "EUFA423"
    "EULAR" "EV18" "EV9" "EYFP-N2" "EYFP-N2a" "EYFP-Nrf2" "EZ-taxiscan"
    "East-Asian" "Easy-LC" "Edman" "Edwards" "Egger" "Egger’s" "Eichler"
    "Eilers" "ElShamy" "Elf-l" "Elk-EN" "Elk-VP16" "Elk-VP16-induced"
    "Emery-Dreifuss" "Endocrinology" "Endometrium" "Endoscopy" "England"
    "English" "Ensembl" "Enzyme-Product" "EpRE" "Epacs" "Epcam" "EpiSCs"
    "Epithelial-to-mesenchymal" "Eponine" "Eqs" "ErB2" "ErbB" "ErbB2-ErbB3"
    "ErbB2-KD" "ErbB2-negative" "ErbB3" "Espina" "Estelles" "Ets-1" "Eugui"
    "Europe" "European" "European-American" "European-Americans"
    "European-ancestry" "Europeans" "Evan" "Evans" "Ewald" "Ex" "Ex-Treg"
    "Ex-Tregs" "Ex-smokers" "Exd4" "ExoI" "Eκ" "Eμ-MYC" "F-12" "F-BAR" "F-CSGE"
    "F-P-A" "F-fluorodeoxyglucose" "F1" "F12" "F120" "F144I" "F2" "F3"
    "F3-BCR-JAK2" "F3-BCR-JAK2-treated" "F3-TEL-JAK2" "F3-TEL-JAK2-treated"
    "F9" "FAIRE" "FAK-null" "FAM169A" "FANCi" "FBRS" "FBRSL1" "FCHO" "FDRq "
    "FERM" "FEV1" "FFLs" "FGF1–10" "FGFR1c" "FGFR1–3" "FIGO" "FKH" "FL-BARD1"
    "FL-COX2-PGL3" "FLAEGGGVCitGPRVVERH" "FLAG" "FLAG-purification"
    "FLAG–HA-tagged" "FLAG–HRP" "FLDLF" "FLJ22536" "FLJ25393" "FLT3-Aurora"
    "FLT3-ITD" "FN-M1c" "FN-M2" "FN-M3" "FN-M6" "FN-TG2" "FOLFOX" "FOP-Flash"
    "FPR1-ΔST" "FR3T3" "FR3T3-Tpr-Met" "FRNK-like" "FSDLWKLL" "FUMI"
    "FUMI-treated" "FURA-2" "FUT1" "FUT11" "FV-10-ASW" "FVBN" "FXIIIa" "Faber"
    "Factor" "Fak-dependent" "Fak-mediated" "Fallot" "Fallot's" "Fas" "Fayette"
    "Fbxw7α–GSK3–p100" "Fbxw7β" "Fbxw7γ" "FcgRIII" "Fedorov" "Feng" "Fernandez"
    "Fgfrs" "FiO2" "Fifty-eight" "Fifty-six" "Fine-tuning" "Finnish"
    "First-line" "FirstChoice" "FirstEF" "Fischer" "Flag" "Flag-BMRPRII"
    "Flag-DTX4–expressing" "Flag-L5" "Flag-M2" "Flag-RPS14" "Flag-Smads"
    "Flag-TWIST" "Fletcher" "Florena" "Flp-in" "Fluro" "Fmoc-Ser"
    "Fmoc-chemistries" "Fmoc-chemistry" "Fmoc-compatible" "Foiani" "FoldX"
    "Fop-Flash" "Fop-flash" "Fordo" "Forty-eight" "Forty-five" "Forty-three"
    "Forty-two" "FoxA" "FoxA1-ChIP" "Framingham" "Franci" "Frederick" "French"
    "Fresh-frozen" "Freud1" "Freyberg" "Friedreich" "Friedreich's" "Friesland"
    "Fritolli" "Frizzled" "Fuchs" "Fujifilm" "Fujita" "Fukuda"
    "Function-loss-mutation" "FxNPxY" "FxxLF" "F–S1I" "G-C" "G-allele"
    "G-coupled" "G0" "G1" "G1-S" "G1-arrest" "G1-checkpoint" "G12D" "G1–G2"
    "G1–G3" "G1–G4" "G2-M" "G2-arrest" "G2-mitosis" "G3–G4" "G719X" "G9a"
    "GA+AA" "GABPα" "GABRIEL" "GADD34-holophosphatase" "GAG1633→AAG" "GAGGAA"
    "GAL3ST1" "GAS1mut" "GAS2mut" "GATA-RE" "GATT" "GBSA" "GC-box" "GCG1-29"
    "GCG9-29" "GCGGAA" "GCGR+Lrp5" "GEJ" "GEMM" "GEMMs" "GENCODE" "GENETIC"
    "GESS" "GF19203X" "GFP-CK1δ" "GFP-CK1ε" "GFP-Gab1ΔP4" "GFP-IRES-FAK"
    "GFP-LRRK1–expressing" "GFP-PP2A-A" "GFP-Polκ" "GFP–Gab1WT" "GG" "GGC→TGC"
    "GGT→GCT" "GGT→GTT" "GGT→TGT" "GKN1" "GKN2" "GLIS1" "GM19240" "GNE493"
    "GOG" "GOG-210" "GOminer" "GQM-DVP" "GQM-VPA" "GR1" "GR526" "GRCh37" "GREB"
    "GREB-1" "GREB-ERE" "GRS211A" "GS" "GS-800" "GSE14020" "GSE21138"
    "GSE31322" "GSH-protein-bead" "GSK-3A" "GSK2" "GSK3i" "GSKi" "GSKi-XV"
    "GST-14-3-3σ" "GST-C" "GST-ICP0-241" "GST-J" "GST-Meg2" "GST-SATB-1-204"
    "GST-SATB1-1-204" "GST-SH3-W93A" "GST-cyto-plexinB1" "GST-pull"
    "GST-pull-down" "GST-pulldown" "GST-pulldowns" "GST–14-3-3ζ" "GT+TT"
    "GTPase-like" "GTTGCCAT" "GVL" "GVV" "GWASs" "Gab1ΔMBD" "Gab1ΔP4" "Gadd45α"
    "Gaedcke" "Gaithersberg" "Gap-phase" "Gelmon" "GenBank" "Gene-environment"
    "Gene-lung" "GeneBank" "GeneChip" "Genomatix" "Genome-Wide" "Genome-scans"
    "Genome-wide" "Genomes" "George" "German" "Germany" "Gibadulinova" "Giemsa"
    "GlaxoSmithKline" "Gleason" "Gli1" "Gli1-positive" "Gli1F1" "Gli1S84E"
    "Gli1WT" "Glienke" "Glondu" "Gloy" "Glp1" "Glu-Glu-Glu-Tyr-Phe" "Glul"
    "Glutarnine" "Glutathione-Sepharose" "Gnγ10" "GoDARTS" "GoldenGate"
    "Goldmann" "Goldstein" "Golgi-apparatus" "Gonzalez" "Gonzalez-Fernandez"
    "Goosecoid" "Gordan" "Gp49a" "Gr1-positive" "Grad" "Grahame"
    "Gram-negative" "Gram-positive" "GraphPad" "Grb-2-like" "Grb2-SOS-Grb2"
    "Grb2-Sos1" "Grg1" "Grob" "Gskβ" "GuHCl" "GuK" "Gualberto" "Guca2a"
    "Guilford" "Gung" "Gupta" "Guschin" "Gy" "Gylceraldehyde"
    "Gylceraldehyde-3-phosphate" "Gypican-3" "Gα" "Gβγ" "G–Sepharose" "H&E"
    "H-RasV12" "H-S" "H-bond" "H-bonding" "H-bonds" "H-score" "H1" "H2"
    "H2-domain" "H226B-K-Ras" "H2AK119" "H2AK119ub1" "H3" "H3-positive" "H3.3"
    "H3K" "H3K14" "H3K14Ac" "H3K27" "H3K56" "H3K56ac" "H3K9" "H3K9ac" "H4"
    "H4K12" "H4K5" "H5" "HA-14.1" "HA-Chk2" "HA-K0R63K" "HA-MDM2" "HA-NLRP4"
    "HA-NLRP4–expressing" "HA-RAC3" "HA-RNF168" "HA-Rac1" "HA-Rad18" "HA-Vpr"
    "HA-mini-LDLR" "HA-p53" "HA-ubiquitin" "HA1E" "HA1E-MYC" "HA1E-MYCER"
    "HA1E-Vector" "HAB" "HAB-18" "HAB-68" "HAB-85" "HAB-92" "HAQ" "HA–IP"
    "HA–SIK2" "HA–agarose" "HBE135-E6E7" "HBEC" "HBEC2-E" "HBT-Dab2" "HBTU"
    "HBX" "HC-20" "HCC-1569" "HCC-827" "HCC2935" "HCG27" "HCT116RAD18"
    "HDAC1-11" "HDAC1-2" "HDAC1-3" "HDAC1-4" "HDAC4-7" "HDAC5tide" "HEARD"
    "HEEBO" "HEK293T-BCR-JAK2" "HELAD1" "HER2-activated" "HER2-negative"
    "HER2-positive" "HFFF" "HFH4" "HGG" "HIEC-6" "HIF" "HIF-α" "HILIC"
    "HILIC-HPLC" "HIV-1+CHX" "HIV-1+Noc" "HIV-1-infection" "HIV-1infection"
    "HK" "HLA-DRB1*04" "HLA-DRB1*09" "HLA-DRB1*10" "HLA-DRB1*11" "HLHLZ"
    "HLRLSTSSGRLLRRR" "HMMCLs" "HMN" "HMN-214" "HMPREF0536" "HNF-3β" "HNSCCs"
    "HNt" "HP-gastritis" "HPDE6" "HPFS" "HPMC" "HPMCs" "HPNE" "HPRT"
    "HR-defective" "HR=3.22" "HR=3.29" "HR=3.51" "HSB4" "HSBP4" "HSPB4" "HSV-1"
    "HTS-466284" "HUGO" "Ha" "HaCaT-ROCK1-KD" "HaCaT-ROCK2-KD" "HaCaT-only"
    "Hadj" "Hadj-Hamou" "Haelens" "Hahn" "Halocarbon" "Hamou" "Hanahan"
    "Hansford" "HapMap" "Hardie" "Hardy-Weinberg" "Hardy–Weinberg" "Harvard"
    "Hatanaka" "Hayashida" "Hayflick" "Hck" "Hck-null" "Hdac"
    "Heat-inactivated" "Heatmaps" "Helle" "Hellwinkel" "Henderson" "Hep27"
    "HepH" "Hermann" "Higgins" "High-dose" "High-doses" "High-grade"
    "High-level" "High-pH" "Higuchi" "Hilgendorf" "HindIII" "His-Flag-RNF8"
    "His-Nrf2" "His-S14" "His-Ub" "His-biotin" "His-β-catenin" "HisNrf2"
    "Hispanic" "Hispanic
Americans"
    "Hispanics" "HistoRx" "HistoneH3-positivity" "His–14-3-3" "Hochberg"
    "Hochst33342" "Hodgkin" "Hodgkin's" "Hodgkin’s" "Hoechst" "Hollestelle"
    "Holliday-junction-specific" "Hong" "Hos3" "Hot-spots" "Houston"
    "Hs00178181" "Hs00178872" "Hs00180679" "Hs00192399" "Hs00933163" "Hs776T"
    "Hs99999034" "HsDMC1" "Hsc70-dependent" "Hsp70" "HuEx" "Huang" "Human"
    "HumanHT" "HumanHT-12" "HumanOmniExpress" "HumanOmniExpress-12v1.0"
    "Huntington" "Huntington's" "Hupki" "Hwang" "HxBruR" "Hyd" "Hygro"
    "Hypospadias" "I)XXLK" "I-FGF1" "I-FGF19" "I-III" "I-SPY" "I-coated"
    "I-labeled" "I-like" "I-targeting" "I-treated" "I124V" "I152L" "IASLC"
    "IC50" "ICN" "ICP0-nls241" "IEC" "IECs" "IFI" "IFI-16"
    "IFN-α-induced-PKC-α" "IFNARs" "IFNα14" "IFNβactivation" "IFNβpromoter"
    "IGF-1-ERK" "IGF-1-PI3K" "IGF-1-driven" "IGF-1-induced" "IGF-1-mediated"
    "IGF-1-sCLU" "IGF-1-stimulated" "IGF-1-treated" "IGF-1-βCLU"
    "IGF-1–induced" "IGF-IRβ" "IGF-stimulated" "IGF1Rb" "IGF1Rs" "IGRG82"
    "II-3" "II-III" "IIB-IV" "III-1" "IIIa" "IIIc" "IIa" "IIα" "II–IV" "II–VII"
    "IKKε-dependent" "IKLE" "IL-18R" "IL-18Rα" "IL-6Rα" "IL12p40dlNF-κB" "ILs"
    "IMPUTE2-info" "IMR" "IMR90-ERMYC" "INF-gamma" "INK" "IP-IB" "IPVAM" "IQR"
    "IQR=0" "IQR=37" "IQR=37.0" "IQR=53.5" "IQR=60.5" "IQR=75.0" "IR-A" "IRB"
    "IRES-GFP" "IRES-motifs" "IRISa" "IRISb" "IRISc" "IRS1tide" "IRβ" "ISEL"
    "ISG" "ISG-56" "ISRE-luciferase" "ITC" "ITG" "ITG-β6" "ITG-β7" "ITGB1BP3"
    "Ig-like" "IgA" "IgE-FcRI" "IgIII" "IgIIIa" "IgIIIb" "Igf" "Igf-H19" "Igfs"
    "Igs" "Igκ" "Igκ-expressing" "Igλ" "IkBs" "Illumina" "ImageJ" "Imclone"
    "Immunocystochemistry" "In-silico" "Inestrosa" "Informativeness"
    "Ingelheim" "Innovagen" "Inoki" "InsP3" "Insulin" "Interaction-like"
    "Intra-vascular" "Invadopodia-like" "Invitrogen" "Invitrogen-USA" "Iowa"
    "Ireland" "Irvine" "Ishibe" "Itahana" "Ivanova" "I–II" "I–IV" "I∶C" "J-810"
    "J774" "JAK-STAT-SOCS" "JAK1-3" "JAK2-Rv-T" "JAK2V167F" "JAK2V617F" "JAK2b"
    "JH1" "JH1-tyrosine-kinase" "JLO-1" "JNK1α1" "JNK–inducible" "JPM50.6"
    "JWE" "Jackson" "Jag1KD" "Jaganathan" "Jain" "Jak3" "Japanese" "Jarcho"
    "Jasco" "Jeang" "Jeghers" "Jeko" "Jeon" "Jewish" "Jian-ping" "Jiang" "Jost"
    "Jungert" "K-S-T" "K-less" "K-means" "K0" "K110R" "K136AK175A" "K280A"
    "K336A" "K36C" "K428RR" "K48" "K492" "K56A" "K56Q" "K56R" "K8" "K9" "K9A"
    "K9C" "KB1P" "KB1PM" "KB1PM-1" "KB1PM-2" "KB1PM-3" "KB1PM-5" "KBLuc" "KCDC"
    "KEGG" "KG8" "KI(D" "KIAA0583" "KIAA0888" "KIHACitEIFDSCitGNPTV" "KK164"
    "KK427" "KLFs" "KMN" "KNL1-C" "KOHBRA" "KQKRK" "KRAHHNALERKRR"
    "KRAS-dependencies" "KRAS-dependency" "KRAS-mutant" "KRH" "KRRK" "KTCL140"
    "KY" "Kai" "Kaituo" "Kal" "Kal-7" "Kalinsky" "Kalirin-7" "Kamino" "Kamiya"
    "Kaneda" "Kaplan" "Kaplan-Meier" "Kaposi" "Kaposi's" "Kapphahn" "Kapur"
    "Karlsson" "Katsifis" "Kawamura" "Kd" "Kendall" "Kendall's" "Kent"
    "Kerlikowske" "Ki-67" "Kim" "KinaseA" "Kinzler" "Kip" "Kirsten" "Kit-8"
    "Kiyosaki" "Kln1" "Klotho-beta" "Knock-down" "Kobba" "Kohno" "Kolmogorov"
    "Kolmogorov-Smirnov" "Kolmogorov–Smirnov" "Kong" "Korea" "Korean" "Koreans"
    "Krebs" "Krebs–Ringer–Hepes" "Kress" "Kretzner" "Krt" "Krt8-knockout"
    "Kruskal-Wallis" "Ku" "Ku-006379" "Kummerowia" "Kunkel" "Kurumizaka"
    "Kyoto" "Kähler" "K–S" "L-Myc" "L-histidine" "L1" "L150I" "L151I" "L15R"
    "L2" "L3" "L3MTBL2" "L41Q" "L5" "L7" "LACE" "LAP2α" "LAP3P2" "LBD-NID"
    "LC3-I" "LCL" "LCL385" "LCLs" "LD50" "LDLRs" "LDMIIIG" "LDN" "LDN-189193"
    "LDS" "LFA" "LFDCEMLDAVDPQHNGYVLVN" "LIN-7" "LINE-1" "LIPA" "LKR13" "LLL-3"
    "LLM" "LLnL" "LNCaP-ARE-Luc" "LNsiE6" "LNsip" "LNsip53-ARE-Luc"
    "LNsip53-ARE-luc" "LNsip53-Hygro" "LNsip53-Luc" "LNsip53-Wig-1" "LOC285296"
    "LOC391426" "LOF" "LOX-PP-mediated" "LOX-PP-transfected" "LOX-PP-treated"
    "LPS" "LPTS" "LPTS-L" "LQRMLPSL" "LRH-1-DNA" "LRHREs" "LRRC4C" "LRRK"
    "LRRK1-C1" "LSL-Rosa26-Lac-Zmutant" "LSL-Rosa26-LacZ"
    "LSL-Rosa26-LacZprostates" "LTHSC" "LTVGLTXXGQPRQY" "LV-ATF4"
    "LV-STAT3siRNA" "LV-Vector" "LVSI" "LXXLL" "LY2940002" "La" "LaA"
    "LaA-proximal" "Labsystems" "Lac" "Lactobacillus" "Lahdesmaki" "Lai"
    "Lamolle" "Langerhans" "Lannigan" "Lapointe" "Laxer" "Lef" "Lefebvre"
    "Leguminosae" "Lehnardt" "Lennard" "Lennard-Jones" "Lenti-miRNAc-Met-neg"
    "Lesley" "Lessard" "Lettre" "Leu-OH" "Leucine-rich-repeats" "Levin" "Li"
    "Liao" "Lin-7" "Linares" "Lindemann" "Lindsay" "Lineweaver"
    "Lineweaver-Burk" "Liu" "Llopis" "LoKe" "Loco-regional" "Log-phase" "Loi"
    "Long-lasting" "Lonza" "Loss-of-function" "Louis" "Louisville" "Loures"
    "Lrp5ECD" "Ludwig" "Lumicycle" "Luminometer" "Luminoskan" "Lund" "Luo"
    "Lyashenko" "Lymphocyte" "Lys-Glu-Arg-Arg-Ala" "Lys-to-Cys" "Lyte" "Lzp"
    "Lzp-s" "M-coffee" "M-group" "M10" "M1b" "M212-09" "M3v" "M4-2-1" "M4-2-10"
    "M5" "M6" "M7" "M8" "M9" "MAF=0.04" "MAF≥1" "MAGI-I" "MALDI-MS" "MALP-2"
    "MALP2" "MALT" "MAMDC1" "MAP-tau" "MAPK-redundant" "MAPKKK-like" "MARK"
    "MBCCOP" "MBM" "MBM-LBM" "MBp" "MBp-large" "MD-2-dependent" "MD-MBA-468"
    "MDA-MB-231MYBup" "MDA-MD-453" "MDA-PC-2b" "MEF-CM" "MEKi" "MEM-148"
    "MEM-18" "MFS" "MGA" "MGC" "MHC" "MHC-1" "MHC-I" "MHC2TA" "MHz" "MIS12-C"
    "MIU" "MKC" "MKCs" "MLC-P" "MLL1MBM-binding" "MM-GBSA" "MM-PB" "MM-PBSA"
    "MMTV-LTR" "MMTV-PyMT" "MOI=0.01" "MOI=3" "MOIs" "MOLM" "MOLM-13-RES-AC"
    "MPYS" "MQPQQGFLNAQMVAQRSRELLS" "MRL" "MS" "MS-HRM" "MSH-H" "MSI-L" "MSMS"
    "MSigDB" "MTMA" "MTS" "MUC4-ErbB2" "MUC4α" "MUC4β" "MUSK" "MUT-A" "MUT-B"
    "MXD1-4" "MYBup" "MYC-335" "MYC-335–bearing" "MYC-YFP" "MYC-YFP-expressing"
    "MYCER" "MYCN-only" "MaTi" "MacDonald" "Mad1–Mad2" "Madin" "Madin-Darby"
    "Mafft" "Maguschak" "Maml" "Manassas" "Manchester" "Manic-like"
    "Mantel-Cox" "Mantovani" "Marchetti" "Martingale" "Martinon" "Maruyama"
    "Marzo" "MassARRAY" "Massagué" "Mastermind-like" "Mastermix" "Material"
    "Maternally-mediated" "Matheson" "Mathilde" "Matrigel" "Matzinger" "Max"
    "Max*HA" "Mayo" "Mazin" "Mcm2-7" "Mdc1-like" "MdmX-null" "MdmX3SA" "Meier"
    "Mem" "Memphis" "Meng" "Mengyao" "Menten" "Merkel" "Met-Gab1" "Met-tRNA"
    "MetaboMiner" "Methodology" "Methods" "Met–Gab1" "Met–cortactin" "Mexican"
    "Mexico" "Mexico-American" "Meyer" "Meyer-Hermann" "MiR-124" "MiR-128"
    "MiR-138" "MiR-19" "MiR-223" "MiR-433" "MiR-592" "Michael" "Michaelis"
    "Michaelis-Menten" "Michaelis–Menten" "Michigan" "Microplate" "Middlesex"
    "Midleg" "Midline" "Millipore" "Mitochondrial-localized" "Mixed-species"
    "Miyaki" "Miyara" "MluI" "Mn" "Mnk1" "MoMaTEC" "Mock" "Mock-GFP" "Mock-YFP"
    "Mock-YFP-expressing" "Mock-expressing" "Monine" "Monje" "Monte"
    "Montgomeryville" "Morris" "Mosmann" "Mtw1" "Muaddi" "Muc" "Muir"
    "Muir-Torre" "MultiZ" "Multilabel" "Multivariable-adjusted" "Multivariate"
    "Munemasa" "Murata" "Murata-Kamiya" "Murray" "Mutationally-activated"
    "MvRadA" "MyD88-IRF7–dependent" "Myc" "Myc-PTPMeg2"
    "Myc-SS18-SSX2-expressing" "Myc-tag" "Myers" "Myf" "Myr-Akt" "Myr-PKCα"
    "MyrAKT1" "Müller-Esterl's" "MβCD" "M∼2" "M∼2.5" "M∼5" "M∼64" "N)XXXF(L"
    "N+1" "N-Acetyl" "N-HMQC" "N-acetyl" "N-diisopropylethylamine" "N-domain"
    "N-fast" "N-glycoproteins" "N-glycosylation" "N-hydroxybenzotriazole"
    "N-labeled" "N-labled" "N-linked" "N-ternimal" "N1" "N2-a" "N2-b" "N2-c"
    "N4" "N=28" "N=50" "NAV2" "NB-4" "NB-Ebc1" "NB26" "NBS" "NCBI36" "NCBI37"
    "NCBIM37" "NCI" "NCI-60" "NCI-H1703" "NCI-H209" "NCI-H522" "NCI60" "NCOA5"
    "NCT00888173" "NCr" "NCr-nu" "NDC80-C" "NE-DLG" "NEEGFFSACitGHRPLDKK"
    "NF-κB1" "NF=10" "NFH-PCGF4-containing" "NFKB" "NFY" "NGL1" "NGP" "NHANES"
    "NHBEC" "NHLFs" "NHT" "NICD-consensus" "NICD1" "NICD3" "NICN87" "NIDCR"
    "NIDCR-NCI" "NL4-3" "NLF" "NLG-deficient-IGF1Rs" "NLRP4-DTX4–mediated"
    "NLRP4a–NLRP4g" "NLRP4b" "NLRP4c" "NLRP4e" "NLRP4g" "NLS" "NLSs"
    "NNK-induced" "NNSplice" "NOD-like" "NOKSI" "NOTCH1-ChIP"
    "NOTCH1-predominant" "NOTCH3-ChIP" "NOTCH3-bound" "NPC7" "NPG" "NPV"
    "NP_997201" "NRAF" "NRP-152" "NSAID" "NSC94-2314-B-182-030"
    "NSC98-2314-B-182-046-MY3" "NSC99-2314-B-182A-036-MY3" "NSE-DTA" "NSFT"
    "NT1-2" "NT_033899" "NUCC" "NUCC-4" "NURD" "NVP" "NVP-BEZ-235" "NVP-BEZ325"
    "NVP-BKM-120" "NYU" "Na" "Na-treated" "NaVO4" "NaeI" "Naik" "Nb-Ebc1" "Nbz"
    "Ndn" "Necker" "Nef-C" "Nef-F2" "Nef-H" "Nef-SF2-mediated" "Nef-defective"
    "Neh4" "Neh5" "Neh6" "Neilsen" "Nestin-CreER" "Net11" "NetPhos"
    "Netherland" "Netherlands" "Neurosurgery" "Never-smokers" "Newcastle" "Nfl"
    "Nguyen" "NheI" "Ni" "Ni-NTA" "Ni-NTA-agarose" "Nikitin" "NimbleGen"
    "Ninety-four" "Ninety-six" "Nippon" "Nishida" "Nnf1" "Nod-like" "Nodal"
    "Nonidet" "Noonan" "Norway" "Not1" "Notch" "Notch-Dependent"
    "Notch-dependent" "Notch-induced" "Notch-mediated" "Notch1" "Notch1-ChIP"
    "Notch3-ChIP" "Nov" "Novabiochem" "Novagen" "Novartis" "Novex" "Novo"
    "Novus" "Nrf2" "Nrf2-partner" "Nrxn" "Nu" "NuPage" "NuRD" "NuSAP" "Nup475"
    "Nutlin-3b" "Nuñez" "O-1" "O-MAD2" "O3" "O6-alkylguanine" "OAM4224g" "OBzl"
    "OCPs" "OCT3" "OMIM" "OPH" "OR=3.05" "ORA" "ORs" "OV-1847" "Oakland"
    "Odds-ratio" "Off-target" "Oh" "Oikawa" "OipA" "Olig" "Olivier" "Olympus"
    "Omomyc" "Oncology" "Oncomine" "Oncominethat" "Oncotype" "Oncotype-DX"
    "One-dimensional" "One-third" "OneShot" "Onguru" "Onufriev" "Open-tTG"
    "Opti" "Opti-Mem" "OriGene" "Orina" "OxLA" "Oxford" "P+4" "P1" "P2" "P30T"
    "P4" "P4C10" "P53-defective" "P6" "P7" "P=0.0024" "P=0.003" "P=0.006"
    "P=0.019" "P=0.026" "P=0.028" "P=0.03" "P=0.61" "P=1.3×10" "P=2.3×10" "P=4"
    "P=4.8×10" "P=5.3×10" "P=6.4×10" "PABP-N" "PAD" "PAGE" "PAK-dependency"
    "PAK2-depleted" "PANC-1s" "PANCs" "PANDA" "PARP-inhibitor-resistance"
    "PBST" "PC3-1" "PC3-2" "PC3-H" "PC3-L" "PC3-shERα" "PC3-shERβ" "PC3shERα"
    "PCE" "PCGF" "PCGF-RING1A" "PCGF3" "PCGFs" "PCK" "PCMA" "PCNY1" "PCR-RFLP"
    "PCRs" "PD-PANC-1s" "PD184352" "PDAs" "PDE4D5" "PDGFbb" "PDR" "PDZ-B"
    "PDZ-like" "PDZRhoGEF" "PEEL" "PEO" "PEO-4" "PEST" "PFCCs" "PFT-α"
    "PG-endoperoxide" "PGC-like" "PGC1-α" "PGF1α" "PGR1" "PGR1-ChIP" "PHA"
    "PHC-containing" "PHLPP1α" "PHLPP1β" "PHLPPs" "PI-PLCγ1" "PI3-K-dependent"
    "PI3KCA" "PIK-90" "PILCs" "PITPNC1" "PK11195" "PKA-dependent"
    "PKA-mediated" "PKC-family" "PKC-ε" "PKCɛ" "PKCδ-fragment" "PKCζ" "PKCθ"
    "PKCι" "PKCλ" "PL+SopE" "PLA-2" "PLC-β" "PLCβ" "PLCβ4"
    "PLCγ-PKCε-dependent" "PLCη" "PLCι" "PLRKTASEPNLKRRR" "PLX4032-resistant"
    "PMA" "PMH" "PMR" "PMR-values" "PNA-DNA" "PNAC-1" "PNGage" "PNT2C2" "POO"
    "POODLE" "PP1-α" "PP2A-A" "PP2A-B56γ" "PP2B" "PPII-helical" "PPIL4" "PPXY"
    "PR-negative" "PR-positive" "PR8011" "PREs" "PRI-4" "PR_WT" "PR_mS1"
    "PR_mS12" "PR_mS123" "PR_mS124" "PR_mS13" "PR_mS134" "PR_mS14" "PR_mS2"
    "PR_mS23" "PR_mS234" "PR_mS24" "PR_mS3" "PR_mS34" "PR_mS4" "PS" "PS-140"
    "PSA61Luc" "PSTAT3" "PSTLSL" "PTD012" "PTEN-dysfunctional" "PTEN-null"
    "PTENCA" "PTH1-34" "PTPRN2" "PU" "PVTT" "PWC" "PWCs" "PXψPXR" "PY1068"
    "PY416" "PY705" "PY992" "PYHIN" "PaO2" "Packings" "Pacman" "Paget"
    "Pair-wise" "Pak1phosphorylation" "Paley" "Paneth" "Par-1" "Par3-Par6-aPKC"
    "Paranjape" "Pardee" "Parella" "Parent-of-origin" "Parrella" "Pas" "PasA"
    "Patterson" "Pattje" "Pattje's" "Paull" "Pc" "PcG-directed" "Pearson"
    "Pearson's" "Pearson’s" "Pekarsky" "Pena" "Pena-Llopis" "Penicillin"
    "Penicillium" "Pentacam" "PepMap" "Per" "Perelson" "Perez" "Perez-Tonorio"
    "PerkinElmer" "Perren" "Peterson" "Pettitt" "Peutz" "Peutz-Jeghers" "Peyer"
    "Peyer's" "Pfizer" "Ph" "Phan" "Pharmingen" "Philadelphia" "Pho"
    "Phosphatidylinositide-3-kinases" "Pi-Cav1" "Pi-cav1" "Piera"
    "Piera-Velazquez" "Pin1consensus" "Pinner" "Pluronic-coated" "Pockley"
    "Pol-III" "Poleta" "PolyPhen" "Polζ" "Polι" "Ponceau" "Ponzo" "Pooley"
    "Popowicz" "Porta" "Possion-Boltzmann" "Post-operatively"
    "Post-transcriptional" "Post-translation" "Post-translational" "Potikyan"
    "PrCa" "Prakken" "Prasad" "Principal" "Principle" "Pro-LOX"
    "Pro-angiogenic" "ProbCons" "Prodomain" "Promega" "Proxeon"
    "Proximity-dependent" "Pscan" "Pt55" "Pterocarpus" "PuGGTCAnnnTGACCPy"
    "Purkinje" "Pvull" "PxxPxR" "PyMT" "Pérez" "Pérez-Tenorio" "P = 0.004"
    "P≤0.05" "P≥0.05" "Q-G" "Q-Q" "Q-Trap" "QK" "QPIF" "QQ" "QQ-plots" "QVD"
    "QVD-OPH" "Qiagen" "Qu" "QualBrowser" "QuikChange" "Quintana" "R-RasGAP"
    "R-RasGTPase" "R-X-R-S-F" "R-motif" "R0" "R1" "R105" "R2" "R233fs" "R279C"
    "R280A" "R281A" "R2A" "R3" "R3A" "R3B" "R3B1" "R3B2" "R3B3" "R3B4" "R3C"
    "R4" "R5" "R5-tropic" "R71-D75" "R80AQ65R" "R=0.328" "RA2009" "RAC3-R3B3"
    "RAC3-pasB" "RAD-001" "RAF-altered" "RAFcopy" "RAFgDNA" "RAFgain" "RAFi"
    "RAFor" "RAFvs" "RAFwhich" "RAP80delE81" "RAR-A" "RAR-G" "RARE1" "RARE2"
    "RAREs" "RAR–chip–Seq" "RAR–chip–chip" "RAS-pathway" "RASSF-1a" "RASSF-1α"
    "RAZ" "RBMXL1" "RBMY" "RBPjκ" "RB–E2F–dependent" "RCB" "RCGTG" "REG3"
    "REG3γ" "RESP" "REx" "RFLP" "RGD" "RICTOR-null" "RIG-I-like" "RISC-IP"
    "RKE" "RKKLR" "RKLKK" "RKT" "RKTs" "RL251" "RMSD" "RNA"
    "RNA-interference-mediated" "RNAP2" "RNAi-vector" "RNApol2" "RNApolII"
    "RNF" "RNeasy" "ROI" "RP-135" "RP-HPLC" "RPA-ssDNA" "RPDR" "RPKM" "RPL"
    "RPL21P44" "RPPAs" "RR=20" "RRHO" "RRMKANARERNRM" "RRSO" "RRVSF" "RRWK"
    "RRXXXW" "RSQ" "RTKs" "RTqPCR" "RWRFPARP" "Rac-GDP" "Rac-GTP" "Rac-family"
    "Rac1-GTP" "Rac1-Pool" "Rac1-SI#1" "RacGTP" "RacL" "RacL61"
    "RacL61-dependent" "Rad18–Polη" "Rad51" "Rad6–Rad18-dependent" "Rag"
    "Ramkissoon" "Ranganathan" "Rap1GEF" "Ras-proximate-1" "RayBioplex"
    "Raynaud" "Raynaud's" "Rb-E2Fs" "Re-endothelialization" "Re-introduction"
    "RecT" "Red+" "RefSeq" "Reg3β" "Reg3γ" "Renilla" "ReoV" "Ressler" "Results"
    "Retroperitoneal" "Rh-EGF" "Rheumatology" "Rho-family" "RhoA" "RhoDGTP"
    "RhoGD12" "RhoGDI1" "RhoGDIs" "RhoGTP" "Rigosertib" "Ritchie" "Rivera"
    "Rlu" "Rnd1N" "Rnd1ΔN" "Rnd2C" "Rnd2N" "Rnf144b" "Roadmap" "Robert"
    "Robinson" "Roche" "Rodnan" "Romagnoli" "Rosa" "Rosa26" "Rosa26-LSL-Rac1b"
    "Rosa26-Luc" "Rosa26-luc" "Rosai" "Rosiglitazon" "Rota-rod" "Rotterdam"
    "Rous" "Rpd" "Rpd3L" "Rpd3S" "Rraf" "Rs1799964" "Rv1" "RxRxxS" "S+100"
    "S+330" "S+G2" "S-IRF3" "S-box" "S-box-A" "S-methionine" "S-transferases"
    "S1" "S100P" "S1101" "S112" "S14" "S14A" "S14D" "S14E" "S17D" "S1981-ATM"
    "S1C" "S1D" "S1F" "S1G" "S1H" "S1P+EGF" "S1–S4" "S246" "S25-53BP1" "S270"
    "S2A" "S2B" "S2C" "S2D" "S2E" "S3" "S33" "S33C" "S37" "S3D" "S3E" "S4"
    "S409-reactive" "S409A-mutant" "S421–423" "S421–434" "S473" "S4A" "S4B"
    "S4C" "S4D" "S4E" "S4H" "S58" "S5A" "S5C" "S6" "S62" "S632" "S632-HDAC4"
    "S636" "S64" "S6A" "S6C" "S6G" "S6K" "S6K1-induced" "S6K1-mediated"
    "S6K1K100R" "S6K1T389A" "S6K1T389E" "S6RP" "S7" "S8" "S807" "S84A" "S84E"
    "S9" "S9mix" "SA-βGal-positive" "SAH-p53" "SAH-p53-8" "SAMP1" "SAPALDIA"
    "SAR" "SB939" "SCC-11" "SCC-14" "SCC-14a" "SCC-16" "SCC-19" "SCC-21"
    "SCC-29" "SCC-30" "SCC-34" "SCC-6" "SCC12f" "SCC47" "SCF-like" "SCG7901"
    "SCIN" "SCM-containing" "SCMs-containing" "SCNCs" "SCOP" "SCOS1" "SDF"
    "SDF-1α" "SDS-polyacrylamide" "SDTD" "SEC14p" "SELEX" "SENS1" "SENS2"
    "SERINE" "SERM-like" "SF-8" "SF0.1" "SFM" "SGIPα" "SGZ" "SH2-SH3"
    "SH2-SH3-SH3" "SH2-domain-containing" "SH3-domain" "SH3-linker" "SHH-N"
    "SHMNT1" "SIFT" "SIPA1L2" "SIRT" "SIRT1-KO" "SIRT1-R" "SIRT1-eIF2α"
    "SIRT1-null" "SIRT1-overexpressing-SIRT1null" "SIRT1H363Y" "SISA" "SIVcpz"
    "SIVmac" "SIVmac239" "SIVmne" "SIVsmm" "SIVstm" "SKI" "SKOV" "SKOV-433"
    "SKOV-6" "SKOV-8" "SKOV8" "SL-50" "SLAP75" "SLMO2" "SLTRIK1" "SMIs" "SNH"
    "SNP" "SNP-SNP" "SNP-probe" "SNP466" "SNPinfo" "SNPs" "SNPsandwere"
    "SNU354" "SNU368" "SNU739" "SNU886" "SNVs" "SNc" "SOCS-JAK" "SOCS1-3"
    "SOCS1-7" "SOCS3-substrate" "SOCS4-3" "SOCS4-7" "SOCS5-3" "SOS" "SPARCL1"
    "SPS2" "SPSS" "SPY" "SQETFSDLWKLLPEN" "SS158,309AA" "SS18-SSX-bound"
    "SS18-SSX-mediated" "SS18-SSX2-knockdown" "SS451,462AA" "SSC" "SSEA4"
    "SSEA4-positive" "SSc" "SSc008" "ST6GALNAC" "STASTVEpYSTVVHSG" "STAT"
    "STAT1α" "STAT3-C" "STAT3-DNA" "STAT3-DNA-binding" "STAT3-plasmid" "STAT3α"
    "STAT3γ" "STATβ" "STATγ" "STATγs" "STCitSVSSSSYCitCitMFGG" "STR7"
    "SUMO-PCNA-dependent" "SUMO-interacting-motif-like" "SUMO-moiety" "SVEP1"
    "SYBR" "SYBR-Green" "Saccaramyces" "Sahai" "Sahay" "Sakamototide"
    "Salicylihalamide" "Samelson" "Sanger" "Saraswathy" "Savino" "ScRad51"
    "Scansite" "Scarff-Bloom-Richardson" "SceGFP" "Scherer"
    "Schizosaccharomyces" "Schuurmans" "Scottish" "Sec61β" "Seed"
    "Semi-quantitative" "Semple" "Sen" "Sendai" "Sentrix" "SeqChIP" "Sequenom"
    "Ser-1177-eNOS" "Ser-280–phosphorylated" "Ser-296" "Ser-296xphosphorylated"
    "Ser-345" "Ser-473" "Ser-636" "Ser-9-phosphorylated" "Ser1981-ATM" "Ser33"
    "Ser426" "Ser463" "Ser473" "Ser707" "Ser866" "Serhan" "Sesn2F" "Set"
    "Seventy-seven" "Seventy-two" "ShSIRT1-1" "ShSIRT1-2" "Shain" "Shandong"
    "Shangdi" "Sharma" "Shea" "Shen" "Shimizu" "Shinyaku" "Shiota" "Sierecki"
    "Sigma-Aldrich" "Sigmaplot" "Significance" "Significances" "Silva" "Sim"
    "Simões" "Sinicrope" "SipA" "Sirtuins" "Sixty-four" "Sjogren" "Sjögren"
    "Sjögren's" "Sjőgren" "Skp1" "Slattery" "Slimb" "Sluis" "Smad1" "Smad2,3"
    "Smad3" "Smad3–4" "Smad5" "Smad8" "Small-molecule" "SmartPool" "Smirnov"
    "Smuc" "Snail-1" "Snail-3" "Snir" "Sobrinho" "Sobrinho-Simões" "Sok"
    "Sol-gel" "Soucek" "South-East" "Sowa" "Sp1" "Spearman" "Spearman's"
    "Spearman’s" "SphI" "Spingosine" "Spingosine-1-phosphate" "Spitz" "Sprague"
    "SqCC" "Squibb" "Src-Tyr-418" "Src-family" "Src-mediated" "Src-signaling"
    "SrcK295M" "SrcY" "SrcY527F" "Srinivasan" "Stanford" "Starr"
    "Stat3-mediated" "StemPro" "Stemke-Hale" "Stg" "Stratagene"
    "Stress-induced" "Stromal" "Structural-functional" "Structure-function"
    "Structure–function" "Stupp" "Su" "Subnetworks" "SuperArray" "SuperScript"
    "Superaggregates" "Supriatno" "Sutherlin" "Suv39h1" "Suv39h2" "Sweden"
    "Swiss" "SwissProt" "Switzerland" "Syk-dependent" "Sylvestre" "SynGAP"
    "Synergism" "Syp1p" "T+T" "T-ALLGene" "T-ALLGenes" "T-ALLmiRNA"
    "T-ALLmiRNA-TF" "T-ALLmiRNAs" "T-Coffee" "T-HESC" "T-HESCs" "T-REx™-293"
    "T-allele" "T-cell" "T-helper" "T-lineage" "T-lymphoid" "T-lymphoma"
    "T-stage" "T-to-G" "T-tracts" "T1" "T1-weighted" "T10" "T10A" "T10D" "T13"
    "T13-dependent" "T15*con" "T1D" "T1N0" "T2" "T2-weighted" "T26*con" "T2D"
    "T2–T4" "T3" "T308" "T315I" "T389" "T4" "T41" "T41*con" "T52-G54" "T58"
    "T6" "T67" "T7" "T7-Dab2-DPF" "T7-T43" "T7-p67" "T7-p96" "T7-tagged"
    "T8*con" "T9" "T9*con" "TAAA" "TAGAGTAAATT" "TAP-MS" "TAPTag" "TATA"
    "TAU-1" "TAU-5" "TAp63-α" "TAp73" "TAp73β" "TAp73δ" "TBBz"
    "TBK1-IRF3–dependent" "TBS" "TCF-dependent" "TCF-regulated" "TCF4-mediated"
    "TCGA-13-1405" "TCGA-13-1492" "TEL-JAK2-expressing" "TELF" "TEMPS"
    "TEMPS-A" "TFBS" "TFBSs" "TFEB–3" "TFEB–GFP-positive" "TFSEARCH" "TGACGT"
    "TGACNNNGC" "TGF-βRII" "TGG" "TGGGCATGTC" "THBS1-mimetic" "THLE2" "TIF-IB"
    "TIP3P" "TIRF" "TLNSDGpYTPEPA" "TMEM45B" "TMPO" "TNF-inhibitory"
    "TNF-suppressive" "TNF-β" "TNF3" "TO" "TO-FLAG" "TOP-CAT" "TOP-FLASH"
    "TOP-Flash" "TOP10" "TOR1AIP" "TPPI" "TPPXS" "TQXF" "TRA-1-81" "TRAF1-C5"
    "TRAIL-R" "TRAIL-Rs" "TRAIL-receptor" "TRAM-l" "TRIMM" "TSA-treatment"
    "TSI" "TSPAN3" "TSQIPASEQ" "TTATGTAAACA" "TTCCCA" "TTCCGGGAA" "TTCCGGGAAN"
    "TTGC" "TTS" "TTTGATAC" "TTTGGCGC" "TUJ1" "TV" "TV-6" "TWIST" "TWIST-NuRD"
    "TWSIT" "Tagged-hits" "Tail-Suspension" "Taiwan" "Taiwanese" "Talos"
    "Tanas" "Tanya" "TaqMan" "Taraboletti" "TargetScan" "Targeting" "Tateishi"
    "Taupenot" "Tayside" "Tbx2" "Tcf" "Tcfeb" "Tecan" "Teckchandani" "Telenti"
    "Tenorio" "Tenovin" "Tenovin-6" "Tet-OFF" "Tet-Off" "Tet-On"
    "Tet-repressible" "Texas" "Tfn" "Tfsitescan" "Tg" "Th17" "Thailand"
    "Thepβ-3" "Therapy-associated" "Thermo" "Theunissen" "Thirty-nine"
    "Thirty-one" "Thirty-seven" "Thirty-six" "Thr-X-X-X-Ser" "Thr-to-Ala"
    "Thr-to-Asp" "Thr197" "Thr403" "Thr410" "Thr423" "Thyd" "Time-lapse"
    "Tinkew" "Toll-like" "Tonorio" "Top-Flash" "Topoisomerasse" "Toronto"
    "Torre" "Tourette" "Tourette’s" "Tpr-Met" "Tpr-Met-dependent"
    "Tpr-Met-mediated" "Tpr-Met-transformed" "Tra-1–80" "Trans-well" "Trevigen"
    "Tri-gas" "Trichostain" "Tricostatin" "Trifolium" "Triple-negative"
    "Triple-staining" "Tris-HCl" "Trithorax" "Triton-X" "Troger" "Trop"
    "Trop-1" "Trop-2" "Truc-2" "TrxG-PcG" "Try705" "Tsai" "Tsutsui" "Turkish"
    "Tween" "Tween-20" "Twenty-eight" "Twenty-four" "Twenty-nine" "Twenty-one"
    "Twenty-six" "Twenty-two" "Two-hybrid" "Two-thirds" "Txn" "Typhimurium"
    "Tyr-14-Cav-1" "Tyr-416" "Tyr-418" "Tyr-418-Src" "Tyr-527" "Tyr-944"
    "Tyr-to-Phe" "TΔΔS" "U-Mann" "U-STAT" "U-STAT1" "U-STAT3" "U-STAT3-GFP"
    "U-STAT92E" "U-shaped" "U1" "U118" "U2" "U20325" "U21459" "U23674" "U251"
    "U2OS-SCR18" "U4A" "U73122" "U73343" "UABCC" "UACC" "UBCs" "UBL3" "UBZ"
    "UCSC" "UDSCC2" "UKPDS" "UMDSCC2" "UMI" "UMSCC" "UMSCC-22B" "UPF0414"
    "UPF0428" "UPF0552" "UPN" "USA" "USCS" "USP7S" "USVs" "UTP23" "UTRs"
    "UV-irradiated" "UV-irradiation" "UV-sensitivity" "UVB" "UWCCC"
    "Ubiquitn-Like" "Uesugi" "Ugras" "UiSo" "Ulrich" "UniProtKB" "Uridine-Rich"
    "Utx" "UvrABC" "V-Ets" "V-shaped" "V1" "V2" "V3a" "V5" "V5-DEST" "V5-MDM2"
    "V5-PDK1" "V5-tagged" "V6" "V600E" "VACO5" "VAS" "VFSSPPSYFQQTH" "VI"
    "VIP21" "VKSE" "VLA5" "VLDL" "VP16-ERα" "VP59" "VPC23019"
    "VSV-eGFP–infected" "VTA" "VX2" "VYATCitSSAVCitLCitSSVP" "Varmus" "Vav1"
    "VavP" "VavP-MYC17" "VavP-Myc17" "Vehicle-Notch" "Velazquez" "Velos"
    "Vencken" "Venn" "Veratrum" "Vertebrata" "Vesuna" "Vidal" "Vidal’s"
    "Vietnamese" "Vina" "VirB7" "Vmax" "Vogelstein" "Volociximab" "Voskas"
    "VprX" "WA07" "WBC" "WBCs" "WCE" "WDLPS" "WHI" "WK23-MDM2" "WK23-MDMX"
    "WK298-MDMX" "WM" "WPE" "WPE1" "WPE1-NB26" "WRD5" "WST-1" "WT-CagA"
    "WT-Cav-1" "WT-Cav-1-YFP" "WT-HEK" "WT-RhoGDI2" "WT-SIRT1" "WT-eNOS"
    "WT-eNOS-CFP" "WT-seq" "WTJurkat" "WTand" "WY" "WY-354" "WYE" "WYE-354"
    "WaGa" "Waals" "Waf1" "Wallac" "Wallis" "Warburg" "Warfel" "Warrington"
    "Washington" "Watson" "Watson–Crick" "Weeder" "Weickert" "Weidner"
    "Weijenberg" "Weinberg" "Well-differentiated" "West-Friesland"
    "Western-blotting" "Wharton" "Wheeler" "Whitney" "Whole-genome" "Wiedemann"
    "Wiedermann" "Wijk" "Wilcoxon" "Wilson" "Wiscott–Aldrich" "Withney"
    "Wnt-10a" "Wnt-2b-13" "Wnt-7a" "Wnt-7b" "Wnt-8a" "Wnt-ligands"
    "Wright-Giemsa" "Wu" "X-irradiation" "X-ray" "X-rays" "X-tremeGENE" "X1"
    "X4" "X4-tropic" "XL" "XV" "XX" "XXLK" "XXXF" "Xa" "XbaI" "Xi" "Xi-mei"
    "Xiao" "Xiao-lei" "Xp11" "XpSXP" "Xq12" "Y-family" "Y1" "Y1250" "Y1349F"
    "Y1356FY" "Y14D-Cav-1-YFP" "Y14F-Cav-1-YFP" "Y2H" "Y306F" "Y419" "Y576"
    "Y845" "YAF" "YAF2-containing" "YAP1_1" "YAP1_2" "YCAAGGYCR" "YHRL" "YRA"
    "YRI" "YRPV" "YTAR" "YTMA" "YWHA" "YXNX" "YXXΦ" "YY1-binding" "Yale"
    "Yamanaka" "Yang" "Yat" "Yat-Sen" "Ye" "Yedavalli" "Yende" "Yes" "Yoo"
    "Yoon" "Yorkie" "Yoruba" "Yoruban" "Yoshimura" "Yu" "Yuille" "Yutaka"
    "YxxΦ" "Z-lines" "Z1" "ZAN75" "ZCTA" "ZCTAs" "ZFP36L3" "ZIRD-Flag"
    "ZIRD-RNAPII" "ZK" "ZK-253" "ZK-703" "ZMP" "ZN326" "ZNF326" "Zeiss" "Zhang"
    "Zhao" "Zhou" "Zhu" "Zn" "Zou" "ZsGreen" "a-TGFβ1" "aBRAF" "aCGH" "aPKCs"
    "ab66129" "abdomino" "abdomino-pelvic" "abscissa" "absorbance" "abundancy"
    "ac" "acceptor-peptide" "accumbens" "acetamidomethyl" "acetoxymethyl"
    "acetyl-coenzyme" "acetylated-lysine" "acetylation-defective"
    "acetylcholine" "acid-GlcN" "acid-related" "acid-sensitive" "acidophilicum"
    "acral" "actin-cortex" "actin-cytoskeleton" "activationdid" "activator-2"
    "activator-3" "activators" "active-site" "activites" "acto-myosin-driven"
    "acyl" "acyloxyacyl" "acylurea" "adaphostin" "adduct" "adducts" "adeno"
    "adenylate" "adenylyl" "adhesiveness" "adipogenic-origin" "advanced-stage"
    "aero" "aero-digestive" "affecteds" "affinity-capture" "ag" "agar"
    "age-associated" "age-effect" "age-specific" "aging-like" "agonist-like"
    "agonist∶receptor" "algorithm" "algorithms" "alk" "alkyl" "alkylguanine"
    "alkyls" "all-or-nothing" "allele-dose" "allelic-imbalance" "allelles"
    "allo" "allo-graft" "allo-grafts" "alpha-helix" "alpha-inhibiting"
    "alternata" "alternative-spliced" "alternatively-spliced" "altrations"
    "alveoli" "amidoalkyl" "amines" "amino-acid" "amino-terminal" "aminoacid"
    "aminoacids" "aminobutanol" "aminoglycan" "aminophenoxy" "aminopropanol"
    "amma" "amoeboid" "amoeboid-mesenchymal" "amoung" "amplicon" "amplicons"
    "amplifications" "amygdala" "anagrelide" "analyis" "analyte"
    "anaphase-telophase" "anaplasia" "anasarca" "ancer" "ancestry-informative"
    "and10" "andC" "andDmp1" "andGucy2c" "andS358A" "andSNPs" "andandheld"
    "andat" "andbetween" "andcan" "andin" "andmodulates" "andof" "andp53"
    "andromedins" "andt" "andvalues" "aneuploid" "aneuploidies" "aneuploidy"
    "angiograms" "angiopoietins" "angolensin's" "angrelide" "anisotropy"
    "anotherBRCA" "anotherBRCA1-associatedgene" "anoxia" "anslyses"
    "antagomirs" "antagonise" "antagonises" "antagonist-like" "anterograde"
    "antibodies" "antibody-toxin" "antidepressant-like" "antidepressive-like"
    "antigen" "antigens" "antiparallel" "antipsychotic-naïve" "antitumour"
    "anucleate" "anxiety-like" "apicalmost" "apico" "apico-basal"
    "apigenin-7-D-glucoside" "apigenin-7-O-beta-D-glucopyranoside"
    "apigenin-7-glucoside" "apocrine" "apomucin" "apparentK"
    "arachidonic-induced" "arisen" "armamentarium" "armentarium"
    "array-comparative" "array-expression" "arrayCGH" "arteriosus" "asHLA"
    "asHLA-DR" "associatedgene" "astroglia" "ataxia-telangiectasia-like"
    "atelocollagen" "atomoxetine" "atorvastatin-treatment" "atypia" "auhors"
    "auto-acetylated" "auto-antibodies" "auto-epitopes" "auto-feedback"
    "auto-inflammatory" "auto-inhibition" "auto-regulates" "auto-regulation"
    "auto-regulatory" "autoantigens" "autocleavage" "autoepitope"
    "autophagosome-like" "autophos" "autoradiography" "autosomal-dominant"
    "avg" "axial" "axis-independent" "axon" "azoxymethane" "a–c" "b-HLH-LZ"
    "b-HLHLZ" "b2-b3" "b5-sCLU" "bHLHZ" "bab" "background-matchedC"
    "bacterial-II-hybrid" "basal-like" "basal-to-apical" "basale"
    "basally-repressive" "base-pair" "based-residue" "basic-region"
    "bead-array" "beaklike" "begun" "benzloxy" "benzo" "benzyl" "benzyloxy"
    "benzyloxyhexanyl" "benzylsulfone" "beta-phenylethyl" "beta1-intergrin"
    "between-study" "betweenGucy2c" "betweenand" "bi" "bi-cistronic"
    "bi-directional" "bi-orientation" "bilayer" "binding-defective"
    "binding-pocket" "bioAMP" "biocharacter" "biodosimeter" "biodosimeters"
    "biodosimetry" "biolayer" "biomolecules" "biotin" "biotinoyl-5"
    "biphosphate" "bisindolmaleimide" "bisphosphate" "blastocyst" "blebb"
    "blebby" "blocker" "blockers" "blood-borne" "blood-brain" "blue-stained"
    "bone-marrow" "botanicals" "bothC" "bothPten" "botulinum" "box-plot"
    "box–containing" "brainstem" "break-apart" "breakpoint" "breakpoints"
    "broad-reaching" "broad-spectrum" "broader" "bromodeoxy" "brute-force"
    "bucca" "build-in" "build-up" "butyl" "by-product" "byBRAF" "c-Flip"
    "c-Myb-Hep27-Mdm2-p53" "c-Raf-dependent" "c4orf21"
    "cAMP-response-element-binding" "cAMPs" "cDNA" "cFLIPL" "cGy" "cJ" "cPKC"
    "cPKCs" "cPKCα" "cPTC" "caPKC" "caPKC-δ" "caPKC-δ-expressing"
    "caPKC-δ-overexpressing" "caSmad3" "caesarean" "cagPAI" "calgranulin"
    "caliper" "calorimetry" "calphostin" "calvaria" "campothecin" "canavanine"
    "cancer-relevant" "cancer-spheroids" "cancer-susceptible" "cap-dependent"
    "cap-independent" "capase-3" "capsase-8" "capsid" "carbonyl" "carboxyehtyl"
    "carboxyfluorescein" "carboxyl" "carboxyl-terminal" "carboxyl-terminus"
    "cardia" "cardio" "cardio-respiratory" "caregivers" "cargo-specific"
    "carnitine" "carotid" "carriers" "cascade–p90RSK" "case-by-case"
    "case-control" "case-only" "case-parent" "case-parents" "case-to-case"
    "case–control" "caspase-like" "catalyse" "catch-up" "catein" "catelin"
    "cathespin" "cation-and-ligand-influenced" "caveolae-like" "caveoli"
    "caveosome" "cavernosus" "caversomes" "ccRCC" "ccRCCs" "celiac"
    "cell-ablation" "cell-autonomous" "cell-autonomously" "cell-by-cell"
    "cell-cell-adhesions" "cell-cycle" "cell-cycle-checkpoint"
    "cell-directional" "cell-intrinsic" "cell-like" "cell-of-origin"
    "cell-permeable" "cell-proliferative" "cell-surface-associated" "cell-to"
    "cell-to-cell" "cell-type-specific" "cell-type–specific" "cellclones"
    "cells" "central-compartment" "centromere"
    "ceramide-sphingosine-sphingosine-1-phosphate" "cerebella" "cerebellum"
    "cerebrum" "cerevisiae" "chain-like" "chamomile" "charcoal-stripped"
    "chemi" "chemically-induced" "chemo-drug" "chemo-endocrine"
    "chemo-radioresistance" "chemo-resistance" "chemo-sensitivity"
    "chemo-therapy" "chemoattractant" "chemoendocrine" "chemoimmunotherapy"
    "chemoprophylaxis" "chemoradiotherapy" "chemoresistance" "chemoresistant"
    "chemotherapy-naïve" "chemtoattractants" "chi-square" "chi-squared"
    "chiasm" "chlorophenyl" "chlorpheniramine" "cholecystectomy"
    "cholesterol-rich" "choroids" "chosen" "chr" "chrX" "chromaffin"
    "chromatid" "chromatin-immunoprecipitation" "chromatin-remodeling"
    "chromophobum" "chromosome–positive" "chromosome–spindle" "cicloheximide"
    "cingulate" "circadian-driven" "circuitries" "circuitry" "circumin"
    "cis-eQTL" "cis-eSNP" "cis-eSNPs" "cis-regulatory" "cispatin" "cistrome"
    "clade" "clades" "classifiers" "clathrin-dependant" "claudin-1was"
    "clear-cut" "clearer" "clinical-grade" "clinical-pathological"
    "clinically-relevant" "clinicians" "clinico" "clinico-pathologic"
    "clinico-pathological" "closely-related" "cluster-like" "coIP"
    "coaccumulate" "coactivator-3" "coactivator-receptor" "coagulant" "codon"
    "codon-by-codon" "codons" "coeruleus" "coex" "coex-pression" "coil-like"
    "coiled-coil" "colectomy" "coli" "collagens" "colocalise" "colonises"
    "colonoscopy" "colony-forming" "colorectum" "commercially-available"
    "commonalities" "commonest" "commonly-occurring" "community-based"
    "comorbid" "compartment-specific" "completely-spliced" "computer-based"
    "concentration-dependant" "conditionally-activated"
    "conformationally-distinct" "conformers" "confounder" "confounders"
    "conjunctiva" "consequences" "consortium-based" "constipation-type"
    "constitutively-activated" "contact-inhibited" "containLAT"
    "context-specificity" "continuum" "control-correction" "copy-loss"
    "copy-neutral" "copy-number" "copynumber" "cord-derived" "corectopia"
    "coregulator-receptor" "cosmetin" "cost-benefit" "cost-effective"
    "counter-evidence" "counter-intuitive" "counter-screening" "counterions"
    "country-specific" "covariate" "covariates" "coworkers" "coxsackievirus"
    "cranio" "cranio-spinal" "cribriform" "criticalvalues" "cross-checked"
    "cross-communicate" "cross-compartmental" "cross-inhibition" "cross-linker"
    "cross-linkers" "cross-peaks" "cross-react" "cross-reacted" "cross-reacts"
    "cross-regulatory" "cross-sectional" "cross-sectionally" "cross-tissue"
    "cross-transactivation" "crossover" "crypt-surface" "crypt-villus"
    "cut-off" "cut-point" "cuvette" "cyan" "cyclic-di-GMP" "cyclo"
    "cyclohexamide" "cycloheximide-chase" "cylinD1" "cystectomy" "cyto"
    "cytoarchitecture" "cytochome" "cytohesin" "cytohesin2" "cytokine-1"
    "cytokine-like" "cytology" "cytopathologists" "cytoscape"
    "cytoskeletal-associated" "cytotrophoblasts" "dA" "dA-dT" "dCCM" "dEBS2"
    "dEBS3" "dEBS6" "dETS3" "dETS4" "dETS5" "dFoxO" "dG" "dKdm2" "dL" "dRAF"
    "dSESN" "dT" "dada" "damage-associated" "damage-induced" "damage-inducing"
    "damage-responsive" "damage–independent" "damage–induced"
    "damage–inducible" "data-base" "dataset" "datasets" "dbSNP" "dcAMP"
    "de-adhesion" "de-differentiate" "de-differentiated" "de-hypermethylation"
    "de-novo" "de-phosphorylator" "de-regulation" "de-represses"
    "de-repression" "de-stabilize" "de-ubiquitinase" "deacetylase-deficient"
    "deacytalases" "decamer" "decouple" "dedifferenciate" "deep-seated"
    "deeper" "deepest" "degradation-resistent" "degree-of-freedom" "degron"
    "dehydrogenases" "dehydrogense" "del81E" "deletion-mutant" "deletions"
    "dense-core" "densitometer" "density-dependent" "denticleless"
    "deoxynucleotide" "deoxyuridine" "dephosphorylators" "depressant"
    "depression-like" "depressive-like" "der" "derepress" "desmoplasia"
    "destabilizers" "detangles" "detergent-insoluble" "detriments"
    "developmentally-restricted" "developmentally-timed" "df "
    "diaminobenzidine" "dibutyryl" "dichroism" "diet-microbiome-host"
    "differentiatedNf1" "differentiation-inducers" "differentvalues"
    "dihydrochloride" "dihydrodiol" "dihydrodiols" "dihydropteridinone"
    "dihydroxyphenyl" "diisopropylethylamine" "dileucine" "dimaprit" "dimmers"
    "dinucleotides" "dioleoyloxy" "diphenylfuropyrimidine"
    "diphenylfuropyrimidines" "diphosphate" "diploid" "directlywith" "dis"
    "dis-contiguous" "discrepant" "disease-specificity" "disorderd"
    "dispase-based" "displayng" "disquilibrium" "disruptants" "disrupter"
    "distance-dependent" "dithiobis" "dnErk1" "dnPKC" "dnPKC-δ" "dnPKC-δ#1"
    "dnPKC-δ#2" "dnPKC-δ-expressing" "dnPKC-δ-overexpressing" "doi"
    "domain-PDZ" "domain-ligand" "dominant-negative" "dominant-negative-Stat3"
    "dop53" "dopamine-β-hydroxylase" "dorsal-lateral" "dose-and" "dose-course"
    "dose-dependently" "dose-escalation" "dose-intensive" "dose-limitations"
    "dose-limiting" "dose-rate" "dose-response" "dose-sensitive" "double-blind"
    "double-immunofluorescence" "double-knockout" "double-mutant" "double-null"
    "double-strand" "doubly-mutated" "down-activation" "down-modulated"
    "down-modulates" "down-modulation" "down-stream" "downfield" "doxycyline"
    "dprohibitins" "drawn" "drinkers" "droplets" "drug-naïve" "drug-saturable"
    "dsDNA" "dsRedII" "dual-inhibitory" "dual-specific" "ductoscopy" "duplexes"
    "dyslipidemia" "dysphagia" "dysplasia" "dysplasias" "dεA" "e-261"
    "eGFP-ICP0-T67A" "eIF2-GTP" "eIF2α-GDP-eIF2B" "eIF2α-bound"
    "eIF2α-holophosphatase" "eIF2α-stress" "eIF2αS51A" "eIF2αS51D"
    "eNOS-S1177A-CFP" "eNOS-S1177D-CFP" "eNOS–Ser-1177" "eNOS–cyan" "eachvalue"
    "early-onset" "early-stage" "ectoderm" "ectodomain" "ectodomains"
    "ectopically-expressed" "effecter" "eightfold" "eitherC" "eitherPb"
    "eitherPb-C" "ele" "electron-dense" "electrospray" "element-binding"
    "element-dependant" "elements" "eluate" "eluates" "em" "embryoid"
    "encephalomyelitis" "encephalomyocarditis" "end-amplification"
    "end-effects" "end-stage" "end-target" "endocrine-metabolic" "endoderm"
    "endogenousp21" "endolysosome" "endometria" "endometrioid"
    "endosalpingeal-derived" "endothall" "endpoint" "endpoints" "ene"
    "enterica" "enterocolitica" "enteroendocrine" "enterotoxins" "enthalpy"
    "entropies" "entropy" "entry-exit" "enzyme–substrate" "eosin"
    "eosinophilia" "epidermoid" "epigenetically-silenced" "epigenome"
    "epiphenomenon" "epithelia" "epithelial-derived" "epithelial-like"
    "epithelial-mesenchymal" "epithelial-origin" "epithelial-stromal"
    "epithelial-to-mesenchymal" "epithelial–mesenchymal" "epithelio"
    "epithelio-mesenchymal" "epithelioid" "epithelium" "epitheliums"
    "equipments" "erithematosus" "erythroblastopenia" "erythrocytes"
    "establishedby" "estrogen-like" "et" "eta" "etheno" "etheno-DNA"
    "eucaryotes" "eukaryots" "eukemia" "eural" "ever-changing"
    "evolutionarily-conserved" "ew" "exocrine" "exocrinopathy" "exograft"
    "exome" "exon-1" "exon-14" "exon-2" "exon-intron" "exon-junction"
    "exon-specifically" "exons" "exon−2" "exon−2a" "exosome" "exosome-like"
    "expansion-associated" "experimentally-generated" "explant" "explants"
    "expressers" "expressio" "extra-embryonic" "extra-genic" "extra-hepatic"
    "extra-intestinal" "extra-nuclear" "extrathyroid" "extrauterine"
    "extravasate" "extrinsically-activated" "exudates" "fIGF1" "facies"
    "factor-2" "factor-kappa-B" "fail-safe" "failsafe" "falciparum"
    "false-positives" "far-reaching" "far-upstream" "farnesyl"
    "father-to-offspring" "fc" "fear-discrimination" "fecal" "feed-back"
    "feed-forward" "feedback-regulatory" "feeding-tube" "femaleK14cre" "femora"
    "ff99SB" "fibroblast-like" "fibroblastoid" "fibronectin-TG2" "field-effect"
    "fill-in" "filter-grown" "fine-specificities" "fine-specificity"
    "fine-tune" "fine-tunes" "fine-tuning" "first-choice" "first-degree"
    "first-in-class" "first-line" "first-order" "first-pass" "five-year"
    "fixedvalue" "fixedvalues" "flag-Gli1S84A" "flag-tagged-GADD34" "flankings"
    "flavonoid" "flavonoids" "flip-flop" "flowchart" "fluorescent-conformation"
    "fluorescently-labeled" "fluorodeoxyglucose" "fluorophore" "fluvastatin"
    "folic" "follicle" "follow-up" "followed-up" "followup" "follow–up"
    "foodborne" "forare" "forebrain" "forebrain-specifically" "fork-head"
    "forkead" "formazan" "forty-eight" "fossa" "four-and-a-half" "four-gene"
    "four-stage" "fractionof" "frameshift" "free-keratinocyte" "fresh-frozen"
    "freshly-thawed" "fromArf" "fromC" "fromDmp1" "fromPb" "fromPb-C" "fucosyl"
    "full-thickness" "fully-functional" "fumarate" "function-1" "fundus"
    "fungal-host" "fungoides" "fusion-positive" "gDNA" "gDNAs" "gain-of"
    "gain-of-function" "gallbladder" "gasteroentiritis" "gastrectomy"
    "gastric-cancer-related" "gastro" "gastro-esophageal" "gastro-intestinal"
    "gastrokines" "gatekeeper" "gb" "gcauuaa" "gel-filtration" "gel-like"
    "gel-shift" "gene-I" "gene-chip" "gene-dose" "gene-environment"
    "gene-environmental" "gene-gene" "gene-regulatory" "generateC"
    "generatedinto" "genes" "genetics-based" "genetic–environment" "genic"
    "genitalia" "geno" "geno-toxic" "genome" "genome-wide" "genomewide"
    "genomic-aberration" "genomic-control" "genotype" "genotype-dose"
    "genotype-phenotype" "genotypes" "geranyl" "geranyl-geranyl"
    "geranylgeranyl" "germ-like" "germ-line" "germline" "getfitnib"
    "glandularatrophy" "glia" "globular-like" "glucoronide"
    "glucose-6-phosphorylating" "glucose-dependence" "glucuronidases"
    "glutamylcystein" "glutathione-Sepharose" "glutathione-agarose"
    "glutathione–Sepharose" "glycan" "glycans" "glycemia" "glycerol-gradient"
    "glycoso" "glycoso-aminoglycan" "glycosoaminoglycan" "glycosoaminoglycans"
    "glycosyl" "goes" "gonadotropinomas" "gonads" "gone" "gp-can"
    "gp-proficient" "gp41CD" "gp41CDs" "graft-versus-leukemia" "grandiflorum"
    "granin" "greater" "greatest" "green-red" "guanylate" "gut-associated"
    "h-ALKF1174L" "h-ALKWT" "h-TERT-immortalized" "h-mCherry" "hCLU" "hE-cad"
    "hESC" "hESCs" "hGBM13" "hGBM2" "hGBM3" "hGBM6" "hGBM8" "hGBM9" "hH23Ra"
    "hHR" "hHR23a-bound" "hIPCs" "hKrt18" "hNPC" "hNPCs" "hNS1" "hNS1-mock"
    "hRANKL-Luc" "hRANKL-luciferase" "hSel10" "hTERT-HPNE" "hTGP" "hUCBSC"
    "halenaquinone" "half-life" "half-lives" "half-maximal" "half-maximum"
    "half-site" "halfsite" "hampster" "haplo" "haplo-insufficiency"
    "haplo-insufficient" "haplotype" "haplotypes" "haplotype " "hapolotypes"
    "hdcA" "hdcP" "head-and-neck" "head-to-tail" "heat-induced"
    "heat-regulated" "heat-responsive" "heat-shock" "heat-stable" "heat-stress"
    "heat-treated" "heatmap" "heavier" "heavily-pre-treated" "heavy-chain"
    "helicase-like" "helices" "helix" "helix-loop-helix"
    "helix-loop-helix-like" "helixes" "hellebore" "hematocrit" "hemidimers"
    "hepatectomy" "hepatoblastomas" "hepatocyte-derived" "hereto-unrecognized"
    "heter" "heter-oligomerize" "hetero-oligomers" "heterochromia"
    "heterocomplex" "heterodimer-selectivity" "heteroduplex" "heteromers"
    "heterotetramers" "heterotrimer" "hexakisphosphate" "hexanucleotides"
    "hexanyl" "hg18" "hg19" "hiPSCs" "hidden" "high-affinity" "high-amplifier"
    "high-amplifiers" "high-cholesterol" "high-concentration" "high-content"
    "high-density" "high-dose" "high-efficiency" "high-endothelial"
    "high-frequency" "high-grade" "high-incidence" "high-level" "high-levels"
    "high-penetrance" "high-quality" "high-resolution" "high-risk" "high-titer"
    "high-white" "higher-affinity" "higher-order" "higher-treatment"
    "highly-related" "hilum" "hinderance" "hippocampal-dependent" "histadine"
    "histamine-N-methyl" "histologies" "histology" "histomorphology"
    "histopathology" "histoscore" "histospot" "histospots" "histotypes"
    "hnRNPE" "hoc" "holo" "holo-enzyme" "homeoprotein" "hominoid"
    "hominoid-lineage" "homo-dimers" "homoduplexes" "homogenates" "homohexamer"
    "homolog" "homologs" "homopurine" "homozygote" "homozygotes"
    "homozygous-deleted" "hormonally-responsive" "hormone-immunonegative"
    "hormone-receptor" "hospho" "host-defense" "host-derived" "host-generated"
    "host-microbe" "host-pathogen" "host-specific" "hot-spots" "hotspot"
    "hotspots" "hr" "hsa-miR-139-5p" "hsa-miR-140-3p" "hsa-miR-143"
    "hsa-miR-145" "hsa-miR-15b" "hsa-miR-183" "hsa-miR-18a" "hsa-miR-18b"
    "hsa-miR-34b" "hsa-miR-34c-3p" "hsa-miR-34c-5p" "hsa-miR-590-5p"
    "hsa-miR-96" "hsa-miR590-5p" "hsa-mir-140-3p" "human-GST-fused"
    "hydrochinone" "hydrophobic-motif" "hydroxybenzotriazole" "hydroxyethyl"
    "hydroxyhexanyl" "hydroxyl" "hydroxymethyl" "hydroxyphenyl"
    "hydroxypropylmethylcellulose" "hydroxytamoxifen" "hyper" "hyper-activity"
    "hyper-proliferation" "hyper-proliferative" "hyperandrogenism"
    "hyperchromasia" "hyperdiploidy" "hyperinsulinemia" "hyperinsulinism"
    "hyperploid" "hyperploidy" "hyperresponsiveness" "hypersensitizes"
    "hypo-aggregation" "hypodense" "hypopharynx" "hypospadia" "hypothese"
    "hypotheses" "i.e.CXCL8" "iGFP" "iIlness" "iPDK" "iPDK1-tide" "iPMSC"
    "iPMSCs" "ice-cold" "icro" "idoxifene" "ie" "ifosphamide" "ii" "iii" "ij"
    "ileum" "ill-defined" "imidazo" "imidazole" "imidazoquinazoline"
    "immediate-early" "immune-associated" "immune-complex" "immune-mediated"
    "immune-related" "immuno" "immunochemistry" "immunocomplex"
    "immunocomplexes" "immunocytochemistry" "immunodominant" "immunoglobulin"
    "immunoglobulin-like" "immunogold" "immunohistochemistry" "immunomodulin"
    "immunomodulins" "immunopathology" "immunoprecipitation-quantitative"
    "immunoresponse" "immunostainings" "immuno–electron" "imperfecta"
    "implications" "importin-beta" "importin-α" "imunohistochemistry"
    "in-depth" "in-frame" "in-house" "in-silico" "in-situ" "in-solution"
    "in-vitro" "inArf" "inAtm" "inCav1" "inDNA" "inDmp1" "inFbxw7" "inGuca2a"
    "inGucy2c" "inHCT116" "inHIV" "inK-ras" "inNf1" "inPten" "inTrp53" "inc"
    "incisura" "indels" "independant" "individuals" "induciblePten"
    "inefficacy" "infacilitat" "infection-associated" "inflammation-associated"
    "inflammation-induced" "inflammation-related" "infranatants" "inger"
    "inhalant" "inhibiton" "inhibitor-BIO" "inhibitor-MDM2"
    "inhibitor-receptor" "inhibitor-residue" "inhibitors"
    "inhibitors-of-apoptosis" "initio" "inositol-1,4" "insertions" "inside-out"
    "instability-high" "insulin-dependent" "insulin-induced" "insulin-like"
    "insulin-responsive" "insulin-sensitive" "insulin-stimulated"
    "insulin-treated" "int" "intactness" "integrin-cell" "integrin-pathway"
    "integrin-treatments" "integrin-β6" "integrin-β7" "inter-MAR"
    "inter-domain" "inter-kingdom" "inter-relationship" "inter-tumoral"
    "interactants" "interactome" "interdomain" "interferometry"
    "interferon-response" "intergrin" "internet" "interobserver"
    "interquartile" "interstrand" "intersubunit" "interwoven" "intestinal-type"
    "intra" "intra-colony" "intra-epithelial" "intra-luminal"
    "intra-molecularly" "intra-uterine" "intra-vascular" "intradomain"
    "intrastrand" "intravasate" "intrinsically-disordered" "intron-1"
    "intron-less" "intronless" "inute" "invG" "invadopodia-like"
    "invadopodial-like" "invaginate" "invaginations" "invariant"
    "inverse-variance" "iodoacetamide" "iodotubercidin" "ionic" "ipid"
    "irradiation-induced" "ischemia-reperfusion" "iskott" "islet-derived"
    "islet-like" "isoform-distinct" "isomer" "isopeptide" "isoprenyl"
    "isoprenylation-mediated" "isopropyl" "isotope-based" "isotype" "isotypes"
    "isozyme" "isozymes" "iv" "job-exposure" "junction-associated" "k-means"
    "k136" "k175" "kappa-B" "karyotype" "karyotypes" "kb-long" "kbp" "kcal"
    "kcal·mol" "keratynocytes" "keto" "kg" "ki-67" "kinase-2" "kinase-A"
    "kinase-substrate" "kinase-ε" "kinase1" "kinome" "klotho-beta" "knock-down"
    "knock-downs" "knock-in" "knocked-down" "lL-7" "lactone" "lactose"
    "lamin-A" "lamina" "laminopathies" "lane3" "lane7" "laparoscopy"
    "laparotomy" "large-array" "large-cell" "large-scale" "laser-capture"
    "late-phase" "late-stage" "latters" "ldrich" "leading-edge" "learnt"
    "leckstrin" "left-handed" "left-right" "lentiviral-mediated"
    "leukocyte-endothelial" "lid-stabilizing" "life-long" "life-time"
    "lifespan" "ligand-13" "ligands-PTCH1-SMO" "ligase–substrate" "like-domain"
    "limbus" "linaclotide" "linages" "lincRNA-p21" "line-widths"
    "lineage-dependent" "lineage-negative" "lineage-specific" "lineages"
    "liopafectamine" "lipid-laden" "lipofectamine" "lipofectimine"
    "lipoplysaccharide" "lipopolysaccaride" "lipopolysacccharide"
    "lipopolysaccharide" "lipoproteins" "liposome" "littermate" "littermates"
    "lo" "lobectomy" "lobules" "loco-regional" "locus-locus" "log-linear"
    "log-phase" "log-scale" "log-transformed" "log2" "long-distance"
    "long-half" "long-lived" "long-range" "long-standing" "longer-lived"
    "longer-term" "loss-and-gain" "loss-of-function" "louder" "low-BRCA1"
    "low-affinity" "low-concentration" "low-density" "low-dose"
    "low-expressing" "low-grade" "low-incidence" "low-invasive" "low-level"
    "low-levels" "low-malignant" "low-miR-19" "low-moderate" "low-nanomolar"
    "low-passage" "low-penetrance" "low-risk" "low-stringency"
    "low-to-moderate" "low-to-moderately" "low-to-moderately-amplified"
    "lower-grade" "loxp" "lp-DLG" "lpr" "lumens" "luminal-like"
    "luminally-differentiated" "lymph-node" "lymphadectomy" "lymphadenectomy"
    "lymphoblastoid" "lymphoblasts" "lymphoma-extra" "lymphotoxin"
    "lysine-less" "lysine-to-arginine" "lysis" "lysosome-like"
    "lysosome-to-nucleus" "m-isoform" "mAKT1" "mATF" "mATF2" "mEPSC" "mEPSCs"
    "mESCs" "mHMS6" "mRFP" "mRFP–Rab7" "mRFP–Rab7-positive" "mRNA" "mSIN3A"
    "mTLE1" "mTOR-C2" "mTOR-pathway" "mTORC1-S6K-mediated" "mTORS" "mTORS2035T"
    "mTeSR1" "mTesr1" "macro-metastases" "macrophage-1" "macrophage-tropic"
    "macrophsges" "macropinsomes" "macroprolactinomas" "maintainance"
    "male-to-female" "maligna" "mammalian-two" "manic-like" "mappings"
    "mastectomy" "master-regulatory" "matchedC" "maternally-mediated"
    "matrix-attached" "maturation-separation" "means±S" "mechano" "medulla"
    "mega-Dalton" "melanogaster" "mellitus" "membrane-permeable"
    "membrane-proximal" "memory-impairing" "memory-related" "menin-null"
    "menin-partner" "mesenchymal-amoeboid" "mesenchymal-associated"
    "mesenchymal-epithelial" "mesenchymal-like" "mesenchymal-origin"
    "mesenchymal-to-epithelial" "mesenchyme" "mesendoderm" "mesentery"
    "meshwork" "mesoderm" "mesonephros" "mesothelium" "message-2" "mestizo"
    "meta-static" "metabolic-regulated" "metallo" "metalloproteinase-1"
    "metaphase-anaphase" "methanesulphonate" "methoxyphenyl" "methyl-sulfate"
    "methyl-β-cyclodextrin" "methyladenine" "methylation-specific"
    "methylcytosine" "methylene" "methylene-5THF" "methylguanosine"
    "mevalonate" "miR-101" "miR-106b" "miR-122" "miR-122-regulated" "miR-124"
    "miR-125" "miR-128" "miR-128-expressing" "miR-128-inhibited" "miR-133b"
    "miR-138" "miR-140-3p" "miR-141" "miR-143" "miR-145" "miR-146a" "miR-147"
    "miR-155" "miR-155-induced" "miR-155–mediated" "miR-17" "miR-17-5p"
    "miR-17-92" "miR-17–92" "miR-180a" "miR-181" "miR-181b" "miR-19"
    "miR-19-CYLD-NF-κB" "miR-190" "miR-193" "miR-193a-3p" "miR-195" "miR-196b"
    "miR-19a" "miR-19b" "miR-19b-1" "miR-200b" "miR-20a" "miR-214" "miR-217"
    "miR-218" "miR-223" "miR-26" "miR-27a" "miR-30e" "miR-31" "miR-330-3p"
    "miR-34" "miR-421" "miR-424" "miR-433" "miR-451" "miR-483-3p" "miR-483-5p"
    "miR-485-5p" "miR-488" "miR-511" "miR-512-3p" "miR-517c" "miR-518a-3p"
    "miR-518b" "miR-518e" "miR-519a" "miR-520g" "miR-522" "miR-525-3p"
    "miR-582" "miR-592" "miR-709" "miR-92a-1" "miR-SCR-expressing" "miR126"
    "miR2Disease" "miRGen" "miRNA" "miRNA-125b" "miRNA-138" "miRNA-17"
    "miRNA-181" "miRNA-181a" "miRNA-218" "miRNA-221" "miRNA-TF" "miRNA–gene"
    "miRNome–protein" "miRWalk" "miRanda" "micro-adenomas" "micro-metastases"
    "micro-satellite" "micro-vascularization" "microRNA" "microRNA-146a"
    "microRNA-223" "microRNA–mRNA" "microbial-derived" "microbiota"
    "microdomains" "microform" "microg" "microglialcells" "micrographs"
    "micrometastases" "microsatellite" "microsatellites" "microscale"
    "microvasculature" "microvessel" "microvessels" "midbrain" "midface"
    "midline" "mini-meta" "mini-review" "minimise" "minute-2" "mir" "mir-145"
    "mir-155’s" "mir-17-92" "mis-localization" "mis-localizations" "mis-sense"
    "misbalance" "mismatch-repair" "missense" "mitomycin"
    "mitomycin-containing" "mitoses" "mitotracker" "mm9" "mmLDL"
    "mock-infected" "mock-transduced" "mock-treated" "mock-treatments"
    "mode-of-action" "modulateactin" "molecues" "molecules" "mono-electronic"
    "mono-methylated" "mono-methylates" "mono-methylation"
    "mono-methylguanosine" "mono-molecular" "monocyte-derived"
    "monocyte-specific" "monocytogenes" "monocytoid" "monodisperse" "monolayer"
    "monomethyl" "monophosphate" "monotherapies" "monotherapy"
    "mood-stabilizing" "more-than-random" "mortem" "mortems"
    "most-well-characterized" "mot" "mother-to-offspring" "motif–containing"
    "motile" "moue" "mt" "mtconstruct" "mucosa" "multi-cellular"
    "multi-component" "multi-disciplinary" "multi-ethnic" "multi-functional"
    "multi-gene" "multi-institutional" "multi-layer" "multi-level"
    "multi-locus" "multi-modal" "multi-modality" "multi-nucleation"
    "multi-organ" "multi-step" "multi-subunit" "multi-ubiquitin" "multicenter"
    "multidomain" "multigene" "multilevel" "multimers" "multiorgan"
    "multiparameter" "multiplatform" "multiple-case" "multiple-organ"
    "multiple-testing" "multiprotein" "multispecies" "multistage"
    "muropeptides" "muscle-invasive" "musculature" "mushroom-like" "mut53"
    "mutARE" "mutation-detection" "mutation-like" "mutation-was" "mutations"
    "mutp53" "myc-BirA*LaA" "myc-hHR23a" "mycBirA*LaA" "myeloproliferatine"
    "myocytes" "myofibroblast-like" "myometrium" "myosin-I" "myrAkt-ER"
    "myristate" "myristoyl" "myxoid" "n-butyl" "n=0" "n=1" "n=10" "n=15"
    "n=195" "n=20-28" "n=21" "n=28" "n=29" "n=3" "n=33" "n=35" "n=4" "n=50"
    "n=6" "n=76" "n=8" "nAChR" "nGAAn" "nM–10" "nPKC" "nPKCs" "nPKCθ" "nSH3"
    "nSH3-SH2-cSH3" "nano" "nano-LC" "nanomolarK" "nasopharyngitis"
    "nasopharynx" "native-state" "naturally-occurring" "naïve" "near-complete"
    "near-endogenous" "near-neighbor" "near-neighbors" "near-normal"
    "near-total" "nearest" "nearly-orthogonal" "necropsy" "neg"
    "negative-control" "neitherC" "neo-enhancer" "neoadjuvant" "neocortex"
    "neoformans" "neointima" "neoplasias" "neoplasmas" "neoplastic-initiated"
    "netrin" "network-analysis" "network-based" "neural-like" "neural-specific"
    "neurite" "neuro" "neuro-oncology" "neurodegeneration-associated"
    "neuroendocrine" "neuromodulators" "neuronal-like" "neuronal-specific"
    "neurooncology" "neuropathology" "neurosphere" "neurospheres"
    "neurotransmission-related" "neutrohil" "neutropenia" "neutrophil-like"
    "never-medicated" "never-smoker" "never-smokers" "never-smoking" "newer"
    "newly-identified" "next-generation" "nitroarginine" "nl" "nmod" "nmrPipe"
    "nocadazole" "nocadozole" "nodules" "nomograms" "nonTreg" "noncardia"
    "noncarida" "noncell" "noncell-autonomous" "nonhistone" "nonimmune"
    "nonlymphoid" "nonraft" "nonrandom" "nonsignificant" "nonusers" "nopol"
    "noradrenalin" "normal-like" "normal-mode" "normal-sized" "normal-to-tumor"
    "normals" "novelty-induced" "nsSNVs" "nt" "nuclear-to-cytoplasmic"
    "nucleases" "nucleo" "nucleolar-spindle-associated"
    "nucleotide-binding-and-oligomerization" "nucleotide-excision" "nullPten"
    "n " "n = 10" "n = 15" "n = 3" "n = 4" "n = 8" "ob" "oblongata"
    "observer-independent" "ocause" "occludens-1" "occurrs" "octahedron"
    "octamers" "odds-ratios" "odorant" "oestrogen" "ofC" "ofCXCR2" "ofFbxw7"
    "ofGucy2c" "ofPten" "ofTP53" "ofat" "off-target" "off-targeting"
    "off-targets" "ofper" "ofpβ-3" "often-fatal" "often-times" "oil-treated"
    "oligo-anovulation" "oligo-deoxynucleotide" "oligodeoxynucleotide"
    "oligofectamine" "oligopyrimidine" "olocumicine" "oloumicine" "omain"
    "omology" "omomyc" "on-plate" "on-target" "on-treatment" "oncogenes"
    "oncomiR" "oncomiRs" "one-armed" "one-carbon" "one-cell" "one-dimensional"
    "one-half" "one-phase" "one-second" "one-step" "one-third" "one-way"
    "one-year" "only-2" "oocytes" "oophorectomy" "open-field" "open-label"
    "operon" "ophthalmology" "opportunities" "orDmp1" "orPb" "orPb-C"
    "orangutan" "orbitrap" "organelles" "organs" "oropharynx" "orp53"
    "ortholog" "orthologues" "osteoblasts" "osteology" "otch" "otic" "ouble"
    "outside-in" "ovariectomy" "over-activated" "over-activation"
    "over-conservative" "over-dominant" "over-energetic" "over-growth"
    "over-night" "over-proliferation" "over-protection" "over-representation"
    "over-representative" "overabundance" "overexpressors" "overridden"
    "overtaken" "overview" "oxaloplatin" "oxan" "oxan-2-yl" "oxychromen"
    "oxychromen-4-one" "oxygenase-1" "p-Ser-1177" "p100–Fbxw7α" "p110a"
    "p18Bax-α" "p21-null" "p21Bax-α" "p220-associated" "p220-dependent"
    "p220-expressing" "p220-expression" "p220-infected" "p220-mutant"
    "p220-negative" "p220-overexpressing" "p220-silenced" "p220-silencing"
    "p37δ" "p38K" "p38MAPK" "p38MAPKs" "p38β" "p4EBP1" "p53-8KR" "p53-ZsGreen"
    "p53-association" "p53-bindig" "p53-interaction" "p53-network" "p53-null"
    "p53-status" "p53175H" "p53K373ac" "p53R175H" "p53R175P" "p53RE" "p53RE1"
    "p53RE2" "p53REs" "p53WT" "p53wt-positive" "p63-null" "p63RE"
    "p70S6K1downstream" "p73-transcriptional" "p85a" "p85α" "p96-specific"
    "p96-ΔC" "p=0.0001" "p=0.0004" "p=0.0008" "p=0.001" "p=0.0014" "p=0.002"
    "p=0.004" "p=0.005" "p=0.006" "p=0.007" "p=0.009" "p=0.02" "p=0.0201"
    "p=0.0223" "p=0.03" "p=0.034" "p=0.035" "p=0.04" "p=0.0432" "p=0.05"
    "p=0.06" "p=0.09" "p=0.11" "p=0.15" "p=0.24" "p=0.2446" "p=0.27" "p=0.28"
    "p=0.59" "p=0.69" "p=1" "p=1.12×10" "p=2.3×10" "p=3" "p=3.3×10" "p=4.4×10"
    "p=5.2×10" "p=5.7×10" "p=9.8×10" "p=NS" "pAkt–Thr-308" "pBabe" "pCBP"
    "pCBP1-4" "pCBP2-silenced" "pCMV-c-MetmiRNA-825" "pCMV-c-MetmiRNA-neg"
    "pCMV5" "pCR" "pCR3.1-ERα" "pEGFP-C3" "pEGFP-C3-PinX1" "pEGFP-Nrf2" "pEGFR"
    "pET28b" "pEV" "pErk1,2" "pFAK" "pFOXO3a" "pG5-Luc" "pGAS-TA-Luc" "pGEM-T"
    "pGEX" "pGEX2T" "pGEX4T" "pGEX6P-1" "pGL3-332ESR1-Pro-Luc" "pGL3-Basic"
    "pGL3-Pro" "pGL3-Pro-Luc" "pGL3-SV40" "pGL3-basic" "pGL3-exon-2e"
    "pGL3-luc" "pGL3-promoter" "pGL3-promotor" "pGL3-β" "pGSK" "pGsk3β" "pHGG"
    "pH " "pIGF-1R" "pI∶C" "pJAK2" "pJAK2V617F" "pJNK" "pLIMK1" "pLPCX-Smad8"
    "pLZR" "pLZR-BJ" "pLZR-IRES-EGFP" "pLZR-mock" "pLe-miR-128-expressing"
    "pLenti6" "pM" "pM+IL-6" "pM+anti-α5β1" "pM+pIL-6" "pM+pM-FL-A141G"
    "pM+rhMMP-2" "pM-2" "pM-FL-A141G" "pM-transfection" "pM-treatment" "pMIR"
    "pMIR-REPORT" "pMLC" "pMXs" "pMyr" "pP70S6K" "pRL-SV40" "pS" "pS14" "pS17"
    "pS17-Nbz" "pS241-PDPK1" "pS280" "pS409" "pS473-Akt" "pS64" "pSS16"
    "pSTAT3" "pSTAT5" "pSV+pIL-6" "pSV-1" "pSV-2" "pSV-treatments" "pSXXT" "pT"
    "pT+1" "pT+3" "pT-3" "pT13" "pT13 " "pT3" "pT308-Akt" "pT555" "pT555-aPKC"
    "pT64" "pT67" "pTRG" "pTyr-14-Cav-1" "pTyr-418-Src" "pUC8" "pUC8F14C"
    "pUSP7S" "pVHL-competent" "pVHL-defective" "pY-2" "pY944" "pY944-specific"
    "pYTPEP" "pYXN" "pack-years" "pair-wise" "paired-end" "pairwise"
    "pan-AKT-1" "pan-Aurora" "pan-acetylation" "pan-genomic" "pan-neuronal"
    "pan-specific" "pancreatitis" "pannus" "para-aortic" "paracrine" "paralog"
    "paralogues" "paremeters" "parenchyma" "parent-of-origin" "parotid"
    "partenolide" "particulate" "partim" "pasA" "pasB" "patho" "pathoetiology"
    "pathogen-associated" "pathogen-containing" "pathogen-induced"
    "pathophysiology" "pathway-either" "pathways" "patient-by-patient"
    "patietns" "patrollers" "pattern-recognition" "pcDNA" "pcDNA3-CXCR2"
    "pcDNA3.0" "pcDNA5" "peak-width" "penetrance" "penetrant" "penile"
    "pentostatin" "peptidases" "peptide-pocket" "peptides" "peptidoglycan"
    "peptidylarginine" "peptidylcitrulline" "per-residue-based" "perhaps"
    "peri-centrosomal" "peri-vascular" "perimetry" "peritoneal-blood"
    "peritoneum" "perlecans" "pg–0.2" "pharmacophore" "pharmacotherapy"
    "phase-activation" "phenomenons" "phenyl" "phenylethyl" "phopho"
    "phopho-Smad1" "phophotyrosine" "phosphagen" "phosphatidylinositide"
    "phosphatidylinositide-3-kinase" "phosphatidylinositol-3-OH"
    "phosphatidylinositol-3-phosphate" "phosphatidylinotisol" "phosphine"
    "phospho-Ser-280" "phospho-Thr-628" "phospho-Tyr-14" "phospho199"
    "phosphoERK1" "phosphoPKA" "phosphoPKB" "phosphoPKB-substrate" "phosphoSer"
    "phosphoThr" "phosphoamino" "phosphoantibodies" "phosphoantibody"
    "phosphodegron" "phosphohistone" "phosphoinositides" "phosphoinositol"
    "phosphonacetyl" "phosphopeptide" "phosphopeptides" "phosphor-PKA"
    "phosphor-mimetic" "phosphor-mutants" "phosphoribosyl"
    "phosphorylation-defective" "phosphorylation-mimetic"
    "phosphorylation-mutant" "phosphorylationbut" "phosphoserines"
    "phosphosite" "phosphosites" "phosphotyrosines" "photoproducts"
    "physically-mediated" "physio" "physio-pathological"
    "physiologically-relevant" "physiopathology" "phytohemagglutinin"
    "placebo-controlled" "placode" "plaque-forming" "plaque-like"
    "plasmacytoid" "plasmon" "platinum-inhibitor" "platinum-sensitivity"
    "pleomorphism" "plexinB1-small" "plexinB1is" "plexinB1with" "ploidy"
    "plus-end" "pneumophila" "point-mutations" "polo-box"
    "poly-ubiquitinylation" "polyA" "polyADP" "polyadenylate"
    "polyethylenimine" "polyhydramnios" "polyhydroxyethylmethacrylate"
    "polymerase-1" "polymorphism" "polymorphisms" "polyphatidylinositol"
    "polyphenol" "polyphenols" "polyphosphoinositides" "polyprotein" "polysomy"
    "polyvinylidine" "pombe" "pontine" "poorer" "poorly-differentiated" "pos"
    "positive--7-AAD" "positive--7-aminoactinomycin" "positron"
    "post-DNA-binding" "post-GWAS" "post-MetMAb" "post-angioplasty"
    "post-entry" "post-exposure" "post-hoc" "post-implantation"
    "post-infection" "post-injection" "post-integration" "post-isolation"
    "post-labelling" "post-menopausal" "post-mitotic" "post-mortem"
    "post-natal" "post-operative" "post-radiotherapy" "post-receptor"
    "post-relapse" "post-stimulation" "post-stress" "post-surgery"
    "post-synaptic" "post-tamoxifen" "post-transcription"
    "post-transcriptional" "post-transcriptionally" "post-transduction"
    "post-transfection" "post-translation" "post-translational"
    "post-translationally" "post-transplant" "post-transplantation"
    "post-treatment" "post-ubiquitination" "postmortem" "postpartum"
    "pouchitis" "pp2ca" "precancer" "prepulse" "pri-miR-17–92" "primary-tumor"
    "primaryC" "prion-like" "priori" "pro-IL-18" "pro-MMP-2" "pro-WD"
    "pro-angiogenic" "pro-asthma" "pro-coagulant" "pro-death"
    "pro-differentiation" "pro-drug" "pro-enzyme" "pro-estrogenic"
    "pro-fibrotic" "pro-growth" "pro-inflammatory" "pro-invasion"
    "pro-invasive" "pro-inﬂammatory" "pro-metastatic" "pro-neurogenic"
    "pro-platelet" "pro-proliferative" "pro-receptors" "pro-self"
    "pro-survival" "pro-tumorigenic" "pro-uPA" "probands" "probiotic-derived"
    "procaspase-3" "procathepsin" "procoagulant" "procollagen" "proenzyme"
    "profilings" "proform" "progenies" "progeny" "progestin" "prognose"
    "prognoses" "progressors" "prolyl-4-hydroxylase-β" "promoter-distant"
    "promoter-less" "promoter-proximal" "promoter-regulatory"
    "promoter-reporter" "promoterless" "proof-of-concept" "proof-of-principle"
    "propan-1-one" "propenyl" "propeptide" "proportional-hazards" "propyl"
    "prostaglandin-endoperoxide" "prostaglandins" "prostaglandis"
    "prostasphere" "prostaspheres" "prostatectomy" "prostatomes" "prostectomy"
    "prosticators" "protease-activated" "proteasome-dependent"
    "proteasome-mediated" "protein-2α" "protein-DNA" "protein-coding"
    "protein-tyrosine" "protein–DNA" "proteome" "proteosome" "proven"
    "proximity-based" "proximity-dependent" "proα2" "psCLU"
    "pseudo-monoclonality" "pseudogene" "pseudoinclusions" "pseudosubstrate"
    "psi-CHECK-2-RalA-UTR" "psi-CHECK-2-RalA-mut-UTR" "pull-down" "pull-downs"
    "pulse-chase" "pulse–chase" "punctae" "punctate-like" "punctuate-like"
    "pylori" "pyra" "pyrazin-8-ylamine" "pyrazolo" "pyra­zolo" "pyridine"
    "pyrido" "pyrilamine" "pyrogen" "pyrogens" "pyruvoyl" "p = 0.002"
    "p = 0.006" "p = 0.009" "p = 0.02" "p = 0.03" "p = 0.035" "p = 0.05"
    "p = 0.09" "p = 0.15" "p = 2.3×10" "p = 3.3×10" "qMSP" "qMSPs" "qPCR"
    "qTOF" "qua" "quadrature" "quadrupole" "quality-of-life-deteriorating"
    "quantitative-PCR" "r=0.14" "r=0.35" "r=0.68" "r=0.69" "r=0.987" "rCop1"
    "rIL-18" "rad-3-related" "rad3-related" "radiation-induced"
    "radiation-sensitive" "radiatum" "radio-activity" "radio-resistance"
    "radio-therapies" "radiochemotherapy" "radioiodine" "radionuclide"
    "radioresistance" "radioresistant" "radix" "raft-like" "raft-targeting"
    "raft–targeting" "random-effect" "random-effects" "rapalog" "rapalogs"
    "rapamcyin" "rapamycin-like" "rare-cutting" "rarer" "re-ChIP" "re-addition"
    "re-analysis" "re-analyzed" "re-associate" "re-association" "re-challenged"
    "re-constructing" "re-create" "re-cultured" "re-endothelialization"
    "re-enforcing" "re-entry" "re-establishment" "re-evaluated" "re-evaluation"
    "re-examination" "re-examine" "re-examined" "re-express" "re-expression"
    "re-growth" "re-instates" "re-introduction" "re-localization"
    "re-localized" "re-localizes" "re-operation" "re-organization"
    "re-phosphorylate" "re-probed" "re-probing" "re-seed" "re-sensitization"
    "re-sensitize" "re-sensitizes" "re-sensitizing" "re-stimulated"
    "re-stimulation" "reactant" "reaction-restriction" "readout" "readouts"
    "realise" "reast" "rebalance" "rebiopsy" "receivedC" "recent-onset"
    "receptor-alpha" "receptor-alpha-negative" "receptor-cofactor"
    "receptor-ligand" "receptor-like" "receptor-β" "rechallenge"
    "recombination-dependent" "rectangular-shaped" "rectosigmoid" "redelivery"
    "redirect" "reengage" "reggie" "reggie-1-EGFP–expressing"
    "reggie-1–monomeric" "reggies" "region-Helix-Loop-Helix-Leucine" "regions"
    "regrowth" "regulateHIV" "regulated-genes" "regulators" "regulome"
    "regulon" "repair-associated" "repair-compromised" "repeat-containing"
    "repeats-containing" "replication-blocking" "replication-independent"
    "replicative-stress" "reporter-driven" "repressors" "respiratory-chain"
    "responder" "responders" "response-to-treatment" "resveratrol-glucuronide"
    "reticulum" "retinol" "retro" "retro-orbital" "retrogenes"
    "retroperitoneum" "retrovirus" "reuptake" "reuteri" "reverse-phase"
    "reverse-transcription" "reversed-phase" "rhIL" "rhIL-11" "rhIL-6" "rhMMP"
    "rhMMP-2" "rhamnosus" "riboprobes" "ribose" "riboside" "ribosomopathies"
    "right-handed" "right-sided" "risk-associated" "risk-factor" "risk-genes"
    "risk-reducing" "risperidone-treatment" "rmIL" "rmIL-18" "ro"
    "rolling-circle" "romatin" "roprolin" "rostral-caudal" "rotein"
    "round-cell" "round-tumor" "rpHPLC" "rpm" "rray" "rs1006737" "rs10069690"
    "rs10174126" "rs10411210" "rs1041981" "rs10435378" "rs10484554"
    "rs10498025" "rs10498026" "rs10761741" "rs10781500" "rs10784774"
    "rs10795668" "rs10808265" "rs10893872" "rs10936599" "rs11169552"
    "rs11171739" "rs11177644" "rs11187842" "rs11187870" "rs11187870C"
    "rs11187870G" "rs11212617" "rs11263441" "rs1128334" "rs11604082"
    "rs11632715" "rs11653144" "rs11717139" "rs11731417" "rs1207774"
    "rs12526480" "rs12899618" "rs12917" "rs13236689" "rs144848" "rs1494961"
    "rs151361" "rs1513691" "rs16852804" "rs16856186" "rs16892766" "rs16945"
    "rs16969681" "rs17136556" "rs17138064" "rs17154155" "rs1799782" "rs1799889"
    "rs1799964" "rs1805794" "rs1834570" "rs183642" "rs1889321" "rs189037"
    "rs1913768" "rs1935" "rs1938526" "rs1957636" "rs20,432" "rs2023748"
    "rs2046210" "rs204938" "rs2068361" "rs210134" "rs210135" "rs2206593"
    "rs2234693" "rs2237717" "rs2242652" "rs2274223" "rs2274223A" "rs2274223G"
    "rs228589" "rs2383658" "rs2393967" "rs2395185" "rs25487" "rs2592232"
    "rs2606241" "rs2658782" "rs2736100" "rs2736118" "rs2742976" "rs2745557"
    "rs2760985" "rs278037" "rs2790" "rs28366298" "rs2853668" "rs2853741"
    "rs2893923" "rs2910164" "rs294938" "rs3213180" "rs321318121" "rs3213182"
    "rs3213183" "rs3218121" "rs3218123" "rs3218148" "rs3218203" "rs3218211"
    "rs342293" "rs342296" "rs34489327" "rs34743033" "rs35933323" "rs3754546"
    "rs3757318" "rs3781264" "rs3794012" "rs3802842" "rs3869109" "rs38859"
    "rs4,648,276" "rs4,648,291" "rs4,648,306" "rs4,648,308" "rs401681"
    "rs41735" "rs41736" "rs41737" "rs41738" "rs41739" "rs4234006" "rs4237769"
    "rs4246742" "rs4444235" "rs449242" "rs4591859" "rs477895" "rs477895 "
    "rs4779584" "rs4813802" "rs4831760" "rs4925386" "rs4930420" "rs4939827"
    "rs5275" "rs5277" "rs56697663" "rs58808873" "rs6023059" "rs6070696"
    "rs6122566" "rs6124914" "rs61764370" "rs6435862" "rs6490294" "rs6517590"
    "rs6566" "rs6667575" "rs6691170" "rs67491583" "rs6785065" "rs678653"
    "rs689,462" "rs689,464" "rs689466" "rs689470" "rs6951311" "rs6983267"
    "rs699517" "rs7105934" "rs7107217" "rs7144584" "rs7177" "rs7208768"
    "rs7217437" "rs73366471" "rs738289" "rs745080" "rs753724" "rs7587476"
    "rs7591615" "rs7599060" "rs760607" "rs77247065" "rs7768330" "rs7776340"
    "rs7896518" "rs7939721" "rs7939830" "rs7948643" "rs8109288" "rs8170"
    "rs867286" "rs909859" "rs9264942" "rs9316500" "rs9340799" "rs9383921"
    "rs9383951" "rs9397435" "rs9460668" "rs9466182" "rs9485372" "rs9494145"
    "rs961253" "rs9929218" "rs9952504" "rs9967368" "rtTA" "rtTA-YAP"
    "rule-based" "run-off" "ryegrass" "s00125-012-2537-x" "s00395-012-0261-9"
    "saline-treated" "salpingo" "salpingo-oophorectomy" "same-size"
    "sample-by-sample" "sander" "saractinib" "sarcomatoid" "sc-29398" "sc-371"
    "sc-7176" "sc-7216" "sc-81436" "schizophrenia-1" "scinderin" "scombroid"
    "scratch-wound" "sdc-4" "second-degree" "second-ranking" "secretome"
    "seeand" "segregants" "self-activation" "self-assessment"
    "self-association" "self-catalyzed" "self-destructive" "self-digestion"
    "self-identified" "self-limited" "self-peptide" "self-reactive"
    "self-reactivity" "self-regulated" "self-renew" "self-renewal"
    "self-report" "self-ubiquitination" "self-ubiquitylation" "self–seeds"
    "sella" "semi" "semi-quantification" "semi-quantitative" "senescence-like"
    "sensitise" "sensitizer" "sensitizers" "seq" "sequelae" "sequence-based"
    "sequence-matching" "sequence-specific" "sequestome" "sequnce"
    "serine-to-alanine" "serine-to-arginine" "serosa" "seven-day" "sex-hormone"
    "sex-specific" "sh-GFP" "sh-Rictor" "shAC" "shGFP" "shHDAC2" "shHdac4"
    "shLuc" "shNTC" "shNeg" "shNet1" "shNoxa" "shPLK1" "shPrP" "shRBMX"
    "shRBMX-7" "shRNA00" "shRNA1" "shRNA99" "shRNAi" "shRNF8" "shSIRT1-1"
    "shSIRT1-2" "shSIRT1-3" "shear-flow" "sheet-like" "shiga" "short-hairpin"
    "short-range" "short-term" "showedBRAF" "shownto" "shp53" "shutoff"
    "siAKT1" "siAKT2" "siAKT3" "siBLIMP1-1" "siBLIMP1-2" "siCNS" "siControl"
    "siCpt1c" "siE6" "siERBB2" "siFF" "siGENOME" "siGFP" "siHIRIP3-1"
    "siHIRIP3-2" "siHIRIP3-4" "siHIRIP3-5" "siHuR" "siLYN" "siLuc" "siNTp"
    "siPLK" "siPLK1" "siPLK1-A" "siRAC3" "siRAC3-III" "siRAC3s" "siRBMX"
    "siRBMX-1" "siRBMX-3" "siRBMX-5" "siRNA-2" "siRNA-Scr" "siRNA-sCLU"
    "siS6K1" "siSTMN1" "siSTMN1-transfectant" "siYES" "sialyl"
    "sialyl-transferases" "side-by-side" "side-chain" "side-chains"
    "side-effect" "side-effects" "side-population" "sidechain" "sidechains"
    "signal-to-noise" "signature-based" "silico" "silver-enhanced" "simpler"
    "simulatedcurves" "simulatedvalues" "single-base" "single-cell"
    "single-channel" "single-factor" "single-marker" "single-mutant"
    "single-nucleotide" "single-patient" "single-strand" "single-tag"
    "single-target" "single-trajectory" "singly-spliced" "sinusoids" "sip110α"
    "sip110β" "sip53" "sip55γ" "sip85α" "sip85β" "sip85β " "sirtuin"
    "sirtuin-like" "site-specifically" "situ" "six-parameter"
    "six-week-induced" "six-well" "sixty-six" "size-dependent" "size-exclusion"
    "skinfolds" "slit-lamp" "slow-growing" "slow-migration" "small-cell"
    "small-interfering" "small-intestinal" "small-molecular" "small-molecule"
    "small-sized" "smokers" "snap-frozen" "social-economic"
    "sodium-2-glycerophosphate" "soft-agar" "soft-tissue" "sol" "sol-gel"
    "solute" "solvent-accessible" "soy-based" "spacer" "spacers" "spatio"
    "spatio-temporal" "spead" "specifc" "specific-effects"
    "specific-protective" "speciments" "speciﬁc" "spectrometer"
    "spectropolorimeter" "sphenoid" "sphere-formation" "sphere-forming"
    "sphingosine" "spirometry" "spitzoid" "sporadicBRAF" "squamous-cell"
    "stably-integrated" "stage-III" "stainings" "standard-of-care"
    "standard-risk" "states-TPPI" "statin-responses" "statin-sensitivity"
    "statin-treatment" "steady-state" "steepest" "stellate" "stem-cell"
    "stem-like" "stem-loop" "stem-progenitor" "stemness" "stents" "stepwise"
    "strain-specific" "strand-specific" "streptavidin-Sepharose"
    "streptavidin-mediated" "stress-activated" "stress-caused"
    "stress-independent" "stress-induced" "stress-inducible" "stress-inducing"
    "stress-mediated" "stress-resistance" "stress-response" "stress-responsive"
    "stress-sensitive" "stress-sensor" "stress-triggered" "stressful"
    "stressors" "stress–independent" "stress–inducing" "striata" "stripes"
    "stromal-to-epithelial" "stromelisine-1" "structurally-destabilizing"
    "structurally-disorderd" "structurally-disordered" "structurally-related"
    "structure-affinity" "structure-based" "structure-function"
    "structure–function" "styryl" "sub-G1" "sub-analysis" "sub-cellular"
    "sub-clusters" "sub-epithelial" "sub-family" "sub-fraction" "sub-fragments"
    "sub-group" "sub-heat" "sub-lethal" "sub-library" "sub-line" "sub-lines"
    "sub-maximal" "sub-nuclear" "sub-optimal" "sub-phenotypes" "sub-population"
    "sub-populations" "sub-ribosomal" "sub-stoichiometric" "sub-units" "subG1"
    "subclass" "subclasses" "subcohort" "subdomain" "subfamilies" "sublines"
    "submucosa" "subnetwork" "subpassage" "subscales" "subset" "subsets"
    "subsite" "subsites" "substantia" "substituents" "substrate-2α"
    "substrate-adherent" "subthreshold" "subtype" "succinimidyl"
    "suggestingNf1" "sulfide" "sulfoglucosamine" "sulfonylurea"
    "super-repressor" "super-shift" "super-shifted" "superaggregate"
    "superhelix" "supernatant" "supernatants" "supperaggregate"
    "suppressor-like" "suppressor–like" "suppressor–oncogene" "supra-additive"
    "survivorship" "symptom-based" "symptomatology" "synapse" "synapses"
    "syncitia" "synovia" "synthesizer" "systemic-onset"
    "t-8-dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo" "tGFP" "tTG" "tagSNP"
    "tagSNPs" "tamoxifen-inducibleNestin-CreER" "target-gene" "target-genes"
    "target-of-rapamycin" "targetcells" "targeted-gene" "targetoid"
    "targetsp21" "tartrate" "taxiscan" "telomerase-negative"
    "telomerase-positive" "temozolamide" "ten-gene" "tenovin-6"
    "teratoma-tumorgenesis" "teratomacarcinoma-like" "tertile" "tertiles"
    "tet-OFF" "tet-off" "tet-on" "tetradecanoylphorbol" "tetralogy"
    "tetranucleotide" "tetraubiquitin" "tetraubiquitins" "thalamus" "thatBRAF"
    "thatC" "thatincreases" "thatvirus" "the-concentration" "theApc" "theBRAF"
    "theC" "theDTA" "theFLIP" "theK14cre" "theNestin-CreER" "thePten" "thep16"
    "thep21" "therapy-induced" "therapy-naive" "therapy-resistent"
    "therapy-sensitive" "thermophilus" "thevalues" "thio" "thio-cleavable"
    "thiogalactopyranoside" "thiophenol" "third-generation" "thirty-seven"
    "thread-like" "three-day" "three-dimensional" "three-residue"
    "three-segment" "three-week" "three-year" "threevalues"
    "threonine-specific" "threshold-length" "thrombi" "thrombocythemia"
    "thrombospondin-I" "thromboxanes" "thrombus" "thymocyte-negative"
    "thyroidectomy" "tibialis" "time-course" "time-dependency" "time-lapse"
    "time-of-flight" "time-period" "time-point" "time-points" "time-responses"
    "timecourse" "timepoint" "timepoints" "tissue-specifically"
    "tissue-specificity" "tissues" "titer" "titers" "tm1Bal" "toC" "toGucy2c"
    "toPten" "tobacco-associated" "tobacco-related" "tolerance=10" "toll-like"
    "tonometry" "top-SNP" "top14" "topology" "trade-off" "traffic-dependent"
    "tranglutaminase-2" "trans-association" "trans-associations" "trans-eQTL"
    "trans-eSNPs" "trans-endothelial" "trans-membrane" "trans-well"
    "transcript-based" "transcript-level" "transcript-specific"
    "transcriptional-independent" "transcription–PCR" "transcriptome"
    "transcriptome-wide" "transdifferentiate" "transduced-Ba" "transducer"
    "transducin-like" "transfectant" "transfections" "transformants"
    "transgenes" "transglutaminase-like" "translocon" "transmigrate"
    "transwell" "trastuzumab-DM1" "treat-to-target" "treatment-naive"
    "treatment-relevant" "tremeGENE" "trend=0.01" "trend=0.02" "trend=0.04"
    "tri-methlyguanosine" "tri-methyl" "tri-methylguanosine" "triacylglycerols"
    "triceps" "trimester" "trinucleotide" "triphosphate" "triple-mutant"
    "triple-negative" "triple-resonance" "trisomy" "trisphosphate"
    "trophoblast-like" "truncus" "tubal" "tubercle" "tubulate"
    "tumor-progressive" "tumor-suppressing" "tumor-suppressive" "tumorsphere"
    "tumorspheres" "tumour-associated" "tumour-inducing" "tumour-initiating"
    "turcica" "twenty-one" "twenty-three" "twenty-two" "two-drug" "two-edged"
    "two-hybrid" "two-marker" "two-phase" "two-point" "two-sample"
    "two-segment" "two-sided" "two-stage" "two-state" "two-step" "two-tailed"
    "two-thirds" "two-way" "two-week-induced" "type-1" "type-I" "type-IV"
    "tyrosine-1068-phosphorylated" "uL" "uanine" "ubiq" "ubiq-uitination"
    "ubiqui" "ubiqui-tination" "ubiquinates" "ubiquitin-proteasome-mediated"
    "ultra-low" "ultrapure" "un" "un-interpretable" "under-appreciated"
    "under-studied" "undergoes" "undergone" "underpinnings" "undertaken"
    "units" "univariate" "unmet" "up-stream" "up-trend" "upfield" "urethra"
    "urothelium" "utero" "v5" "vMCF" "vMCF-7" "vacuole" "vacuoles" "valueand"
    "vasculopathy" "vdw" "vehicle-treated" "venlafaxine" "venules" "vera"
    "vernier" "vesicle-associated" "vesicle-like" "vi" "vide" "villi" "villus"
    "virB7" "viral-sarcoma" "virally-encoded" "vitro" "vivo" "viz"
    "waist-to-hip" "wash-out" "washings" "waspΔvca" "water-soluble" "weakest"
    "web-based" "website" "websites" "wel" "well-characterised"
    "well-conserved" "well-controlled" "well-coordinated" "well-curated"
    "well-defined" "well-demarcated" "well-designed" "well-differentiated"
    "well-documented" "well-folded" "well-identified" "well-ordered"
    "well-organized" "well-oriented" "well-powered" "well-recognized"
    "well-studied" "well-tolerated" "wet-lab" "wherep14" "wherep19" "whichgoes"
    "whole-body" "whole-brain" "whole-cell" "whole-genome" "whole-lung"
    "whole-mount" "whole-transcriptome" "wide-range" "wide-ranging"
    "wide-spread" "wide-type" "widely-utilized" "wildtype" "withC" "withK"
    "withNestin" "withNestin-CreER" "withPb" "withPb-C" "withdrawn" "wk" "wks"
    "work-around" "workers" "workflow" "world-wide" "wound-closure" "wpf"
    "writen" "written" "wt-DLG" "wt-β-catenin" "wtARE" "wtp53" "x-axis" "x2"
    "xPPxPxKPx" "xchange" "xenographs" "xenopus" "xenotransplant" "xerostomia"
    "xy" "xz" "y-axis" "yb-like" "yclin" "yclin-D1" "year-old"
    "yeast-II-hybrid" "yeast-two-hybrid" "yet-to-be" "yet-to-be-identified"
    "yl" "yndrome" "youngNf1" "yr" "z-axis" "z-scores" "z-test" "zash1a"
    "zero-valent" "zeste" "zolo" "zymography" "×1" "×10" "×100" "×150" "×488"
    "×ERE" "×NES" "×length" "×width" "× 10" "× 10" "Δ1139" "Δ1172" "Δ150"
    "Δ189" "Δ1–156" "Δ1–289" "Δ204" "Δ224–244" "Δ328" "Δ436" "Δ45"
    "Δ45-mutated" "Δ87–237" "ΔC" "ΔE" "ΔEx3" "ΔG" "ΔGQM" "ΔH" "ΔICP0" "ΔM3"
    "ΔMBD" "ΔN" "ΔNES" "ΔNT" "ΔNT-DLG" "ΔNp63" "ΔNp73" "ΔP4" "ΔP5" "ΔPBM"
    "ΔPDZ" "ΔPDZ-SATB1" "ΔPTP" "ΔRING" "ΔRaf-1" "ΔS" "ΔSEC" "ΔSH3" "ΔTAp73"
    "ΔVV" "ΔVifVprX" "ΔVifVprX-infected" "Δcβ1" "ΔinvG" "Δloxp" "Δmfi" "ΔsopB"
    "Δvca" "ΔΔG" "ΔΔG " "ΔΔH" "ΔΔS" "ΔΨm" "Δδ" "ΨKxE" "α-AMPK" "α-AcK31"
    "α-CD3" "α-FLAG" "α-GFP" "α-Max" "α-TGFβ1" "α-Thr172" "α-adrenergic"
    "α-enolase" "α-helical" "α-helices" "α-helicity" "α-helix" "α-induced"
    "α-isoforms" "α-methyl" "α-pT67" "α-subunit" "α-β" "α1-Ser485" "α1β1γ1"
    "α1–2" "α2-subunit" "α2–α7" "α3" "α3β1" "α4" "α5" "α6"
    "α6β4-integrin-dependent" "α8" "αA" "αCOSR" "αChk1" "αE" "αERKO" "αL" "αM"
    "αMβ2" "αpS280" "αpS280-immunocytochemical" "αpS280-immunoreactive"
    "αβ-folds" "α–induced" "β-3-tubulin" "β-Ser108" "β-adrenergic" "β-barrel"
    "β-catein" "β-catelin" "β-catenin-Adenomatous" "β-catenin-induced"
    "β-chain" "β-hairpin" "β-heterodimer" "β-heterodimers" "β-integrins"
    "β-isoform" "β-isoforms" "β-propeller" "β-sandwich" "β-sheet" "β-sheets"
    "β-strand" "β-strands" "β-synemin" "β-transducin" "β1-RACK1" "β1-Ser108"
    "β1-subunit" "β1–2" "β2-chimaerin" "β3" "β4" "βB-crystallin" "βERKO" "βI"
    "βII" "γ-AMPK" "γ-activated" "γ-aminobutyric" "γ-glutamylcystein"
    "γ-irradiation" "γ-null" "γ-subunit" "γ-subunits" "γ1" "γ1–3" "γ2" "γ3"
    "γGCS" "γH2-AX" "γc" "δ-BARD1" "ε-stable" "ε1" "ε2" "εA" "εV1-2"
    "κ-light-chain-enhancer" "κB" "λ-phosphatases" "λPPase" "μ-homology" "μ1"
    "μ1B" "μ2" "μHD" "μHDs" "μg" "μg-2" "μg-3.0" "μl" "μmol" "π–π" "ρ=0.04"
    "‘amoeboid’" "‘biodosimeters’" "‘biodosimeter’" "‘naïve’" "’n’" "∶2" "ﬁnd"
    "ﬁrst"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-7201-7500*
  '("ECOP" "C-like" "co-amplified" "more fragile genomes" "nonrandom"
    "three main postsurgical treatment subsets" "thalamus" "cerebrum"
    "followup" "chr" "7p12" "P = 0.61" "co-amplification" "P = 0.15" "= 0.013"
    "= 0.35" "= 0.91" "= 9" "= 56" "Non-amplified" "P = 0.24" "3C"
    "non-amplified" "bronchial epithelium explants" "explant" "NHBEC"
    "hematological neoplasias" "neoplasias" "Wharton" "87.03±5.04%" "Burkle"
    "1q42" "non-Hodgkin's" "Gylceraldehyde" "Atelocollagen" "dedifferenciate"
    "ORA" "YRA" "ACHMS" "polyhydroxyethylmethacrylate" "Velazquez" "Piera"
    "some point all the progeny" "Hayflick" "hTERT-" "atelocollagen"
    "senescence-like" "2-week" "-10" "DMEM/F12" "-mir-124" "RNApolII" "pos"
    "5-aza-2" "MassARRAY" "Sequenom" "Karlsson" "nomograms" "CGI" "homopurine"
    "Xq12" "HER2/" "PR +" "P = 0.007" "P = 0.0001" "n = 15" "n = 29"
    "micrometastases" "rebiopsy" "FcgRIII" "Berns" "non-cleavable" "DACT"
    "Fordo" "Gloy" "Cheyette" "LSCM" "S+G2/M" "Wnt/β-catenin" "musculature"
    "caliper" "vernier" "colectomy" "normal control colonic mucosa" "Dpr"
    "14q22.3" "/mL" "re-probed" "∶2" "G0/G1 phases" "normal gastric epithelium"
    "Targetscan" "transfectant" "siSTMN1" "non-tumorous" "Jeon" "bab"
    "glandularatrophy" "= 25" "= 10" "2B" "C/EBPs" "p  = 0.05" "= 0.07"
    "p  = 0.004" "= 0.043" "imunohistochemistry" "co-segregation"
    "cicloheximide" "hydrophilic aminoacid" "aminoacid" "spead" "HDGC/EODGC"
    "aminoacids" "prodomain" "Prodomain" "EC2" "DialignTX" "ProbCons"
    "ClustalW" "Mafft" "PCMA" "PDB 1L3W" "xenopus" "FoldX" "−ΔG" "USVs"
    "Guilford" "EODGC" "IGCLC" "Missense" "presence/absence" "H-bonds" "ΔΔG "
    "a structurally stable C-terminal immunoglobulin" "isoprenyl" "RhoGDIs"
    "SmartPool" "Gö" "isoform/s" "R/K" "Hyd" "RhoGDI1" "diphosphate (GDP)"
    "non-stimulated" "E1B" "SCIN" "scinderin" "ets" "the repressive H3K9"
    "B5/589" "anti-rabbit" "∼4-fold" "anti-H3" "H3K14" "H3K9Ac" "3SA"
    "the Atm  −/− neuronal genome" "and 3SA" "co-injected" "Ac" "shHdac4"
    "pp2ca" "endothall" "S/T" "Homogenates" "inAtm" "rpm" "AcH4" "AcH3" "Nrxn"
    "Atf" "neocortex" "cerebella" "Purkinje" "/ml" "rs1799964" "rs5275"
    "Bonferroni’s" "Belsey" "Rs1799964" "acute pancreatitis" "survivorship"
    "QOL" "Mayo" "5+" "≥ 0.8" "Rs5277" "rs5277" "TBBz" "NetPhos" "Scansite"
    "websites" "tetraubiquitins" "tetraubiquitin" "CIAP"
    "underwent radical gastrectomy" "re-entry" "= 0.048" "= 0.043" "p = 0.003"
    "= 0.98" "= 0.042" "p = 0.007" "CRTCs" "Na/K" "/Ser 575" "abundancy"
    "to 14-3-3" "Epacs" "cAMPs" "phosphoPKB" "phosphoPKA-" "phosphoPKA" "ZMP"
    "Edman" "** P" "×1" "Apochromat" "QualBrowser" "SwissProt" "nl/min"
    "0.1% formic acid/water" "PepMap" "Packings" "Proxeon" "Velos" "orbitrap"
    "iodoacetamide" "-thiogalactopyranoside" "thiogalactopyranoside"
    "isopropyl" "TBS" "14-3-3ζ" "BAS" "Fujifilm" "AMARA (AMARAASAAALARRR)"
    "HLRLSTSSGRLLRRR" "PLRKTASEPNLKRRR" "ALNRTSSDSALHRRR" "Sakamototide"
    "AMARAASAAALARRR" "AMARA" "polyethylenimine" "penicillin/streptavidin"
    "pcDNA5" "™-293" "triacylglycerols" "KRH" "penicillin/streptomycin" "Lund"
    "Bradford" "infranatants" "Nonidet" "Biolabs" "dCCM" "Novagen" "pGEX"
    "anti-mouse" "Hardie" "Dundee" "DSTT" "DGRQRRPpSTIAEQTV"
    "LFDCEMLDAVDPQHNGYVLVN" "Innovagen" "Novus" "phosphoThr" "phosphoSer"
    "HDAC5tide" "IRS1tide" "Bloomberg" "Grahame" "Novo" "Biomol" "Toronto"
    "Novex" "I/IV" "5-amino-4-imidazolecarboxamide" "particulate"
    "Phosphopeptide" "riboside" "β 3" "* P" "=10 " "16 h" "100 MOI" "anti-FLAG"
    "and 3T3" "AMP/ATP" "minimise" "the colorectal cell line DLD1"
    "reconstituted heterozygous β -catenin genotype" "HAB-85" "HAB-18" "+121"
    "Kohno" "the heterozygous β -catenin genotype" "Δ45" "HAB-92" "HAB-68"
    "HAB" "non-related" "colorectal epithelium" "Wnt/" "isogenic sublines"
    "sublines" "antitumour" "sphenoid" "Bladowska" "Vidal’s" "Vidal" "Onguru"
    "non-functioning" "IQR=60.5" "Endocrinology" "recurrence/progression"
    "=53.5" "chiasm" "=75.0" "IQR" "=60.5" "6/60" "partim" "acidophilicum"
    "chromophobum" "macroprolactinomas" "neurosurgery"
    "post-operative regrowth" "cavernosus" "turcica" "sella" "gonadotropinomas"
    "post-operative recurrence/progression" "Microvessel" "=37"
    "Material/Methods" "anti-miR-125b" "SYBR" "miRNA-125b" "endometrium (NE)"
    "miR-17-5p" "multilevel" "German" "writen" "anslyses" "prosticators" "PVTT"
    "louder" "Atta" "95% CI: 2" "low/undetectable" "patietns" "Egger’s" "2b"
    "Oxford" "= 0.07" "= 0.12" "= 0.001" "= 0.22" "≥50"
    "a atherogenic dyslipidemia" "Turkish" "Estelles" "VLDL"
    "subscapular skinfolds" "skinfolds" "triceps" "Mestizo"
    "systemic lupus erithematosus" "erithematosus" "polymorphisms (SNP)"
    "formation/progression" "an inactive proenzyme" "proenzyme"
    "atherogenic dyslipidemia" "C/G" "mg/dL" "mestizo" "Mexican" "dyslipidemia"
    "4 G/5 G" "G/A + A/A" "p = 0.04" "= 0.66" "= 0.62" "p = 1" "= 0.005"
    "GA + AA" "kg/m 2" "= 2.6" "≥ 2" "MLCP" "total cortical homogenates"
    "neurite" "AOD" "p=NS" "=14.1" "=17.4" "=NS" "=2.6" "Kal" "schizophrenia-1"
    "pMLC" "DLPFC" "cingulate" "postmortem" "RhoA/ROCK" "=0.0004" "=35" "=29"
    "=33" "the translational apparatus xref perhaps" "CTIF" "methylguanosine"
    "mono-methylguanosine" "methlyguanosine" "Jeang" "Yedavalli" "RRE"
    "acute HIV-1 infection" "+EDTA" "HxBruR−" "HxBruR" "3–6" "P-4E- BP1"
    "R80AQ65R" "P-eIF2α" "P-4E-BP1" "ΔVV" "yet-to-be-identified" "ΔVifVprX"
    "VprX" "autoradiography" "nocadozole" "CEMx174" "encephalomyocarditis"
    "polyadenylate" "EJC" "reengage" "Retroviruses" "CBC" "mg/mL" "Vesuna"
    "Trichostain" "deacytalases" "TWSIT" "E-boxes (CANNTG)" "catelin"
    "TWIST/NuRD" "re-ChIP" "254RR" "phosphohistone" "paralogues" "Poleta"
    "KK164" "methanesulphonate (MMS)" "methanesulphonate" "eucaryotes" "2 h"
    "KG" "predominant alveolar architecture and epithelioid cytology" "cFLIPL"
    "Lannigan" "HA-Rad18–" "∼66%" "ssDNA-" "− / −cells" "− / −HCT116 cells"
    "S-box" "JNK1α1" "pS409" "PEEL" "CFSQSKLD" "Polκ" "Polι" "UBZ" "Tateishi"
    "Ulrich" "photoproducts"
    "t-8-dihydroxy-t-9,10-epoxy-7,8,9,10-tetrahydrobenzo" "Polη" "anti–phospho"
    "the absolute HbA 1c" "caregivers" "sulfonylurea" "antagonises" "Egger  "
    "ESM" "Harbord  " "UKPDS" "Tayside" "GoDARTS" "mmol/mol" "≤7" "HbA 1c"
    "≤7 " "Rotterdam" "Friesland" "n  " "rs11212617" "p  = 0.05" "= 0.013"
    "95 % CI" "= 1" "= 0.05" "non-white" "= 1.0" "= 0.46" "p  = 0.27" "n  = 3"
    "= 0" "p  = 0.15" "= 0.028" "= 182" "a robust subset"
    "possible dysregulated microRNA/mRNA" "C8ORF30A" "genes/microRNA"
    "hsa-mir-140-3p" "hsa-miR-140-3p/RAD51AP1" "53 possible microRNA/mRNA"
    "ASPM" "hsa-miR-139-5p" "normals" "hsa-miR-140-3p" "anti-correlation"
    "microRNA/mRNA" "miR-34b" "tumor/normal" "5p" "anti-correlated" "K-Means"
    "rapalog-" "LDN" "WY-354" "BMRPII" "BMRII" "BMRPRII" "WY" "Ku" "≥12 h"
    "6/6" "n=6" "H-score" "BioMax" "prostectomy" "0–3" "phopho" "RTqPCR"
    "pLPCX" "&5" "NRP-152" "Smad1/5/8" "Ds" "weakest" "Ser426/428" "Ser463/465"
    "xenographs" "Pfizer" "Rapalogs" "phospho-Smad1/5" "phospho-Smad1"
    "Smad1/5" "BMPRI" "Smads" "re-analyzed" "non-treated" "or/and" "DMEM/F-12"
    "1.6-3.6" "non-tobacco-related"
    "their corresponding common homozygous genotypes"
    "the p27 109 TT common homozygous genotype" "TG/GG" "non-squamous"
    "Patterson" "teratomacarcinoma-like" "re-examination" "Grad" "OCT3/4"
    "Silva" "Theunissen" "Grob" "Kawamura" "TUJ1" "4 TF" "TUJ 1" "eosin"
    "traditional 4TF" "the traditional 4TF" "pMXs" "4TF" "generatedinto"
    "Yamanaka" "DNp73" "SSEA 4" "Non-Essential" "consequent re-expression"
    "Affimetrix" "re-express" "1GX" "ΔRaf-1" "vMCF" "/low"
    "extra-embryonic mesoderm" "EGR" "chemoendocrine" "4-week" "Nu/Nu"
    "transmigrate" "FPRs" "family 2C" "purified active p38 MAPK"
    "active p38 MAPK" "The active p38 MAPK" "ΔST" "FPR1-" "FPR"
    "chemtoattractants" "taxiscan" "~20%" "~80%" "highly pure cell subsets"
    "DR53" "the predominant cell subset" "UC" "p=3" "Informativeness" "*1203"
    "C*0602" "rs9264942" "−17 p" "DRB1*04/*07/*09" "rs28366298" "*07" "DRB1*04"
    "rs2395185" "acyloxyacyl" "LAP3P2" "pseudogene" "hexakisphosphate"
    "=5.8×10" "rs11171739" "self-reactive auto-antibodies" "12q13.2" "p=1"
    "rs10784774" "12q15" "trans associated eSNPs" "Bonferonni" "TSPAN3" "AKAP7"
    "DFNA5" "eSNP" "eSNPs" "HumanOmniExpress" "BeadChips" "HumanHT"
    "288 healthy European" "physiologically active cell type-specific eQTLs"
    "eQTLs" "AOAH" "eQTL" "=1.9×10" "=5.2" "rs10484554" "17 p" "7.0×10" "=0.11"
    "=1.4×10" "=5.7" "=9" "non-cultured" "=2×10" "DBIRD-like"
    "incorporation/immunoprecipitation" "around included exons" "GeneChip"
    "ZN326" "ZNF326" "DBIRD" "ZIRD" "interactome" "RNAPII" "= 71%"
    "co-precipitates" "A/T" "the phosphomimetic mutation S17D" "downfield"
    "N-Ala21-" "N-labled" "peptide/protein" "ETFSDLWKLLPE" "FSDLWKLL" "analyte"
    "non-contact" "SQETFSDLWKLLPEN" "Nbz" "-acylurea" "acylurea" "K36C/pS17"
    "AgOAc" "acetamidomethyl" "ESI-MS" "αCOSR" "K36C/S17D"
    "withdrawal/addition" "cuvette" "1-mm" "spectropolorimeter" "Jasco"
    "nmrPipe" "TPPI" "quadrature" "spectrometer" "Avance" "Bruker" "MHz" "•C/"
    "GraphPad" "L/min" "Plasmon" "em" "Tecan" "-acetyle-" "N -acetyl-"
    "Succinimidyl" "mg/ml" "Acm" "GuHCl" "activation/DIEA" "SPPS" "Kent" "HBTU"
    "synthesizer" "Sweden" "Irvine" "Biochemicals" "ICN" "ultrapure" "Louis"
    "thiophenol" "DIEA" "diisopropylethylamine" "Montgomeryville" "Matheson"
    "Halocarbon" "Switzerland" "Novabiochem" "Dbz" "Dawson" "OBzl" "KY"
    "Louisville" "hydroxybenzotriazole" "TSQIPASEQ" "heter"
    "the phospho-mimetic mutation S17D" "S17D" "pS17" "Kcal/mol" "Non-linear"
    "N -acetyl" "FGF15−/−" "pharmacotherapy" "FGF15/19" "FGF19/21" "KLB−/−"
    "Kd" "nano" "glycemia" "discrepant" "ileum" "distal tissues/organs"
    "glycan" "FGFR1–3" "Cre+" "co-incubated" "molecules/peptides" "Espina"
    "explants" "fluorescent immunohistochemistry" "mol/L" "weight/day" "BaxKO"
    "HCS-2/8" "Dexa" "C57BL/6" "= 0" "Pekarsky" "miR-181b" "Ramkissoon" "CSDA"
    "botulinum" "miR-180a" "psi-CHECK-2-RalA-mut-UTR" "psi-CHECK-2-RalA-UTR"
    "a v-ral simian leukemia viral oncogene homolog" "Computational algorithms"
    "cytoscape" "miRNA-181a" "* p" "SPSS" "microvessels" "miR-128-expressing"
    "miR-128-" "pMIR" "pathoetiology" "p-p70S6K" "4-weeks" "6×10" "# 4"
    "Ca 2+ -activated PKC isozymes" "OipA" "cagPAI" "cPKCα"
    "constitutively active isozymes" "I-coated" "activator-3" "ac" "Muc"
    "calphostin" "PLCβ" "human gastric biopsies" "PKCɛ" "virB7" "myristoyl"
    "3–6 " "phospholipase Cγ" "Brandt" "muropeptides" "cPKC"
    "at least 10 isozymes" "pylori" "colonises" "kinase 1" "24 h" "6 h"
    "non-infected" "–6 " "72 h" "RVRK" "FXIIIa"
    "widespread biological consequences/implications" "perlecans" "Biacore"
    "nanomolarK" "/Lys 205" "BXBBB" "/Lys 602" "/Arg 601" "/Lys 600" "M1c"
    "conformers" "tTG" "glycosoaminoglycan" "BBXB" "plasmon" "M1b" "∼30–40%"
    "XX" "HS/heparin" "-sulfoglucosamine" "sulfoglucosamine" "Cα"
    "glycosoaminoglycans" "immunoresponse" "basic RRWK" "KQKRK" "RRWK"
    "trafficking/externalization" "RGD" "extracellular tranglutaminase-2"
    "non-bonded" "histadine" "situ" "non-ocular" "Fernandez" "p=0.0008"
    "p=0.0201" "Kiyosaki" "non-melanoma" "non-head" "Torre" "Muir" "=0.0008"
    "=1" "n= 8" "=0" "n= 10" "rat Barrett’s" "p-S6K1" "BE3/EV" "BE3/S84A"
    "BE3/Gli1" "BE3/S84E" "Gli1S84E" "WYE-354" "Gli1S84A" "79-KKRALS-84"
    "Gli1F1" "S6K1K100R" "exogenous S6K1T389A" "S6K1T389A" "S6K1T389E" "BE3"
    "mTORS2035T" "mTORS" "WYE" "TSC1/2" "RAD-001" "alk" "Dβh" "Hansford"
    "multiparameter" "penetrant"
    "a developmentally-timed apoptotic response at 5.5 wpf"
    "the neuronal marker Hu" "TH+/Hu+" "Hu−" "Hu+" "TH+" "coeruleus"
    "anti-activated" "non-PSNS" "oblongata" "riboprobes" "mesonephros"
    "ALKF1174L" "ALKWT" "6-month" "wpf" "h:ALKF1174L" "h:EGFP" "DβH"
    "noradrenalin" "the adrenal medulla" "PSNS" "chromaffin" "p= 0.004"
    "p=0.03" "=0.007" "derepress" "co-elution" "SB939" "mATF2-" "mATF" "mATF2"
    "SSXRD" "SNH" "co-existence" "RA2009" "interactants" "TrxG" "Trithorax"
    "ifosphamide" "~ 4-fold" "transducin-like" "MMP1/9" "Gupta" "Hep27" "PyMT"
    "MMP9/1" "a transcriptional transactivator/repressor" "Glondu"
    "BM/Matrigel" "Bhattarai" "stromal/interstitial" "extract/Matrigel"
    "Stromal/interstitial" "collagens" "MYBup" "BMs" "substrate/matrix"
    "Gaithersberg" "Trevigen" "Cultrex" "MDA-MB-231MYBup" "migratory/invasive"
    "Migration/invasion" "expression/secretion" "protein-2α"
    "acute and direct anti-proliferative" "2c" "FGFR1c" "substrate-2α"
    "a homozygous FGFR4 G388R polymorphism" "THLE2" "Oncominethat" "= 0"
    "2 μg/mL" "KSXXXW" "RRXXXW" "KTXXXW" "CCK1" "Rlu" "Lrp5ECD" "GCGR+Lrp5"
    "GCG9-29" "GCG1-29" "catein" "glucagon-like peptide-1" "Gs" "10-cm" "Ig κ"
    "Gα s" "fIGF1" "Gualberto" "IRβ" "hemidimers" "IGF1Rs" "YTAR" "NPG"
    "PNGage" "NLG" "ng/50 µ" "ELISAs" "SNU739" "SNU368" "glycans" "N-linked"
    "Anti-proliferative" "Romagnoli" "Mathilde" "ΔM3" "dox" "∼54%" "Oncomine"
    "siBlimp1-2"
    "siRNA-2 resulted in effective knockdown of Blimp1 protein expression"
    "siRNA-2" "siBLIMP1-1" "siBLIMP1-2" "WCE" "propeptide" "∼2-fold" "anti-V5"
    "non-hematopoietic" "IFNβ promoter" "S6G" "Immunostainings"
    "a classic blocker" "blockers" "μm/min" "shLuc" "shPrP" "coaccumulate"
    "epidermoid" "redelivery" "Reggies" "reggie" "reggies" "6H" "S4C"
    "special subsets" "withdrawing Dox" "withdrawn" "9d+" "doxycyline" "rtTA"
    "moue" "co-stain" "hilum" "neoplasmas" "nonusers" "Paranjape" "cribriform"
    "Hollestelle" "HBOC" "rs61764370" "HRT" "Non-small-cell" "HER2 +" "≥ 1"
    "= 29" "English" "the Egger's" "Begg's" "Egger" "written" "1q25.2-q25.3"
    "co-dominant" "rs2745557" "Non-differential" "= 0.26" "= 0.80" "= 0.51"
    "= 1" "= 0.14" "=0.66" "= 0.88" "= 1.04" "P-values" "P = 0.04" "PDK"
    "dnPKC-δ-expressing" "dnPKC-δ-" "caPKC" "pJNK" "Hayashida" "IFNARs" "dnPKC"
    "kinase1" "anti-phospho" "6 h" "p38MAPK" "p38MAPKs" "ΔΨm" "polyA"
    "hypoxia-inducible factor-1alpha" "heterotrimer" "Spearman’s"
    "progression/prognosis" "GKN1/2" "GKN1" "the intestinal subtype"
    "gastrokines" "phosphagen" "GOminer" "genome/transcriptome" "RPKM"
    "the largest RNA-seq datasets" "a WT-seq dataset" "seq"
    "multidimensional datasets" "P = 4" "non-redundant" "= 1.1×10" "± 0.04"
    "≥10" "ZCTA" "MBCCOP" "A:T" "non-TN" "Lai" "ER/PR-negative" "IV/I"
    "1.04–3.17" "III/I" "1.10–2.58" "PR+" "HER2+" "0.86–2.36" "AA/non-AA"
    "ER/PR-" "ER/PR" "worse/above" "ZCTAs" "comorbid" "ER/" "non-AAs"
    "triple negative (ER−, PR−, HER2−) subtype" "non-AA" "race/ethnic"
    "non-Hispanics" "ER+" "A/B" "ER/PR+" "P = 0.026" "5/6" "race/ethnicity"
    "ETS4/ETS5" "CCGGAA" "CAGGAG" "CAGGAA" "GAGGAA" "CAGGAT" "GCGGAA" "ETS5"
    "EBS6" "ETS4" "+744" "+905" "the repressive R-motif" "exosome-" "exosome"
    "nucleo" "CCCH" "p38 MAPK" "FTA/FTC" "p=0.06" "p=0.0001"
    "post-operative radioiodine (RAI)" "radioiodine" "=0.59"
    "uniformly underwent total thyroidectomy" "thyroidectomy" "p=0.003" "27b"
    "Ivanova" "Simões" "Sobrinho" "EFPVTC" "subtype (EFVPTC)"
    "non-encapsulated" "pseudoinclusions" "Rosai" "Lindsay" "cPTC"
    "just presence/absence" "12/13" "extrathyroid" "NYU" "NFVPTC" "μL"
    "=0.0001" "WM" "ElShamy" "BRCA1-IRIS-" "no/low" "~1000bp" "co-silencing"
    "siLuc" "siHuR" "siGFP" "C-rich" "and 10h" "the last 10h" "10h" "pCBP2-"
    "pCBP" "AUF1-" "AUF" "24-168h" "5`-UTR" "168h" "IRISc" "IRISb" "IRISa"
    "3`-UTRs" "siLuc/no" "the last 24h" "BRCA1/p220 -mutant" "RT/qPCR" "3`-UTR"
    "expression/activation" "`-UTR" "triple negative/basal-like" "TN/BL" "HME"
    "negative/basal-like" "Caspase 3/7" "≤ 0.05" "one-half" "caspase3/7" "~50%"
    "ER +" "+ 3" "ABT-737/263" "the triple-negative subtype"
    "co-overexpression" "arisen" "0/I" "RCB" "SPY" "bHLHZ"
    "the most challenging receptor triple-negative subtype"
    "the most clinically challenging subtype" "mg/kg/dose" "∼70%"
    "hydrochinone" "which repairs O6-alkylguanine DNA adducts"
    "-alkylguanine-DNAalkyltransferase" "alkylguanine" "rs144848" "rs1805794"
    "rs12917" "Connecticut" "Non-significant" "ever/never" "Non-Hodgkin"
    "= 0.0024" "non-Hodgkin" "Frederick" "shNoxa" "~68kDa" "~42kDa" "shGFP"
    "bromodeoxy" "antagonist/killer" "-L-aspartate" "δN" "-L-aspartate (PALA)"
    "phosphonacetyl" "Biscardi" "Jaganathan" "3~3.5" "Sec61β" "siLYN" "siYES"
    "non-RTKs" "translocon" "importinβ1" "~70%" "~3.5" "~ 3-fold" "~4-fold"
    "LKR13" "pBabe" "12-week" "24-weeks" "18-weeks" "T/L" "p=0.006" "PAK1/2"
    "AACR" "Gelmon" "commonalities" "Vencken" "platinum/cyclophosphamide"
    "carboplatin/docetaxel" "Histology" "at 5-years" "IRB"
    "BRCA-associated EOC" "sporadic EOC" "EOC" "= 5 × 10" "= 0.08"
    "humans cause severe congenital neutropenia" "neutropenia"
    "megakaryocytic lineages" "homozygotes" "0.97–1.41" "GM19240" "monomethyl"
    "orangutan" "multispecies" "CAGTGATTTG" "GATT (AATC)" "AATC" "GATT"
    "CAGAGATTGC" "TTGC" "18q21" "8q23" "rs16892766" "rs4939827" "T-allele"
    "the original CRC-associated SNP rs4779584" "rs4779584" "rs67491583" "GFI"
    "the colorectal cancer (CRC) risk variant rs6983267" "rs6983267" "8q24"
    "= 1.7" "GRCh37" "+ 1" "Massagué" "Paget" "HEARD" "internet"
    "the last 262 bp" "Tanas" "both multifocal EHEs" "EHEs"
    "the longer introns" "EHE#2" "the exonic breakpoint" "the last 464 bp"
    "EHE#1" "sinusoids" "Intra" "MF/50HPFs" "only minimal cytologic atypia"
    "underwent partial hepatectomy" "hepatectomy" "multicentric hepatic EHE"
    "multifocal EHE" "EHE" "thrombus" "7p"
    "Numerous previously published large-array CGH datasets" "Gaedcke"
    "7p22.1-p15.3" "D10S190" "D10S173" "MBp" "D10S1765" "D10S541"
    "10q22.3-qter" "Microsatellite" "7p11.2" "10p" "16p" "18q" "8p" "16q" ".1-"
    "P = 0.001" "both benign ACAs" "ACAs" "placode" "otic" "Affadin" "cylinD1"
    "Topoisomerasse" "Clv" "Maml" "non-cell" "Red+/90%" "Red+/10%" "Red+"
    "dsRedII" "Non-cell-autonomous" "NL" "RKE" "non-cell-autonomous" "omain"
    "Delta-like" "Jag1KD" "DNMaml" "p=0.05" "=0.35" "-6" "autophos" "ER- α 36"
    "Tsai" "prophylactic ovariectomy" "ovariectomy" "&beta" "5b" "specifc"
    "ER-α66" "ER-α36" "E2β" "phosphorylationbut" "non-monotonic" "on/off"
    "serosa" "Paley" "the peritoneal washings" "peritoneal washings"
    "laparotomy" "The benign PWC" "relevant tubal" "Colgan" "BRCA1 or"
    "submucosa" "relevant abnormal tubal" "laparoscopy" "cytopathologists"
    "underwent RRSO" "7-mm" "a bilateral mastectomy" "whose PWC"
    "the concurrently acquired PWCs" "abdomino-pelvic washings" "washings"
    "abdomino" "1–6" "risk-reducing salpingo- oophorectomy (RRSO)"
    "oophorectomy (RRSO)" "salpingo-" "benign PWCs" "tubal"
    "suspicious or malignant PWCs" "the 2 atypical PWCs"
    "peritoneal washing cytology (PWC)" "cytology (PWC)" "RRSO" "salpingo"
    "PWCs" "PWC" "a 10-year" "–6" "confounder" "non-genetic" "Busselton"
    "=2.0×10" "rs6785065" "4q28" "4q24" "15q23" "±0.04" "C-allele" "rs4831760"
    "annual FEV1" "rs9316500" "P=4.8×10" "SVEP1" "13q14.3" "MUSK" "DLEU7"
    "8p22" "spirometry" "FEV1/FVC" "FEV1" "British" "ARIC" "non-asthmatics"
    "ECRHS" "SAPALDIA" "EGEA" "FVC" "P=2.3×10" "P=3.3×10" "=1.3" "=0.61"
    "P = 5.3×10" "P≤0.05" "P=5.3×10" "P=0.03" "hyper-" "carotid" "the most
significant SNP"
    "G-allele" "rs10761741" "the most significant BAK1 SNP" "rs210134" "ARP2/3"
    "anucleate" "The last 2
SNPs"
    "rs6490294" "rs342296" "17q11" "only 684 bp" "rs342293" "A-allele"
    "all previously
reported SNPs"
    "rs8109288" "19p13" "7q22" "6q23" "6p21" "= 1.1×10" "9.4×10" "rs151361"
    "SLMO2" "rs4930420" "rs477895 " "rs477895" "The most significant SNP"
    "rs7896518" "Yoruban" "rs1935" "WHI" "rs17154155" "2.8×10" "rs13236689"
    "hematocrit" "CARDIA" "rs12526480" "Hispanic Americans"
    "all genome-wide significant SNPs" "Lettre" "JHS" "Jackson" "12q24"
    "Hispanic
Americans"
    "7q11" "10q21" "20q13" "= 5×10" "= 0.81" "= 1.4" "p = 3.3×10" "1.6×10"
    "= 0.39" "N = 4" "N = 3" "p = 2.3×10" "6p22" "PCRs"
    "anthracyclines/mitomycin" "Oncotype" "prognoses" "Jiang" "FUMI" "_033899"
    "L2/L3-" "L2/L3" "tertile" "UICC" "mitomycin" "insertions/deletions"
    "possible POO" "8p24" "genes/regions" "the maternal genome"
    "maternal genotypes" "some untyped causative SNPs" "odorant"
    "the associated SNP" "microform" "6p23" "the maternal and fetal genomes"
    "rs1834570" "rs2383658" "The most significant TRIMM" "actual SNPs"
    "rs10174126" "rs17138064" "QQ" "CLP" "CL" "CL/P" "POO" "affecteds" "OC"
    "Denmark" "Norway" "neither maternal genome" "TRIMM" "=20" "=2.3×10" "−6"
    "Chemoresistance" "Dulloo" "PPXY" "Costanzo"
    "the most well-defined transcriptional co-activator" "heterotetramers"
    "-helix" "ɛ" "arrest/apoptosis" "non-stressed" "stents"
    "re-endothelialization" "erythrocytes" "μl" "n  " "SDF" "neointima" "*P  "
    "TUNEL+" "n  = 4" "12 h" "* P  " "= 6" "De-differentiated" "MKc" "ploidy"
    "imidazoquinazoline" "anti-myeloproliferative" "diphosphate" "mature MKCs"
    "immature MKCs" "Florena" "Cas-3+" "Ann" "MKC" "angrelide (ANA)"
    "angrelide" "myeloproliferatine" "anagrelide"
    "Essential thrombocythemia (ET)" "MKCs" "p  = 0.001" "= 0.43" "p  = 0.004"
    "p  = 0.03" "3 h" "× 10" "= 0.04" "p  = 0.02" "primary Sjögren's"
    "conjunctiva" "Nguyen" "Katsifis" "Loures" "Aliahmadi"
    "a unique CD4 + T-cell subset" "IL-17-producing non-T cells" "Mosmann"
    "immunopathology" "exocrine" "Sjögren's" "exocrinopathy" "Sjögren"
    "primary Sjogren's" "Sjogren" "Th17" "toll-like" "Amygdala" "Ressler"
    "Maguschak" "Rosiglitazon" "Morris" "accumbens" "atomoxetine" "venlafaxine"
    "reuptake" "depressive-like" "neuromodulators" "manic-like" "Ser33/37"
    "Scottish" "existing neural circuitry" "substantia" "co-occur" "mEPSC"
    "mEPSCs" "Synapse" "Inestrosa" "uterine epithelia"
    "endometrial cancer biopsies" "Tricostatin"
    "the top-ranked compounds significantly ( P <0.01) anti-correlated"
    "Withney" "non-endometrioid" "Oestrogen" "an external dataset" "P =0.002"
    ".1–" "P =0.006" "n =76" "P =0.003" "Pattje's" "Pattje" "Tonorio" "Perez"
    "Tsutsui" "Perren" "Califano" "postoperative radiochemotherapy"
    "radiochemotherapy" "prognose" "unfavorable LRC" "84/132" "4/15"
    "cavity/oropharynx" "42/73" "LRC" "CAIR" "= 0.033" "p = 0.035"
    "non-significant" "p = 0.15" "Five-year" "p = 0.006" "∼90%" "8 Gy" "462v5"
    "451v5" "serine 456v5" "LQRMLPSL" "-2D" "-2A" "NLSs" "451/462" "T10"
    "SS451,462AA" "SS158,309AA" "phosphoserines" "immunocomplexes" "NDV"
    "Newcastle" "anti-T7" ". 1–" "insulin-like" "HNF-3β" "NFY" "V/3" "+43"
    "+52" "III/7" "III/5" "+72" "NheI" "IV/4" "V/0" "III/0" "IV/0" "III/8"
    "DNaseI" "+182" "the residual 550 bp" "Tumourigenic segregants"
    "segregants" "Jeghers" "Peutz" "5 /6" "3 h" "non-denaturing"
    "co-transfections" "10 bp" "only two potentially functional SNPs"
    "noncarida" "non-significantly" "IDMS" "polyphosphoinositides"
    "four possible hapolotypes" "hapolotypes" "HAPLOTYPE" "CG/CC" "AG/GG"
    "rs11187870 C" "rs2274223 G" "the wild-type homozygous genotypes"
    "1.05–1.50" "1.14–1.60" "CG+CC" "AG+GG" "disquilibrium (LD)" "rs11187870G"
    "disquilibrium" "SNPinfo" "rs2274223A" "polyphatidylinositol" "noncardia"
    "10q23" "Eastern Europe" "Further real-time PCR" "rs11187870C" "rs2274223G"
    "rs11187870" "rs2274223" "= 1.04" "= 1.12" "= 0.96" "non-cardia"
    "P  = 0.028" "P  = 0.001" "non-synonymous" "= 0.65"
    "Conclusions/Significances" "nucleoplasmic mycBirA*LaA"
    "no available primary amines" "EDMD" "Dreifuss" "Y2H" "protein C15orf38"
    "C20orf30" "CXorf56" "SLAP75" "SAMP1" "TMPO" "exogenous biotin"
    "myc-BirA*LaA" "*LaA" "available free biotin"
    "the highly reactive yet labile bioAMP" "bioAMP" "BAT"
    "the biotin biosynthetic operon" "operon" "laminopathies"
    "a filamentous protein meshwork" "meshwork" "lamina" "LaA" "BioID" "2H"
    "B-type" "A-type" "epigenome" "DR-GFP" "EJ5-GFP" "shSIRT1-3" "Ag3"
    "tenovin" "Ag" "phosphoribosyl" "3 ×10" "non-homologous" "/II" "shSIRT1-2"
    "shSIRT1-1" "as 1 μM" "MdmX3SA" "Linares" "heterocomplex" "Itahana"
    "homoduplexes" "ene" "ew" "inute" "ouble" "xerostomia" "dysphagia"
    "circuitries" "significantly younger" "UDSCC2"
    "clinically relevant rapalogs" "two clinically relevant rapalogs" "NOKSI"
    "SCC47" "immunostainings" "p16+" "Thailand" "Mexico" "Argentina" "America"
    "NIDCR" "the squamous epithelia" "CCSCC" "HPV+" "=21" "gb"
    "a distance-dependent dielectric function 4 R  ij" "ij"
    "The conformational entropies" "entropies" "MSMS" "Onufriev" "non-polar"
    "int" "nmod" "Amber10" "the last 2 ns" "Ewald" "steepest" "solute" "sander"
    "Amber 10" "octahedron" "counterions" "Lennard" "GAFF" "RESP" "HF/6-31G"
    "ff99SB" "imidazole" "carbonyl" "CH–π" "alkyls" "phenyl" "α4/α" "ele"
    "nopol" "vdw" "the previous RMSD" "Boltzmann" "Phan" "LTFEHWWAQLTS" "WK23"
    "WK" "Popowicz" "non-peptide" "GBSA" "Δ S" "Δ G" "Claudin-1was"
    "mild dysplasia" "severe dysplasia" "Claudin-1 was" "altrations"
    "Domínguez" "Franci" "nontumorous colon epithelium" "ectodomains" "Snail-3"
    "Smuc" "membranous/cytoplasmic" "nontumorous epithelium"
    "cytoplasmic/nuclear" "Snail-1" "indirect immunohistochemistry" "p = 0.034"
    "= 0.026" "p = 0.009" "β-catenin/Tcf" "= 0.0001" "YANG" "CHEN" "Xiao"
    "NUCC" "peritoneal mesothelium" "mesothelium" "HPMC"
    "epidermal growth factor receptor-2" "mesentery" "radix"
    "Lenti-miRNAc-Met-neg" "α3β1" "pCMV-c-MetmiRNA-825" "pCMV- c-MetmiRNA-825"
    "hyperchromasia" "human peritoneal mesothelial cells (HPMCs) monolayer"
    "HPMCs" "peritoneum" "PFCCs" "co-transfecting" "2 h" "anti-human"
    "12q24.31" "2p21" "the renal tubular epithelium" "rs7939721"
    "the causative polymorphism" "tagSNP" "rs678653" "rs7177"
    "heterozygous SNPs" "KTCL140" "RNApol2" "rs77247065" "rs7948643" "CCDN1"
    "re-introduction" "an active enhancer" "FAIRE" "RCGTG"
    "the RCC-associated SNP" "Pairwise" "rs7105934" "sporadic ccRCC" "ccRCC"
    "ccRCCs" "intergenic polymorphisms" "Non-parametric" "16h" "=0.08"
    "promoter/enhancer" "expressio" "S6RP" "cytoarchitecture"
    "transdifferentiate" "retinol" "droplets" "Disse" "NAFLD" "1/10"
    "urothelium" "Blehm" "erbB" "μ mol/L" "SUMO-interacting-motif-like" "MIU"
    "pSXXT" "pT-3" "Mdc1-like" "co-purifying" "pS64/pT67" "pS64"
    "approximately 10-fold less progeny" "these input viral genomes" "shRNF8"
    "HFFF" "shNeg" "ΔICP0" "ICP0-nls241" "phosphoamino" "TELF" "phosphosites"
    "the viral genome" "RNF8-" "RNF" "TQXF" "phosphosite" "co- transfected"
    "co-stained" "re-localizes" "wild type/mutant" "micrographs" "208G4"
    "a triple negative genotype" "Polo-like kinase-1" "re-examined" "= 0.011"
    "= 0.007" "= 0.041" "= 81" "= 21" "antagonise" "active RhoGTP" "RhoGTP"
    "discernible lamellipodia 2 h" "RacL61" "Pak1 phosphorylation"
    "plexinB1 with" "RacL" "RhoDGTP" "A5359G" "A5653G" "RacGTP" "axon"
    "PDZRhoGEF" "anti-Human" "8/9" "non-oncogenic" "pharmacological/natural"
    "cispatin" "oxaloplatin" "repair/tolerate" "non-covalent" "intradomain"
    "Sluis" "Menten" "Michaelis" "–non-specific" "interdomain" "QPIF" "RKLKK"
    "COS-1" "kbp" "Centenera" "LxxLL" "FxxLF" "A765T"
    "the extremely active mutation A586V" "A587S" "A586V" "VKSE" "IKLE"
    "PSTLSL" "A234T" "Overview" "only GRE 2 -TATA-Luc" "PSA61Luc" "-TATA-Luc"
    "Haelens" "10/11" "co-repressor" "p16/INK" "DNp63" "activationdid" "γH2-AX"
    "AX" "expression/activity" "eukemia" "ro"
    "differentiated luminal secretory epithelium" "ΔNp63" "ARNSM"
    "secretory luminal epithelium" "andromedins" "24 hrs" "±0.3 µ" "WST-1"
    "non-genomic" "clearer" "pro-apoptotic Bcl-2 homologs"
    "consequent distinct engagement/roles" "IEC" "P4C10"
    "a consequent promotion/maintenance" "sip85β " "sip55γ" "sip85β" "sip85α"
    "sip110β" "sip110α" "siCNS" "ISEL" "R/C" "IP/co-IP" "apoptosis/anoikis"
    "physiopathology" "recruitment/binding" "engagement/activation" "HIEC"
    "non-targeted" "≥ 3" "non-immortalized" "p85α" "Sahay"
    "the neuronal-specific RAS-GAP protein SynGAP" "SynGAP" "depression-like"
    "NSFT" "μ g/g" "3-month-old" "the immature neuronal marker Dcx"
    "8-month-old" "glia" "Dcx" "SVZ" "littermate" "theDTA" "withNestin" "DTA"
    "SGZ" "theNestin" "CreER" "antidepressive-like" "anxiety-like" "DG" "= 11"
    "μ g/ml" "Darby" "Madin" "synthesis/degradation"
    "the postnuclear supernatant" "the postnuclear supernatants"
    "the intestinal villi" "deeper" "Tfn" "deepest" "apicalmost" "xz" "xy"
    "refolding/rephosphorylation" "pT555" "Ponceau" "cyclo" "BX-912" "BX"
    "iPDK" "overexpressors" "intestinal villi" "villi" "Hsc/Hsp70" "Krt"
    "PKCι/λ" "inhibitors—BX-912" "∼1.5" "μ1" "microglialcells" "neuropathology"
    "rebalance" "an average Pearson’s" "GSE21138"
    "generating pro-inflammatory prostaglandins" "Harvard" "=76" "ALOX" "PTGS"
    "pathophysiology" "mg/kg/day" "n=4" "Log2" "_2" "YAP1_1" "AllStars" "Neg"
    "p-YAP1" "HPNE" "hTERT" "HPDE6" "pancreatitis" "MST1/2" "LATS1/2" "Yorkie"
    "Kendall's" "Spearman's" "Kendall" "Wilcoxon" "G0/G1" "_1" "= 0.011"
    "72 hrs" "co-activator" "HBX" "MGC" "Ets-1/IRFs/DNA" "IRFs/DNA" "Ets-1/DNA"
    "Igλ" "Igκ" "EICE" "GAAAAC" "uterine cervical epithelia"
    "oligodeoxynucleotide" "isotypes" "κPU" "DNA/protein" "Biotin"
    "mtconstruct" "ofpβ-3" "E κ" "Kim" "TTTGGGGAA" "Igκ-expressing"
    "the intronic enhancer" "Two important kappa enhancers" "iE"
    "Immunoglobulin" "PU" "Igs" "lane 7" "superaggregates" "containLAT"
    "an added multivalent antigen" "Wilson" "immunogold" "Sol" "Monine" "hoc"
    "molecues" "supperaggregate" "andvalues" "simulatedvalues"
    "differentvalues" "4.2molecules/cell" "7.5and" "fixedvalue" "forare"
    "fixedvalues" "andat" "thevalues" "simulatedcurves" "finite non-zero"
    "whichgoes" "ofat" "andandheld" "threevalues" "thatincreases" "valueand"
    "Superaggregates" "criticalvalues" "eachvalue" "8.4molecules/cell"
    "fractionof" "Eqs" "ofper" "andin" "Goldstein" "Perelson" "Carlo" "Monte"
    "sol" "bi-" "YXNX" "FcRI" "superaggregate" "and 2∶1" "a 2∶1" "Wildtype"
    "the unique C3/N1" "C3/N1" "only 6 bp" "+496" "NICD3/CSL"
    "normal ovarian surface epitheliums" "epitheliums"
    "a previously published transcriptome dataset" "BioMart" "GTTGCCAT"
    "TTCCCA" "NICD3" "NimbleGen" "NICD1" "otch" "PEST" "Transcriptome"
    "p = 0.005" "BRCA1-like" "aneuploid" "classifiers" "special algorithms"
    "GEMM" "*con" "Xa" "2-3" "Utx" "Xi" "Barr" "KB1PM" "femaleK14cre" "5/22"
    "non-responders" "Lzp" "theK14cre" "sarcomatoid" "Orina" "Sentrix" "MEEBO"
    "KB1P" "F/F" "GEMMs" "1P" "three-day" "RAFvs" "MEKi" "RNA/cDNA" "#13"
    "viral titers" "Modest V600E B-RAFover-expression" "B-RAFover-expression"
    "RAFwhich" "RAFor" "RAFgDNA" "RAFgain" "gDNA" "#5"
    "our bioinformatic workflow" "workflow" "nsSNVs" "gDNAs"
    "AZD6244/selumetinib" "RAFcopy" "RAFi" "pmol/L" "insertion/deletions"
    "Kaituo" "Shangdi" "Meng" "Sen" "Yat" "Feng" "Mengyao" "Try705"
    "a Spearman's" "spearman" "APRE" "ΔSEC" "dada" "SEC14p" "ErB2" "xl"
    "PTPMeg2" "= 0.023" "p = 0.004" "P ≤ 0.05" "STAT5a/b" "falciparum"
    "punctate-like" "cyclic-di-GMP" "Burdette" "ISD" "monocytogenes" "IFI-16"
    "PYHIN" "IFI" "endolysosome" "MPYS" "prion-like" "HSV-1" "~1.5-fold"
    "overridden" "non-epithelial" "Non-epithelial" "184A1"
    "the dual PI3K and mTOR inhibitor PIK-90" "quantitative real-time PCR"
    "-hydroxytamoxifen" "hydroxytamoxifen" "IGF-1-stimulated" "Covariate"
    "~2-fold" "HCIF" "miR-221/222" "Wiedemann" "Beckwith" "-trisphosphate"
    "-bisphosphate" "~1.5" "PIK-90" "IGF-1 -mediated" "co-stimulation" "H-bond"
    "kcal·mol" "Calc" "kcal" "·mol" "acyl" "P+4" "phophotyrosine" "fluorophore"
    "viz" "Vina" "AutoDock" "TLNSDGpYTPEPA" "pYTPEP" "SMIs" "decouple" "UBCs"
    "TKB" "SAR" "~8-" "± 0.3" "-naïve" "Freyberg" "interwoven" "Kapur" "–naïve"
    "possible confounders" "PANSS" "iIlness" "eta" "df "
    "heterogeneous biological underpinnings" "wel" "prepulse" "N = 15" "= 30"
    "= 39" "N = 8" "= 21" "= 20" "= 29" "syncitia"
    "the unsubstituted 4-amino DFP pharmacophore" "pharmacophore" "-Lyte"
    "Lyte" "Nef:SH3" "Y/F120" "M-group"
    "4-amino-substituted diphenylfuropyrimidine (DFP)" "diphenylfuropyrimidine"
    "PxxPxR" "AIDS-like" "non-progressors" "clades" "aminobutanol"
    "aminopropanol" "4-amino substituted diphenylfuropyrimidines"
    "diphenylfuropyrimidines" "HIV-1 infections" "down/stop" "β1/β4"
    "keratynocytes" "cell migration/invasion" "migration/invasion" "TGF-βRII"
    "activating protein-1" "sialyl" "integrin-β7" "ITG" "fc"
    "comparative transcriptome" "EV9" "EV18" "M4-2-10" "XL" "Bcl" "G2M phase"
    "EGF3+1+2" "proliferation/differentiation" "Carraway" "EGF-like" "MUC4β"
    "MUC4α" "apomucin" "p = 0.09" "= 0.19" "= 0.017" "±0.4" "subG1" "/Tyr182"
    "VavP" "lpr" "Varmus" "only BCL-X L -GFP" "-GFP" "Mock/MYC-"
    "all moribund Mock/MYC" "Immunohistochemical stainings" "-f" "f" "DBA/2"
    "AML-like" "+7" "Mock/Mock" "non-coagulating" "Mock/MYC" "Necropsy"
    "theFLIP" "Eμ-" "Trisomy" "failsafe" "co-transduced" "Ctsk" "tartrate"
    "PDGFbb" "titers" "venules" "Synovial fibroblasts form pannus" "100 ng/mL"
    ":2" "Twenty-one" "KIAA0583" "wt-" "ΔPBM" "independant" "ΔNT" "3PDZ"
    "DLGCT" "72hrs" "12hrs" "24hrs" "de-regulation" "PBM" "apico"
    "the imaginal disc epithelium" "co-precipitating" "ΔSH3"
    "the developing mouse genital tubercle" "gonads" "taking OCPs" "OCPs"
    "the ambisexual genital tubercle" "tubercle" "Jost" "ambiguous genitalia"
    "external genitalia" "incompletely virilized external genitalia"
    "genitalia" "CAGGTG" "basale" "Immunocystochemistry" "penile" "urethra"
    "utero" "hypospadias" "Hypospadias" "severe hypospadia" "hypospadia" "PcR"
    "BCR-ABL + S6K1" "siS6K1" "Cpt1c" "CPT1C" "carnitine"
    "1-β-D-ribofuranoside" "BCR-ABL+ S" "BCR-ABL + S" "BCR-ABL +" "BCR-ABL+"
    "timepoint" "myrAkt" "redirect" "μg/mL" "HDAC1- 3" "non-Hodgkin’s"
    "HDAC1-3" "cervical dysplasias" "sirtuins" "~10%" "Non-histone"
    "non-histone" "Boothman" "Zou" "Luo" "wtp53" "B5-sCLU" "b5-sCLU" "Scr"
    "13C4" "non-irradiated" "message-2" "Greater" "TβRII+" "~3-fold" "Thyd"
    "AKTKD" "PTENCA" "=0.987" "psCLU" "luminometer" "hCLU" "‘biodosimeter’"
    "non-linear" "IGF-1-sCLU" "secretome" "Biodosimeters" "biodosimetry"
    "biodosimeter" "PCC" "‘biodosimeters’" "biodosimeters" "radionuclide" "cGy"
    "sCLU" "≤10" "D-luciferin" "mg/Kg" "FVB/N" "normal colonic epithelia"
    "DLD1" "Δ1139" "PHLPPs" "Sowa" "occurrs" "homohexamer" "ribosomopathies"
    "absorbance" "Kit-8" "pcDNA" "5q-syndrome-associated"
    "a congenital erythroblastopenia" "erythroblastopenia" "RPL5-" "RPL11-"
    "RPL" "Tris/HCl" "lane 3" "a larger dataset" "qMSPs" "neurooncology" "Dunn"
    "Rivera" "Parrella" "Parella" "PCR (MSP)" "PMR" "a tabular overview"
    "Stupp" "quantitative methylation specific PCR" "qMSP" "primer/probe"
    "= 58" "2 Gy" "n = 10" "Framingham" "Yende" "coagulant" "PaO2/FiO2"
    "the primary=cause" "anoxia" "allografts" "procoagulant"
    "an acute phase reactant" "reactant" "multiorgan" "Oakland" "CTDN" "allo"
    "geno" "ocause" "4G/4G" "4G/5G" "thrombi" "P = 0.03" "= 0.8" "= 0.57"
    "p = 0.05" "p = 0.03" "p = 0.02" "Non-Hispanic" "Hu" "Ackermann" "Kyoto"
    "Shinyaku" "Nippon" "HMN" "Middlesex" "GlaxoSmithKline" "S4B" "shNTC"
    "shPLK1" "S4A" "Germany" "Ingelheim" "Boehringer" "dihydropteridinone"
    "siPLK1" "siPLK" "pediatric cerebellum" "UPN"
    "normal pediatric and adult cerebellum" "fetal cerebellum" "cerebellum"
    "cranio" "S2B" "non-silencing" "≥ 3" ": 2" "PCK" "pathological endometria"
    "endometrium" "FAI" "Endometrium" "hyperinsulinemia"
    "biochemical hyperandrogenism" "hyperandrogenism" "hyperinsulinism" "HESC"
    "Immunocytochemistry" "NPE" "HESCs" "endometria" "GEC" "Cepero" "anti-Met"
    "HGF/Met" "rechallenge" "copy/cell" "non-signet" "CEP7" "/cell" "≥2"
    "polysomy/FISH+" "copies/cell" "Cappuzo" "anasarca" "hypodense" "FOLFOX"
    "MacDonald" "gallbladder" "cholecystectomy" "lymphadenectomy" "gastrectomy"
    "the gastric incisura" "incisura" "year-old" "15mg/kg" "PITPNC1"
    "lipopolysaccaride" "Fujita" "Assisi" "rs6517590" "rs6023059" "halfsite"
    "flowchart" "Weickert" "Postpartum" "postpartum" "life-time" "CIDI"
    "polymorphism (SNP)" "= 0.023"
    "some supratentorial deep-seated infiltrating HGG" "hemispheric HGG"
    "diagnostic DIPG" "recurrent DIPG" "immunochemistry" "PBTC" "armentarium"
    "ectodomain" "2/206" "pediatric DIPG" "pediatric HGG" "co-deletion" "19q"
    "pHGG" "IDH1/2" "Olig" "amplifications/mutations" "other pediatric HGG"
    "epithelio" "phenomenons" "the more differentiated PDGFRA-driven DIPG"
    "the pediatric DIPG" "midline/thalamic" "midline/thalamus" "Monje"
    "supratentorial HGG" "fossa" "Pediatric DIPG" "gain/amplification"
    "other pediatric supratentorial HGG" "astroglia" "OPC" "5 neural linages"
    "Cahoy" "linages" "IGRG82" "3/34" "gastro" "CHIC2" "Amplification/mutation"
    "resembled mesenchymal subtype" "phenocopies" "stem-like"
    "a more astrocytic histology" "FDRq " "4q12" "HGG" "midline" "15/27" "7/32"
    "CDKN2A/B" "CAV1/2" "PTPRN2" "CGHarray" "Midline/thalamic" "arrayCGH"
    "microg" "61 patients underwent stereotactic biopsies" "Necker"
    "Neurosurgery" "Biopsy" "stereotactic biopsies" "neuro" "ie" "brainstem"
    "CGHarrays" "stereotactic biopsy" "DIPGs" "DIPG" "pontine"
    "autocrine/paracrine" "= 0.052" "3/8" "= 0.034" "= 0.8" "= 0.02" "9/13"
    "= 0.01" "= 0.041" "Adr-treated hESCs" "SSEA4" "the distal p53RE"
    "the proximal p53RE" "p53RE" "exogenous p53WT"
    "mesodermal marker Brachyury" "p53R175H" "∼4-" "p53WT" "siControl" "p53REs"
    "pluripotent hESCs" "Pluripotent hESCs" "p53K373ac" "circumin"
    "Co-Immunoprecipitation" "10 ng/ml" "mTeSR1" "S2A" "S1C" "Nikitin"
    "De Marzo’s" "Marzo" "overtaken" "p53+" "Ariol" "ofCXCR2" "SCNCs"
    "an important histological subtype" "non-NE" "sheet-like" "~1%"
    "Ser866/870" "GSK3 is" "retroviruses" "4×NES" "inFbxw7" "KRRK" "×NES"
    "ΔNES" "Fbxw7γ" "Fbxw7β" "GSK3i" "Ser 866/870" "Ser707/711Ala"
    "phosphodegron" "degron" "FLAG–HA-tagged Fbxw7α" "HMMCLs" "lymphotoxin"
    "xenotransplant" "Fbxw7α" "re-instates"
    "neurodegeneration-associated neurotoxic stressors" "Aβ-" "Braak" "Cdk5cKO"
    "Hdac2-" "Hdac" "GR526" "-GRE" "PGR1" "GR1" "GRE" "42-1" "Aβ" "radiatum"
    "shHDAC2" "H4K12" "AAV" "NuRD" "Stg" "Nfl" "amygdala" "Co-IP"
    "CpG-A–DOTAP–" "propyl" "dioleoyloxy" "DOTAP" "liposomes" "plasmacytoid"
    "ubiqui" "anti-Flag" "ubiq" "PYD" "coex" "NLRP4g" "NLRP4b" "ISG" "dA:dT"
    "renilla" "soluble or bound non-specifically" "non-specifically" "QK"
    "the residual H3K56" "some residual H3K56" "octamers" "H3/H4"
    "histone chaperone Asf1a/1b" "K9A" "K56A" "Foiani" "Branzei"
    "replication-independent histone H3.3" "H3.3" "K56R" "K56Q" "H3K27" "H3K"
    "Heterochromatin Protein 1α" "~0.8%" "H3K56ac" "H3K56"
    "the nucleosomal DNA superhelix" "superhelix" "H3K9"
    "experimental allergic encephalomyelitis" "encephalomyelitis" "Bay117085"
    "Eugui" "and 2h" "100 ng/ml" "EpiSCs" "‘naïve’" "Lyashenko" "Voskas" "XV"
    "GSKi" "Igfs" "Activin A/Nodal" "mTesr1" "caSmad3" "EKAR" "100ng/ml" "pGsk"
    "+HAI" "MEF-CM" "StemPro" "SFM" "hESC" "hiPSCs" "mESCs" "endoderm"
    "mesoderm" "Goosecoid" "mesendoderm" "hESCs" "Activin A/Smad2,3" "GFP +"
    "tumorspheres" "JLO-1" "Dontu" "CD44 +" "HNSCCs" "CD44+" "Cytokeratin5/14"
    "tumorsphere" "UMSCC" "& D" "Ba/F3-BCR-JAK2-treated" "Abelson"
    "undetectable MRD" "CML-like" "breakpoints" "anti-pSTAT5" "anti-pTyr"
    "JAK2V617F" "pSTAT5" "pJAK2" "pLZR" "pLZR-IRES-EGFP" "CMR" "MRD" "300-kb"
    "eosinophilia" "Philadelphia" "in 1X" "hg18" "+19" "CD34 +" "non-receptor"
    "Hilgendorf" "responders" "J774" "BMDM" "mmLDL" "an important transducer"
    "PCE" "intronless" "re-stimulated" "Endpoint" "Ct"
    "followed IL-7 re-addition" "re-addition" "Jak1/Jak3" "nonlymphoid" "HXKII"
    "IkBs" "co-chaperone" "M∼2 µ" "anti-myeloma" "U/mL" "Savino" "RKKLR"
    "KRAHHNALERKRR" "AF488" "Max*HA" "vide" "*HA" "RRMKANARERNRM" "HLHLZ"
    "Omomyc/Max" "Evan" "Soucek" "E-Box (CANNTG)" "CANNTG" "PTD" "Omomyc"
    "omomyc" "v / v" "1 p" "E-Boxes" "E-Box" "viral polymorphisms" "10/15"
    "co-infection" "Kaposi's" "high grade non-Hodgkin's" "Blake" "Kong" "Hong"
    "5/5" "Vietnamese" "_33F144I/D150A/L151I" "Alaskan" "China1" "Dolcetti"
    "the relevant polymorphisms" "F144I/D150A/L151I" "I124V/I152L" "AG876"
    "Telenti" "Edwards" "the unique polymorphism" "/B95-8" "/P1" "NaeI"
    "GeneBank" "non-toxic" "Polymorphism" "HAART" "the exact polymorphisms"
    "Burkitt's" "D150A/L151I" "SHCS" "Swiss" "Hodgkin's" "Hodgkin"
    "Freud1/Aki1" "Higuchi" "Shiota" "Gi" "Uesugi" "Abcam" "Dufour" "Fukuda"
    "realise" "epithelial-like" "non-target" "non-adhesive"
    "relevant molecular readouts" "readouts" "WRD5" "LOF" "BIOGPS"
    "dprohibitins" "Lumicycle" "_997201" "CXORF39" "YWHA" "CRYPTOCHROME"
    "TAPTag" "eluates" "non-reducing" "eluate" "dithiobis" "thio" "CK1δ-"
    "CK1δ/ε" "BMAL" "CRYs" "CRYPTOCHROMES" "a cell-based circadian readout"
    "CK1ε" "CK1δ" "pCDNA3" "ε 1" "co-purification"
    "the only active immunomodulin" "other biogenic amines" "amines"
    "foodborne" "scombroid" "fecal" "lactose" "thermophilus"
    "only four genomes" "NEC" "microbiota" "IECs" "Peyer's" "enterocolitica"
    "Peyer" "dimaprit" "a probiotic immunomodulin" "immunomodulin" "dcAMP"
    "dibutyryl" "the bacterial supernatant" "pyrilamine" "chlorpheniramine"
    "HMPREF0536" "RecT" "HdcA" "hdcA" "pyruvoyl" "hdcP" "non-TNF-inhibitory"
    "quadrupole" "bacterial cell-free supernatants" "m/z" "LDMIIIS" "LDMIIIG"
    "qTOF" "electrospray" "TOCSY" "C-heteronuclear" "MetaboMiner" "HSQC"
    "monocytoid" "pouchitis" "Known strain-specific probiotic immunomodulins"
    "immunomodulins" "rhamnosus" "HILIC" "reuteri" "Lactobacillus" "v/v"
    "= 1.5" "D/N" "pg/mL" "3 were" "locally invasive and metastatic CRPCs"
    "lactone" "hydroxyethyl" "supra-additive anti-proliferative" "LY294002/Akt"
    "transrectal ultrasound-guided needle biopsy" "l/mL" "cytochome"
    "the dense prostaspheres" "partenolide" "l/ml" "no secondary prostasphere"
    "many dense prostaspheres" "-pEGFR" "speciments" "= 6–10" "*p" "±0.3"
    "non-malignant" "progenies" "non-SP" "dehydrogense" "stem cell-like"
    "anti-hormonal" "chemoresistant" "prostaspheres" "prostasphere" "NB26"
    "WPE1" "WPE" "cytokine-1" "anti-invasive" "non-adherent" "2+ " "1+ " "+3"
    "nPKC" "εV1-2" "its inactive analogue U73343" "U73343" "U73122" "ε2" "ε1"
    "AdVs" "chimaerin" "establishedby" "GF19203X" "bisindolmaleimide"
    "chimaerins" "classical/conventional" "myristate" "PKC θ" "#2" "#1"
    "linaclotide" "ofGucy2c" "armamentarium" "inGucy2 +/+"
    "human intestinal cell monolayers" "epiphenomenon"
    "normally compartmentalized lumenal antigens" "patho" "enteroendocrine"
    "Paneth" "lumenal antigens" "MyrAKT1" "azoxymethane" "Guca2a" "toGucy2c"
    "inGucy2c" "the intestinal epithelium" "the heat-stable enterotoxins"
    "enterotoxins" "akt murine thymoma viral oncogene homolog (AKT)"
    "homolog (AKT)" "chemoprophylaxis" "villus" "valuable polymorphisms"
    "maternal genotype" "the maternal genotype" "the neonatal genotype"
    "intron-1" "Kaneda" "detriments" "methylene-5THF" "haplotype " "Shandong"
    "rs34489327" "rs34743033" "dbSNP" "ASDs" "insertion/deletion"
    "-monophosphate" "CCSD" "Polymorphisms" "CCSDs" "folic" "case/control"
    "Tcf/Lef" "Enhancer" "Coli" "the pluripotent iPMSCs" "PC1/3" "Islet-like"
    "islet-like" "BIO-treated IPMSCs" "IPMSCs" "adhesiveness" "Tcf" "52.7±1.9%"
    "iPMSC" "follicle" "a finite proliferative lifespan" "Langerhans"
    "mellitus" "tunel" "iPMSCs" "6-bromoindirubin-30-oxime (BIO)" "5-Bromo-2"
    "cardia" "KCDC" "non-phosphorylated" "Non-phosphorylated" "multigene"
    "rs41737" "rs6124914" "rs41738" "rs6566" "rs41739" "-LRT" "immunodominant"
    "rs7208768" "rs6122566" "= 0.0013" "= 0.0001" "= 0.0004" "nmol/L" "= 1.33"
    "p  = 0.02" "p  = 0.03" "smoking/drinking" "95% CIs" "P -values" "n = 15"
    "= 1.1" "95% CI " "Brivinib" "GOG" "MoMaTEC" "Cheung" "Dutt"
    "smaller subsets" "Washington" "0.06–1" "1.09–3.65" "yrs" "46/401" "84/392"
    "25/149" "4/62" "29/249" "2/65" "17/152" "17/230" "7/71" "40/365" "8/88"
    "36/135" "4/17" "44/230" "1/71" "5/88" "80/365" "-wildtype" "44/377" "4/87"
    "158/466" "D32Y" "S33C" "88/454" "SIFT" "104/464" "87/464" "A391E" "48/466"
    "18/115" "systematic pelvic lymphadectomy" "myometrium" "lymphadectomy"
    "FIGO" "LVSI" "extrauterine" "endometrioid" "= 0.013" "11 p " "= 0.26"
    "= 0.019" "p = 0.009" "= 0.007" "= 0.048" "= 0.43" "p = 0.03" "p = 0.004"
    "= 0.04" "= 0.10" "= 0.08" "p = 0.002" "= 0.003" "= 12" "= 0.045" "= 0.23"
    "= 0.025" "= 0.008" "= 0.06" "p = 0.05" "P -value" "rs2234693" "rs9340799"
    "XbaI" "Pvull" "rs9383921" "≥0.05" "≥0.3" "GRS" "rs2046210" "4.6×10" "ORs"
    "P-value" "1.9×10" "Bonferroni" "3.8×10" "≤0.05" "IIa" "11q24.3"
    "rs7107217" "rs9383951" "6q25.1" "rs9485372" "P = 0.004" "n = 3" "= 0.05"
    "= 3" "= 4" "= 1.9" "of 45S" "Lessard" "activation/silencing"
    "re-establishment" "seeand" "NPM/B23" "5 × 10" "∼1.5 " "72 h" "12 h" "4B"
    "#3" "Concato" "Hygro" "LNsip" "Semi" "HepH" "H3K9ac" "USCS" "AACA" "CAES"
    "FoxA" "CEAS" "C4-2Bsip53" "TTS" "MDA-PC-2b" "LNsip53" "sip53" "siE6" "FKH"
    "cistrome" "Burchardt" "CRPCs" "analyis" "sequnce" "non-promoter" "Adepoju"
    "Calicchio" "Ranganathan" "Wu" "Sylvestre" "Donnell" "Inoki" "Bradham"
    "Nov" "several histological sarcoma subtypes" "ABT-510" "Potikyan"
    "Taraboletti" "Kaposi" "miR-19b-1" "noncell" "Kretzner" "Hamou" "Hadj"
    "amplification/overexpression" "Ugras" "amplicon" "5q35.3" "anaplasia"
    "multiple focal amplicons" "amplicons" "Subset" "Gordan" "Dews" "Baudino"
    "Albihn" "Eilers" "8q24.21" "Fayette" "Fletcher" "P = 0.05" "= 0.19"
    "= 0.06" "= 0.18" "= 0.15" "miR-18a" "WDLPS/DDLPS" "= 20" "= 23" "= 26"
    "= 12" "Koreans" "5615del11insA" "Jewish" "Ashkenazi" "ASCO"
    "Caucasian Americans" "prophylactic oophorectomy"
    "Both prophylactic mastectomy" "oophorectomy" "non-familial" "KOHBRA"
    "BRCA1 /2" "= 0.01" "≥10%" "BRCA1/2" "DLR" "caesarean" "ED" "Alzheimer’s"
    "OxLA" "trophoblast-like" "Non-transfected" "n = 4" "± 4.8" "TTCNNNGAA"
    "STATγs" "S/MARs" "Yoo" "withK" "apparentK" "Microscale"
    "parental plasmid pUC8" "pUC8" "heteroduplex" "spacer" "drawn" "pUC8F14C"
    "microscale" "-CAAAAA" "CAAAAA" "-AACAAA" "AACAAA" "-AAACAA" "AAACAA"
    "hexanucleotides" "S+330" "S+100" "+S100" "4.8-kb" "SphI" "TTCCGGGAA"
    "TTCCGGGAAN" "pGAS-TA-Luc" "STAT3α" "STATβ" "STATγ" "amma" "spacers"
    "p = 0.001" "elevated diagnostic WBC" "= 1.0" "=0.28" "=1.0" "1/35" "7/23"
    "cardio" "CCG-2911" "p=0.009" "=0.035" "lower diagnostic WBC"
    "high diagnostic WBC" "n=50" "non-APL" "higher diagnostic WBC"
    "Diagnostic WBC" "=15" "Korea" "FLT3/WT" "microgranular variant histology"
    "diagnostic WBC" "cells/uL" "Median diagnostic WBC" "FLT3/ALM" "=0.020"
    "=0.15" "=0.0024" "=0.024" "non-analyzed" "n=28" "p=0.005" "=0.009" "N=28"
    "=50" "anti-adhesive" "PC3-2/β5" "IGF-IRβ" "PC3-2/Mock" "PC3-2/Trop-2"
    "9EG7" "CLIBS" "PC3-1" "PC3-2"
    "the cAMP-degrading phosphodiesterase PDE4D5" "PDE4D5" "Trop-1" "spatio"
    "Trop" "PrCa" "=195" "±4.8" "/ 5" "non-immune" "&D" "SNPS" "1.05–3.23"
    "1.09–3.21" "AIC" "Fedorov" "the heterozygous genotype" "1.8–3.7"
    "rs4,648,308" "rs4,648,306" "rs4,648,291" "rs4,648,276" "rs689,464"
    "rs689,462" "SNP466" "Haplotype" "prostaglandis" "+ 2" "= 0.036" "= 1.12"
    "P = 0.034" "Rraf" "displayng" "Wallis" "Adjacent normal colorectal mucosa"
    "Whitney" "the Spearman's" "the superficial epithelium"
    "Normal colorectal mucosa" "Hanahan" "microsatellites" "45/63" "35/53"
    "C-terminally" "non-leucocytic" "exon −2e" "and −2c"
    "the previously identified exons −2b and −2a" "and −2a" "exon −2a"
    "and −2d" "exon −2d" "currently known first exons" "Ludwig" "NHLFs"
    "FirstEF" "Eponine" "≥0.6" "Txn" "MultiZ" "browser" "Ensembl" "PerkinElmer"
    "Multilabel" "Wallac" "complete medium only (unstimulated control) 24 h"
    "pGL3-exon-2e" "Stratagene" "QuikChange" "exon −2c" "OriGene" "BglII"
    "MluI" "MluI/BglII" "and −2e" "TOP10" "OneShot" "FirstChoice"
    "TaqMan Universal PCR Mastermix" "Mastermix" "Hs00180679" "Hs00933163"
    "_m1" "Biosystems" "SuperScript" "Qiagen" "RNeasy" "densitometer" "GS"
    "SDS/PAGE" "pH " "DMEM" "Lonza" "DOCA" "non–leucocytes" "non-leucocytes"
    "non-essential" "Exon −2" "exon-2" "exon −2" "exon−2" "exon −1"
    "Non-skeletal" "a lethal skeletal dysplasia" "mortems"
    "Our prevalence ofthanatophoric dysplasia" "skeletal dysplasias"
    "skeletal dysplasia" "severe costovertebral dysplasia"
    "possible Pacman dysplasia" "Levin" "Jarcho" "Fallot's" "tetralogy"
    "Fallot" "polyhydramnios" "Noonan" "had characteristic dysmorphic facies"
    "arteriosus" "truncus" "facies" "22qll" "George" "trisomy" "Karyotype"
    "karyotype" "Pacman" "a skeletal dysplasia" "lethal skeletal dysplasias"
    "femora" "French" "OMIM" "Lethal skeletal dysplasias" "trimester"
    "The genetic skeletal dysplasias" "0.07/10,000" "0.15/10,000"
    "thanatophoric dysplasia 0.80/10,000" "0.80/10,000"
    "the common skeletal dysplasias" "Thanatophoric dysplasia" "mortem"
    "Northern Ireland" "all perinatal lethal skeletal dysplasias (SD)"
    "thanatophoric dysplasia" "Ireland" "dysplasias" "dysplasia" "imperfecta"
    "Bacco" "= 0.020" "95% CI: 1.19-6.64" "P = 0.028" "95% CI: 1.08-3.94"
    "= 0.025" "HR: 1.92, 95%" "HR: 3.18, 95% CI: 1.43-7.11"
    "triple-negative subtype" "P = 0.019" "= 0.014" "= 0.033"
    "HR: 1.64, 95% CI: 1.04-2.60" "P = 0.003" "HR: 2.44, 95% CI: 1.34-4.44"
    "Lindemann" "7q31" "=0.019" "=0.014" "P=0.003" "Martingale" "/signal"
    "= 0.128" "P=0.006" "Sim" "MQPQQGFLNAQMVAQRSRELLS" "Nrf2/ARE" "EYFP" "ECFP"
    "pET28b" "R3B1" "R3B4" "R3B3" "R3C" "R3B" "R3A" "pasA" "siRAC3s" "siRAC3"
    "PasA" "PasB" "Pas" "co-regulators" "Neh5" "Neh4" "TGACNNNGC" "’n’"
    "glutamylcystein" "pasB" "oxygenase-1" "co-regulator" "n=3" "Anti-HA" "3B"
    "Bevan" "Lahdesmaki" "Ishibe" "Yuille" "Austen" "Pettitt" "non-damaging"
    "log-transformed WBC" "NSV" "SNVs" "CALGB" "11q22.3" "pentostatin"
    "17p13.1" "IWCLL" "non-silent" "IGVH" "p = 0.006" "= 0.81" "n = 3" "InPten"
    "inPten" "a cancer-initiating subset" "mesenchymal-like" "ofPten"
    "bothPten" "thePten" "loxp/loxp" "DG-2" "4EBP2" "an important regulon"
    "regulon" "PRTE" "oligopyrimidine" "≤–1.5" "p70S6K1/2" "log 2" "thatBRAF"
    "desmoplasia" "theBRAF" "11p" "a typical epithelioid histomorphology"
    "histomorphology" "neg" "sporadicBRAF" "byBRAF" "maligna" "acral" "aBRAF"
    "showedBRAF" "Kamino" "interobserver" "spitzoid"
    "commonly vesicular and exhibited substantial pleomorphism" "pleomorphism"
    "epithelioid" "Spitz" "3p21" "juvenile and adult SSc" "Aliprantis" "Rodnan"
    "co-stimulator" "overabundance" "Warrington" "lymphoblasts" "MCSFR"
    "cytokines/growth factors" "RayBioplex" "SSc 008" "SSc008" "subpassage"
    "SSC" "Laxer" "Peterson" "Raynaud's" "Raynaud" "diffuse cutaneous (dc)SSc"
    "Supernatants" "vasculopathy" "× 10" "48 h" "24 h" "2 × 10" "ACR/EULAR"
    "72 h" "fibroblast-like" "3-year" "HNSCLC" "Oikawa" "Y1349F/Y1356FY"
    "xPPxPxKPx" "GFP–Gab1WT" "Gab1ΔP4/5" "Gab1ΔMBD" "ΔP4/5" "ΔMBD"
    "a contact-inhibited monolayer" "FR3T3" "Fischer" "invadopodia-like"
    "Ponzo" "Aldrich" "Rous" "extravasate" "microvasculature" "intravasate"
    "P4/5" "and 10 µ" "∼5%" "∼30%" "DIGS" "covariate" "12p13.3" "Cloninger’s"
    "Cloninger" "Tourette’s" "Tourette" "13q31" "BDII" "subthreshold"
    "co-morbid" "netrin" "LRRC4C" "denticleless" "at least two additional SNPs"
    "at least two SNPs" "=0.14" "important covariates" "co-morbidity"
    "potential covariates" "covariates" "subscales" "GWA" "BDI" "underpinnings"
    "probands" "bipolar symptomatology" "symptomatology" "TEMPS"
    "Autoquestionnaire" "Memphis" "BiGS" "3×10" "=0.68" "4.1×10" "7×10"
    "blebby" "diffusion/deposition" "JWE" "soluble PAI-1 14-1b" "non-coated"
    "RhoA/ROCK1" "Sahai" "Pinner" "Zeiss" "14-1b-" "formation/retraction"
    "g/cm 2" "14-1b" "attachment/detachment" "Mantovani" "Amoeboid" "type-1"
    "anti-β1" "sensitizer" "SENS2" "8Gy"
    "radiation-induced AMPK activity/expression" "activity/expression"
    "0.05–1 µ" "Sesn2F" "AMPKγ1" "α1β1γ1" "γ1" "cellular AMP/ATP" "SESN1/2"
    "dSESN" "AMPKβ1" "AMPKα1β1γ1" "OH" "LCRMP-1 (WT)" "non-small-cell"
    "LCRMP-1" "non-tagged" "Glycogen synthase kinase-3β"
    "almost all the adverse stressors" "ACGT" "TGACGTCA" "TGACGT"
    "re-sensitization" "re-sensitizes" "procaspase-3" "re-sensitize"
    "Genomatix" "Tfsitescan" "SCR" "SGC7901/VCR" "SGC7901/ADR" "0.5 µg"
    "and 10 µ" "the respective homologs" "10q" "Dunnett's" "Dunnett" "UISO"
    "BroLi" "MaTi" "WaGa" "LoKe" "UiSo" "parotid" "2/46" "Merkel" "+2"
    "histotypes" "BEN1" "ArrayExpress" "PI3KCA" "SCC-29" "3q26.32" "SCC-14"
    "13/24" "SCC-11" "27/92" "18/83" "∼19%" "17/96" "+++"
    "either normal alveolar or bronchial epithelium"
    "normal alveolar epithelium" "LCC" "n " "∼20%" "n = 10" "n = 8" "n = 4"
    "7/37" "≥40" "P21 and" "520G" "p = 0.02" "= 26" "nearest" "Robert"
    "acetylation/deacetylation" "Rpd3-" "Rpd" "SPS2" "Friedreich's"
    "Friedreich" "4b" "Rpd3S" "and 10-" "pho23" "hda3" "HDA3" "PHO23"
    "disruptants" "canavanine" "•CAG" "CTG" "knockin"
    "trinucleotide repeats (TNRs) causes Huntington's" "Rpd3L" "trinucleotide"
    "+1" "The antagonistic co-regulation" "4.5-kb" "luminal-like" "RARE2"
    "TTNPB" "propenyl" "hTGp" "PNT2C2" "Bioinformatic re-analysis" "mesenchyme"
    "RAREs" "hTGP" "1–3" "co-repressors" "Co-transfection" "and 10 "
    "a leukemogenic homeoprotein" "homeoprotein" "miR-19 as" "miR-92a-1"
    "tremeGENE" "mimics/inhibitors" "miR-19b" "MiR-19a" "miR-20a" "miR-19a"
    "NFKB" "subnetworks" "Subnetworks" "significantly more FFLs" "non-thymus"
    "MSigDB" "TFBSs" "Browser" "UCSC" "ALLGene" "miR2Disease" "ALLmiRNA"
    "Chordata" "Vertebrata" "ALLmiRNAs" "ALLGenes" "midbrain" "pri-miR-17–92"
    "co-regulatory" "FFL" "FFLs" "3 B" "co-regulate" "anti-sense" "Histone 2A"
    "48 h" "1 × 10" "Dataset" "halenaquinone" "Kurumizaka" "HsRad51/dsDNA"
    "HsRad51/ssDNA/ADP" "the protein filament around ssDNA"
    "HsRad51/ssDNA/ATP/Mg 2+" "RecA/" "/Mg 2+" "P-terminus" "P-loop" "ATP/ADP"
    "1XU4" "1V5W" "1SZP" "ScRad51" "HsDMC1" "is 2–3" "Mazin" "Bugreev"
    "ADP/Ca 2+" "ADP/Mg 2+" "ATP/Mg 2+" "dεA" "Rad51/poly" "/ATP"
    "HsRad51/poly" "RecA/DNA" "HsRad51/DNA" "the archaeal homologue MvRadA"
    "MvRadA" "HsRad51/ssDNA/ATP" "etheno" "HsRad51/ssDNA" "ATP/Ca 2+"
    "HsRad51/single-stranded" "ionic" "dichroism" "catalyses" "50 ns" "andcan"
    "zeste" "ErbB" "MiR-517c" "MiR-27a" "miR-483-3p" "miR-27a" "miR-518a-3p"
    "miR-512-3p" "miR-519a" "miR-517c" "miR-518b" "miRanda" "miR-518e"
    "MiR-520g" "miR-483-5p" "miR-525-3p" "miR-520g" "TLDA" "non-tumor"
    "multistage" "Taqman" "e" "g" "c" "G 1 /S" "non-transfected"
    "HER2/neu+/Ki67+" "Kerlikowske" "HER2/neu+" "13/51" "13/162" "=0.0009"
    "HR=3.22" "Ki-67+" "Younger" "mastectomy" "neu+" "calgranulin" "10-year"
    "P =0.03" "P =0.02" "=0.003" "non-invasive" "regulome" "-KLF4-" "KLFs"
    "heteromers" "latters" "mutp53/p63" "decamer" "SELEX" "CNTG" "CANG"
    "tetranucleotide" "p53/p63 RE" "Bourdon" "Neilsen" "profilings" "IIα"
    "KinaseA" "-1644-" "-1649-" "-50%-" "-PHK-" "flankings" "TGGGCATGTC"
    "Weeder" "Myf" "p63/mutp53" "Pscan" "TFBS" "Ab7" "FANCi" "4A4" "DO1" "UVB"
    "p53/p63RE" "Mutp53" "mutp53" "-TFs-" "12h" "E-boxes" "misbalance"
    "USP7S18A" "previously dephosphorylated wild-type USP7S" "pUSP7S" "USP7S"
    "and 10 " "Samelson" "nSH3-SH2-cSH3" "30ns" "ns" "RMSF" "RMSD" "initio"
    "topology" "the aliphatic sidechains" "benzyl" "Ducruix" "enthalpy"
    "an unfavorable ΔΔH" "favorable TΔΔS" "PR_mS23" "PR_mS13"
    "an unfavorable TΔΔS" "favorable ΔΔH" "ΔΔS" "ΔΔH" "ΔS" "ΔH"
    "this favorable ΔΔG" "ΔΔG" "kcal/mol" "ΔG" "re-association" "_mS234"
    "_mS134" "_mS124" "_mS123" "triple-mutant" "_mS34" "PR_mS14" "_mS4" "_mS3"
    "_mS2" "_mS1" "single-mutant" "_mS24" "_mS23" "_mS13" "_mS12"
    "double-mutant" "_mS14" "PR_WT" "disorderd" "POODLE" "entropy"
    "monodisperse" "w /M" "S2/S3" "S1/S2" "S3/S4" "S2/S4" "S1/S4" "S1/S3"
    "a 2:1" "multimers" "nSH3" "pYXN" "pairwise" "PXψPXR" "co-workers" "# 1"
    "× 10µ" "colocalise" "vital enhancer" "GREB" "2×ERE" "SeqChip"
    "co-occupancy" "GREB-1" "×ERE" "ERE1" "SeqChIP" "PuGGTCAnnnTGACCPy"
    "LRHREs" "LRHRE" "YCAAGGYCR" "subclass" "co-operatively" "co-localisation"
    "co-operative" "and 10" "antibodies/antagonists" "Srinivasan" "Deng"
    "Miyara" "Kapphahn" "Munemasa" "Saraswathy" "the principal DAMP" "Kobba"
    "DeMeester" "Wheeler" "Lehnardt" "Asea" "pyrogens" "Wiedermann" "Kähler"
    "granin" "Nishida" "a principal DAMP" "βB-crystallin" "Lesley" "Choi"
    "liposome" "chemical/mechanical" "pyrogen" "Gonzalez" "blocker" "Dixit"
    "Naik" "Martinon" "Prakken" "Wijk" "Cohen" "Quintana" "Pockley" "Henderson"
    "Taupenot" "Helle" "Troger" "DAMPs" "h" "Cowland" "Borregaard" "Oh"
    "limbus" "DAMP" "Matzinger" "Alzheimer's" "Serhan" "Nuñez" "Alzheimer"
    "HSPB4" "pcDNA 3" "/2 µ" "gene/protein" "Baquero" "DDFS" "lobules" "Yale"
    "UACC" "destabilizers" "expressers" "Univariate" "negative/low" "= 0.003"
    "= 0.0004" "P = 0.005" "6-Diamidino-2-phenylindole" "= 0.01" "= 1.19"
    "biomolecules" "pGSK" "further molecular sequelae" "sequelae" "H226B-K-Ras"
    "pIGF-1R/IR" "pyrazin-8-ylamine (PQIP)" "-imidazo" "pIGF-1R"
    "IGF-1–induced" "our larger dataset" "similarly sized datasets" "-mutated/"
    "mutated/" "confounders" "wild-type/" "HRs" "= 2.68" "HR = 3.51" "= 0.0008"
    "= 0.031" "interquartile" "HPFS" "LINE-1" "Phosphatidylinositide-3-kinases"
    "Phosphatidylinositide" "phosphatidylinositide" "= 0.024" "= 0.030" "N/C"
    "cascade–p90RSK" "HU" "Akt1/2" "Dox" "αChk1" "pS280" "epithelia" "αpS280"
    "anti–phospho-Ser-280" "rad3-related" "μg/ml" "active RhoA" "MβCD"
    "The CAAX (where C represents cysteine, A is an aliphatic amino acid, and X is a terminal amino acid)"
    "CAAX" "Rnd2N/1C" "Rnd1ΔN" "Rnd1N/2C" "nonraft" "subdomains"
    "geranylgeranyl" "KERRA" "ΔN" "associatedgene" "anotherBRCA" "aero"
    "breast cancer–associated mutation RAP80delE81" "RAP80delE81" "IRIF"
    "BR-02101" "BR-0194" "NNSplice" "PolyPhen" "rs8170" "HUGO" "gatekeeper"
    "Finnish" "Germline" "/CCL4" "macrophage inflammatory protein-1β"
    "macrophage inflammatory protein-1α" "the proteolytic cleavage/activation"
    "the atypical aPKCs" "the classical cPKCs" "aPKCs" "nPKCs" "cPKCs"
    "fluvastatin" "mevalonate" "-1β" "μmol/L" "βII" "βI" "PDR"
    "de-phosphorylator" "shutoff" "stressful" "-CReP" "CReP"
    "phosphorylation-mutant" "effecter" "shRNAi"
    "approximately 10.5×10 6 transformants" "transformants" "dephosphorylators"
    "eIF" "ISR" "CreP" "The eukaryotic initiation factor-2" "factor-2" "48 h"
    "Faber" "sensitizers" "their respective single drug IC 50" "Titer"
    "HCC2935" "pP70S6K" "HBE135-E6E7" "rapamcyin" "mTOR"
    "sensitivity/resistance" "normal bronchial epithelium" "lobectomy"
    "Novartis" "NVP" "Spearman" "YTMA" "histologic subtype" "Histospots"
    "histospots" "histospot" "MTMA" "adeno" "exome" "activites" "biphosphate"
    "co-inhibition" "= 6" "dominant-negative Fgfrs" "Fgfrs" "Robinson"
    "corectopia" "Kress" "ﬁrst" "codon (CCG)" "codon (CAG)" "Glutarnine"
    "III-1" "Axial" "choroids" "axial" "II-3" "tonometry" "just two exons"
    "IgIII" "IIIc" "IIIa" "10q26" "IgIIIb" "IgIIIa" "ophthalmology" "beaklike"
    "osteology" "midface" "perimetry" "Goldmann" "Pentacam" "fundus" "Exons"
    "Crouzon" "andSNPs" "ﬁnd" "SNPsandwere" "Japanese" "betweenand"
    "andbetween" "andof" "CTLA" "3were" "asHLA"
    "monozygotic twins both developed Fuchs" "heterochromia" "stellate"
    "speciﬁc" "/rs1128334" "Genotype" "/rs10893872" "/rs2910164" "miR-146a"
    "microRNA-146a" "Fuchs" "Lamolle" "non-transforming" "Semple" "Weidner"
    "two previously reported and validated polymorphisms" "H&E" "GDCFP" "PILCs"
    "often some more atypia" "typical lobular cytology"
    "frequently intracytoplasmic vacuoles" "atypia" "mitoses" "cytology"
    "targetoid" "vacuoles" "PILC" "non-functional" "= 0.01" "≥5%" "~ 20%"
    "= 0.04" "regrowth" "MTS" "an orally bioavailable imidazo" "undergone"
    "13q" "pyridine" "imidazo" "-TKD" "Newer" "-ITD-D835Y" "MOLM-13-" "MOLM"
    "TKD" "-ITD" "ITD" "= 4" "=0.026" "Pearson's" "T-stage" "clinico" "Yes"
    "cystectomy" "EORTC" "histoscore" "RhoGD12" "P =0.005" "non-cutaneous"
    "=0.008" "P =0.001" "=0. 01" "synergistic anti-tumor" "adaphostin"
    "phenylethyl" "SDF-1α" "SDF-1α/CXCL12"
    "the follicular dendritic cell line (FDC) HK" "HK" "Jeko" "dimmers"
    "forkead" "mitotracker" "11q" "17p" "LD50" "healthy donors ex vivo"
    "Prasad" "non-ATP" "benzylsulfone" "styryl"
    "the clinically more aggressive CLL subtype" "chemoimmunotherapy" "IGHV"
    "Rigosertib" "G 0 /G 1 phase" "Sok" "Chung" "HR=3.29" "= 2.75" "PY416"
    "PY705" "=0.24" "tertiles" "PY992" "polysomy" "heavier" "=0.69" "AJCC"
    "pack-years (PY)" "approximately 2.5:1" "=0.09" "LRT" "hyperploid"
    "hyperploidy" "Squibb" "Myers" "Bristol" "Imclone"
    "chemoradiotherapy (CRT)" "PY1068" "EDRN" "PSTAT3" "=0.034" "=28" "p=0.02"
    "P=0.004" "only seven TERT SNPs" "MSI+" "longer TL" "homozygote"
    "larger BMIs" "shorter TL" "BMIs" "Pooley" "rs401681" "Shorter TL"
    "rs4246742" "rs10069690" "rs2736100" "GG genotype" "Cl" "rs2242652" "HWE"
    "taqMan" "Diego" "Illumina" "GoldenGate" "TagSNPs" "bps" "aspirin/NSAIDs"
    "TL" "aspirin/NSAID" "TTAGGG" "BMI" "CIMP+" "rs2853668" "rs2736118"
    "non-Hispanic" "95%CIs" "antagomirs" "multiprotein"
    "the dominant pathways/targets" "OncomiRs" "mir" "oncomiR"
    "signaling/cyclin D1" "WB" "lipo224B cells" "gcauuaa" "miRGen" "frozen"
    "potential WD/DDLPS" "WD/DDLPS" "oncomiRs" "pure WDLPS" "a recurrent WDLPS"
    "Evans" "DDLPS" "retroperitoneal/abdominal" "non-surgical"
    "retroperitoneum" "the most common liposarcoma histologic subtype" "myxoid"
    "WDLPS" "the most common soft tissue sarcoma histologies" "histologies"
    "de-differentiated" "/targets" "Casein kinase 1α" "five-year" "HNt"
    "Supriatno" "=−0.389" "=0.328" "Hwang" "Hochst33342" "LLM" "LLnL"
    "Non-keratinizing" "nasopharyngitis" "Alaska" "nasopharynx" "= 0.028"
    "= 0.008" "= 100" "stemness" "co-targeting" "n=10" "theC" "Rosa26"
    "mg/kg/d" "Rosa" "eitherC" "receivedC" "withC" "AlthoughC" "primaryC" "=4"
    "Epcam" "fromPb" "withPb" "orPb" "eitherPb" "Lapointe" "RRHO" "wks" "ofC"
    "thatC" "fromC" "andC" "bothC" "matchedC" "L/WT" "neitherC" "inC" "toC"
    "generateC" "L/W" "G12D/W" "NHT" "neoadjuvant" "G12D/WT" "CRPC" "Ki67+"
    "Stem/progenitor" "=3" "L/L" "either distal splicing enhancers" "enhancers"
    "cytotrophoblasts" "pcDNA3" "NLF" "avg"
    "a homozygous major allele genotype (TT)" "genotype (TT)" "GI" "TaqMan"
    "HuEx" "hyperdiploidy" "a homozygous risk allele genotype (GG)"
    "genotype (GG)" "LCLs" "BARD1 β" "NGP" "AUG" "eight other associated SNPs"
    "breakpoint" "rs10498026" "CNV" "CNVs" "the intronic SNPs" "2q35"
    "dose-intensive chemoradiotherapy" "BARD1β" "= 0.017" "= 6"
    "non-overlapping" "= 33" "= 0.009" "MMP-2/β1" "Volociximab"
    "Interaction-like" "N-glycosylation" "ATN-161" "ATN" "Shain" "Δcβ1"
    "hampster" "anti-α5β1" "anti-α5" "co-operativity" "pM+pM-FL-A141G"
    "pM-FL-A141G-" "pM+rhMMP-2" "re-probing" "rhMMP-2-" "rhMMP" "rhMMP-2"
    "pM+pIL-6" "pSV+pIL-6" "pM-2" "pSV-1" "pM-" "~48%" "pEV" "pM-FL-A141G"
    "MMP-2/α5β1" "MMP-2/α5" "a strong co-localization" "un" "zymography"
    "immunocomplex" "Transducers" "Antigen" "Zn" "metallo-" "metallo"
    "inefficacy" "pM" "-6-diamidino-2-phenylindole" "5-bromo-2" "2×10" "~60%"
    "re-growth" "≥4N" "U20325" "U21459" "U23674" "Clinicaltrials" "PKCθ" "gone"
    "12-Otetradecanoyl-Phorbol-13-acetate (TPA)"
    "new therapeutic targets/opportunities" "non-proliferative" "MNC"
    "anti-tumor" "necropsy" "the alveolar subtype" "anti-rheumatic"
    "at least 12 isozymes" "ERMS" "histological subtype" "cells/ well"
    "Non-targeting" "3 × 10" "≥4" "non–small cell lung carcinoma" "10–100 nM"
    "GVL" "Sharma" "15q15.1" "Pharmingen" "TTTGATAC" "TTTGGCGC" "−-431" "431bp"
    "-luc" "luc" "TRANSFAC" "non-recurrent" "SIPA1L2" "_AA496936"
    "prognostic and included NuSAP"
    "underwent radical retropubic prostatectomy" "JDB" "Stanford" "HEEBO"
    "ERSPC" "nt" "NuSAP" "2 × 10" "non–small cell lung carcinomas" "=0.8"
    "= 0.05" "the CRC subsets defined by combinations" "rectal subsites"
    "rectosigmoid" "Porta" "Miyaki" "Dutch" "subcohort" "Weijenberg"
    "Netherlands" "Slattery" "=0.05" "distal colorectum" "=0.01" "trend=0.04"
    "pack-years" "=0.31" "=0.27" "=0.25" "cumulative pack-years" "507/555"
    "95 % CI" "=0.06" "=0.04" "=0.03" "mg/day" "= 3" "G:C" "= 0.04" "P = 0.02"
    "Roadmap" "more comprehensive transcriptome" "GENCODE" "PANDA" "dis"
    "re-evaluated" "phenocopy" "ChIA" "ag" "romatin" "Non-coding"
    "any other sub-cellular organelles" "sub-cellular organelles" "monotherapy"
    "temozolamide" "chemo-" "U251" "pFAK" "hGBM13" "hGBM2" "hGBM8" "hGBM9"
    "hGBM6" "pEGFR" "caveoli" "hUCBSC" "co-cultures" "Conclusions/Significance"
    "mechano" "Boyden" "non-phosphorylatable" "Boeuef"
    "non-receptor tyrosine kinase" "SCC12f" "oligos" "TIRF" "learnt"
    "bidirectional signal transducers" "transducers" "orthologs" "Hahn"
    "and 2A" "goes" "Fritolli" "∼30–55" "∼15–30" "Yoruba" "Eichler" "Hatanaka"
    "anti-B56γ" "OA" "S6K:T389" "p70 S6K" "IRS-1:S270" "Ye" "duplexes"
    "a quantitative real-time PCR" "scr" "Manassas"
    "dephosphorylation/inactivation" "hyper" "B56γ" "regulatory subunit B56γ"
    "protein phosphatase 2A" "S636/639" "insulin/IGF-1" "hominoid" "IC 50  "
    "IGF-1-induced" "non-chaperone" "de-novo" "1,5–3" "E-box" "CAAT" "ATTTA"
    "prostaglandins" "non-specific (NS)" "CHBA"
    "phosphorylation/dephosphorylation" "Δ-HSE-" "Akiyama" "Yutaka" "TFSEARCH"
    "element/elements" "tetradecanoylphorbol" "PPRE" "PGF1α" "keto"
    "lymphoblastoid" "thromboxanes" "the pentameric motif nGAAn" "nGAAn"
    "stepwise" "genomes" "non-classical" "non-steroidal" "Bradner"
    "Saccaramyces" "detangles" "ICA" "PCA" "mathematic algorithms" "Venn"
    "induciblePten" "NKI" "Netherland" "mAKT1" "CACGTG" "Δloxp/Δloxp"
    "Heatmaps" "toPten" "Δloxp" "Δloxp/" "nullPten" "DamID"
    "stability/activity" "re-expression" "1-3" "reticulum" "hypotheses"
    "K-less" "isopeptide" "co-localizes" "striata" "Kummerowia" "hellebore"
    "grandiflorum" "Veratrum" "anti-spasmodic" "5-hydroxy-2-"
    "7-O-beta-glucoside" "chamomile" "flavonoid" "oxychromen" "yl" "oxan"
    "hydroxymethyl" "hydroxyphenyl" "Apigetrin" "Cosmosiine" "cosmetin"
    "apigenin-7-glucoside"
    "1-(2,4-dihydroxyphenyl)-2-(4-methoxyphenyl)propan-1-one"
    "″-methoxy-α-methyldeoxybenzoin" "Pterocarpus" "methoxyphenyl"
    "dihydroxyphenyl" "Trifolium" "Leguminosae" "flavonoids" "Biomax"
    "rray (TMA)" "HistoRx" "rray" "icro" "∼25%" "angolensin's"
    "dihydrochloride" "formazan" "caspase 3/7" "caspases 3/7" "ERα/α" "ERβ/β"
    "angolensin" "cosmosiin" "UWCCC" "KBLuc" "Angolensin" "Cosmosiin" "βERKO"
    "physio-" "physio" "Qu" "ERα/β" "g/mL" "patrollers"
    "other bacterial antigens" "macrophsges" "lo" "adenylyl" "Dictyostelium"
    "Rap1 GEFs" "KRIT-1/CCM" "AF-6/Cno" "LFA" "parenchyma" "TLR2/4" "non-LPS"
    "synergism" "geranyl" "5-cyclic monophosphate" "monophosphate" "CalDAG"
    "aminoglycan" "glycoso" "MEM-148" "/EDTA" "MEM" "hidden" "p44/42" "andt"
    "the fluorescent Ca ++ indicator FURA-2" "FURA-2" "++" "Gβγ" "cyto-" "cyto"
    "neutrohil" "CXCR1/2" "MALP-2" "MALP2" "deoxynucleotide" "inhibiton"
    "lipoplysaccharide" "hetero-" "hetero" "chemoattractants" "CKRs"
    "chemoattractant" "100X" "I∶C" "/5" "EC 50" "pg/ml" "alternata" "IL-18Rα"
    "11B11" "IL-18R" "GABRIEL" "greatest" "Multicenter" "non-skewing" "7AAD"
    "NHBE" "intraepithelial class II major histocompatibility complex antigen"
    "ryegrass" "NHANES" "hyperresponsiveness" "Bermuda" "Penicillium"
    "inhalant" "CAMP" "multicenter" "genomewide" "rmIL" "Alternaria"
    "Methodology/Principal" "n=8" "= 8" "=8" "methyladenine" "sequestome"
    "HBSS" "minute-2" "ubiquinates" "phosphine (TCEP)" "phosphine"
    "carboxyehtyl" "interferometry" "biolayer" "organelles" "3.3 × 10"
    "API-1 and" "Lac" "SqCC/Y1" "autocleavage" "pyrido" "≤ 57" "Caucasians"
    "website" "Hapmap" "rs760607" "1.14–2.30" "0.86–1.26" "GA+AA" "rs321318121"
    "rs3218121" "rs3218211" "rs3218148" "rs3218203" "rs3213180" "rs3213183"
    "rs3213182" "rs3218123" "rs6667575" "rs2742976" "Weinberg" "Genotypes"
    "hypothese" "E2F3a" "1p" "20q" "RefSeq" "hypopharynx" "non-drinkers"
    "non-smokers" "GT+TT" "CC" "GG" "tagSNPs" "= 0.034" "0.1–1" "getfitnib"
    "antagonist/inhibitors" "=6" "~92%" "HBEC" "chemi-" "chemi"
    "sphingosine kinase-1" "Spingosine" "VPC23019" "~30%" "VPC 23019" "begun"
    "hypersensitizes" "siHIRIP3-2" "genome-wide datasets (GESS)" "≥3"
    "siRBMX-1" "siRBMX-3" "shRBMX" "siRBMX" "anti-stripes" "retrogenes"
    "paralog (RBMY)" "RBMY" "GESS" "siFF" "GFP+" "Hoechst" "MOI" "AdNGUS24i"
    "siGENOME" "Dharmacon" "DSB–" "two premature stop codons" "iGFP" "SceGFP"
    "paralogs" "nucleases" "ExoI" "w/v" "cells / well" "~ 40%" "TSC2−/−"
    "Llopis" "Pena" "phosphoantibody" "vitro" "Tcfeb" "stressors"
    "re-stimulation" "mRFP" "EC50" "nuclear/cytoplasmic" "Salicylihalamide"
    "CQ" "TFEB–3" "p-P70S6K" "MALT" "nonimmune" "global transcriptome"
    "transcriptome" "subunit IκBα" "PMA/ionomycin" "L41Q" "pulldown" "NCBI"
    "casein kinase 1α" "Aα" "GuK" "guanylate" "CBM" "CARMA" "kinome" "Starr"
    "catalyse" "abscissa" "Burk" "Lineweaver" "Sigmaplot" "timepoints" "Bowden"
    "Cornish" "pseudosubstrate" "upfield" "sidechains" "αA" "subdomain" "/2"
    "sidechain" "soluble IL-6Rα" "Guschin" "JAK2b" "GQT" "DVP" "GQM" "rpHPLC"
    "STASTVEpYSTVVHSG" "100x" "SOCS1-3" "Zhao" "SOCS4-3" "JH1"
    "non-competitive" "Alexander" "Yoshimura" "Thrombocythemia" "Murray" "Shea"
    "=100" "2 +" "IGF-1-ERK" "farnesyl" "IGF-1-mediated" "gavages" "RKTs" "RKT"
    "Hs776T" "PCR-RFLP" "RFLP" "PCR" "rapalogs" "neuroendocrine" "mt" "Rapalog"
    "rapalog" "7 × 10" "1,2,3,4,6-penta-O-galloyl-beta-D-glucose"
    "hypoxia-inducible factor-1α" "C/EBPdelta" "S100P" "Gibadulinova"
    "LV-STAT3siRNA" "Yang" "Cruciferae" "Cucurbitaceae" "fungoides" "ASONDs"
    "phosphopeptides" "circuitry" "Glienke" "Sinicrope" "Huang" "BA"
    "anti-pancreatic" "Jungert" "a highly motile fibroblastoid" "fibroblastoid"
    "Higgins" "Abdelrahim" "microvessel" "ILs" "angiopoietins" "PDAs"
    "the pancreatic ductal epithelium" "invasive PDA"
    "the most common and deadliest histological subtype" "PDA"
    "anti-inflammatory" "capsid" "FP" "co-precipitated" "κB"
    "phytohemagglutinin (PHA)" "phytohemagglutinin" "CD8-gp41Δ C762"
    "the NF-κB-activating gp41CD" "casein kinase 1α1" "co-precipitation"
    "-7-Oxozeaenol" "the membrane-proximal endocytosis motif 721 YRPV" "YRPV"
    "SIVstm" "SIVsmm" "SIVmne" "SIVcpz" "YHRL" "VFSSPPSYFQQTH" "CLFSYHRLRDLL"
    "JPM50.6" "NL4-3" "clade" "SIVmac239" "gp41CDs" "CD8α" "SIVmac" "LTR"
    "gp41CD" "anti-HA" "48 h" "Δ C" "YXXΦ" "synapses" "FRNK-like"
    "both the viral polyprotein" "the viral polyprotein" "polyprotein"
    "FAK -/-" "ISRE" "IFNβ activation" "IFNβactivation" "I:C"
    "herpes simplex virus-1" "Sendai" "ReoV" "CVB" "coxsackievirus" "FERM" "1x"
    "and 3C" "non-catalytic" "vacuole" "pneumophila" "+buffer"
    "pathogen-induced macropinsomes" "macropinsomes" "R279C/K336A" "∼46%"
    "omology" "leckstrin" "∼10%" "∼73%" "cytohesin" "subfamilies" "SipA"
    "adherent ΔE/E2" "ΔinvG" "ΔE/E2" "invG" "Typhimurium" "Arfl" "waspΔvca"
    "Δvca" "+SopE" "ipid" "hospho" "gasteroentiritis" "enterica" "roprolin"
    "yndrome" "ldrich" "iskott-" "iskott" "eural" "xchange" "uanine" "∼40%"
    "∼60%" "NAV2" "the relevant genotypes" "mutant/" "KRAS -mutant" "S33Y"
    "BIO" "co-localization" "K-means" "either daily intraperitoneal 15mg/kg"
    "3 different viral MOIs" "MOIs" "KEGG" "algorithm" "DAVID" "ribose"
    "polyADP" "RDI" "an identifiable subset" "-mutant" "log2" "NOD/SCID" "Yu"
    "Sierecki" "peptidases" "Warfel" "Huntington's" "Huntington" "Hellwinkel"
    "undergoes" "Gleason" "prostatectomy" "Meier" "Kaplan" "PTEN+/-"
    "forebrain" "Pardee" "Shimizu" "Kunkel" "AGC" "CYR1" "adenylate" "DTAL"
    "DTPL" "bisphosphate" "phosphatidylinotisol" "phosphoinositides" "Mn"
    "PHLPP1β" "PHLPP1α" "the alternatively-spliced PHLPP1β" "SCOP" "isozymes"
    "isozyme" "β 1" "stem/progenitor" "p53-8KR" "Ndn" "BaF3/T315I"
    "50mg/kg/day" "residual GFP + WBCs" "WBCs" "LTHSC" "Leukemic GFP + WBC"
    "WBC" "gavage" "KO" "SIRT" "Tenovin-6" "TV" "Tenovin" "ShSIRT1-2"
    "ShSIRT1-1" "Giemsa" "succinimidyl" "carboxyfluorescein" "theApc"
    "Sirtuins" "AP" "1× 10" "S5C" "Hermann" "Jain" "Muaddi" "dFoxO" "eukaryots"
    "pleural and peritoneal fluid exudates" "exudates" "&E" "GNE493"
    "Sutherlin" "potential IRES" "48h"
    "the cap-independent Cricket Paralysis Virus IRES" "mTORC1/2" "IGF1Rβ"
    "SrcY" "lumens" "alveoli" "Non-transformed" "ΔNp73" "Talos" "UABCC"
    "Birmingham" "Alabama" "Anderson" "mot" "nocadazole" "Anti-Flag"
    "transactivation defective ΔNp73" "paralog" "anti-phosphor" "λPPase"
    "aneuploidy" "TAp73" "oocytes" "APC/C" "T1D" "Scherer" "HLA-DRB1*11"
    "allelles" "HLA-DRB1*09" "haplotype" "*09" "Snir" "antigens" "subclasses"
    "KIHACitEIFDSCitGNPTV" "NEEGFFSACitGHRPLDKK" "FLAEGGGVCitGPRVVERH"
    "VYATCitSSAVCitLCitSSVP" "STCitSVSSSSYCitCitMFGG" "non-RA" "auto-epitopes"
    "autoepitope" "Lefebvre" "EIIIA" "datasets" "UniProtKB" "Ritchie" "HAQ"
    "VAS" "*11" "*16" "*08" "HLA-DRB1*04" "HLA-DRB1*10" "*10" "*04" "*01"
    "immunoglobulins" "IgA" "anti-CCP2-positive" "31 primary Sjőgren's"
    "Sjőgren" "Anti-citrullinated" "IIICS" "a schematic overview" "overview"
    "USA" "Boston" "Inc" "colloidal Coomassie" "CBB" "Coomassie"
    "anti-citrullinated" "pannus" "CCP2" "autoantigens" "anti-CCP2" "PAD"
    "peptidylcitrulline" "peptidylarginine" "synovia" "isotype"
    "LTVGLTXXGQPRQY" "Toll-like" "LC-MS/MS" "the Begg's" "the Cochran's"
    "Cochran" "histopathology" "only one SNP" "intrastrand" "1.20-3.45"
    "1.06-1.44" "Begg" "1.88-3.10" "the unfavorable genotype"
    "the favorable XRCC1 194 genotypes" "1.39-3.06" "1.95-3.31" "95% CI" "PFS"
    "rs1799782" "rs25487" "DRC" "G/A+A/A" "C/T+T/T" "G/G" "A/A" "G/A" "95%CI"
    "T/T" "C/C" "C/T" "CNKI" "commonest" "= 10" "Rheumatology" "procollagen"
    "Cambridge" "Addenbrooke" "endoperoxide" "Achilles" "tibialis"
    "immunoglobulin" "phosphopeptide" "phosphoinositol" "pS241-PDPK1"
    "-triphosphate" "triphosphate" "∼50%" "phosphoantibodies" "pS146-p21 Cip1"
    "pT145-p21 Cip1" "CDIs" "campothecin" "∼80%" "Cɛ" "myocytes" "type 2A" "Rb"
    "ESCRT" "GFP-LRRK1–" "fluorescent punctae" "punctae"
    "degradation/recycling" "Alexa" "anti-pY944" "LRRK" "anti-phosphotyrosine"
    "These mature MVBs/late endosomes" "6-diamidino-2-phenylindole" "S6A"
    "progestins" "CIMP" "the distal colorectum" "incident CRC subtypes"
    "microsatellite" "colorectum" "anatomic subsite" "subsite" "IWHS" "Iowa"
    "PMH" "DOH99-TD-C-111-006" "Gung" "Cheng" "Kai" "assessing HER2 IHC"
    "subsites" "chemoradiotherapy" "bucca" "Taiwanese" "11q13" "Taiwan"
    "clinicopathological paremeters" "paremeters" "DFS" "p = 0.002" "P = 0.002"
    "miRNA/target" "proteome" "Watson"
    "the strong inhibitory effect miR-193a-3p" "miR-193a-3p" "193a-3p"
    "co-downregulated" "co-regulating" "their potential co-regulation"
    "Hochberg" "Benjamini" "co-regulated" "potential co-regulation"
    "co-regulation" "non-parametric" "Smirnov" "Kolmogorov" "-UTRs" "UTRs" "b"
    "miRWalk" "TargetScan" "subnetwork" "mappings" "heatmap" "si"
    "an average Pearson's" "specificity/sensitivity" "RPPAs" "-UTR"
    "a high-throughput proteomic readout" "readout" "miRNome" "/target"
    "co-upregulated" "non-conserved" "non-targeting" "G1/S" "oncology"
    "clinicians" "simpler" "BOADICEA" "England" "Manchester" "NICE"
    "the predominant cancer subtype" "oestrogen"
    "the predominant breast cancer subtype" "glucuronidases"
    "the predominant resveratrol isomer" "precancer" "nonsignificant"
    "RASSF-1a" "inDNA" "6/30" "CV" "CTC" "yr" "22/30" "28/30"
    "collection exceeded 12 h" "at least 4 wk" "wk" "kg" "ng/g" "glucoronide"
    "lipoproteins" "botanicals" "and 3b" "dinucleotides"
    "the breast ductal epithelium" "polyphenols"
    "DMBA-treated female Sprague Dawley" "Dawley" "Sprague" "isomer"
    "polyphenol" "RASSF-1 α" "ductoscopy" "12 h" "RRVSF" "Caf4" "multidomain"
    "M 2OH-BNPP1" "intra-" "intra" "α5" "α3" "coli" "Waals" "der" "anisotropy"
    "antiparallel" "intersubunit" "Δ189" "KI2" "KI(D/N)XXXF(L/I)XXLK" "XXLK"
    "XXXF" "KMN" "pombe" "Schizosaccharomyces" "cerevisiae" "BD" "Bub" "GLEBS"
    "centromere" "aneuploidies" "BubR" "16 h" "g/ml"
    "the E-cadherin-expressing epithelial and TUBB3-expressing neural lineages"
    "PANCs" "immune/inflammatory response" "hIPCs" "PANC-1s"
    "the neural proteins β-3-tubulin" "immunocytochemistry" "neural-like"
    "β-3-tubulin" "PD-PANC-1s" "PAC" "Li" "orp53"
    "barely detectable inDmp1 −/− thymus even 4–6 hrs" "fromArf" "fromDmp1"
    "thymic medulla" "wt" "medulla" "Cip1/Waf1" "thep21" "DKO" "Synergism"
    "ZsGreen" "Ni" "Δ1–289" "bindig" "~5%" "RAZ" "hrs" "andDmp1" "bothDmp1 +"
    "~40%" "inDmp1" "Eμ" "rotein" "blastocyst" "inArf" "haplo"
    "non-small cell lung carcinomas" "~35%" "markedly better MFS" "Barbareschi"
    "more favorable MFS" "MFS" "basal-like" "HR +" "Loi" "Kalinsky" "Tenorio"
    "Pérez" "Maruyama" "receptor-alpha-negative" "NRAF" "hotspot" "'hotspots'"
    "P = 0.004" "= 0.03" "superarray" "formation/activation"
    "lipopolysaccharide" "formation/activity" "paracrine" "osteoblasts"
    "oligofectamine" "phospho-ERK1/2" "NCr" "calvaria" "SuperArray" "EV"
    "SCC-14a" "invariant" "stromal/preosteoblast" "oropharynx" "HNSCC"
    "bone/osteolysis" "immuno" "hRANKL" "co-transfection" "=10" "Non-specific"
    "1/2" "mg/kg" "Michigan" "lipopolysacccharide" "nAChR" "unmet" "1q32.1"
    "chemoresistance" "NNK" "anti-cancer" "P = 0.006" "non-canonical"
    "algorithms" "karyotypes" "RAE" "-copynumber" "copynumber"
    "immunohistochemistry (IHC)" "dataset" "diploid" "OPH" "QVD" "siNTp"
    "AKT1/2" "AKTi-1/2" "AKTi-1" "AKT-1/2" "copy-neutral aCGH" "aCGH" "PEO"
    "SKOV" "TCGA" "multiplatform" "Akt8" "co-treatment" "IC 50 s" "IC 50"
    "non-activated" "proα2" "Cheon" "glycogen synthase kinase-3β" "p=0.004"
    "p=0.002" "prolyl-4-hydroxylase-β" "auhors" "SSc" "=0.004" "p=0.001"
    "PDZ-like" "NURD" "HindIII" "Very weak re-ChIP" "K136AK175A" "ΔPDZ-SATB1"
    "ΔPDZ" "k136/k175" "retrovirus" "GST-SATB1-1-204" "sirtuin" "Igf"
    "rs9460668" "Africans" "The most significant FLJ22536" "rs9466182"
    "rs3794012" "The second most significant LMO1 SNP"
    "the only other genotyped SNP" "=0.001" "the associated SNPs" "genic"
    "rs4237769" "the most significant imputed SNP"
    "the second most significant genotyped SNPs"
    "the most significant genotyped SNP" "intron"
    "the most significant BARD1 SNP" "associated SNP" "rs16852804"
    "the most significant SNP" "=0.02" "rs6435862" "rs7587476"
    "the most significant SNPs" "continuum" "YRI" "FLJ22536" "Oncology"
    "Africa" "rarer" "Americans" "NBL" "≥1" "0.8–3.1%" "Asians" "African"
    "44-year-old" "a previously unrecognized subset" "Immunohistochemistry"
    "C2orf44-ALK" "C2orf44" "heterogeneous cancer biopsies" "indels" "introns"
    "FFPE" "≥ 10%" "mucosa" "squamous epithelium" "Michael" "diaminobenzidine"
    "Carpinteria" "Dako" "nonurgent upper endoscopy" "colonoscopy"
    "Esophageal biopsies" "endoscopy" "Texas" "Houston" "Endoscopy"
    "a columnar epithelium" "the squamous epithelium" "co-activators" "α4" "αE"
    "Helix" "non-globular" "LBM" "A242V" "A284Q" "MLL1 MBM -binding" "RWRFPARP"
    "MBM" "A/G" "idoxifene" "SERM-like" "agonist-like" "benzloxy" "occludes"
    "C7α" "butyl" "n" "AFs" "methylene" "amidoalkyl" "substituents"
    "Co-treatment" "4HT" "ERE" "Beckman" "Protein A/G" "Co-immunoprecipitation"
    "ImageJ" "Millipore" "Cruz" "PBST" "1X" "NuPage" "LDS" "Roche" "Luc" "Bio"
    "a Luminoskan Ascent Microplate Luminometer" "Labsystems" "Thermo"
    "Luminometer" "Microplate" "Luminoskan" "Promega" "Lysis" "pH"
    "ERE-E1b-Luc" "pCR" "Mem" "Opti" "Invitrogen" "Lipofectamine" "cells/well"
    "Dulbecco’s" "DME" "ATCC" "Zhu" "benzyloxyhexanyl" "hydroxyhexanyl" "ZK"
    "LXXLL" "coactivator-3" "ICI" "the uterine epithelium" "helixes" "helix"
    "helices" "LBD" "function-1" "biocharacter" "hexanyl" "C-7α"
    "agonist/antagonist" "benzyloxy" "hydroxyl" "alkyl" "human Burkitt’s"
    "Burkitt" "HA1E-MYC" "MYCER" "sulfide (BPTES)" "BPTES" "sulfide" "HA1E"
    "OHT" "ERMYC" "IMR" "bronchial epithelium" "C-glutamate" "fumarate" "holo"
    "Vmax" "F-fluorodeoxyglucose (FDG)" "positron" "fluorodeoxyglucose"
    "C-lactate" "FVBN" "Warburg" "immature hepatoblastomas" "hepatoblastomas"
    "Kinzler" "Vogelstein" "Krebs" "Glul" "S4H" "germline" "ortholog"
    "crossover" "titer" "pT13 " "S2E" "S2D" "EUFA423" "AAVS1" "promoterless"
    "ZFN" "DSTV" "hr" "UTR" "isothermal titration calorimetry (ITC)"
    "calorimetry (ITC)" "ITC" "calorimetry" "S14E" "Paull" "Tanya" "T13/S14"
    "S14D" "pT13/pS14" "pT13" "S14A" "SDTD" "DTSV" "pS14" "x" "pT-" "pT"
    "carboxyl" "radioresistant" "dsDNA" "MRN" "ssDNA" "DSB"
    "which repairs DSBs" "chromatid" "DSBs" "5 × 10" "/1.4" "dRAF" "non-coding"
    "MGA" "PREs" "AUTS2" "ectoderm" "Brachyury" "co-exist" "co-occupied"
    "exclusively—or predominantly—by only one PCGF" "-CBX2" "co-purified"
    "co-IP" "FBRS" "PCGF3" "REx" "CBXs" "undertaken" "Pho" "PRE" "H2AK119"
    "Pc/CBX" "BcoR-" "BcoR" "PCGFs" "Midleg" "Ph" "Pc" "melanogaster"
    "embryoid" "H2AK119ub1" "YAF2-" "YAF" "RING1A/B" "co-localize" "PCGF"
    "actin cytoskeletal re-organization" "a virological synapse" "Pearson’s"
    "Olympus" "modulateactin" "shownto" "the virological synapse"
    "directlywith" "andmodulates" "infacilitat" "virological synapse (VS)"
    "synapse" "thatvirus" "supernatants" "Supernatant" "regulateHIV" "Δ1–156"
    "Amaxa" "phosphotyrosines" "PHA" "Non-Targeting" "inHIV" "WTJurkat" "WTand"
    "HIV-1 infection" "-cellclones" "cellclones" "re-organization"
    "targetcells" "76kDa" "pre-" "co-cultured" "1×10" "InsP3" "microdomains"
    "acetylcholine" "VZ" "neurospheres" "Schuurmans" "∼15%" "neurosphere"
    "hNPC" "/BrdU" "0–1" "∼95%" "Tg" "acetoxymethyl" "-aminophenoxy"
    "aminophenoxy" "bis" "tGFP" "2–3" "Tuj1 +" "-deoxyuridine" "deoxyuridine"
    "olocumicine" "oloumicine" "DIV" "hNS1" "hNPCs"
    "neural progenitor/stem cells" "CNS" "progeny" "S5A" "1 +" "1  +" "Y14F"
    "Y14D" "expression/stability" "p-Tyr-418-Src" "Y14F-Cav-1-YFP"
    "Y14D-Cav-1-YFP" "iodotubercidin" "phosphorylation/activation" "eightfold"
    "CoIP" "zolo" "pyra" "p-Tyr-14-Cav-1" "U/ml" "homogenates" "coIP" "ROI"
    "cyan" "coworkers" "Barrett"
    "Src kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-( t -butyl) pyrazolo"
    "-7-" "4-amino-5-" "pyrazolo" "chlorophenyl" "-nitroarginine"
    "nitroarginine" "BSC1" "FCHO1/2" "larger CCSs" "plaque-like" "LDLRs"
    "normal-sized CCVs" "CCVs" "T7-Dab2-DPF" "°C" "Teckchandani"
    "T7-tagged FCHO2 μHD" "T7-p96" "NPV" "ΔC" "FLDLF" "EH" "μHD" "CCSs" "CHC"
    "HBT" "biotin" "FCHO" "μHDs" "tubulate" "VI" "β1" "FxNPxY" "dileucine"
    "CCV" "invaginate" "bilayer" "DPF" "only-2" "Disabled-2" "201/375"
    "multivariate" "p-53BP1" "Representative p-ATM stainings"
    "phospho-Ser1981-ATM" "stainings" "phospho-S1981-ATM" "radioresistance"
    "sensitise" "non-transformed" "Gy" "p-" "p" "BJ" "chemo" "1 × 10" "= 0.006"
    "anterograde" "prostatomes" "procathepsin" "et" "CatB" "cathespin" "CA074"
    "LCL385" "shAC" "SKI" "LCL" "proform" "cyclohexamide" "sphingosine"
    "non-proteolytic" "1 ×10" "Dulbecco's" "TATA" "polyvinylidine" "Dulbecco"
    "non-cancerous" "G1/G0" "48-hour" "approximately 60 pmol/l" "pmol/l"
    "Epithelium" "supernatant" "nmol/l" "Renilla" "ARIBE-1" "ARIBE" "IRES" "9p"
    "non-tumorigenic" "Sanger" "progestin" "apocrine" "signaling/activation"
    "p21 and" "co-culture" "× 10" "5 × 10" "DNE" "DBS" "mutated codons"
    "crosslink" "interstrand" "Hupki" "Yoon" "HPRT" "adduct" "LMPCR" "UvrABC"
    "-dG" "dG" "o" "dihydrodiols" "dehydrogenases" "dihydrodiol" "Olivier"
    "hotspots" "24/205" "Shen" "1/37" "more-base insertions/deletions"
    "P-exposed" "methylcytosine" "TGG" "CGG" "7/8" "DNA bulky adducts" "easier"
    "AG1521" "bulky adducts" "adducts" "AFB" "UV" "frameshift" "IARC" "benzo"
    "FASAY" "codon" "= 2.10" "auto-inflammatory"
    "non-receptor tyrosine kinases" "I/II" "JAK1/2" "CMML" "thrombocythemia"
    "vera" "Tween" "subsets" "Soft Agar" "Agar" "LACE" "the IHC" "Pearson"
    "immunohistochemistry" "pSTAT3" "timecourse" "ELISA" "NCI" "Perhaps"
    "Kirsten rat sarcoma viral oncogene homolog (KRAS)" "homolog (KRAS)"
    "homolog" "Kirsten" "Non-small cell lung carcinoma" "soft agar" "agar"
    "5×10" "LIPA" "genotype" "angiograms" "non-ethnically" "MIGC" "C4D"
    "Affymetrix" "rs1041981" "which lies ~350Kbp" "~350Kbp" "qua" "*0602"
    "3.2×10 −7" "Europe" "TSI" "CEU" "Europeans" "celiac" "SNP" "HCG27"
    "global p=1.12×10" "p= 5.3×10" "p=3.3×10" "priori" "rs3869109" "=1.12"
    "= 5.3" "=3.3" "Approximately 5 million SNPs" "newer"
    "approximately 10 million SNPs" "approximately 2.5 million SNPs"
    "which uses reference haplotypes" "genotypes" "HapMap" "haplotypes"
    "Genome" "6p21.3" "×10" "approximately 5 million SNPs" "SNPs" "GWASs"
    "Genomes" "GWAS" "genome" "vi" "iv" "iii" "ii" "anti-apoptotic" "FACS"
    "CK2-I-induced" "CK2-I-treated" "CK2-I-mediated" "CK2-I-" "TUNEL" "biopsy"
    "kinase-2" "μ g" "non-specific" "24 h" "co-ordinate"
    "invasive mucinous adenocarcinoma (IMA) subtype" "Marchetti"
    "the acinar predominant subtype" "the acinar subtype"
    "lepidic predominant subtype" "poorer" "youngest" "a unique subset"
    "Korean" "ERS" "ATS" "IASLC" "=0.006" "=0.017" "=0.030" "=0.005" "=0.013"
    "Multivariate" "=0.021" "=0.002" "≤61" "≤54" "=0.036" "V3a/b" "GVV" "IPVAM"
    "ELREAT" "naïve" "AIS" "The most common histological subtype" "Asian"
    "the predominant subtype" "European" "American" "histology" "subtypes"
    "=0.028" "acinar predominant subtype" "subtype" "younger" "univariate"
    "5-year" "LPTS/PinX1" "Chang" "de-hypermethylation" "a benign polymorphism"
    "codons" "missense" "polymorphisms" "Banik" "Zhou" "Zhang" "Liao" "LPTS"
    "maintainance" "liopafectamine" "G0/G1 phase" "lipofectimine" "pEGFP"
    "lipofectamine" "bp" "bi" "telomerase/telomere" "polymorphism" "exograft"
    "CD" "equipments" "pEGFP-C3-PinX1" "semi" "Transwell" "72 h" "shiga"
    "rafts/caveolae" "monolayers" "yellow/orange" "thread-like" "B-4500FO2"
    "caveosome" "intactness" "TEER" "transwell" "caveolae/lipid" "oligo"
    "peri-centrosomal caversomes" "caversomes" "VIP21" "invaginations" "HA"
    "BMEC" "BBB" "disrupter" "monolayer" "neoformans" "24 h" "-H1047R-induced"
    "IDC" "exons" "trisphosphate" "Liu" "Meyer" "Pre" "de-ubiquitinase"
    "non-K48" "auto-" "Slimb" "PS-140" "PS" "RPDR" "XpSXP" "amoung" "lifespan"
    "steric hinderance" "hinderance" "greater" "silico" "CHX" "Co-expression"
    "2+" "1+" "3+" "co-localized" "multi" "μg-3.0" "μg" "co-transfected"
    "pulldowns" "SOS" "pMyr" "pTRG" "Cytotrap" "Bacteriomatch" "14-3-3σ"
    "chosen" "RING-" "Ciechanover" "Bie" "BZF" "inger" "inc-" "inc" "ancer"
    "reast" "hHR" "IHC" "RING" "co-habiting" "lysis" "re-evaluation"
    "Gram-positive Actinobacteria" "Actinobacteria" "broader" "non-gastric"
    "lineages" "endpoints" "Tinkew" "Bronte" "ligand/receptor" "IL-6Rα"
    "orthologues" "perhaps" "yclin" "rhIL" "non-stably" "Reg3γ" "Reg3β"
    "non-induced" "doxycycline (DOX)-repressible transgenes" "transgenes" "DOX"
    "CagA-negative H. pylori -infected gastric mucosal biopsies"
    "gastric mucosal biopsies" "gastric epithelial biopsies" "biopsies"
    "peptidoglycan" "C-type" "Kamiya" "Murata" "subset" "penetrance"
    "the gastric epithelium" "epithelium" "EPIYA"
    "cytotoxin-associated antigen" "transducer" "REG3γ" "REG3 γ" "allograft"
    "TCR/TGF-β" "enhancer" "acetylation/ubiquitinylation"
    "control-treated littermates" "littermates" "Boy/J" "retro" "responder"
    "and 3KR" "MFI" "vivo" "ex" "3KR" "antigen" "nonhistone" "homologs"
    "acetylation/deactylation" "Ex" "nonTreg" "gene/protein (GITR)" "wildtype"
    "co-treated" "anti-proliferative" "endpoint" "pre" "72h" "saractinib"
    "‘amoeboid’" "amoeboid" "blebb" "TPA" "intergrin" "24h" "PD184352/CI-1040"
    "IC50" "motile" "monotherapies" "proven" "GA" "TAAA" "TTATGTAAACA"
    "TAGAGTAAATT" "complex/cyclosome" "RhoA" "proteosome"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-7201-7500*
  '(("additional retrospective cohorts" . SPARSER::MOLECULE)
    ("LANCL2 or ECOP" . SPARSER::COLLECTION) ("Synthetase" . SPARSER::PROTEIN)
    ("Lanthionine" . SPARSER::MOLECULE) ("extrachromosomal DNA" . SPARSER::DNA)
    ("wherein all the EGFR genes" . SPARSER::GENE)
    ("EGFR and other receptor tyrosine kinases" . SPARSER::COLLECTION)
    (":CEP7" . SPARSER::BIO-COMPLEX) ("CEP7" . SPARSER::PROTEIN)
    ("EGFR:CEP7" . SPARSER::PROTEIN-PAIR) ("carmustine" . SPARSER::DRUG)
    ("an occipital lobe" . SPARSER::PROTEIN)
    ("a parietal lobe" . SPARSER::PROTEIN)
    ("a temporal lobe" . SPARSER::PROTEIN)
    ("a frontal lobe" . SPARSER::PROTEIN)
    ("which uses fluorophore-labeled DNA" . SPARSER::DNA)
    ("a transmembrane tyrosine kinase" . SPARSER::PROTEIN)
    ("LANCL2" . SPARSER::PROTEIN) ("COL2A1" . SPARSER::PROTEIN)
    ("its DNA-dependence" . SPARSER::DNA) ("DNA-dependence" . SPARSER::DNA)
    ("Poly (ADP-ribose) polymerase 1 ( PARP-1 ) gene" . SPARSER::GENE)
    ("Reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("GRP78 and hTERT" . SPARSER::COLLECTION)
    ("chondrocytes and articular cartilage matrix" . SPARSER::COLLECTION)
    ("viable chondrocytes" . SPARSER::PROTEIN) ("hyaline" . SPARSER::PROTEIN)
    ("hTERT/GRP78" . SPARSER::COLLECTION)
    ("Glycosaminoglycan" . SPARSER::MOLECULE) ("PDL" . SPARSER::MOLECULE)
    ("proteoglycans, and gene" . SPARSER::COLLECTION)
    ("virus 40 large T antigen and telomerase" . SPARSER::COLLECTION)
    ("Chondrocytes" . SPARSER::PROTEIN)
    ("glycosaminoglycans (GAGs) and the expression level of type II collagen"
     . SPARSER::COLLECTION)
    ("glycosaminoglycans" . SPARSER::MOLECULE) ("safranin O" . SPARSER::DRUG)
    ("dimethylmethylene blue" . SPARSER::DRUG) ("gag-pol" . SPARSER::PROTEIN)
    ("mL -1" . SPARSER::PROTEIN)
    ("Glucose-regulated protein" . SPARSER::PROTEIN)
    ("an informative prognostic biomarker" . SPARSER::MOLECULE)
    ("informative biomarkers" . SPARSER::MOLECULE)
    ("miRNAs and AR" . SPARSER::COLLECTION) ("pSG5-" . SPARSER::PROTEIN)
    ("either oncogenes or tumour suppressor genes that are crucial"
     . SPARSER::COLLECTION)
    ("the AR or the SV40 promoter" . SPARSER::COLLECTION)
    ("RUNX1, En1 and Pax6" . SPARSER::COLLECTION)
    ("any previously reported AR variants" . SPARSER::VARIANT)
    ("CpGs" . SPARSER::PROTEIN) ("-deoxycytidine" . SPARSER::COLLECTION)
    ("aza" . SPARSER::DRUG) ("the AR minimal promoter" . SPARSER::PROMOTER)
    ("bisulfite" . SPARSER::MOLECULE) ("HRM" . SPARSER::PROTEIN-FAMILY)
    ("new prognostic biomarkers" . SPARSER::MOLECULE)
    ("an informative biomarker" . SPARSER::MOLECULE)
    ("more informative biomarkers" . SPARSER::MOLECULE)
    ("pcDNA 3" . SPARSER::PROTEIN) ("En1" . SPARSER::PROTEIN)
    ("trastuzumab and pertuzumab" . SPARSER::COLLECTION)
    ("trastuzumab, lapatinib, taxanes, and anthracyclines"
     . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG) ("maytansine" . SPARSER::DRUG)
    ("neratinib" . SPARSER::DRUG) ("survivin and Mcl-1" . SPARSER::COLLECTION)
    ("the pro-apoptotic BH3-only Bcl2 family member BIM" . SPARSER::PROTEIN)
    ("Jak2 and Src" . SPARSER::COLLECTION) ("EpoR" . SPARSER::PROTEIN)
    ("ATK" . SPARSER::PROTEIN)
    ("the dual PI3K-mTOR inhibitor BEZ235" . SPARSER::DRUG)
    ("XL147, or trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("catalytic subunit of PI3K, AKT1, or PIK3R1" . SPARSER::COLLECTION)
    ("PIK3CA or AKT2" . SPARSER::COLLECTION)
    ("AKT and AKT" . SPARSER::COLLECTION) ("Jak and Src" . SPARSER::COLLECTION)
    ("EphA2" . SPARSER::PROTEIN) ("EphA" . SPARSER::PROTEIN-FAMILY)
    ("EGFR and HER3" . SPARSER::COLLECTION)
    ("TGFa, amphiregulin, and heregulin" . SPARSER::COLLECTION)
    ("TGFa" . SPARSER::PROTEIN) ("TACE" . SPARSER::PROTEIN)
    ("lapatinib or trastuzumab" . SPARSER::COLLECTION)
    ("a membrane-associated glycoprotein" . SPARSER::PROTEIN)
    ("HER2 and mask" . SPARSER::COLLECTION) ("traditional DNA" . SPARSER::DNA)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("capecitabine and lapatinib" . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG) ("p95-HER2" . SPARSER::COLLECTION)
    ("inhibitor (TKI)" . SPARSER::INHIBITOR) ("Lapatinib" . SPARSER::DRUG)
    ("HER2 and EGFR" . SPARSER::COLLECTION)
    ("Heterodimers" . SPARSER::HETERODIMER)
    ("homology (SH)" . SPARSER::PROTEIN) ("SH" . SPARSER::PROTEIN-FAMILY)
    ("EGFR, HER3, or HER4" . SPARSER::COLLECTION)
    ("the monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib"
     . SPARSER::COLLECTION)
    ("HER2, the monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib"
     . SPARSER::COLLECTION)
    ("T-DM1" . SPARSER::PROTEIN) ("Jak2" . SPARSER::PROTEIN)
    ("XL147" . SPARSER::DRUG) ("INPP4B" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN)
    ("ADAM17" . SPARSER::PROTEIN) ("mucin-4" . SPARSER::PROTEIN)
    ("β-catenin and target" . SPARSER::COLLECTION)
    ("axin and APC" . SPARSER::COLLECTION)
    ("β-catenin or E-cadherin" . SPARSER::COLLECTION)
    ("Dvl-1 and Dvl-3" . SPARSER::COLLECTION)
    ("β-catenin-T-cell" . SPARSER::COLLECTION)
    ("axin/GSK-3β" . SPARSER::COLLECTION)
    ("axin and GSK-3β" . SPARSER::COLLECTION)
    ("β-catenin, APC, and GSK-3β" . SPARSER::COLLECTION)
    ("Axin" . SPARSER::PROTEIN) ("axin, GSK-3β, and APC" . SPARSER::COLLECTION)
    ("β-catenin and Dvl-2" . SPARSER::COLLECTION)
    ("displayed membrane-associated β-catenin" . SPARSER::PROTEIN)
    ("the control siRNA or the DACT1 siRNA" . SPARSER::COLLECTION)
    ("the subcellular localized β-catenin" . SPARSER::PROTEIN)
    ("GSK-3β, and DACT1" . SPARSER::COLLECTION)
    ("APC or β-catenin" . SPARSER::COLLECTION)
    ("DACT1 and GSK-3β, DACT1 and axin" . SPARSER::COLLECTION)
    ("GSK-3β, DACT1 and axin" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("axin, APC, and glycogen synthase kinase-3β" . SPARSER::COLLECTION)
    ("β-catenin and the components" . SPARSER::COLLECTION)
    ("Both membrane-associated β-catenin and DACT1" . SPARSER::COLLECTION)
    ("β-catenin and DACT1" . SPARSER::COLLECTION)
    ("DACT1 and β-catenin" . SPARSER::COLLECTION)
    ("membrane-associated β-catenin" . SPARSER::PROTEIN)
    ("the β-catenin membrane-associated fraction" . SPARSER::COMPONENT)
    ("cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("β-catenin, cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("the β-catenin and the Wnt/β-catenin target genes" . SPARSER::COLLECTION)
    ("siRNA or DACT1" . SPARSER::COLLECTION) ("Dpr1" . SPARSER::PROTEIN)
    ("GSK-3β and axin" . SPARSER::COLLECTION)
    ("parathyroid" . SPARSER::PROTEIN-FAMILY)
    ("the adenomatous polyposis coli ( APC ) gene" . SPARSER::GENE)
    ("FAP" . SPARSER::PROTEIN)
    ("its membrane-associated fraction" . SPARSER::COMPONENT)
    ("WNT/β-catenin" . SPARSER::COLLECTION)
    ("Membrane Protein" . SPARSER::PROTEIN) ("axin1" . SPARSER::PROTEIN)
    ("Axin1" . SPARSER::PROTEIN) ("Dvl-3" . SPARSER::PROTEIN)
    ("Dvl-1" . SPARSER::PROTEIN)
    ("lipoprotein receptor-related protein" . SPARSER::PROTEIN)
    ("Ca2+" . SPARSER::CALCIUM-ION) ("Dvl-2" . SPARSER::PROTEIN)
    ("LiC1" . SPARSER::PROTEIN) ("DACT 1" . SPARSER::PROTEIN)
    ("CTNB1" . SPARSER::PROTEIN) ("DACT1" . SPARSER::PROTEIN)
    ("p-Stat3" . SPARSER::COLLECTION)
    ("19 showed weak (1+) STMN1" . SPARSER::PROTEIN)
    ("some oncogenetic miRNAs" . SPARSER::PROTEIN)
    ("miR-21 and miR-27a" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressors in human cancers" . SPARSER::COLLECTION)
    ("novel diagnostic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("tumor suppressor genes and mismatch repair genes" . SPARSER::COLLECTION)
    ("pro-inflammatory cyclooxygenase enzyme" . SPARSER::ENZYME)
    ("vac" . SPARSER::PROTEIN) ("EPB41L3" . SPARSER::PROTEIN)
    ("Mef2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miR-106a" . SPARSER::MOLECULE)
    ("single-stranded RNA" . SPARSER::RNA)
    ("oncoprotein 18" . SPARSER::PROTEIN)
    ("yes-associated protein 1" . SPARSER::PROTEIN)
    ("retinoic acid-regulated nuclear matrix-associated protein"
     . SPARSER::PROTEIN)
    ("peroxisome proliferator activated receptor gamma" . SPARSER::PROTEIN)
    ("frizzled-related protein" . SPARSER::PROTEIN)
    ("death-associated protein kinase" . SPARSER::PROTEIN)
    ("Protocadherin 10" . SPARSER::PROTEIN) ("STMN1" . SPARSER::PROTEIN)
    ("Stathmin1" . SPARSER::PROTEIN) ("HDGC or EODGC" . SPARSER::COLLECTION)
    ("EC2" . SPARSER::PROTEIN) ("immature E-cad" . SPARSER::PROTEIN)
    ("immature protein" . SPARSER::PROTEIN) ("Arginine" . SPARSER::AMINO-ACID)
    ("Cysteine" . SPARSER::AMINO-ACID) ("TP and TN" . SPARSER::COLLECTION)
    ("TP" . SPARSER::PROTEIN)
    ("the hereditary mutation V832M efficiently binds β-catenin"
     . SPARSER::PROTEIN)
    ("E-cadherin/β-catenin" . SPARSER::COLLECTION)
    ("EC2–EC3" . SPARSER::PROTEIN-PAIR) ("ProP" . SPARSER::PROTEIN)
    ("HDGC and EODGC" . SPARSER::COLLECTION)
    ("E-cadherin and p120" . SPARSER::COLLECTION) ("OP" . SPARSER::MOLECULE)
    ("E-cadherin and xenopus" . SPARSER::COLLECTION) ("DGC" . SPARSER::PROTEIN)
    ("HDGC" . SPARSER::PROTEIN) ("P30" . SPARSER::PROTEIN)
    ("E-cad" . SPARSER::PROTEIN) ("PDB 2" . SPARSER::PROTEIN)
    ("EP-cadherin" . SPARSER::PROTEIN) ("PDB 1" . SPARSER::PROTEIN)
    ("C-cadherin" . SPARSER::PROTEIN)
    ("the phospho-mimetic Y153E-RhoGDI2 mutant" . SPARSER::MUTANT)
    ("the ordered state and the helical hairpin structure that is essential"
     . SPARSER::COLLECTION)
    ("a disordered state and an ordered state" . SPARSER::COLLECTION)
    ("RhoGDI2-Rac2" . SPARSER::COLLECTION)
    ("the S31E-RhoGDI2 phospho-mimetic mutant" . SPARSER::MUTANT)
    ("the predominant kinase" . SPARSER::KINASE)
    ("WT RhoGDI2 and the Ser 31 mutants" . SPARSER::COLLECTION)
    ("GST-Pak-Rac/Cdc42" . SPARSER::COLLECTION)
    ("Rac1 and RhoGDI2" . SPARSER::COLLECTION)
    ("PMA and RhoGDI2" . SPARSER::COLLECTION)
    ("Rac-RhoGDI2" . SPARSER::COLLECTION)
    ("the phospho-mimetic mutant" . SPARSER::MUTANT)
    ("a phospho-mimetic mutant" . SPARSER::MUTANT)
    ("RhoGDI2 and Rac" . SPARSER::COLLECTION)
    ("the predominant PKC isoform" . SPARSER::ISOFORM)
    ("PKCα or PKCβ" . SPARSER::COLLECTION)
    ("FLAG-RhoGDI2" . SPARSER::COLLECTION)
    ("LyGDI or D4GDI" . SPARSER::COLLECTION) ("LyGDI" . SPARSER::PROTEIN)
    ("Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("RhoGDI2 and active" . SPARSER::COLLECTION)
    ("Phospho-mimetic S31E-RhoGDI2" . SPARSER::PROTEIN)
    ("GDIs" . SPARSER::PROTEIN) ("calyculin A" . SPARSER::MOLECULE)
    ("PKC α" . SPARSER::PROTEIN) ("anti-FLAG" . SPARSER::PROTEIN)
    ("anti-HA" . SPARSER::PROTEIN) ("Rac2" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("PKCγ" . SPARSER::PROTEIN)
    ("GF 109203X" . SPARSER::DRUG) ("GTPase activating" . SPARSER::PROTEIN)
    ("RhoGDI2" . SPARSER::PROTEIN)
    ("SUV39H1 as well as p53 and targets both proteins" . SPARSER::COLLECTION)
    ("p53 and targets both proteins" . SPARSER::COLLECTION)
    ("p53–MDM2–SUV39H1" . SPARSER::COLLECTION)
    ("exogenously expressed p53 and either exogenously expressed or amplified MDM2"
     . SPARSER::COLLECTION)
    ("another adenoviral protein" . SPARSER::PROTEIN)
    ("RB and p53" . SPARSER::COLLECTION)
    ("3 repressive chromatin" . SPARSER::PROTEIN)
    ("RB–E2F" . SPARSER::COLLECTION) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myostatin" . SPARSER::PROTEIN) ("GHR" . SPARSER::PROTEIN)
    ("sh-p21 and" . SPARSER::PROTEIN-PAIR)
    ("p53 pro-apoptotic target genes" . SPARSER::GENE)
    ("p53 RNA ( xref ) or protein levels ( xref )" . SPARSER::COLLECTION)
    ("sh-SUV39H1" . SPARSER::COLLECTION)
    ("any p53 pro-apoptotic transcriptional target" . SPARSER::TARGET-PROTEIN)
    ("Doxycycline" . SPARSER::DRUG) ("p53–MDM2" . SPARSER::COLLECTION)
    ("SUV39H1 and H3K9" . SPARSER::COLLECTION)
    ("this repressive heterochromatin" . SPARSER::PROTEIN)
    ("tet-" . SPARSER::PROTEIN)
    ("the proteosomal inhibitor MG-132" . SPARSER::DRUG)
    ("sh-p21" . SPARSER::COLLECTION)
    ("EJ-p53 and EJ-p21" . SPARSER::COLLECTION)
    ("p53 or p21" . SPARSER::COLLECTION)
    ("EJ-p53 and B5/589" . SPARSER::COLLECTION)
    ("survivin, stathmin, CDC25C , cyclin A2 and cyclin B1"
     . SPARSER::COLLECTION)
    ("sh-p53" . SPARSER::COLLECTION)
    ("p21, PIG3 and MDM2" . SPARSER::COLLECTION)
    ("several new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the p53 established target genes are enriched with this"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("euchromatin, and H3K9" . SPARSER::COLLECTION)
    ("euchromatin" . SPARSER::BIO-COMPLEX) ("active genes" . SPARSER::GENE)
    ("representative p53 target genes" . SPARSER::GENE)
    ("Hydrogen peroxide" . SPARSER::MOLECULE) ("Nutlin3a" . SPARSER::DRUG)
    ("E4-ORF3" . SPARSER::PROTEIN) ("GDF8" . SPARSER::PROTEIN)
    ("growth hormone receptor" . SPARSER::PROTEIN)
    ("cyclin A2" . SPARSER::PROTEIN) ("Lys9" . SPARSER::PROTEIN)
    ("Several neuronal genes" . SPARSER::GENE)
    ("Creb , Mef2A and Bdnf" . SPARSER::COLLECTION)
    ("MEF2A and/or CREB" . SPARSER::COLLECTION)
    ("the CaMK kinases nor HDAC4" . SPARSER::COLLECTION)
    ("an essential part" . SPARSER::COMPONENT)
    ("ATM and HDAC4" . SPARSER::COLLECTION)
    ("mutant (L1062A) and a non-phosphorylatable mutant (3SA)"
     . SPARSER::COLLECTION)
    ("Hdac4" . SPARSER::PROTEIN) ("pr65 and pp2ca" . SPARSER::COLLECTION)
    ("pr65" . SPARSER::PROTEIN) ("pr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("2 mM caffeine or 10 μM KU55933" . SPARSER::COLLECTION)
    ("caffeine" . SPARSER::DRUG)
    ("kinases, CaMKII and CaMKIV" . SPARSER::COLLECTION)
    ("mutant or wild-type GFP-PP2A-A" . SPARSER::COLLECTION)
    ("mCherry-PP2A-C" . SPARSER::COLLECTION)
    ("the phosphomimetic (S401D) isoform" . SPARSER::ISOFORM)
    ("HDAC4-PP2A" . SPARSER::COLLECTION) ("Flag-HDAC4" . SPARSER::COLLECTION)
    ("PP2A-C or HDAC4" . SPARSER::COLLECTION)
    ("HDAC4 and its phosphatase" . SPARSER::COLLECTION)
    ("HDAC4/PP2A" . SPARSER::COLLECTION)
    ("a tissue specificity regulatory B subunit (PR55) and a catalytic C subunit (pp2ca)"
     . SPARSER::COLLECTION)
    ("A subunit (PR65), a tissue specificity regulatory B subunit (PR55) and a catalytic C subunit (pp2ca)"
     . SPARSER::COLLECTION)
    ("a tissue specificity regulatory B subunit" . SPARSER::PROTEIN)
    ("CaMKII and CaMKIV" . SPARSER::COLLECTION) ("CaMKIV" . SPARSER::PROTEIN)
    ("a second HDAC4 phosphospecific antibody" . SPARSER::PROTEIN)
    ("cleaved caspase-3 and the cell cycle markers PCNA and cyclin D1"
     . SPARSER::COLLECTION)
    ("neuronal survival proteins" . SPARSER::PROTEIN)
    ("PCNA and cyclin D1" . SPARSER::COLLECTION)
    ("Na-butyrate" . SPARSER::COLLECTION)
    ("Atm  −/− and wild-type mice" . SPARSER::COLLECTION)
    ("approximately 900 bp" . SPARSER::PROTEIN)
    ("multiple neuronal genes" . SPARSER::GENE)
    ("Bdnf , NR2a and Nrxn" . SPARSER::COLLECTION) ("NR2a" . SPARSER::PROTEIN)
    ("multiple neuronal growth genes" . SPARSER::GENE)
    ("AcH" . SPARSER::PROTEIN) ("Egr3, Fos and Mef2a" . SPARSER::COLLECTION)
    ("GFP-HDAC4" . SPARSER::COLLECTION)
    ("HDAC5 or HDAC9" . SPARSER::COLLECTION)
    ("HDAC5 and HDAC9" . SPARSER::COLLECTION)
    ("strong HDAC4" . SPARSER::PROTEIN) ("MEF2A-" . SPARSER::PROTEIN)
    ("HDAC4 and MEF2-" . SPARSER::COLLECTION) ("MEF2-" . SPARSER::PROTEIN)
    ("the prosurvival transcription factors MEF2 (myocyte enhancer factor 2) and CREB (cAMP response element-binding protein )"
     . SPARSER::COLLECTION)
    ("the prosurvival transcription factors MEF2" . SPARSER::PROTEIN)
    ("CaMKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Class I and class" . SPARSER::COLLECTION) ("Ataxia" . SPARSER::PROTEIN)
    ("MEF2A and CREB" . SPARSER::COLLECTION) ("Atm" . SPARSER::PROTEIN)
    ("Mef2A" . SPARSER::PROTEIN) ("P39" . SPARSER::PROTEIN)
    ("P18" . SPARSER::PROTEIN) ("A – R" . SPARSER::PROTEIN)
    ("PP2A-C" . SPARSER::PROTEIN) ("pp2" . SPARSER::DRUG)
    ("PR55" . SPARSER::PROTEIN) ("PR65" . SPARSER::PROTEIN)
    ("Erg-1" . SPARSER::PROTEIN) ("Mef2a" . SPARSER::PROTEIN)
    ("Egr3" . SPARSER::PROTEIN) ("MEF2" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("MEF2A" . SPARSER::PROTEIN) ("histone deacetylase 4" . SPARSER::PROTEIN)
    ("A-T" . SPARSER::PROTEIN) ("analgesic" . SPARSER::DRUG)
    ("IL-6, IL-1, and TNF-a" . SPARSER::COLLECTION) ("VIF" . SPARSER::PROTEIN)
    ("TNF-α and LTA" . SPARSER::COLLECTION)
    ("LTA and PTGS2" . SPARSER::COLLECTION)
    ("PTGS2 and LTA" . SPARSER::COLLECTION)
    ("the Mayo Clinic Lung Cancer Cohort" . SPARSER::MOLECULE)
    ("several cytokine and inflammation genes" . SPARSER::COLLECTION)
    ("TNF-alpha" . SPARSER::PROTEIN)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("lymphotoxin-alpha" . SPARSER::PROTEIN)
    ("Prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("CKI and ATM" . SPARSER::COLLECTION)
    ("CKI and CKII" . SPARSER::COLLECTION) ("CKII" . SPARSER::PROTEIN)
    ("ATM/ATR" . SPARSER::COLLECTION) ("UBC13 and Skp2" . SPARSER::COLLECTION)
    ("H2A and H2AX" . SPARSER::COLLECTION)
    ("BRCA1/RAP80" . SPARSER::COLLECTION) ("polyubiquitins" . SPARSER::PROTEIN)
    ("the NBS1 ubiquitinationdeficient mutant" . SPARSER::MUTANT)
    ("only target proteins" . SPARSER::PROTEIN)
    ("NBS1-ATM" . SPARSER::COLLECTION) ("only K735R mutant" . SPARSER::MUTANT)
    ("ATM and ATM" . SPARSER::COLLECTION) ("a major E2" . SPARSER::MOLECULE)
    ("ATM-NBS1" . SPARSER::COLLECTION) ("IR, and Skp2" . SPARSER::COLLECTION)
    ("Ligase" . SPARSER::LIGASE) ("ATM and ATR" . SPARSER::COLLECTION)
    ("NBS1 and Skp2" . SPARSER::COLLECTION)
    ("Skp2 and NBS1" . SPARSER::COLLECTION)
    ("serial truncation mutants" . SPARSER::MUTANT)
    ("ATM and Skp2" . SPARSER::COLLECTION)
    ("NBS1 and ATM" . SPARSER::COLLECTION)
    ("ATM and NBS1" . SPARSER::COLLECTION) ("Skp2-NBS1" . SPARSER::COLLECTION)
    ("the WT Skp2 and catalytic inactive mutant Skp2-NES"
     . SPARSER::COLLECTION)
    ("Skp2-NES" . SPARSER::COLLECTION) ("Skp2 and ATM" . SPARSER::COLLECTION)
    ("Foci" . SPARSER::PROTEIN) ("Forms" . SPARSER::FORM)
    ("pATM" . SPARSER::PROTEIN) ("NBS1 or Mre11" . SPARSER::COLLECTION)
    ("progressive cerebellar ataxia" . SPARSER::PROTEIN)
    ("Mre11/Rad50/NBS1" . SPARSER::COLLECTION) ("UBCH5c" . SPARSER::PROTEIN)
    ("UEV1A" . SPARSER::PROTEIN) ("UBC13" . SPARSER::PROTEIN)
    ("Smad4" . SPARSER::PROTEIN) ("Ligase Activity" . SPARSER::PROTEIN)
    ("SMC1" . SPARSER::PROTEIN)
    ("MEK inhibitor and Raf inhibitor" . SPARSER::COLLECTION)
    ("Molecules" . SPARSER::MOLECULE) ("HER1 or HER3" . SPARSER::COLLECTION)
    ("MEK, ERK, and RAF" . SPARSER::COLLECTION)
    ("ERK or MEK" . SPARSER::COLLECTION)
    ("various regulators or negative feedback mechanisms"
     . SPARSER::COLLECTION)
    ("protein tyrosine phosphatase (PTP) or other MAPK phosphatases"
     . SPARSER::COLLECTION)
    ("/AKT/mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("MEK and ERK" . SPARSER::COLLECTION)
    ("RKIP, MEK, and ERK" . SPARSER::COLLECTION)
    ("Histopathological type and depth" . SPARSER::COLLECTION)
    ("significantly longer RFS" . SPARSER::PROTEIN)
    ("RKIP (p = 0.042) and p-ERK (p = 0.007)" . SPARSER::COLLECTION)
    ("phosphorylated MEK (p-MEK) and RKIP" . SPARSER::COLLECTION)
    ("Ras and B-Raf" . SPARSER::COLLECTION)
    ("a 20-25 kDa globular protein" . SPARSER::PROTEIN)
    ("PEBP" . SPARSER::PROTEIN)
    ("threonine and tyrosine" . SPARSER::COLLECTION)
    ("proteins, and oncogene" . SPARSER::COLLECTION)
    ("ERK-activated protein kinase" . SPARSER::COLLECTION)
    ("Trastuzumab" . SPARSER::DRUG) ("RKIP and p-ERK" . SPARSER::COLLECTION)
    ("significantly shorter RFS" . SPARSER::PROTEIN)
    ("protein (RKIP)" . SPARSER::PROTEIN)
    ("ERK, and Raf" . SPARSER::COLLECTION) ("TRAPPC4" . SPARSER::PROTEIN)
    ("trafficking protein particle complex 4" . SPARSER::PROTEIN)
    ("dual specificity phosphatase" . SPARSER::PROTEIN)
    ("p-MEK 1" . SPARSER::PROTEIN)
    ("Extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("catecholamine" . SPARSER::MOLECULE) ("CRTC" . SPARSER::PROTEIN)
    ("PKA or PKB" . SPARSER::COLLECTION)
    ("CaMK or CaMKK" . SPARSER::COLLECTION) ("CaMKK" . SPARSER::PROTEIN)
    ("activator and inhibitor" . SPARSER::COLLECTION)
    ("brown adipocytes" . SPARSER::PROTEIN)
    ("AICAR or phenformin" . SPARSER::COLLECTION)
    ("a crude particulate fraction" . SPARSER::COMPONENT)
    ("Primary adipocytes" . SPARSER::PROTEIN)
    ("SIK3 and the Par-1/MARK family" . SPARSER::COLLECTION)
    ("SIK1, SIK3 and the Par-1/MARK family" . SPARSER::COLLECTION)
    ("the crude particulate fraction" . SPARSER::COMPONENT)
    ("crude particulate fractions" . SPARSER::COMPONENT)
    ("directly bind 14-3-3 " . SPARSER::PROTEIN)
    ("anti-HA–SIK2" . SPARSER::PROTEIN-PAIR)
    ("this tryptic peptide" . SPARSER::PEPTIDE)
    ("SIK2 and 14-3-3" . SPARSER::COLLECTION)
    ("forskolin and the β 3 -adrenergic receptor agonist CL"
     . SPARSER::COLLECTION)
    ("GST–14-3-3" . SPARSER::COLLECTION) ("cAMPs" . SPARSER::CAMP)
    ("activator (PMA)" . SPARSER::ACTIVATOR) ("Akti" . SPARSER::PROTEIN)
    ("-adrenergic" . SPARSER::COLLECTION) ("PKA and PKB" . SPARSER::COLLECTION)
    ("AICAR, phenformin, forskolin and ionomycin" . SPARSER::COLLECTION)
    ("the Ca 2+ ionophore ionomycin and insulin ( xref A)"
     . SPARSER::COLLECTION)
    ("AICAR and phenformin" . SPARSER::COLLECTION)
    ("an optimal substrate" . SPARSER::SUBSTRATE)
    ("HDAC5 (HDAC5tide) and IRS1 (IRS1tide)" . SPARSER::COLLECTION)
    ("AMPK-" . SPARSER::PROTEIN) ("Secondary antibody" . SPARSER::PROTEIN)
    ("SIK1 and SIK2" . SPARSER::COLLECTION)
    ("serine, threonine and tyrosine" . SPARSER::COLLECTION)
    ("mixtures" . SPARSER::MOLECULE) ("an LTQ-orbitrap" . SPARSER::MOLECULE)
    ("LTQ-orbitrap" . SPARSER::MOLECULE) ("Trap" . SPARSER::PROTEIN)
    ("IPTG" . SPARSER::MOLECULE)
    ("pGEX expression constructs encoding human-GST-fused HDAC5 (1–550) and 14-3-3ζ"
     . SPARSER::COLLECTION)
    ("HDAC5 (1–550) and 14-3-3ζ" . SPARSER::COLLECTION)
    ("14-3-3ζ" . SPARSER::PROTEIN)
    ("using HRP-conjugated secondary antibodies and ECL (enhanced chemiluminescence) reagent"
     . SPARSER::COLLECTION)
    ("using HRP-conjugated secondary antibodies" . SPARSER::ANTIBODY)
    ("GST–14-3-3ζ" . SPARSER::PROTEIN-PAIR) ("type " . TYPE)
    ("FLA" . SPARSER::PROTEIN) ("mercaptoethanol" . SPARSER::MOLECULE)
    ("GST–SIK2" . SPARSER::COLLECTION)
    ("AMPK and SIK isoforms [ xref ]" . SPARSER::COLLECTION)
    ("anti-SIK2 or 1 μg" . SPARSER::COLLECTION)
    ("0.27 M sucrose and 20 mM glutathione" . SPARSER::COLLECTION)
    ("HA– or GST" . SPARSER::COLLECTION) ("FLAG–SIK2" . SPARSER::COLLECTION)
    ("Ser358Ala SIK2 and 4.5 μg" . SPARSER::COLLECTION)
    ("1 mM DTT and complete protease inhibitor" . SPARSER::COLLECTION)
    ("5% FBS, 1% penicillin/streptomycin and 0.5% BSA" . SPARSER::COLLECTION)
    ("Adipocytes" . SPARSER::PROTEIN)
    ("1 mM DTT (dithiothreitol) and complete protease inhibitor (one tablet/50 ml)"
     . SPARSER::COLLECTION)
    ("dithiothreitol" . SPARSER::PROTEIN) ("GFP–SIK2" . SPARSER::COLLECTION)
    ("KOD" . SPARSER::DRUG)
    ("Ser575Ala HA– and GFP–SIK1" . SPARSER::COLLECTION)
    ("pGEX expression constructs encoding human HDAC5 (1–550) and 14-3-3ζ"
     . SPARSER::COLLECTION)
    ("SIK2–FLAG" . SPARSER::COLLECTION) ("GFP–SIK1" . SPARSER::COLLECTION)
    ("HA–" . SPARSER::MOLECULE) ("–SIK2" . SPARSER::COLLECTION)
    ("FRT" . SPARSER::PROTEIN) ("Fluor" . SPARSER::MOLECULE)
    ("Secondary antibodies" . SPARSER::ANTIBODY) ("BMH" . SPARSER::PROTEIN)
    ("anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and anti-FLAG–HRP (horseradish peroxidase) antibodies"
     . SPARSER::COLLECTION)
    ("anti-FLAG–HRP" . SPARSER::PROTEIN-PAIR) ("HSL" . SPARSER::PROTEIN)
    ("phosphocellulose" . SPARSER::DRUG) ("streptomycin" . SPARSER::DRUG)
    ("Flp-recombinase" . SPARSER::COLLECTION) ("Flp" . SPARSER::PROTEIN)
    ("phenformin" . SPARSER::DRUG) ("IBMX" . SPARSER::MOLECULE)
    ("particular SIK1" . SPARSER::PROTEIN)
    ("CaMK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIK1 and SIK3" . SPARSER::COLLECTION)
    ("SIK2 and its related kinases" . SPARSER::COLLECTION)
    ("QSK" . SPARSER::PROTEIN) ("QIK" . SPARSER::PROTEIN)
    ("–SIK2 " . SPARSER::COLLECTION)
    ("haemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the cAMP-elevating agent forskolin and the β-adrenergic receptor agonist CL"
     . SPARSER::COLLECTION)
    ("inducers or AICAR" . SPARSER::COLLECTION)
    ("peptide or protein" . SPARSER::COLLECTION)
    ("lipid droplet" . SPARSER::PROTEIN) ("Par-1" . SPARSER::PROTEIN)
    ("14-3-3 " . SPARSER::PROTEIN) ("AMPKα 1" . SPARSER::PROTEIN)
    ("hormone-sensitive lipase" . SPARSER::PROTEIN)
    ("insulin receptor substrate1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRTC2" . SPARSER::PROTEIN)
    ("Ca 2+ /calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("SIK1" . SPARSER::PROTEIN) ("SIK3" . SPARSER::PROTEIN)
    ("Qin-induced kinase" . SPARSER::PROTEIN)
    ("salt-inducible kinase" . SPARSER::PROTEIN) ("SIK2 " . SPARSER::PROTEIN)
    ("salt-inducible kinase 2" . SPARSER::PROTEIN) ("SIK2" . SPARSER::PROTEIN)
    ("these MDR-associated drugs" . SPARSER::DRUG)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("paclitaxel and irinotecan" . SPARSER::COLLECTION)
    ("the MDR-associated proteins ABCC1, ABCG2 and MVP" . SPARSER::COLLECTION)
    ("ABCC1, ABCG2, and MVP" . SPARSER::COLLECTION)
    ("ABCC1 , ABCG2 and MVP" . SPARSER::COLLECTION)
    ("ABCB1 and drug" . SPARSER::COLLECTION)
    ("matrilysin, BMP4 and S100A4" . SPARSER::COLLECTION)
    ("matrilysin" . SPARSER::PROTEIN)
    ("c-myc and cyclin D1" . SPARSER::COLLECTION)
    ("β -catenin and ABCB1" . SPARSER::COLLECTION)
    ("c-myc, cyclinD1 and S100A4" . SPARSER::COLLECTION)
    ("the mut or the wt β -catenin allele" . SPARSER::COLLECTION)
    ("its MDR-associated target gene ABCB1" . SPARSER::PROTEIN)
    ("these chemoresistance-associated genes" . SPARSER::GENE)
    ("ABCC1, ABCG2 and MVP" . SPARSER::COLLECTION) ("MVP" . SPARSER::PROTEIN)
    ("membranous ABCB1" . SPARSER::PROTEIN)
    ("strong ABCB1 protein" . SPARSER::PROTEIN) ("sulindac" . SPARSER::DRUG)
    ("Sulindac" . SPARSER::DRUG)
    ("a pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("mut and HAB-92" . SPARSER::COLLECTION)
    ("Derivatives" . SPARSER::DERIVATIVE)
    ("the wt or the mut β -catenin allele" . SPARSER::COLLECTION)
    ("mut and HAB-68" . SPARSER::COLLECTION)
    ("wt and HAB-92" . SPARSER::COLLECTION)
    ("β -catenin/TCF4" . SPARSER::COLLECTION)
    ("taxanes and anthracyclines" . SPARSER::COLLECTION)
    ("MDR-associated genes" . SPARSER::GENE)
    ("serine and threonine" . SPARSER::COLLECTION)
    ("the phosphorylation complex or the phosphorylation sites on β -catenin"
     . SPARSER::COLLECTION)
    ("APC and β -catenin" . SPARSER::COLLECTION) ("S100A4" . SPARSER::PROTEIN)
    ("a 37 " . SPARSER::PROTEIN) ("β -tubulin" . SPARSER::PROTEIN)
    ("Housekeeping Gene" . SPARSER::PROTEIN) ("G6PDH" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("C 20 " . SPARSER::PROTEIN)
    ("CAT1" . SPARSER::PROTEIN) ("β -Catenin" . SPARSER::PROTEIN)
    ("T-cell factor 4" . SPARSER::PROTEIN) ("β -catenin" . SPARSER::PROTEIN)
    ("GH-" . SPARSER::PROTEIN) ("bromocriptine" . SPARSER::MOLECULE)
    ("octreotide" . SPARSER::DRUG)
    ("COX-2 and prostaglandin" . SPARSER::COLLECTION)
    ("colorectal carcinomas COX-2" . SPARSER::PROTEIN)
    ("somatostatin" . SPARSER::PROTEIN) ("FSH" . SPARSER::DRUG)
    ("TSH" . SPARSER::PROTEIN) ("GH" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN) ("ACTH" . SPARSER::PROTEIN)
    ("MR" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Bcl 2" . SPARSER::PROTEIN)
    ("Ras, miR-16 and Bcl-2 and miR-17-5p and E2F1" . SPARSER::COLLECTION)
    ("Bcl-2 and miR-17-5p and E2F1" . SPARSER::COLLECTION)
    ("ECC" . SPARSER::MOLECULE) ("ERBB3 and forms" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase and phosphatidylinositol-3"
     . SPARSER::COLLECTION)
    ("ERBB2-ERBB3" . SPARSER::COLLECTION)
    ("around 580 miRNAs" . SPARSER::PROTEIN)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX)
    ("The mature miRNAs" . SPARSER::PROTEIN) ("Dicer" . SPARSER::PROTEIN)
    ("MiR-125b" . SPARSER::MOLECULE) ("pri-miRNAs" . SPARSER::RNA)
    ("HR and 95% CI" . SPARSER::COLLECTION)
    ("antibody and RFS" . SPARSER::COLLECTION) ("mutagen" . SPARSER::MOLECULE)
    ("a shorter RFS" . SPARSER::PROTEIN)
    ("class and serum" . SPARSER::COLLECTION)
    ("p53 and low/undetectable" . SPARSER::COLLECTION)
    ("α-fetoprotein" . SPARSER::PROTEIN)
    ("the MetS and its components" . SPARSER::COLLECTION)
    ("triglyceride" . SPARSER::MOLECULE) ("leptin" . SPARSER::PROTEIN)
    ("subcutaneous fat" . SPARSER::PROTEIN)
    ("allele and G/G" . SPARSER::COLLECTION)
    ("MetS and its components" . SPARSER::COLLECTION)
    ("triglycerides and low HDL" . SPARSER::COLLECTION)
    ("introns" . SPARSER::PROTEIN) ("HDL" . SPARSER::PROTEIN)
    ("MetS" . SPARSER::PROTEIN) ("HOMA-IR" . SPARSER::COLLECTION)
    ("DBP" . SPARSER::PROTEIN) ("SBP" . SPARSER::PROTEIN)
    ("dL" . SPARSER::MOLECULE) ("low density lipoprotein" . SPARSER::PROTEIN)
    ("high density lipoprotein" . SPARSER::PROTEIN)
    ("HDL-C" . SPARSER::PROTEIN) ("HDL-cholesterol" . SPARSER::MOLECULE)
    ("Cdc42/PAK1" . SPARSER::COLLECTION)
    ("Duo/Rac-1/PAK1" . SPARSER::COLLECTION) ("MLCP" . SPARSER::PHOSPHATASE)
    ("proteins ( xref ) or myosin" . SPARSER::COLLECTION)
    ("soma" . SPARSER::DRUG) ("PMI" . SPARSER::PROTEIN)
    ("total cofilin ( xref ) and its phosphorylated form ( xref )"
     . SPARSER::COLLECTION)
    ("LIMK1/cofilin" . SPARSER::COLLECTION)
    ("Cdc42 and Duo" . SPARSER::COLLECTION)
    ("Duo/Rac-1/PAK-1" . SPARSER::COLLECTION)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("Duo/PAK1" . SPARSER::COLLECTION) ("synaptic proteins" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor (GEF)" . SPARSER::PROTEIN)
    ("Kalirin" . SPARSER::PROTEIN) ("Rac-1 and Cdc42" . SPARSER::COLLECTION)
    ("Fragile X mental retardation protein (FMRP)" . SPARSER::PROTEIN)
    ("protein (FMRP)" . SPARSER::PROTEIN) ("FMRP" . SPARSER::PROTEIN)
    ("ACC and DLPFC" . SPARSER::COLLECTION)
    ("regulatory myosin light chain (MLC) and cofilin" . SPARSER::COLLECTION)
    ("regulatory myosin light chain (MLC)" . SPARSER::PROTEIN)
    ("Duo and Cdc42" . SPARSER::COLLECTION) ("Duo" . SPARSER::PROTEIN)
    ("Myosin light chain" . SPARSER::PROTEIN) ("PAK-1" . SPARSER::PROTEIN)
    ("bis-tris" . SPARSER::MOLECULE) ("LIMK1" . SPARSER::PROTEIN)
    ("Rac-1" . SPARSER::PROTEIN) ("DISC-1" . SPARSER::PROTEIN)
    ("mental retardation" . SPARSER::PROTEIN)
    ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("tri-methlyguanosine" . SPARSER::PROTEIN-PAIR)
    ("cellular mRNAs" . SPARSER::PROTEIN)
    ("induced-fit" . SPARSER::PROTEIN-FAMILY)
    ("methylguanine" . SPARSER::MOLECULE)
    ("the spliced cellular mRNAs" . SPARSER::PROTEIN)
    ("NXF1/NXT1" . SPARSER::COLLECTION)
    ("the unspliced viral RNAs" . SPARSER::RNA) ("env" . SPARSER::PROTEIN)
    ("Rev" . SPARSER::PROTEIN-FAMILY) ("PHAX" . SPARSER::PROTEIN)
    ("snRNP" . SPARSER::BIO-COMPLEX) ("snRNA" . SPARSER::RNA)
    ("selected cellular mRNAs" . SPARSER::PROTEIN)
    ("the viral accessory protein Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("purified virions detected both CBP80 and eIF4E" . SPARSER::COLLECTION)
    ("cell-associated proteins" . SPARSER::PROTEIN) ("RPAs" . SPARSER::PROTEIN)
    ("RNPs" . SPARSER::PROTEIN)
    ("the 80S ribosomal fractions ( xref , fractions 9–11, −EDTA) and the fractions"
     . SPARSER::COLLECTION)
    ("the 80S ribosomal fractions" . SPARSER::COMPONENT)
    ("the 80S ribosomal fraction" . SPARSER::COMPONENT)
    ("eIF4E and eIF4E" . SPARSER::COLLECTION)
    ("protein (odd number) and RNA (even number)" . SPARSER::COLLECTION)
    ("ribosomal RNAs" . SPARSER::RNA) ("−EDTA" . SPARSER::MOLECULE)
    ("the CBC-associated mRNAs" . SPARSER::PROTEIN)
    ("their respective antisera" . SPARSER::PROTEIN)
    ("CBP80 and eIF4E" . SPARSER::COLLECTION)
    ("CBP80 and histone" . SPARSER::COLLECTION)
    ("CBP80, α-tubulin and histone" . SPARSER::COLLECTION)
    ("proteins and Vif" . SPARSER::COLLECTION)
    ("HA and Vif" . SPARSER::COLLECTION) ("antisera" . SPARSER::PROTEIN)
    ("Mnk2 and other components" . SPARSER::COLLECTION)
    ("Vif or the Vpr mutants" . SPARSER::COLLECTION)
    ("the phosphorylated forms or total amounts of eIF4E or 4E-BP1"
     . SPARSER::COLLECTION)
    ("eIF4E or 4E-BP1" . SPARSER::COLLECTION)
    ("eIF4E and 4E-BP1" . SPARSER::COLLECTION)
    ("total eIF2α and Ser51-phosphorylated eIF2α (P-eIF2α)"
     . SPARSER::COLLECTION)
    ("the Cul4A DDB1/DCAF1 E3 ligase and a yet-to-be-identified substrate"
     . SPARSER::COLLECTION)
    ("DDB1/DCAF1" . SPARSER::COLLECTION)
    ("polyribosomes" . SPARSER::BIO-COMPLEX)
    ("vpr (VprX) or vpr and vif (ΔVifVprX)" . SPARSER::COLLECTION)
    ("the HIV-1 accessory proteins Vpr and Vif" . SPARSER::COLLECTION)
    ("Vpr and Vif" . SPARSER::COLLECTION) ("vpr and vif" . SPARSER::COLLECTION)
    ("vif" . SPARSER::PROTEIN) ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vif" . SPARSER::PROTEIN) ("Noc" . SPARSER::PROTEIN)
    ("Tubulin and GRP78" . SPARSER::COLLECTION) ("Tubulin" . SPARSER::PROTEIN)
    ("membrane-associated ribosomal RNA" . SPARSER::RNA)
    ("soluble ribosomes and membrane-associated ribosomes"
     . SPARSER::COLLECTION)
    ("membrane-associated ribosomes" . SPARSER::BIO-COMPLEX)
    ("soluble ribosomes" . SPARSER::BIO-COMPLEX)
    ("polyribosome" . SPARSER::BIO-COMPLEX)
    ("the unspliced viral mRNA" . SPARSER::PROTEIN)
    ("the viral mRNPs" . SPARSER::BIO-COMPLEX)
    ("the viral RNP" . SPARSER::PROTEIN) ("viral protein" . SPARSER::PROTEIN)
    ("rRNA and tRNA" . SPARSER::COLLECTION)
    ("picornaviral mRNAs" . SPARSER::PROTEIN)
    ("eIF4E and eIF4G" . SPARSER::COLLECTION)
    ("eIF4E and/or the eIF4E-binding proteins (4E-BPs)" . SPARSER::COLLECTION)
    ("BPs" . SPARSER::PROTEIN) ("PABP" . SPARSER::PROTEIN)
    ("EJC" . SPARSER::BIO-COMPLEX) ("complex (EJC)" . SPARSER::BIO-COMPLEX)
    ("RNP" . SPARSER::PROTEIN) ("CBP80 and CBP20" . SPARSER::COLLECTION)
    ("the viral mRNAs" . SPARSER::PROTEIN)
    ("completely spliced viral mRNAs" . SPARSER::PROTEIN)
    ("the viral and cellular mRNA-ribonucleoprotein complexes"
     . SPARSER::BIO-COMPLEX)
    ("the viral structural proteins" . SPARSER::PROTEIN)
    ("HIV-1 accessory protein Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CBP80-bound cellular mRNAs" . SPARSER::PROTEIN)
    ("CBC" . SPARSER::BIO-COMPLEX)
    ("the nuclear cap binding complex (CBC)-bound viral mRNAs"
     . SPARSER::PROTEIN)
    ("complex (CBC)" . SPARSER::BIO-COMPLEX)
    ("completely-spliced viral and cellular mRNAs" . SPARSER::PROTEIN)
    ("RNA-coimmunoprecipitation" . SPARSER::RNA)
    ("viral structural proteins" . SPARSER::PROTEIN)
    ("the HIV-1 accessory protein Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NXT1" . SPARSER::PROTEIN)
    ("capsid protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DHX9" . SPARSER::PROTEIN) ("Mnk2" . SPARSER::PROTEIN)
    ("P-4" . SPARSER::PROTEIN) ("cullin 4" . SPARSER::PROTEIN)
    ("DCAF1" . SPARSER::PROTEIN) ("Gag protein" . SPARSER::PROTEIN)
    ("Mnk1" . SPARSER::PROTEIN) ("NXF1" . SPARSER::PROTEIN)
    ("PABP-1" . SPARSER::PROTEIN) ("cap-binding protein" . SPARSER::PROTEIN)
    ("CBP20" . SPARSER::PROTEIN) ("7-methylguanosine" . SPARSER::MOLECULE)
    ("CBP80" . SPARSER::PROTEIN)
    ("ribonucleoprotein complexes" . SPARSER::BIO-COMPLEX)
    ("HDAC1-DNMT3B" . SPARSER::COLLECTION) ("acinus" . SPARSER::PROTEIN)
    ("proteins and lipids" . SPARSER::COLLECTION)
    ("relatively high-level TWIST protein" . SPARSER::PROTEIN)
    ("a heterologous promoter" . SPARSER::PROMOTER)
    ("mRNA and proteins" . SPARSER::COLLECTION)
    ("gene and TWIST-mediated" . SPARSER::COLLECTION)
    ("either non-targeting shRNA or TWIST mRNA-targeting shRNA"
     . SPARSER::COLLECTION)
    ("MTA2, HDAC2 and RbAp46" . SPARSER::COLLECTION)
    ("Mi-2, MTA2 and HDAC2" . SPARSER::COLLECTION)
    ("P3 and P4" . SPARSER::COLLECTION)
    ("SNAIL, SLUG, Zeb1 and SIP1" . SPARSER::COLLECTION)
    ("hypoxia/HIF1" . SPARSER::COLLECTION)
    ("TGF-β/SMADs" . SPARSER::COLLECTION)
    ("ERα and other epithelial marker genes" . SPARSER::COLLECTION)
    ("estrogen or ERα" . SPARSER::COLLECTION)
    ("ErbB2 or H-RasV12" . SPARSER::COLLECTION)
    ("the nucleosome remodeling and deacetylase (NuRD) gene repression complex"
     . SPARSER::COLLECTION)
    ("SNAIL1, SNAIL2 and PDGF receptor-α" . SPARSER::COLLECTION)
    ("tamoxifen and raloxifene" . SPARSER::COLLECTION)
    ("DNMT3B" . SPARSER::PROTEIN) ("RbAp46" . SPARSER::PROTEIN)
    ("Mi-2" . SPARSER::PROTEIN) ("SIP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF1" . SPARSER::PROTEIN) ("RasV12" . SPARSER::DRUG)
    ("PDGF receptor" . SPARSER::PROTEIN)
    ("functional homologues" . SPARSER::PROTEIN)
    ("FBH1 and RTEL1" . SPARSER::COLLECTION) ("Rad51-" . SPARSER::PROTEIN)
    ("PCNA-" . SPARSER::PROTEIN) ("enzymes or nucleases" . SPARSER::COLLECTION)
    ("PCNA-ubiquitin" . SPARSER::COLLECTION)
    ("PCNA and translesion synthesis polymerases ( xref B)"
     . SPARSER::COLLECTION)
    ("PCNA and RFC" . SPARSER::COLLECTION)
    ("nicked plasmid DNA or their combination" . SPARSER::COLLECTION)
    ("PIAS" . SPARSER::PROTEIN-FAMILY) ("SUMO-PCNA" . SPARSER::COLLECTION)
    ("Pias1, Pias2, Pias3 and Pias4" . SPARSER::COLLECTION)
    ("SUMO1, SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("Pias3" . SPARSER::PROTEIN) ("SUMO-ligases" . SPARSER::COLLECTION)
    ("SAE1/SAE2" . SPARSER::COLLECTION) ("Pias" . SPARSER::PROTEIN-FAMILY)
    ("PCNAs" . SPARSER::PROTEIN) ("FLAG-SUMO1" . SPARSER::COLLECTION)
    ("SUMO2 and SUMO3" . SPARSER::COLLECTION)
    ("SUMO1, SUMO2 or SUMO3" . SPARSER::COLLECTION)
    ("PCNA-SUMO" . SPARSER::COLLECTION) ("protein (PARI)" . SPARSER::PROTEIN)
    ("PARI" . SPARSER::PROTEIN) ("PCNA–SUMO" . SPARSER::COLLECTION)
    ("PCNA-SUMO1" . SPARSER::COLLECTION) ("RTEL1" . SPARSER::PROTEIN)
    ("FBH1" . SPARSER::PROTEIN) ("Ubc9" . SPARSER::PROTEIN)
    ("SAE2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SAE1" . SPARSER::PROTEIN)
    ("SUMO3" . SPARSER::PROTEIN) ("SUMO2" . SPARSER::PROTEIN)
    ("SUMO1" . SPARSER::PROTEIN) ("Srs2" . SPARSER::PROTEIN)
    ("rapamycin and everolimus" . SPARSER::COLLECTION)
    ("robust tuberin protein" . SPARSER::PROTEIN)
    ("STR3, KG8 and STR7" . SPARSER::COLLECTION)
    ("ASPL-TFE3" . SPARSER::COLLECTION) ("ASPL" . SPARSER::PROTEIN)
    ("ASPS" . SPARSER::PROTEIN)
    ("MiTF, TFEB, TFEC, and TFE3" . SPARSER::COLLECTION)
    ("TFEC" . SPARSER::PROTEIN) ("MiTF" . SPARSER::PROTEIN)
    ("Complex (TSC)" . SPARSER::BIO-COMPLEX)
    ("TSC1 or TSC2" . SPARSER::COLLECTION) ("TFE3" . SPARSER::PROTEIN)
    ("HMB45" . SPARSER::DRUG) ("the relevant kinases" . SPARSER::KINASE)
    ("JNK or DDK" . SPARSER::COLLECTION)
    ("a proximal trigger" . SPARSER::PROTEIN) ("ssDNA" . SPARSER::PROTEIN)
    ("ERK8 and perhaps" . SPARSER::COLLECTION)
    ("the S-box serines and S409" . SPARSER::COLLECTION)
    ("UV, and UV" . SPARSER::COLLECTION) ("Polκ" . SPARSER::PROTEIN)
    ("GFP-Polκ" . SPARSER::COLLECTION) ("YFP–Polη" . SPARSER::COLLECTION)
    ("YFP-Polη" . SPARSER::COLLECTION)
    ("Rad18-complemented" . SPARSER::COLLECTION)
    ("–Polη" . SPARSER::COLLECTION) ("Rad18 or Rad18" . SPARSER::COLLECTION)
    ("RPA-ssDNA" . SPARSER::PROTEIN-PAIR)
    ("PCNA and other Rad18 substrates" . SPARSER::COLLECTION)
    ("Rad18 and Polη" . SPARSER::COLLECTION)
    ("the detergent-insoluble chromatin" . SPARSER::PROTEIN)
    ("-Rad18 (WT)" . SPARSER::COLLECTION) ("-Rad18" . SPARSER::COLLECTION)
    ("MKK4 and JNK" . SPARSER::COLLECTION)
    ("JNK and p38" . SPARSER::COLLECTION) ("JNK and DDK" . SPARSER::COLLECTION)
    ("DDK" . SPARSER::BIO-COMPLEX)
    ("possible in vitro substrates" . SPARSER::SUBSTRATE)
    ("GST-Rad18" . SPARSER::COLLECTION)
    ("most likely not relevant protein kinases" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases (CDKs) and/or SAPKs" . SPARSER::COLLECTION)
    ("bacterial glutathione S -transferase (GST)–Rad18" . SPARSER::COLLECTION)
    ("–Rad18" . SPARSER::COLLECTION) ("Rad18–Rad6" . SPARSER::COLLECTION)
    ("The S409-reactive protein" . SPARSER::PROTEIN)
    ("phosphospecific antiserum" . SPARSER::PROTEIN)
    ("immunoblotting experiments anti–phosphoserine/phosphothreonine antibodies"
     . SPARSER::ANTIBODY)
    ("phosphothreonine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("JNK and other SAPKs" . SPARSER::COLLECTION)
    ("SAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Chk1 and Rad18" . SPARSER::COLLECTION)
    ("polymerase/helicase" . SPARSER::COLLECTION)
    ("Polη and Rad18" . SPARSER::COLLECTION)
    ("the preferred TLS polymerase and the default enzyme"
     . SPARSER::COLLECTION)
    ("the replicative DNA polymerase" . SPARSER::PROTEIN)
    ("UBM" . SPARSER::PROTEIN)
    ("Rad18 (an E3 ubiquitin ligase) and Rad6 (an E2 ubiquitin–conjugating enzyme)"
     . SPARSER::COLLECTION)
    ("Saccharomyces cerevisiae Rad30 and its mammalian homologue Polη ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("REV1, and DNA polymerase" . SPARSER::COLLECTION)
    ("replicative polymerases" . SPARSER::PROTEIN)
    ("ATR/Chk1" . SPARSER::COLLECTION)
    ("helicase–polymerase" . SPARSER::COLLECTION)
    ("stalled polymerase" . SPARSER::PROTEIN) ("Mcm" . SPARSER::PROTEIN)
    ("BPDE or CPD" . SPARSER::COLLECTION)
    ("ATR and Chk1" . SPARSER::COLLECTION) ("CPD" . SPARSER::PROTEIN)
    ("pyrimidone" . SPARSER::MOLECULE) ("CPDs" . SPARSER::PROTEIN)
    ("cyclobutane" . SPARSER::MOLECULE) ("pyrene (BPDE)" . SPARSER::PROTEIN)
    ("genotoxic metabolites" . SPARSER::PROTEIN)
    ("Polη−PCNA" . SPARSER::COLLECTION)
    ("JNK and its upstream kinase mitogen-activated protein kinase kinase 4"
     . SPARSER::COLLECTION)
    ("Polη" . SPARSER::PROTEIN) ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rad18–Polη" . SPARSER::COLLECTION)
    ("Phospho–serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("Rad5" . SPARSER::PROTEIN) ("RFC2" . SPARSER::PROTEIN)
    ("Siah2" . SPARSER::PROTEIN) ("ERK8" . SPARSER::PROTEIN)
    ("HBO1" . SPARSER::PROTEIN) ("Cdc7" . SPARSER::PROTEIN)
    ("RAD18" . SPARSER::PROTEIN) ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dbf4" . SPARSER::PROTEIN) ("hRad18" . SPARSER::PROTEIN)
    ("stress-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("T-T" . SPARSER::PROTEIN) ("p95" . SPARSER::PROTEIN)
    ("Rad6" . SPARSER::PROTEIN) ("Rad30" . SPARSER::PROTEIN)
    ("REV1" . SPARSER::PROTEIN) ("Cdc45" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase 4" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN) ("Rad18" . SPARSER::PROTEIN)
    ("the most robust metformin response variant" . SPARSER::VARIANT)
    ("prospective cohorts" . SPARSER::MOLECULE)
    ("the three new cohorts" . SPARSER::MOLECULE)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("the previously described GoDARTS and UKPDS stage 2 replication cohorts"
     . SPARSER::MOLECULE)
    ("these new cohorts" . SPARSER::MOLECULE) ("Atorvastatin" . SPARSER::DRUG)
    ("Metformin" . SPARSER::DRUG)
    ("the previously published cohorts" . SPARSER::MOLECULE)
    ("the smaller Rotterdam Study cohort" . SPARSER::MOLECULE)
    ("Aims" . SPARSER::PROTEIN) ("HbA 1" . SPARSER::PROTEIN)
    ("a significant ovarian cancer biomarker" . SPARSER::MOLECULE)
    ("E2F3, C8ORF30A, and SCAMP5" . SPARSER::COLLECTION)
    ("Hsa-miR-16" . SPARSER::COLLECTION) ("Hsa" . SPARSER::PROTEIN)
    ("GINS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a nucleolar-spindle-associated protein" . SPARSER::PROTEIN)
    ("miR-18a" . SPARSER::PROTEIN)
    ("these microRNA and the downstream effects they have on the target mRNA"
     . SPARSER::COLLECTION)
    ("Baculoviral inhibitor" . SPARSER::INHIBITOR)
    ("Topoisomerase" . SPARSER::PROTEIN)
    ("TOP2A and AURKA" . SPARSER::COLLECTION) ("ZWINT" . SPARSER::PROTEIN)
    ("SCAMP" . SPARSER::PROTEIN) ("NCAPH" . SPARSER::PROTEIN)
    ("NCAPG" . SPARSER::PROTEIN) ("MELK" . SPARSER::PROTEIN)
    ("TTK" . SPARSER::PROTEIN) ("HJURP" . SPARSER::PROTEIN)
    ("CENPA" . SPARSER::PROTEIN) ("hsa-miR-133a" . SPARSER::COLLECTION)
    ("hsa-miR-34b" . SPARSER::PROTEIN-PAIR)
    ("hsa-miR-16" . SPARSER::COLLECTION) ("hsa-miR-18a" . SPARSER::COLLECTION)
    ("18 microRNA and 53 mRNA" . SPARSER::COLLECTION)
    ("HG" . SPARSER::MOLECULE) ("mRNA or microRNA" . SPARSER::COLLECTION)
    ("regulatory mRNA" . SPARSER::PROTEIN)
    ("mRNA and microRNA" . SPARSER::COLLECTION)
    ("hsa-miR-133a/GCLC" . SPARSER::COLLECTION) ("GCLC" . SPARSER::PROTEIN)
    ("hsa" . SPARSER::PROTEIN) ("whose class" . CLASS)
    ("their functional mRNA" . SPARSER::PROTEIN)
    ("genes or proteins" . SPARSER::COLLECTION)
    ("GINS complex subunit 1" . SPARSER::PROTEIN)
    ("nucleolar and spindle associated protein 1" . SPARSER::PROTEIN)
    ("Rac GTPase-activating protein 1" . SPARSER::PROTEIN)
    ("Glutamate-cysteine ligase" . SPARSER::PROTEIN)
    ("transcription factor 3" . SPARSER::PROTEIN)
    ("SERPINA6" . SPARSER::PROTEIN) ("ADH6" . SPARSER::PROTEIN)
    ("ASF1A" . SPARSER::PROTEIN) ("GINS1" . SPARSER::PROTEIN)
    ("NUSAP1" . SPARSER::PROTEIN) ("KIF11" . SPARSER::PROTEIN)
    ("RANGAP1" . SPARSER::PROTEIN) ("ESPL1" . SPARSER::PROTEIN)
    ("KIF15" . SPARSER::PROTEIN) ("ERCC6L" . SPARSER::PROTEIN)
    ("PSMB2" . SPARSER::PROTEIN) ("HEATR3" . SPARSER::PROTEIN)
    ("EHMT2" . SPARSER::PROTEIN) ("KDM2A" . SPARSER::PROTEIN)
    ("EXO1" . SPARSER::PROTEIN) ("KIFC1" . SPARSER::PROTEIN)
    ("CCNB2" . SPARSER::PROTEIN) ("CCNA2" . SPARSER::PROTEIN)
    ("KIF23" . SPARSER::PROTEIN) ("CDC25C" . SPARSER::PROTEIN)
    ("c-5" . SPARSER::PROTEIN) ("c-3" . SPARSER::PROTEIN)
    ("miR-15b" . SPARSER::MOLECULE) ("PC2" . SPARSER::PROTEIN)
    ("MAS5" . SPARSER::PROTEIN) ("miR-133a" . SPARSER::PROTEIN)
    ("RAD51AP1" . SPARSER::PROTEIN) ("mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("an mTOR/PI3K dual kinase inhibitor" . SPARSER::INHIBITOR)
    ("mTOR/PI3K" . SPARSER::COLLECTION) ("at least part" . SPARSER::COMPONENT)
    ("rapamycin or Ku-0063794" . SPARSER::COLLECTION)
    ("BMP mRNAs or other known activators" . SPARSER::COLLECTION)
    ("novel mTORC1/2 dual kinase inhibitors" . SPARSER::INHIBITOR)
    ("ALKs" . SPARSER::PROTEIN) ("BMP and TGF-β" . SPARSER::COLLECTION)
    ("Akt and mTOR" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase/PI3K/Akt" . SPARSER::COLLECTION)
    ("Smads" . SPARSER::PROTEIN) ("Flag-Smads" . SPARSER::PROTEIN-PAIR)
    ("Flag-Smad8" . SPARSER::COLLECTION) ("Flag-Smad5" . SPARSER::COLLECTION)
    ("Flag-Smad1" . SPARSER::COLLECTION) ("Myc-mTOR" . SPARSER::COLLECTION)
    ("BMPRII" . SPARSER::PROTEIN) ("sh-mTOR" . SPARSER::COLLECTION)
    ("Sh-Raptor" . SPARSER::COLLECTION) ("Sh" . SPARSER::PROTEIN-FAMILY)
    ("a secretory protein" . SPARSER::PROTEIN)
    ("P-S6 and P-Smad1/5/8" . SPARSER::COLLECTION)
    ("P-S6 and survivin" . SPARSER::COLLECTION)
    ("Complementing" . SPARSER::PROTEIN)
    ("LNCaP and DU145" . SPARSER::COLLECTION)
    ("mRNA or Id1" . SPARSER::COLLECTION)
    ("BMP4 or TGF-β" . SPARSER::COLLECTION)
    ("LDN-193189 (500 nmol/L) or HTS-466284 (2 μmol/L) 2 h"
     . SPARSER::COLLECTION)
    ("ALK2, ALK3, and ALK6" . SPARSER::COLLECTION)
    ("Smad1, Smad5 and Smad8" . SPARSER::COLLECTION)
    ("pLPCX-Smad8" . SPARSER::PROTEIN-PAIR)
    ("Smad1, Smad5, and Smad8" . SPARSER::COLLECTION)
    ("Smad1 or Smad5" . SPARSER::COLLECTION) ("sh-LacZ" . SPARSER::COLLECTION)
    ("sh-Smad8" . SPARSER::COLLECTION) ("sh-Smad5" . SPARSER::COLLECTION)
    ("sh-Smad1" . SPARSER::COLLECTION) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("Smad1 and Smad5" . SPARSER::COLLECTION)
    ("mTOR, PTEN or Akt1" . SPARSER::COLLECTION)
    ("bone morphogenetic protein (BMP)" . SPARSER::PROTEIN)
    ("everolimus (afinitor ® , Novartis, New Jersey) and temsirolimus"
     . SPARSER::COLLECTION)
    ("Torisel" . SPARSER::DRUG) ("immunophilin" . SPARSER::PROTEIN)
    ("PI3K and Ras" . SPARSER::COLLECTION) ("Noggin" . SPARSER::PROTEIN)
    ("ShRNA" . SPARSER::PROTEIN) ("pCDNA3" . SPARSER::PROTEIN)
    ("ALK7" . SPARSER::PROTEIN) ("ALK5" . SPARSER::PROTEIN)
    ("ALK4" . SPARSER::PROTEIN) ("ALK6" . SPARSER::PROTEIN)
    ("ALK3" . SPARSER::PROTEIN) ("ALK2" . SPARSER::PROTEIN)
    ("Smad5" . SPARSER::PROTEIN) ("Cyclin D2" . SPARSER::PROTEIN)
    ("Smad-1" . SPARSER::PROTEIN)
    ("bone morphogenetic protein" . SPARSER::PROTEIN)
    ("FKBP12" . SPARSER::PROTEIN) ("Ku-0063794" . SPARSER::DRUG)
    ("LDN-193189" . SPARSER::DRUG) ("Smad8" . SPARSER::PROTEIN)
    ("tobacco-associated SPM or non-tobacco" . SPARSER::COLLECTION)
    ("SPM or non-tobacco" . SPARSER::COLLECTION)
    ("a relatively larger cohort" . SPARSER::MOLECULE)
    ("anti- and pro-tumorigenic" . SPARSER::COLLECTION)
    ("polymorphic CDK inhibitors" . SPARSER::INHIBITOR)
    ("a universal inhibitor" . SPARSER::INHIBITOR)
    ("p27 and p21 proteins" . SPARSER::COLLECTION)
    ("an approximately 42% amino acid homology" . SPARSER::PROTEIN)
    ("'variant'" . SPARSER::VARIANT) ("developed SPM" . SPARSER::PROTEIN)
    ("4 developed SPMs" . SPARSER::PROTEIN)
    ("35 developed SPMs" . SPARSER::PROTEIN)
    ("81 developed SPMs" . SPARSER::PROTEIN) ("SPMs" . SPARSER::PROTEIN)
    ("cyclin D1-CDK" . SPARSER::COLLECTION)
    ("p21 C98A (a non-synonymous serine-to-arginine substitution at codon 31), p21 C70T (a single C-to-T substitution 20 nt downstream of the stop codon at exon 3), and p27 T109G"
     . SPARSER::COLLECTION)
    ("universal CDK inhibitors and play active roles in the development of SPM"
     . SPARSER::COLLECTION)
    ("universal CDK inhibitors" . SPARSER::INHIBITOR)
    ("cyclin and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("CC, and p21" . SPARSER::COLLECTION) ("SPM" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p27KIP1" . SPARSER::PROTEIN)
    ("Jun activation domain-binding protein 1" . SPARSER::PROTEIN)
    ("p21 proteins" . SPARSER::PROTEIN) ("glycine)" . SPARSER::PROTEIN)
    ("MEK, WNT and ROCK" . SPARSER::COLLECTION) ("TGF" . SPARSER::DRUG)
    ("OCT4 and SOX2" . SPARSER::COLLECTION)
    ("an oncogene and increases iPS cell efficiency and kinetics"
     . SPARSER::COLLECTION)
    ("DNP" . SPARSER::DRUG)
    ("OCT4, SOX2, cMyc, and Klf4" . SPARSER::COLLECTION)
    ("p73-" . SPARSER::PROTEIN) ("cMYC and KLF4" . SPARSER::COLLECTION)
    ("cMYC" . SPARSER::PROTEIN) ("mEF" . SPARSER::PROTEIN)
    ("Oct4, Sox2, Klf4 and cMyc" . SPARSER::COLLECTION)
    ("iPS" . SPARSER::PROTEIN) ("PDX 1" . SPARSER::PROTEIN)
    ("Alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("POU5F1" . SPARSER::PROTEIN) ("LIN28" . SPARSER::PROTEIN)
    ("DPPA4" . SPARSER::PROTEIN) ("LIN28B" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN) ("OCT3" . SPARSER::PROTEIN)
    ("TRA-1" . SPARSER::PROTEIN) ("P73" . SPARSER::PROTEIN)
    ("Klf4" . SPARSER::PROTEIN)
    ("EMT inducer genes (TGFB2, TWIST1 and FOXC1) and overexpression of BMB7, CXCR7 and EGR family of transcription factors"
     . SPARSER::COLLECTION)
    ("EGR2, EGR3 and EGR4" . SPARSER::COLLECTION)
    ("TWIST1 and FOXC1" . SPARSER::COLLECTION)
    ("TGFB2 and BMP7" . SPARSER::COLLECTION)
    ("TGFB2 and CXCR7" . SPARSER::COLLECTION)
    ("EMT and MET" . SPARSER::COLLECTION)
    ("Raf-1/MEK/MAPK" . SPARSER::COLLECTION) ("GX" . SPARSER::PROTEIN)
    ("hydroxyurea and daunorubicin" . SPARSER::COLLECTION)
    ("daunorubicin" . SPARSER::DRUG) ("chemo" . SPARSER::PROTEIN)
    ("TWIST1, SNAIL, SLUG, FOXC1, ZEB1 and SMADs" . SPARSER::COLLECTION)
    ("EMT and stemness" . SPARSER::COLLECTION) ("SMADs" . SPARSER::PROTEIN)
    ("SLUG" . SPARSER::PROTEIN) ("SNAIL" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("chemo-endocrine" . SPARSER::COLLECTION)
    ("TGFB2, TWIST1 and FOXC1" . SPARSER::COLLECTION)
    ("BMB7, CXCR7 and EGR" . SPARSER::COLLECTION) ("BMB" . SPARSER::PROTEIN)
    ("Raf/MEK/MAPK" . SPARSER::COLLECTION) ("EGR4" . SPARSER::PROTEIN)
    ("EGR3" . SPARSER::PROTEIN) ("EGR2" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("CXCR7" . SPARSER::PROTEIN)
    ("FOXC1" . SPARSER::PROTEIN) ("TGFB2" . SPARSER::PROTEIN)
    ("GRK2 and two MAPKs" . SPARSER::COLLECTION)
    ("MAPKs or GRKs" . SPARSER::COLLECTION)
    ("p38 and Erk" . SPARSER::COLLECTION)
    ("different heterotrimeric G protein" . SPARSER::PROTEIN)
    ("GRK2 and p38 MAPK" . SPARSER::COLLECTION)
    ("the classical GRK2" . SPARSER::PROTEIN)
    ("Erk-GRK2" . SPARSER::COLLECTION) ("GRK2 and FPR1" . SPARSER::COLLECTION)
    ("FPRs" . SPARSER::PROTEIN) ("MKP1 or MKP5" . SPARSER::COLLECTION)
    ("MKP1 and MKP5" . SPARSER::COLLECTION)
    ("other possible G proteins" . SPARSER::PROTEIN)
    ("different heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("wild-type FPR1 and two mutants" . SPARSER::COLLECTION)
    ("FPR1 and GRK2" . SPARSER::COLLECTION)
    ("Erk and FPR1" . SPARSER::COLLECTION)
    ("examining membrane-associated GRK2" . SPARSER::PROTEIN)
    ("FPR1-YFP" . SPARSER::COLLECTION)
    ("chemotactic neutrophils" . SPARSER::PROTEIN) ("ΔST" . SPARSER::PROTEIN)
    ("FPR1-ΔST" . SPARSER::COLLECTION) ("Ala or Gly" . SPARSER::COLLECTION)
    ("Attractants" . SPARSER::PROTEIN)
    ("SB203580 or p38α" . SPARSER::COLLECTION)
    ("PD98059 or Erk" . SPARSER::COLLECTION)
    ("p38α (the predominant isoform expressed in HL60 cells  xref  ) or p38 MAPK inhibitor"
     . SPARSER::COLLECTION)
    ("EZ" . SPARSER::PROTEIN-FAMILY)
    ("MAPKs, p38 and Erk" . SPARSER::COLLECTION)
    ("Erk and Jnk" . SPARSER::COLLECTION)
    ("Erk, Jnk and p38" . SPARSER::COLLECTION)
    ("Jnk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor-arrestin" . SPARSER::COLLECTION)
    ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the appropriate trimeric G proteins" . SPARSER::PROTEIN)
    ("GRKs" . SPARSER::PROTEIN) ("attractants" . SPARSER::PROTEIN)
    ("different trimeric G proteins" . SPARSER::PROTEIN)
    ("attractant" . SPARSER::PROTEIN)
    ("neutrophils and neutrophil-like" . SPARSER::COLLECTION)
    ("fMet-Leu-phe" . SPARSER::COLLECTION) ("fMLP" . SPARSER::PROTEIN)
    ("phe" . SPARSER::AMINO-ACID) ("Erk and p38 MAPK" . SPARSER::COLLECTION)
    ("GRK" . SPARSER::PROTEIN) ("FPR2" . SPARSER::PROTEIN)
    ("MKP5" . SPARSER::PROTEIN) ("MKP1" . SPARSER::PROTEIN)
    ("WIP1" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase" . SPARSER::PROTEIN)
    ("MAP Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FPR1" . SPARSER::PROTEIN)
    ("formyl peptide receptor" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase GRK2" . SPARSER::PROTEIN)
    ("stimulant" . SPARSER::DRUG) ("superantigen" . SPARSER::MOLECULE)
    ("strong cis-eQTLs" . SPARSER::COLLECTION)
    ("self-reactive antibodies" . SPARSER::ANTIBODY)
    ("cell-directional eQTLs" . SPARSER::PROTEIN)
    ("genes and variants" . SPARSER::COLLECTION)
    ("monocyte-specific eQTL" . SPARSER::PROTEIN)
    ("many disease-associated eQTL" . SPARSER::PROTEIN)
    ("classical HLA genes" . SPARSER::GENE) ("DEF" . SPARSER::PROTEIN)
    ("MHC and AOAH" . SPARSER::COLLECTION) ("eSNP" . SPARSER::PROTEIN)
    ("lipase" . SPARSER::PROTEIN) ("associated HLA alleles" . SPARSER::ALLELE)
    ("the actual gene" . SPARSER::GENE) ("p21/CIP1" . SPARSER::COLLECTION)
    ("self-reactive antibody" . SPARSER::PROTEIN)
    ("Trans-eQTL" . SPARSER::COLLECTION)
    ("the homozygous G allele" . SPARSER::ALLELE)
    ("p300 and LYZ" . SPARSER::COLLECTION)
    ("YEATS4 , CREB1 and LYZ" . SPARSER::COLLECTION)
    ("trans-associated genes" . SPARSER::GENE)
    ("a previously published primary cell eQTL" . SPARSER::PROTEIN)
    ("LYZ and CREB1" . SPARSER::COLLECTION) ("Lysozyme" . SPARSER::PROTEIN)
    ("a monocyte-specific master regulator" . SPARSER::REGULATOR)
    ("cis-eQTLs" . SPARSER::COLLECTION) ("trans-eQTLs" . SPARSER::COLLECTION)
    ("trans-eSNPs" . SPARSER::PROTEIN-PAIR)
    ("KLF4 ( xref , xref ) and LYZ (discussed below)" . SPARSER::COLLECTION)
    ("two highly cell specific examples" . SPARSER::EXAMPLE)
    ("autosomal genes" . SPARSER::GENE) ("trans-eQTL" . SPARSER::COLLECTION)
    ("multiple cell-specific trans-associated eQTL" . SPARSER::PROTEIN)
    ("AKAP" . SPARSER::PROTEIN) ("TSPAN" . SPARSER::PROTEIN)
    ("glycosyltransferase" . SPARSER::PROTEIN) ("intron" . SPARSER::PROTEIN)
    ("SELL" . SPARSER::PROTEIN)
    ("The most significant directional eQTL" . SPARSER::PROTEIN)
    ("deafness" . SPARSER::PROTEIN) ("directional eQTL" . SPARSER::PROTEIN)
    ("Previously reported eQTL" . SPARSER::PROTEIN)
    ("subtle primary cell-specific eQTL" . SPARSER::PROTEIN)
    ("eSNPs" . SPARSER::PROTEIN) ("eQTLs" . SPARSER::PROTEIN)
    ("cis-eSNPs" . SPARSER::PROTEIN-PAIR)
    ("locally acting eQTL" . SPARSER::PROTEIN) ("eQTL" . SPARSER::PROTEIN)
    ("cis-eQTL" . SPARSER::COLLECTION) ("an innate myeloid" . SPARSER::PROTEIN)
    ("tissue specific distal enhancers" . SPARSER::PROTEIN)
    ("fat and LCLs" . SPARSER::COLLECTION) ("LYZ" . SPARSER::PROTEIN)
    ("cis- and trans-eQTL" . SPARSER::COLLECTION) ("cis-" . SPARSER::PROTEIN)
    ("RAB27A" . SPARSER::PROTEIN) ("ERAP2" . SPARSER::PROTEIN)
    ("CARD9" . SPARSER::PROTEIN) ("SDCCAG3" . SPARSER::PROTEIN)
    ("SNAPC4" . SPARSER::PROTEIN)
    ("small nuclear RNA activating complex" . SPARSER::PROTEIN)
    ("Rho-GTPase activating protein" . SPARSER::PROTEIN)
    ("HLA-DRB4" . SPARSER::PROTEIN) ("LAP3" . SPARSER::PROTEIN)
    ("RPS26" . SPARSER::PROTEIN) ("YEATS4" . SPARSER::PROTEIN)
    ("SYNGR1" . SPARSER::PROTEIN) ("MGAT3" . SPARSER::PROTEIN)
    ("KIFAP3" . SPARSER::PROTEIN) ("CD62L" . SPARSER::PROTEIN)
    ("L-selectin" . SPARSER::PROTEIN) ("cation channel" . SPARSER::PROTEIN)
    ("MCOLN2" . SPARSER::PROTEIN) ("ARHGAP24" . SPARSER::PROTEIN)
    ("PRIC285" . SPARSER::PROTEIN) ("IP6K2" . SPARSER::PROTEIN)
    ("genes or exons" . SPARSER::COLLECTION)
    ("mRNPs and RNAPII" . SPARSER::COLLECTION) ("mRNPs" . SPARSER::BIO-COMPLEX)
    ("exon-intron" . SPARSER::PROTEIN-PAIR) ("Bromo" . SPARSER::MOLECULE)
    ("RAD50 and SLC36A4" . SPARSER::COLLECTION) ("mers" . SPARSER::PROTEIN)
    ("the 1024 possible 5-mer oligonucleotides" . SPARSER::MOLECULE)
    ("the relevant exon" . SPARSER::PROTEIN) ("RIP" . SPARSER::PROTEIN)
    ("ZIRD or DBC1" . SPARSER::COLLECTION) ("EXON" . SPARSER::PROTEIN)
    ("DBC1 or ZIRD" . SPARSER::COLLECTION) ("MonoQ" . SPARSER::DRUG)
    ("ZIRD-DBC1" . SPARSER::COLLECTION) ("ZIRD and DBC1" . SPARSER::COLLECTION)
    ("DBC1 and ZIRD" . SPARSER::COLLECTION) ("ZIRD" . SPARSER::PROTEIN)
    ("ZIRD-Flag" . SPARSER::COLLECTION) ("RPB3-Flag" . SPARSER::COLLECTION)
    ("DBC1-Flag" . SPARSER::COLLECTION) ("NPs" . SPARSER::PROTEIN)
    ("DBC1 and ZNF326" . SPARSER::COLLECTION)
    ("a heterogeneous mixture" . SPARSER::MOLECULE)
    ("subunits and proteins" . SPARSER::COLLECTION)
    ("RNAse" . SPARSER::PROTEIN)
    ("Breast Cancer 1 (DBC1) and a protein" . SPARSER::COLLECTION)
    ("RNAPII" . SPARSER::PROTEIN) ("DBC1" . SPARSER::PROTEIN)
    ("mRNP" . SPARSER::BIO-COMPLEX) ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("elongation factor" . SPARSER::PROTEIN) ("SLC36A4" . SPARSER::PROTEIN)
    ("RPB3" . SPARSER::PROTEIN) ("hnRNP A1" . SPARSER::PROTEIN)
    ("Cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and pS17" . SPARSER::COLLECTION)
    ("ATM and DNA-PK" . SPARSER::COLLECTION) ("apo-" . SPARSER::PROTEIN)
    ("Asp/Glu" . SPARSER::COLLECTION)
    ("Ser, Thr, or Tyr" . SPARSER::COLLECTION)
    ("a largely α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("aqueous solution" . SPARSER::MOLECULE)
    ("a singly labeled 15 N-Ala21-(1–24)MDM2 peptide and a doubly labeled 15 N-Val14/ 15 N-Ala21-(1–24)MDM2 peptide ( xref )"
     . SPARSER::COLLECTION)
    ("Ala-Ser-Glu-Gln" . SPARSER::COLLECTION) ("MDM2-" . SPARSER::PROTEIN)
    ("MDM2 and p53" . SPARSER::COLLECTION)
    ("active Nutlin-3a and substantially less active Nutlin-3b  xref"
     . SPARSER::COLLECTION)
    ("a racemic mixture" . SPARSER::MOLECULE)
    ("MDM2 of Nutlin-3a and three p53-derived peptides" . SPARSER::COLLECTION)
    ("peptide (SQETFSDLWKLLPEN)" . SPARSER::PEPTIDE)
    ("piperidine" . SPARSER::DRUG) ("thioester" . SPARSER::MOLECULE)
    ("Boc- and Fmoc-chemistries" . SPARSER::COLLECTION)
    ("Boc-" . SPARSER::PROTEIN) ("Prism" . SPARSER::PROTEIN)
    ("50 nM (25–109)MDM2 or 250 nM (1–109)MDM2 proteins (wide-type, S17D or pS17)"
     . SPARSER::COLLECTION)
    ("surfactant" . SPARSER::PROTEIN) ("HEPES" . SPARSER::MOLECULE)
    ("p53-FAM-MDM2" . SPARSER::COLLECTION)
    ("the resultant product N -acetyle-(15–29)p53-FAM" . SPARSER::COLLECTION)
    ("p53-FAM" . SPARSER::COLLECTION) ("FAM-NHS" . SPARSER::COLLECTION)
    ("ether" . SPARSER::MOLECULE) ("HBS-EP" . SPARSER::COLLECTION)
    ("Sigma-Aldrich" . SPARSER::PROTEIN-PAIR) ("cresol" . SPARSER::MOLECULE)
    ("Tri" . SPARSER::PROTEIN)
    ("15 N-labeled Fmoc- and Boc-amino acids" . SPARSER::COLLECTION)
    ("Fmoc-" . SPARSER::MOLECULE) ("-OH" . SPARSER::COLLECTION)
    ("acetonitrile" . SPARSER::MOLECULE) ("DMF" . SPARSER::DRUG)
    ("PAM" . SPARSER::PROTEIN) ("OCH" . SPARSER::PROTEIN)
    ("BHA" . SPARSER::MOLECULE) ("OH" . SPARSER::PROTEIN)
    ("Fmoc" . SPARSER::MOLECULE) ("HOBt" . SPARSER::MOLECULE)
    ("MDM2 and its Ser17-phosphorylated analog (1–109)MDM2 pS17"
     . SPARSER::COLLECTION)
    ("p53-MDM2" . SPARSER::COLLECTION) ("p53 and MDM2" . SPARSER::COLLECTION)
    ("apo-MDM2" . SPARSER::COLLECTION) ("apo" . SPARSER::PROTEIN)
    ("the p53-binding domain (1–109)MDM2 and its Ser17-phosphorylated analog (1–109)MDM2 pS17"
     . SPARSER::COLLECTION)
    ("pS15" . SPARSER::PROTEIN) ("nutlin-3a" . SPARSER::DRUG)
    ("MMD2" . SPARSER::PROTEIN) ("CH 2" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("Zn 2+" . SPARSER::MOLECULE)
    ("S17" . SPARSER::PROTEIN) ("a binary complex" . SPARSER::BIO-COMPLEX)
    ("FGFR and FGFR-KLB directly in the presence" . SPARSER::COLLECTION)
    ("the transmembrane KLB" . SPARSER::PROTEIN)
    ("the canonic FGF1 and endocrine FGF19 and FGF21" . SPARSER::COLLECTION)
    ("certain physiological and altered pathological states"
     . SPARSER::BIO-STATE)
    ("the weakly expressed FGFR2 and/or FGFR3" . SPARSER::COLLECTION)
    ("the dominant FGFR4" . SPARSER::PROTEIN)
    ("these binary complexes" . SPARSER::BIO-COMPLEX)
    ("cyp7a1" . SPARSER::PROTEIN) ("cyp" . SPARSER::PROTEIN)
    ("KLB and endocrine" . SPARSER::COLLECTION)
    ("FGFs and endocrine" . SPARSER::COLLECTION)
    ("KLB and FGFRs" . SPARSER::COLLECTION) ("FGF1-FGFR" . SPARSER::COLLECTION)
    ("FGF1 and FGF19/21" . SPARSER::COLLECTION)
    ("canonic member FGF1" . SPARSER::PROTEIN)
    ("canonic FGFs" . SPARSER::PROTEIN)
    ("FGF19, FGF21 and FGF23" . SPARSER::COLLECTION)
    ("FGFR4 and FGF15" . SPARSER::COLLECTION) ("Cyp7a1" . SPARSER::PROTEIN)
    ("Cyp" . SPARSER::PROTEIN)
    ("the biological receptor complex" . SPARSER::BIO-COMPLEX)
    ("KLB and FGFR1" . SPARSER::COLLECTION)
    ("FGF19 and vehicle PBS" . SPARSER::COLLECTION)
    ("FGF19, FGF21 and FGF1" . SPARSER::COLLECTION)
    ("FGF19 and FGF1" . SPARSER::COLLECTION)
    ("FGFR4 or FGFR1" . SPARSER::COLLECTION)
    ("KLB, and KLB" . SPARSER::COLLECTION)
    ("the binary FGFR-KLB complex" . SPARSER::BIO-COMPLEX)
    ("the canonic FGF1 and endocrine FGF19 or FGF21" . SPARSER::COLLECTION)
    ("FGF1 and endocrine" . SPARSER::COLLECTION)
    ("FGF19 or FGF21" . SPARSER::COLLECTION)
    ("the heparin-binding canonic FGFs" . SPARSER::PROTEIN)
    ("KLB and inducible FGFR1 or FGFR4" . SPARSER::COLLECTION)
    ("FGFR and KLB" . SPARSER::COLLECTION) ("tracer" . SPARSER::MOLECULE)
    ("FGFR1 and KLB" . SPARSER::COLLECTION)
    ("FGFR1 or FGFR4" . SPARSER::COLLECTION)
    ("FGF19 and canonic FGF1" . SPARSER::COLLECTION)
    ("canonic FGF1" . SPARSER::PROTEIN)
    ("FGF19 and the canonic FGF1" . SPARSER::COLLECTION)
    ("the canonic FGF1" . SPARSER::PROTEIN)
    ("thermogenic genes" . SPARSER::GENE) ("brown fat" . SPARSER::PROTEIN)
    ("DIO" . SPARSER::MOLECULE) ("triglycerides" . SPARSER::MOLECULE)
    ("adipocytes and white fat" . SPARSER::COLLECTION)
    ("Skeletal muscle" . SPARSER::PROTEIN) ("hyperglycemia" . SPARSER::PROTEIN)
    ("FGFR1 and KL" . SPARSER::COLLECTION)
    ("farnesoid X receptor (FXR)" . SPARSER::PROTEIN)
    ("The postprandial FGF19" . SPARSER::PROTEIN) ("FXR" . SPARSER::PROTEIN)
    ("form productive signaling complexes" . SPARSER::BIO-COMPLEX)
    ("these hormonal FGFs" . SPARSER::PROTEIN)
    ("FGFRs and cofactor" . SPARSER::COLLECTION)
    ("KL/KLB" . SPARSER::COLLECTION) ("KL and KLB" . SPARSER::COLLECTION)
    ("FGFR and KL or KLB" . SPARSER::COLLECTION)
    ("KL or KLB" . SPARSER::COLLECTION)
    ("transmembrane cofactors Klotho (KL) and betaKlotho (KLB)"
     . SPARSER::COLLECTION)
    ("systemic lipid" . SPARSER::LIPID) ("Klotho (KL)" . SPARSER::PROTEIN)
    ("KL" . SPARSER::PROTEIN) ("the canonic FGFs" . SPARSER::PROTEIN)
    ("the principal IIIb" . SPARSER::DRUG) ("IIIb" . SPARSER::DRUG)
    ("FGF21 and FGF19" . SPARSER::COLLECTION)
    ("FGFR1-KLB" . SPARSER::COLLECTION) ("KLB or FGFR1" . SPARSER::COLLECTION)
    ("FGFR4-KLB" . SPARSER::COLLECTION)
    ("FGFR1 and FGFR4" . SPARSER::COLLECTION)
    ("FGFR-KLB" . SPARSER::COLLECTION) ("betaKlotho (KLB)" . SPARSER::PROTEIN)
    ("FGF19 and FGF21" . SPARSER::COLLECTION) ("betaKlotho" . SPARSER::PROTEIN)
    ("T-Rex" . SPARSER::PROTEIN-FAMILY) ("PGC-1alpha" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("PPARα" . SPARSER::PROTEIN)
    ("FGF23" . SPARSER::PROTEIN) ("Vitamin D" . SPARSER::MOLECULE)
    ("farnesoid X receptor" . SPARSER::PROTEIN) ("FGF15" . SPARSER::PROTEIN)
    ("FGF1" . SPARSER::PROTEIN) ("FGF21" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bax" . SPARSER::PROTEIN)
    ("humanin" . SPARSER::PROTEIN-FAMILY)
    ("proliferative chondrocytes" . SPARSER::PROTEIN)
    ("hypertrophic chondrocytes" . SPARSER::PROTEIN)
    ("Proliferative chondrocytes" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein" . SPARSER::PROTEIN)
    ("Dexa-treated cells cytochrome c" . SPARSER::PROTEIN)
    ("a strong mitochondrial Bax" . SPARSER::PROTEIN)
    ("strong mitochondrial Bax" . SPARSER::PROTEIN)
    ("glycosaminoglycan" . SPARSER::MOLECULE)
    ("The pro-apoptotic Bax protein" . SPARSER::PROTEIN)
    ("apoptogenic proteins" . SPARSER::PROTEIN)
    ("essential growth factors" . SPARSER::GROWTH-FACTOR)
    ("the exact molecular mediators" . SPARSER::PROTEIN)
    ("GCs" . SPARSER::PROTEIN) ("Glucocorticoids" . SPARSER::PROTEIN)
    ("chondrocytes" . SPARSER::PROTEIN) ("Dexamethasone" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN) ("HCS-2" . SPARSER::PROTEIN)
    ("at least partially targets RalA" . SPARSER::PROTEIN)
    ("receptors and interleukin-1β" . SPARSER::COLLECTION)
    ("Northern blot" . SPARSER::PROTEIN) ("normal HSCs" . SPARSER::PROTEIN)
    ("Alox5" . SPARSER::PROTEIN) ("CDC42 and Grb2" . SPARSER::COLLECTION)
    ("RALBP1, CDC42, RAC1, RAC2, RAC3, ZONAB, and SEC5 and EXO84"
     . SPARSER::COLLECTION)
    ("SEC5 and EXO84" . SPARSER::COLLECTION)
    ("AMPK and/or AXL" . SPARSER::COLLECTION) ("Bcr/Abl" . SPARSER::COLLECTION)
    ("Bcr" . SPARSER::PROTEIN) ("RalA and RalB" . SPARSER::COLLECTION)
    ("RalA and its isoform RalB" . SPARSER::COLLECTION)
    ("RalB" . SPARSER::PROTEIN)
    ("RalA and its potential targets( xref )" . SPARSER::COLLECTION)
    ("protein A (CSDA)" . SPARSER::PROTEIN)
    ("the Y-box transcription factor ZO-1-associated nucleic acidbinding protein"
     . SPARSER::PROTEIN)
    ("RLIP76 and ralA" . SPARSER::COLLECTION) ("ZONAB" . SPARSER::PROTEIN)
    ("ralA" . SPARSER::PROTEIN) ("RLIP" . SPARSER::PROTEIN)
    ("miR-181a and RalA" . SPARSER::COLLECTION)
    ("miR-181a or RalA" . SPARSER::COLLECTION)
    ("functional miR-181a" . SPARSER::MOLECULE)
    ("RalA-3" . SPARSER::COLLECTION) ("v-ral" . SPARSER::COLLECTION)
    ("ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("miR-181a duplex molecule RNA" . SPARSER::RNA)
    ("genes and oncogenes" . SPARSER::COLLECTION)
    ("any given miRNA and its targets" . SPARSER::COLLECTION)
    ("any given miRNA" . SPARSER::PROTEIN)
    ("miRNAs and their targets" . SPARSER::COLLECTION)
    ("a given miRNA" . SPARSER::PROTEIN) ("RalA" . SPARSER::PROTEIN)
    ("particularly chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA)
    ("Tcl1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PI 3" . SPARSER::PROTEIN)
    ("EXOC8" . SPARSER::PROTEIN) ("EXO84" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EXOC2" . SPARSER::PROTEIN)
    ("exocyst complex component 2" . SPARSER::PROTEIN)
    ("SEC5" . SPARSER::PROTEIN)
    ("Y-box transcription factor" . SPARSER::PROTEIN)
    ("RAC1" . SPARSER::PROTEIN) ("cell division cycle 42" . SPARSER::PROTEIN)
    ("RALBP1" . SPARSER::PROTEIN) ("RLIP76" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("bcr-abl" . SPARSER::PROTEIN) ("miR-181a" . SPARSER::MOLECULE)
    ("post-transcriptional gene regulators" . SPARSER::REGULATOR)
    ("miR-128-inhibited downstream molecules" . SPARSER::MOLECULE)
    ("hypoxia, growth factors, and oncogenes" . SPARSER::COLLECTION)
    ("a heterodimeric transcription factor" . SPARSER::PROTEIN)
    ("HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("p70S6K1 and p-p70S6K1" . SPARSER::COLLECTION) ("pLe" . SPARSER::PROTEIN)
    ("U87 and U251" . SPARSER::COLLECTION) ("miR-SCR" . SPARSER::COLLECTION)
    ("SCR" . SPARSER::PROTEIN) ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("p70S6K1, HIF-1α, and VEGF" . SPARSER::COLLECTION)
    ("mTOR/p70S6K1" . SPARSER::COLLECTION)
    ("Reelin and DCX" . SPARSER::COLLECTION) ("DCX" . SPARSER::PROTEIN)
    ("Reelin" . SPARSER::PROTEIN) ("PTEN and RB1" . SPARSER::COLLECTION)
    ("usually 18∼23 nucleotides" . SPARSER::NUCLEOTIDE)
    ("p70S6K1 and its downstream signaling molecules" . SPARSER::COLLECTION)
    ("HIF-1 and VEGF" . SPARSER::COLLECTION)
    ("Hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("P70S6K1" . SPARSER::PROTEIN) ("MiR-7" . SPARSER::PROTEIN)
    ("serum response factor (SRF)" . SPARSER::PROTEIN)
    ("CREB/ATF" . SPARSER::COLLECTION)
    ("MAPK, c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("MAPK and AP-1" . SPARSER::COLLECTION)
    ("Cytokines, growth factors and LPS" . SPARSER::COLLECTION)
    ("katA" . SPARSER::PROTEIN) ("entactin" . SPARSER::PROTEIN)
    ("DAG- and Ca 2+" . SPARSER::COLLECTION) ("DAG-" . SPARSER::DAG)
    ("PI-PLC and PC-PLC" . SPARSER::COLLECTION)
    ("MARCKS, vinculin and adducin" . SPARSER::COLLECTION)
    ("adducin" . SPARSER::PROTEIN-FAMILY)
    ("c-Jun, ERK, JNK and MKK4" . SPARSER::COLLECTION)
    ("PKCα, PKCδ or PKCθ" . SPARSER::COLLECTION)
    ("PKCδ and PKCθ" . SPARSER::COLLECTION)
    ("JNK1/2 and p38" . SPARSER::COLLECTION)
    ("ERK, p38 or JNK" . SPARSER::COLLECTION)
    ("Fos (c-Fos, FosB, Fra-1, Fra-2) and Jun (c-Jun, JunD, JunB) proteins"
     . SPARSER::COLLECTION)
    ("Muc-5ac and Muc-6" . SPARSER::COLLECTION)
    ("pan-cytokeratins" . SPARSER::PROTEIN) ("Muc-6" . SPARSER::PROTEIN)
    ("Muc-5ac" . SPARSER::PROTEIN) ("BIS" . SPARSER::PROTEIN)
    ("genistein and PI3K" . SPARSER::COLLECTION)
    ("PLCγ1 or PLCβ3" . SPARSER::COLLECTION)
    ("PLCβ2 and PLCβ4" . SPARSER::COLLECTION)
    ("receptor and non-receptor tyrosine kinases" . SPARSER::COLLECTION)
    ("PC-PLC and PI-PLC" . SPARSER::COLLECTION)
    ("phosphatidylinositol-specific PLC (PI-PLC) or PC-specific PLC (PC-PLC)"
     . SPARSER::COLLECTION)
    ("PI-PLC or PC-PLC" . SPARSER::COLLECTION)
    ("kinases and PI3K" . SPARSER::COLLECTION) ("-active" . SPARSER::ACTIVE)
    ("A pan-specific antibody" . SPARSER::PROTEIN)
    ("PKCα, PKCδ and PKCθ" . SPARSER::COLLECTION)
    ("wt and vacA" . SPARSER::COLLECTION) ("vacA" . SPARSER::PROTEIN-FAMILY)
    ("wt and cagA" . SPARSER::COLLECTION) ("Arg or Lys" . SPARSER::COLLECTION)
    ("–2 or +2" . SPARSER::COLLECTION) ("wt and CagA" . SPARSER::COLLECTION)
    ("PKCα, PKCɛ and PKCζ/λ" . SPARSER::COLLECTION)
    ("nPKCδ and nPKCθ" . SPARSER::COLLECTION) ("CagA-" . SPARSER::PROTEIN)
    ("wt, cagA or virB7" . SPARSER::COLLECTION)
    ("PKCδ or PKCθ" . SPARSER::COLLECTION) ("cagA" . SPARSER::PROTEIN)
    ("CagA or VirB7" . SPARSER::COLLECTION) ("Phorbol" . SPARSER::DRUG)
    ("PKCα, PKCδ, PKCθ and PKCμ" . SPARSER::COLLECTION)
    ("the classical upstream PKC regulators PI3K" . SPARSER::PROTEIN-FAMILY)
    ("PKCα and PKCδ" . SPARSER::COLLECTION) ("adhesins" . SPARSER::PROTEIN)
    ("γ bind Ca 2+ and phosphatidylserine" . SPARSER::COLLECTION)
    ("Phospholipase C, phosphatidylinositol 3-kinase and Ca 2+"
     . SPARSER::COLLECTION)
    ("substrate (MARCKS)" . SPARSER::SUBSTRATE)
    ("PKCμ and myristoylated" . SPARSER::COLLECTION)
    ("MARCKS" . SPARSER::PROTEIN) ("serum response factor" . SPARSER::PROTEIN)
    ("PI-PLCs" . SPARSER::PROTEIN)
    ("inositol 1,4,5-triphosphate" . SPARSER::IP3)
    ("outer membrane protein" . SPARSER::PROTEIN) ("MKK4" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN) ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bisindolylmaleimide I" . SPARSER::DRUG) ("PLCγ2" . SPARSER::PROTEIN)
    ("PLCβ2" . SPARSER::PROTEIN) ("PLCβ1" . SPARSER::PROTEIN)
    ("PLCβ3" . SPARSER::PROTEIN) ("PC-PLC" . SPARSER::PROTEIN)
    ("PI-PLC" . SPARSER::PROTEIN) ("PLCγ1" . SPARSER::PROTEIN)
    ("nPKCδ" . SPARSER::PROTEIN)
    ("virulence factors" . SPARSER::PROTEIN-FAMILY)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("only TG2 and TG1 bind heparin" . SPARSER::PROTEIN)
    ("TG3 and FXIIIa" . SPARSER::COLLECTION)
    ("no obvious homology" . SPARSER::PROTEIN)
    ("a neutral Gln" . SPARSER::AMINO-ACID)
    ("a neutral amino acid" . SPARSER::AMINO-ACID)
    ("the closed form and the HS interaction" . SPARSER::COLLECTION)
    ("HSs" . SPARSER::PROTEIN)
    ("elastase and cathepsin G" . SPARSER::COLLECTION)
    ("elastase" . SPARSER::PROTEIN) ("-nucleotide" . SPARSER::NUCLEOTIDE)
    ("syndecan or glypican" . SPARSER::COLLECTION)
    ("glypican" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("syndecan" . SPARSER::PROTEIN)
    ("guanine or adenine" . SPARSER::COLLECTION)
    ("spatially close individual basic amino acids" . SPARSER::AMINO-ACID)
    ("fibronectin-associated Open-tTG TM" . SPARSER::PROTEIN)
    ("M1c" . SPARSER::PROTEIN) ("FN-M1c and FN-M3" . SPARSER::COLLECTION)
    ("FN-M1c" . SPARSER::PROTEIN-PAIR)
    ("soluble RGD peptide or control inactive RAD peptide ( xref , xref )"
     . SPARSER::COLLECTION)
    ("soluble RGD peptide" . SPARSER::PEPTIDE)
    ("The basic amino acids" . SPARSER::AMINO-ACID)
    ("strong salt" . SPARSER::MOLECULE)
    ("the previously calculated energy maps" . SPARSER::PROTEIN)
    ("disaccharides" . SPARSER::MOLECULE) ("GlcN" . SPARSER::MOLECULE)
    ("the basic amino acids" . SPARSER::AMINO-ACID)
    ("pentasaccharides" . SPARSER::MOLECULE)
    ("whose open conformation" . SPARSER::BIO-CONFORMATION)
    ("Boc" . SPARSER::PROTEIN) ("wt and mutant" . SPARSER::COLLECTION)
    ("Wt" . SPARSER::PROTEIN) ("wt and Mutant" . SPARSER::COLLECTION)
    ("Heparin" . SPARSER::PROTEIN) ("GlcNac" . SPARSER::PROTEIN-FAMILY)
    ("GlcNAc" . SPARSER::PROTEIN-FAMILY) ("glucosamine" . SPARSER::MOLECULE)
    ("specific cell surface proteins ( e.g. the aforementioned syndecans and glypicans) and ECM proteins (agrin, perlecan, collagen XVIII)"
     . SPARSER::COLLECTION)
    ("syndecans and glypicans" . SPARSER::COLLECTION)
    ("XVIII" . SPARSER::PROTEIN) ("agrin" . SPARSER::PROTEIN)
    ("glypicans" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("syndecans" . SPARSER::PROTEIN) ("disaccharide" . SPARSER::MOLECULE)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE)
    ("kinase, and ERK1/2" . SPARSER::COLLECTION)
    ("active and inactive" . SPARSER::COLLECTION)
    ("integrin-β1" . SPARSER::COLLECTION) ("sdc" . SPARSER::PROTEIN)
    ("an unconventional GTPase" . SPARSER::GTPASE)
    ("pentasaccharide" . SPARSER::MOLECULE) ("/heparin" . SPARSER::COLLECTION)
    ("heparin" . SPARSER::PROTEIN)
    ("Extracellular transglutaminase-2" . SPARSER::PROTEIN)
    ("TG3" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("α 5 β 1" . SPARSER::PROTEIN) ("O-2" . SPARSER::PROTEIN)
    ("heparin binding protein" . SPARSER::PROTEIN)
    ("N -hydroxysuccinimide" . SPARSER::DRUG) ("M1a" . SPARSER::MOLECULE)
    ("2.3.2.13" . SPARSER::PROTEIN) ("syndecan-4" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("Heparan sulfate" . SPARSER::MOLECULE)
    ("heparan sulfate" . SPARSER::MOLECULE)
    ("transglutaminase-2" . SPARSER::PROTEIN)
    ("targets and effectors" . SPARSER::COLLECTION)
    ("proteins and microsatellite" . SPARSER::COLLECTION)
    ("Fhit and p53" . SPARSER::COLLECTION)
    ("FHIT and p53" . SPARSER::COLLECTION) ("Fhit" . SPARSER::PROTEIN)
    ("the fragile histadine triad gene ( FHIT )" . SPARSER::GENE)
    ("gene ( FHIT )" . SPARSER::GENE) ("FHIT" . SPARSER::PROTEIN)
    ("focal or weak p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type and site" . SPARSER::COLLECTION)
    ("strong p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("male and 33 (41%)" . SPARSER::COLLECTION)
    ("sebaceous tumor type, location, and histology" . SPARSER::COLLECTION)
    ("type, location, and histology" . SPARSER::COLLECTION)
    ("MLH1 and MSH2" . SPARSER::COLLECTION) ("HNPCC" . SPARSER::PROTEIN)
    ("strong nuclear p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mismatch repair protein" . SPARSER::PROTEIN)
    ("SMO and PI3K/AKT inhibitors ( xref )" . SPARSER::COLLECTION)
    ("GDC-0449 and IPI-926" . SPARSER::COLLECTION)
    ("RAD001 and AP23573" . SPARSER::COLLECTION)
    ("Gli1, and p-S6K1" . SPARSER::COLLECTION)
    ("RAD001 and GDC-0449" . SPARSER::COLLECTION)
    ("PTCH and hedgehog interacting protein" . SPARSER::COLLECTION)
    ("the previously reported AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AKT or ERK" . SPARSER::COLLECTION) ("AKT and ERK" . SPARSER::COLLECTION)
    ("cyclopamine or GDC-0449" . SPARSER::COLLECTION)
    ("mTOR/S6K1/Gli1" . SPARSER::COLLECTION) ("p-Gli1" . SPARSER::COLLECTION)
    ("GST-Gli1" . SPARSER::COLLECTION) ("SuFu and Gli1" . SPARSER::COLLECTION)
    ("Gli1S84A" . SPARSER::PROTEIN)
    ("Rapamycin and WYE-354" . SPARSER::COLLECTION)
    ("S6K1, and mTORC2" . SPARSER::COLLECTION) ("TSC" . SPARSER::PROTEIN)
    ("TNFα/mTOR/S6K1" . SPARSER::COLLECTION)
    ("exogenous S6K1" . SPARSER::PROTEIN)
    ("TNFα stimulated flag-Gli1" . SPARSER::COLLECTION)
    ("TNFα or flag-Gli1S84A" . SPARSER::COLLECTION)
    ("flag-Gli1S84A" . SPARSER::PROTEIN-PAIR)
    ("flag-Gli1" . SPARSER::COLLECTION) ("TNFα or S6K1" . SPARSER::COLLECTION)
    ("rapamycin and TNFα" . SPARSER::COLLECTION)
    ("TNFα and rapamycin" . SPARSER::COLLECTION)
    ("an exogenous S6K1" . SPARSER::PROTEIN)
    ("the activated S6K1 formed complex" . SPARSER::BIO-COMPLEX)
    ("S6K1 or S6K1T389E" . SPARSER::COLLECTION)
    ("Gli1 and rapamycin" . SPARSER::COLLECTION)
    ("S6K1 and Gli1" . SPARSER::COLLECTION)
    ("S6K1 and S6K1T389E" . SPARSER::COLLECTION)
    ("neither Gli2 nor Gli3" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("mTOR, S6K1, or 4EB-P1" . SPARSER::COLLECTION)
    ("Gli1 and mTOR" . SPARSER::COLLECTION)
    ("Gli1 and S6K1" . SPARSER::COLLECTION)
    ("Gli1 and mTOR or 4EB-P1" . SPARSER::COLLECTION)
    ("Gli1, Gli2, and Gli3" . SPARSER::COLLECTION)
    ("SHH and TNFα" . SPARSER::COLLECTION)
    ("cyclopamine and GDC-0449" . SPARSER::COLLECTION)
    ("SHH or TNFα" . SPARSER::COLLECTION)
    ("glioma-associated oncogenes" . SPARSER::ONCOGENE)
    ("Gli" . SPARSER::PROTEIN) ("Sonic Hedgehog (SHH)" . SPARSER::PROTEIN)
    ("Desert Hedgehog (DHH)" . SPARSER::PROTEIN) ("DHH" . SPARSER::PROTEIN)
    ("IHH" . SPARSER::PROTEIN) ("S6K1 and 4E-BP1" . SPARSER::COLLECTION)
    ("SMO" . SPARSER::PROTEIN) ("which releases Gli1" . SPARSER::PROTEIN)
    ("mTOR/S6K1" . SPARSER::COLLECTION) ("SuFu" . SPARSER::PROTEIN)
    ("TNFα/mTOR" . SPARSER::COLLECTION)
    ("the most prevalent esophageal cancer type" . TYPE)
    ("P-1" . SPARSER::PROTEIN) ("IPI-926" . SPARSER::DRUG)
    ("hedgehog interacting protein" . SPARSER::PROTEIN)
    ("Amino acids" . SPARSER::AMINO-ACID) ("4EB-P1" . SPARSER::PROTEIN)
    ("Gli3" . SPARSER::PROTEIN) ("GDC-0449" . SPARSER::DRUG)
    ("Patched 1" . SPARSER::PROTEIN) ("Desert Hedgehog" . SPARSER::PROTEIN)
    ("Gli1" . SPARSER::PROTEIN) ("this aggressive form" . SPARSER::FORM)
    ("RANBP2-ALK" . SPARSER::COLLECTION)
    ("the sympathetic cervical ganglia complex" . SPARSER::BIO-COMPLEX)
    ("neuronal-specific Hu proteins" . SPARSER::PROTEIN)
    ("two MYCN transgenic fish and two MYCN" . SPARSER::COLLECTION)
    ("residual cells at 5 dpf" . SPARSER::PROTEIN)
    ("54 hpf and 80 hpf" . SPARSER::COLLECTION)
    ("phox2b, zash1a and AP-2 alpha" . SPARSER::COLLECTION)
    ("tfap2a" . SPARSER::PROTEIN) ("EGFP-MYCN" . SPARSER::COLLECTION)
    ("dpf" . SPARSER::PROTEIN) ("hpf" . SPARSER::PROTEIN)
    ("h-ALKWT" . SPARSER::COLLECTION) ("h-ALKF1174L" . SPARSER::PROTEIN-PAIR)
    ("h" . SPARSER::PROTEIN) ("ALKWT or ALKF1174L" . SPARSER::COLLECTION)
    ("h-mCherry , or iii" . SPARSER::COLLECTION)
    ("h-mCherry" . SPARSER::COLLECTION) ("ALKWT" . SPARSER::PROTEIN)
    ("wild-type ALK (ALKWT) as well as mutationally activated ALK"
     . SPARSER::COLLECTION)
    ("either activated human ALK or human ALKWT" . SPARSER::COLLECTION)
    ("ALK (ALKWT)" . SPARSER::PROTEIN) ("MYCN and ALK" . SPARSER::COLLECTION)
    ("proteins and ALK" . SPARSER::COLLECTION)
    ("ALK, and iv" . SPARSER::COLLECTION) ("h:EGFP" . SPARSER::PROTEIN)
    ("Synaptophysin" . SPARSER::PROTEIN)
    ("h:EGFP-MYCN" . SPARSER::PROTEIN-PAIR)
    ("enhanced green fluorescent protein (EGFP)" . SPARSER::PROTEIN)
    ("ALK and MYCN" . SPARSER::COLLECTION) ("AMT 2" . SPARSER::PROTEIN)
    ("RANBP2" . SPARSER::PROTEIN) ("PF-02341066" . SPARSER::DRUG)
    ("AP-2 alpha" . SPARSER::PROTEIN) ("phox2b" . SPARSER::PROTEIN)
    ("SS18-SSX-TLE1" . SPARSER::COLLECTION)
    ("ATF2/SS18-SSX" . SPARSER::COLLECTION)
    ("a model ( xref ) wherein HDAC inhibitors" . SPARSER::INHIBITOR)
    ("a diagnostic biomarker" . SPARSER::MOLECULE) ("Atf2" . SPARSER::PROTEIN)
    ("the sequence-specific transcriptional activator ATF2" . SPARSER::PROTEIN)
    ("together two important transcriptional regulators, ATF2 and TLE1"
     . SPARSER::COLLECTION)
    ("transcriptional regulators, ATF2 and TLE1" . SPARSER::COLLECTION)
    ("TrxG-PcG" . SPARSER::PROTEIN-PAIR)
    ("TLE1 and its associated HDAC/PcG proteins" . SPARSER::COLLECTION)
    ("the repressive H3K27me3" . SPARSER::PROTEIN)
    ("its associated HDAC/PcG proteins" . SPARSER::PROTEIN)
    ("romidepsin and SB939" . SPARSER::COLLECTION)
    ("Egr1 and Atf3" . SPARSER::COLLECTION)
    ("SSX and its DNA-binding partner ATF2" . SPARSER::COLLECTION)
    ("romidepsin or SB939 ( xref )" . SPARSER::COLLECTION)
    ("romidepsin" . SPARSER::DRUG) ("HDAC or PcG" . SPARSER::COLLECTION)
    ("SS18-SSX-mediated gene" . SPARSER::GENE)
    ("TLE1, HDAC1, and EZH2" . SPARSER::COLLECTION)
    ("HDAC1 and EZH2" . SPARSER::COLLECTION) ("HDAC/PcG" . SPARSER::COLLECTION)
    ("protein and suppressor" . SPARSER::COLLECTION) ("EED" . SPARSER::PROTEIN)
    ("its functional co-factor" . SPARSER::MOLECULE)
    ("Myc-SS18-SSX2" . SPARSER::COLLECTION)
    ("EGR1 and ATF3" . SPARSER::COLLECTION)
    ("dominant-negative ( dn ) ATF2" . SPARSER::PROTEIN)
    ("Egr1 or Atf3" . SPARSER::COLLECTION) ("Atf3" . SPARSER::PROTEIN)
    ("both SS18-SSX1 and -SSX2 fusion proteins" . SPARSER::COLLECTION)
    ("-SSX2" . SPARSER::COLLECTION)
    ("two known SS18-SSX targets EGR1 and Nuclear Protein 1 ( NUPR1 , or Candidate of Metastasis 1 , COM1 )"
     . SPARSER::COLLECTION)
    ("-TCACGTCA-3" . SPARSER::COLLECTION) ("S18-SSX" . SPARSER::COLLECTION)
    ("SYT" . SPARSER::PROTEIN) ("Myc-SS18" . SPARSER::COLLECTION)
    ("ATF2, or TLE1" . SPARSER::COLLECTION)
    ("ATF2 or TLE1" . SPARSER::COLLECTION)
    ("SMARCA2, HDAC1 and EZH2" . SPARSER::COLLECTION)
    ("oncoprotein, ATF2 and TLE1" . SPARSER::COLLECTION)
    ("ATF2-TLE1" . SPARSER::COLLECTION) ("DTC" . SPARSER::MOLECULE)
    ("ATF2 (mATF2) and TLE1 (mTLE1/Grg1)" . SPARSER::COLLECTION)
    ("Grg" . SPARSER::PROTEIN)
    ("both SS18-SSX1 and SS18-SSX2 fusion proteins" . SPARSER::COLLECTION)
    ("ethidium" . SPARSER::MOLECULE) ("anti-SS18-SSX" . SPARSER::COLLECTION)
    ("Groucho" . SPARSER::PROTEIN)
    ("two previously uncharacterized components" . SPARSER::COMPONENT)
    ("ATF2 and TLE1" . SPARSER::COLLECTION)
    ("other sarcoma-associated fusion oncoproteins" . SPARSER::PROTEIN)
    ("a poised bivalent state" . SPARSER::BIO-STATE)
    ("SS18-SSX2" . SPARSER::COLLECTION)
    ("doxorubicin and ifosphamide" . SPARSER::COLLECTION)
    ("activating transcription factor 2 (ATF2) and transducin-like enhancer"
     . SPARSER::COLLECTION)
    ("SS18-SSX" . SPARSER::COLLECTION) ("SSX" . SPARSER::PROTEIN)
    ("H3k27me3" . SPARSER::MOLECULE) ("C-9" . SPARSER::PROTEIN)
    ("FK228" . SPARSER::DRUG) ("Myf5" . SPARSER::PROTEIN)
    ("SUZ12" . SPARSER::PROTEIN) ("zeste 12" . SPARSER::PROTEIN)
    ("embryonic ectoderm development" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN)
    ("co-factor" . SPARSER::MOLECULE) ("COM1" . SPARSER::PROTEIN)
    ("NUPR1" . SPARSER::PROTEIN) ("Early Growth Response 1" . SPARSER::PROTEIN)
    ("SMARCA2" . SPARSER::PROTEIN) ("SS18-SSX1" . SPARSER::PROTEIN)
    ("SSX4" . SPARSER::PROTEIN) ("SSX1" . SPARSER::PROTEIN)
    ("SSX2" . SPARSER::PROTEIN) ("TLE1" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN)
    ("activating transcription factor 2" . SPARSER::PROTEIN)
    ("SS18" . SPARSER::PROTEIN)
    ("growth factors and adaptor proteins [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("MMP1 , EREG , COX2 , and MMP2" . SPARSER::COLLECTION)
    ("MMP1 , EREG , and COX2" . SPARSER::COLLECTION)
    ("epiregulin (EREG)" . SPARSER::PROTEIN) ("EREG" . SPARSER::PROTEIN)
    ("epiregulin" . SPARSER::PROTEIN) ("c- myb-" . SPARSER::PROTEIN)
    ("ER- and p53wt-positive" . SPARSER::COLLECTION)
    ("-NEU" . SPARSER::COLLECTION) ("NEU" . SPARSER::PROTEIN)
    ("the mammary fat" . SPARSER::PROTEIN)
    ("mRNA/protein" . SPARSER::COLLECTION) ("pepstatin" . SPARSER::DRUG)
    ("oligonucleotides and shRNA" . SPARSER::COLLECTION)
    ("MMP1 , MMP9 , and cathepsin D" . SPARSER::COLLECTION)
    ("laminin, perlecan, and nidogen" . SPARSER::COLLECTION)
    ("nidogen" . SPARSER::PROTEIN) ("perlecan" . SPARSER::PROTEIN)
    ("E-cadherin, N-cadherin, or vimentin" . SPARSER::COLLECTION)
    ("Exogenous murine c-Myb" . SPARSER::PROTEIN)
    ("Matrigel/collagen" . SPARSER::COLLECTION)
    ("substantially less active" . SPARSER::ACTIVE)
    ("Matrigel and collagen" . SPARSER::COLLECTION)
    ("MMP9 and MMP1" . SPARSER::COLLECTION)
    ("the MMP9 (1.38 kb) and MMP1 (4.3, 1.606, and 0.624 kb) promoter"
     . SPARSER::COLLECTION)
    ("MMP9, MMP1, and cathepsin D" . SPARSER::COLLECTION)
    ("both intracellular and extracellular cathepsin D" . SPARSER::PROTEIN)
    ("this lysosomal aspartic protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fibronectin, proteoglycans, and collagens" . SPARSER::COLLECTION)
    ("MMP1 and MMP9" . SPARSER::COLLECTION) ("Ilomastat" . SPARSER::DRUG)
    ("MMPs or cathepsins" . SPARSER::COLLECTION)
    ("cathepsin D and MMP9" . SPARSER::COLLECTION) ("CIM" . SPARSER::PROTEIN)
    ("RTCA" . SPARSER::PROTEIN) ("exogenous c-Myb" . SPARSER::PROTEIN)
    ("The exogenous c-Myb protein" . SPARSER::PROTEIN)
    ("myb" . SPARSER::PROTEIN)
    ("MMP1, MMP9, and cathepsin D" . SPARSER::COLLECTION)
    ("osteopontin" . SPARSER::PROTEIN)
    ("CXCL12 and CXCR4" . SPARSER::COLLECTION)
    ("the transforming retroviral oncogene" . SPARSER::ONCOGENE)
    ("cathepsin D and matrix metalloproteinase" . SPARSER::COLLECTION)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN) ("βgal" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("LRP1" . SPARSER::PROTEIN)
    ("Cathepsin D" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("v- myb" . SPARSER::PROTEIN) ("c- myb" . SPARSER::PROTEIN)
    ("c-Myb protein" . SPARSER::PROTEIN) ("cathepsin D" . SPARSER::PROTEIN)
    ("Klotho" . SPARSER::PROTEIN)
    ("traditional chemotherapy drugs doxorubicin and fluorouracil"
     . SPARSER::COLLECTION)
    ("doxorubicin and fluorouracil" . SPARSER::COLLECTION)
    ("FGFR4 or KLB" . SPARSER::COLLECTION)
    ("ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("FGFR4 and KLB" . SPARSER::COLLECTION) ("- 1" . SPARSER::PROTEIN)
    ("bona fide stemness-associated genes" . SPARSER::GENE)
    ("KLB-" . SPARSER::PROTEIN)
    ("a clinically relevant HCC biomarker" . SPARSER::MOLECULE)
    ("KLB or FGFR4" . SPARSER::COLLECTION)
    ("AFP and stemness" . SPARSER::COLLECTION)
    ("FRS2α, ERK1/2 and Akt" . SPARSER::COLLECTION)
    ("MAPK and PI-3 kinase" . SPARSER::COLLECTION)
    ("Ras-Raf-ERK1/2" . SPARSER::COLLECTION)
    ("multi-foci" . SPARSER::COLLECTION)
    ("KLB -/- and FGFR4 -/- knockout mice" . SPARSER::COLLECTION)
    ("KLB and FGFR4" . SPARSER::COLLECTION)
    ("FGF19-FGFR4" . SPARSER::COLLECTION)
    ("trans-membrane protein" . SPARSER::COLLECTION)
    ("mature hepatocytes" . SPARSER::PROTEIN)
    ("unresectable HCC" . SPARSER::PROTEIN) ("KLB-FGFR4" . SPARSER::COLLECTION)
    ("KLB" . SPARSER::PROTEIN) ("klotho" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glyceraldehyde 3- phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor-4" . SPARSER::PROTEIN)
    ("Fibroblast growth factor 19" . SPARSER::PROTEIN)
    ("Alpha-fetoprotein" . SPARSER::PROTEIN) ("FRS2α" . SPARSER::PROTEIN)
    ("P10" . SPARSER::PROTEIN) ("PD173074" . SPARSER::DRUG)
    ("CYP7A1" . SPARSER::PROTEIN) ("FGF19" . SPARSER::PROTEIN)
    ("alpha-fetoprotein" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor-4" . SPARSER::PROTEIN)
    ("GLP1R and GCGR" . SPARSER::COLLECTION)
    ("glucagon and Wnt3a" . SPARSER::COLLECTION)
    ("GCGR, PTH1R, and Lrp5/6" . SPARSER::COLLECTION)
    ("GCGR and Lrp5/6" . SPARSER::COLLECTION)
    ("PTH1R, GLP-1R and GCGR" . SPARSER::COLLECTION)
    ("an oligomeric complex" . SPARSER::BIO-COMPLEX)
    ("Rlu-tagged Lrp5 and YFP-tagged GCGR ( xref )" . SPARSER::COLLECTION)
    ("GCGR or Lrp5" . SPARSER::COLLECTION) ("CCK" . SPARSER::PROTEIN)
    ("YFP and Lrp5" . SPARSER::COLLECTION)
    ("Lrp5 and anti-v5" . SPARSER::COLLECTION)
    ("HA-tagged GCGR and v5-tagged Lrp5" . SPARSER::COLLECTION)
    ("ECD" . SPARSER::PROTEIN) ("GCGR and GLP1R" . SPARSER::COLLECTION)
    ("GLP-1R and Lrp5" . SPARSER::COLLECTION)
    ("GCGR and Lrp6" . SPARSER::COLLECTION)
    ("GCGR and Lrp5" . SPARSER::COLLECTION)
    ("an essential coreceptor" . SPARSER::PROTEIN)
    ("TCF-Luc" . SPARSER::COLLECTION) ("STF" . SPARSER::PROTEIN)
    ("CRE-Luc" . SPARSER::COLLECTION)
    ("a classical GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glucagon" . SPARSER::PROTEIN)
    ("PTH1R, GLP-1R, and GCGR" . SPARSER::COLLECTION)
    ("PTH1R and GCGR" . SPARSER::COLLECTION) ("coreceptor" . SPARSER::PROTEIN)
    ("Norrin" . SPARSER::PROTEIN) ("LRP5/6-" . SPARSER::PROTEIN)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("PKA and PKC" . SPARSER::COLLECTION)
    ("Gq" . SPARSER::DRUG) ("adrenergic" . SPARSER::PROTEIN)
    ("classical GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lrp5 and Lrp6" . SPARSER::COLLECTION) ("Lrp6" . SPARSER::PROTEIN)
    ("a Fz receptor and its co-receptor low-density-lipoprotein receptor–related protein 5/6 (Lrp5/6)"
     . SPARSER::COLLECTION)
    ("normally targets β-catenin" . SPARSER::PROTEIN)
    ("atypical GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("heterotrimeric G proteins" . SPARSER::PROTEIN)
    ("glucagon and β-catenin" . SPARSER::COLLECTION)
    ("Lrp5/6" . SPARSER::PROTEIN)
    ("an essential co-receptor" . SPARSER::PROTEIN) ("Lrp5" . SPARSER::PROTEIN)
    ("the classic cAMP/protein kinase" . SPARSER::KINASE)
    ("glucagon" . SPARSER::PROTEIN)
    ("glucagon receptor (GCGR)" . SPARSER::PROTEIN) ("GCGR" . SPARSER::PROTEIN)
    ("TCF7L2" . SPARSER::PROTEIN) ("Fz5" . SPARSER::PROTEIN)
    ("in Chinese Hamster" . SPARSER::PROTEIN) ("GLP1" . SPARSER::PROTEIN)
    ("GLP1R" . SPARSER::PROTEIN) ("lithium chloride" . SPARSER::DRUG)
    ("LRP5/6" . SPARSER::PROTEIN) ("GLP-1" . SPARSER::PROTEIN)
    ("glucagon-like peptide" . SPARSER::PROTEIN)
    ("glucagon-like peptide 1 receptor" . SPARSER::PROTEIN)
    ("G protein–coupled" . SPARSER::PROTEIN)
    ("low-density-lipoprotein" . SPARSER::PROTEIN)
    ("GLP-1R" . SPARSER::PROTEIN)
    ("glucagon-like peptide 1" . SPARSER::PROTEIN) ("PTH1R" . SPARSER::PROTEIN)
    ("class B" . SPARSER::PROTEIN) ("glucagon receptor" . SPARSER::PROTEIN)
    ("GC or HCC" . SPARSER::COLLECTION)
    ("potential predictive biomarkers" . SPARSER::MOLECULE)
    ("fIGF" . SPARSER::PROTEIN)
    ("a potential predictive biomarker" . SPARSER::MOLECULE)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("oligosaccharide" . SPARSER::MOLECULE)
    ("HRs and figitumumab" . SPARSER::COLLECTION)
    ("IGF1R and HRs" . SPARSER::COLLECTION) ("HR:IGF1R" . SPARSER::BIO-COMPLEX)
    ("IR as well as IGF1R ( xref )" . SPARSER::COLLECTION)
    ("a possible diagnostic biomarker" . SPARSER::MOLECULE)
    ("GC and HCC" . SPARSER::COLLECTION) ("sugar" . SPARSER::MOLECULE)
    ("sugars" . SPARSER::MOLECULE) ("the tryptic peptide" . SPARSER::PEPTIDE)
    ("Da" . SPARSER::MOLECULE) ("IGF1Rβ and IRβ" . SPARSER::COLLECTION)
    ("two isoforms around 95 and 105 kDa" . SPARSER::PROTEIN)
    ("HRs and drug" . SPARSER::COLLECTION)
    ("IR and IGF1R" . SPARSER::COLLECTION)
    ("the IGF1R/IR heterodimeric receptor" . SPARSER::RECEPTOR)
    ("proteins, and IGF1R" . SPARSER::COLLECTION)
    ("IGF1R or IR" . SPARSER::COLLECTION)
    ("both the IGF1R homodimer and IGF1R/IR heterodimer" . SPARSER::COLLECTION)
    ("IGF1R or its phosphorylated form" . SPARSER::COLLECTION)
    ("IGF1R related-proteins and downstream signaling molecules"
     . SPARSER::COLLECTION)
    ("Overexpressed IGF1R and IR form IGF1R/IR heterodimeric receptors"
     . SPARSER::PROTEIN)
    ("IGF1R and IRS1" . SPARSER::COLLECTION)
    ("IGF1R sequence-specific siRNAs" . SPARSER::PROTEIN)
    ("siRNA and figitumumab" . SPARSER::COLLECTION)
    ("pAKT, pERK, or pSTAT3" . SPARSER::COLLECTION)
    ("IR or IGF1R" . SPARSER::COLLECTION)
    ("total cellular IGF1R" . SPARSER::PROTEIN)
    ("AKT and STAT3" . SPARSER::COLLECTION) ("Figitumumab" . SPARSER::DRUG)
    ("IGF1R/IR heterodimeric receptors as well as IGF1 homodimer receptors"
     . SPARSER::COLLECTION)
    ("IGF/IGF1R" . SPARSER::COLLECTION)
    ("HRs, IGF1 and IGF2" . SPARSER::COLLECTION) ("IGFs" . SPARSER::PROTEIN)
    ("IRs" . SPARSER::PROTEIN)
    ("two extracellular alpha subunits and two beta subunits"
     . SPARSER::COLLECTION)
    ("IGF1 and IGF2" . SPARSER::COLLECTION)
    ("IGF1R/IR heterodimeric receptor" . SPARSER::RECEPTOR)
    ("IGF1R and figitumumab" . SPARSER::COLLECTION)
    ("IGF1R and IR" . SPARSER::COLLECTION)
    ("heterodimeric receptors" . SPARSER::PROTEIN)
    ("IGF1-dependent heterodimeric receptors" . SPARSER::PROTEIN)
    ("IGF1R/IR heterodimeric receptors" . SPARSER::PROTEIN)
    ("IGF1R/IR" . SPARSER::COLLECTION)
    ("IGF1R and insulin receptor (IR)" . SPARSER::COLLECTION)
    ("IGF1R and insulin receptor" . SPARSER::COLLECTION)
    ("successful IGF1R" . SPARSER::PROTEIN) ("figitumumab" . SPARSER::DRUG)
    ("α Tubulin" . SPARSER::PROTEIN) ("Dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("glutamine residue" . SPARSER::MOLECULE)
    ("Insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("Fra-1 and Fra-2" . SPARSER::COLLECTION)
    ("CD40L/IL-4" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos and Fra-1" . SPARSER::COLLECTION)
    ("a dominant-negative Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GST-LOX-PP" . SPARSER::COLLECTION) ("Glutathione" . SPARSER::DRUG)
    ("the LOX-PP peptide as well as c-Raf" . SPARSER::COLLECTION)
    ("B-Raf, Hsp90, Erk1/2 and MEK1/2" . SPARSER::COLLECTION)
    ("LOX-PP-GST" . SPARSER::COLLECTION) ("rLOX-PP" . SPARSER::COLLECTION)
    ("subunits and Blimp1" . SPARSER::COLLECTION)
    ("mLOX-PP" . SPARSER::COLLECTION) ("hLOX-PP" . SPARSER::COLLECTION)
    ("Blimp1 and its upstream AP-1 activators" . SPARSER::COLLECTION)
    ("Fra-1 or Fra-2" . SPARSER::COLLECTION)
    ("c-Jun, Fra-1 or Fra-2" . SPARSER::COLLECTION)
    ("the pre-immune IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Jun, Fra-1, or Fra-2" . SPARSER::COLLECTION)
    ("BLIMP1 and GAPDH" . SPARSER::COLLECTION)
    ("proteins and mRNA" . SPARSER::COLLECTION)
    ("previously described TREs" . SPARSER::PROTEIN)
    ("an anti-c-Jun or control IgG antibody" . SPARSER::COLLECTION)
    ("an anti-c-Jun" . SPARSER::ANTIBODY) ("TRE" . SPARSER::PROTEIN)
    ("hetero" . SPARSER::PROTEIN) ("c-Jun-c-Jun" . SPARSER::COLLECTION)
    ("Fra-1, Fra-2, or c-Fos" . SPARSER::COLLECTION)
    ("possibly c-Jun homodimers" . SPARSER::HOMODIMER)
    ("Fra-1, Fra-2 and c-Fos" . SPARSER::COLLECTION)
    ("c-Jun-c-Fos" . SPARSER::COLLECTION) ("c-Jun-Fra-2" . SPARSER::COLLECTION)
    ("c-Jun-Fra-1" . SPARSER::COLLECTION)
    ("c-Jun, Fra-1, Fra-2 or c-Fos" . SPARSER::COLLECTION)
    ("Fra-1, Fra-2 or c-Fos" . SPARSER::COLLECTION)
    ("c-Jun and Fra-2" . SPARSER::COLLECTION)
    ("c-Jun and Fra-1" . SPARSER::COLLECTION)
    ("either FRA-1 or FRA-2 siRNA or a negative control siRNA"
     . SPARSER::COLLECTION)
    ("FRA-1 or FRA-2" . SPARSER::COLLECTION)
    ("c-Jun, Fra-2 and Fra-1" . SPARSER::COLLECTION)
    ("c-Jun, Fra-1 and Fra-2" . SPARSER::COLLECTION)
    ("Fra-1 (65%) and Fra-2 (43%)" . SPARSER::COLLECTION)
    ("c-Jun (53%), Fra-1 (65%) and Fra-2 (43%)" . SPARSER::COLLECTION)
    ("TREs" . SPARSER::PROTEIN) ("si-c-RAF" . SPARSER::COLLECTION)
    ("c- RAF siRNA or control siRNA" . SPARSER::COLLECTION)
    ("a negative control siRNA or an siRNA" . SPARSER::COLLECTION)
    ("c-" . SPARSER::PROTEIN) ("c-Raf/Erk" . SPARSER::COLLECTION)
    ("si-" . SPARSER::PROTEIN) ("-luc" . SPARSER::COLLECTION)
    ("siRNA-1" . SPARSER::COLLECTION) ("siRNA and EV" . SPARSER::COLLECTION)
    ("Blimp1 or EV" . SPARSER::COLLECTION)
    ("K-Ras or N-Ras" . SPARSER::COLLECTION)
    ("Ras/c-Raf/AP-1" . SPARSER::COLLECTION) ("enzyme (LOX)" . SPARSER::ENZYME)
    ("rrg" . SPARSER::PROTEIN) ("acceptors" . SPARSER::MOLECULE)
    ("The exact transcription factor" . SPARSER::PROTEIN)
    ("PGC" . SPARSER::PROTEIN)
    ("NF-κB, AP-1, IRF4, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN) ("HMTs" . SPARSER::PROTEIN)
    ("B lymphocyte-induced maturation protein 1 (Blimp1) or Positive-Regulatory Domain I Binding Factor 1 (PRDI-BF1)"
     . SPARSER::COLLECTION)
    ("PRDI-BF1 and RIZ" . SPARSER::COLLECTION) ("RIZ" . SPARSER::PROTEIN)
    ("Ras/Raf/AP-1" . SPARSER::COLLECTION) ("LOX-PP" . SPARSER::COLLECTION)
    ("PP" . SPARSER::PROTEIN) ("LOX" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Blimp-1" . SPARSER::PROTEIN) ("chemo-attractant" . SPARSER::PROTEIN)
    ("L38" . SPARSER::PROTEIN) ("FRA-2" . SPARSER::PROTEIN)
    ("FRA-1" . SPARSER::PROTEIN) ("Fra-2" . SPARSER::PROTEIN)
    ("TR2" . SPARSER::PROTEIN) ("Blimp 1" . SPARSER::PROTEIN)
    ("Lysyl oxidase" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN) ("IRF4" . SPARSER::PROTEIN)
    ("PRDM1" . SPARSER::PROTEIN) ("domain 1" . SPARSER::PROTEIN)
    ("PRDI-BF1" . SPARSER::PROTEIN)
    ("Positive-Regulatory Domain I Binding Factor 1" . SPARSER::PROTEIN)
    ("lysyl oxidase" . SPARSER::PROTEIN)
    ("Activator Protein" . SPARSER::PROTEIN) ("BLIMP1" . SPARSER::PROTEIN)
    ("Blimp1" . SPARSER::PROTEIN)
    ("reggie-2/flotillin-1" . SPARSER::COLLECTION)
    ("EGFR (only at Y1173) and Erk1/2" . SPARSER::COLLECTION)
    ("its associated signaling molecules" . SPARSER::MOLECULE)
    ("β-catenin/plakoglobin" . SPARSER::COLLECTION)
    ("plakoglobin" . SPARSER::PROTEIN)
    ("E-cadherin, EGFR, and PrP" . SPARSER::COLLECTION)
    ("PI3K and Rac1" . SPARSER::COLLECTION)
    ("EGFR and Src" . SPARSER::COLLECTION) ("PrP-" . SPARSER::PROTEIN)
    ("tyrosine kinase, and c-cbl" . SPARSER::COLLECTION)
    ("E-cadherin and reggie-1" . SPARSER::COLLECTION)
    ("E-cadherin–EGFP and reggie-1–monomeric red fluorescent protein"
     . SPARSER::PROTEIN)
    ("S4 and S5" . SPARSER::COLLECTION) ("p85 and p55" . SPARSER::COLLECTION)
    ("MEK1/2, PLC, and ROCK" . SPARSER::COLLECTION)
    ("macropinocytic cargo proteins" . SPARSER::PROTEIN)
    ("reggie-1, EGFR, and E-cadherin" . SPARSER::COLLECTION)
    ("β-catenin and p120" . SPARSER::COLLECTION)
    ("EGF and reggie-1" . SPARSER::COLLECTION)
    ("EGF-rhodamine" . SPARSER::COLLECTION)
    ("Erk1/2, PI3K, and Akt" . SPARSER::COLLECTION)
    ("EGFR or EGF-rhodamine–labeled" . SPARSER::COLLECTION)
    ("caveolin-1–EGFP" . SPARSER::COLLECTION)
    ("reggie-1–EGFP" . SPARSER::COLLECTION)
    ("AG-1478 and PD158780" . SPARSER::COLLECTION)
    ("E-cadherin–EGFP" . SPARSER::COLLECTION)
    ("perijunctional actin" . SPARSER::PROTEIN)
    ("catenins" . SPARSER::PROTEIN-FAMILY)
    ("p120-catenin or E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin, β-catenin, or p120-catenin" . SPARSER::COLLECTION)
    ("E-cadherin–enhanced green fluorescent protein (EGFP)"
     . SPARSER::COLLECTION)
    ("reggie-1 or PrP" . SPARSER::COLLECTION)
    ("E-cadherin–enhanced green fluorescent protein" . SPARSER::COLLECTION)
    ("reggie-1 and PrP" . SPARSER::COLLECTION)
    ("shR1 and shPrP" . SPARSER::COLLECTION)
    ("E-cadherin and coaccumulate" . SPARSER::COLLECTION)
    ("reggie-1, PrP, and E-cadherin" . SPARSER::COLLECTION)
    ("amiloride, Rac1, and PI3K" . SPARSER::COLLECTION)
    ("amiloride" . SPARSER::DRUG)
    ("the amyloid precursor protein and the transporters"
     . SPARSER::COLLECTION)
    ("glycosylphosphatidylinositol" . SPARSER::MOLECULE)
    ("the ubiquitin ligase c-cbl and the GTPase TC10" . SPARSER::COLLECTION)
    ("exocyst" . SPARSER::BIO-COMPLEX)
    ("Src tyrosine kinases and adaptor proteins" . SPARSER::COLLECTION)
    ("ponsin" . SPARSER::PROTEIN) ("flotillins" . SPARSER::PROTEIN-FAMILY)
    ("–PrP" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase (PI3K) and Rac1" . SPARSER::COLLECTION)
    ("Typical activators" . SPARSER::ACTIVATOR)
    ("E-cadherin/catenin" . SPARSER::COLLECTION)
    ("junction-associated E-cadherin" . SPARSER::PROTEIN)
    ("kinases and epidermal growth factor receptor (EGFR)"
     . SPARSER::COLLECTION)
    ("kinases and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("Src and c-cbl" . SPARSER::COLLECTION)
    ("the cellular prion protein" . SPARSER::PROTEIN)
    ("reggie/flotillin" . SPARSER::COLLECTION) ("PrP" . SPARSER::PROTEIN)
    ("flotillin" . SPARSER::PROTEIN) ("sulfo-NHS" . SPARSER::DRUG)
    ("U-73122" . SPARSER::MOLECULE) ("SB 202190" . SPARSER::DRUG)
    ("flotillin-1" . SPARSER::PROTEIN)
    ("dopamine transporter" . SPARSER::PROTEIN) ("p120" . SPARSER::PROTEIN)
    ("PD158780" . SPARSER::DRUG) ("AG-1478" . SPARSER::DRUG)
    ("reggie-2" . SPARSER::PROTEIN) ("shR1" . SPARSER::PROTEIN)
    ("reggie-1" . SPARSER::PROTEIN) ("CD59" . SPARSER::PROTEIN)
    ("p120-catenin" . SPARSER::PROTEIN) ("c-cbl" . SPARSER::PROTEIN)
    ("prion protein" . SPARSER::PROTEIN)
    ("DNA, RNA and protein" . SPARSER::COLLECTION) ("HCCs" . SPARSER::PROTEIN)
    ("BEC" . SPARSER::MOLECULE) ("Nf2 or Sav1" . SPARSER::COLLECTION)
    ("Sav1" . SPARSER::PROTEIN)
    ("Survivin and Glypican-3" . SPARSER::COLLECTION)
    ("ApoE" . SPARSER::PROTEIN)
    ("biliary membrane marker CK7" . SPARSER::PROTEIN)
    ("BECs" . SPARSER::MOLECULE)
    ("the EGF family member amphiregulin ( AREG ) ( xref ) and the AXL receptor kinase ( Axl )"
     . SPARSER::COLLECTION)
    ("the secreted Cystein-rich protein connective tissue growth factor ( CTGF ) ( xref ), the EGF family member amphiregulin ( AREG ) ( xref ) and the AXL receptor kinase ( Axl )"
     . SPARSER::COLLECTION)
    ("amphiregulin ( AREG )" . SPARSER::PROTEIN)
    ("connective tissue growth factor ( CTGF )" . SPARSER::PROTEIN)
    ("BIRC5/Survivin" . SPARSER::COLLECTION) ("AXL" . SPARSER::PROTEIN)
    ("AREG" . SPARSER::PROTEIN) ("Cystein" . SPARSER::MOLECULE)
    ("IAPs" . SPARSER::PROTEIN) ("Nf2" . SPARSER::PROTEIN)
    ("Glypican-3" . SPARSER::PROTEIN) ("CK7" . SPARSER::PROTEIN)
    ("Histone H2A.Z" . SPARSER::PROTEIN)
    ("Beta-glucuronidase" . SPARSER::PROTEIN) ("HPF" . SPARSER::PROTEIN)
    ("RAF/MEK/mitogen activated protein kinase" . SPARSER::COLLECTION)
    ("growth factor- and let-7" . SPARSER::COLLECTION)
    ("steroid hormone-" . SPARSER::MOLECULE)
    ("the KRAS variant and BRCA1 mutations" . SPARSER::COLLECTION)
    ("BRCA2 or non- BRCA breast cancer families" . SPARSER::COLLECTION)
    ("HR and HER2" . SPARSER::COLLECTION) ("histologic type" . TYPE)
    ("other special types" . TYPE)
    ("BRCA2 (13.5%) or non- BRCA1/2 families (15.8%)" . SPARSER::COLLECTION)
    ("ovarian cancer (HBOC) families" . SPARSER::PROTEIN-FAMILY)
    ("the miRNA and its target mRNA" . SPARSER::COLLECTION)
    ("Progesterone receptor" . SPARSER::PROTEIN)
    ("Mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTGS" . SPARSER::PROTEIN) ("CC, and T" . SPARSER::COLLECTION)
    ("TC" . SPARSER::PROTEIN) ("an intronic variant" . SPARSER::VARIANT)
    ("an integral membrane bifunctional enzyme" . SPARSER::ENZYME)
    ("prostaglandin-endoperoxide synthase (PTGS)" . SPARSER::PROTEIN)
    ("Prostaglandin-endoperoxide synthase" . SPARSER::PROTEIN)
    ("PKC-α-NF-κB" . SPARSER::COLLECTION) ("PKC-δ-JNK" . SPARSER::COLLECTION)
    ("PI3-K and phosphoinositide-dependent kinase (PDK)" . SPARSER::COLLECTION)
    ("kinase (PDK)" . SPARSER::KINASE)
    ("Src-tyrosine kinase" . SPARSER::COLLECTION)
    ("Stat1, Stat2, and IRF-9" . SPARSER::COLLECTION)
    ("c-Jun/c-Fos" . SPARSER::COLLECTION)
    ("a possible IFN-stimulated response element (ISRE) and AP-1 sites [ xref - xref ]"
     . SPARSER::COLLECTION)
    ("a possible IFN-stimulated response element (ISRE)"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("PKC-δ and TRAIL" . SPARSER::COLLECTION)
    ("JNK and Stat1" . SPARSER::COLLECTION)
    ("pro-apoptotic molecule JNKs" . SPARSER::PROTEIN)
    ("JNK and the TRAIL promoter" . SPARSER::COLLECTION)
    ("JNK and TRAIL" . SPARSER::COLLECTION)
    ("a pro-apoptotic molecule" . SPARSER::MOLECULE)
    ("hygromycin" . SPARSER::MOLECULE) ("Rottlerin" . SPARSER::DRUG)
    ("dominant-negative PKC-δ" . SPARSER::PROTEIN)
    ("TRAIL-Luc" . SPARSER::COLLECTION)
    ("phospho-PKC-δ and total PKC-δ" . SPARSER::COLLECTION)
    ("phospho-PKC-δ (Thr505) or total PKC-δ" . SPARSER::COLLECTION)
    ("JNK1 and Stat1" . SPARSER::COLLECTION) ("Jak/Stat" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("Jak1/Tyk2" . SPARSER::COLLECTION)
    ("receptor-associated Janus kinases" . SPARSER::PROTEIN)
    ("Jak1 and Tyk2" . SPARSER::COLLECTION) ("Jak1" . SPARSER::PROTEIN)
    ("JNK1 and the TRAIL promoter" . SPARSER::COLLECTION)
    ("rottlerin" . SPARSER::DRUG)
    ("The dominant-negative form" . SPARSER::FORM) ("Stat2" . SPARSER::PROTEIN)
    ("ISGF3" . SPARSER::PROTEIN) ("factor-3" . SPARSER::PROTEIN)
    ("p18" . SPARSER::PROTEIN) ("SP-600125" . SPARSER::DRUG)
    ("TRAIL protein" . SPARSER::PROTEIN) ("PKC-delta" . SPARSER::PROTEIN)
    ("PKC-γ" . SPARSER::PROTEIN) ("PKC-α" . SPARSER::PROTEIN)
    ("interferon-α" . SPARSER::DRUG) ("PKC-δ" . SPARSER::PROTEIN)
    ("Interferon-α" . SPARSER::DRUG) ("rRNAs or tRNAs" . SPARSER::COLLECTION)
    ("long non-coding RNA and miRNA" . SPARSER::COLLECTION)
    ("PRKAG1 , and siRNA-" . SPARSER::COLLECTION)
    ("HNF4α and HIF-1α" . SPARSER::COLLECTION)
    ("fatty acid and lipid metabolism" . SPARSER::COLLECTION)
    ("ATP and AMP" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("a strong candidate target gene" . SPARSER::GENE)
    ("mRNA:miRNA" . SPARSER::BIO-COMPLEX)
    ("AMPK, PRKAA1 , PRKAB1 and PRKAG1" . SPARSER::COLLECTION)
    ("other genes using Wilcoxon’s" . SPARSER::GENE)
    ("both the available coding gene" . SPARSER::GENE)
    ("non-redundant mature miRNAs" . SPARSER::PROTEIN)
    ("RPM" . SPARSER::PROTEIN) ("the exact mutant alleles" . SPARSER::ALLELE)
    ("gastric-cancer-related differentially" . SPARSER::PROTEIN)
    ("tRNAs" . SPARSER::PROTEIN) ("ABI" . SPARSER::PROTEIN-FAMILY)
    ("comprehensive mRNA and miRNA" . SPARSER::COLLECTION)
    ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("mRNA and non-coding" . SPARSER::COLLECTION)
    ("mRNAs and microRNAs" . SPARSER::COLLECTION)
    ("hepatocyte nuclear factor 4 alpha" . SPARSER::PROTEIN)
    ("PRKAG2" . SPARSER::PROTEIN) ("PRKAG1" . SPARSER::PROTEIN)
    ("β 2 -microglobulin" . SPARSER::PROTEIN) ("HNF4α" . SPARSER::PROTEIN)
    ("PRKG1" . SPARSER::PROTEIN) ("PRKAB1" . SPARSER::PROTEIN)
    ("PRKAA1" . SPARSER::PROTEIN) ("PRKAA2" . SPARSER::PROTEIN)
    ("actual SES" . SPARSER::PROTEIN)
    ("cross-sectional SES" . SPARSER::PROTEIN)
    ("only 12.1% AAs and 36.5% non-AAs" . SPARSER::COLLECTION)
    ("only 12.1% AAs" . SPARSER::MOLECULE)
    ("neither TN nor basal type" . SPARSER::COLLECTION)
    ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("TN, and luminal" . SPARSER::COLLECTION)
    ("type, location, and multiplicity" . SPARSER::COLLECTION)
    ("TN type ( P = 0.430) nor p53 status ( P = 0.431)" . SPARSER::COLLECTION)
    ("TN (OR 1.53; 95% CI 0.75–3.12) and basal type (OR 1.79; 95% CI 0.73–4.43)"
     . SPARSER::COLLECTION)
    ("TN (OR 2.67; 95% CI 1.55–4.59) and basal type (OR 3.39; 95% CI 1.86–6.19)"
     . SPARSER::COLLECTION)
    ("ER−, PR−, and HER2−" . SPARSER::COLLECTION) ("SES" . SPARSER::PROTEIN)
    ("PR−" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER−" . SPARSER::PROTEIN)
    ("/progesterone receptor" . SPARSER::COLLECTION)
    ("OR 1" . SPARSER::PROTEIN) ("OR 2" . SPARSER::MOLECULE)
    ("CK 5" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("c-ErbB1" . SPARSER::COLLECTION) ("HER-2/Neu" . SPARSER::COLLECTION)
    ("EBS3 and ETS4/ETS5" . SPARSER::COLLECTION)
    ("Ets-1 and ELK-1" . SPARSER::COLLECTION) ("DPP" . SPARSER::MOLECULE)
    ("proteins and DNA" . SPARSER::COLLECTION)
    ("MCPIP-1 and PAI-1" . SPARSER::COLLECTION)
    ("EGR-1, TR3, Pip92, MCL-1 and SRF" . SPARSER::COLLECTION)
    ("constitutively active (Elk-VP16) and dominant-negative (Elk-EN)"
     . SPARSER::COLLECTION)
    ("bp and ELK-1" . SPARSER::COLLECTION)
    ("anti-ELK-1 or nonspecific IgG (Figure xref lower panel)"
     . SPARSER::COLLECTION)
    ("nonspecific IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-ELK-1 or nonspecific antibody" . SPARSER::COLLECTION)
    ("anti-EGR-1, anti-ELK-1 or nonspecific antibody" . SPARSER::COLLECTION)
    ("nonspecific antibody" . SPARSER::PROTEIN)
    ("EBS3 or ETS4/ETS5" . SPARSER::COLLECTION)
    ("ETS3, ETS4 or EBS6" . SPARSER::COLLECTION) ("dETS" . SPARSER::DRUG)
    ("ETS3, ETS4 and ETS5" . SPARSER::COLLECTION)
    ("ETS family and EBS6" . SPARSER::COLLECTION)
    ("both c-FOS (AP-1 component) and EGR-1" . SPARSER::COLLECTION)
    ("AP-1 and EBS2" . SPARSER::COLLECTION)
    ("EBS2 and EBS3" . SPARSER::COLLECTION) ("EBS" . SPARSER::PROTEIN-FAMILY)
    ("bp and +744" . SPARSER::COLLECTION)
    ("active and dominant-negative" . SPARSER::COLLECTION)
    ("all canonical MAPK" . SPARSER::PROTEIN)
    ("p38 and anti-phospho" . SPARSER::COLLECTION)
    ("EGR-1 and FOS" . SPARSER::COLLECTION)
    ("ternary complex" . SPARSER::BIO-COMPLEX)
    ("SREs" . SPARSER::PROTEIN-FAMILY) ("SRF" . SPARSER::PROTEIN)
    ("STAT6 and SMAD" . SPARSER::COLLECTION) ("Zfp36" . SPARSER::PROTEIN)
    ("SMAD" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPKs (including MK2, the p38 substrate or MK3) or AKT"
     . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("LPS and anti-inflammatory" . SPARSER::COLLECTION)
    ("c-FOS and tristetraprolin" . SPARSER::COLLECTION)
    ("metalloproteinase-1" . SPARSER::COLLECTION)
    ("specifically binds mRNAs" . SPARSER::PROTEIN)
    ("Uridine" . SPARSER::PROTEIN) ("Adenine" . SPARSER::NUCLEOBASE)
    ("TTP, BRF-1, BRF-2 and ZFP36L3" . SPARSER::COLLECTION)
    ("G0S24, ZFP36, TIS11, and Nup475" . SPARSER::COLLECTION)
    ("tristetraprolin" . SPARSER::PROTEIN)
    ("ELK-1 and EGR-1" . SPARSER::COLLECTION)
    ("cytokines, mitogens and drugs" . SPARSER::COLLECTION)
    ("immediate-early response proteins" . SPARSER::PROTEIN)
    ("TTP" . SPARSER::PROTEIN) ("Tristetraprolin" . SPARSER::PROTEIN)
    ("pEF1" . SPARSER::PROTEIN) ("CCL-2" . SPARSER::PROTEIN)
    ("c-ErbB2" . SPARSER::PROTEIN) ("TPE1" . SPARSER::PROTEIN)
    ("MCPIP-1" . SPARSER::PROTEIN) ("nur77" . SPARSER::PROTEIN)
    ("c- FOS" . SPARSER::PROTEIN) ("TR3" . SPARSER::PROTEIN)
    ("F3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ETS family" . SPARSER::PROTEIN)
    ("dAP-1" . SPARSER::PROTEIN) ("EBS3" . SPARSER::PROTEIN)
    ("EBS2" . SPARSER::PROTEIN) ("HDAC-2" . SPARSER::PROTEIN)
    ("SAP-2" . SPARSER::PROTEIN) ("SAP-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFNγ" . SPARSER::PROTEIN) ("MK2" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("BRF-2" . SPARSER::PROTEIN)
    ("BRF-1" . SPARSER::PROTEIN) ("zinc finger protein" . SPARSER::PROTEIN)
    ("TIS11" . SPARSER::PROTEIN) ("G0S24" . SPARSER::PROTEIN)
    ("EGR-1" . SPARSER::PROTEIN) ("ELK-1" . SPARSER::PROTEIN)
    ("ZFP36" . SPARSER::PROTEIN) ("hypoparathyroidism" . SPARSER::PROTEIN)
    ("RAS and BRAF" . SPARSER::COLLECTION)
    ("The two histologic subtypes" . SPARSER::PROTEIN)
    ("ATA" . SPARSER::MOLECULE)
    ("the diffuse follicular variant" . SPARSER::VARIANT)
    ("FTA and FTC" . SPARSER::COLLECTION) ("FTC" . SPARSER::DRUG)
    ("FTA" . SPARSER::PROTEIN) ("The follicular variant" . SPARSER::VARIANT)
    ("classical PTC" . SPARSER::PROTEIN)
    ("The most common histologic type" . TYPE)
    ("RET/PTC1" . SPARSER::COLLECTION) ("Endocrine" . SPARSER::PROTEIN)
    ("diffuse follicular variant" . SPARSER::VARIANT)
    ("PTC1" . SPARSER::PROTEIN) ("TERT/LT/BRCA1-IRIS" . SPARSER::COLLECTION)
    ("TERT/LT/Ras" . SPARSER::COLLECTION)
    ("AUF1 and HuR" . SPARSER::COLLECTION)
    ("AKT and several other proliferation and survival proteins [ xref - xref , xref , xref , and this study]"
     . SPARSER::COLLECTION)
    ("clinically relevant BRCA1/p220 mutant" . SPARSER::MUTANT)
    ("p-Bad" . SPARSER::COLLECTION) ("AKT, and survivin" . SPARSER::COLLECTION)
    ("AKT and its down-stream targets survivin and BAD 72h"
     . SPARSER::COLLECTION)
    ("survivin and BAD" . SPARSER::COLLECTION)
    ("AUF1, pCBP2 and GADD45" . SPARSER::COLLECTION)
    ("cyclin D1, CK5 and EGFR" . SPARSER::COLLECTION)
    ("CK5, EGFR and cyclin D1" . SPARSER::COLLECTION)
    ("GADD45, AUF1 and pCBP2" . SPARSER::COLLECTION)
    ("CK5, EGFR or cyclin D1" . SPARSER::COLLECTION)
    ("Oct1-" . SPARSER::PROTEIN) ("-CycD1" . SPARSER::COLLECTION)
    ("-CK5" . SPARSER::COLLECTION) ("-GADD45" . SPARSER::COLLECTION)
    ("-pCBP2" . SPARSER::COLLECTION) ("pGL3-AUF1" . SPARSER::COLLECTION)
    ("CK5, CK17, CH3 and EGFR" . SPARSER::COLLECTION)
    ("c-Jun/AP1" . SPARSER::COLLECTION) ("AP1" . SPARSER::PROTEIN)
    ("CK5, CK17, CDH3 and EGFR" . SPARSER::COLLECTION)
    ("BRCA1-IRIS or BRCA1/p220 monoclonal antibodies" . SPARSER::ANTIBODY)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("CK5, CK17, CDH3, EGFR and cyclin E" . SPARSER::COLLECTION)
    ("AUF1, pCBP2 and HuR" . SPARSER::COLLECTION)
    ("HuR and BRCA1/p220 antibodies" . SPARSER::COLLECTION)
    ("polysome" . SPARSER::BIO-COMPLEX)
    ("IgG or BRCA1/p220 antibodies" . SPARSER::COLLECTION)
    ("reverse transcriptase (RT)" . SPARSER::PROTEIN)
    ("AUF1, pCBP2, HuR or IgG" . SPARSER::COLLECTION)
    ("polysomes" . SPARSER::BIO-COMPLEX) ("RSV-Luc" . SPARSER::COLLECTION)
    ("AUF1- or pCBP2-silenced" . SPARSER::COLLECTION)
    ("AUF1-" . SPARSER::PROTEIN) ("p220-" . SPARSER::PROTEIN)
    ("BRCA1/p220/AUF1" . SPARSER::COLLECTION)
    ("AUF1 or pCBP2" . SPARSER::COLLECTION)
    ("proteins, AUF-1 and pCBP2" . SPARSER::COLLECTION)
    ("`-ITR" . SPARSER::COLLECTION) ("ITR" . SPARSER::PROTEIN)
    ("decreased BRCA1-IRIS mRNA (see red lines in Figure xref , left) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("BRCA1-IRIS mRNA (black lines in Figure xref , left) and protein (Figure xref )"
     . SPARSER::COLLECTION)
    ("an exogenous promoter" . SPARSER::PROMOTER) ("BARD1-" . SPARSER::PROTEIN)
    ("mouse monoclonal antibodies [ xref , xref ] and real time RT/qPCR"
     . SPARSER::COLLECTION)
    ("BRCA1/p220 protein (Figure xref ) and mRNA (Figure xref )"
     . SPARSER::COLLECTION)
    ("mouse monoclonal antibodies" . SPARSER::ANTIBODY)
    ("EGFR and cyclin E" . SPARSER::COLLECTION)
    ("proteins, AUF1 and pCBP2" . SPARSER::COLLECTION)
    ("geminin" . SPARSER::PROTEIN)
    ("proteins ( aka hnRNPE/pCBP1-4, see [ xref ]) or mRNA"
     . SPARSER::COLLECTION)
    ("sequence-specific trans" . SPARSER::PROTEIN-FAMILY)
    ("hnRNPD/AUF1" . SPARSER::COLLECTION) ("HuR" . SPARSER::PROTEIN)
    ("hnRNPD" . SPARSER::PROTEIN)
    ("dysfunctional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p-cadherin, EGFR and cyclin E" . SPARSER::COLLECTION)
    ("AKT and survivin" . SPARSER::COLLECTION)
    ("cytokeratins" . SPARSER::PROTEIN)
    ("AUF1 and pCBP2" . SPARSER::COLLECTION)
    ("BRCA1-IRIS" . SPARSER::COLLECTION) ("IRIS" . SPARSER::PROTEIN)
    ("BRCA1/p220" . SPARSER::COLLECTION) ("Actinomycin D" . SPARSER::MOLECULE)
    ("CycD1" . SPARSER::PROTEIN) ("Oct1" . SPARSER::PROTEIN)
    ("CK17" . SPARSER::PROTEIN) ("c-fos" . SPARSER::PROTEIN)
    ("AUF-1" . SPARSER::PROTEIN) ("CDH3" . SPARSER::PROTEIN)
    ("ELAVL1" . SPARSER::PROTEIN) ("pCBP1" . SPARSER::PROTEIN)
    ("p-cadherin" . SPARSER::PROTEIN) ("pCBP2" . SPARSER::PROTEIN)
    ("AUF1" . SPARSER::PROTEIN) ("p220" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE)
    ("obatoclax" . SPARSER::DRUG) ("MYC and BIM" . SPARSER::COLLECTION)
    ("the longest isoform BIM-EL" . SPARSER::COLLECTION)
    ("CDK1-MYC" . SPARSER::COLLECTION)
    ("kinases, CDK2 and aurora kinase B" . SPARSER::COLLECTION)
    ("a conditional dominant-negative mutant" . SPARSER::MUTANT)
    ("estrogen receptor, progesterone receptor, and HER2"
     . SPARSER::COLLECTION)
    ("BCL-2, BCL-xL, and MCL-1" . SPARSER::COLLECTION)
    ("BIM-EL" . SPARSER::COLLECTION)
    ("presumptive CDK substrates" . SPARSER::SUBSTRATE)
    ("the chemotherapeutic agents paclitaxel and doxorubicin"
     . SPARSER::COLLECTION)
    ("paclitaxel and doxorubicin" . SPARSER::COLLECTION)
    ("the only mitotic CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("previously published mRNA" . SPARSER::PROTEIN)
    ("RPE-NEO" . SPARSER::COLLECTION) ("RPE-MYC" . SPARSER::COLLECTION)
    ("Dinaciclib" . SPARSER::DRUG) ("dinaciclib" . SPARSER::DRUG)
    ("purvalanol" . SPARSER::MOLECULE) ("Purvalanol" . SPARSER::MOLECULE)
    ("the mitotic kinase CDK1" . SPARSER::PROTEIN)
    ("MXD4 and MAX" . SPARSER::COLLECTION)
    ("MYC/MAX heteromeric complexes" . SPARSER::BIO-COMPLEX)
    ("MAX/MAX" . SPARSER::COLLECTION) ("MXD/MAX" . SPARSER::COLLECTION)
    ("MYC protein and phospho-MYC" . SPARSER::COLLECTION)
    ("the mitotic cyclin-dependent kinase (CDK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lack obvious druggable targets" . SPARSER::TARGET-PROTEIN)
    ("this aggressive tumor type" . TYPE)
    ("MAD, MGA, MXD4, and MNT" . SPARSER::COLLECTION)
    ("MNT" . SPARSER::PROTEIN) ("MAD" . SPARSER::PROTEIN)
    ("small molecule kinase inhibitors, treatment with inhibitory monoclonal antibodies, and antihormonal therapies"
     . SPARSER::COLLECTION)
    ("inhibitory monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Clinically relevant biomarkers" . SPARSER::MOLECULE)
    ("BIM" . SPARSER::PROTEIN)
    ("Estrogen, progesterone, and HER2" . SPARSER::COLLECTION)
    ("β-ACTIN" . SPARSER::PROTEIN) ("aurora kinase B" . SPARSER::PROTEIN)
    ("protein phosphatase 1" . SPARSER::PROTEIN) ("MXD1" . SPARSER::PROTEIN)
    ("MYC protein" . SPARSER::PROTEIN) ("MXD4" . SPARSER::PROTEIN)
    ("protein MAX" . SPARSER::PROTEIN)
    ("a generic job-exposure matrix" . SPARSER::PROTEIN-FAMILY)
    ("catechol, and benzoquinones" . SPARSER::COLLECTION)
    ("benzoquinones" . SPARSER::MOLECULE) ("catechol" . SPARSER::PROTEIN)
    ("oxide" . SPARSER::MOLECULE) ("organic solvents" . SPARSER::MOLECULE)
    ("chlorinated solvents and risk" . SPARSER::COLLECTION)
    ("major NHL histological subtypes" . SPARSER::PROTEIN)
    ("MGMT (rs12917) and NBS1 (rs1805794)" . SPARSER::COLLECTION)
    ("solvents" . SPARSER::MOLECULE) ("P/CAF" . SPARSER::PROTEIN)
    ("O6" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("XRCC4" . SPARSER::PROTEIN) ("RAD23B" . SPARSER::PROTEIN)
    ("ERCC5" . SPARSER::PROTEIN) ("ERCC2" . SPARSER::PROTEIN)
    ("APEX1" . SPARSER::PROTEIN) ("DNA-damage ( xref , xref )" . SPARSER::DNA)
    ("p21 or other cell cycle regulatory protein" . SPARSER::COLLECTION)
    ("most cancers lack functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("several pro-apoptotic Bcl-2 proteins" . SPARSER::PROTEIN)
    ("p53 or dominant negative p73" . SPARSER::COLLECTION)
    ("siRNA or shNoxa" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and dominant negative p73" . SPARSER::COLLECTION)
    ("p53 or expressing mutant p53" . SPARSER::COLLECTION)
    ("dominant negative p73 or wild-type p53" . SPARSER::COLLECTION)
    ("anti-PARP and anti-caspase-3" . SPARSER::COLLECTION)
    ("dUTP" . SPARSER::MOLECULE) ("fluorescein" . SPARSER::MOLECULE)
    ("mutant p53 or no p53" . SPARSER::COLLECTION)
    ("reconstituted p53 or expressing dominant negative p73 (Materials and Methods)"
     . SPARSER::COLLECTION)
    ("Bim and Noxa" . SPARSER::COLLECTION)
    ("the longer isoforms" . SPARSER::ISOFORM)
    ("the shorter isoforms" . SPARSER::ISOFORM)
    ("All three Bim isoforms namely Bim EL" . SPARSER::PROTEIN)
    ("EL" . SPARSER::PROTEIN) ("Bax/Bak" . SPARSER::COLLECTION)
    ("Bim, Bad, Puma and Noxa" . SPARSER::COLLECTION)
    ("Bcl2-associated X protein (Bax) and Bcl2 antagonist/killer (Bak)"
     . SPARSER::COLLECTION)
    ("Bcl2-associated X protein" . SPARSER::PROTEIN)
    ("effector proteins and the BH3-only proteins" . SPARSER::COLLECTION)
    ("Bcl2, Bcl-xL, Bcl-w and Mcl-1" . SPARSER::COLLECTION)
    ("Caspases" . SPARSER::PROTEIN) ("TA and δN" . SPARSER::COLLECTION)
    ("the predominant isoforms" . SPARSER::ISOFORM)
    ("p73 mRNA and/or protein" . SPARSER::COLLECTION)
    ("proteins, p63 and p73" . SPARSER::COLLECTION)
    ("chemopreventive drugs" . SPARSER::DRUG)
    ("p53 and TAp73" . SPARSER::COLLECTION)
    ("Noxa and Bim" . SPARSER::COLLECTION) ("M/L" . SPARSER::PROTEIN)
    ("c-abl" . SPARSER::PROTEIN)
    ("macrophage inhibitory cytokine 1" . SPARSER::PROTEIN)
    ("Concanavalin A" . SPARSER::DRUG) ("COX4" . SPARSER::PROTEIN)
    ("uridine triphosphate" . SPARSER::MOLECULE)
    ("cetuximab, cisplatin and gefitinib" . SPARSER::COLLECTION)
    ("two monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Further investigation using dasatinib" . SPARSER::DRUG)
    ("importinβ1" . SPARSER::PROTEIN)
    ("cisplatin and gefitinib" . SPARSER::COLLECTION)
    ("HER" . SPARSER::PROTEIN)
    ("wild-type EGFR (WT) or the following EGFR mutants" . SPARSER::COLLECTION)
    ("EGFR (WT)" . SPARSER::PROTEIN)
    ("Nuclear EGFR and various transcription factor" . SPARSER::COLLECTION)
    ("cyclin D1, iNOS, B-Myb, Aurora Kinase A, COX2, c-Myc, BCRP and GRP78"
     . SPARSER::COLLECTION)
    ("siRNA (NT)" . SPARSER::PROTEIN)
    ("Lyn (~ 3-fold) and Yes (~1.5 fold)" . SPARSER::COLLECTION)
    ("kinases and ~3-fold" . SPARSER::COLLECTION)
    ("EGFR and dasatinib" . SPARSER::COLLECTION) ("HP" . SPARSER::PROTEIN)
    ("Sprycel" . SPARSER::DRUG) ("Src and EGFR" . SPARSER::COLLECTION)
    ("Fgr, Blk and Yrk" . SPARSER::COLLECTION) ("Yrk" . SPARSER::PROTEIN)
    ("cisplatin and radiation therapy ( xref – xref )" . SPARSER::COLLECTION)
    ("proliferating cell nuclear antigen (PCNA)" . SPARSER::PROTEIN)
    ("Breast Cancer Related Protein (BCRP) and GRP78 ( xref – xref )"
     . SPARSER::COLLECTION)
    ("cyclin D1, inducible nitric oxide synthase (iNOS), Aurora Kinase A, B-Myb, COX2, c-Myc, Breast Cancer Related Protein (BCRP) and GRP78 ( xref – xref )"
     . SPARSER::COLLECTION)
    ("Protein (BCRP)" . SPARSER::PROTEIN) ("BCRP" . SPARSER::PROTEIN)
    ("EGFR-importinβ1" . SPARSER::PROTEIN-PAIR)
    ("COPI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-Akt" . SPARSER::COLLECTION)
    ("src" . SPARSER::PROTEIN) ("each dimer’s" . SPARSER::DIMER)
    ("B-Myb and iNOS" . SPARSER::COLLECTION) ("iNOS" . SPARSER::PROTEIN)
    ("kinases (SFK)" . SPARSER::PROTEIN) ("Ctx" . SPARSER::PROTEIN)
    ("Cetuximab" . SPARSER::DRUG) ("YES1" . SPARSER::PROTEIN)
    ("HC8" . SPARSER::PROTEIN) ("GRP78" . SPARSER::PROTEIN)
    ("Aurora Kinase A" . SPARSER::PROTEIN) ("Sec61" . SPARSER::PROTEIN)
    ("nucleoporin 62" . SPARSER::PROTEIN) ("B-Myb" . SPARSER::PROTEIN)
    ("Pak1/2" . SPARSER::PROTEIN)
    ("specifically knockdown either Rac1 or Rac1b" . SPARSER::COLLECTION)
    ("Rac1 or Rac1b" . SPARSER::COLLECTION)
    ("RhoGDI and the p21-activated kinases (PAKs)" . SPARSER::COLLECTION)
    ("-kinase and p38" . SPARSER::COLLECTION)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR) ("inLSL-K-ras" . SPARSER::COLLECTION)
    ("a conditionally-activated oncogenic allele" . SPARSER::ALLELE)
    ("PAK1/2" . SPARSER::PROTEIN) ("Pak1 or Pak2" . SPARSER::COLLECTION)
    ("p-PAK1/2" . SPARSER::COLLECTION) ("Rac1b and Rac1" . SPARSER::COLLECTION)
    ("SI" . SPARSER::PROTEIN)
    ("specifically knockdown Rac1b" . SPARSER::PROTEIN)
    ("LKR" . SPARSER::PROTEIN) ("toLSL-K-ras" . SPARSER::COLLECTION)
    ("caspase 3 or ki-67" . SPARSER::COLLECTION)
    ("andLSL-K-ras" . SPARSER::COLLECTION)
    ("both the K-ras  G12D and Rac1b alleles" . SPARSER::COLLECTION)
    ("a conditional activated allele" . SPARSER::ALLELE)
    ("generateLSL-K-ras" . SPARSER::COLLECTION)
    ("ofK-ras" . SPARSER::COLLECTION) ("theLSL-K-ras" . SPARSER::COLLECTION)
    ("Cre-recombinase" . SPARSER::COLLECTION)
    ("exogenous Rac1b" . SPARSER::PROTEIN) ("Rac1-" . SPARSER::PROTEIN)
    ("Oxygen" . SPARSER::MOLECULE)
    ("the p21-activated kinases (PAKs) or Jun N-terminal Kinase (JNK) ( xref )"
     . SPARSER::COLLECTION)
    ("Kinase (JNK)" . SPARSER::KINASE) ("IkB" . SPARSER::PROTEIN)
    ("RhoGDI" . SPARSER::PROTEIN) ("Rho-GAPs" . SPARSER::COLLECTION)
    ("Rho-GEFs" . SPARSER::COLLECTION) ("Guanine" . SPARSER::PROTEIN)
    ("Rac1 and Rac1b" . SPARSER::COLLECTION)
    ("p120 catenin" . SPARSER::PROTEIN)
    ("GTPase activating protein" . SPARSER::PROTEIN)
    ("Exchange Factors" . SPARSER::EXCHANGE-FACTOR)
    ("Rac1b" . SPARSER::PROTEIN)
    ("epigenetically-silenced BRCA1" . SPARSER::PROTEIN)
    ("platinum-" . SPARSER::MOLECULE) ("EMSY" . SPARSER::PROTEIN)
    ("BRCA and BRCA2" . SPARSER::COLLECTION) ("BRCA1-" . SPARSER::PROTEIN)
    ("BRCA2-" . SPARSER::PROTEIN)
    ("DNA-damage caused by the cross-linking effects of platinum"
     . SPARSER::DNA)
    ("insC" . SPARSER::PROTEIN) ("PARP-1" . SPARSER::PROTEIN)
    ("enhancer and MYC" . SPARSER::COLLECTION)
    ("megakaryocytic leukemia" . SPARSER::PROTEIN)
    ("functional Gfi1" . SPARSER::PROTEIN)
    ("erythroid and megakaryocytic lineages ( xref )" . SPARSER::COLLECTION)
    ("Gfi1b" . SPARSER::PROTEIN)
    ("a somewhat weaker enhancer" . SPARSER::PROTEIN)
    ("Lysine" . SPARSER::AMINO-ACID)
    ("the lymphoblast cell line GM19240" . SPARSER::PROTEIN)
    ("GFI1 and GFI1B" . SPARSER::COLLECTION) ("GM" . SPARSER::PROTEIN)
    ("CCL" . SPARSER::DRUG) ("proteins, GFI1 and GFI1b" . SPARSER::COLLECTION)
    ("CAGA" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bp" . SPARSER::PROTEIN)
    ("SMAD7 and EIF3H/UTP23" . SPARSER::COLLECTION) ("UTP" . SPARSER::MOLECULE)
    ("BMP2 (rs4813802) and BMP4 (rs1957636)" . SPARSER::COLLECTION)
    ("147,000 new CRC" . SPARSER::PROTEIN)
    ("GFI1 and GFI1b" . SPARSER::COLLECTION) ("GFI1b" . SPARSER::PROTEIN)
    ("A 2-bp" . SPARSER::PROTEIN-PAIR) ("GA" . SPARSER::DRUG)
    ("Math1" . SPARSER::PROTEIN) ("Gfi1" . SPARSER::PROTEIN)
    ("broad complex" . SPARSER::PROTEIN) ("K4" . SPARSER::PROTEIN)
    ("GFI1B" . SPARSER::PROTEIN) ("EIF3H" . SPARSER::PROTEIN)
    ("SMAD7" . SPARSER::PROTEIN) ("GREM1" . SPARSER::PROTEIN)
    ("BMP2" . SPARSER::PROTEIN) ("GFI1" . SPARSER::PROTEIN)
    ("NOS" . SPARSER::PROTEIN)
    ("our previously reported WWTR1-CAMTA1 variants" . SPARSER::VARIANT)
    ("IgH" . SPARSER::PROTEIN) ("An illustrative example" . SPARSER::EXAMPLE)
    ("the last 262 bp CAMTA1 exon" . SPARSER::PROTEIN)
    ("HPFs" . SPARSER::PROTEIN) ("WWTR1 and CAMTA1" . SPARSER::COLLECTION)
    ("WWTR1-CAMTA1" . SPARSER::COLLECTION) ("A’" . SPARSER::PROTEIN)
    ("p36" . SPARSER::PROTEIN) ("CAMTA1" . SPARSER::PROTEIN)
    ("WWTR1" . SPARSER::PROTEIN) ("the two predominant genes" . SPARSER::GENE)
    ("the predominant types" . TYPE) ("ERBB2/HER2" . SPARSER::COLLECTION)
    ("independent larger cohorts" . SPARSER::MOLECULE)
    ("massively parallel DNA" . SPARSER::DNA) ("Ding" . SPARSER::PROTEIN)
    ("HBEGF" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor ( EGFR )"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one gene" . SPARSER::GENE) ("a complete exon" . SPARSER::PROTEIN)
    ("the recently described tumor-suppressor gene HTRA1 [ xref ] and three other genes ( GFRA1, HSPA12A, RGS10 )"
     . SPARSER::COLLECTION)
    ("/CR1" . SPARSER::COLLECTION) ("Differentially" . SPARSER::PROTEIN)
    ("q-arm" . SPARSER::COLLECTION) ("p-arm" . SPARSER::COLLECTION)
    ("especially phosphatase and tensin homologue ( PTEN )" . SPARSER::PROTEIN)
    ("homologue ( PTEN )" . SPARSER::PROTEIN)
    ("PTEN and EGFR" . SPARSER::COLLECTION) ("qter" . SPARSER::DRUG)
    ("the possible target gene" . SPARSER::GENE)
    ("brain-specific" . SPARSER::PROTEIN) ("RGS10" . SPARSER::PROTEIN)
    ("GFRA1" . SPARSER::PROTEIN) ("HTRA1" . SPARSER::PROTEIN)
    ("CR2" . SPARSER::PROTEIN) ("CR1" . SPARSER::PROTEIN)
    ("30 K" . SPARSER::PROTEIN) ("p11" . SPARSER::PROTEIN)
    ("Wnt/β-Catenin" . SPARSER::COLLECTION)
    ("Jag1 and DLL1" . SPARSER::COLLECTION)
    ("Jag1 and Affadin" . SPARSER::COLLECTION)
    ("Jag1 and the other Notch ligands" . SPARSER::COLLECTION)
    ("KI67 and Topoisomerasse" . SPARSER::COLLECTION)
    ("Ki67 and Top2a" . SPARSER::COLLECTION) ("Top2a" . SPARSER::PROTEIN)
    ("late stage ACC" . SPARSER::PROTEIN)
    ("Ctnnb1 (β-catenin) and Sf1 (steroidogenic factor 1)"
     . SPARSER::COLLECTION)
    ("Sf1" . SPARSER::PROTEIN)
    ("the canonical Notch target gene Hes1 and the putative target Cdkn1a"
     . SPARSER::COLLECTION)
    ("NICD and CSL" . SPARSER::COLLECTION) ("Maml1" . SPARSER::PROTEIN)
    ("the basally-repressive CSL" . SPARSER::PROTEIN)
    ("NICD, and transcriptional coactivator" . SPARSER::COLLECTION)
    ("etc" . SPARSER::PROTEIN)
    ("Jag1 and the related Notch ligands DLL1 and DLL3" . SPARSER::COLLECTION)
    ("DLL1 and DLL3" . SPARSER::COLLECTION) ("Clv-Csp-3" . SPARSER::COLLECTION)
    ("Csp" . SPARSER::PROTEIN) ("ligand and receptor" . SPARSER::COLLECTION)
    ("Notch1 and Notch2" . SPARSER::COLLECTION)
    ("the biologically relevant Notch ligand" . SPARSER::MOLECULE)
    ("Jag2 and Dll1/3/4 ligands" . SPARSER::COLLECTION)
    ("Jag2" . SPARSER::PROTEIN) ("ACA and NL" . SPARSER::COLLECTION)
    ("JAG1 and JAG2" . SPARSER::COLLECTION)
    ("NL and ACA" . SPARSER::COLLECTION) ("NL" . SPARSER::DRUG)
    ("JAG" . SPARSER::PROTEIN) ("and 10 normal adrenals (NL)" . SPARSER::DRUG)
    ("adrenals" . SPARSER::DRUG) ("Notch-dependent genes" . SPARSER::GENE)
    ("the essential transcriptional coactivator MAML" . SPARSER::PROTEIN)
    ("/Lag-1" . SPARSER::COLLECTION) ("Mastermind" . SPARSER::PROTEIN-FAMILY)
    ("MAML" . SPARSER::PROTEIN) ("ntra" . SPARSER::PROTEIN)
    ("ACA" . SPARSER::PROTEIN) ("Caspase-6" . SPARSER::PROTEIN)
    ("steroidogenic factor 1" . SPARSER::PROTEIN)
    ("Proliferating Cell Nuclear Antigen" . SPARSER::PROTEIN)
    ("Mg2+" . SPARSER::MOLECULE) ("Hes1" . SPARSER::PROTEIN)
    ("Dll1" . SPARSER::PROTEIN) ("Notch2" . SPARSER::PROTEIN)
    ("KI67" . SPARSER::PROTEIN) ("DLL4" . SPARSER::PROTEIN)
    ("DLL3" . SPARSER::PROTEIN) ("Lag-1" . SPARSER::PROTEIN)
    ("RBPjκ" . SPARSER::PROTEIN) ("CBF-1" . SPARSER::PROTEIN)
    ("DLL1" . SPARSER::PROTEIN) ("Jag1" . SPARSER::PROTEIN)
    ("JAG1" . SPARSER::PROTEIN) ("EGFR/Src/STAT5" . SPARSER::COLLECTION)
    ("c-Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("the kinase or the phosphatase" . SPARSER::COLLECTION)
    ("CSK kinase (phosphorylates) or SHP-1 phosphorylase (dephosphorylates)"
     . SPARSER::COLLECTION)
    ("phosphorylase" . SPARSER::PROTEIN)
    ("effectively folds Src" . SPARSER::PROTEIN)
    ("mutated GAS1 (GAS1mut) and GAS2mut" . SPARSER::COLLECTION)
    ("Two dominant-negative mutants" . SPARSER::MUTANT)
    ("STAT5a" . SPARSER::PROTEIN)
    ("the dominant-negative mutant" . SPARSER::MUTANT)
    ("Src or pCMV5/SrcY527F" . SPARSER::COLLECTION)
    ("AG1478 and LY294002" . SPARSER::COLLECTION)
    ("the EGFR inhibitor AG1478 or the PI3K inhibitor LY294002"
     . SPARSER::COLLECTION)
    ("PP2 and dasatinib" . SPARSER::COLLECTION)
    ("both dominant-negative mutants" . SPARSER::MUTANT)
    ("two naturally occurring dominant-negative mutants" . SPARSER::MUTANT)
    ("pTATA-TK-luciferase" . SPARSER::COLLECTION)
    ("c-Src and EGFR" . SPARSER::COLLECTION)
    ("MAPK/ERK1/2" . SPARSER::COLLECTION) ("EGFR/Src" . SPARSER::COLLECTION)
    ("ERs or co-regulators" . SPARSER::COLLECTION)
    ("receptors, ER-α and ER-β" . SPARSER::COLLECTION)
    ("EGFR/STAT5" . SPARSER::COLLECTION)
    ("Src/EGFR/STAT5" . SPARSER::COLLECTION)
    ("receptors (ER)" . SPARSER::RECEPTOR) ("SHP-1" . SPARSER::PROTEIN)
    ("ER- α" . SPARSER::PROTEIN) ("GAS2" . SPARSER::PROTEIN)
    ("γ-interferon" . SPARSER::DRUG) ("Stat5" . SPARSER::PROTEIN)
    ("GAS1" . SPARSER::PROTEIN) ("ER-β" . SPARSER::PROTEIN)
    ("ER-α" . SPARSER::PROTEIN)
    ("paclitaxel and carboplatin" . SPARSER::COLLECTION)
    ("anastrozole" . SPARSER::DRUG) ("BRCA1or BRCA2" . SPARSER::COLLECTION)
    ("PPC" . SPARSER::PROTEIN) ("CA-125" . SPARSER::PROTEIN)
    ("SYNE2 , RORA, BCAS1 and PLXN4" . SPARSER::COLLECTION)
    ("HHIP and DLEU7" . SPARSER::COLLECTION)
    ("HHIP , GPR126 and PTCH" . SPARSER::COLLECTION)
    ("PTCH" . SPARSER::PROTEIN) ("at least some gene" . SPARSER::GENE)
    ("VC" . SPARSER::MOLECULE)
    ("SYNE2 , RORA , BCAS1, or PLXNA4" . SPARSER::COLLECTION)
    ("RORA" . SPARSER::PROTEIN) ("GSTCD" . SPARSER::PROTEIN)
    ("variants and loci" . SPARSER::COLLECTION)
    ("MPP7 and SYNE2" . SPARSER::COLLECTION)
    ("TXN , MUSK and SVEP1" . SPARSER::COLLECTION) ("TXN" . SPARSER::PROTEIN)
    ("three population-based cohorts (FHS, ARIC, B58C) and one family-based asthma study (the Dutch Asthma Study)"
     . SPARSER::COLLECTION)
    ("HHIP and FAM13A" . SPARSER::COLLECTION) ("HHIP" . SPARSER::PROTEIN)
    ("COPD" . SPARSER::PROTEIN) ("FHS" . SPARSER::PROTEIN)
    ("FEV" . SPARSER::PROTEIN) ("PLXN4" . SPARSER::PROTEIN)
    ("GPR126" . SPARSER::PROTEIN) ("SLC45A3" . SPARSER::PROTEIN)
    ("PLXNA4" . SPARSER::PROTEIN) ("BCAS1" . SPARSER::PROTEIN)
    ("KIRREL3" . SPARSER::PROTEIN) ("ZIC1" . SPARSER::PROTEIN)
    ("MMP15" . SPARSER::PROTEIN) ("THSD4" . SPARSER::PROTEIN)
    ("SYNE2" . SPARSER::PROTEIN) ("MPP7" . SPARSER::PROTEIN)
    ("(Beta" . SPARSER::PROTEIN) ("TUSC3" . SPARSER::PROTEIN)
    ("beta1-tubulin" . SPARSER::COLLECTION)
    ("normal
mature platelets"
     . SPARSER::PROTEIN)
    ("Tropomyosin" . SPARSER::PROTEIN)
    ("alkaline phosphatase and
lipoprotein"
     . SPARSER::COLLECTION)
    ("epinephrine" . SPARSER::DRUG)
    ("another pro-apoptotic gene" . SPARSER::GENE)
    ("the pro-apoptotic BAK1 gene" . SPARSER::GENE)
    ("CD36 and thrombospondin" . SPARSER::COLLECTION)
    ("the latter part" . SPARSER::COMPONENT)
    ("the Hispanic cohort" . SPARSER::MOLECULE)
    ("BAD and PLCB3" . SPARSER::COLLECTION)
    ("SLC22A11 and SLC22A12" . SPARSER::COLLECTION)
    ("BCL-xL and
BCL-2"
     . SPARSER::COLLECTION)
    ("the Hispanic cohorts" . SPARSER::MOLECULE)
    ("−3 and
p "
     . SPARSER::COLLECTION)
    ("thrombospondin" . SPARSER::PROTEIN) ("ferritin" . SPARSER::PROTEIN)
    ("hemoglobin" . SPARSER::MOLECULE) ("HFE" . SPARSER::PROTEIN)
    ("hemochromatosis" . SPARSER::PROTEIN) ("CARMIL" . SPARSER::PROTEIN)
    ("thrombopoietin" . SPARSER::PROTEIN)
    ("the GeneSTAR cohort" . SPARSER::MOLECULE) ("MPV" . SPARSER::MOLECULE)
    ("TAOK1" . SPARSER::PROTEIN) ("PIK3CG" . SPARSER::PROTEIN)
    ("ACAD10" . SPARSER::PROTEIN) ("TPM4" . SPARSER::PROTEIN)
    ("tropomyosin 4" . SPARSER::PROTEIN) ("BAK1" . SPARSER::PROTEIN)
    ("TUBB1" . SPARSER::PROTEIN) ("SLC22A12" . SPARSER::PROTEIN)
    ("SLC22A11" . SPARSER::PROTEIN) ("PLCB3" . SPARSER::PROTEIN)
    ("BCL2-associated agonist of cell death" . SPARSER::PROTEIN)
    ("jumonji domain containing 1C" . SPARSER::PROTEIN)
    ("uric acid" . SPARSER::MOLECULE) ("ARP2" . SPARSER::PROTEIN)
    ("capping protein" . SPARSER::PROTEIN) ("JMJD1C" . SPARSER::PROTEIN)
    ("CD36" . SPARSER::PROTEIN) ("LRRC16A" . SPARSER::PROTEIN)
    ("uracil" . SPARSER::DRUG)
    ("p53 and its upstream activators" . SPARSER::COLLECTION)
    ("Chk2 and ATM" . SPARSER::COLLECTION)
    ("adjuvant and not primary chemotherapy" . SPARSER::COLLECTION)
    ("weak p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TP53/CHEK2" . SPARSER::COLLECTION) ("Luminal" . SPARSER::DRUG)
    ("either TP53 (L2/L3) or CHEK2" . SPARSER::COLLECTION)
    ("CHEK2/TP53" . SPARSER::COLLECTION)
    ("doxorubicin or 5-fluorouracil/mitomycin" . SPARSER::COLLECTION)
    ("doxorubicin and mitomycin" . SPARSER::COLLECTION)
    ("TP53 and CHK2" . SPARSER::COLLECTION)
    ("ATM-Chk2-p53" . SPARSER::COLLECTION)
    ("TP53 or CHEK2" . SPARSER::COLLECTION)
    ("ATM-chk2-p53" . SPARSER::COLLECTION)
    ("TP53 and CHEK2" . SPARSER::COLLECTION)
    ("CHEK2 and TP53" . SPARSER::COLLECTION)
    ("a separate patient cohort" . SPARSER::MOLECULE)
    ("p53 and Chk2" . SPARSER::COLLECTION)
    ("p53 or its upstream activator Chk2" . SPARSER::COLLECTION)
    ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("topoisomerase-II" . SPARSER::PROTEIN) ("C-myc" . SPARSER::PROTEIN)
    ("N-myc" . SPARSER::PROTEIN) ("P190" . SPARSER::PROTEIN)
    ("rpP2" . SPARSER::PROTEIN) ("ddH2" . SPARSER::PROTEIN)
    ("CHK2" . SPARSER::PROTEIN) ("5FU" . SPARSER::DRUG)
    ("Topoisomerase-II" . SPARSER::PROTEIN) ("chk2" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("IRF6 [ xref ; xref ] and 8p24 [ xref ; xref ; xref ]"
     . SPARSER::COLLECTION)
    ("congenital malformations" . SPARSER::PROTEIN)
    ("Olfactory receptors" . SPARSER::PROTEIN)
    ("the largest multigene families" . SPARSER::PROTEIN-FAMILY)
    ("Bmp6" . SPARSER::PROTEIN) ("Bmp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMPs" . SPARSER::PROTEIN) ("HIC1 , and ZNF189" . SPARSER::COLLECTION)
    ("FLNB" . SPARSER::PROTEIN)
    ("425 Norwegian triad families" . SPARSER::PROTEIN-FAMILY)
    ("PAX3 and three SNPs" . SPARSER::COLLECTION)
    ("PAX3 , PAX6 , PAX7 and PAX9" . SPARSER::COLLECTION)
    ("lip (CL)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("maternal genes" . SPARSER::GENE) ("IRF6" . SPARSER::PROTEIN)
    ("olfactory receptor" . SPARSER::PROTEIN) ("p23" . SPARSER::PROTEIN)
    ("ZNF189" . SPARSER::PROTEIN) ("TCOF1" . SPARSER::PROTEIN)
    ("PAX9" . SPARSER::PROTEIN) ("PAX7" . SPARSER::PROTEIN)
    ("TGFB3" . SPARSER::PROTEIN) ("BMP6" . SPARSER::PROTEIN)
    ("p53-p73" . SPARSER::COLLECTION)
    ("proteins and p73" . SPARSER::COLLECTION)
    ("the high structural and functional homology" . SPARSER::PROTEIN)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p 73-" . SPARSER::PROTEIN) ("Itch" . SPARSER::PROTEIN)
    ("Ubiquitin and Protein" . SPARSER::COLLECTION) ("Wwox" . SPARSER::PROTEIN)
    ("only TAp73 isoforms" . SPARSER::ISOFORM) ("sumo" . SPARSER::PROTEIN)
    ("CDK2/CDK1" . SPARSER::COLLECTION) ("isomerase" . SPARSER::ISOMERASE)
    ("JNK/p38" . SPARSER::COLLECTION) ("CBP or PCAF" . SPARSER::COLLECTION)
    ("p300 and CBP" . SPARSER::COLLECTION)
    ("kinases and histone" . SPARSER::COLLECTION)
    ("the adenovirus E1B 55-kDa protein and polyomavirus SV40 T antigen"
     . SPARSER::COLLECTION)
    ("an inactive complex" . SPARSER::BIO-COMPLEX)
    ("promyelocytic leukemia protein (PML)" . SPARSER::PROTEIN)
    ("Mdm2 and Bax" . SPARSER::COLLECTION) ("p300/CBP" . SPARSER::COLLECTION)
    ("p300 and CREB-binding protein (CBP)" . SPARSER::COLLECTION)
    ("p300 and CREB-binding protein" . SPARSER::COLLECTION)
    ("p73-Mdm2" . SPARSER::COLLECTION)
    ("only mutant p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, p63 and p73" . SPARSER::COLLECTION)
    ("Protein–Protein" . SPARSER::COLLECTION)
    ("the remarkable homology" . SPARSER::PROTEIN)
    ("at least 24 different isoforms" . SPARSER::ISOFORM)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION)
    ("antizyme 1" . SPARSER::PROTEIN) ("c-jun" . SPARSER::PROTEIN)
    ("IBRDC2" . SPARSER::PROTEIN) ("p 73" . SPARSER::PROTEIN)
    ("PIR2" . SPARSER::PROTEIN) ("N4BP1" . SPARSER::PROTEIN)
    ("Nedd4" . SPARSER::PROTEIN)
    ("WW domain containing oxidoreductase" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("PIAS-1" . SPARSER::PROTEIN)
    ("STAT-1" . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("homeodomain-interacting protein kinase 2" . SPARSER::PROTEIN)
    ("PKC δ" . SPARSER::PROTEIN) ("Pin1" . SPARSER::PROTEIN)
    ("B 55" . SPARSER::PROTEIN)
    ("promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("CIP1" . SPARSER::PROTEIN)
    ("polypyrimidine tract-binding protein" . SPARSER::PROTEIN)
    ("lipids and proteoglycans" . SPARSER::COLLECTION)
    ("genuine SMCs" . SPARSER::PROTEIN) ("myo-" . SPARSER::PROTEIN)
    ("myo" . SPARSER::PROTEIN)
    ("RANTES, MCP-1, and SDF-1α" . SPARSER::COLLECTION)
    ("significantly more active" . SPARSER::ACTIVE)
    ("leukocytes, erythrocytes, or platelets" . SPARSER::COLLECTION)
    ("neointimal SMC" . SPARSER::PROTEIN) ("NI/media" . SPARSER::COLLECTION)
    ("the internal and external elastic laminae" . SPARSER::PROTEIN)
    ("laminae" . SPARSER::PROTEIN)
    ("WP1066 (200 μg/ml) or vehicle control" . SPARSER::COLLECTION)
    ("apoptotic (TUNEL+) SMCs" . SPARSER::PROTEIN)
    ("human coronary SMCs" . SPARSER::PROTEIN)
    ("Survivin and cyclin D1" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("STAT3/p-STAT3" . SPARSER::COLLECTION)
    ("vascular SMCs" . SPARSER::PROTEIN)
    ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-BB, angiotensin II, or interleukin (IL)" . SPARSER::COLLECTION)
    ("-BB, angiotensin II, or interleukin" . SPARSER::COLLECTION)
    ("-BB" . SPARSER::MOLECULE) ("neointimal SMCs" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein (MCP)-1" . SPARSER::PROTEIN)
    ("MCP" . SPARSER::PROTEIN)
    ("various chemotactic cytokines" . SPARSER::PROTEIN)
    ("medial SMCs" . SPARSER::PROTEIN)
    ("SMC and neointima" . SPARSER::COLLECTION) ("SMC" . SPARSER::PROTEIN)
    ("cyclin D1 and survivin" . SPARSER::COLLECTION)
    ("wire" . SPARSER::PROTEIN) ("SMCs" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("angiotensin II" . SPARSER::PROTEIN) ("derived factor" . SPARSER::PROTEIN)
    ("WP1066" . SPARSER::DRUG)
    ("signal transducer and activator of transcription-3" . SPARSER::PROTEIN)
    ("ANA or HU" . SPARSER::COLLECTION) ("ANA and HU" . SPARSER::COLLECTION)
    ("HU or ANA" . SPARSER::COLLECTION)
    ("Bcl-2 and the tumor suppressor p53 protein [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("ribonucleoside" . SPARSER::MOLECULE) ("antimetabolite" . SPARSER::DRUG)
    ("HU and ANA" . SPARSER::COLLECTION)
    ("cytoreductive drugs" . SPARSER::DRUG)
    ("pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("the pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins"
     . SPARSER::PROTEIN)
    ("Bax and anti-apoptotic" . SPARSER::COLLECTION)
    ("The actual fraction" . SPARSER::COMPONENT)
    ("Bax and Bcl-2" . SPARSER::COLLECTION) ("PLT" . SPARSER::PROTEIN)
    ("ANA ( p  = 0.02) and HU ( p  = 0.03)" . SPARSER::COLLECTION)
    ("particular cytoreductive drugs" . SPARSER::DRUG)
    ("Fas, FAIM or c -FLIP" . SPARSER::COLLECTION) ("FAIM" . SPARSER::PROTEIN)
    ("chronic myelogenous leukemia" . SPARSER::PROTEIN)
    ("The classical example" . SPARSER::EXAMPLE) ("HU" . SPARSER::DRUG)
    ("ANA" . SPARSER::PROTEIN) ("Bax/Bcl-2" . SPARSER::COLLECTION)
    ("platelets" . SPARSER::PROTEIN) ("Cas - 3" . SPARSER::PROTEIN)
    ("c - FLIP" . SPARSER::PROTEIN) ("Janus Kinase 2" . SPARSER::PROTEIN)
    ("CD61" . SPARSER::PROTEIN) ("CD42b" . SPARSER::PROTEIN)
    ("1–4 " . SPARSER::PROTEIN) ("c -FLIP" . SPARSER::PROTEIN)
    ("Cas-3" . SPARSER::PROTEIN) ("annexin-V" . SPARSER::PROTEIN)
    ("IL-17/IL-23" . SPARSER::COLLECTION)
    ("IL-23, IL-6, IL-1β, and TNF-α" . SPARSER::COLLECTION)
    ("TNF-α, IL-1β, and IL-6" . SPARSER::COLLECTION)
    ("TGF-β, IL-6, and IL-23" . SPARSER::COLLECTION)
    ("IL-17 and IL-6" . SPARSER::COLLECTION)
    ("its associated cytokines" . SPARSER::PROTEIN)
    ("IL-6 and IL-23" . SPARSER::COLLECTION)
    ("TLRs and IL-17/Th17 cells" . SPARSER::COLLECTION)
    ("a highly inflammatory cytokine" . SPARSER::PROTEIN)
    ("STAT3, phospho-STAT3, and phosphor-IκB" . SPARSER::COLLECTION)
    ("STAT3, phospho-STAT3, phosphor-IκB, IL-6, TNF-α, and IL-1β"
     . SPARSER::COLLECTION)
    ("IL-6, TNF-α, and IL-1β" . SPARSER::COLLECTION)
    ("IL-23, TNF-α, and IL-1β" . SPARSER::COLLECTION)
    ("IL-23, IL-6, TNF-α, and IL-1β" . SPARSER::COLLECTION)
    ("IL-6, STAT3, and NF-κB" . SPARSER::COLLECTION)
    ("TLR4 and TLR6" . SPARSER::COLLECTION)
    ("TLR4 or TLR6" . SPARSER::COLLECTION)
    ("IL-23 and IL-17" . SPARSER::COLLECTION)
    ("TLRs and the Th17-associated cytokines" . SPARSER::COLLECTION)
    ("various TLRs (TLR2, TLR4, and TLR6) and Th17-associated cytokines"
     . SPARSER::COLLECTION)
    ("the Th17-associated cytokines" . SPARSER::PROTEIN)
    ("TLR2, TLR4, and TLR6" . SPARSER::COLLECTION)
    ("TLR2, TLR4, TLR6, IL-17, and IL-23" . SPARSER::COLLECTION)
    ("various TLRs and Th17-associated cytokines" . SPARSER::COLLECTION)
    ("both TLRs and Th17-associated cytokines" . SPARSER::COLLECTION)
    ("Th17-associated cytokines" . SPARSER::PROTEIN)
    ("TLRs and IL-17" . SPARSER::COLLECTION)
    ("IL-17, IL-23, and IL-6" . SPARSER::COLLECTION)
    ("IL-23, and IL-1β" . SPARSER::COLLECTION)
    ("a proinflammatory cytokine" . SPARSER::PROTEIN)
    ("SS, or pSS" . SPARSER::COLLECTION) ("TLR/IL-17" . SPARSER::COLLECTION)
    ("IL-6, STAT3 and NF-kB" . SPARSER::COLLECTION)
    ("IL-23/IL-17" . SPARSER::COLLECTION)
    ("TLR2, TLR4 and TLR6" . SPARSER::COLLECTION)
    ("TLR2, TLR4, TLR6, IL-17 and the cytokines" . SPARSER::COLLECTION)
    ("IL-17 and IL-23" . SPARSER::COLLECTION)
    ("IL-17 and the cytokines" . SPARSER::COLLECTION)
    ("tumor necrosis factor-alpha (TNF-α) and IL-1β" . SPARSER::COLLECTION)
    ("toll-like receptor (TLR) and interleukin (IL)" . SPARSER::COLLECTION)
    ("receptor (TLR)" . SPARSER::RECEPTOR)
    ("TLR and IL-17" . SPARSER::COLLECTION) ("M-LC" . SPARSER::PROTEIN)
    ("antinuclear antibody" . SPARSER::PROTEIN) ("AG490" . SPARSER::DRUG)
    ("CA-3" . SPARSER::PROTEIN) ("IL-23 p19" . SPARSER::PROTEIN)
    ("A '" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("interleukin-17" . SPARSER::PROTEIN) ("TLR6" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("β-catenin-cadherin" . SPARSER::COLLECTION)
    ("β-catenin and cadherin" . SPARSER::COLLECTION)
    ("Wnt1 and Dkk-1" . SPARSER::COLLECTION)
    ("β-catenin/cadherin" . SPARSER::COLLECTION)
    ("Sevoflurane" . SPARSER::DRUG)
    ("PI3 kinase and PKC" . SPARSER::COLLECTION) ("predate" . SPARSER::DRUG)
    ("amyloid" . SPARSER::PROTEIN)
    ("amyloid precursor protein (APP)" . SPARSER::PROTEIN)
    ("Presenilins" . SPARSER::PROTEIN-FAMILY)
    ("the insoluble β-amyloid peptide" . SPARSER::PEPTIDE)
    ("pathological states" . SPARSER::BIO-STATE)
    ("Wnt/DVL/GSK-3β" . SPARSER::COLLECTION)
    ("a dominant-negative mutant" . SPARSER::MUTANT)
    ("NAc" . SPARSER::MOLECULE) ("DVL" . SPARSER::PROTEIN)
    ("SPT" . SPARSER::PROTEIN) ("NSF" . SPARSER::PROTEIN)
    ("citalopram" . SPARSER::DRUG) ("norepinephrine" . SPARSER::DRUG)
    ("serotonin, and dopamine" . SPARSER::COLLECTION)
    ("GSK-3/β-catenin" . SPARSER::COLLECTION)
    ("GSK-3β/β-catenin" . SPARSER::COLLECTION) ("amphetamine" . SPARSER::DRUG)
    ("GSK-3β and β-catenin" . SPARSER::COLLECTION)
    ("LEF/TCF" . SPARSER::COLLECTION)
    ("DISC1 and β-catenin" . SPARSER::COLLECTION)
    ("DISC1, Wnt, and β-Catenin" . SPARSER::COLLECTION)
    ("a pro-neurogenic transcription factor" . SPARSER::PROTEIN)
    ("a dominant-negative Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the hippocampal dentate gyrus" . SPARSER::PROTEIN)
    ("the substantia nigraventral tegmental area complex"
     . SPARSER::BIO-COMPLEX)
    ("Fosl1" . SPARSER::PROTEIN)
    ("tyrosine kinase or phosphatase" . SPARSER::COLLECTION)
    ("the postsynaptic protein PSD-95" . SPARSER::PROTEIN)
    ("NMDAR" . SPARSER::PROTEIN) ("AMPA" . SPARSER::MOLECULE)
    ("postsynaptic β-catenin" . SPARSER::PROTEIN) ("Wnt5a" . SPARSER::PROTEIN)
    ("post-synaptic components" . SPARSER::COMPONENT)
    ("Wnt7a and Wnt3" . SPARSER::COLLECTION)
    ("a monomeric form" . SPARSER::FORM)
    ("cadherin-catenin" . SPARSER::COLLECTION)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Dvl" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Wnt receptor" . SPARSER::PROTEIN)
    ("Frizzled 9" . SPARSER::PROTEIN) ("Wnt1" . SPARSER::PROTEIN)
    ("Dickkopf-1" . SPARSER::PROTEIN) ("PS1" . SPARSER::PROTEIN)
    ("presenilin-1" . SPARSER::PROTEIN) ("Wnt2" . SPARSER::PROTEIN)
    ("Disrupted in Schizophrenia 1" . SPARSER::PROTEIN)
    ("DISC1" . SPARSER::PROTEIN) ("Dickkopf1" . SPARSER::PROTEIN)
    ("NEUROD1" . SPARSER::PROTEIN) ("PSD-95" . SPARSER::PROTEIN)
    ("brain-derived neurotrophic factor" . SPARSER::PROTEIN)
    ("Wnt5" . SPARSER::PROTEIN) ("Wnt3" . SPARSER::PROTEIN)
    ("protein Dishevelled" . SPARSER::PROTEIN)
    ("ER α and its response genes ( xref )" . SPARSER::COLLECTION)
    ("PKA and EGFR" . SPARSER::COLLECTION)
    ("a relevant drug target" . SPARSER::TARGET-PROTEIN)
    ("Vorinostat" . SPARSER::DRUG) ("Wortmannin" . SPARSER::MOLECULE)
    ("GPER−" . SPARSER::PROTEIN)
    ("at least one receptor and 61% lost both receptors" . SPARSER::COLLECTION)
    ("at least one receptor" . SPARSER::RECEPTOR)
    ("ER α and GPER" . SPARSER::COLLECTION)
    ("GPER and ERs" . SPARSER::COLLECTION)
    ("GPER and ESR1" . SPARSER::COLLECTION)
    ("GPER and ER α" . SPARSER::COLLECTION)
    ("GPER agonists ( xref , xref ; xref ) and the risk" . SPARSER::COLLECTION)
    ("The ER modulator tamoxifen and the ER inhibitor fulvestrant"
     . SPARSER::COLLECTION)
    ("the classic oestrogen receptors" . SPARSER::RECEPTOR)
    ("ER α and ER β" . SPARSER::COLLECTION)
    ("ER α or PR" . SPARSER::COLLECTION) ("a 2–3" . SPARSER::COLLECTION)
    ("/GPER" . SPARSER::COLLECTION) ("GPER" . SPARSER::PROTEIN)
    ("G15" . SPARSER::PROTEIN) ("ER β" . SPARSER::PROTEIN)
    ("17 β -estradiol" . SPARSER::PROTEIN) ("GPR30" . SPARSER::PROTEIN)
    ("ER α" . SPARSER::PROTEIN) ("PTEN/P53" . SPARSER::COLLECTION)
    ("his" . SPARSER::AMINO-ACID)
    ("EGFR, Ki-67, P53, nm23, and cyclin D" . SPARSER::COLLECTION)
    ("PTEN, EGFR, nm23, Ki-67, p-53, and cyclin D1" . SPARSER::COLLECTION)
    ("Loco" . SPARSER::PROTEIN)
    ("EGFR, Ki-67, p-53, nm23, and cyclin D" . SPARSER::COLLECTION)
    ("IGFR" . SPARSER::PROTEIN)
    ("a dual-specific phosphatase" . SPARSER::PHOSPHATASE)
    ("nm23" . SPARSER::PROTEIN) ("CAIR" . SPARSER::PROTEIN)
    ("p-CAIR" . SPARSER::COLLECTION) ("RR " . SPARSER::MOLECULE)
    ("loco" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("the autoinhibitory conformation" . SPARSER::BIO-CONFORMATION)
    ("the longest form" . SPARSER::FORM)
    ("IRF5, and amino acid" . SPARSER::COLLECTION)
    ("IRF3, IRF5, and IRF7" . SPARSER::COLLECTION)
    ("RIP2 or directly influenced IRF5" . SPARSER::COLLECTION)
    ("Polyubiquitination" . SPARSER::PROTEIN)
    ("SS451,462DD or wt" . SPARSER::COLLECTION)
    ("diverse PRRs and kinases" . SPARSER::COLLECTION)
    ("PRRs and kinases" . SPARSER::COLLECTION)
    ("ligases, and kinases" . SPARSER::COLLECTION)
    ("far more effective activators" . SPARSER::ACTIVATOR)
    ("TLR and NOD" . SPARSER::COLLECTION)
    ("wt IRF5 or the IRF5 mutants" . SPARSER::COLLECTION)
    ("the active phosphomimetic mutant" . SPARSER::MUTANT)
    ("IRF5 or RIP2" . SPARSER::COLLECTION) ("Polyubiquitin" . SPARSER::PROTEIN)
    ("wt or mutant" . SPARSER::COLLECTION)
    ("RIP2 and TRAF6" . SPARSER::COLLECTION)
    ("RIP2 or TBK-1" . SPARSER::COLLECTION) ("SS451,462DD" . SPARSER::PROTEIN)
    ("IRF5 wt and phosphorylation site mutants" . SPARSER::COLLECTION)
    ("a static image latent IRF5" . SPARSER::PROTEIN)
    ("either wt IRF5 or the IRF5 alanine substitution SS451,462AA"
     . SPARSER::COLLECTION)
    ("dipeptide (MDP)" . SPARSER::MOLECULE) ("PGN" . SPARSER::PROTEIN)
    ("alanine or aspartic acid" . SPARSER::COLLECTION)
    ("IRF5 and either TBK-1, TRAF6, or RIP2" . SPARSER::COLLECTION)
    ("TRAF6 and RIP2" . SPARSER::COLLECTION)
    ("TRAF6 or RIP2" . SPARSER::COLLECTION)
    ("the slowest form" . SPARSER::FORM)
    ("a smaller IRF5 protein" . SPARSER::PROTEIN)
    ("diverse cytokines" . SPARSER::PROTEIN)
    ("IRF5 and NF-κB" . SPARSER::COLLECTION)
    ("TBK-1, TRAF6, or RIP2" . SPARSER::COLLECTION)
    ("latent IRF5" . SPARSER::PROTEIN)
    ("TBK-1, TRAF6, and RIP2" . SPARSER::COLLECTION)
    ("an E3 ubiquitin ligase that stimulates K63-linked ubiquitination and subsequent activation of numerous signaling molecules and protein kinases"
     . SPARSER::COLLECTION)
    ("TBK-1 or NF-κB" . SPARSER::COLLECTION)
    ("a latent transcription factor" . SPARSER::PROTEIN)
    ("MRL" . SPARSER::PROTEIN-FAMILY)
    ("the primary trigger" . SPARSER::PROTEIN) ("IL12 p40" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN) ("IL-12 p40" . SPARSER::PROTEIN)
    ("IL12p40" . SPARSER::PROTEIN) ("interleukin-12" . SPARSER::PROTEIN)
    ("FcγRIIB" . SPARSER::PROTEIN) ("RIP2" . SPARSER::PROTEIN)
    ("TBK-1" . SPARSER::PROTEIN) ("TANK-binding kinase-1" . SPARSER::PROTEIN)
    ("Interferon regulatory factor 5" . SPARSER::PROTEIN)
    ("Sp1 and NF-Y" . SPARSER::COLLECTION)
    ("NF-YB and GAPDH" . SPARSER::COLLECTION)
    ("NF-Y and the FOXO proteins" . SPARSER::COLLECTION)
    ("NF-Y and FOXO" . SPARSER::COLLECTION)
    ("NF-Y as well as FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("Sp1, NF-Y as well as FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("protein kinase B (PKB)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the respective mutant LKB1 Pro Mut V/0" . SPARSER::PROTEIN)
    ("LKB1 Pro Mut V/0" . SPARSER::PROTEIN)
    ("NF-Y and the FOXO transcription factors FOXO3 and FOXO4"
     . SPARSER::COLLECTION)
    ("Sp1, NF-Y and the FOXO transcription factors FOXO3 and FOXO4"
     . SPARSER::COLLECTION)
    ("NF-Y, FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("NF-YA, Sp1, FOXO3 and FOXO4" . SPARSER::COLLECTION)
    ("Sp1 and the FOXO proteins" . SPARSER::COLLECTION)
    ("NF-Y, Sp1 and the FOXO proteins" . SPARSER::COLLECTION)
    ("the used cell lines expressed FOXO1 or FOXO6" . SPARSER::COLLECTION)
    ("FOXO1 or FOXO6" . SPARSER::COLLECTION)
    ("FOXO4 (lane 3) or mutant FOXO4 A3 (lane 4)" . SPARSER::COLLECTION)
    ("proteins or siRNA" . SPARSER::COLLECTION)
    ("FOXO proteins and the LKB1 promoter" . SPARSER::COLLECTION)
    ("The heterotrimeric transcription factor NF-Y" . SPARSER::PROTEIN)
    ("oligos" . SPARSER::PROTEIN)
    ("generated one predominant protein-DNA complex" . SPARSER::BIO-COMPLEX)
    ("CCAAT-1" . SPARSER::COLLECTION) ("V/3" . SPARSER::PROTEIN)
    ("oligo" . SPARSER::PROTEIN)
    ("AP-1, AP-2, Oct-1, CRE, SRE and E2F" . SPARSER::COLLECTION)
    ("DSE" . SPARSER::PROTEIN)
    ("functionally link FOXO proteins" . SPARSER::PROTEIN)
    ("-GTAAACAA-3" . SPARSER::COLLECTION)
    ("NF-Y and Sp1" . SPARSER::COLLECTION)
    ("Sp1, NF-Y and FOXO" . SPARSER::COLLECTION)
    ("FOXO3 and FOXO4" . SPARSER::COLLECTION) ("NF-YC" . SPARSER::PROTEIN)
    ("DNA-polymerase" . SPARSER::PROTEIN) ("SGK-1" . SPARSER::PROTEIN)
    ("LKB1-AMPK" . SPARSER::PROTEIN) ("NF-YB" . SPARSER::PROTEIN)
    ("FOXO3 A" . SPARSER::PROTEIN) ("HNF-3" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("FOXO6" . SPARSER::PROTEIN)
    ("Oct-1" . SPARSER::PROTEIN) ("AP-2" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Liver Kinase B1" . SPARSER::PROTEIN)
    ("a complex and multifactorial disease, gene-gene and gene-environment interactions"
     . SPARSER::COLLECTION)
    ("AG or GG" . SPARSER::COLLECTION)
    ("H-Ras and Rap1A" . SPARSER::COLLECTION) ("Rap1A" . SPARSER::PROTEIN)
    ("H-Ras and/or Rap1" . SPARSER::COLLECTION)
    ("AG and GG" . SPARSER::COLLECTION) ("PROC" . SPARSER::PROTEIN)
    ("risk alleles and the risk" . SPARSER::COLLECTION)
    ("Rho-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inositol 1,4,5-trisphosphate and 4,5-diacylglycerol"
     . SPARSER::COLLECTION)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION) ("nitrated" . SPARSER::MOLECULE)
    ("rs2274223 variant G allele (adjusted OR = 1.35, 95% CI = 1.14–1.60 for AG+GG vs. AA) and rs11187870 variant C allele (adjusted OR = 1.26, 95% CI = 1.05–1.50 for CG+CC vs. GG)"
     . SPARSER::COLLECTION)
    ("Ras family" . SPARSER::PROTEIN) ("CDC25" . SPARSER::PROTEIN)
    ("PLCE1" . SPARSER::PROTEIN) ("H1.3/H1.4" . SPARSER::COLLECTION)
    ("Nup153 and Nup50" . SPARSER::COLLECTION)
    ("a primary amine" . SPARSER::MOLECULE)
    ("The significantly more abundantly represented nucleoplasmic NPC proteins"
     . SPARSER::PROTEIN)
    ("Nup153, Nup50, ELYS, and TPR" . SPARSER::COLLECTION)
    ("nucleoporins" . SPARSER::PROTEIN)
    ("Nup214 and Nup358" . SPARSER::COLLECTION) ("ACE" . SPARSER::PROTEIN)
    ("nesprin-1 and nesprin-2" . SPARSER::COLLECTION)
    ("at least three other proteins, nesprin-1, nesprin-2, and FHL1"
     . SPARSER::COLLECTION)
    ("proteins, nesprin-1, nesprin-2, and FHL1" . SPARSER::COLLECTION)
    ("LMNA and EMD" . SPARSER::COLLECTION)
    ("PARP1, MDC1, NUMA, and NONO" . SPARSER::COLLECTION)
    ("NUMA" . SPARSER::PROTEIN) ("receptor (LBR)" . SPARSER::RECEPTOR)
    ("LBR" . SPARSER::PROTEIN)
    ("a previously uncharacterized protein" . SPARSER::PROTEIN)
    ("Emerin, and MAN1" . SPARSER::COLLECTION) ("Emerin" . SPARSER::PROTEIN)
    ("both the fusion protein and neighboring proteins" . SPARSER::COLLECTION)
    ("an exogenous protein" . SPARSER::PROTEIN)
    ("a highly insoluble protein" . SPARSER::PROTEIN)
    ("partner proteins and vice versa" . SPARSER::COLLECTION)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins, or protein" . SPARSER::COLLECTION)
    ("a highly promiscuous form" . SPARSER::FORM)
    ("LaA-associated proteins" . SPARSER::PROTEIN)
    ("a valuable complement" . SPARSER::PROTEIN)
    ("only two other soluble proteins" . SPARSER::PROTEIN)
    ("BAF" . SPARSER::PROTEIN) ("digitonin" . SPARSER::MOLECULE)
    ("FLNA" . SPARSER::PROTEIN)
    ("Nup153, Nup50, and ELYS" . SPARSER::COLLECTION)
    ("ELYS" . SPARSER::PROTEIN) ("lamins and LINC" . SPARSER::COLLECTION)
    ("LINC" . SPARSER::PROTEIN) ("Also known as NET5" . SPARSER::PROTEIN)
    ("NET" . SPARSER::PROTEIN)
    ("emerin (EMD; xref ) and MAN1 (LEMD3; xref )" . SPARSER::COLLECTION)
    ("Two other INM proteins, emerin (EMD; xref ) and MAN1 (LEMD3; xref )"
     . SPARSER::COLLECTION)
    ("EMD" . SPARSER::PROTEIN) ("emerin" . SPARSER::PROTEIN)
    ("a soluble LAP2 isoform" . SPARSER::ISOFORM)
    ("lamina-associated polypeptide 2 (LAP2, TMPO) and lamina-associated polypeptide 1 (LAP1, TOR1AIP)"
     . SPARSER::COLLECTION)
    ("lamina-associated polypeptide 1" . SPARSER::PROTEIN)
    ("lamina-associated polypeptide 2" . SPARSER::PROTEIN)
    ("AIP" . SPARSER::PROTEIN)
    ("doxycycline and 50 µM biotin" . SPARSER::COLLECTION)
    ("fluorescent streptavidin" . SPARSER::PROTEIN)
    ("standard complete media" . SPARSER::PROTEIN)
    ("myc-BirA" . SPARSER::COLLECTION)
    ("streptavidin-HRP" . SPARSER::COLLECTION)
    ("a far more promiscuous biotin ligase" . SPARSER::LIGASE)
    ("-AMP" . SPARSER::AMP) ("biotinoyl" . SPARSER::MOLECULE)
    ("avidin" . SPARSER::PROTEIN) ("BirA" . SPARSER::PROTEIN)
    ("the INM as well as NPC components" . SPARSER::COLLECTION)
    ("LaA-proximal proteins" . SPARSER::PROTEIN) ("INM" . SPARSER::PROTEIN)
    ("lamins" . SPARSER::PROTEIN) ("LMNA" . SPARSER::PROTEIN)
    ("vicinal proteins" . SPARSER::PROTEIN)
    ("a promiscuous prokaryotic biotin protein ligase" . SPARSER::LIGASE)
    ("potentially interacting proteins" . SPARSER::PROTEIN)
    ("the prokaryotic Dam methylase" . SPARSER::PROTEIN)
    ("methylase" . SPARSER::PROTEIN) ("proximate proteins" . SPARSER::PROTEIN)
    ("SLAP" . SPARSER::PROTEIN) ("interactors" . SPARSER::PROTEIN)
    ("lamin" . SPARSER::PROTEIN)
    ("a promiscuous Escherichia coli biotin protein ligase" . SPARSER::LIGASE)
    ("PH3" . SPARSER::MOLECULE) ("SA1" . SPARSER::PROTEIN)
    ("H1.0" . SPARSER::PROTEIN) ("H1.4" . SPARSER::PROTEIN)
    ("H1.3" . SPARSER::PROTEIN) ("Nup358" . SPARSER::PROTEIN)
    ("Nup214" . SPARSER::PROTEIN)
    ("angiotensin-converting enzyme" . SPARSER::PROTEIN)
    ("FHL1" . SPARSER::PROTEIN) ("nesprin-2" . SPARSER::PROTEIN)
    ("nesprin-1" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("lamin B" . SPARSER::PROTEIN-FAMILY) ("75 kD" . SPARSER::PROTEIN)
    ("Nup50" . SPARSER::PROTEIN) ("Nup153" . SPARSER::PROTEIN)
    ("TMEM201" . SPARSER::PROTEIN) ("LEMD3" . SPARSER::PROTEIN)
    ("MAN1" . SPARSER::PROTEIN) ("LAP1" . SPARSER::PROTEIN)
    ("polypeptide 1" . SPARSER::PROTEIN) ("LAP2" . SPARSER::PROTEIN)
    ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("DNA-binding protein" . SPARSER::PROTEIN) ("actual DNA" . SPARSER::DNA)
    ("SIRT1 and HDACs" . SPARSER::COLLECTION)
    ("SIRT1 or Ku70" . SPARSER::COLLECTION)
    ("NBS1 or RAD51" . SPARSER::COLLECTION)
    ("NBS1 and RAD51" . SPARSER::COLLECTION)
    ("MRE11-RAD50-NBS1" . SPARSER::COLLECTION)
    ("sirtinol or nicotinamide" . SPARSER::COLLECTION)
    ("aminopterin" . SPARSER::DRUG)
    ("shRNA, shSIRT1-1 or shSIRT1-2" . SPARSER::COLLECTION)
    ("SIRT1 inhibitors and HDAC inhibitors" . SPARSER::COLLECTION)
    ("sirtinol, nicotinamide and tenovin-6" . SPARSER::COLLECTION)
    ("sirtinol" . SPARSER::DRUG)
    ("histones and chromatin" . SPARSER::COLLECTION)
    ("histone/protein" . SPARSER::COLLECTION) ("WRN" . SPARSER::PROTEIN)
    ("Gleevec" . SPARSER::DRUG) ("hypoxanthine" . SPARSER::DRUG)
    ("EF1α" . SPARSER::PROTEIN) ("Ds-Red" . SPARSER::PROTEIN)
    ("STI-571" . SPARSER::DRUG) ("c-ABL" . SPARSER::PROTEIN)
    ("RAD50" . SPARSER::PROTEIN) ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("xeroderma pigmentosum" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN)
    ("the Mdm2-MdmX-p53 ternary complex" . SPARSER::BIO-COMPLEX)
    ("Mdm2-MdmX-p53" . SPARSER::COLLECTION) ("knockin" . SPARSER::PROTEIN)
    ("the principal p53 ubiquitin ligase" . SPARSER::PROTEIN)
    ("hetero-oligomers" . SPARSER::PROTEIN-PAIR)
    ("dual-inhibitory drugs" . SPARSER::DRUG) ("SAH" . SPARSER::MOLECULE)
    ("Nutlin-3a and other drugs" . SPARSER::COLLECTION)
    ("mitotic inhibitors" . SPARSER::INHIBITOR) ("Nutlin" . SPARSER::DRUG)
    ("p53-Mdm2" . SPARSER::COLLECTION) ("INHIBITORS" . SPARSER::INHIBITOR)
    ("Mdm2 and MdmX and Mdm2" . SPARSER::COLLECTION)
    ("MdmX and Mdm2" . SPARSER::COLLECTION)
    ("ATM and Chk2" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("type and length" . SPARSER::COLLECTION)
    ("Mdm2 homodimers or Mdm2/MdmX heterodimers" . SPARSER::COLLECTION)
    ("Mdm2/MdmX" . SPARSER::COLLECTION) ("Linker" . SPARSER::LINKER)
    ("a relatively weak E3" . SPARSER::MOLECULE)
    ("a relatively inefficient E3 ubiquitin ligase" . SPARSER::PROTEIN)
    ("Mdm2-MdmX" . SPARSER::COLLECTION)
    ("these two homologous proteins" . SPARSER::PROTEIN)
    ("neither Mdm2 nor MdmX" . SPARSER::COLLECTION)
    ("the two essential negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("Mdm2 or MdmX" . SPARSER::COLLECTION)
    ("MDM2 AND MDMX" . SPARSER::COLLECTION)
    ("a highly homologous gene" . SPARSER::GENE)
    ("p53 and masking p53's" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and masking" . SPARSER::COLLECTION)
    ("Mdm2 and MdmX" . SPARSER::COLLECTION) ("MdmX" . SPARSER::PROTEIN)
    ("the most frequently inactivated tumor suppressor gene"
     . SPARSER::PROTEIN)
    ("a stress-inducible protein" . SPARSER::PROTEIN)
    ("p53, and inhibitors" . SPARSER::COLLECTION)
    ("Mdm2/Mdmx" . SPARSER::COLLECTION) ("Mdm2 and Mdmx" . SPARSER::COLLECTION)
    ("Mdmx" . SPARSER::PROTEIN)
    ("an attractive cancer therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("Nutlin-3a" . SPARSER::DRUG)
    ("HPV+ oropharyngeal and cervical SCCs" . SPARSER::PROTEIN)
    ("mTORC1, rapamycin and RAD001" . SPARSER::COLLECTION)
    ("cervical SCCs" . SPARSER::PROTEIN)
    ("nearly all HPV-associated cervical and oral SCCs" . SPARSER::PROTEIN)
    ("tumor suppressive molecules" . SPARSER::MOLECULE)
    ("p70-S6 kinase" . SPARSER::COLLECTION)
    ("growth factor-" . SPARSER::GROWTH-FACTOR)
    ("KDM6A and KDM6B" . SPARSER::COLLECTION)
    ("demethylases" . SPARSER::PROTEIN) ("cdk6-cyclin D" . SPARSER::COLLECTION)
    ("cdk4-" . SPARSER::PROTEIN)
    ("clinically relevant mTOR inhibitors" . SPARSER::INHIBITOR)
    ("a fibrous collagen matrix" . SPARSER::PROTEIN-FAMILY)
    ("rapamycin, or RAD001" . SPARSER::COLLECTION)
    ("pS6 and pAkt" . SPARSER::COLLECTION)
    ("Rapamycin and RAD001" . SPARSER::COLLECTION)
    ("UD-SCC2" . SPARSER::COLLECTION) ("p16− and p16+" . SPARSER::COLLECTION)
    ("p16−" . SPARSER::PROTEIN) ("heat-map" . SPARSER::PROTEIN)
    ("pS6 and Akt" . SPARSER::COLLECTION)
    ("mTOR complex 1 (mTORC1) and mTORC2 ( xref )" . SPARSER::COLLECTION)
    ("a cervical cancer TMA" . SPARSER::MOLECULE)
    ("a central component of multiple growth promoting and metabolic pathways"
     . SPARSER::COLLECTION)
    ("nut" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rapamycin and RAD001" . SPARSER::COLLECTION)
    ("a cervical cancer (CCSCC) TMA" . SPARSER::MOLECULE)
    ("p70" . SPARSER::PROTEIN) ("Rheb1" . SPARSER::PROTEIN)
    ("tumor-suppressor protein" . SPARSER::PROTEIN)
    ("KDM6B" . SPARSER::PROTEIN) ("KDM6A" . SPARSER::PROTEIN)
    ("MTS1" . SPARSER::PROTEIN) ("SCC2" . SPARSER::PROTEIN)
    ("INK4A" . SPARSER::PROTEIN) ("p16 INK4A" . SPARSER::PROTEIN)
    ("the potent dual inhibitors" . SPARSER::INHIBITOR)
    ("proline and alanine" . SPARSER::COLLECTION)
    ("computational alanine" . SPARSER::AMINO-ACID)
    ("the inhibitor and each MDM2 residue" . SPARSER::COLLECTION)
    ("The former component" . SPARSER::COMPONENT)
    ("pol and Δ G" . SPARSER::COLLECTION) ("atm" . SPARSER::PROTEIN)
    ("HF" . SPARSER::PROTEIN)
    ("the protein and crystal water molecules" . SPARSER::COLLECTION)
    ("bank (PDB)" . SPARSER::PROTEIN) ("pDI6W-MDM" . SPARSER::COLLECTION)
    ("MDM" . SPARSER::PROTEIN)
    ("the non-polar solvation energy component and polar interaction energy"
     . SPARSER::COLLECTION)
    ("the separate energy component" . SPARSER::COMPONENT)
    ("polar interaction component" . SPARSER::COMPONENT)
    ("Wk23-MDM2" . SPARSER::COLLECTION) ("Wk23" . SPARSER::PROTEIN)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("nitrogen" . SPARSER::MOLECULE) ("MDM2-pDI6W" . SPARSER::COLLECTION)
    ("pDI6W and WK23" . SPARSER::COLLECTION) ("pol" . SPARSER::PROTEIN)
    ("exp" . SPARSER::PROTEIN) ("pbsa" . SPARSER::DRUG)
    ("WK23" . SPARSER::PROTEIN) ("MDMX and pDI6W" . SPARSER::COLLECTION)
    ("the last 500 ps" . SPARSER::PROTEIN) ("ps" . SPARSER::PROTEIN)
    ("pDI6W-MDMX" . SPARSER::COLLECTION) ("WK23-MDMX" . SPARSER::COLLECTION)
    ("pDI6W-MDM2" . SPARSER::COLLECTION) ("WK23-MDM2" . SPARSER::COLLECTION)
    ("the potent dual inhibitor" . SPARSER::INHIBITOR) ("PBSA" . SPARSER::DRUG)
    ("FEP" . SPARSER::PROTEIN) ("inhibitors and points" . SPARSER::COLLECTION)
    ("inhibitor (LTFEHWWAQLTS)" . SPARSER::INHIBITOR)
    ("a peptide inhibitor pDI6W and a non-peptide inhibitor WK23"
     . SPARSER::COLLECTION)
    ("pDI" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("potent dual inhibitors" . SPARSER::INHIBITOR)
    ("dual inhibitors" . SPARSER::INHIBITOR)
    ("peptide and non-peptide" . SPARSER::COLLECTION)
    ("Nutlins and MI-219" . SPARSER::COLLECTION) ("Nutlins" . SPARSER::DRUG)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("MDM2/MDMX" . SPARSER::COLLECTION) ("p53-MDM2/MDMX" . SPARSER::COLLECTION)
    ("oxygen atom" . SPARSER::MOLECULE) ("OE1" . SPARSER::PROTEIN)
    ("nitrogen atom" . SPARSER::MOLECULE) ("MI-219" . SPARSER::DRUG)
    ("EGF and TGF-beta" . SPARSER::COLLECTION)
    ("intestinal epithelial TJ proteins" . SPARSER::PROTEIN)
    ("E-cadherin and Snail-1" . SPARSER::COLLECTION)
    ("Wnt and EGFR" . SPARSER::COLLECTION)
    ("immunosuppressive cytokines" . SPARSER::PROTEIN)
    ("mesenchymal genes" . SPARSER::GENE) ("enhancer" . SPARSER::PROTEIN)
    ("a complex and multistep process" . SPARSER::COLLECTION)
    ("claudins" . SPARSER::PROTEIN) ("claudin" . SPARSER::PROTEIN)
    ("ions, water, and macromolecules" . SPARSER::COLLECTION)
    ("cytoskeletal actin" . SPARSER::PROTEIN)
    ("functionally related transmembrane glycoproteins" . SPARSER::PROTEIN)
    ("Snail-2 (Slug) and Snail-3 (Smuc)" . SPARSER::COLLECTION)
    ("E-cadherin and claudin-1" . SPARSER::COLLECTION)
    ("Snail-1" . SPARSER::COLLECTION)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("Claudin-1" . SPARSER::PROTEIN) ("Snail-2" . SPARSER::PROTEIN)
    ("Chang-qin" . SPARSER::PROTEIN-PAIR) ("qin" . SPARSER::PROTEIN)
    ("mei" . SPARSER::MOLECULE) ("WANG" . SPARSER::PROTEIN)
    ("HGF-MET" . SPARSER::COLLECTION)
    ("hepatocyte growth factor/c-Met" . SPARSER::COLLECTION)
    ("c-Met and CD44" . SPARSER::COLLECTION)
    ("E-cadherin and α3β1" . SPARSER::COLLECTION)
    ("artificial engineered pre-miRNA sequences specifically targeting c-Met"
     . SPARSER::PROTEIN)
    ("kinase and signaling pathway inhibitors" . SPARSER::COLLECTION)
    ("β1 and integrin" . SPARSER::COLLECTION) ("FCM" . SPARSER::MOLECULE)
    ("SCG" . SPARSER::PROTEIN) ("blasticidin" . SPARSER::MOLECULE)
    ("Lenti-miRNA" . SPARSER::COLLECTION) ("lenti-miRNA" . SPARSER::COLLECTION)
    ("c-Met and HGF" . SPARSER::COLLECTION)
    ("form 24 distinct integrins" . SPARSER::PROTEIN)
    ("integrin and E-cadherin" . SPARSER::COLLECTION)
    ("Lenti-miRNAc-Met" . SPARSER::COLLECTION)
    ("adhesion molecule" . SPARSER::PROTEIN) ("group B" . SPARSER::PROTEIN)
    ("group A" . SPARSER::PROTEIN) ("Adhesion molecule" . SPARSER::PROTEIN)
    ("CK20" . SPARSER::PROTEIN) ("-HIF" . SPARSER::COLLECTION)
    ("neo-enhancer" . SPARSER::PROTEIN-PAIR) ("HIF-2-" . SPARSER::PROTEIN)
    ("HIF-2α and cyclin D1" . SPARSER::COLLECTION)
    ("HIF-1 and HIF-2" . SPARSER::COLLECTION) ("Allele" . SPARSER::ALLELE)
    ("VHL" . SPARSER::PROTEIN) ("HIF-2α and HIF-1β" . SPARSER::COLLECTION)
    ("polymorphic nucleotides" . SPARSER::NUCLEOTIDE)
    ("HIF-2α and its dimerization partner HIF-1β" . SPARSER::COLLECTION)
    ("HIF-1α and HIF-2α" . SPARSER::COLLECTION) ("pVHL" . SPARSER::PROTEIN)
    ("EEF1G" . SPARSER::PROTEIN) ("ammonium chloride" . SPARSER::MOLECULE)
    ("H10" . SPARSER::PROTEIN) ("chr8" . SPARSER::PROTEIN)
    ("SCARB1" . SPARSER::PROTEIN) ("HK-2" . SPARSER::PROTEIN)
    ("FAM13A" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("HIF-1β" . SPARSER::PROTEIN) ("EPAS1" . SPARSER::PROTEIN)
    ("HIF-1α" . SPARSER::PROTEIN) ("von Hippel Lindau" . SPARSER::PROTEIN)
    ("HIF-2" . SPARSER::PROTEIN)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("the pro-apoptotic factor TRAIL" . SPARSER::PROTEIN)
    ("AICAR, metformin and adiponectin" . SPARSER::COLLECTION)
    ("ELF" . SPARSER::PROTEIN)
    ("the pro-apoptotic gene TRAIL and anti-apoptotic gene Bcl-2"
     . SPARSER::PROTEIN)
    ("TRAIL and anti-apoptotic" . SPARSER::COLLECTION)
    ("tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and subsequent activation of a protease cascade ( xref )"
     . SPARSER::COLLECTION)
    ("PEPCK and LPL" . SPARSER::COLLECTION) ("LPL" . SPARSER::PROTEIN)
    ("PEPCK" . SPARSER::PROTEIN) ("MCP-1 and IL-1β" . SPARSER::COLLECTION)
    ("chemokines/cytokines" . SPARSER::COLLECTION)
    ("AICAR-" . SPARSER::PROTEIN) ("TLR4/LPS" . SPARSER::COLLECTION)
    ("4EBP1 and S6K" . SPARSER::COLLECTION)
    ("TSC2 ( xref ) and mTORC1 subunit Raptor ( xref )" . SPARSER::COLLECTION)
    ("Raptor" . SPARSER::PROTEIN) ("AICAR or metformin" . SPARSER::COLLECTION)
    ("BMP and activin" . SPARSER::COLLECTION) ("activin" . SPARSER::PROTEIN)
    ("adiponectin" . SPARSER::PROTEIN)
    ("Adiponectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-inflammatory cytokines (such as TGF-β, RANTES, and MCP-1) and adhesion molecules (including integrins, VCAM-1, and ICAM-1)"
     . SPARSER::COLLECTION)
    ("TGF-β, RANTES, and MCP-1" . SPARSER::COLLECTION)
    ("integrins, VCAM-1, and ICAM-1" . SPARSER::COLLECTION)
    ("α-smooth muscle actin and myocyte enhancer factor-2"
     . SPARSER::COLLECTION)
    ("pathological extracellular matrix (ECM) proteins" . SPARSER::PROTEIN)
    ("myogenic" . SPARSER::PROTEIN)
    ("fibroblast growth factor (FGF)" . SPARSER::PROTEIN-FAMILY)
    ("profibrogenic cytokines" . SPARSER::PROTEIN)
    ("transforming growth factor-β1" . SPARSER::COLLECTION)
    ("hepatocytes and non-parenchymal" . SPARSER::COLLECTION)
    ("cirrhosis" . SPARSER::PROTEIN) ("siRNA-Bambi" . SPARSER::COLLECTION)
    ("Bambi" . SPARSER::PROTEIN) ("AICAR and metformin" . SPARSER::COLLECTION)
    ("quiescent HSCs" . SPARSER::PROTEIN)
    ("metformin and AICAR" . SPARSER::COLLECTION)
    ("glucose and lipid" . SPARSER::COLLECTION) ("metformin" . SPARSER::DRUG)
    ("TCF-4" . SPARSER::PROTEIN) ("sensitive to apoptosis" . SPARSER::PROTEIN)
    ("vitamin D" . SPARSER::MOLECULE) ("18h" . SPARSER::PROTEIN)
    ("vitamin D 3" . SPARSER::MOLECULE) ("anti-diabetic" . SPARSER::DRUG)
    ("beta-4" . SPARSER::PROTEIN)
    ("5-aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("adenosine monophosphate" . SPARSER::MOLECULE)
    ("decoy receptor" . SPARSER::PROTEIN)
    ("Adenosine monophosphate" . SPARSER::MOLECULE)
    ("cyclooxygen-ase-2" . SPARSER::COLLECTION)
    ("growth factor and interleukin-8" . SPARSER::COLLECTION)
    ("Phosphatidylinositol 3-kinase/AKT" . SPARSER::COLLECTION)
    ("phosphatidylinositol 3-kinase/AKT" . SPARSER::COLLECTION)
    ("Ras/Raf/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("erbB4" . SPARSER::PROTEIN) ("erbB2" . SPARSER::PROTEIN)
    ("pTa/pTis" . SPARSER::COLLECTION) ("pTis" . SPARSER::PROTEIN)
    ("pTa" . SPARSER::PROTEIN)
    ("a monoclonal anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("hypoxia-inducible factor" . SPARSER::PROTEIN)
    ("B-myb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-8" . SPARSER::PROTEIN) ("HER4" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("pT1" . SPARSER::PROTEIN)
    ("RNF8 and ICP0, and RNF168 and ICP0" . SPARSER::COLLECTION)
    ("ICP0, and RNF168 and ICP0" . SPARSER::COLLECTION)
    ("RNF168 and ICP0" . SPARSER::COLLECTION) ("SUMO" . SPARSER::PROTEIN)
    ("an inactive dimer" . SPARSER::DIMER)
    ("ATM and CK1" . SPARSER::COLLECTION)
    ("Glu instead of Gln" . SPARSER::COLLECTION)
    ("Mdc1 and ICP0" . SPARSER::COLLECTION)
    ("other viral genes" . SPARSER::GENE) ("STD" . SPARSER::PROTEIN)
    ("Chk2-ICP0" . SPARSER::COLLECTION) ("Chk2 and ICP0" . SPARSER::COLLECTION)
    ("TAP-ICP0" . SPARSER::COLLECTION)
    ("RNF8, Chk2, Nbs1, or FOXK2" . SPARSER::COLLECTION)
    ("pulldowns, Nbs1 and FOXK2" . SPARSER::COLLECTION)
    ("approximately 60 and 102 kDa" . SPARSER::PROTEIN)
    ("pulldowns" . SPARSER::PROTEIN)
    ("peptide or peptides" . SPARSER::COLLECTION) ("ICP0-" . SPARSER::PROTEIN)
    ("a control shRNA (shNeg) or shRNA" . SPARSER::COLLECTION)
    ("DNA-PKcs, USP7, and RNF168" . SPARSER::COLLECTION)
    ("purified recombinant GST-RNF8-FHA protein or the R42A mutant"
     . SPARSER::COLLECTION)
    ("the first 241 amino acids of ICP0 fused" . SPARSER::PROTEIN)
    ("CK1 and CK2" . SPARSER::COLLECTION) ("Asp and Glu" . SPARSER::COLLECTION)
    ("proteins and glutathione-Sepharose" . SPARSER::COLLECTION)
    ("CK1 or CK2" . SPARSER::COLLECTION)
    ("the N-terminal 241 amino acids of ICP0 ( xref )" . SPARSER::PROTEIN)
    ("CK2 and CK1" . SPARSER::COLLECTION) ("Ser and Thr" . SPARSER::COLLECTION)
    ("Ubc13 and Uve1" . SPARSER::COLLECTION) ("Uve1" . SPARSER::PROTEIN)
    ("radiation-induced foci (IRIF)" . SPARSER::PROTEIN)
    ("RNF8 or RNF168" . SPARSER::COLLECTION)
    ("Phe or Tyr" . SPARSER::COLLECTION) ("orthovanadate" . SPARSER::MOLECULE)
    ("pulldown" . SPARSER::PROTEIN)
    ("recombinant GST-RNF8-FHA protein and the R42A mutant"
     . SPARSER::COLLECTION)
    ("GST-RNF8-FHA" . SPARSER::COLLECTION) ("RNF8-ICP0" . SPARSER::COLLECTION)
    ("Flag-RNF8" . SPARSER::COLLECTION) ("hpi" . SPARSER::PROTEIN)
    ("eGFP-ICP0" . SPARSER::COLLECTION) ("discrete foci" . SPARSER::PROTEIN)
    ("DNA-PKcs ( xref ), ND10 components ( xref ), and centromeric proteins ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("centromeric proteins" . SPARSER::PROTEIN)
    ("many virally-encoded proteins" . SPARSER::PROTEIN)
    ("53BP1, and effector" . SPARSER::COLLECTION)
    ("H2A and H2AX, and ubiquitin" . SPARSER::COLLECTION)
    ("H2AX, and ubiquitin" . SPARSER::COLLECTION)
    ("ligases, RNF8 and RNF168" . SPARSER::COLLECTION)
    ("this viral E3" . SPARSER::MOLECULE)
    ("RNF8 and RNF168" . SPARSER::COLLECTION) ("FOXK2" . SPARSER::PROTEIN)
    ("ICP27" . SPARSER::PROTEIN) ("Ubc13" . SPARSER::PROTEIN)
    ("HSV-2" . SPARSER::PROTEIN) ("DNA-PKcs" . SPARSER::PROTEIN)
    ("RNF168" . SPARSER::PROTEIN) ("RNF8" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor-2" . SPARSER::COLLECTION)
    ("CSV" . SPARSER::PROTEIN)
    ("wild type functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLK1 ( P = 0.015) and the progesterone receptor ( P = 0.04)"
     . SPARSER::COLLECTION)
    ("MDM2 and PLK1" . SPARSER::COLLECTION)
    ("PLK1 and MDM2" . SPARSER::COLLECTION)
    ("MDM2 (see below) or MDM4" . SPARSER::COLLECTION)
    ("a significantly larger cohort" . SPARSER::MOLECULE)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("ERα, PR and HER-2" . SPARSER::COLLECTION)
    ("clinically-relevant genotoxic drugs" . SPARSER::DRUG)
    ("centrosomes" . SPARSER::PROTEIN)
    ("key cancer-associated proteins" . SPARSER::PROTEIN)
    ("PLK1 and TP53" . SPARSER::COLLECTION)
    ("PLK1, MDM2 and Ki67" . SPARSER::COLLECTION)
    ("polo-like kinase-1" . SPARSER::PROTEIN) ("MDM4" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("Polo-like Kinase" . SPARSER::PROTEIN)
    ("ErbB2, c-Met or PDZRhoGEF" . SPARSER::COLLECTION)
    ("ErbB2, c-Met and RhoA" . SPARSER::COLLECTION)
    ("RasGAP" . SPARSER::PROTEIN) ("Rnd1 and Rac1" . SPARSER::COLLECTION)
    ("ErbB2 or c-Met" . SPARSER::COLLECTION)
    ("plexinB1 and the WT form" . SPARSER::COLLECTION)
    ("the receptor tyrosine kinases ErbB2 [ xref ] and c-Met [ xref ]"
     . SPARSER::COLLECTION)
    ("ErbB2 and c-met" . SPARSER::COLLECTION)
    ("exogenous plexinB1" . SPARSER::PROTEIN)
    ("VSV-plexinB1" . SPARSER::COLLECTION)
    ("RhoGEFs, PDZRhoGEF and LARG" . SPARSER::COLLECTION)
    ("RhoGEFs" . SPARSER::PROTEIN)
    ("plexinB1(T1697A) and plexinB1(T1795A)" . SPARSER::COLLECTION)
    ("plexinB1 (WT or mutant) and RacL61" . SPARSER::COLLECTION)
    ("Sema4D-AP" . SPARSER::COLLECTION)
    ("plexinB1 (T1795A) or plexinB1 (L1815P)" . SPARSER::COLLECTION)
    ("WT plexinB1 or three different mutant" . SPARSER::COLLECTION)
    ("the receptor tyrosine kinases c-Met [ xref ] and ErbB2 [ xref ]"
     . SPARSER::COLLECTION)
    ("c-Met and ErbB2" . SPARSER::COLLECTION)
    ("Sema4D/plexinB1" . SPARSER::COLLECTION) ("LARG" . SPARSER::PROTEIN)
    ("integrin and PI3K" . SPARSER::COLLECTION)
    ("Semaphorin/plexin" . SPARSER::COLLECTION) ("plexin" . SPARSER::PROTEIN)
    ("Semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("neuropilins and plexins" . SPARSER::COLLECTION)
    ("neuropilins" . SPARSER::PROTEIN-FAMILY)
    ("semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("semaphorin" . SPARSER::PROTEIN-FAMILY)
    ("ErbB2 or c-Met or ErbB2" . SPARSER::COLLECTION)
    ("c-Met or ErbB2" . SPARSER::COLLECTION) ("RhoD" . SPARSER::PROTEIN)
    ("chemotactic cues" . SPARSER::PROTEIN-FAMILY)
    ("plexins" . SPARSER::PROTEIN) ("Semaphorins" . SPARSER::PROTEIN-FAMILY)
    ("V-myc" . SPARSER::PROTEIN) ("Protein-G" . SPARSER::PROTEIN)
    ("R-Ras GAP" . SPARSER::PROTEIN) ("plexinA1" . SPARSER::PROTEIN)
    ("c-met" . SPARSER::PROTEIN) ("p21-activated kinase1" . SPARSER::PROTEIN)
    ("R-Ras" . SPARSER::PROTEIN) ("Sema4D" . SPARSER::PROTEIN)
    ("Semaphorin 4D" . SPARSER::PROTEIN) ("PlexinB1" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN) ("plexinB1" . SPARSER::PROTEIN)
    ("selectively kill certain types" . TYPE) ("urethane" . SPARSER::MOLECULE)
    ("kinases and c-Abl" . SPARSER::COLLECTION)
    ("diacylglycerol and phorbol" . SPARSER::COLLECTION)
    ("TARGET" . SPARSER::TARGET-PROTEIN)
    ("carboplatin and oxaloplatin" . SPARSER::COLLECTION)
    ("CISPLATIN AND NEPHROTOXICITY" . SPARSER::COLLECTION)
    ("CISPLATIN" . SPARSER::DRUG)
    ("Recently developed anti-cancer drugs" . SPARSER::DRUG)
    ("c-Abl" . SPARSER::PROTEIN)
    ("the epithelial AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a growth promoter and a tumor suppressor" . SPARSER::COLLECTION)
    ("androstenedione" . SPARSER::DRUG)
    ("adrenal steroids androstenediol and DHEA" . SPARSER::COLLECTION)
    ("androstenediol and DHEA" . SPARSER::COLLECTION) ("DHEA" . SPARSER::DRUG)
    ("androstenediol" . SPARSER::DRUG) ("gonadotropin" . SPARSER::PROTEIN)
    ("the dominant androgen" . SPARSER::PROTEIN)
    ("testosterone and DHT" . SPARSER::COLLECTION)
    ("PC-3 and CV-1" . SPARSER::COLLECTION)
    ("the rat probasin promoter (nucleotides −285 to 32) or two AREs"
     . SPARSER::COLLECTION)
    ("unactivated AR and the androgen-specific AREs" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID)
    ("NCoA1 and NCoA2" . SPARSER::COLLECTION) ("NCoA2" . SPARSER::PROTEIN)
    ("NCoA1" . SPARSER::PROTEIN) ("antiandrogens" . SPARSER::DRUG)
    ("TIF-2 or CBP" . SPARSER::COLLECTION)
    ("ligand and modest gain of function at all concentrations of DHT"
     . SPARSER::COLLECTION)
    ("a classic example" . SPARSER::EXAMPLE) ("TFIIF" . SPARSER::PROTEIN)
    ("TAU" . SPARSER::PROTEIN) ("The predominant type" . TYPE)
    ("a predominant novel class" . CLASS)
    ("the androgen receptor's" . SPARSER::PROTEIN)
    ("a representative blot" . SPARSER::PROTEIN)
    ("MMTV-luciferase" . SPARSER::COLLECTION) ("CV-1" . SPARSER::PROTEIN)
    ("COS" . SPARSER::MOLECULE) ("MMTV-LTR" . SPARSER::PROTEIN-PAIR)
    ("MMTV-Luc" . SPARSER::COLLECTION)
    ("approximately residues 55 and 230 displays particularly low homology"
     . SPARSER::PROTEIN)
    ("an ancestral steroid receptor gene" . SPARSER::GENE)
    ("the receptor's" . SPARSER::RECEPTOR)
    ("its hemizygous state" . SPARSER::BIO-STATE)
    ("functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hormone" . SPARSER::MOLECULE) ("exoteric-androgen" . SPARSER::PROTEIN)
    ("Type 3" . SPARSER::PROTEIN) ("type 3" . SPARSER::PROTEIN)
    ("TIF-2" . SPARSER::PROTEIN) ("ART-27" . SPARSER::PROTEIN)
    ("RAP74" . SPARSER::PROTEIN) ("N-CoR" . SPARSER::PROTEIN)
    ("GRE 2" . SPARSER::PROTEIN)
    ("a more aggressive hormone-independent PCa" . SPARSER::PROTEIN)
    ("SASP" . SPARSER::PROTEIN) ("Ras and Myc" . SPARSER::COLLECTION)
    ("Rb and p21" . SPARSER::COLLECTION) ("Rb/E2F/HDAC" . SPARSER::COLLECTION)
    ("AR directly binds p21 promoter" . SPARSER::PROMOTER)
    ("TA-p63" . SPARSER::COLLECTION)
    ("p53, p21, and p16/INK" . SPARSER::COLLECTION)
    ("DDR and SIS" . SPARSER::COLLECTION)
    ("p53, or p16/INK" . SPARSER::COLLECTION) ("p14/Arf" . SPARSER::COLLECTION)
    ("PaCa" . SPARSER::PROTEIN) ("SIS" . SPARSER::PROTEIN)
    ("eotaxin" . SPARSER::PROTEIN) ("Eotaxin" . SPARSER::PROTEIN)
    ("Rantes" . SPARSER::PROTEIN)
    ("16 inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("DNp" . SPARSER::DRUG)
    ("One possible p63 target" . SPARSER::TARGET-PROTEIN)
    ("DHT and noticeably decreased ΔNp63" . SPARSER::COLLECTION)
    ("cysteine (NAC)" . SPARSER::MOLECULE)
    ("PC3-AR and LNCaP" . SPARSER::COLLECTION)
    ("p53 and p16" . SPARSER::COLLECTION) ("RWPE-AR" . SPARSER::COLLECTION)
    ("AR and testosterone" . SPARSER::COLLECTION)
    ("p21 or Rb" . SPARSER::COLLECTION)
    ("phospho-Rb and p63" . SPARSER::COLLECTION)
    ("p21, p53, Rb, and PML" . SPARSER::COLLECTION)
    ("AR and p63" . SPARSER::COLLECTION)
    ("p53 and TAp63" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rb or p53" . SPARSER::COLLECTION)
    ("p21, Bax and PIG3" . SPARSER::COLLECTION) ("flutamide" . SPARSER::DRUG)
    ("c-Met and VEGF-C" . SPARSER::COLLECTION)
    ("Akt and anti-apoptotic" . SPARSER::COLLECTION)
    ("Bcl-2 and Mcl" . SPARSER::COLLECTION) ("PCa" . SPARSER::PROTEIN)
    ("senescence-associated chromatin foci" . SPARSER::PROTEIN)
    ("cysteine and p63" . SPARSER::COLLECTION)
    ("tumor-suppressive AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Gal" . SPARSER::PROTEIN) ("p14 Arf" . SPARSER::PROTEIN)
    ("GROα" . SPARSER::PROTEIN) ("βGAL" . SPARSER::PROTEIN)
    ("βGal" . SPARSER::PROTEIN) ("Beclin-1" . SPARSER::PROTEIN)
    ("P63" . SPARSER::PROTEIN) ("TAp63" . SPARSER::PROTEIN)
    ("p53-related protein" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIG3" . SPARSER::PROTEIN) ("VEGF-C" . SPARSER::PROTEIN)
    ("c-Met" . SPARSER::PROTEIN) ("HIF-1" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG)
    ("gastrointestinal disorders—such as CRC" . SPARSER::PROTEIN)
    ("individual anti- and pro-apoptotic Bcl-2 homologs [ xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("PIP 3 and the serine-threonine kinase activity of another PI3-K effector"
     . SPARSER::COLLECTION)
    ("p110α, p85β or p55γ" . SPARSER::COLLECTION)
    ("p38 and Akt" . SPARSER::COLLECTION) ("Fak, or Src" . SPARSER::COLLECTION)
    ("Fak or Src" . SPARSER::COLLECTION) ("Shc or IRS-1" . SPARSER::COLLECTION)
    ("Src and Fak" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) [ xref – xref , xref , xref , xref ]"
     . SPARSER::COLLECTION)
    ("the two predominant PI3-K" . SPARSER::PROTEIN)
    ("the predominant PI3-K isoform" . SPARSER::ISOFORM)
    ("the predominant PI3-K C subunit" . SPARSER::FRAGMENT)
    ("the predominant class I PI3-K isoform" . SPARSER::ISOFORM)
    ("p110γ and p110δ" . SPARSER::COLLECTION)
    ("PI3-K isoforms and their roles in the integrin β1/Fak/Src-mediated regulation of HIEC cell survival"
     . SPARSER::COLLECTION)
    ("Fak/Src" . SPARSER::COLLECTION) ("Fak-Src" . SPARSER::COLLECTION)
    ("again co-IP p85β and p55γ" . SPARSER::COLLECTION)
    ("p85β and p55γ" . SPARSER::COLLECTION)
    ("p85β and p110α" . SPARSER::COLLECTION)
    ("p110α, p85β and p55γ" . SPARSER::COLLECTION)
    ("β1/Fak/Src" . SPARSER::COLLECTION)
    ("Fak, Src and Akt-1" . SPARSER::COLLECTION)
    ("Fak (Fig.  xref a, PF573228) or Src (Fig.  xref a, PP2)"
     . SPARSER::COLLECTION)
    ("Akt-1 and a consequent promotion/maintenance" . SPARSER::COLLECTION)
    ("p85β (sip85β) or p55γ (sip55γ)" . SPARSER::COLLECTION)
    ("p110α (sip110α), p85β (sip85β) or p55γ (sip55γ)" . SPARSER::COLLECTION)
    ("their respective isoform subunit" . SPARSER::FRAGMENT)
    ("PI3-K and its main effector Akt-1" . SPARSER::COLLECTION)
    ("the largely predominant PI3-K isoform" . SPARSER::ISOFORM)
    ("reciprocal analyses whereby C subunits" . SPARSER::FRAGMENT)
    ("weakly detectable p110α and no detectable p110β (Fig.  xref c)"
     . SPARSER::COLLECTION)
    ("p110γ or p110δ" . SPARSER::COLLECTION) ("GMCSF" . SPARSER::PROTEIN)
    ("p85β, p55γ and p110α" . SPARSER::COLLECTION)
    ("p85β, p55γ, p110α and p110δ" . SPARSER::COLLECTION)
    ("isoforms and isoform" . SPARSER::COLLECTION)
    ("PI3-K isoforms and their roles in the integrin β1/Fak/Src-mediated regulation of cell survival"
     . SPARSER::COLLECTION)
    ("Fak-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fak and Src" . SPARSER::COLLECTION)
    ("its associated C subunit" . SPARSER::FRAGMENT)
    ("PI3-K/Akt" . SPARSER::COLLECTION) ("/Akt-1" . SPARSER::COLLECTION)
    ("a complex and finely tuned process which performs crucial functions"
     . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN) ("Fak and/or Src" . SPARSER::COLLECTION)
    ("the predominant PI3-K" . SPARSER::PROTEIN)
    ("p85β or p55γ" . SPARSER::COLLECTION)
    ("integrin/Fak/Src" . SPARSER::COLLECTION)
    ("p110α/p55γ" . SPARSER::COLLECTION) ("p110α/p85β" . SPARSER::COLLECTION)
    ("PI3-K/Akt-1" . SPARSER::COLLECTION) ("Akt-2" . SPARSER::PROTEIN)
    ("Akt-3" . SPARSER::PROTEIN) ("p38δ" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("nSH2" . SPARSER::PROTEIN)
    ("iSH2" . SPARSER::PROTEIN) ("E  − F" . SPARSER::PROTEIN)
    ("Asp-Glu" . SPARSER::MOLECULE) ("CASP-3" . SPARSER::PROTEIN)
    ("Caspase-activated DNAse" . SPARSER::PROTEIN) ("PF573228" . SPARSER::DRUG)
    ("Ly294002" . SPARSER::MOLECULE) ("IC87114" . SPARSER::MOLECULE)
    ("TGX221" . SPARSER::DRUG) ("PIK-75" . SPARSER::DRUG)
    ("colony-stimulating factor" . SPARSER::PROTEIN)
    ("p60 Src" . SPARSER::PROTEIN) ("p125 Fak" . SPARSER::PROTEIN)
    ("p55γ" . SPARSER::PROTEIN) ("Akt-1" . SPARSER::PROTEIN)
    ("fluoxetine and desipramine" . SPARSER::COLLECTION)
    ("serotonin" . SPARSER::MOLECULE) ("desipramine" . SPARSER::DRUG)
    ("redundant GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NPCs or their progeny ( xref )" . SPARSER::COLLECTION)
    ("trans-" . SPARSER::PROTEIN-FAMILY) ("a unique form" . SPARSER::FORM)
    ("chronic antidepressant" . SPARSER::DRUG) ("splash" . SPARSER::PROTEIN)
    ("a separate cohort" . SPARSER::MOLECULE)
    ("a mature neuronal pheno-type" . TYPE)
    ("BrdU and NeuN" . SPARSER::COLLECTION) ("pheno" . SPARSER::DRUG)
    ("subchronic antidepressant" . SPARSER::DRUG)
    ("subchronic fluoxetine" . SPARSER::DRUG)
    ("subchronic fluoxetine or imipramine" . SPARSER::COLLECTION)
    ("fluoxetine (18 μ g/g) or imipramine (20 μ g/g)" . SPARSER::COLLECTION)
    ("fluoxetine or imipramine" . SPARSER::COLLECTION)
    ("FST" . SPARSER::PROTEIN) ("TST" . SPARSER::PROTEIN)
    ("chronic fluoxetine (18 μ g/g) or imipramine (20 μ g/g)"
     . SPARSER::COLLECTION)
    ("chronic fluoxetine" . SPARSER::DRUG) ("doublecortin" . SPARSER::PROTEIN)
    ("Nestin ( xref ) or Sox2" . SPARSER::COLLECTION)
    ("mature neuronal marker NeuN" . SPARSER::PROTEIN)
    ("ERK and PI3K" . SPARSER::COLLECTION)
    ("adult hippocampal NPCs" . SPARSER::MOLECULE)
    ("NeuN or GFAP" . SPARSER::COLLECTION)
    ("BrdU, and NeuroD" . SPARSER::COLLECTION)
    ("Nf1 and theNestin-CreER T2 transgene" . SPARSER::COLLECTION)
    ("two conditional (flox) alleles" . SPARSER::ALLELE)
    ("theNestin" . SPARSER::PROTEIN) ("NSE-DTA" . SPARSER::PROTEIN-PAIR)
    ("theNestin-CreER" . SPARSER::COLLECTION) ("CreER" . SPARSER::PROTEIN)
    ("DTA" . SPARSER::PROTEIN) ("Nestin-CreER" . SPARSER::COLLECTION)
    ("fluoxetine" . SPARSER::DRUG) ("imipramine" . SPARSER::DRUG)
    ("hippocampal NPCs" . SPARSER::MOLECULE) ("GABA" . SPARSER::MOLECULE)
    ("neurotrophins and Trk" . SPARSER::COLLECTION)
    ("Neurofibromin" . SPARSER::PROTEIN)
    ("chronic antidepressants" . SPARSER::DRUG) ("TrkB" . SPARSER::PROTEIN)
    ("BDNF, neurotrophin-3, and VEGF" . SPARSER::COLLECTION)
    ("antidepressive stimulants" . SPARSER::DRUG)
    ("stimulants" . SPARSER::DRUG) ("Nf1-Ras" . SPARSER::COLLECTION)
    ("subchronic antidepressants" . SPARSER::DRUG)
    ("RAS-GAP" . SPARSER::COLLECTION) ("Nf1" . SPARSER::PROTEIN)
    ("neurofibromin" . SPARSER::PROTEIN) ("DG" . SPARSER::PROTEIN)
    ("gyrus (DG)" . SPARSER::PROTEIN) ("F–I" . SPARSER::PROTEIN)
    ("subunit A" . SPARSER::PROTEIN) ("diphtheria toxin" . SPARSER::PROTEIN)
    ("β -Gal" . SPARSER::PROTEIN) ("neurotrophin-3" . SPARSER::PROTEIN)
    ("a soluble cytosolic protein" . SPARSER::PROTEIN)
    ("PIP3 or perhaps" . SPARSER::COLLECTION)
    ("aPKC and pAkt" . SPARSER::COLLECTION)
    ("PKCι and Akt" . SPARSER::COLLECTION)
    ("the soluble (S1) fraction" . SPARSER::COMPONENT)
    ("aPKC, Hsp70, PDK1, and ATP" . SPARSER::COLLECTION)
    ("soluble recombinant PDK1" . SPARSER::PROTEIN)
    ("IF-associated Hsp70" . SPARSER::PROTEIN)
    ("Akt2 and PI3K" . SPARSER::COLLECTION)
    ("the PDK1-positive apical puncta" . SPARSER::PROTEIN)
    ("EGFRs" . SPARSER::PROTEIN)
    ("at least two important targets" . SPARSER::TARGET-PROTEIN)
    ("dynasore" . SPARSER::MOLECULE)
    ("Nearly all Rab11-positive puncta" . SPARSER::PROTEIN)
    ("fluorescent transferrin" . SPARSER::PROTEIN)
    ("either soluble cytosolic or vesicle-associated PDK1" . SPARSER::PROTEIN)
    ("Hsp70 ( xref ; xref ; xref ) and Hsp40 ( xref )" . SPARSER::COLLECTION)
    ("the filamentous keratin scaffold" . SPARSER::SCAFFOLD)
    ("PDK1 and PKCι" . SPARSER::COLLECTION) ("soluble aPKC" . SPARSER::PROTEIN)
    ("Hsp70/Hsc70" . SPARSER::COLLECTION)
    ("this highly insoluble P fraction" . SPARSER::COMPONENT)
    ("actin and tubulin" . SPARSER::COLLECTION) ("KCl" . SPARSER::MOLECULE)
    ("the Triton X-100–soluble fraction" . SPARSER::COMPONENT)
    ("nonphosphorylatable PDK1 pseudosubstrate myristoylated peptide"
     . SPARSER::PEPTIDE)
    ("either PDK1 or a different enzyme" . SPARSER::COLLECTION)
    ("a cytosolic kinase, either PDK1 or a different enzyme"
     . SPARSER::COLLECTION)
    ("around intermediate filaments" . SPARSER::PROTEIN-FAMILY)
    ("Krt18" . SPARSER::PROTEIN) ("Krt8" . SPARSER::PROTEIN)
    ("native filamentous keratin (Krt) intermediate filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("PKCι and PKCζ" . SPARSER::COLLECTION) ("–Akt" . SPARSER::COLLECTION)
    ("PDK1, pT555-aPKC, and pAkt" . SPARSER::COLLECTION)
    ("intestinal crypt enterocytes PDK1" . SPARSER::PROTEIN)
    ("atypical PKC" . SPARSER::PROTEIN) ("aPKC and Akt" . SPARSER::COLLECTION)
    ("The polarity complex atypical PKC" . SPARSER::PROTEIN)
    ("aPKC" . SPARSER::PROTEIN) ("Dynamin 2" . SPARSER::PROTEIN)
    ("dynamin 2" . SPARSER::PROTEIN) ("Hsp40" . SPARSER::PROTEIN)
    ("Hsc70" . SPARSER::PROTEIN) ("Krt19" . SPARSER::PROTEIN)
    ("Atypical protein kinase" . SPARSER::PROTEIN) ("Rab11" . SPARSER::PROTEIN)
    ("microglial genes" . SPARSER::GENE)
    ("various pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("risperidone" . SPARSER::DRUG) ("Celecoxib" . SPARSER::DRUG)
    ("NMDA" . SPARSER::MOLECULE) ("eicosanoid" . SPARSER::MOLECULE)
    ("PTGS1 and ALOX5" . SPARSER::COLLECTION) ("recorded drug" . SPARSER::DRUG)
    ("PTGS1, PTGS2 and PTGER3" . SPARSER::COLLECTION)
    ("PTGS1 and PTGER3" . SPARSER::COLLECTION)
    ("PTGER3 and CYP4Z1" . SPARSER::COLLECTION)
    ("PTGS1, PTGER3, CYP4A11, PLA2G12A and PLA2G4C" . SPARSER::COLLECTION)
    ("PTGS2, CYP4Z1, CYP1B1, CYP19A1, PLA2G5, PLA2G6 and PLA2G12A"
     . SPARSER::COLLECTION)
    ("AA and schizophrenia" . SPARSER::COLLECTION)
    ("endoperoxide" . SPARSER::PROTEIN) ("subsequent PGE 2" . SPARSER::DRUG)
    ("AA and phospholipase A 2" . SPARSER::COLLECTION)
    ("Eicosanoids" . SPARSER::MOLECULE)
    ("lipooxygenase (ALOX) and cytochrome P450 family member (CYP) enzymes ( xref )"
     . SPARSER::COLLECTION)
    ("phospholipase A2 (PLA2), prostaglandin-endoperoxide synthase (PTGS), lipooxygenase (ALOX) and cytochrome P450 family member (CYP) enzymes ( xref )"
     . SPARSER::COLLECTION)
    ("CYP" . SPARSER::PROTEIN) ("lipooxygenase" . SPARSER::PROTEIN)
    ("eicosanoids" . SPARSER::MOLECULE)
    ("prostaglandin-endoperoxide synthase 1 ( PTGS1 ; aka COX-1) and prostaglandin-endoperoxide receptor 3 ( PTGER3 ) mRNA"
     . SPARSER::COLLECTION)
    ("prostaglandin-endoperoxide" . SPARSER::COLLECTION)
    ("aka" . SPARSER::PROTEIN)
    ("arachidonic acid-related genes" . SPARSER::GENE)
    ("COX1" . SPARSER::PROTEIN) ("PLA2G4C" . SPARSER::PROTEIN)
    ("CYP4A11" . SPARSER::PROTEIN) ("ALOX5" . SPARSER::PROTEIN)
    ("PLA2G12A" . SPARSER::PROTEIN) ("PLA2G6" . SPARSER::PROTEIN)
    ("PLA2G5" . SPARSER::PROTEIN) ("CYP1B1" . SPARSER::PROTEIN)
    ("CYP4Z1" . SPARSER::PROTEIN)
    ("hypoxanthine-guanine phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("β-2-microglobulin" . SPARSER::PROTEIN) ("BA46" . SPARSER::PROTEIN)
    ("PLA 2" . SPARSER::PROTEIN) ("PTGER1" . SPARSER::PROTEIN)
    ("cytochrome P450" . SPARSER::PROTEIN-FAMILY)
    ("prostaglandin-endoperoxide synthase" . SPARSER::PROTEIN)
    ("PTGS2" . SPARSER::PROTEIN)
    ("prostaglandin-endoperoxide synthase 2" . SPARSER::PROTEIN)
    ("PTGER3" . SPARSER::PROTEIN) ("PTGS1" . SPARSER::PROTEIN)
    ("prostaglandin-endoperoxide synthase 1" . SPARSER::PROTEIN)
    ("YAP1 and its downstream effectors" . SPARSER::COLLECTION)
    ("shRNA, siRNA, and miRNA" . SPARSER::COLLECTION)
    ("trypsinization" . SPARSER::PROTEIN)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("The AllStars Negative Control siRNA (Neg siRNA) and AllStars Death Control siRNA (Qiagen)"
     . SPARSER::COLLECTION)
    ("relatively more YAP1" . SPARSER::PROTEIN)
    ("strong YAP1" . SPARSER::PROTEIN) ("differential YAP1" . SPARSER::PROTEIN)
    ("be cell type and/or cellular context" . SPARSER::COLLECTION)
    ("loss of heterozygosity, and shRNA" . SPARSER::COLLECTION)
    ("Hpo and Sav" . SPARSER::COLLECTION) ("Yki" . SPARSER::PROTEIN)
    ("Mats" . SPARSER::PROTEIN) ("Wts" . SPARSER::PROTEIN)
    ("Sav" . SPARSER::PROTEIN) ("Salvador" . SPARSER::PROTEIN)
    ("Hpo" . SPARSER::PROTEIN) ("signed-rank" . SPARSER::PROTEIN)
    ("caspase-7" . SPARSER::PROTEIN) ("p-YAP" . SPARSER::PROTEIN)
    ("a 20 µ" . SPARSER::PROTEIN) ("Glo 3" . SPARSER::PROTEIN)
    ("YAP65" . SPARSER::PROTEIN) ("MOB1" . SPARSER::PROTEIN)
    ("WW45" . SPARSER::PROTEIN) ("MST1" . SPARSER::PROTEIN)
    ("YAP1" . SPARSER::PROTEIN) ("Yes Associated Protein 1" . SPARSER::PROTEIN)
    ("E6 and E7" . SPARSER::COLLECTION) ("IRFs" . SPARSER::PROTEIN)
    ("Ets and IRF family" . SPARSER::COLLECTION)
    ("ternary complexes" . SPARSER::BIO-COMPLEX)
    ("IRF-4 or IRF-8" . SPARSER::COLLECTION)
    ("IRF-1, IRF-2, IRF-3, IRF-7 and IRF-9" . SPARSER::COLLECTION)
    ("IRF-4 and IRF-8" . SPARSER::COLLECTION)
    ("enhancers ,CD20, gp91 phox , and toll-like receptor 4"
     . SPARSER::COLLECTION)
    ("Ets-IRF" . SPARSER::COLLECTION)
    ("Ets-1, Elf-1, and GABPα" . SPARSER::COLLECTION)
    ("Ets-1 and Elf-l" . SPARSER::COLLECTION)
    ("Elf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Prf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRE, PIP and E-box" . SPARSER::COLLECTION) ("PIP" . SPARSER::PROTEIN)
    ("antibody, and IgG" . SPARSER::COLLECTION)
    ("chromatin and the cross-linked chromatin" . SPARSER::COLLECTION)
    ("formaldehyde" . SPARSER::MOLECULE) ("κPU" . SPARSER::PROTEIN)
    ("Ets-1 , E1AF and ERM" . SPARSER::COLLECTION)
    ("E1AF and ERM" . SPARSER::COLLECTION)
    ("Ets-1 , Ets-2 , E1AF and ERM" . SPARSER::COLLECTION)
    ("Ets-1, E1AF and ERM" . SPARSER::COLLECTION) ("ERM" . SPARSER::PROTEIN)
    ("E1AF , ESE1 , TEL2 and PDEF" . SPARSER::COLLECTION)
    ("PDEF" . SPARSER::PROTEIN) ("si-ERK" . SPARSER::COLLECTION)
    ("LMP1/ERK/Ets/kappa" . SPARSER::COLLECTION)
    ("Ets-1 and Ets-2" . SPARSER::COLLECTION)
    ("kinases, Raf, MEK and ERKs" . SPARSER::COLLECTION)
    ("Ras/ERK/MAPK" . SPARSER::COLLECTION)
    ("il-6, il-8, bcl-2, cd23, a20 and egfr" . SPARSER::COLLECTION)
    ("cd23" . SPARSER::PROTEIN) ("p38/MAPK" . SPARSER::COLLECTION)
    ("egfr" . SPARSER::PROTEIN) ("Pip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GGAA" . SPARSER::PROTEIN) ("ETS" . SPARSER::PROTEIN)
    ("pro-B and pre-B cell" . SPARSER::COLLECTION)
    ("MEK/ERKs" . SPARSER::COLLECTION) ("Core protein" . SPARSER::PROTEIN)
    ("IRF family" . SPARSER::PROTEIN) ("IRF-8" . SPARSER::PROTEIN)
    ("IRF-4" . SPARSER::PROTEIN) ("IRF-9" . SPARSER::PROTEIN)
    ("IRF-7" . SPARSER::PROTEIN) ("IRF-3" . SPARSER::PROTEIN)
    ("IRF-2" . SPARSER::PROTEIN) ("IRF-1" . SPARSER::PROTEIN)
    ("toll-like receptor 4" . SPARSER::PROTEIN)
    ("gp91 phox" . SPARSER::PROTEIN) ("PEA3" . SPARSER::PROTEIN)
    ("transcription factor Spi-C" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("Elf-1" . SPARSER::PROTEIN)
    ("TEL2" . SPARSER::PROTEIN) ("ESE1" . SPARSER::PROTEIN)
    ("E1AF" . SPARSER::PROTEIN) ("Bay11-7082" . SPARSER::DRUG)
    ("B15" . SPARSER::PROTEIN) ("a20" . SPARSER::PROTEIN)
    ("bcl-2" . SPARSER::PROTEIN) ("il-8" . SPARSER::PROTEIN)
    ("il-6" . SPARSER::PROTEIN) ("NH 2" . SPARSER::MOLECULE)
    ("Spi-C" . SPARSER::PROTEIN) ("Spi-B" . SPARSER::PROTEIN)
    ("Sap-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ets-2" . SPARSER::PROTEIN)
    ("LAB and LAX" . SPARSER::COLLECTION)
    ("three distal tyrosines" . SPARSER::AMINO-ACID)
    ("LAT, LAX and LAB" . SPARSER::COLLECTION)
    ("a monovalent inhibitor" . SPARSER::INHIBITOR)
    ("at least another adaptor Grap" . SPARSER::PROTEIN)
    ("Grap" . SPARSER::PROTEIN)
    ("The only adaptor molecule" . SPARSER::MOLECULE)
    ("only trivalent LAT and bivalent LAT molecules" . SPARSER::COLLECTION)
    ("bivalent LAT molecules" . SPARSER::MOLECULE)
    ("only trivalent LAT" . SPARSER::PROTEIN)
    ("Grb2-Cbl-Grb2" . SPARSER::COLLECTION)
    ("the bivalent LAT" . SPARSER::PROTEIN)
    ("increase bivalent LAT" . SPARSER::PROTEIN)
    ("no monovalent LAT" . SPARSER::PROTEIN)
    ("increase monovalent LAT" . SPARSER::PROTEIN)
    ("no bivalent LAT" . SPARSER::PROTEIN)
    ("kinase and LAT" . SPARSER::COLLECTION)
    ("SOS1 and trivalent LAT" . SPARSER::COLLECTION)
    ("Grb2, SOS1 and trivalent LAT" . SPARSER::COLLECTION)
    ("only bivalent and trivalent LAT" . SPARSER::PROTEIN)
    ("the monovalent LAT" . SPARSER::PROTEIN)
    ("only monovalent and trivalent LAT" . SPARSER::PROTEIN)
    ("fix" . SPARSER::PROTEIN)
    ("bivalent and monovalent LAT" . SPARSER::PROTEIN)
    ("monovalent and bivalent LAT" . SPARSER::PROTEIN)
    ("a homogeneous population oftrivalent LAT" . SPARSER::PROTEIN)
    ("monovalent, bivalent and trivalent LAT" . SPARSER::PROTEIN)
    ("monovalent LAT, Grb2 and SOS1" . SPARSER::COLLECTION)
    ("trivalent ligands" . SPARSER::LIGAND)
    ("bivalent cell surface receptors" . SPARSER::RECEPTOR)
    ("bivalent receptors" . SPARSER::PROTEIN)
    ("monovalent LAT" . SPARSER::PROTEIN) ("Monovalent LAT" . SPARSER::PROTEIN)
    ("bivalent LAT" . SPARSER::PROTEIN) ("smaller LAT" . SPARSER::PROTEIN)
    ("trivalent LAT, Grb2 and SOS1" . SPARSER::COLLECTION)
    ("LAT, Grb2 and SOS1" . SPARSER::COLLECTION)
    ("trivalent LAT" . SPARSER::PROTEIN)
    ("Grb2 and SOS1" . SPARSER::COLLECTION) ("FcRI" . SPARSER::PROTEIN)
    ("a bivalent ligand" . SPARSER::LIGAND)
    ("a trivalent scaffolding protein" . SPARSER::PROTEIN)
    ("this bivalent ligand" . SPARSER::LIGAND)
    ("SOS1 and Grb2" . SPARSER::COLLECTION)
    ("at least one phosphorylated distal tyrosine" . SPARSER::AMINO-ACID)
    ("Grb2-SOS1-Grb2" . SPARSER::COLLECTION)
    ("Grb2-SOS1" . SPARSER::COLLECTION)
    ("the extracellular allergen" . SPARSER::MOLECULE)
    ("IgE-FcRI" . SPARSER::COLLECTION) ("IgE" . SPARSER::PROTEIN)
    ("The distal three tyrosines" . SPARSER::AMINO-ACID)
    ("SOS1 and SLP-76" . SPARSER::COLLECTION)
    ("phospholipase C(PLC) and the adaptor proteins Grb2"
     . SPARSER::COLLECTION)
    ("mast cell" . SPARSER::PROTEIN)
    ("multivalent scaffolding molecules" . SPARSER::MOLECULE)
    ("other bivalent signaling molecules" . SPARSER::MOLECULE)
    ("bivalent scaffolding molecules" . SPARSER::MOLECULE)
    ("trivalent LAT molecules" . SPARSER::MOLECULE)
    ("Grb2, SOS1 and LAT" . SPARSER::COLLECTION)
    ("a separate LAT" . SPARSER::PROTEIN)
    ("LAT, LAB and LAX" . SPARSER::COLLECTION) ("LAX" . SPARSER::PROTEIN)
    ("LAB" . SPARSER::PROTEIN) ("LAT" . SPARSER::PROTEIN)
    ("Grb-2" . SPARSER::PROTEIN) ("branched chain" . SPARSER::PROTEIN)
    ("a chain" . SPARSER::PROTEIN) ("SOS1" . SPARSER::PROTEIN)
    ("NICD/CSL" . SPARSER::COLLECTION)
    ("a major mitotic serine/threonine kinase" . SPARSER::KINASE)
    ("PBX1, RNA Polymerase II, RSF-1, and SNF2H" . SPARSER::COLLECTION)
    ("NOTCH1 and NOTCH3" . SPARSER::COLLECTION)
    ("Notch3- and Notch1-" . SPARSER::COLLECTION)
    ("Notch1-" . SPARSER::PROTEIN) ("Notch3-" . SPARSER::PROTEIN)
    ("GCC" . SPARSER::PROTEIN) ("unique co-factors" . SPARSER::MOLECULE)
    ("DLGAP5-shRNA" . SPARSER::COLLECTION)
    ("shRNA or MRK003" . SPARSER::COLLECTION)
    ("NOTCH3 and DLGAP5" . SPARSER::COLLECTION)
    ("MRK003 or NOTCH3" . SPARSER::COLLECTION)
    ("cis/trans isomerase-1" . SPARSER::COLLECTION)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("the parental wildtype N1" . SPARSER::PROTEIN)
    ("three consecutive G or C nucleotides" . SPARSER::NUCLEOTIDE)
    ("CSL and NOTCH3" . SPARSER::COLLECTION) ("ATG" . SPARSER::DRUG)
    ("EHF, DLGAP5, DNAJC19, NCOA5 , and NRAS" . SPARSER::COLLECTION)
    ("EHF" . SPARSER::PROTEIN) ("NOTCH1/CSL" . SPARSER::COLLECTION)
    ("LGMN" . SPARSER::PROTEIN) ("N1-CSL" . SPARSER::COLLECTION)
    ("CSL and N1" . SPARSER::COLLECTION)
    ("a previously reported NOTCH1 target gene" . SPARSER::GENE)
    ("NEXT" . SPARSER::PROTEIN) ("Genes and pathways" . SPARSER::COLLECTION)
    ("whose promoters" . SPARSER::PROMOTER)
    ("NOTCH3 and its ligand" . SPARSER::COLLECTION)
    ("RBPJk" . SPARSER::PROTEIN) ("NICD" . SPARSER::PROTEIN)
    ("metalloprotease and γ-secretase" . SPARSER::COLLECTION)
    ("metalloprotease" . SPARSER::PROTEIN) ("ADAM" . SPARSER::PROTEIN)
    ("NOTCH1-NOTCH4" . SPARSER::COLLECTION)
    ("NOTCH3 and highlight DLGAP5" . SPARSER::COLLECTION)
    ("HURP/DLG7" . SPARSER::COLLECTION) ("HURP" . SPARSER::PROTEIN)
    ("NOTCH3/CSL" . SPARSER::COLLECTION) ("CSL" . SPARSER::PROTEIN)
    ("SNF2H" . SPARSER::PROTEIN) ("RSF-1" . SPARSER::PROTEIN)
    ("PBX1" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("trans isomerase" . SPARSER::PROTEIN)
    ("hepatoma up-regulated protein" . SPARSER::PROTEIN)
    ("Disks large-associated protein 5" . SPARSER::PROTEIN)
    ("DNAJC19" . SPARSER::PROTEIN) ("PIN1" . SPARSER::PROTEIN)
    ("NaHCO3" . SPARSER::DRUG) ("MRK003" . SPARSER::DRUG)
    ("Jagged1" . SPARSER::PROTEIN) ("NOTCH4" . SPARSER::PROTEIN)
    ("DLGAP5" . SPARSER::PROTEIN) ("NOTCH3" . SPARSER::PROTEIN)
    ("had lost localized XIST RNA" . SPARSER::RNA)
    ("docetaxel and cisplatin" . SPARSER::COLLECTION)
    ("significantly fewer XIST" . SPARSER::PROTEIN)
    ("Jarid1c" . SPARSER::PROTEIN) ("XIST" . SPARSER::PROTEIN)
    ("cis and subsequently trigger chromatin" . SPARSER::COLLECTION)
    ("subsequently trigger chromatin" . SPARSER::BIO-COMPLEX)
    ("wt" . SPARSER::PROTEIN) ("PM" . SPARSER::PROTEIN)
    ("MTD" . SPARSER::PROTEIN) ("functional P-gp" . SPARSER::PROTEIN)
    ("Abcb1a/b" . SPARSER::COLLECTION) ("MEEBO" . SPARSER::MOLECULE)
    ("doxorubicin-" . SPARSER::PROTEIN) ("Slc11a1" . SPARSER::PROTEIN)
    ("Lilrb4" . SPARSER::PROTEIN) ("Trem2" . SPARSER::PROTEIN)
    ("lysozyme" . SPARSER::PROTEIN) ("Abcb1a and Abcb1b" . SPARSER::COLLECTION)
    ("Brca1 and p53" . SPARSER::COLLECTION)
    ("gene expression ( xref ) two poor responders (T26*con and T41*con) form"
     . SPARSER::FORM)
    ("ABCC2 ( xref ) and ABCC10 ( xref )" . SPARSER::COLLECTION)
    ("ABCB1/P-glycoprotein" . SPARSER::COLLECTION)
    ("a meaningful delta" . SPARSER::PROTEIN)
    ("Oligonucleotide" . SPARSER::MOLECULE)
    ("cisplatin or docetaxel" . SPARSER::COLLECTION)
    ("drug or not" . SPARSER::COLLECTION)
    ("the Brca1 and the p53 genes" . SPARSER::COLLECTION)
    ("the topoisomerase II-inhibiting anthracycline doxorubicin"
     . SPARSER::PROTEIN)
    ("classical and novel targeted anti-cancer drugs" . SPARSER::DRUG)
    ("olaparib" . SPARSER::DRUG) ("anthracycline" . SPARSER::MOLECULE)
    ("topotecan" . SPARSER::DRUG)
    ("Prognostic and predictive biomarkers" . SPARSER::MOLECULE)
    ("Xist" . SPARSER::PROTEIN)
    ("docetaxel or cisplatin" . SPARSER::COLLECTION)
    ("Eif2s3x" . SPARSER::PROTEIN) ("PM-1" . SPARSER::PROTEIN)
    ("Abcc1" . SPARSER::PROTEIN) ("Abcb1b" . SPARSER::PROTEIN)
    ("Abcb1a" . SPARSER::PROTEIN) ("ABCC10" . SPARSER::PROTEIN)
    ("ABCC2" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("RNF12" . SPARSER::PROTEIN) ("Brca1" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("Abcb1" . SPARSER::PROTEIN)
    ("B-RAF, MEK or ERK" . SPARSER::COLLECTION)
    ("overcoming both mutant N-RAS" . SPARSER::PROTEIN)
    ("vemurafenib and selumetinib" . SPARSER::COLLECTION)
    ("K-RAS and MEK1" . SPARSER::COLLECTION)
    ("PDGFRβ or IGF-1R" . SPARSER::COLLECTION) ("COT" . SPARSER::PROTEIN)
    ("DP" . SPARSER::PROTEIN)
    ("selumetinib or its combination" . SPARSER::COLLECTION)
    ("pERK and re-sensitizing" . SPARSER::COLLECTION)
    ("delta-" . SPARSER::PROTEIN) ("DP2" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("GSK2118436" . SPARSER::DRUG)
    ("C-RAF" . SPARSER::PROTEIN) ("N-RAS" . SPARSER::PROTEIN)
    ("Interferon" . SPARSER::PROTEIN) ("STAT3/EGFR" . SPARSER::COLLECTION)
    ("Src kinase [ xref ] and PTPN12" . SPARSER::COLLECTION)
    ("PTPL1/PTPN13" . SPARSER::COLLECTION)
    ("PTPN7 [ xref ] and PTPN13 [ xref ]" . SPARSER::COLLECTION)
    ("PTPN1, PTPN3, and PTPN6" . SPARSER::COLLECTION)
    ("PTPMeg2 and pSTAT3" . SPARSER::COLLECTION)
    ("a strong phosphatase" . SPARSER::PHOSPHATASE)
    ("Bcl-xL and cyclin D1" . SPARSER::COLLECTION)
    ("pMSCV/PTPMeg2" . SPARSER::COLLECTION) ("INF" . SPARSER::PROTEIN)
    ("PTP" . SPARSER::PROTEIN) ("Meg2" . SPARSER::PROTEIN)
    ("Meg" . SPARSER::DRUG) ("GST-PTPMeg2CS" . SPARSER::COLLECTION)
    ("GST-PTPMeg2" . SPARSER::COLLECTION) ("PTPMeg2CS" . SPARSER::PROTEIN)
    ("PTPMeg2/STAT3" . SPARSER::COLLECTION)
    ("STAT3 and PTPMeg2" . SPARSER::COLLECTION)
    ("Myc-PTPMEG2" . SPARSER::COLLECTION) ("PTPMEG2" . SPARSER::PROTEIN)
    ("PTPMeg2 and STAT3" . SPARSER::COLLECTION)
    ("STAT5 or STAT1" . SPARSER::COLLECTION) ("PTPMeg2" . SPARSER::PROTEIN)
    ("Flag-STAT3" . SPARSER::COLLECTION) ("Myc-PTPMeg2" . SPARSER::COLLECTION)
    ("phosphatases, and PTPMeg2" . SPARSER::COLLECTION)
    ("PTPMeg2 directly targets STAT3" . SPARSER::PROTEIN)
    ("STAT3 [ xref ] and STAT5 [ xref , xref ]" . SPARSER::COLLECTION)
    ("retinaldehyde-binding protein and yeast SEC14p" . SPARSER::COLLECTION)
    ("EGFR, ErB2 and Fox-1" . SPARSER::COLLECTION) ("ErB" . SPARSER::PROTEIN)
    ("retinaldehyde" . SPARSER::MOLECULE)
    ("SHP2 [ xref - xref ] and TC-PTP (PTPN2)" . SPARSER::COLLECTION)
    ("STAT1, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("JAK2, TYK2, STAT5a/b [ xref , xref ], and STAT6 [ xref ] in the nucleus"
     . SPARSER::COLLECTION)
    ("PTPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK or Src kinase" . SPARSER::COLLECTION)
    ("Kinase (JAK) or growth factor receptor-associated tyrosine kinase (Src)"
     . SPARSER::COLLECTION)
    ("growth factor receptor-associated tyrosine kinase" . SPARSER::PROTEIN)
    ("many extracellular cytokines and growth factors" . SPARSER::COLLECTION)
    ("Suppressor of Cytokine Signaling 3" . SPARSER::PROTEIN)
    ("SOCS 3" . SPARSER::PROTEIN)
    ("Protein Tyrosine Phosphatase" . SPARSER::PROTEIN)
    ("Glutathione S-transferase" . SPARSER::PROTEIN)
    ("PTPL1" . SPARSER::PROTEIN) ("PTPN13" . SPARSER::PROTEIN)
    ("PTPN7" . SPARSER::PROTEIN) ("PTPN12" . SPARSER::PROTEIN)
    ("PTPN6" . SPARSER::PROTEIN) ("PTPN3" . SPARSER::PROTEIN)
    ("PTPN1" . SPARSER::PROTEIN) ("c-nu" . SPARSER::PROTEIN)
    ("MK3" . SPARSER::PROTEIN) ("M67" . SPARSER::PROTEIN)
    ("F-2" . SPARSER::PROTEIN) ("Fox-1" . SPARSER::PROTEIN)
    ("SEC14" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase, non-receptor type 9" . SPARSER::PROTEIN)
    ("PTPN9" . SPARSER::PROTEIN) ("PTPN2" . SPARSER::PROTEIN)
    ("TC-PTP" . SPARSER::PROTEIN) ("PTP1B" . SPARSER::PROTEIN)
    ("IRF3 or interferon" . SPARSER::COLLECTION)
    ("STING and TBK1" . SPARSER::COLLECTION)
    ("TRAF2, TRAF3 and TRAF6" . SPARSER::COLLECTION)
    ("TRAF" . SPARSER::PROTEIN-FAMILY)
    ("IRF3 and a C-terminal fragment" . SPARSER::COLLECTION)
    ("TBK1, IRF3 and a C-terminal fragment" . SPARSER::COLLECTION)
    ("only three proteins" . SPARSER::PROTEIN)
    ("MAVS and TRIF" . SPARSER::COLLECTION)
    ("IL-1 and TNF" . SPARSER::COLLECTION)
    ("RIG-I and MDA5, and STING" . SPARSER::COLLECTION)
    ("MDA5, and STING" . SPARSER::COLLECTION)
    ("TLR2 and TLR5" . SPARSER::COLLECTION)
    ("TNF or IL-1" . SPARSER::COLLECTION)
    ("calf intestinal phosphatase (CIP)" . SPARSER::PHOSPHATASE)
    ("STING and IRF3" . SPARSER::COLLECTION)
    ("STING, IRF3 and TBK1" . SPARSER::COLLECTION)
    ("GST-STING" . SPARSER::COLLECTION)
    ("STING and TBK1 or IRF3" . SPARSER::COLLECTION)
    ("TBK1 or IRF3" . SPARSER::COLLECTION) ("GST-TBK1" . SPARSER::COLLECTION)
    ("Flag-TBK1" . SPARSER::COLLECTION) ("IKKα or IKKβ" . SPARSER::COLLECTION)
    ("Flag-NEMO" . SPARSER::COLLECTION)
    ("just 3 amino acids" . SPARSER::AMINO-ACID)
    ("-IRF3" . SPARSER::COLLECTION)
    ("phosphoserine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("-STING" . SPARSER::COLLECTION) ("STING-Flag" . SPARSER::COLLECTION)
    ("ISD" . SPARSER::DNA) ("interferon stimulatory DNA (ISD)" . SPARSER::DNA)
    ("RIG-I, MDA5 or MAVS" . SPARSER::COLLECTION)
    ("just 39 amino acids" . SPARSER::AMINO-ACID)
    ("HIN" . SPARSER::PROTEIN-FAMILY) ("DAI" . SPARSER::PROTEIN)
    ("the microbial DNA" . SPARSER::DNA)
    ("antiviral and proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IRF3 and NF-κB" . SPARSER::COLLECTION)
    ("IPS-1, CARDIF, and VISA" . SPARSER::COLLECTION)
    ("CARDIF" . SPARSER::PROTEIN)
    ("RIG-I, MDA5 and LGP2" . SPARSER::COLLECTION) ("Viral RNA" . SPARSER::RNA)
    ("RLRs" . SPARSER::PROTEIN) ("MITA, MPYS and ERIS" . SPARSER::COLLECTION)
    ("ERIS" . SPARSER::PROTEIN) ("MITA" . SPARSER::PROTEIN)
    ("P20" . SPARSER::PROTEIN) ("Texas Red" . SPARSER::DRUG)
    ("TRIM56" . SPARSER::PROTEIN) ("P100" . SPARSER::PROTEIN)
    ("caspase-1" . SPARSER::PROTEIN) ("AIM2" . SPARSER::PROTEIN)
    ("LGP2" . SPARSER::PROTEIN) ("which targets p57" . SPARSER::PROTEIN)
    ("c-Myc, Elk-1, and EZH-2" . SPARSER::COLLECTION)
    ("kinases and p57" . SPARSER::COLLECTION)
    ("PI3K and ERK" . SPARSER::COLLECTION)
    ("ERK-Akt-p57" . SPARSER::COLLECTION) ("Akt and ERK" . SPARSER::COLLECTION)
    ("cyclin D1, c-Myc, and mTOR" . SPARSER::COLLECTION)
    ("mammary acini" . SPARSER::PROTEIN) ("methylases" . SPARSER::PROTEIN)
    ("little basal p57" . SPARSER::PROTEIN) ("PI3K-mTOR" . SPARSER::COLLECTION)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pERK and pAkt" . SPARSER::COLLECTION) ("PI3K-TOR" . SPARSER::COLLECTION)
    ("Torin-1 or BEZ-235" . SPARSER::COLLECTION)
    ("EGF-, or EGF-" . SPARSER::COLLECTION) ("myrAkt" . SPARSER::PROTEIN)
    ("myrAkt-ER" . SPARSER::COLLECTION)
    ("Torin-1 and BEZ-235" . SPARSER::COLLECTION)
    ("specifically targets mTOR Complex" . SPARSER::BIO-COMPLEX)
    ("four unique shRNA" . SPARSER::PROTEIN)
    ("p21 or p57" . SPARSER::COLLECTION)
    ("IGF-1 and EGF" . SPARSER::COLLECTION)
    ("c-Fos and c-Myc" . SPARSER::COLLECTION)
    ("c-Myc, c-Fos, and phospho-S6" . SPARSER::COLLECTION)
    ("EGF and IGF-1" . SPARSER::COLLECTION)
    ("EGF and insulin-like growth factor" . SPARSER::COLLECTION)
    ("CDK4/6-cyclin D" . SPARSER::COLLECTION)
    ("CDKN1A, CDKN1B, and CDKN1C" . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 Kip1 , and p57 Kip2" . SPARSER::COLLECTION)
    ("cyclin-CDK" . SPARSER::COLLECTION) ("CIP/KIP" . SPARSER::COLLECTION)
    ("KIP" . SPARSER::PROTEIN) ("CIP" . SPARSER::PROTEIN)
    ("CKIs" . SPARSER::PROTEIN)
    ("pathological or deregulated states" . SPARSER::BIO-STATE)
    ("ERK and its target p90RSK (p90 ribosomal S6 kinase)"
     . SPARSER::COLLECTION)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY)
    ("phospho-Akt and phospho-ERK" . SPARSER::COLLECTION)
    ("c-Fos and Ets-1" . SPARSER::COLLECTION)
    ("IRS-1 (insulin receptor substrate 1) or Gab1" . SPARSER::COLLECTION)
    ("associated adaptor proteins" . SPARSER::PROTEIN)
    ("PI3K-Akt" . SPARSER::COLLECTION)
    ("guanosine triphosphate (GTP)" . SPARSER::MOLECULE)
    ("Raf-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERK or PI3K" . SPARSER::COLLECTION)
    ("mammary epithelial acini" . SPARSER::PROTEIN)
    ("tumor-associated PI3K mutant variants" . SPARSER::VARIANT)
    ("p21 Cip1 and p57 Kip2" . SPARSER::COLLECTION)
    ("RPLP0" . SPARSER::PROTEIN) ("Egr-1" . SPARSER::PROTEIN)
    ("cAMP-response element binding protein" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("EZH-2" . SPARSER::PROTEIN) ("4OHT" . SPARSER::DRUG)
    ("Torin-1" . SPARSER::DRUG) ("FoxO3a" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::GROWTH-FACTOR) ("CDK4/6" . SPARSER::PROTEIN)
    ("phosphoinositide-dependent protein kinase 1" . SPARSER::PROTEIN)
    ("protein kinase kinase" . SPARSER::PROTEIN)
    ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("son of sevenless" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("CDKN1C" . SPARSER::PROTEIN) ("p57 Kip2" . SPARSER::PROTEIN)
    ("pentapeptides" . SPARSER::MOLECULE) ("-protein" . SPARSER::COLLECTION)
    ("guanidinium" . SPARSER::MOLECULE)
    ("the phosphate group and the P+4 Pro residue" . SPARSER::COLLECTION)
    ("carboxamide" . SPARSER::MOLECULE) ("GST-" . SPARSER::PROTEIN)
    ("Sepharose" . SPARSER::MOLECULE)
    ("an immortal human mammary epithelial cell line 16A5" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cbl(TKB)" . SPARSER::PROTEIN) ("-peptide" . SPARSER::PEPTIDE)
    ("SPR" . SPARSER::PROTEIN)
    ("its parental 12-mer peptide" . SPARSER::PEPTIDE)
    ("biochemical reagents" . SPARSER::MOLECULE) ("TKB" . SPARSER::PROTEIN)
    ("PTK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the parental peptide" . SPARSER::PEPTIDE) ("Cbl" . SPARSER::PROTEIN)
    ("pentapeptide" . SPARSER::MOLECULE) ("16A" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitin conjugating enzymes" . SPARSER::PROTEIN-FAMILY)
    ("Casitas B-Lineage Lymphoma" . SPARSER::PROTEIN)
    ("olanzapine and clozapine" . SPARSER::COLLECTION)
    ("clozapine" . SPARSER::DRUG) ("olanzapine" . SPARSER::DRUG)
    ("haloperidol" . SPARSER::DRUG) ("Hypoxia" . SPARSER::PROTEIN)
    ("Inositol" . SPARSER::PROTEIN) ("neurotrophin/trk" . SPARSER::COLLECTION)
    ("trk" . SPARSER::PROTEIN) ("BDNF" . SPARSER::PROTEIN)
    ("Neurotrophins" . SPARSER::PROTEIN)
    ("growth factor and cytokine" . SPARSER::COLLECTION)
    ("neurotrophin/Trk" . SPARSER::COLLECTION) ("Trk" . SPARSER::PROTEIN)
    ("Neuregulin" . SPARSER::PROTEIN)
    ("an immunological component" . SPARSER::COMPONENT)
    ("Xenobiotic" . SPARSER::MOLECULE) ("RI" . SPARSER::MOLECULE)
    ("Epsilon" . SPARSER::PROTEIN)
    ("both AKT2 (p = 0.07) and AKT3 (p = 0.06)" . SPARSER::COLLECTION)
    ("substance" . SPARSER::SUBSTANCE) ("Antipsychotic" . SPARSER::DRUG)
    ("AKT1 in PBMC's" . SPARSER::PROTEIN) ("neurotrophin" . SPARSER::PROTEIN)
    ("AKT2 and AKT3" . SPARSER::COLLECTION)
    ("nicotine or cannabis" . SPARSER::COLLECTION) ("cannabis" . SPARSER::DRUG)
    ("Male" . SPARSER::MOLECULE) ("antipsychotics" . SPARSER::DRUG)
    ("AKT1, AKT2, and AKT3" . SPARSER::COLLECTION)
    ("neurotrophins" . SPARSER::PROTEIN) ("antipsychotic" . SPARSER::DRUG)
    ("Insulin Receptor" . SPARSER::PROTEIN)
    ("Brain-Derived Neurotrophic Factor" . SPARSER::PROTEIN)
    ("Ephrin receptor" . SPARSER::PROTEIN) ("GSK-3B" . SPARSER::PROTEIN)
    ("GSK-3A" . SPARSER::PROTEIN) ("4-amino DFP analogs" . SPARSER::ANALOG)
    ("these 4-amino substituted DFP analogs" . SPARSER::ANALOG)
    ("Fyn, Lck, and Fgr" . SPARSER::COLLECTION)
    ("c-Src and Hck" . SPARSER::COLLECTION)
    ("the Nef-defective mutant and the Nef chimeras in the absence or presence"
     . SPARSER::COLLECTION)
    ("the Nef-defective mutant" . SPARSER::MUTANT)
    ("inhibitors of both Nef-dependent SFK activation and HIV replication xref"
     . SPARSER::COLLECTION)
    ("4-amino substituted DFP analogs" . SPARSER::ANALOG)
    ("major capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/CXCR4" . SPARSER::COLLECTION)
    ("4-amino-substituted DFP" . SPARSER::PROTEIN-FAMILY)
    ("CD4 and the co-receptor CXCR4" . SPARSER::COLLECTION)
    ("4-amino substituted derivatives" . SPARSER::DERIVATIVE)
    ("Lck, Fyn or Fgr" . SPARSER::COLLECTION)
    ("Hck-YEEI" . SPARSER::COLLECTION) ("galactose" . SPARSER::MOLECULE)
    ("Hck and other Src-family kinases" . SPARSER::COLLECTION)
    ("YEEI" . SPARSER::PROTEIN)
    ("soluble recombinant proteins" . SPARSER::PROTEIN)
    ("a binding-defective mutant" . SPARSER::MUTANT)
    ("yielded soluble recombinant proteins" . SPARSER::PROTEIN)
    ("the many allelic variants" . SPARSER::VARIANT)
    ("a unique activated conformation" . SPARSER::BIO-CONFORMATION)
    ("dominant-negative Hck or CD45 phosphatase" . SPARSER::PHOSPHATASE)
    ("Hck or CD45" . SPARSER::COLLECTION)
    ("c-Src and Lyn" . SPARSER::COLLECTION)
    ("Nef-defective forms" . SPARSER::FORM)
    ("CD4 and MHC-1" . SPARSER::COLLECTION)
    ("Hck, Lyn and c-Src" . SPARSER::COLLECTION)
    ("U87MG and CEM-T4" . SPARSER::COLLECTION)
    ("DFP" . SPARSER::PROTEIN-FAMILY) ("DFPs" . SPARSER::PROTEIN-FAMILY)
    ("Representative Nef proteins" . SPARSER::PROTEIN)
    ("Hck and Lyn" . SPARSER::COLLECTION)
    ("Gag proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("c-Yes" . SPARSER::PROTEIN) ("MT2" . SPARSER::PROTEIN)
    ("pYC2" . SPARSER::PROTEIN) ("GAL10" . SPARSER::PROTEIN)
    ("DNA2" . SPARSER::PROTEIN)
    ("capsid proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MT-2" . SPARSER::PROTEIN) ("SF2" . SPARSER::PROTEIN)
    ("protein-tyrosine kinase" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::PROTEIN)
    ("Smad3 and TGF-βRII" . SPARSER::COLLECTION) ("Muc16" . SPARSER::PROTEIN)
    ("cyclin D1 and MUC4" . SPARSER::COLLECTION)
    ("p42/p44" . SPARSER::COLLECTION)
    ("ErbB1 (EGF-R) and ErbB4" . SPARSER::COLLECTION)
    ("MUC4, ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("ErbB3 and MUC4" . SPARSER::COLLECTION)
    ("MUC4 and galectin-3" . SPARSER::COLLECTION)
    ("galectins" . SPARSER::PROTEIN) ("mucins" . SPARSER::PROTEIN)
    ("Galectins" . SPARSER::PROTEIN)
    ("lectins, selectins, and receptors" . SPARSER::COLLECTION)
    ("selectins" . SPARSER::PROTEIN)
    ("an active MUC4-ErbB2 complex" . SPARSER::BIO-COMPLEX)
    ("CA-9, ITG-β6, ITG-β7 and TGF-β1" . SPARSER::COLLECTION)
    ("MUC4, and carbonic anhydrase 9" . SPARSER::COLLECTION)
    ("Serpina3" . SPARSER::PROTEIN) ("JNK and p42/44" . SPARSER::COLLECTION)
    ("Akt and FAK" . SPARSER::COLLECTION)
    ("p42/p44 MAPK" . SPARSER::COLLECTION)
    ("p42/44, p38 and JNK" . SPARSER::COLLECTION)
    ("laminin" . SPARSER::PROTEIN) ("Bax and Bcl" . SPARSER::COLLECTION)
    ("p27 kip1 cell cycle inhibitor and decrease of cyclin D1 ( xref )"
     . SPARSER::COLLECTION)
    ("ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("ErbB1 and ErbB4" . SPARSER::COLLECTION)
    ("the GST-MUC4 EGF3+1+2 fusion protein or the GST" . SPARSER::COLLECTION)
    ("GST-MUC4" . SPARSER::COLLECTION)
    ("using irrelevant rabbit IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ErbB2 or MUC4" . SPARSER::COLLECTION) ("known ligand" . SPARSER::LIGAND)
    ("ErbB3 and ErbB4" . SPARSER::COLLECTION) ("ErbB4" . SPARSER::PROTEIN)
    ("EGFR/ErbB1" . SPARSER::COLLECTION)
    ("Muc4 and ErbB2" . SPARSER::COLLECTION)
    ("EGF3, EGF1 and EGF2" . SPARSER::COLLECTION)
    ("MUC4-KD" . SPARSER::COLLECTION) ("MUC4 or ErbB2" . SPARSER::COLLECTION)
    ("MUC4 and ErbB2" . SPARSER::COLLECTION)
    ("ErbB2 and MUC4" . SPARSER::COLLECTION) ("mucin" . SPARSER::PROTEIN)
    ("COL8A1" . SPARSER::PROTEIN) ("TGF-β 1" . SPARSER::PROTEIN)
    ("Muc1" . SPARSER::PROTEIN) ("cyclin G2" . SPARSER::PROTEIN)
    ("ECT2" . SPARSER::PROTEIN) ("fibronectin type III" . SPARSER::PROTEIN)
    ("galectin-3" . SPARSER::PROTEIN) ("galectin-1" . SPARSER::PROTEIN)
    ("ST6" . SPARSER::PROTEIN) ("FUT8" . SPARSER::PROTEIN)
    ("B3GNT3" . SPARSER::PROTEIN) ("B3GNT5" . SPARSER::PROTEIN)
    ("ST3GAL6" . SPARSER::PROTEIN) ("CA-9" . SPARSER::PROTEIN)
    ("carbonic anhydrase 9" . SPARSER::PROTEIN)
    ("type VIII" . SPARSER::PROTEIN) ("keratin86" . SPARSER::PROTEIN)
    ("keratin81" . SPARSER::PROTEIN) ("ATP2C2" . SPARSER::PROTEIN)
    ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("type 2C" . SPARSER::PROTEIN)
    ("p44 MAPK" . SPARSER::PROTEIN) ("p42" . SPARSER::PROTEIN)
    ("anti-MUC1" . SPARSER::DRUG) ("CF2" . SPARSER::PROTEIN)
    ("anti-ErbB2" . SPARSER::DRUG) ("MUC1" . SPARSER::PROTEIN)
    ("H-5" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("ErbB-3" . SPARSER::PROTEIN) ("p42/44" . SPARSER::PROTEIN)
    ("ErbB-2" . SPARSER::PROTEIN) ("ErbB1" . SPARSER::PROTEIN)
    ("Muc4" . SPARSER::PROTEIN) ("EGF2" . SPARSER::PROTEIN)
    ("EGF1" . SPARSER::PROTEIN) ("MUC4" . SPARSER::PROTEIN)
    ("myeloid or lymphoid" . SPARSER::COLLECTION)
    ("VavP-Myc" . SPARSER::COLLECTION) ("CD2-MYC" . SPARSER::COLLECTION)
    ("proteins and NFκB" . SPARSER::COLLECTION) ("Eμ-" . SPARSER::PROTEIN)
    ("Eμ" . SPARSER::PROTEIN) ("Eμ-MYC" . SPARSER::PROTEIN-PAIR)
    ("BLC" . SPARSER::PROTEIN) ("A–B" . SPARSER::PROTEIN)
    ("MYC-" . SPARSER::PROTEIN) ("MYC/BCL-2" . SPARSER::COLLECTION)
    ("CD3 and MPO" . SPARSER::COLLECTION) ("Abs" . SPARSER::PROTEIN)
    ("-c" . SPARSER::COLLECTION) ("Gr1 and CD11b" . SPARSER::COLLECTION)
    ("/YFP" . SPARSER::COLLECTION) ("BCL-2/MYC" . SPARSER::COLLECTION)
    ("MYC and BCL-2" . SPARSER::COLLECTION) ("BALB/c" . SPARSER::COLLECTION)
    ("MYC/BCL-X" . SPARSER::COLLECTION) ("-GFP/MYC-YFP" . SPARSER::COLLECTION)
    ("myeloid and lymphoid" . SPARSER::COLLECTION)
    ("the erythroid markers anti-CD71" . SPARSER::ANTIBODY)
    ("the B-cell markers anti-CD19 and anti-IgM" . SPARSER::COLLECTION)
    ("the T-cell markers anti-CD4 and anti-CD8" . SPARSER::COLLECTION)
    ("the myeloid markers anti-CD11b and anti-Gr1" . SPARSER::COLLECTION)
    ("anti-CD11b and anti-Gr1" . SPARSER::COLLECTION)
    ("anti-CD4 and anti-CD8" . SPARSER::COLLECTION)
    ("anti-CD19 and anti-IgM" . SPARSER::COLLECTION)
    ("agonistic anti-Fas mAb" . SPARSER::DRUG) ("-GFP" . SPARSER::COLLECTION)
    ("/MYC" . SPARSER::COLLECTION) ("MYC and BCL-X" . SPARSER::COLLECTION)
    ("myeloid, erythroid and lymphoid" . SPARSER::COLLECTION)
    ("YFP and GFP" . SPARSER::COLLECTION) ("GFP and YFP" . SPARSER::COLLECTION)
    ("MYC-YFP" . SPARSER::COLLECTION) ("a bicistronic mRNA" . SPARSER::PROTEIN)
    ("GFP or YFP" . SPARSER::COLLECTION) ("IRES" . SPARSER::PROTEIN)
    ("the retroviral LTR promoter" . SPARSER::PROMOTER)
    ("/CD8" . SPARSER::COLLECTION)
    ("myeloid and T-lymphoid" . SPARSER::COLLECTION)
    ("receptor or FADD" . SPARSER::COLLECTION) ("TRAIL-" . SPARSER::PROTEIN)
    ("RAS, MAPK and PI3 kinase" . SPARSER::COLLECTION)
    ("Part" . SPARSER::COMPONENT) ("Fas or TRAIL-R" . SPARSER::COLLECTION)
    ("Fas-ligand, TNF-α or TRAIL" . SPARSER::COLLECTION)
    ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bim and Bax" . SPARSER::COLLECTION)
    ("BCL-2 or BCL-X" . SPARSER::COLLECTION)
    ("BCL-2 and BCL-X" . SPARSER::COLLECTION)
    ("Further evidence linking MYC" . SPARSER::PROTEIN)
    ("MYC or MYCN" . SPARSER::COLLECTION) ("MLL-ENL" . SPARSER::COLLECTION)
    ("ENL" . SPARSER::PROTEIN) ("MYC and MYCN" . SPARSER::COLLECTION)
    ("MYCL" . SPARSER::PROTEIN)
    ("MLL, AML1, CBF, EVI1 and RARα" . SPARSER::COLLECTION)
    ("CBF" . SPARSER::PROTEIN) ("MYC/FLIP" . SPARSER::COLLECTION)
    ("MYC and FLIP" . SPARSER::COLLECTION) ("/BCL-2" . SPARSER::COLLECTION)
    ("target cell" . SPARSER::PROTEIN) ("T–cell" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("anti-IgM" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN) ("Gr1" . SPARSER::PROTEIN)
    ("TNFR superfamily" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("Fas-ligand" . SPARSER::PROTEIN) ("p19Arf" . SPARSER::PROTEIN)
    ("EVI1" . SPARSER::PROTEIN) ("BCL-X" . SPARSER::PROTEIN)
    ("mitochondrial)" . SPARSER::PROTEIN)
    ("EGF and MCP-1" . SPARSER::COLLECTION) ("etanercept" . SPARSER::DRUG)
    ("C-reactive protein and IgM" . SPARSER::COLLECTION)
    ("EGFR, Erk and Akt" . SPARSER::COLLECTION)
    ("AG1478 and PD153035" . SPARSER::COLLECTION)
    ("EGF and EGFR" . SPARSER::COLLECTION)
    ("RANKL and TNF" . SPARSER::COLLECTION)
    ("IL-8 and MCP-1" . SPARSER::COLLECTION)
    ("IL-8, VEGF, MMP-3 and MCP-1" . SPARSER::COLLECTION)
    ("MMPs and proinflammatory molecules ( xref )" . SPARSER::COLLECTION)
    ("TNF and IL-1β" . SPARSER::COLLECTION)
    ("VEGF, IL-8, GM-CSF, and IL-6" . SPARSER::COLLECTION)
    ("Amphiregulin" . SPARSER::PROTEIN) ("Betacellulin" . SPARSER::PROTEIN)
    ("the exact EGF ligand" . SPARSER::MOLECULE)
    ("TGFα, HB-EGF, or amphiregulin" . SPARSER::COLLECTION)
    ("EGF, TGFα, and amphiregulin" . SPARSER::COLLECTION)
    ("M-CSF and RANKL" . SPARSER::COLLECTION)
    ("EGFR, Akt and Erk1/2" . SPARSER::COLLECTION)
    ("erlotinib and PD153035" . SPARSER::COLLECTION)
    ("TNFα-receptor type" . SPARSER::COLLECTION)
    ("integrin beta-3, and Nfatc1" . SPARSER::COLLECTION)
    ("Itgb3" . SPARSER::PROTEIN) ("phosphatase (TRAP)" . SPARSER::PHOSPHATASE)
    ("TRAP" . SPARSER::PROTEIN) ("EGF and HB-EGF" . SPARSER::COLLECTION)
    ("Akt and Erk1/2" . SPARSER::COLLECTION)
    ("erlotinib or PD153035" . SPARSER::COLLECTION)
    ("VEGF, IL-8, MCP-1 and MMP-3" . SPARSER::COLLECTION)
    ("Erlotinib and PD153035" . SPARSER::COLLECTION)
    ("tested erlotinib’s" . SPARSER::DRUG)
    ("the IgG1 or IgG2a titers ( xref )" . SPARSER::COLLECTION)
    ("EGFR and P-EGFR" . SPARSER::COLLECTION)
    ("EGFR and tyrosine-1068-phosphorylated" . SPARSER::COLLECTION)
    ("RA and CIA" . SPARSER::COLLECTION)
    ("TGFα, amphiregulin, or HB-EGF" . SPARSER::COLLECTION)
    ("EGF and betacellulin" . SPARSER::COLLECTION)
    ("betacellulin" . SPARSER::PROTEIN)
    ("EGF, TGFα, or amphiregulin" . SPARSER::COLLECTION)
    ("amphiregulin" . SPARSER::PROTEIN) ("Tarceva" . SPARSER::DRUG)
    ("EGFR, ErbB2 and ErbB3" . SPARSER::COLLECTION)
    ("soluble herstatin" . SPARSER::PROTEIN) ("herstatin" . SPARSER::PROTEIN)
    ("inflammatory mediators and chemokines" . SPARSER::COLLECTION)
    ("mediators and chemokines" . SPARSER::COLLECTION)
    ("abatacept, rituximab and tocilizumab" . SPARSER::COLLECTION)
    ("abatacept" . SPARSER::DRUG)
    ("cytokines and autoantibodies" . SPARSER::COLLECTION)
    ("CIA" . SPARSER::PROTEIN) ("cytoplasmic 1" . SPARSER::PROTEIN)
    ("integrin beta-3" . SPARSER::PROTEIN) ("Cathepsin K" . SPARSER::PROTEIN)
    ("Von-Willebrand factor" . SPARSER::PROTEIN)
    ("Lactic acid" . SPARSER::MOLECULE) ("Nfatc1" . SPARSER::PROTEIN)
    ("Mmp3" . SPARSER::PROTEIN) ("Hprt1" . SPARSER::PROTEIN)
    ("Acp5" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("HB-EGF" . SPARSER::PROTEIN) ("CD11c" . SPARSER::PROTEIN)
    ("CD20" . SPARSER::PROTEIN) ("H37" . SPARSER::PROTEIN)
    ("von-Willebrand Factor" . SPARSER::PROTEIN)
    ("triton X-100" . SPARSER::MOLECULE) ("M-CSF" . SPARSER::PROTEIN)
    ("PD153035" . SPARSER::DRUG) ("ErbB3" . SPARSER::PROTEIN)
    ("S33Y" . SPARSER::PROTEIN) ("the viral oncoprotein" . SPARSER::PROTEIN)
    ("a complex in vivo and downregulation of DLG expression"
     . SPARSER::COLLECTION)
    ("both PDZ domain-containing junctional proteins" . SPARSER::PROTEIN)
    ("MAGI-1 or Scribble" . SPARSER::COLLECTION)
    ("MAGI-1 and β-catenin" . SPARSER::COLLECTION)
    ("wt-β-catenin and wt-DLG" . SPARSER::COLLECTION)
    ("wt-DLG" . SPARSER::PROTEIN-PAIR) ("wt-β-catenin" . SPARSER::PROTEIN-PAIR)
    ("proteins, Scribble and MAGI-1" . SPARSER::COLLECTION)
    ("E7 and EJ-ras" . SPARSER::COLLECTION)
    ("the ΔPBM mutant of β-catenin (lanes 7-9) and the residual levels of DLG"
     . SPARSER::COLLECTION)
    ("Wild type DLG and the 3PDZ and ΔNT mutants" . SPARSER::COLLECTION)
    ("mutant (DLGCT)" . SPARSER::MUTANT)
    ("the N-terminal 222 amino acids of DLG" . SPARSER::PROTEIN)
    ("anti-β-catenin" . SPARSER::COLLECTION) ("GST-Dlg" . SPARSER::COLLECTION)
    ("GST and Histidine" . SPARSER::COLLECTION)
    ("Dlg and β-catenin" . SPARSER::COLLECTION)
    ("either wild type HA-tagged β-catenin or a mutant HA-tagged β-catenin"
     . SPARSER::COLLECTION)
    ("DLG and β-catenin" . SPARSER::COLLECTION)
    ("antibody and co-precipitating" . SPARSER::COLLECTION)
    ("β-catenin and DLG" . SPARSER::COLLECTION)
    ("MAGI-1 and Lin-7" . SPARSER::COLLECTION)
    ("a β-catenin siRNA and si-Luc" . SPARSER::COLLECTION)
    ("si-Luc" . SPARSER::COLLECTION) ("si" . SPARSER::PROTEIN)
    ("MAGI-1 and Scribble" . SPARSER::COLLECTION)
    ("Scribble and MAGI-1" . SPARSER::COLLECTION)
    ("Scribble, NE-DLG and MAGI-1" . SPARSER::COLLECTION)
    ("Erbin" . SPARSER::PROTEIN)
    ("the adenovirus 9 E4ORF1 oncoprotein ( xref ) and the cancer-causing HPV E6 oncoprotein ( xref )"
     . SPARSER::COLLECTION)
    ("viral oncoproteins" . SPARSER::PROTEIN)
    ("E-Cadherin/catenin" . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell-cell junctional proteins" . SPARSER::PROTEIN)
    ("β-catenin, MAGI-1 and Scribble" . SPARSER::COLLECTION)
    ("DLG" . SPARSER::PROTEIN) ("Discs" . SPARSER::BIO-COMPLEX)
    ("S-SCAM" . SPARSER::PROTEIN) ("PDZ1" . SPARSER::PROTEIN)
    ("Protein-A" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("ORF1" . SPARSER::PROTEIN)
    ("tight junction protein ZO-1" . SPARSER::PROTEIN)
    ("E-Cadherin" . SPARSER::PROTEIN) ("E- cadherin" . SPARSER::PROTEIN)
    ("MAGI-1" . SPARSER::PROTEIN)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("androgens and estrogens" . SPARSER::COLLECTION)
    ("estrogen receptor and progesterone receptor" . SPARSER::COLLECTION)
    ("exogenous estrogen" . SPARSER::MOLECULE)
    ("AR, estrogen receptor, and progesterone" . SPARSER::COLLECTION)
    ("GADD45b" . SPARSER::PROTEIN)
    ("the intercellular molecule E-cadherin" . SPARSER::PROTEIN)
    ("Androgen receptor (AR) and ZEB1" . SPARSER::COLLECTION)
    ("zeb1" . SPARSER::PROTEIN) ("zeb" . SPARSER::PROTEIN)
    ("intercellular adhesion molecules" . SPARSER::MOLECULE)
    ("antibody and polymerase" . SPARSER::COLLECTION)
    ("ZEB1 and AR" . SPARSER::COLLECTION)
    ("ZeB1 and the androgen receptor (AR)" . SPARSER::COLLECTION)
    ("β-Estradiol" . SPARSER::MOLECULE) ("delta–" . SPARSER::PROTEIN)
    ("ZeB1" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("PI3K-Akt-mTORC1-S6K1" . SPARSER::COLLECTION)
    ("rapamycin and its analogs in solid tumor settings ( xref )"
     . SPARSER::COLLECTION)
    ("S6K2 and/or ULK1" . SPARSER::COLLECTION)
    ("4EBP-1, S6K2 and/or ULK1" . SPARSER::COLLECTION)
    ("low-glucose" . SPARSER::PROTEIN)
    ("Akt, mTORC1, and S6K1" . SPARSER::COLLECTION) ("siS" . SPARSER::PROTEIN)
    ("Prkaa1 and Prkaa2" . SPARSER::COLLECTION) ("Prkaa2" . SPARSER::PROTEIN)
    ("Prkaa1" . SPARSER::PROTEIN) ("Cpt1a or Cpt1c" . SPARSER::COLLECTION)
    ("Cpt1a, Cpt1b , and Cpt1c" . SPARSER::COLLECTION)
    ("Cpt1a" . SPARSER::PROTEIN) ("Cpt1" . SPARSER::PROTEIN)
    ("palmitoyltransferase" . SPARSER::PROTEIN)
    ("AICAR and S6K1" . SPARSER::COLLECTION) ("AICAR" . SPARSER::PROTEIN)
    ("Etomoxir" . SPARSER::DRUG) ("etomoxir" . SPARSER::DRUG)
    ("palmitate" . SPARSER::PROTEIN) ("oxidative forms" . SPARSER::FORM)
    ("mTORC1 and S6K1" . SPARSER::COLLECTION)
    ("a separate S6K1" . SPARSER::PROTEIN)
    ("a strong activator" . SPARSER::ACTIVATOR)
    ("mTORC1-S6K1" . SPARSER::COLLECTION) ("mTORC1/S6K1" . SPARSER::COLLECTION)
    ("rapamycin and S6K1" . SPARSER::COLLECTION)
    ("Chronic Myelogenous Leukemia (CML)" . SPARSER::PROTEIN)
    ("bromopyruvate" . SPARSER::DRUG) ("deoxyglucose" . SPARSER::MOLECULE)
    ("dichloroacetate" . SPARSER::MOLECULE) ("Oncogene" . SPARSER::ONCOGENE)
    ("myc and ErbB2" . SPARSER::COLLECTION)
    ("Ras, Akt and myc" . SPARSER::COLLECTION)
    ("Chronic Myelogenous Leukemia" . SPARSER::PROTEIN)
    ("Fatty Acid" . SPARSER::MOLECULE) ("H-H" . SPARSER::PROTEIN)
    ("S6k1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p235" . SPARSER::PROTEIN)
    ("4EBP-1" . SPARSER::PROTEIN) ("CPT1" . SPARSER::PROTEIN)
    ("Cpt1b" . SPARSER::PROTEIN)
    ("5-Aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("S6K2" . SPARSER::PROTEIN) ("GLUT-1" . SPARSER::PROTEIN)
    ("Cpt1c" . SPARSER::PROTEIN) ("Fatty acid" . SPARSER::MOLECULE)
    ("HDACs and their inhibitors" . SPARSER::COLLECTION)
    ("HDAC8 and HoxA5" . SPARSER::COLLECTION)
    ("HDAC inhibitors or HDAC8 knockdown" . SPARSER::COLLECTION)
    ("mutant and wild-type p53 expression ( xref , compare lanes 3–4)"
     . SPARSER::COLLECTION)
    ("PTN" . SPARSER::PROTEIN)
    ("a well-defined activator" . SPARSER::ACTIVATOR)
    ("CPT" . SPARSER::PROTEIN) ("siRNA or siRNA" . SPARSER::COLLECTION)
    ("their respective siRNA" . SPARSER::PROTEIN)
    ("butyrate" . SPARSER::PROTEIN) ("HDAC6-HSP90" . SPARSER::COLLECTION)
    ("HDAC inhibitors or specific knockdown of an individual HDAC"
     . SPARSER::COLLECTION)
    ("polyubiquitination and proteasomal" . SPARSER::COLLECTION)
    ("HoxA5 and p53" . SPARSER::COLLECTION)
    ("vorinostat (SAHA)" . SPARSER::DRUG)
    ("hydroxamic acid derivative" . SPARSER::DERIVATIVE)
    ("SAHA" . SPARSER::DRUG) ("vorinostat" . SPARSER::DRUG)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("histones and non-histone" . SPARSER::COLLECTION)
    ("HoxA5" . SPARSER::PROTEIN) ("HoxA" . SPARSER::PROTEIN)
    ("an 1" . SPARSER::DRUG) ("precursor mRNA" . SPARSER::RNA)
    ("precursor mRNAs" . SPARSER::RNA)
    ("IR or other toxins" . SPARSER::COLLECTION)
    ("LEF-1/β-catenin" . SPARSER::COLLECTION)
    ("ATM and TGFβ1" . SPARSER::COLLECTION)
    ("IR-ATM-IGF-1-IGF-1R" . SPARSER::COLLECTION)
    ("ATM or TGFβ1" . SPARSER::COLLECTION) ("iron" . SPARSER::MOLECULE)
    ("IGF-1 and sCLU" . SPARSER::COLLECTION)
    ("PI3K and AKT" . SPARSER::COLLECTION)
    ("TGFβ1-Smad-IGF-1" . SPARSER::COLLECTION)
    ("ATM-IGF-1" . SPARSER::COLLECTION)
    ("DNA-PK, ATR, and ATM" . SPARSER::COLLECTION)
    ("functional biological response biomarkers" . SPARSER::MOLECULE)
    ("exogenous sCLU" . SPARSER::PROTEIN) ("shRNA-Scr" . SPARSER::COLLECTION)
    ("Scr" . SPARSER::PROTEIN) ("sCLU" . SPARSER::PROTEIN)
    ("siRNA-sCLU or mock-transfected using siRNA-Scr" . SPARSER::COLLECTION)
    ("siRNA-Scr" . SPARSER::COLLECTION) ("siRNA-sCLU" . SPARSER::COLLECTION)
    ("mature sCLU protein" . SPARSER::PROTEIN)
    ("gene and sCLU" . SPARSER::COLLECTION) ("BLI or ex" . SPARSER::COLLECTION)
    ("TβRII-" . SPARSER::PROTEIN) ("UT" . SPARSER::PROTEIN-FAMILY)
    ("TβRII−" . SPARSER::PROTEIN) ("promoter and sCLU" . SPARSER::COLLECTION)
    ("promoter and ligand" . SPARSER::COLLECTION)
    ("RSV-β-gal" . SPARSER::COLLECTION) ("hIGF-1p-Luc" . SPARSER::COLLECTION)
    ("IGF-1 and CLU" . SPARSER::COLLECTION)
    ("functional p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("related immature and mature sCLU protein" . SPARSER::PROTEIN)
    ("IGF-1R-Src-MAPK-Erk1/2-Egr1" . SPARSER::COLLECTION)
    ("‘biomarker’" . SPARSER::MOLECULE) ("drug-" . SPARSER::DRUG)
    ("antisense oligomers ( xref , xref ) or siRNA nanoparticles ( xref )"
     . SPARSER::COLLECTION)
    ("p53/NF-YA" . SPARSER::COLLECTION)
    ("only Ataxia telangiectasia mutated kinase (ATM)" . SPARSER::KINASE)
    ("kinase (ATM)" . SPARSER::KINASE) ("SSBs" . SPARSER::PROTEIN)
    ("p53 or pRb" . SPARSER::COLLECTION) ("CLU" . SPARSER::PROTEIN)
    ("Secretory clusterin" . SPARSER::PROTEIN)
    ("hCLUp-Luc" . SPARSER::COLLECTION) ("Luc" . SPARSER::PROTEIN)
    ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("β-Galactosidase" . SPARSER::PROTEIN) ("MMR+" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("N-term" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("TGF-β1" . SPARSER::PROTEIN) ("TRPM-2" . SPARSER::PROTEIN)
    ("TβRII" . SPARSER::PROTEIN) ("AG1024" . SPARSER::DRUG)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN) ("β-TrCP, and PHLPP" . SPARSER::COLLECTION)
    ("PHLPP1 or USP46" . SPARSER::COLLECTION)
    ("USP46, PHLPP1, or USP46" . SPARSER::COLLECTION)
    ("USP46 and PHLPP1" . SPARSER::COLLECTION)
    ("USP46 and PHLPP" . SPARSER::COLLECTION)
    ("the degradation-resistent 4A mutant" . SPARSER::MUTANT)
    ("the full-length PHLPP1 or the USP46 binding-deficient Δ1139 mutant"
     . SPARSER::COLLECTION)
    ("PHLPP and USP46" . SPARSER::COLLECTION)
    ("sequential truncation mutants" . SPARSER::MUTANT)
    ("proteins and GST" . SPARSER::COLLECTION) ("DLD" . SPARSER::PROTEIN)
    ("USP7 and USP16" . SPARSER::COLLECTION) ("USP" . SPARSER::PROTEIN)
    ("USP1, USP12, and USP46" . SPARSER::COLLECTION)
    ("PHLPP1 and USP46" . SPARSER::COLLECTION)
    ("eukaryotic proteins" . SPARSER::PROTEIN)
    ("Akt, PKC, and Mst1" . SPARSER::COLLECTION)
    ("MAPK, and Mst1" . SPARSER::COLLECTION) ("c- nu" . SPARSER::PROTEIN)
    ("N-Ethylmaleimide" . SPARSER::MOLECULE) ("ml -1" . SPARSER::PROTEIN)
    ("GST-P1" . SPARSER::PROTEIN) ("P 4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("γ tubulin" . SPARSER::PROTEIN) ("GLR-1" . SPARSER::PROTEIN)
    ("USP16" . SPARSER::PROTEIN) ("USP12" . SPARSER::PROTEIN)
    ("USP1" . SPARSER::PROTEIN) ("USP28" . SPARSER::PROTEIN)
    ("USP9X" . SPARSER::PROTEIN) ("USP46" . SPARSER::PROTEIN)
    ("RPL11 ( xref ) and RPS7 ( xref )" . SPARSER::COLLECTION)
    ("RPL26 or RPS7" . SPARSER::COLLECTION)
    ("RPs and MDM2" . SPARSER::COLLECTION)
    ("the MDM2-interating sub-ribosomal complex" . SPARSER::BIO-COMPLEX)
    ("RPL30 and RPL29" . SPARSER::COLLECTION)
    ("the homohexameric complex" . SPARSER::BIO-COMPLEX)
    ("a sub-ribosomal complex" . SPARSER::BIO-COMPLEX)
    ("RPL11 and RPL5" . SPARSER::COLLECTION) ("the MDM2’s" . SPARSER::PROTEIN)
    ("RPL5 and RPL11" . SPARSER::COLLECTION)
    ("RPL5 or RPL11" . SPARSER::COLLECTION)
    ("RPL5- and RPL11-" . SPARSER::COLLECTION) ("RPL11-" . SPARSER::PROTEIN)
    ("RPL5-" . SPARSER::PROTEIN)
    ("RPS7 ( xref ) or RPL11 ( xref )" . SPARSER::COLLECTION)
    ("Doxorubicin" . SPARSER::PROTEIN) ("pEGFP-RPS14" . SPARSER::COLLECTION)
    ("pEGFP" . SPARSER::PROTEIN)
    ("RPL11, RPL5, or RPL23" . SPARSER::COLLECTION)
    ("exogenous p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPL23-MDM2" . SPARSER::COLLECTION) ("RPL5-MDM2" . SPARSER::COLLECTION)
    ("RPL5 or RPL23" . SPARSER::COLLECTION) ("GST-MDM2" . SPARSER::COLLECTION)
    ("RPS27 ( xref ) and RPS27a ( xref )" . SPARSER::COLLECTION)
    ("RPS7 ( xref , xref ), RPS3 ( xref ), RPS27 ( xref ) and RPS27a ( xref )"
     . SPARSER::COLLECTION)
    ("Flag-L11" . SPARSER::COLLECTION) ("Flag-S14" . SPARSER::COLLECTION)
    ("Myc-MDMX" . SPARSER::COLLECTION)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("nucleolar RPS14 molecules" . SPARSER::MOLECULE)
    ("Flag-RPS19" . SPARSER::COLLECTION) ("Flag-RPS14" . SPARSER::COLLECTION)
    ("RPL11, RPL5 and RPS7" . SPARSER::COLLECTION)
    ("RPS19 and 5q-syndrome-associated" . SPARSER::COLLECTION)
    ("RPS19 or 5q-syndrome-associated" . SPARSER::COLLECTION)
    ("RPL11 ( xref , xref ) or RPS7 ( xref )" . SPARSER::COLLECTION)
    ("RPL5, RPL11 ( xref , xref ) or RPS7 ( xref )" . SPARSER::COLLECTION)
    ("further deleting TP53" . SPARSER::PROTEIN)
    ("Diamond-Blackfan anemia (DBA)" . SPARSER::PROTEIN)
    ("RP-MDM2" . SPARSER::COLLECTION)
    ("RPS27 ( xref ) or RPS27a ( xref )" . SPARSER::COLLECTION)
    ("RPS27a" . SPARSER::PROTEIN) ("RPs" . SPARSER::PROTEIN)
    ("cisplatin or UV" . SPARSER::COLLECTION)
    ("a nucleolar protein" . SPARSER::PROTEIN)
    ("nucleolar proteins" . SPARSER::PROTEIN)
    ("RPL29 and RPL30" . SPARSER::COLLECTION)
    ("nucleostemin" . SPARSER::PROTEIN) ("nucleophosmin" . SPARSER::PROTEIN)
    ("TP53 and mdm2" . SPARSER::COLLECTION)
    ("a p53’s" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RPS14 and RPS19" . SPARSER::COLLECTION)
    ("RPS14 or RPS19" . SPARSER::COLLECTION)
    ("RPL11 or RPL5" . SPARSER::COLLECTION)
    ("RPS14-MDM2" . SPARSER::COLLECTION)
    ("RPL5 and RPL23" . SPARSER::COLLECTION)
    ("Several ribosomal proteins" . SPARSER::PROTEIN)
    ("RPL11, RPL5, RPL23, RPL26, or RPS7" . SPARSER::COLLECTION)
    ("N-20" . SPARSER::PROTEIN) ("CA5" . SPARSER::PROTEIN)
    ("P8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pcDNA3" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN) ("Zinc finger" . SPARSER::PROTEIN)
    ("RPS6" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("RPS3" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("Diamond-Blackfan anemia" . SPARSER::PROTEIN) ("RPS27" . SPARSER::PROTEIN)
    ("RPL37" . SPARSER::PROTEIN) ("PAK1IP1" . SPARSER::PROTEIN)
    ("Bop1" . SPARSER::PROTEIN) ("RPL30" . SPARSER::PROTEIN)
    ("RPL29" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("RPS19" . SPARSER::PROTEIN) ("RPS14" . SPARSER::PROTEIN)
    ("ribosomal protein S14" . SPARSER::PROTEIN) ("RPS7" . SPARSER::PROTEIN)
    ("RPL26" . SPARSER::PROTEIN) ("RPL23" . SPARSER::PROTEIN)
    ("RPL5" . SPARSER::PROTEIN) ("RPL11" . SPARSER::PROTEIN)
    ("previously reported MSP" . SPARSER::PROTEIN)
    ("traditional MSP" . SPARSER::PROTEIN)
    ("MSP and qMSP" . SPARSER::COLLECTION) ("MSP" . SPARSER::PROTEIN)
    ("methylated MGMT promoter" . SPARSER::PROMOTER)
    ("at least concomitant TMZ" . SPARSER::DRUG)
    ("O-6-methylguanine-DNA methyltransferase (MGMT)" . SPARSER::PROTEIN)
    ("temozolomide (TMZ)" . SPARSER::DRUG) ("temozolomide" . SPARSER::DRUG)
    ("a methylated MGMT promoter" . SPARSER::PROMOTER)
    ("MGMT" . SPARSER::PROTEIN)
    ("O-6-methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("DNA repair enzyme" . SPARSER::PROTEIN) ("O 6" . SPARSER::PROTEIN)
    ("IDH2" . SPARSER::PROTEIN)
    ("O 6 -methylguanine-DNA methyltransferase" . SPARSER::PROTEIN)
    ("a prospective cohort" . SPARSER::MOLECULE) ("fibrin" . SPARSER::PROTEIN)
    ("a smaller fraction" . SPARSER::COMPONENT)
    ("tPA and an acute phase reactant" . SPARSER::COLLECTION)
    ("tPA" . SPARSER::PROTEIN) ("thromboplastin" . SPARSER::PROTEIN)
    ("PaO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("serpine-1" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN) ("BI" . SPARSER::PROTEIN)
    ("heterozygotes" . SPARSER::PROTEIN)
    ("aurora kinase A and PLK1" . SPARSER::COLLECTION)
    ("NES, Nanog , and c-Myc" . SPARSER::COLLECTION)
    ("SOX2, Nanog, NES and c-Myc" . SPARSER::COLLECTION)
    ("SER" . SPARSER::AMINO-ACID) ("fractions (SF)" . SPARSER::COMPONENT)
    ("siRNA and shRNA" . SPARSER::COLLECTION)
    ("SHH or WNT" . SPARSER::COLLECTION)
    ("Group C and Group D" . SPARSER::COLLECTION) ("SHH" . SPARSER::PROTEIN)
    ("shRNA or chemical inhibitors" . SPARSER::COLLECTION)
    ("Complex (APC)" . SPARSER::BIO-COMPLEX)
    ("cyclin B1 and CDK1" . SPARSER::COLLECTION) ("AURKA" . SPARSER::PROTEIN)
    ("SRY (sex determining region Y)-box 2 ( SOX2 ) mRNA" . SPARSER::PROTEIN)
    ("GSK461364" . SPARSER::DRUG) ("Group D" . SPARSER::PROTEIN)
    ("B-27" . SPARSER::PROTEIN) ("1-C" . SPARSER::PROTEIN)
    ("1-B" . SPARSER::PROTEIN) ("aurora kinase A" . SPARSER::PROTEIN)
    ("BI 2536" . SPARSER::DRUG) ("PLK1" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("Munc18c, PKCζ, phospho-PKCζ, and Syntaxin-4" . SPARSER::COLLECTION)
    ("Munc18c and phospho-PKCζ" . SPARSER::COLLECTION)
    ("both phospho-PKCζ (Thr410) and Munc18c" . SPARSER::COLLECTION)
    ("that testosterone and insulin" . SPARSER::COLLECTION)
    ("cortical actin" . SPARSER::PROTEIN)
    ("specifically PI3K/PDK-1 pathway molecules" . SPARSER::MOLECULE)
    ("PI3K/PDK-1" . SPARSER::COLLECTION)
    ("GLUT4 mRNA and its protein" . SPARSER::COLLECTION)
    ("androgens and insulin resistance" . SPARSER::COLLECTION)
    ("IOD" . SPARSER::MOLECULE)
    ("Munc18c, PKCζ, phospho-PKCζ and Syntaxin-4" . SPARSER::COLLECTION)
    ("SHBG" . SPARSER::PROTEIN)
    ("VAMP2, SNAP23, and Syntaxin-4" . SPARSER::COLLECTION)
    ("SNARE" . SPARSER::PROTEIN)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IR and hyperandrogenism" . SPARSER::COLLECTION)
    ("mRNA, IRS-1 and GLUT4" . SPARSER::COLLECTION)
    ("PKB/Akt" . SPARSER::COLLECTION) ("Fat" . SPARSER::PROTEIN)
    ("Zeta and phospho-PKC" . SPARSER::COLLECTION)
    ("Munc18c and phospho-PKC" . SPARSER::COLLECTION)
    ("Western Blot and/or immunohistochemistry" . SPARSER::COLLECTION)
    ("Western Blot" . SPARSER::PROTEIN) ("PCOSE-IR" . SPARSER::COLLECTION)
    ("Zeta, and Syntaxin-4" . SPARSER::COLLECTION)
    ("Zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dehydroepiandrosterone sulfate" . SPARSER::MOLECULE)
    ("Munc18" . SPARSER::PROTEIN) ("SNAP23" . SPARSER::PROTEIN)
    ("VAMP2" . SPARSER::PROTEIN) ("VAMP-2" . SPARSER::PROTEIN)
    ("GLUT4" . SPARSER::PROTEIN) ("Syntaxin-4" . SPARSER::PROTEIN)
    ("Munc18c" . SPARSER::PROTEIN) ("metastatic GC" . SPARSER::PROTEIN)
    ("RON" . SPARSER::PROTEIN) ("original MetMab" . SPARSER::DRUG)
    ("‘HGF’" . SPARSER::PROTEIN) ("subsequent MetMab" . SPARSER::DRUG)
    ("MetMab" . SPARSER::DRUG) ("a strong Met" . SPARSER::AMINO-ACID)
    ("a monovalent antibody" . SPARSER::PROTEIN) ("FISH-" . SPARSER::PROTEIN)
    ("irinotecan" . SPARSER::DRUG) ("the previous CR" . SPARSER::PROTEIN)
    ("an ongoing CR" . SPARSER::PROTEIN)
    ("monovalent (one-armed) antibody" . SPARSER::PROTEIN)
    ("VEGFR2 and many other tyrosine kinases" . SPARSER::COLLECTION)
    ("an investigational small molecule receptor tyrosine kinase (RTK) inhibitor"
     . SPARSER::INHIBITOR)
    ("perioperative epirubicin" . SPARSER::DRUG) ("epirubicin" . SPARSER::DRUG)
    ("leucovorin" . SPARSER::DRUG) ("ring" . SPARSER::PROTEIN)
    ("cyclophosphamide and doxorubicin" . SPARSER::COLLECTION)
    ("HER2−" . SPARSER::PROTEIN) ("multiple new foci" . SPARSER::PROTEIN)
    ("MetMAb" . SPARSER::DRUG) ("P 20" . SPARSER::PROTEIN)
    ("MST1R" . SPARSER::PROTEIN) ("TGM2 and GRB14" . SPARSER::COLLECTION)
    ("phosphatidylinositol and phosphatidylcholine" . SPARSER::COLLECTION)
    ("epsilon (PRKCE)" . SPARSER::PROTEIN)
    ("several pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("microglia" . SPARSER::PROTEIN)
    ("highly regulated multifunctional protein" . SPARSER::PROTEIN)
    ("RPRD1B and TGM2" . SPARSER::COLLECTION)
    ("a substantial polygenic component" . SPARSER::COMPONENT)
    ("DSCAM" . SPARSER::PROTEIN) ("PRKCE" . SPARSER::PROTEIN)
    ("a ERE-sequence" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERE-sequence" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERE-halfsite" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERα- and ERβ-genes" . SPARSER::COLLECTION) ("ERα-" . SPARSER::PROTEIN)
    ("Many functional ERE-sequences" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("functional ERE-sequences" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERE-sequences" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("-GGTCAnnnTGACC-3" . SPARSER::COLLECTION)
    ("AP-1 and SP-1" . SPARSER::COLLECTION)
    ("this receptor forms either homodimers (α/α or β/β) or heterodimers (α/β)"
     . SPARSER::COLLECTION)
    ("antidepressant" . SPARSER::DRUG) ("NCS" . SPARSER::PROTEIN)
    ("GRB14" . SPARSER::PROTEIN)
    ("growth factor receptor binding protein" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN) ("γ-glutamyl" . SPARSER::MOLECULE)
    ("RPRD1B" . SPARSER::PROTEIN)
    ("Down syndrome cell adhesion molecule" . SPARSER::PROTEIN)
    ("RPRD 1B" . SPARSER::PROTEIN) ("Transglutaminase 2" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("G-protein coupled receptor" . SPARSER::PROTEIN)
    ("TGM2" . SPARSER::PROTEIN) ("transglutaminase 2" . SPARSER::PROTEIN)
    ("P-gp and ABCG2" . SPARSER::COLLECTION)
    ("PDGFRA, PDGFRB or KIT" . SPARSER::COLLECTION)
    ("PDGFRB" . SPARSER::PROTEIN)
    ("the central nervous system-restricted transcription factor Olig2"
     . SPARSER::PROTEIN)
    ("Nkx2.2 , PDGFRA and SOX10" . SPARSER::COLLECTION)
    ("the mesenchymal type" . TYPE) ("PENK" . SPARSER::PROTEIN)
    ("SHh" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("FOXG1 and ZFHX4" . SPARSER::COLLECTION)
    ("LHX2 and IRX2" . SPARSER::COLLECTION)
    ("the mesenchymal and classical classes" . CLASS)
    ("the proneural class" . CLASS)
    ("LNX1 , RPL21P44 , CHIC2 , GSK2 , KIT and KDR" . SPARSER::COLLECTION)
    ("KIT" . SPARSER::PROTEIN) ("EGFR and PDGFRA" . SPARSER::COLLECTION)
    ("PDGFRA and MET" . SPARSER::COLLECTION)
    ("the mesenchymal markers YKL40, SNAIL1 and SNAIL2" . SPARSER::COLLECTION)
    ("YKL40, SNAIL1 and SNAIL2" . SPARSER::COLLECTION)
    ("FABP7/BLBP" . SPARSER::COLLECTION) ("BLBP" . SPARSER::PROTEIN)
    ("BMI1 , CD34, CD44, CXCR4, LIF, DKK1, VIM and RUNX2"
     . SPARSER::COLLECTION)
    ("whose promoter" . SPARSER::PROMOTER) ("LDHA" . SPARSER::PROTEIN)
    ("HK1" . SPARSER::PROTEIN) ("VEGFA and YKL40" . SPARSER::COLLECTION)
    ("VEGFA , VWF , PECAM1 , TREM1, OSMR and PLAU" . SPARSER::COLLECTION)
    ("PLAU" . SPARSER::PROTEIN) ("VWF" . SPARSER::PROTEIN)
    ("VEGFA" . SPARSER::PROTEIN)
    ("TNC , OSMR , VIM and YKL40/CHI3L1" . SPARSER::COLLECTION)
    ("OSMR" . SPARSER::PROTEIN) ("TNC" . SPARSER::PROTEIN)
    ("CEBPA" . SPARSER::PROTEIN)
    ("SNAI1 and SNAI2/Slug genes ( xref )" . SPARSER::COLLECTION)
    ("the master epithelial-mesenchymal transition regulators"
     . SPARSER::REGULATOR)
    ("SNAI2/Slug" . SPARSER::COLLECTION) ("Slug" . SPARSER::PROTEIN)
    ("PPAT" . SPARSER::PROTEIN)
    ("Supervised hierarchical clustering identified 643 genes differentially"
     . SPARSER::PROTEIN)
    ("MAFB" . SPARSER::PROTEIN)
    ("PTEN (1), CDKN2A/B (1) and FAS (1)" . SPARSER::COLLECTION)
    ("PDGFB" . SPARSER::PROTEIN) ("frozen" . SPARSER::PROTEIN)
    ("snap-frozen" . SPARSER::PROTEIN-PAIR)
    ("CGH and gene" . SPARSER::COLLECTION) ("MRI" . SPARSER::PROTEIN)
    ("the oligodendroglial type" . TYPE) ("MIB-1" . SPARSER::PROTEIN)
    ("FIP1L1" . SPARSER::PROTEIN) ("P-gp" . SPARSER::PROTEIN)
    ("IDH1" . SPARSER::PROTEIN) ("Nkx2.2" . SPARSER::PROTEIN)
    ("Sonic Hedgehog" . SPARSER::PROTEIN) ("GAD1" . SPARSER::PROTEIN)
    ("KCND2" . SPARSER::PROTEIN) ("SLC1A6" . SPARSER::PROTEIN)
    ("GJA1" . SPARSER::PROTEIN) ("PTCH1" . SPARSER::PROTEIN)
    ("ZFHX4" . SPARSER::PROTEIN) ("FOXG1" . SPARSER::PROTEIN)
    ("IRX2" . SPARSER::PROTEIN) ("LHX2" . SPARSER::PROTEIN)
    ("P44" . SPARSER::PROTEIN) ("RPL21" . SPARSER::PROTEIN)
    ("LNX1" . SPARSER::PROTEIN) ("SOX10" . SPARSER::PROTEIN)
    ("SNAIL2" . SPARSER::PROTEIN) ("FABP7" . SPARSER::PROTEIN)
    ("Musashi1" . SPARSER::PROTEIN) ("RUNX2" . SPARSER::PROTEIN)
    ("DKK1" . SPARSER::PROTEIN) ("P4HA2" . SPARSER::PROTEIN)
    ("HK2" . SPARSER::PROTEIN) ("ENO2" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("TREM1" . SPARSER::PROTEIN)
    ("PECAM1" . SPARSER::PROTEIN) ("CHI3" . SPARSER::PROTEIN)
    ("YKL40" . SPARSER::PROTEIN) ("ZNF238" . SPARSER::PROTEIN)
    ("FOSL2" . SPARSER::PROTEIN) ("BHLHE40" . SPARSER::PROTEIN)
    ("EXOC1" . SPARSER::PROTEIN) ("SRD5A3" . SPARSER::PROTEIN)
    ("SRP72" . SPARSER::PROTEIN) ("HOXA2" . SPARSER::PROTEIN)
    ("OLIG2" . SPARSER::PROTEIN) ("GAL3" . SPARSER::PROTEIN)
    ("RAB31" . SPARSER::PROTEIN) ("WNT2" . SPARSER::PROTEIN)
    ("ETS1" . SPARSER::PROTEIN) ("KDM5A" . SPARSER::PROTEIN)
    ("CAV1" . SPARSER::PROTEIN)
    ("miR-34a and miR-145 ( xref )" . SPARSER::COLLECTION)
    ("Gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 family, p63 and p73" . SPARSER::COLLECTION)
    ("miR-34a and miR-145 expression during RA-mediated differentiation of hESCs"
     . SPARSER::COLLECTION)
    ("MDM2 and TRIM24" . SPARSER::COLLECTION)
    ("HDM2- and TRIM24" . SPARSER::COLLECTION) ("HDM2-" . SPARSER::PROTEIN)
    ("a stress-responsive transcription regulator" . SPARSER::REGULATOR)
    ("mature miRNAs" . SPARSER::PROTEIN)
    ("KLF4 and LIN28A" . SPARSER::COLLECTION)
    ("c-Myc and indirectly activating p21" . SPARSER::COLLECTION)
    ("OCT4, SOX2, and KLF4" . SPARSER::COLLECTION)
    ("SOX2 and KLF4" . SPARSER::COLLECTION)
    ("SOX2 and SIRT1" . SPARSER::COLLECTION)
    ("OCT4, SOX2 , and KLF4" . SPARSER::COLLECTION)
    ("CyclinD1 and CDK6" . SPARSER::COLLECTION)
    ("mutated forms" . SPARSER::FORM)
    ("further confirming p21" . SPARSER::PROTEIN) ("t " . SPARSER::PROTEIN)
    ("GATA4 and AFP" . SPARSER::COLLECTION)
    ("KLF4, NANOG , and OCT4" . SPARSER::COLLECTION)
    ("CDKN1A and HDM2" . SPARSER::COLLECTION)
    ("wild-type p53 (p53WT) or p53" . SPARSER::COLLECTION)
    ("IRES-GFP" . SPARSER::PROTEIN-PAIR)
    ("OCT4 and NANOG" . SPARSER::COLLECTION)
    ("HDM2 or TRIM24" . SPARSER::COLLECTION)
    ("OCT4 and SSEA4" . SPARSER::COLLECTION) ("SSEA" . SPARSER::PROTEIN)
    ("NANOG and OCT4" . SPARSER::COLLECTION) ("AP" . SPARSER::PROTEIN-FAMILY)
    ("CDKN1A , MDM2 , BAX , and GADD45A" . SPARSER::COLLECTION)
    ("GADD45A and BAX" . SPARSER::COLLECTION)
    ("the distal p53 response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("p21/WAF1" . SPARSER::COLLECTION) ("Adr" . SPARSER::PROTEIN)
    ("MG132 (lanes 2 and 4, xref and xref ) and lactacystin ( xref )"
     . SPARSER::COLLECTION)
    ("lactacystin" . SPARSER::DRUG) ("p53 and p53K373ac" . SPARSER::COLLECTION)
    ("p53S15 or p53S46" . SPARSER::COLLECTION) ("p53S15" . SPARSER::PROTEIN)
    ("neural progenitor gene Nestin" . SPARSER::PROTEIN)
    ("ectodermal marker PAX6" . SPARSER::PROTEIN)
    ("endodermal marker GATA4" . SPARSER::PROTEIN)
    ("proteins and RNAs" . SPARSER::COLLECTION)
    ("NANOG, OCT4, SOX2, and KLF4" . SPARSER::COLLECTION)
    ("AFP" . SPARSER::PROTEIN)
    ("increases miR-34a and miR-145" . SPARSER::COLLECTION)
    ("mESC" . SPARSER::PROTEIN) ("ARF/p53" . SPARSER::COLLECTION)
    ("p21, p27, and p57" . SPARSER::COLLECTION)
    ("OCT4, SOX2, NANOG, and KLF4" . SPARSER::COLLECTION)
    ("miR-34a and miR-145" . SPARSER::COLLECTION)
    ("OCT4, KLF4, LIN28A, and SOX2" . SPARSER::COLLECTION)
    ("HDM2 and TRIM24" . SPARSER::COLLECTION)
    ("genes and microRNAs" . SPARSER::COLLECTION) ("SIN3A" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stem cell factor" . SPARSER::PROTEIN) ("mir-34a" . SPARSER::MOLECULE)
    ("p53 regulator" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("mdm2" . SPARSER::PROTEIN) ("p53S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP4" . SPARSER::PROTEIN) ("PAX6" . SPARSER::PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("SOX2" . SPARSER::PROTEIN)
    ("LIN28A" . SPARSER::PROTEIN) ("OCT4" . SPARSER::PROTEIN)
    ("miR-34a" . SPARSER::MOLECULE) ("TRIM24" . SPARSER::PROTEIN)
    ("HDM2" . SPARSER::PROTEIN) ("Rb as well as p53" . SPARSER::COLLECTION)
    ("p53 and Rb" . SPARSER::COLLECTION)
    ("p53 and/or Rb" . SPARSER::COLLECTION)
    ("the transgene or the Cre recombinase" . SPARSER::COLLECTION)
    ("IL8 ( xref ) and IL8 receptor CXCR2 ( xref )" . SPARSER::COLLECTION)
    ("CgA and NSE" . SPARSER::COLLECTION) ("a pure SCNC" . SPARSER::PROTEIN)
    ("pure SCNC" . SPARSER::PROTEIN) ("TRAMP" . SPARSER::PROTEIN)
    ("the resultant SCNC" . SPARSER::PROTEIN)
    ("Abiraterone and MDV3100" . SPARSER::COLLECTION)
    ("Abiraterone" . SPARSER::DRUG)
    ("hydrophilic amino acid asparagine" . SPARSER::AMINO-ACID)
    ("CgA and p53" . SPARSER::COLLECTION) ("SL" . SPARSER::PROTEIN)
    ("IL8–CXCR2–P53" . SPARSER::COLLECTION)
    ("IL8 ( xref ) and CXCR2 ( xref )" . SPARSER::COLLECTION)
    ("functional P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LNCaP/CXCR2" . SPARSER::COLLECTION)
    ("pcDNA3-CXCR2" . SPARSER::PROTEIN-PAIR)
    ("CgA and neuron-specific enolase (NSE)" . SPARSER::COLLECTION)
    ("CgA and neuron-specific enolase" . SPARSER::COLLECTION)
    ("NSE" . SPARSER::PROTEIN) ("IL8–CXCR2" . SPARSER::COLLECTION)
    ("IL8 and its receptor" . SPARSER::COLLECTION)
    ("–CXCR2–p53" . SPARSER::COLLECTION) ("CgA" . SPARSER::PROTEIN)
    ("chromogranin" . SPARSER::PROTEIN) ("Prostatic" . SPARSER::PROTEIN)
    ("AR and PSA" . SPARSER::COLLECTION)
    ("androgen receptor (AR) and prostate-specific antigen (PSA)"
     . SPARSER::COLLECTION)
    ("IL8–CXCR2–p53" . SPARSER::COLLECTION)
    ("–CXCR2–P53" . SPARSER::COLLECTION) ("SCNC" . SPARSER::PROTEIN)
    ("MDV3100" . SPARSER::DRUG) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("neuron-specific enolase" . SPARSER::PROTEIN) ("MACH2" . SPARSER::DRUG)
    ("c-Myc, cyclin E and Mcl1" . SPARSER::COLLECTION)
    ("Fbxw7–GSK3–p100" . SPARSER::COLLECTION) ("RING" . SPARSER::PROTEIN)
    ("the substrate’s" . SPARSER::SUBSTRATE)
    ("Fbxw7α and GSK3" . SPARSER::COLLECTION) ("Fbxw7α" . SPARSER::PROTEIN)
    ("p100–Fbxw7α" . SPARSER::PROTEIN-PAIR)
    ("XVI and GSK3i" . SPARSER::COLLECTION) ("XXII" . SPARSER::PROTEIN)
    ("XVI" . SPARSER::PROTEIN) ("bortezomib or MLN4924" . SPARSER::COLLECTION)
    ("Cullin–RING" . SPARSER::COLLECTION) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("p100 or p100" . SPARSER::COLLECTION)
    ("wild-type p100 and the p100(Ser707/711Ala) mutant" . SPARSER::COLLECTION)
    ("ARP-1" . SPARSER::PROTEIN)
    ("p100(Ser707/711Ala) or p100(4×NES)" . SPARSER::COLLECTION)
    ("NFKB2 , MCP1 and MIP2" . SPARSER::COLLECTION)
    ("LTβR-unresponsive genes ( IL-6, CCND1 ) or non-NF-κB target genes ( 18S, SPARC )"
     . SPARSER::COLLECTION)
    ("RANTES , NFKB2 , MCP-1 , VCAM-1 and NFKBIA" . SPARSER::COLLECTION)
    ("SPARC" . SPARSER::PROTEIN) ("RANTES" . SPARSER::PROTEIN)
    ("CD40L or TNF" . SPARSER::COLLECTION)
    ("NFKB2, MCP-1, VCAM-1 and NFKBIA" . SPARSER::COLLECTION)
    ("NFKBIA" . SPARSER::PROTEIN) ("RHD:RHD" . SPARSER::BIO-COMPLEX)
    ("p100–Fbxw7" . SPARSER::COLLECTION) ("deoxycholate" . SPARSER::MOLECULE)
    ("RelA and RelB" . SPARSER::COLLECTION)
    ("p52 or RelB" . SPARSER::COLLECTION) ("exogenous p52" . SPARSER::PROTEIN)
    ("the ARD (between the sixth and seventh ankyrin repeats) and NF-κB proteins (particularly p52 and RelB)"
     . SPARSER::COLLECTION)
    ("p52 and RelB" . SPARSER::COLLECTION) ("ankyrin" . SPARSER::PROTEIN)
    ("ARD" . SPARSER::PROTEIN)
    ("Fbxw7α constitutively targets p100" . SPARSER::PROTEIN)
    ("the last 180 amino acids" . SPARSER::AMINO-ACID)
    ("Leptomycin B (LMB)" . SPARSER::MOLECULE)
    ("CRM1/exportin1" . SPARSER::COLLECTION) ("LMB" . SPARSER::MOLECULE)
    ("c-Myc and β-catenin" . SPARSER::COLLECTION)
    ("p100, p105 and IκBα" . SPARSER::COLLECTION)
    ("p100 and Fbxw7α" . SPARSER::COLLECTION)
    ("Cdh1 and Cdc20" . SPARSER::COLLECTION)
    ("Skp1 and Cul1" . SPARSER::COLLECTION)
    ("previously unknown substrates" . SPARSER::SUBSTRATE)
    ("Fbxw7α constitutively targets nuclear p100" . SPARSER::PROTEIN)
    ("NIK" . SPARSER::PROTEIN)
    ("p52 preferentially binds RelB" . SPARSER::PROTEIN)
    ("activating factor (BAFF)" . SPARSER::PROTEIN)
    ("p50:RelA" . SPARSER::BIO-COMPLEX) ("BAFF" . SPARSER::PROTEIN)
    ("RHDs" . SPARSER::PROTEIN) ("RHD" . SPARSER::PROTEIN)
    ("p50 and p52" . SPARSER::COLLECTION)
    ("IκBα, IκBβ and IκB ε" . SPARSER::COLLECTION) ("Rel" . SPARSER::PROTEIN)
    ("Mcl1" . SPARSER::PROTEIN) ("Mcl" . SPARSER::PROTEIN)
    ("an essential gene" . SPARSER::GENE)
    ("Fbw7, hCdc4 and hSel10" . SPARSER::COLLECTION)
    ("Fbw7" . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("MIP2" . SPARSER::PROTEIN) ("MCP1" . SPARSER::PROTEIN)
    ("CD40L" . SPARSER::PROTEIN) ("LTβR" . SPARSER::PROTEIN)
    ("lymphotoxin-β" . SPARSER::PROTEIN) ("Nfκb2" . SPARSER::PROTEIN)
    ("Leptomycin B" . SPARSER::MOLECULE) ("exportin1" . SPARSER::PROTEIN)
    ("cIAP1" . SPARSER::PROTEIN) ("βTrCP" . SPARSER::PROTEIN)
    ("NFKB2" . SPARSER::PROTEIN) ("CD40 ligand" . SPARSER::PROTEIN)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ankyrin repeat" . SPARSER::PROTEIN) ("IκB ε" . SPARSER::PROTEIN)
    ("IκBβ" . SPARSER::PROTEIN) ("hCdc4" . SPARSER::PROTEIN)
    ("Cul1" . SPARSER::PROTEIN) ("Fbxw7" . SPARSER::PROTEIN)
    ("either H 2 O 2 or Aβ 1-42" . SPARSER::COLLECTION)
    ("Hdac2-" . SPARSER::PROTEIN) ("cKO" . SPARSER::PROTEIN)
    ("PGR" . SPARSER::PROTEIN)
    ("transcriptional activators or repressors" . SPARSER::COLLECTION)
    ("GRs" . SPARSER::PROTEIN) ("Hdac2" . SPARSER::PROTEIN)
    ("hydrogen peroxide (H 2 O 2 ) and amyloid-β (Aβ) oligomers xref"
     . SPARSER::COLLECTION)
    ("LTP" . SPARSER::PROTEIN) ("NeuN" . SPARSER::PROTEIN)
    ("Svp and MAP2" . SPARSER::COLLECTION)
    ("such regained chromatin and transcriptional plasticity"
     . SPARSER::COLLECTION)
    ("hippocampal CK-p25" . SPARSER::COLLECTION)
    ("CoREST, NuRD, and Sin3" . SPARSER::COLLECTION)
    ("tau, p53, and tubulin" . SPARSER::COLLECTION)
    ("a gene’s" . SPARSER::GENE) ("HDAC1 and HDAC3" . SPARSER::COLLECTION)
    ("β- actin , β- globin and β- tubulin" . SPARSER::COLLECTION)
    ("Svp (synaptophysin) and Stg (synaptotagmin)" . SPARSER::COLLECTION)
    ("the immediate-early genes Arc" . SPARSER::PROTEIN)
    ("Egr1 , Homer1 , and Cdk5" . SPARSER::COLLECTION)
    ("GluR1 , GluR2 , NR2A , and NR2B" . SPARSER::COLLECTION)
    ("synaptotagmin" . SPARSER::PROTEIN) ("Svp" . SPARSER::PROTEIN)
    ("Bdnf" . SPARSER::PROTEIN) ("Arc" . SPARSER::PROTEIN)
    ("the structurally highly-related HDAC1" . SPARSER::PROTEIN)
    ("hippocampal area CA3 or the dentate gyrus ( xref )"
     . SPARSER::COLLECTION)
    ("hippocampal area CA3" . SPARSER::PROTEIN) ("gyrus" . SPARSER::PROTEIN)
    ("dentate" . SPARSER::PROTEIN) ("hippocampal area CA1" . SPARSER::PROTEIN)
    ("CA1" . SPARSER::PROTEIN) ("CK-p25" . SPARSER::COLLECTION)
    ("CK" . SPARSER::PROTEIN)
    ("neighboring histones and the DNA" . SPARSER::COLLECTION)
    ("neighboring histones" . SPARSER::PROTEIN) ("2-4" . SPARSER::PROTEIN)
    ("H2BK" . SPARSER::PROTEIN) ("MTA2" . SPARSER::PROTEIN)
    ("A-D" . SPARSER::PROTEIN) ("A-M" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("β 1" . SPARSER::PROTEIN) ("amyloid-β" . SPARSER::MOLECULE)
    ("MAP2" . SPARSER::PROTEIN)
    ("microtubule-associated protein 2" . SPARSER::PROTEIN)
    ("Sin3" . SPARSER::PROTEIN) ("RNA Polymerase II" . SPARSER::PROTEIN)
    ("K5" . SPARSER::PROTEIN) ("β- tubulin" . SPARSER::PROTEIN)
    ("β- globin" . SPARSER::PROTEIN) ("β- actin" . SPARSER::PROTEIN)
    ("NR2B" . SPARSER::PROTEIN) ("NR2A" . SPARSER::PROTEIN)
    ("GluR2" . SPARSER::PROTEIN) ("GluR1" . SPARSER::PROTEIN)
    ("glutamate receptor" . SPARSER::PROTEIN) ("Homer1" . SPARSER::PROTEIN)
    ("CA3" . SPARSER::PROTEIN) ("β-amyloid" . SPARSER::MOLECULE)
    ("only one NLRP4" . SPARSER::PROTEIN)
    ("MyD88 or IRF7" . SPARSER::COLLECTION)
    ("TBK1, and DTX4" . SPARSER::COLLECTION)
    ("MAVS and STING" . SPARSER::COLLECTION)
    ("NAP1 and SINTBAD" . SPARSER::COLLECTION) ("SINTBAD" . SPARSER::PROTEIN)
    ("RIG-I, Mda5, IFI16 and DDX41" . SPARSER::COLLECTION)
    ("TLR3 and TLR4" . SPARSER::COLLECTION)
    ("TBK1 and type I" . SPARSER::COLLECTION)
    ("TBK1 or DTX4" . SPARSER::COLLECTION)
    ("wild-type TBK1 or the K504R or K661R TBK1 mutant" . SPARSER::COLLECTION)
    ("IL-6 and IL-1β" . SPARSER::COLLECTION)
    ("IFN-α, IFN-β, IL-6 and IL-1β" . SPARSER::COLLECTION)
    ("NLRP4 or DTX4" . SPARSER::COLLECTION)
    ("siRNA or DTX4" . SPARSER::COLLECTION)
    ("NLRP4 and MyD88" . SPARSER::COLLECTION)
    ("-trimethylammonium" . SPARSER::MOLECULE)
    ("MyD88–IRF7" . SPARSER::COLLECTION)
    ("trimethylammonium" . SPARSER::MOLECULE) ("liposomes" . SPARSER::PROTEIN)
    ("dinucleotide" . SPARSER::MOLECULE)
    ("TBK1 and IRF3" . SPARSER::COLLECTION)
    ("considerable K48-linked polyubiquitination" . SPARSER::PROTEIN)
    ("DTX4 and TBK1" . SPARSER::COLLECTION)
    ("NLRP4 and DTX4" . SPARSER::COLLECTION)
    ("DTX4, TBK1 and NLRP4" . SPARSER::COLLECTION)
    ("NLRP4, TBK1 and DTX4" . SPARSER::COLLECTION)
    ("anti-TBK1 or anti-NLRP4" . SPARSER::COLLECTION)
    ("NLRP4 and its Nod" . SPARSER::COLLECTION)
    ("DTX4 and NLRP4" . SPARSER::COLLECTION)
    ("NLRP4 and NLRP4" . SPARSER::COLLECTION)
    ("Nod or LRR" . SPARSER::COLLECTION) ("pyrin" . SPARSER::PROTEIN)
    ("HA-tagged K63- or K48-linked ubiquitin" . SPARSER::COLLECTION)
    ("K63-" . SPARSER::PROTEIN) ("particular TBK1" . SPARSER::PROTEIN)
    ("IKKα, IKKβ or IKKi" . SPARSER::COLLECTION)
    ("TBK1 and hemagglutinin" . SPARSER::COLLECTION)
    ("NLRP4-TBK1" . SPARSER::COLLECTION)
    ("NLRP4 and IRF3" . SPARSER::COLLECTION)
    ("neither IKKi nor IRF3" . SPARSER::COLLECTION)
    ("IKKi or IRF3" . SPARSER::COLLECTION)
    ("NLRP4 and TBK1" . SPARSER::COLLECTION)
    ("NLRP4 (anti-NLRP4) and anti-IRF3" . SPARSER::COLLECTION)
    ("NLRP4-associated proteins and IRF3-associated proteins"
     . SPARSER::COLLECTION)
    ("IRF3-associated proteins" . SPARSER::PROTEIN)
    ("NLRP4-associated proteins" . SPARSER::PROTEIN)
    ("IKKi, IRF3 or IRF7" . SPARSER::COLLECTION)
    ("TBK1 or IKBKE" . SPARSER::COLLECTION)
    ("IFN-β or ISRE" . SPARSER::COLLECTION)
    ("TRIF, RIG-I, Mda5, MAVS, STING and TBK1" . SPARSER::COLLECTION)
    ("IKKi" . SPARSER::PROTEIN)
    ("IFIT1 (which encodes ISG-54) and CCL5" . SPARSER::COLLECTION)
    ("ISG15 , IFIT2 (which encodes ISG-56), IFIT1 (which encodes ISG-54) and CCL5"
     . SPARSER::COLLECTION)
    ("mRNA and IFN-β" . SPARSER::COLLECTION) ("IFNB" . SPARSER::PROTEIN)
    ("an NLRP4 -specific small interfering RNA (siRNA) and two NLRP4 -specific lentivirus short hairpin RNA (shRNA)"
     . SPARSER::COLLECTION)
    ("RIG-I, Mda5, MAVS or TRIF" . SPARSER::COLLECTION)
    ("VSV-eGFP" . SPARSER::COLLECTION) ("eGFP" . SPARSER::PROTEIN)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("the internal control renilla luciferase" . SPARSER::PROTEIN)
    ("IKK and beclin-1" . SPARSER::COLLECTION)
    ("IFN-α and IFN-β" . SPARSER::COLLECTION)
    ("TRIF, MAVS and STING" . SPARSER::COLLECTION)
    ("RNA and DNA" . SPARSER::COLLECTION)
    ("IFI16 and DDX41" . SPARSER::COLLECTION)
    ("viral AT-rich double-stranded DNA" . SPARSER::DNA)
    ("viral DNA" . SPARSER::DNA) ("viral doublestranded RNA" . SPARSER::RNA)
    ("RIG-I and Mda5" . SPARSER::COLLECTION)
    ("VISA, IPS-1 or Cardif" . SPARSER::COLLECTION) ("Mda5" . SPARSER::PROTEIN)
    ("Mda" . SPARSER::DRUG) ("helicases" . SPARSER::PROTEIN)
    ("NLRs" . SPARSER::PROTEIN) ("Nod" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NLRP4-DTX4" . SPARSER::COLLECTION)
    ("TBK1 and the transcription factor IRF3" . SPARSER::COLLECTION)
    ("DTX4 or NLRP4" . SPARSER::COLLECTION)
    ("RNA or DNA" . SPARSER::COLLECTION) ("AIP4" . SPARSER::PROTEIN)
    ("PCBP2" . SPARSER::PROTEIN) ("NRDP1" . SPARSER::PROTEIN)
    ("NAP1" . SPARSER::PROTEIN) ("TMEM173" . SPARSER::PROTEIN)
    ("IFIH1" . SPARSER::PROTEIN) ("DDX58" . SPARSER::PROTEIN)
    ("TICAM1" . SPARSER::PROTEIN) ("CCL5" . SPARSER::PROTEIN)
    ("ISG-54" . SPARSER::PROTEIN) ("IFIT1" . SPARSER::PROTEIN)
    ("IFIT2" . SPARSER::PROTEIN) ("ISG15" . SPARSER::PROTEIN)
    ("interferon induced" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("NLR family" . SPARSER::PROTEIN) ("beclin-1" . SPARSER::PROTEIN)
    ("NLRC5" . SPARSER::PROTEIN) ("NLRX1" . SPARSER::PROTEIN)
    ("IFN-β" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("DDX41" . SPARSER::PROTEIN) ("IFI16" . SPARSER::PROTEIN)
    ("DTX4" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("NLRP4" . SPARSER::PROTEIN) ("Glp" . SPARSER::PROTEIN)
    ("RK" . SPARSER::PROTEIN) ("G9a and GLP" . SPARSER::COLLECTION)
    ("GLP/KMT1D" . SPARSER::COLLECTION) ("GLP" . SPARSER::PROTEIN)
    ("PCNA and H3K56" . SPARSER::COLLECTION)
    ("PCNA and histone" . SPARSER::COLLECTION)
    ("nucleosomal H3K4" . SPARSER::PROTEIN) ("CoREST" . SPARSER::PROTEIN)
    ("cofactor or nucleosome" . SPARSER::COLLECTION)
    ("octamer" . SPARSER::PROTEIN)
    ("H3/H4 tetramers and H2A/H2B dimers ( xref )" . SPARSER::COLLECTION)
    ("H2A/H2B" . SPARSER::COLLECTION) ("tetramers" . SPARSER::TETRAMER)
    ("either chromatin-associated RPA or RFC" . SPARSER::COLLECTION)
    ("RPA or RFC" . SPARSER::COLLECTION) ("protein A (RPA)" . SPARSER::PROTEIN)
    ("arc" . SPARSER::PROTEIN) ("ethynyl" . SPARSER::MOLECULE)
    ("tri" . SPARSER::PROTEIN) ("SETDB1/SETDB2" . SPARSER::COLLECTION)
    ("Ezh2" . SPARSER::PROTEIN) ("DAPI-dense ( xref )" . SPARSER::DRUG)
    ("DAPI-dense" . SPARSER::DRUG)
    ("competitive western blot" . SPARSER::PROTEIN)
    ("Heterochromatin" . SPARSER::BIO-COMPLEX) ("Histones" . SPARSER::PROTEIN)
    ("G9a or H3K56" . SPARSER::COLLECTION) ("G9a/KMT1C" . SPARSER::COLLECTION)
    ("S -adenosylmethionine" . SPARSER::DRUG)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("Amino Acids" . SPARSER::AMINO-ACID)
    ("leukemia inhibitory factor" . SPARSER::PROTEIN)
    ("S-T" . SPARSER::PROTEIN) ("KMT1D" . SPARSER::PROTEIN)
    ("histone chaperone Asf1" . SPARSER::PROTEIN) ("Suv39h" . SPARSER::PROTEIN)
    ("SETDB2" . SPARSER::PROTEIN) ("SETDB1" . SPARSER::PROTEIN)
    ("SET8" . SPARSER::PROTEIN) ("HP1α" . SPARSER::PROTEIN)
    ("Heterochromatin Protein 1" . SPARSER::PROTEIN)
    ("KMT1C" . SPARSER::PROTEIN) ("G9a" . SPARSER::PROTEIN)
    ("K56" . SPARSER::PROTEIN) ("monocyte-derived IL-6" . SPARSER::PROTEIN)
    ("IL-6 and C-reactive protein" . SPARSER::COLLECTION)
    ("a pleiotropic cytokine" . SPARSER::PROTEIN)
    ("c-Fos and Fra-1" . SPARSER::COLLECTION)
    ("Fra-1, c-Fos and Jun D" . SPARSER::COLLECTION)
    ("Fra-1 and c-Fos" . SPARSER::COLLECTION)
    ("ERK-1 and/or ERK2" . SPARSER::COLLECTION)
    ("NFκB and AP-1" . SPARSER::COLLECTION)
    ("PD98059 and simvastatin" . SPARSER::COLLECTION)
    ("ERK/JNK" . SPARSER::COLLECTION)
    ("simvastatin, SP600125 and SB203580" . SPARSER::COLLECTION)
    ("IL-6 and MMP-1" . SPARSER::COLLECTION)
    ("parthenolide" . SPARSER::MOLECULE) ("Simvastatin" . SPARSER::DRUG)
    ("ERK/AP-1" . SPARSER::COLLECTION)
    ("c-Fos, Fra-1, and Jun D" . SPARSER::COLLECTION)
    ("phorbol-12-myristate-13-acetate (PMA)" . SPARSER::DRUG)
    ("MAPK and NFκB" . SPARSER::COLLECTION)
    ("p50 and p65" . SPARSER::COLLECTION) ("P50 and P65" . SPARSER::COLLECTION)
    ("ERK, JNK and p38" . SPARSER::COLLECTION)
    ("ERK and JNK" . SPARSER::COLLECTION)
    ("PD98059 and SP600125" . SPARSER::COLLECTION)
    ("MAPK, and NFκB" . SPARSER::COLLECTION)
    ("LPS, and IL-6" . SPARSER::COLLECTION) ("tocilizumab" . SPARSER::DRUG)
    ("a key inflammatory cytokine" . SPARSER::PROTEIN)
    ("ERK-AP-1" . SPARSER::COLLECTION) ("simvastatin" . SPARSER::DRUG)
    ("c-Fos, Fra-1 and Jun D" . SPARSER::COLLECTION)
    ("AP-1 and NFκB" . SPARSER::COLLECTION)
    ("C-reactive protein" . SPARSER::PROTEIN) ("ERK-1" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("P50" . SPARSER::PROTEIN)
    ("p38 mitogen activated protein kinase" . SPARSER::PROTEIN)
    ("SP600125" . SPARSER::PROTEIN)
    ("Glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Jun D" . SPARSER::PROTEIN) ("Fra-1" . SPARSER::PROTEIN)
    ("Eomesodermin, Xbra and Mix1" . SPARSER::COLLECTION)
    ("Xbra" . SPARSER::PROTEIN) ("Eomesodermin" . SPARSER::PROTEIN)
    ("a ‘primed’ pluripotent state" . SPARSER::BIO-STATE)
    ("separate Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AIF" . SPARSER::PROTEIN) ("Akt, Erk and Gsk3β" . SPARSER::COLLECTION)
    ("Akt, Erk or Gsk3β" . SPARSER::COLLECTION)
    ("Fgf2 and Wnt" . SPARSER::COLLECTION)
    ("Erk and Wnt" . SPARSER::COLLECTION)
    ("exogenous Wnt3a" . SPARSER::PROTEIN) ("KSR" . SPARSER::PROTEIN)
    ("Igf-1, heregulin and Fgf2" . SPARSER::COLLECTION)
    ("around Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("Activin/Smad" . SPARSER::COLLECTION)
    ("Smad and Wnt" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K, Erk and Gsk3β" . SPARSER::COLLECTION)
    ("Erk, Gsk3β, Smad2 or c-myc" . SPARSER::COLLECTION)
    ("exogenous Wnt ligands" . SPARSER::LIGAND) ("BIO" . SPARSER::INHIBITOR)
    ("Nanog, E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("E-cadherin and Nanog" . SPARSER::COLLECTION)
    ("inhibitor (BIO)" . SPARSER::INHIBITOR)
    ("Erk directly binds Gsk3β" . SPARSER::PROTEIN)
    ("MEK-ER" . SPARSER::COLLECTION) ("Mek and Erk" . SPARSER::COLLECTION)
    ("a dominant-negative Erk1" . SPARSER::PROTEIN)
    ("EKAR/Erk" . SPARSER::COLLECTION) ("Akt1-cRaf" . SPARSER::COLLECTION)
    ("cRaf" . SPARSER::PROTEIN) ("®/HAI" . SPARSER::COLLECTION)
    ("−HAI" . SPARSER::COLLECTION) ("media and MEF-CM" . SPARSER::COLLECTION)
    ("MAPK/Erk" . SPARSER::COLLECTION) ("pErk" . SPARSER::PROTEIN)
    ("-luciferase" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN-FAMILY)
    ("active or inactive" . SPARSER::COLLECTION)
    ("MixL1-luciferase" . SPARSER::COLLECTION)
    ("SB 431542 (SB)" . SPARSER::DRUG)
    ("Activin A and Smad2" . SPARSER::COLLECTION)
    ("heregulin and Igf-1" . SPARSER::COLLECTION) ("myr" . SPARSER::MOLECULE)
    ("BG" . SPARSER::PROTEIN) ("Eomes and MixL1" . SPARSER::COLLECTION)
    ("Nanog and Oct4" . SPARSER::COLLECTION)
    ("Igf-1 and heregulin" . SPARSER::COLLECTION) ("Eomes" . SPARSER::PROTEIN)
    ("Heregulin and Igf-1" . SPARSER::COLLECTION)
    ("PI3K/Akt1" . SPARSER::COLLECTION) ("Heregulin" . SPARSER::PROTEIN)
    ("Activin A (A) and Igf-1 (I)" . SPARSER::COLLECTION)
    ("heregulin" . SPARSER::PROTEIN) ("HAI" . SPARSER::PROTEIN)
    ("Mek/Erk" . SPARSER::COLLECTION) ("Activin/Nodal" . SPARSER::COLLECTION)
    ("XBRA" . SPARSER::PROTEIN) ("Nodal" . SPARSER::PROTEIN)
    ("Fgf2" . SPARSER::PROTEIN) ("Alk4/Activin" . SPARSER::COLLECTION)
    ("Activin" . SPARSER::PROTEIN) ("Wnt/Gsk3β" . SPARSER::COLLECTION)
    ("/PI3K" . SPARSER::COLLECTION) ("which targets Gsk3β" . SPARSER::PROTEIN)
    ("Raf/Mek/Erk" . SPARSER::COLLECTION)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mix1" . SPARSER::PROTEIN)
    ("Tcf3" . SPARSER::PROTEIN) ("CHIR99021" . SPARSER::MOLECULE)
    ("SSEA3" . SPARSER::MOLECULE) ("Sox17" . SPARSER::PROTEIN)
    ("Tra-1" . SPARSER::PROTEIN) ("Gsk3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("UO126" . SPARSER::DRUG) ("F 10" . SPARSER::PROTEIN)
    ("Erk1" . SPARSER::PROTEIN) ("MIXL1" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SB 431542" . SPARSER::DRUG)
    ("Brachyury protein" . SPARSER::PROTEIN) ("MixL1" . SPARSER::PROTEIN)
    ("Receptor Type" . SPARSER::PROTEIN) ("Alk4" . SPARSER::PROTEIN)
    ("Gsk3β" . SPARSER::PROTEIN) ("Activin A" . SPARSER::MOLECULE)
    ("CD44, BMI-1, Nanog, and Oct-4" . SPARSER::COLLECTION)
    ("Sdf-1" . SPARSER::COLLECTION) ("exogenous EGFR" . SPARSER::PROTEIN)
    ("CD44 or BMI-1" . SPARSER::COLLECTION)
    ("BMI-1 and CD44" . SPARSER::COLLECTION)
    ("Bmi-1, CD44, Oct-4, Nanog, CXCR4 and SDF-1" . SPARSER::COLLECTION)
    ("CXCR4/SDF-1" . SPARSER::COLLECTION)
    ("Oct-4 and Nanog" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("CD44 and BMI-1" . SPARSER::COLLECTION)
    ("EGFR and ErbB2" . SPARSER::COLLECTION) ("ErbB2" . SPARSER::PROTEIN)
    ("ras/raf-1/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("EGFR and Akt" . SPARSER::COLLECTION)
    ("proto-oncogenes and tumor suppressors" . SPARSER::COLLECTION)
    ("CD44−" . SPARSER::PROTEIN) ("involucrin" . SPARSER::PROTEIN)
    ("Drugs" . SPARSER::DRUG) ("Iressa" . SPARSER::DRUG)
    ("Gefinitib" . SPARSER::DRUG)
    ("CD44, BMI-1, Oct-4, NANOG, CXCR4, and SDF-1" . SPARSER::COLLECTION)
    ("NANOG" . SPARSER::PROTEIN) ("HN-1" . SPARSER::PROTEIN)
    ("Bmi-1" . SPARSER::PROTEIN) ("or 2 µ" . SPARSER::MOLECULE)
    ("Anti-EGFR" . SPARSER::PROTEIN) ("SDF1" . SPARSER::PROTEIN)
    ("Oct4" . SPARSER::PROTEIN) ("Oct-3" . SPARSER::PROTEIN)
    ("beta-actin" . SPARSER::PROTEIN) ("CXCR-4" . SPARSER::PROTEIN)
    ("ZD1839" . SPARSER::DRUG) ("L-glutamate" . SPARSER::MOLECULE)
    ("raf-1" . SPARSER::PROTEIN) ("TGFα" . SPARSER::PROTEIN)
    ("Proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("Cytokeratin5" . SPARSER::PROTEIN) ("Oct-4" . SPARSER::PROTEIN)
    ("BMI-1" . SPARSER::PROTEIN) ("acute types" . TYPE)
    ("JAK2/STAT5" . SPARSER::COLLECTION)
    ("a hyperactive TK" . SPARSER::PROTEIN)
    ("JAK2 and STAT5" . SPARSER::COLLECTION) ("Fusion TK's" . SPARSER::PROTEIN)
    ("JAK2/STAT5/Bcl-xL" . SPARSER::COLLECTION)
    ("transformed BCR-ABL" . SPARSER::PROTEIN)
    ("growth factor or cytokine" . SPARSER::COLLECTION)
    ("receptor and non-receptor" . SPARSER::COLLECTION)
    ("myeloid/lymphoid" . SPARSER::COLLECTION)
    ("BCR/ABL" . SPARSER::COLLECTION) ("Balb/c" . SPARSER::COLLECTION)
    ("leukemic fusion proteins" . SPARSER::PROTEIN)
    ("Both treated BCR-JAK2" . SPARSER::COLLECTION)
    ("Bcl-xL, Osm and Socs2" . SPARSER::COLLECTION)
    ("pTEL-JAK2" . SPARSER::COLLECTION) ("Socs2" . SPARSER::PROTEIN)
    ("Osm" . SPARSER::PROTEIN)
    ("IL-3 and Ba/F3-BCR-JAK2 and -TEL-JAK2" . SPARSER::COLLECTION)
    ("-TEL-JAK2" . SPARSER::COLLECTION) ("p-STAT5" . SPARSER::COLLECTION)
    ("approximately 90 kDa" . SPARSER::PROTEIN)
    ("BCR-FGFR1" . SPARSER::COLLECTION) ("BCR-PDGFRA" . SPARSER::COLLECTION)
    ("BCR-TK" . SPARSER::COLLECTION) ("BCR and JAK2" . SPARSER::COLLECTION)
    ("BCR (BCR-Fw-T) and the stop codon" . SPARSER::COLLECTION)
    ("Fw" . SPARSER::MOLECULE)
    ("BCR (BCR-B) and the stop codon" . SPARSER::COLLECTION)
    ("adult and high-risk pediatric B-ALL" . SPARSER::PROTEIN)
    ("MLL , TCF3 , TEL and BCR-ABL" . SPARSER::COLLECTION)
    ("SEC31A-JAK2" . SPARSER::COLLECTION) ("STRN3-JAK2" . SPARSER::COLLECTION)
    ("SSBP2-JAK2" . SPARSER::COLLECTION) ("PCM1-JAK2" . SPARSER::COLLECTION)
    ("JAK2 or STAT5" . SPARSER::COLLECTION)
    ("JAK2-cytokine" . SPARSER::COLLECTION) ("kinases (TK)" . SPARSER::PROTEIN)
    ("-BCR" . SPARSER::COLLECTION)
    ("Acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("BCR-JAK2" . SPARSER::COLLECTION) ("BcL-2" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling-2" . SPARSER::PROTEIN)
    ("Foxn1" . SPARSER::PROTEIN) ("pro-B" . SPARSER::DRUG)
    ("PCR2" . SPARSER::PROTEIN) ("interferon alpha" . SPARSER::PROTEIN)
    ("CD22" . SPARSER::PROTEIN) ("HLA-DR" . SPARSER::PROTEIN)
    ("CD79a" . SPARSER::PROTEIN) ("TCF3" . SPARSER::PROTEIN)
    ("SEC31A" . SPARSER::PROTEIN) ("STRN3" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("SSBP2" . SPARSER::PROTEIN)
    ("PCM1" . SPARSER::PROTEIN) ("BCR-ABL fusion gene" . SPARSER::PROTEIN)
    ("TG101209" . SPARSER::DRUG) ("Ldlr" . SPARSER::PROTEIN)
    ("host-derived ligands" . SPARSER::LIGAND) ("fostamatinib" . SPARSER::DRUG)
    ("TLR4 and its Syk signaling component" . SPARSER::COLLECTION)
    ("microbial PAMPs" . SPARSER::PROTEIN) ("PRR" . SPARSER::PROTEIN)
    ("TLR4/Syk" . SPARSER::COLLECTION)
    ("a strong MyD88/NF-κB component" . SPARSER::COMPONENT)
    ("MyD88/NF-κB" . SPARSER::COLLECTION)
    ("c-Fos and JNK-" . SPARSER::COLLECTION) ("JNK-" . SPARSER::PROTEIN)
    ("CXCL2 (MIP-2) and IL6 protein" . SPARSER::COLLECTION)
    ("Cxcl2 and Il-6" . SPARSER::COLLECTION)
    ("a strong NF-κB component" . SPARSER::COMPONENT)
    ("JNK and c-Jun" . SPARSER::COLLECTION) ("TLR4/MD2" . SPARSER::COLLECTION)
    ("AP-1-Luc" . SPARSER::PROTEIN-PAIR)
    ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("JNK and IKKε" . SPARSER::COLLECTION)
    ("a heterodimeric AP-1 transcriptional complex" . SPARSER::BIO-COMPLEX)
    ("ERK1/2, JNK and c-Jun" . SPARSER::COLLECTION)
    ("TLR4/MD-2" . SPARSER::COLLECTION) ("Flag-TLR4" . SPARSER::COLLECTION)
    ("GFP-TLR4" . SPARSER::COLLECTION) ("Cre−" . SPARSER::PROTEIN)
    ("primary macrophages" . SPARSER::PROTEIN)
    ("Cdc42, Ras and Rho" . SPARSER::COLLECTION)
    ("Vav-Ras-Raf-MEK1-ERK1/2" . SPARSER::COLLECTION)
    ("a host-derived TLR4 ligand" . SPARSER::MOLECULE)
    ("SH-2" . SPARSER::PROTEIN) ("SLP76/SLP65" . SPARSER::COLLECTION)
    ("ITAMs" . SPARSER::PROTEIN)
    ("receptor or Fc receptor" . SPARSER::COLLECTION)
    ("host-generated ligands" . SPARSER::LIGAND)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("CXCL2 and IL-6" . SPARSER::COLLECTION)
    ("ERK1/2 and JNK" . SPARSER::COLLECTION)
    ("TLR4 and TLR4 and Syk" . SPARSER::COLLECTION)
    ("TLR4 and Syk" . SPARSER::COLLECTION) ("Syk" . SPARSER::PROTEIN)
    ("LDL" . SPARSER::PROTEIN) ("Il-6" . SPARSER::PROTEIN)
    ("Cxcl2" . SPARSER::PROTEIN) ("MD2" . SPARSER::PROTEIN)
    ("MIP-2" . SPARSER::PROTEIN) ("IgG3" . SPARSER::BIO-COMPLEX)
    ("K1" . SPARSER::PROTEIN) ("colony stimulating factor" . SPARSER::PROTEIN)
    ("toll-like receptor-4" . SPARSER::PROTEIN) ("SLP65" . SPARSER::PROTEIN)
    ("Fc receptor" . SPARSER::PROTEIN)
    ("Spleen tyrosine kinase" . SPARSER::PROTEIN)
    ("spleen tyrosine kinase" . SPARSER::PROTEIN) ("MD-2" . SPARSER::PROTEIN)
    ("low-density lipoprotein" . SPARSER::PROTEIN) ("RHA" . SPARSER::PROTEIN)
    ("essential growth effectors" . SPARSER::EFFECTOR)
    ("possible JunD" . SPARSER::PROTEIN) ("JAK/STAT5" . SPARSER::COLLECTION)
    ("Pim-1 and JunD" . SPARSER::COLLECTION)
    ("previously unrecognized JunD gene" . SPARSER::GENE)
    ("at least two essential mediators" . SPARSER::PROTEIN)
    ("CD4 and CD8" . SPARSER::COLLECTION)
    ("JunD and Pim1" . SPARSER::COLLECTION)
    ("JunD and Pim-1" . SPARSER::COLLECTION)
    ("The repetitive blot" . SPARSER::PROTEIN)
    ("target and IL-7" . SPARSER::COLLECTION) ("ID (GO)" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("functional homology" . SPARSER::PROTEIN)
    ("Suppressive genes" . SPARSER::GENE) ("AP-1/JunD" . SPARSER::COLLECTION)
    ("more HXKII promoter DNA" . SPARSER::DNA)
    ("the HXKII promoter DNA" . SPARSER::DNA)
    ("the HXKII promoter" . SPARSER::PROMOTER)
    ("JNK and IL-7" . SPARSER::COLLECTION)
    ("JunD mRNA (∼60%) and protein (∼50%)" . SPARSER::COLLECTION)
    ("JNK or p38" . SPARSER::COLLECTION) ("MAPK/JNK" . SPARSER::COLLECTION)
    ("c-Fos and c-Jun" . SPARSER::COLLECTION)
    ("c-Fos, c-Jun and JunD" . SPARSER::COLLECTION)
    ("the recognized factors included SP-1" . SPARSER::PROTEIN)
    ("IL-4/IL-7 receptor" . SPARSER::COLLECTION)
    ("IL-4/IL-7" . SPARSER::COLLECTION) ("JunD/AP-1" . SPARSER::COLLECTION)
    ("IL-7-" . SPARSER::PROTEIN) ("c-Jun and JunB" . SPARSER::COLLECTION)
    ("c-Jun and JunD" . SPARSER::COLLECTION) ("JNKs" . SPARSER::PROTEIN)
    ("JNK1, JNK2, and JNK3" . SPARSER::COLLECTION)
    ("ERK, JNK, or FRK" . SPARSER::COLLECTION) ("FRK" . SPARSER::PROTEIN)
    ("proteins and Maf" . SPARSER::COLLECTION)
    ("Jun (c-Jun, JunB and JunD) and Fos (c-Fos, FosB, Fra1 and Fra2)"
     . SPARSER::COLLECTION)
    ("c-Jun, JunB and JunD" . SPARSER::COLLECTION)
    ("c-Fos, FosB, Fra1 and Fra2" . SPARSER::COLLECTION)
    ("FosB" . SPARSER::PROTEIN) ("JunB" . SPARSER::PROTEIN)
    ("MAPK and JNK" . SPARSER::COLLECTION) ("Fyn or Lyn" . SPARSER::COLLECTION)
    ("receptor-associated kinases" . SPARSER::KINASE)
    ("JNK and JunD" . SPARSER::COLLECTION)
    ("JNK or JunD" . SPARSER::COLLECTION)
    ("possible JunD-regulated gene" . SPARSER::GENE)
    ("JNK/JunD" . SPARSER::COLLECTION) ("c-Fos or c-Jun" . SPARSER::COLLECTION)
    ("an essential cytokine" . SPARSER::PROTEIN) ("Na3VO4" . SPARSER::MOLECULE)
    ("JNK protein" . SPARSER::PROTEIN) ("JUND1" . SPARSER::PROTEIN)
    ("IL-4 receptor" . SPARSER::PROTEIN) ("RNA helicase A" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 4" . SPARSER::PROTEIN)
    ("cIAP-2" . SPARSER::PROTEIN) ("GLUT1" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("Pim1" . SPARSER::PROTEIN)
    ("Phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("PD169316" . SPARSER::DRUG) ("SP-1" . SPARSER::PROTEIN)
    ("Cdc25A" . SPARSER::PROTEIN) ("JNK2" . SPARSER::PROTEIN)
    ("Fyn-Related Kinase" . SPARSER::PROTEIN) ("Fra2" . SPARSER::PROTEIN)
    ("Fra1" . SPARSER::PROTEIN)
    ("Extracellular signal-Regulated Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-7Rα" . SPARSER::PROTEIN) ("IL-7R" . SPARSER::PROTEIN)
    ("Pim-1" . SPARSER::PROTEIN) ("c-Fos" . SPARSER::PROTEIN)
    ("Activating Protein" . SPARSER::PROTEIN)
    ("IL-7 receptor" . SPARSER::PROTEIN) ("IL-7" . SPARSER::PROTEIN)
    ("Interleukin-7" . SPARSER::PROTEIN) ("COOH" . SPARSER::MOLECULE)
    ("geldanamycin" . SPARSER::DRUG) ("Cdc37" . SPARSER::PROTEIN)
    ("arsenite" . SPARSER::DRUG) ("thiol" . SPARSER::MOLECULE)
    ("scriptaid" . SPARSER::DRUG)
    ("the Jun N-terminal kinase (JNK) and p38" . SPARSER::COLLECTION)
    ("p50-p65" . SPARSER::COLLECTION) ("Hsp90-IKK" . SPARSER::COLLECTION)
    ("As 2 O 3 , and As 2 O 3" . SPARSER::COLLECTION)
    ("IKKα and IKKβ" . SPARSER::COLLECTION) ("cdc37" . SPARSER::PROTEIN)
    ("Chaperone" . SPARSER::PROTEIN)
    ("HDAC1, HDAC2, HDAC3, and HDAC8" . SPARSER::COLLECTION)
    ("HDAC4, HDAC5, HDAC7, and HDAC9" . SPARSER::COLLECTION)
    ("HDAC6 and HDAC10" . SPARSER::COLLECTION)
    ("acetyltransferases (HAT)" . SPARSER::PROTEIN)
    ("IL-6 and VEGF" . SPARSER::COLLECTION) ("melphalan" . SPARSER::DRUG)
    ("HDAC6-Hsp90-IKKα-NFκB" . SPARSER::COLLECTION)
    ("IKKα-associated Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("α-tubulin and Hsp90" . SPARSER::COLLECTION) ("ddH 2" . SPARSER::PROTEIN)
    ("CCK-8" . SPARSER::PROTEIN) ("CD138" . SPARSER::PROTEIN)
    ("l-glutamine" . SPARSER::MOLECULE) ("TNF-a" . SPARSER::PROTEIN)
    ("IKK2" . SPARSER::PROTEIN) ("IKK1" . SPARSER::PROTEIN)
    ("HDAC11" . SPARSER::PROTEIN) ("HDAC10" . SPARSER::PROTEIN)
    ("HDAC5" . SPARSER::PROTEIN) ("HDAC4" . SPARSER::PROTEIN)
    ("HDAC8" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC6" . SPARSER::PROTEIN)
    ("As 2 O 3" . SPARSER::DRUG) ("Arsenic trioxide" . SPARSER::MOLECULE)
    ("its homodimeric state" . SPARSER::BIO-STATE)
    ("*/c-Myc" . SPARSER::COLLECTION)
    ("CyclinD1, CyclinB1 and Nucleolin" . SPARSER::COLLECTION)
    ("Nucleolin" . SPARSER::PROTEIN)
    ("a key cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p21, p27 and Rb1" . SPARSER::COLLECTION)
    ("E1 and CDK4" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CyclinD1 ( xref ) and CyclinB1 as well as cdc25a (24 hours)"
     . SPARSER::COLLECTION)
    ("CyclinB1 as well as cdc25a (24 hours)" . SPARSER::COLLECTION)
    ("CDK4 (48–72 hours) and CyclinE1 (72 hours)" . SPARSER::COLLECTION)
    ("cdc25a" . SPARSER::PROTEIN) ("Rb1" . SPARSER::PROTEIN)
    ("p21 ( xref ) and p27" . SPARSER::COLLECTION)
    ("clathrin-" . SPARSER::PROTEIN) ("Dynasore" . SPARSER::MOLECULE)
    ("Dynamin" . SPARSER::PROTEIN) ("Transferrin-" . SPARSER::PROTEIN)
    ("Transferrin" . SPARSER::PROTEIN)
    ("endogenous Max and exogenous Max" . SPARSER::COLLECTION)
    ("exogenous Max" . SPARSER::PROTEIN) ("Max and HA" . SPARSER::COLLECTION)
    ("NeuroD" . SPARSER::PROTEIN) ("c-Myc/Max/Mad" . SPARSER::COLLECTION)
    ("a valid therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a mutated form" . SPARSER::FORM)
    ("cell cycle inhibitors and the repression of the transcription of pro-proliferative genes"
     . SPARSER::COLLECTION)
    ("pro-proliferative genes" . SPARSER::GENE)
    ("p15Ink4b, p21cip1 and p27kip1" . SPARSER::COLLECTION)
    ("the ribosomal genesis" . SPARSER::PROTEIN)
    ("ribosomal RNAs and proteins" . SPARSER::COLLECTION)
    ("CDKs and cyclins" . SPARSER::COLLECTION)
    ("RNAs and proteins" . SPARSER::COLLECTION)
    ("TRAPP and GCN5" . SPARSER::COLLECTION) ("Histone" . SPARSER::PROTEIN)
    ("TRAPP" . SPARSER::PROTEIN-FAMILY) ("Myc and Mad" . SPARSER::COLLECTION)
    ("The Myc and the Mad proteins" . SPARSER::COLLECTION)
    ("Mad/Max" . SPARSER::COLLECTION)
    ("N-Myc and the proteins" . SPARSER::COLLECTION)
    ("Mad1, Mxi1, Mad3 and Mad4" . SPARSER::COLLECTION)
    ("c-Myc and Max" . SPARSER::COLLECTION) ("c-Myc/Max" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN) ("LZ" . SPARSER::PROTEIN)
    ("Triton X–100" . SPARSER::MOLECULE) ("IgG 1" . SPARSER::BIO-COMPLEX)
    ("H-2" . SPARSER::PROTEIN) ("cdc25" . SPARSER::PROTEIN)
    ("Dynamin1" . SPARSER::PROTEIN) ("α-HA" . SPARSER::MOLECULE)
    ("p27kip1" . SPARSER::PROTEIN) ("p21cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p15Ink4b" . SPARSER::PROTEIN) ("GCN5" . SPARSER::PROTEIN)
    ("Myc/Max" . SPARSER::PROTEIN) ("Mad4" . SPARSER::PROTEIN)
    ("Mxi1" . SPARSER::PROTEIN) ("N-Myc" . SPARSER::PROTEIN)
    ("type 1 and type 2" . SPARSER::COLLECTION)
    ("gene and analysis" . SPARSER::COLLECTION)
    ("LMP1 and LMP1" . SPARSER::COLLECTION)
    ("Ch2 and AL" . SPARSER::COLLECTION) ("Med" . SPARSER::PROTEIN)
    ("the prototypic B95-8 LMP1" . SPARSER::PROTEIN)
    ("the first group and F144I" . SPARSER::COLLECTION)
    ("only EBV type 2" . SPARSER::PROTEIN)
    ("only EBV type 1" . SPARSER::PROTEIN)
    ("CAO and the five variants 7924, 7705, 7950, 7823 and 7910"
     . SPARSER::COLLECTION)
    ("Variants" . SPARSER::VARIANT)
    ("randomly chosen genomic DNA" . SPARSER::DNA)
    ("A2 and P1 share polymorphisms" . SPARSER::COLLECTION)
    ("the first 118 amino acids of either variant" . SPARSER::VARIANT)
    ("the 231 N-terminal amino acids of A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("/A2" . SPARSER::COLLECTION)
    ("the first 231 amino acids of either variant" . SPARSER::VARIANT)
    ("A2 and CAO" . SPARSER::COLLECTION)
    ("the prototype LMP1 and the two variants" . SPARSER::COLLECTION)
    ("CAO" . SPARSER::MOLECULE) ("a powerful inducer" . SPARSER::PROTEIN)
    ("a multifunctional oncoprotein" . SPARSER::PROTEIN)
    ("Ch2" . SPARSER::MOLECULE) ("group C" . SPARSER::PROTEIN)
    ("EBNA-2" . SPARSER::PROTEIN) ("EBNA2" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("A3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LMP1" . SPARSER::PROTEIN)
    ("possibly other scaffold proteins" . SPARSER::PROTEIN)
    ("PAK and Freud1/Aki1" . SPARSER::COLLECTION)
    ("PI3K and PDK1" . SPARSER::COLLECTION)
    ("residual Ser473-phosphorylated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the available LPA receptors" . SPARSER::RECEPTOR)
    ("p110β and PDK1" . SPARSER::COLLECTION)
    ("BAD and FOXO" . SPARSER::COLLECTION)
    ("pThr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("an accessory protein" . SPARSER::PROTEIN)
    ("the principal PDK2" . SPARSER::PROTEIN)
    ("TORC2 and ILK" . SPARSER::COLLECTION)
    ("PDK1 and PDK2" . SPARSER::COLLECTION)
    ("the pathological states" . SPARSER::BIO-STATE)
    ("integrins and LPA" . SPARSER::COLLECTION)
    ("RICTOR and ILK" . SPARSER::COLLECTION)
    ("RICTOR-mTOR and PAK" . SPARSER::COLLECTION)
    ("type I or vitronectin" . SPARSER::COLLECTION)
    ("both invasin (2-fold) and collagen type I (1.5-fold; xref )"
     . SPARSER::COLLECTION)
    ("glass" . SPARSER::MOLECULE) ("anoikis" . SPARSER::PROTEIN)
    ("the soluble fraction" . SPARSER::COMPONENT)
    ("AKT1 and AKT2, and β1" . SPARSER::COLLECTION)
    ("AKT2, and β1" . SPARSER::COLLECTION) ("siRNA-" . SPARSER::PROTEIN)
    ("RAC" . SPARSER::PROTEIN) ("PAK1, PAK2 and PAK3" . SPARSER::COLLECTION)
    ("PAKs" . SPARSER::PROTEIN-FAMILY) ("PAK1 and PAK2" . SPARSER::COLLECTION)
    ("invasin or collagen" . SPARSER::COLLECTION)
    ("the primary PDK2" . SPARSER::PROTEIN) ("invasin" . SPARSER::PROTEIN)
    ("the principal AKT Ser473 kinase" . SPARSER::KINASE)
    ("EGF-" . SPARSER::PROTEIN) ("PAK1/PAK2" . SPARSER::COLLECTION)
    ("integrin-" . SPARSER::PROTEIN)
    ("TORC2 or another enzyme" . SPARSER::COLLECTION)
    ("matrices" . SPARSER::PROTEIN-FAMILY) ("drosophila" . SPARSER::PROTEIN)
    ("SIN1/MIP1" . SPARSER::COLLECTION)
    ("DNA-PK, ATM or ATR" . SPARSER::COLLECTION)
    ("DNA-PK, ATM and ATR" . SPARSER::COLLECTION)
    ("AKT1–3" . SPARSER::COLLECTION)
    ("receptors, and cytokine" . SPARSER::COLLECTION)
    ("LPA and PDGF" . SPARSER::COLLECTION)
    ("ILK and PAK1/2" . SPARSER::COLLECTION)
    ("RICTOR, ILK, and PAK" . SPARSER::COLLECTION)
    ("receptors, and tyrosine-kinase" . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE) ("AKT/PKB" . SPARSER::COLLECTION)
    ("Freud1" . SPARSER::PROTEIN) ("LPA3" . SPARSER::PROTEIN)
    ("LPA1" . SPARSER::PROTEIN) ("LPA2" . SPARSER::PROTEIN)
    ("COS1" . SPARSER::PROTEIN)
    ("G protein-coupled receptor" . SPARSER::PROTEIN)
    ("IPA3" . SPARSER::MOLECULE) ("PAK3" . SPARSER::PROTEIN)
    ("Group I" . SPARSER::PROTEIN) ("MIP1" . SPARSER::PROTEIN)
    ("SIN1" . SPARSER::PROTEIN) ("DNA-PK" . SPARSER::PROTEIN)
    ("DNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("PDK2s" . SPARSER::PROTEIN) ("PDK2" . SPARSER::PROTEIN)
    ("3-phosphoinositide-dependent protein kinase-1" . SPARSER::PROTEIN)
    ("TORC2" . SPARSER::PROTEIN) ("RICTOR-mTOR" . SPARSER::PROTEIN)
    ("CK1δ, CK1ε, PHB2 and WRD5" . SPARSER::COLLECTION)
    ("CK1δ and/or CK1ε" . SPARSER::COLLECTION) ("CKI" . SPARSER::PROTEIN)
    ("ACTIN" . SPARSER::PROTEIN) ("PHB2 and PER2" . SPARSER::COLLECTION)
    ("PHB2 , CK1δ and CK1ε" . SPARSER::COLLECTION)
    ("BMAL1/CLOCK" . SPARSER::COLLECTION)
    ("BMAL1 and CLOCK" . SPARSER::COLLECTION)
    ("PHB1 and PHB2" . SPARSER::COLLECTION) ("prohibitin" . SPARSER::PROTEIN)
    ("PROHIBITIN" . SPARSER::PROTEIN) ("CK1δ and CK1ε" . SPARSER::COLLECTION)
    ("P 32 and HA" . SPARSER::COLLECTION) ("CK1ε" . SPARSER::PROTEIN)
    ("CK1δ" . SPARSER::PROTEIN) ("SERINE" . SPARSER::AMINO-ACID)
    ("a novel CK1 substrate and binding partner" . SPARSER::COLLECTION)
    ("GFP-CK1δ or GFP-CK1ε" . SPARSER::COLLECTION)
    ("GFP-CK1ε" . SPARSER::PROTEIN-PAIR) ("GFP-CK1δ" . SPARSER::PROTEIN-PAIR)
    ("Blot" . SPARSER::PROTEIN) ("orthophosphate" . SPARSER::ORTHOPHOSPHATE)
    ("GTPASE-ACTIVATING PROTEIN AND VP59" . SPARSER::COLLECTION)
    ("VP" . SPARSER::PROTEIN)
    ("phospho-serine/threonine" . SPARSER::COLLECTION)
    ("a PER1-associated protein" . SPARSER::PROTEIN)
    ("PER2 and CRYPTOCHROME" . SPARSER::COLLECTION) ("NONO" . SPARSER::PROTEIN)
    ("PROTEIN" . SPARSER::PROTEIN) ("OCTAMER" . SPARSER::PROTEIN)
    ("DTT" . SPARSER::MOLECULE) ("larger CK1ε protein" . SPARSER::PROTEIN)
    ("a homobifunctional crosslinker" . SPARSER::PROTEIN)
    ("a cell-permeable thio-cleavable crosslinker" . SPARSER::PROTEIN)
    ("DSP" . SPARSER::PROTEIN) ("propionate" . SPARSER::MOLECULE)
    ("crosslinker" . SPARSER::PROTEIN) ("dexamethasone" . SPARSER::PROTEIN)
    ("PERs and CRYPTOCHROMES" . SPARSER::COLLECTION) ("CRY" . SPARSER::PROTEIN)
    ("CLOCK" . SPARSER::PROTEIN) ("PERs" . SPARSER::PROTEIN)
    ("NP" . SPARSER::PROTEIN) ("the biological clock" . SPARSER::PROTEIN)
    ("delta and epsilon" . SPARSER::COLLECTION) ("epsilon" . SPARSER::PROTEIN)
    ("delta" . SPARSER::PROTEIN) ("external cues" . SPARSER::PROTEIN-FAMILY)
    ("IRS4" . SPARSER::PROTEIN) ("CRY2" . SPARSER::PROTEIN)
    ("STIP1" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("BIG3" . SPARSER::PROTEIN) ("CKIε" . SPARSER::PROTEIN)
    ("PHB 1" . SPARSER::PROTEIN) ("PHB1" . SPARSER::PROTEIN)
    ("BMAL1" . SPARSER::PROTEIN) ("SAPS3" . SPARSER::PROTEIN)
    ("REGULATORY SUBUNIT 3" . SPARSER::PROTEIN)
    ("THREONINE-PROTEIN PHOSPHATASE" . SPARSER::PROTEIN)
    ("P 32" . SPARSER::PROTEIN) ("PROTEIN 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPASE-ACTIVATING PROTEIN" . SPARSER::PROTEIN)
    ("GAPVD1" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("POU DOMAIN" . SPARSER::PROTEIN) ("CRY1" . SPARSER::PROTEIN)
    ("PER1" . SPARSER::PROTEIN) ("reducing agent" . SPARSER::MOLECULE)
    ("PERIOD 2" . SPARSER::PROTEIN) ("PHB2" . SPARSER::PROTEIN)
    ("PROHIBITIN 2" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("microbial metabolites" . SPARSER::PROTEIN)
    ("neurotransmitter" . SPARSER::MOLECULE)
    ("histamine, tryptophan and phenylalanine" . SPARSER::COLLECTION)
    ("bacterial metabolites" . SPARSER::PROTEIN)
    ("dietary components" . SPARSER::COMPONENT)
    ("dietary amino acids like histidine" . SPARSER::AMINO-ACID)
    ("dietary amino acids" . SPARSER::AMINO-ACID)
    ("histamine and other biogenic amines" . SPARSER::COLLECTION)
    ("poisoning" . SPARSER::MOLECULE)
    ("the histidine biosynthetic pathway promoter" . SPARSER::PROMOTER)
    ("bacterial promoters" . SPARSER::PROMOTER)
    ("bifidobacterial genes" . SPARSER::GENE)
    ("exopolysaccharide and folate" . SPARSER::COLLECTION)
    ("exopolysaccharide" . SPARSER::MOLECULE) ("HMP" . SPARSER::PROTEIN)
    ("fructose" . SPARSER::PROTEIN) ("dietary histidine" . SPARSER::AMINO-ACID)
    ("the pro-inflammatory cytokine IL-8" . SPARSER::PROTEIN)
    ("an essential amino acid" . SPARSER::AMINO-ACID)
    ("two intestinal enzymes" . SPARSER::ENZYME)
    ("pro- or anti-inflammatory" . SPARSER::COLLECTION)
    ("pro- and anti-inflammatory" . SPARSER::COLLECTION)
    ("galactosamine" . SPARSER::MOLECULE)
    ("pro-inflammatory cytokines, IL-1, IL-12, and TNF" . SPARSER::COLLECTION)
    ("cytokines, IL-1, IL-12, and TNF" . SPARSER::COLLECTION)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("c-Jun and AP-1" . SPARSER::COLLECTION)
    ("cAMP, and PKA" . SPARSER::COLLECTION)
    ("the biogenic amine" . SPARSER::MOLECULE)
    ("histamine or U0126" . SPARSER::COLLECTION)
    ("Ras/c-Raf" . SPARSER::COLLECTION)
    ("MEK1/2 and ERK1/2" . SPARSER::COLLECTION)
    ("histamine and dcAMP" . SPARSER::COLLECTION)
    ("cAMP and cAMP" . SPARSER::COLLECTION)
    ("antagonists, ranitidine and cimetidine" . SPARSER::COLLECTION)
    ("cimetidine" . SPARSER::DRUG) ("ranitidine" . SPARSER::DRUG)
    ("rpoB" . SPARSER::PROTEIN) ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fraction" . SPARSER::COMPONENT) ("Histidine" . SPARSER::AMINO-ACID)
    ("Tryptophan and phenylalanine" . SPARSER::COLLECTION)
    ("Tryptophan" . SPARSER::AMINO-ACID)
    ("The biogenic amine" . SPARSER::MOLECULE)
    ("MAPKs, ERK and p38" . SPARSER::COLLECTION)
    ("receptors (GPCR)" . SPARSER::RECEPTOR)
    ("cAMP/protein" . SPARSER::COLLECTION) ("ERK or JNK" . SPARSER::COLLECTION)
    ("receptors and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("new drugs and probiotics" . SPARSER::COLLECTION)
    ("these microbial metabolites" . SPARSER::PROTEIN)
    ("TNF-inhibitory molecules or immunomodulins" . SPARSER::COLLECTION)
    ("p40/p75" . SPARSER::COLLECTION)
    ("bacterial bioactive metabolites" . SPARSER::PROTEIN)
    ("Bacterial histamine" . SPARSER::PROTEIN) ("hdcB" . SPARSER::PROTEIN)
    ("antiporter" . SPARSER::PROTEIN) ("histamine" . SPARSER::PROTEIN)
    ("decarboxylase" . SPARSER::PROTEIN) ("Histamine" . SPARSER::PROTEIN)
    ("HD2" . SPARSER::PROTEIN) ("1–8" . SPARSER::PROTEIN)
    ("1–C" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("H 1 R" . SPARSER::PROTEIN) ("diamine oxidase" . SPARSER::PROTEIN)
    ("MAP2K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MAP3K" . SPARSER::PROTEIN)
    ("lactic acid" . SPARSER::MOLECULE) ("AI-3" . SPARSER::PROTEIN)
    ("p75" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p40" . SPARSER::PROTEIN)
    ("Toll-like receptor 2" . SPARSER::PROTEIN)
    ("NF-κB p65 and/or MIC-1" . SPARSER::COLLECTION)
    ("NF-κB and Src-related signaling components" . SPARSER::COLLECTION)
    ("sesquiterpene" . SPARSER::MOLECULE)
    ("-rapamycin or CCl-779" . SPARSER::COLLECTION)
    ("the CD133 + /CD44 + cell fraction and the bulk PC cell mass"
     . SPARSER::COLLECTION)
    ("dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("PI-103 or NVP-BEZ235" . SPARSER::COLLECTION)
    ("/CD44" . SPARSER::COLLECTION) ("-rapamycin" . SPARSER::DRUG)
    ("PI3K/Akt/mTOR" . SPARSER::COLLECTION) ("CCl" . SPARSER::DRUG)
    ("the chemotherapeutic drug, docetaxel or mitoxantrone"
     . SPARSER::COLLECTION)
    ("EGFR and sonic hedgehog" . SPARSER::COLLECTION)
    ("gefitinib and cyclopamine" . SPARSER::COLLECTION)
    ("drug, docetaxel or mitoxantrone" . SPARSER::COLLECTION)
    ("cyclopamine" . SPARSER::DRUG)
    ("the current chemotherapeutic drug" . SPARSER::DRUG)
    ("NF-κB/MIC-1" . SPARSER::COLLECTION)
    ("NF-κB or MIC-1" . SPARSER::COLLECTION)
    ("the current histological biomarkers" . SPARSER::MOLECULE)
    ("docetaxel and mitoxantrone" . SPARSER::COLLECTION)
    ("mitoxantrone" . SPARSER::DRUG)
    ("MIC-1, interleukin-6, Bcl-2 and survivin" . SPARSER::COLLECTION)
    ("EGFR/PI3K/Akt" . SPARSER::COLLECTION)
    ("p65 or MIC-1" . SPARSER::COLLECTION)
    ("new biomarkers" . SPARSER::MOLECULE)
    ("pAkt and p63" . SPARSER::COLLECTION) ("AMACR" . SPARSER::PROTEIN)
    ("the current diagnostic and prognostic biomarkers" . SPARSER::MOLECULE)
    ("prostate-specific antigen (PSA)" . SPARSER::PROTEIN)
    ("10 µM Akt inhibitor VIII, 10 µM partenolide or 10 µl/mL"
     . SPARSER::COLLECTION)
    ("fragment and TUNEL" . SPARSER::COLLECTION)
    ("fragment-" . SPARSER::FRAGMENT)
    ("cytochrome c and MitoTracker Red" . SPARSER::COLLECTION)
    ("the mitochondria as well as the cleaved caspase-9 fragment"
     . SPARSER::COLLECTION)
    ("mitochondria-" . SPARSER::PROTEIN) ("CMXRos" . SPARSER::MOLECULE)
    ("the current chemotherapeutic drug docetaxel" . SPARSER::DRUG)
    ("VIII, partenolide or anti-MIC-1" . SPARSER::COLLECTION)
    ("10 µM Akt inhibitor VIII or 10 µM partenolide" . SPARSER::COLLECTION)
    ("NF-κB (partenolide) or MIC-1 (anti-MIC-1 antibody)"
     . SPARSER::COLLECTION)
    ("VIII" . SPARSER::PROTEIN) ("FAC" . SPARSER::PROTEIN)
    ("PI3K/pAkt" . SPARSER::COLLECTION)
    ("different drug resistance-associated molecules" . SPARSER::MOLECULE)
    ("CD133 and CD44" . SPARSER::COLLECTION)
    ("phycoerythrin" . SPARSER::PROTEIN-FAMILY)
    ("NF-κB and MIC-1" . SPARSER::COLLECTION)
    ("EGFR and its phosphorylated Tyr 1173 -pEGFR" . SPARSER::COLLECTION)
    ("therapeutic targets in PC stem/progenitor cells and their progenies that could be used"
     . SPARSER::COLLECTION)
    ("androgen receptor and prostatic" . SPARSER::COLLECTION)
    ("PC-" . SPARSER::PROTEIN) ("ALDH" . SPARSER::PROTEIN)
    ("aldehyde" . SPARSER::MOLECULE)
    ("diverse receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("-kinase" . SPARSER::KINASE)
    ("highly invasive and metastatic PCs" . SPARSER::PROTEIN)
    ("the metastatic PC" . SPARSER::PROTEIN)
    ("NF-κB and/or MIC-1" . SPARSER::COLLECTION) ("docetaxel" . SPARSER::DRUG)
    ("EGFR, pAkt, NF-κB or MIC-1" . SPARSER::COLLECTION)
    ("EGF-EGFR" . SPARSER::COLLECTION) ("p65 and MIC-1" . SPARSER::COLLECTION)
    ("-pAkt" . SPARSER::COLLECTION)
    ("nuclear factor-kappaB (NF-κB) and macrophage inhibitory cytokine-1 (MIC-1)"
     . SPARSER::COLLECTION)
    ("PI-103" . SPARSER::DRUG) ("sonic hedgehog" . SPARSER::PROTEIN)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("Texas red" . SPARSER::DRUG) ("prominin-1" . SPARSER::PROTEIN)
    ("EGFR antibody" . SPARSER::PROTEIN) ("ABCG2" . SPARSER::PROTEIN)
    ("ATP-binding cassette" . SPARSER::PROTEIN)
    ("tensin homolog" . SPARSER::PROTEIN) ("CD133" . SPARSER::PROTEIN)
    ("MIC-1" . SPARSER::PROTEIN) ("Rac-GAPs" . SPARSER::COLLECTION)
    ("STEF, β1-Pix, and GEF-H1 xref" . SPARSER::COLLECTION)
    ("β1-Pix" . SPARSER::COLLECTION)
    ("serine/threonines" . SPARSER::COLLECTION) ("Pix" . SPARSER::PROTEIN)
    ("STEF" . SPARSER::PROTEIN) ("threonines" . SPARSER::AMINO-ACID)
    ("Rho/Rac-GEF" . SPARSER::COLLECTION)
    ("an essential component" . SPARSER::COMPONENT)
    ("the atypical PKC family" . SPARSER::PROTEIN-FAMILY)
    ("at least 25 Rac-GEFs" . SPARSER::COLLECTION)
    ("MMP9, MMP2 and MMP1" . SPARSER::COLLECTION)
    ("protease/protease" . SPARSER::COLLECTION)
    ("ADAMTS1, MMP1, MMP2, MMP10, MMP13, MMP14 and MMP16"
     . SPARSER::COLLECTION)
    ("PKCε and Rac" . SPARSER::COLLECTION) ("Ect2" . SPARSER::PROTEIN)
    ("Rac-GEFs" . SPARSER::COLLECTION) ("chimaerin" . SPARSER::PROTEIN)
    ("Rac1 or its downstream effectors" . SPARSER::COLLECTION)
    ("MMP3, MMP9, MMP10, and MMP13" . SPARSER::COLLECTION)
    ("TIMP1 and TIMP2" . SPARSER::COLLECTION)
    ("ADAMTS1, MMP13, and MMP16" . SPARSER::COLLECTION)
    ("relevant ECM proteases and protease inhibitors" . SPARSER::INHIBITOR)
    ("FBS or EGF" . SPARSER::COLLECTION) ("peptide (TAT)" . SPARSER::PEPTIDE)
    ("AG1478 and EGFR" . SPARSER::COLLECTION) ("PRI" . SPARSER::PROTEIN)
    ("EGFR or PDGFR" . SPARSER::COLLECTION)
    ("PMA and FBS" . SPARSER::COLLECTION)
    ("β2-chimaerin or N17-Rac1" . SPARSER::COLLECTION)
    ("β2-chimaerin" . SPARSER::COLLECTION)
    ("a dominant-negative Rac mutant" . SPARSER::MUTANT)
    ("Rac-GAP" . SPARSER::COLLECTION)
    ("RasGRPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MRCK" . SPARSER::PROTEIN)
    ("PKCs and cell motility/invasiveness" . SPARSER::COLLECTION)
    ("PKCα or PKCδ" . SPARSER::COLLECTION)
    ("phorbol esters and the second messenger diacylglycerol (DAG)"
     . SPARSER::COLLECTION)
    ("tyrosine-kinase and G-protein-coupled receptors" . SPARSER::COLLECTION)
    ("diacylglycerol (DAG)" . SPARSER::DAG) ("DAG" . SPARSER::DAG)
    ("diacylglycerol" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor (EGFR) and Bcl2" . SPARSER::COLLECTION)
    ("p53, Rb, and Pten" . SPARSER::COLLECTION)
    ("proteases and protease" . SPARSER::COLLECTION)
    ("DLC1" . SPARSER::PROTEIN) ("Rho-GAP" . SPARSER::PROTEIN)
    ("Rho-GEF" . SPARSER::PROTEIN) ("GEF-H1" . SPARSER::PROTEIN)
    ("DEPC1" . SPARSER::PROTEIN) ("Rac-GEF" . SPARSER::PROTEIN)
    ("MMP14" . SPARSER::PROTEIN) ("MMP1" . SPARSER::PROTEIN)
    ("MMP10" . SPARSER::PROTEIN) ("MMP9" . SPARSER::PROTEIN)
    ("MMP3" . SPARSER::PROTEIN) ("TIMP2" . SPARSER::PROTEIN)
    ("TIMP1" . SPARSER::PROTEIN) ("MMP16" . SPARSER::PROTEIN)
    ("MMP13" . SPARSER::PROTEIN) ("ADAMTS1" . SPARSER::PROTEIN)
    ("AG1478" . SPARSER::DRUG) ("GF109203X" . SPARSER::DRUG)
    ("1–2 µ" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("p21 cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospholipase C" . SPARSER::PROTEIN)
    ("antimicrobial peptides" . SPARSER::PEPTIDE)
    ("AKT1, occludin and claudin 4" . SPARSER::COLLECTION)
    ("interferon gamma and IL-12" . SPARSER::COLLECTION)
    ("junctional proteins" . SPARSER::PROTEIN)
    ("JAM-A and claudin 2, and barrier" . SPARSER::COLLECTION)
    ("claudin 2, and barrier" . SPARSER::COLLECTION)
    ("JAM-A and claudin 2" . SPARSER::COLLECTION)
    ("components in transepithelial transport and primary determinants"
     . SPARSER::COLLECTION)
    ("GUCY2C and AKT1" . SPARSER::COLLECTION)
    ("claudin 2 or JAM-A" . SPARSER::COLLECTION) ("AOM" . SPARSER::PROTEIN)
    ("the bacterial peptide ST" . SPARSER::PROTEIN)
    ("dextran" . SPARSER::DEXTRAN)
    ("occludin, claudin 2, claudin 4 and JAM-A" . SPARSER::COLLECTION)
    ("junctional complex components" . SPARSER::COMPONENT)
    ("GUCA2A and GUCA2B" . SPARSER::COLLECTION) ("CFTR" . SPARSER::PROTEIN)
    ("PKG" . SPARSER::PROTEIN) ("cGMP" . SPARSER::PROTEIN)
    ("the endogenous paracrine hormones guanylin (GUCA2A) and uroguanylin (GUCA2B)"
     . SPARSER::COLLECTION)
    ("the intestinal receptor" . SPARSER::RECEPTOR)
    ("uroguanylin" . SPARSER::MOLECULE) ("GUCA" . SPARSER::PROTEIN)
    ("guanylin" . SPARSER::PROTEIN)
    ("junctional complexes" . SPARSER::BIO-COMPLEX)
    ("toxins and microorganisms" . SPARSER::COLLECTION)
    ("the intestinal barrier" . SPARSER::PROTEIN)
    ("occludin and claudin 4" . SPARSER::COLLECTION)
    ("occludin" . SPARSER::PROTEIN)
    ("increased junctional proteins" . SPARSER::PROTEIN)
    ("reduced junctional proteins" . SPARSER::PROTEIN)
    ("Gucy2c" . SPARSER::PROTEIN)
    ("an intestinal tumor suppressor" . SPARSER::SUPPRESSOR)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN) ("JAM-A" . SPARSER::PROTEIN)
    ("claudin 3" . SPARSER::PROTEIN) ("claudin 2" . SPARSER::PROTEIN)
    ("claudin 1" . SPARSER::PROTEIN)
    ("cystic fibrosis transmembrane conductance regulator" . SPARSER::PROTEIN)
    ("Guanylyl cyclase C" . SPARSER::PROTEIN) ("claudin 4" . SPARSER::PROTEIN)
    ("GUCY2C" . SPARSER::PROTEIN) ("promoter and UTR" . SPARSER::COLLECTION)
    ("the exon's" . SPARSER::PROTEIN) ("DNA or protein" . SPARSER::COLLECTION)
    ("the available TYMS" . SPARSER::PROTEIN) ("MTHFR" . SPARSER::PROTEIN)
    ("THF" . SPARSER::MOLECULE) ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("the polymorphic TYMS' s" . SPARSER::PROTEIN)
    ("the polymorphic TYMS" . SPARSER::PROTEIN)
    ("acute lymphocytic leukemia" . SPARSER::PROTEIN)
    ("group and 259 cases" . SPARSER::COLLECTION) ("ASD" . SPARSER::PROTEIN)
    ("Folate" . SPARSER::MOLECULE) ("gene and CCSDs" . SPARSER::COLLECTION)
    ("dTMP" . SPARSER::MOLECULE) ("TYMS" . SPARSER::PROTEIN)
    ("purine and pyrimidine" . SPARSER::COLLECTION)
    ("homocysteine" . SPARSER::MOLECULE)
    ("5,10-methylenetetrahydrofolate reductase" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN)
    ("Thymidylate synthase" . SPARSER::PROTEIN)
    ("C-Myc, TERT and CDK2" . SPARSER::COLLECTION)
    ("p-β-catenin" . SPARSER::COLLECTION)
    ("β-catenin and E-cadherin" . SPARSER::COLLECTION)
    ("the β-catenin-Adenomatous Polyposis Coli (APC) complex"
     . SPARSER::BIO-COMPLEX)
    ("Dsh" . SPARSER::PROTEIN)
    ("secreted glycoproteins and extracellular Wnt-ligands"
     . SPARSER::COLLECTION)
    ("Some growth factors and small molecules" . SPARSER::COLLECTION)
    ("LiCL" . SPARSER::DRUG)
    ("PCNA, CDK2, CyclinA and CyclinD1" . SPARSER::COLLECTION)
    ("a very strong proto-oncogene" . SPARSER::PROTEIN)
    ("Wnt, Shh and EGF" . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("Shh" . SPARSER::PROTEIN)
    ("Cyclin D1 and Cyclin A" . SPARSER::COLLECTION)
    ("C-Myc, TERT and PCNA" . SPARSER::COLLECTION)
    ("inhibitor-" . SPARSER::INHIBITOR) ("Mafa" . SPARSER::PROTEIN)
    ("C-peptide and Insulin" . SPARSER::COLLECTION) ("FOP" . SPARSER::PROTEIN)
    ("LiCl" . SPARSER::DRUG) ("Wnt3a and Dkk1" . SPARSER::COLLECTION)
    ("CyclinA and CyclinD" . SPARSER::COLLECTION)
    ("CyclinD" . SPARSER::PROTEIN) ("C-Myc and PDX1" . SPARSER::COLLECTION)
    ("PCNA, C-Myc and PDX1" . SPARSER::COLLECTION)
    ("PDX1, PCNA, C-Myc and TERT" . SPARSER::COLLECTION)
    ("PDX1, C-Myc and PCNA" . SPARSER::COLLECTION)
    ("PDX1 and C-Myc" . SPARSER::COLLECTION)
    ("C-Myc and PCNA" . SPARSER::COLLECTION)
    ("PDX1, Glut2, TERT, C-Myc and PCNA" . SPARSER::COLLECTION)
    ("PDX1 and Glut2" . SPARSER::COLLECTION)
    ("TERT, C-Myc and PCNA" . SPARSER::COLLECTION) ("Glut2" . SPARSER::PROTEIN)
    ("PDX1, Ngn3, PCNA and C-Myc" . SPARSER::COLLECTION)
    ("two highly homologous isoforms" . SPARSER::ISOFORM)
    ("GSK3α and GSK3β" . SPARSER::COLLECTION)
    ("regenerative medicine" . SPARSER::DRUG) ("MSCs" . SPARSER::PROTEIN)
    ("type I and type II" . SPARSER::COLLECTION) ("oxime" . SPARSER::MOLECULE)
    ("Proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("Cyclin A" . SPARSER::PROTEIN) ("Dkk-1" . SPARSER::PROTEIN)
    ("Ngn3" . SPARSER::PROTEIN) ("exendin-4" . SPARSER::PROTEIN)
    ("C-Myc" . SPARSER::PROTEIN) ("Dkk1" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β-cell" . SPARSER::PROTEIN)
    ("C-peptide" . SPARSER::MOLECULE)
    ("gene and gene-environment" . SPARSER::COLLECTION)
    ("secondary interacting molecules" . SPARSER::MOLECULE)
    ("RAS and ERK" . SPARSER::COLLECTION)
    ("anatomical subtypes" . SPARSER::PROTEIN) ("p-" . SPARSER::PROTEIN)
    ("SRC, c-MET, CRK and SHP2" . SPARSER::COLLECTION)
    ("SRC (rs6122566 and rs6124914), c-MET (rs41739) and CRK (rs7208768)"
     . SPARSER::COLLECTION)
    ("SRC, c-MET, CRK, SHP2, CRKL and GRB2" . SPARSER::COLLECTION)
    ("c-MET-HGF" . SPARSER::COLLECTION)
    ("adaptor protein and SHP2" . SPARSER::COLLECTION)
    ("RAS/MEK/ERK" . SPARSER::COLLECTION) ("CagA-SHP2" . SPARSER::COLLECTION)
    ("PTPN11 , CRKL , CSK , and GRB2" . SPARSER::COLLECTION)
    ("TK and c-MET" . SPARSER::COLLECTION)
    ("SRC, c-MET and CRK" . SPARSER::COLLECTION)
    ("the risky genetic variants" . SPARSER::VARIANT)
    ("Grb2, PLCγ, and SHP-2" . SPARSER::COLLECTION) ("TKs" . SPARSER::PROTEIN)
    ("SHP-2, CRK and CSK" . SPARSER::COLLECTION)
    ("tyrosine kinase (TK)" . SPARSER::PROTEIN)
    ("biomarkers, genistein, daidzein, equol and enterolactone"
     . SPARSER::COLLECTION)
    ("c-MET (rs41739) and CRK (rs7208768)" . SPARSER::COLLECTION)
    ("genistein, daidzein and enterolactone" . SPARSER::COLLECTION)
    ("gene and rs7208768" . SPARSER::COLLECTION)
    ("SRC , c-MET , and CRK" . SPARSER::COLLECTION)
    ("CagA/VacA" . SPARSER::COLLECTION) ("VacA" . SPARSER::PROTEIN-FAMILY)
    ("CRK, CRKL and CSK" . SPARSER::COLLECTION)
    ("CagA and diverse proteins" . SPARSER::COLLECTION)
    ("SRC, SHP2, CRK, CRKL, and CSK" . SPARSER::COLLECTION)
    ("c-MET and GRB2" . SPARSER::COLLECTION)
    ("a major carcinogenic and virulent component" . SPARSER::COMPONENT)
    ("Cytotoxin-associated gene" . SPARSER::GENE)
    ("Cytotoxin" . SPARSER::PROTEIN) ("phytoestrogen" . SPARSER::MOLECULE)
    ("genistein, daidzein, equol and enterolactone" . SPARSER::COLLECTION)
    ("enterolactone" . SPARSER::MOLECULE) ("equol" . SPARSER::MOLECULE)
    ("SRC , c-MET and CRK" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("SRC , PTPN11 , CRK , CRKL , CSK , c-MET and GRB2" . SPARSER::COLLECTION)
    ("CRKL" . SPARSER::PROTEIN) ("CRK" . SPARSER::PROTEIN)
    ("CRK-II" . SPARSER::PROTEIN)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN) ("A-2" . SPARSER::PROTEIN)
    ("CT10" . SPARSER::PROTEIN) ("anti-oxidant" . SPARSER::DRUG)
    ("group I" . SPARSER::PROTEIN) ("Dovitinib" . SPARSER::DRUG)
    ("the entire cohort" . SPARSER::MOLECULE) ("Wnt/TCF" . SPARSER::COLLECTION)
    ("KRAS or CTNNB1" . SPARSER::COLLECTION)
    ("the largest cohort" . SPARSER::MOLECULE)
    ("four endometrial oncogenes" . SPARSER::ONCOGENE)
    ("CTNNB1 and PIK3CA" . SPARSER::COLLECTION) ("yrs" . SPARSER::PROTEIN)
    ("FGFR2 and CTNNB1" . SPARSER::COLLECTION)
    ("MSS and MSI" . SPARSER::COLLECTION)
    ("CTNNB1 and KRAS" . SPARSER::COLLECTION)
    ("FGFR2 and KRAS" . SPARSER::COLLECTION)
    ("receptor tyrosine kinase-MAPK" . SPARSER::COLLECTION)
    ("the active dimer" . SPARSER::DIMER) ("FGFR1-FGFR3" . SPARSER::COLLECTION)
    ("KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("FGFR2, CTNNB1, KRAS and PIK3CA" . SPARSER::COLLECTION)
    ("para" . SPARSER::PROTEIN-FAMILY)
    ("anti-FGFR or anti-MEK" . SPARSER::COLLECTION) ("HR " . SPARSER::PROTEIN)
    ("KRAS and CTNNB1" . SPARSER::COLLECTION)
    ("KRAS and FGFR2" . SPARSER::COLLECTION)
    ("CTNNB1 (88/454) and PIK3CA (104/464)" . SPARSER::COLLECTION)
    ("FGFR2 , KRAS , CTNNB1 , and PIK3CA" . SPARSER::COLLECTION)
    ("KRAS , CTNNB1 , PIK3CA and FGFR2" . SPARSER::COLLECTION)
    ("FGFR1" . SPARSER::PROTEIN) ("gene and chromosome" . SPARSER::COLLECTION)
    ("alternatively spliced ESR1 isoforms and control breast cancer cell growth"
     . SPARSER::COLLECTION)
    ("BARX2 and estrogen receptor-alpha" . SPARSER::COLLECTION)
    ("SUMO4 , LATS1 , PPIL4 , and UST" . SPARSER::COLLECTION)
    ("UST" . SPARSER::PROTEIN) ("MAPK8/JNK" . SPARSER::COLLECTION)
    ("MAP3K7/TAK1" . SPARSER::COLLECTION)
    ("the top 5 or 10 principal components" . SPARSER::COMPONENT)
    ("gene, and rs7107217" . SPARSER::COLLECTION)
    ("gene and 11q24.3" . SPARSER::COLLECTION)
    ("gene, and SNP" . SPARSER::COLLECTION) ("BARX2" . SPARSER::PROTEIN)
    ("LATS1" . SPARSER::PROTEIN) ("SUMO4" . SPARSER::PROTEIN)
    ("MAPK8" . SPARSER::PROTEIN) ("estrogen receptor 1" . SPARSER::PROTEIN)
    ("TGF-beta" . SPARSER::PROTEIN) ("TAB2" . SPARSER::PROTEIN)
    ("free ribosomal proteins" . SPARSER::PROTEIN)
    ("/p14 ARF" . SPARSER::COLLECTION) ("ARF and MDM2" . SPARSER::COLLECTION)
    ("MDM2–TTF" . SPARSER::COLLECTION) ("MDM2 or ARF" . SPARSER::COLLECTION)
    ("ARF–TTF" . SPARSER::COLLECTION) ("MDM2-TTF" . SPARSER::COLLECTION)
    ("TTF" . SPARSER::PROTEIN)
    ("Three independent monoclonal antibodies" . SPARSER::ANTIBODY)
    ("Myc-MDM2" . SPARSER::COLLECTION)
    ("wild-type MDM2 and the inactive C462A MDM2 mutant" . SPARSER::COLLECTION)
    ("Exogenous FLAG-TTF-I" . SPARSER::COLLECTION)
    ("transgene and TTF-I" . SPARSER::COLLECTION)
    ("exogenous TTF-I" . SPARSER::PROTEIN)
    ("the mature 28S and 18S rRNAs" . SPARSER::RNA)
    ("active rRNA genes" . SPARSER::GENE) ("psoralen" . SPARSER::DRUG)
    ("the exogenous FLAG-TTF-I" . SPARSER::COLLECTION)
    ("FLAG-TTF-I" . SPARSER::COLLECTION) ("the mature rRNAs" . SPARSER::RNA)
    ("ARF-MDM2" . SPARSER::COLLECTION)
    ("the deacetylase HDAC1 and a DNA methyltransferase" . SPARSER::COLLECTION)
    ("NoRC" . SPARSER::PROTEIN) ("nucleosomes" . SPARSER::PROTEIN)
    ("Myb" . SPARSER::PROTEIN) ("NPM" . SPARSER::PROTEIN)
    ("snoRNAs" . SPARSER::RNA) ("pre-ribosomal proteins" . SPARSER::PROTEIN)
    ("UBF" . SPARSER::PROTEIN) ("TIF" . SPARSER::PROTEIN)
    ("RPI" . SPARSER::PROTEIN) ("SL1" . SPARSER::PROTEIN)
    ("the 28S and 18S ribosomal RNAs" . SPARSER::RNA) ("rRNAs" . SPARSER::RNA)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("Rb, ARF, p53 and MDM2" . SPARSER::COLLECTION) ("1B" . SPARSER::PROTEIN)
    ("p19 ARF" . SPARSER::PROTEIN) ("small nucleolar RNAs" . SPARSER::RNA)
    ("RNA polymerase I" . SPARSER::PROTEIN) ("TTF-I" . SPARSER::PROTEIN)
    ("repressive histone" . SPARSER::PROTEIN)
    ("a chromatin-associated complex" . SPARSER::BIO-COMPLEX)
    ("p53 and LSD1" . SPARSER::COLLECTION) ("demethylase" . SPARSER::PROTEIN)
    ("the histone signature around AR-specific genes" . SPARSER::GENE)
    ("PB and PSA" . SPARSER::COLLECTION)
    ("p53, and Wig-1" . SPARSER::COLLECTION) ("LNsip53" . SPARSER::PROTEIN)
    ("LNsip53-Wig-1" . SPARSER::PROTEIN-PAIR)
    ("-thymidine" . SPARSER::COLLECTION)
    ("LNCaP and this group" . SPARSER::COLLECTION)
    ("ACCA and NRP1" . SPARSER::COLLECTION)
    ("complex and function" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("a sequence-specific DNA binding protein" . SPARSER::PROTEIN)
    ("ACCA" . SPARSER::PROTEIN) ("FKBP5 and KLK3" . SPARSER::COLLECTION)
    ("anti-AR and anti-FOXA1" . SPARSER::COLLECTION)
    ("TACC2 and SLC43A1" . SPARSER::COLLECTION)
    ("KLK3, KLK2, FKBP5, TACC2 and SLC43A1" . SPARSER::COLLECTION)
    ("Freac-2" . SPARSER::COLLECTION) ("LNCaP-AR" . SPARSER::COLLECTION)
    ("a proximal promoter" . SPARSER::PROMOTER)
    ("FoxA1 and AR" . SPARSER::COLLECTION)
    ("AR- and FoxA1-ChIP" . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AR and FoxA1" . SPARSER::COLLECTION)
    ("anti-AR or anti-FoxA1" . SPARSER::COLLECTION)
    ("the classical response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("AR or FoxA1" . SPARSER::COLLECTION)
    ("LNCaP and LNsip53" . SPARSER::COLLECTION)
    ("classical AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("AR and FoxA1-DNA binding" . SPARSER::COLLECTION)
    ("luc" . SPARSER::PROTEIN) ("DHT" . SPARSER::PROTEIN)
    ("Rv" . SPARSER::MOLECULE) ("probasin" . SPARSER::PROTEIN)
    ("which lacks androgens" . SPARSER::DRUG)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nucleosomal DNA" . SPARSER::DNA)
    ("ERα and AR" . SPARSER::COLLECTION) ("PCs" . SPARSER::PROTEIN)
    ("AP-1 and Sp1" . SPARSER::COLLECTION) ("p53 and AR" . SPARSER::COLLECTION)
    ("AR and p53" . SPARSER::COLLECTION) ("primary PC" . SPARSER::PROTEIN)
    ("AR, and chromatin" . SPARSER::COLLECTION) ("Hsp70" . SPARSER::PROTEIN)
    ("LSD1" . SPARSER::PROTEIN) ("Wig1" . SPARSER::PROTEIN)
    ("Wig-1" . SPARSER::PROTEIN) ("C11" . SPARSER::PROTEIN)
    ("ASH2L" . SPARSER::PROTEIN) ("H3K27ac" . SPARSER::MOLECULE)
    ("NRP1" . SPARSER::PROTEIN) ("neuropilin-1" . SPARSER::PROTEIN)
    ("Acetyl-CoA" . SPARSER::MOLECULE) ("SLC43A1" . SPARSER::PROTEIN)
    ("TACC2" . SPARSER::PROTEIN) ("KLK2" . SPARSER::PROTEIN)
    ("FoxO3" . SPARSER::PROTEIN) ("FoxO1" . SPARSER::PROTEIN)
    ("PC-2" . SPARSER::PROTEIN) ("C4-2" . SPARSER::PROTEIN)
    ("HNF-3-alpha" . SPARSER::PROTEIN)
    ("hepatocyte nuclear factor" . SPARSER::PROTEIN)
    ("potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a potential target gene" . SPARSER::GENE)
    ("clusterin" . SPARSER::PROTEIN) ("Wisp-3" . SPARSER::PROTEIN)
    ("Wisp-2" . SPARSER::PROTEIN) ("Wisp-1" . SPARSER::PROTEIN)
    ("CCN" . SPARSER::PROTEIN-FAMILY) ("ABT" . SPARSER::MOLECULE)
    ("six mature miRNAs" . SPARSER::PROTEIN) ("MYC/MAX" . SPARSER::COLLECTION)
    ("array-CGH and FISH" . SPARSER::COLLECTION)
    ("THBS1 and CTGF" . SPARSER::COLLECTION) ("genesis" . SPARSER::PROTEIN)
    ("Effector" . SPARSER::EFFECTOR)
    ("hsr or multiple focal amplicons" . SPARSER::COLLECTION)
    ("hsr" . SPARSER::PROTEIN)
    ("an extracellular matrix-associated molecule" . SPARSER::MOLECULE)
    ("CTGF" . SPARSER::PROTEIN) ("Guo" . SPARSER::MOLECULE)
    ("Radical" . SPARSER::MOLECULE)
    ("a new potential oncogene" . SPARSER::ONCOGENE)
    ("CCN6" . SPARSER::PROTEIN) ("CCN4" . SPARSER::PROTEIN)
    ("elm1" . SPARSER::PROTEIN) ("CCN3" . SPARSER::PROTEIN)
    ("CCN1" . SPARSER::PROTEIN) ("Cyr61" . SPARSER::PROTEIN)
    ("CCN2" . SPARSER::PROTEIN) ("angiogenesis inhibitor" . SPARSER::DRUG)
    ("FGF-2" . SPARSER::PROTEIN) ("Fas ligand" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 3" . SPARSER::PROTEIN)
    ("AS3" . SPARSER::PROTEIN) ("Micro-RNA" . SPARSER::MICRO-RNA)
    ("chr5" . SPARSER::PROTEIN) ("FLT4" . SPARSER::PROTEIN)
    ("ADM2" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("THBS1" . SPARSER::PROTEIN) ("thrombospondin-1" . SPARSER::PROTEIN)
    ("MAML1" . SPARSER::PROTEIN) ("CSGE" . SPARSER::PROTEIN-FAMILY)
    ("BRCA PRO and Myriad II" . SPARSER::COLLECTION)
    ("PRO" . SPARSER::AMINO-ACID) ("approximately 1–4" . SPARSER::PROTEIN)
    ("NCCN" . SPARSER::MOLECULE) ("insA" . SPARSER::PROTEIN)
    ("BRCA1 or BRCA2" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("etc." . SPARSER::PROTEIN) ("substances" . SPARSER::SUBSTANCE)
    ("the maternal vasculature" . SPARSER::PROTEIN)
    ("vascular smooth muscle" . SPARSER::PROTEIN)
    ("IL-8 and ICAM-1" . SPARSER::COLLECTION)
    ("the maternal systemic vasculature" . SPARSER::PROTEIN)
    ("vasculature" . SPARSER::PROTEIN) ("NF-κB and TNFα" . SPARSER::COLLECTION)
    ("superoxide" . SPARSER::MOLECULE) ("Hg" . SPARSER::MOLECULE)
    ("TNFα and COX-2" . SPARSER::COLLECTION) ("antioxidants" . SPARSER::DRUG)
    ("cytokines and oxidants" . SPARSER::COLLECTION)
    ("oxidants" . SPARSER::MOLECULE) ("IkappaB" . SPARSER::PROTEIN)
    ("placental NF-κB" . SPARSER::PROTEIN)
    ("Placental NF-κB" . SPARSER::PROTEIN)
    ("TNFα, or OxLA" . SPARSER::COLLECTION)
    ("more TNFα and more thromboxane (TX)" . SPARSER::COLLECTION)
    ("thromboxane (TX)" . SPARSER::MOLECULE) ("TX" . SPARSER::PROTEIN)
    ("vascular cell adhesion molecule-1" . SPARSER::PROTEIN)
    ("phospholipase A 2" . SPARSER::PROTEIN)
    ("thiobarbituric acid" . SPARSER::MOLECULE) ("NF-κB 2" . SPARSER::PROTEIN)
    ("glutathione peroxidase" . SPARSER::PROTEIN)
    ("thymidine kinase" . SPARSER::PROTEIN)
    ("von Willebrand factor" . SPARSER::PROTEIN) ("BH2" . SPARSER::MOLECULE)
    ("potential molecular targets" . SPARSER::TARGET-PROTEIN)
    ("isoform and its binding" . SPARSER::COLLECTION)
    ("DNA looping and chromatin reorganization" . SPARSER::COLLECTION)
    ("DNAs" . SPARSER::DNA) ("JAK3-STAT5" . SPARSER::COLLECTION)
    ("Ifng" . SPARSER::PROTEIN) ("Shi" . SPARSER::PROTEIN)
    ("architectural proteins" . SPARSER::PROTEIN)
    ("potentially biologically relevant transcription factor"
     . SPARSER::PROTEIN)
    ("a shorter isoform" . SPARSER::ISOFORM)
    ("this shorter isoform" . SPARSER::ISOFORM)
    ("DNA or DNA" . SPARSER::COLLECTION)
    ("AFM, DAPA, and microscale" . SPARSER::COLLECTION)
    ("the only fluorescent molecule" . SPARSER::MOLECULE)
    ("STAT3-GFP" . SPARSER::COLLECTION)
    ("fluorescent molecules" . SPARSER::MOLECULE)
    ("−S100" . SPARSER::COLLECTION) ("DAPA" . SPARSER::PROTEIN-FAMILY)
    ("fragments and protein" . SPARSER::COLLECTION)
    ("dimer or monomer" . SPARSER::COLLECTION) ("APS" . SPARSER::PROTEIN)
    ("an architectural protein and regulator" . SPARSER::COLLECTION)
    ("protein and regulator" . SPARSER::COLLECTION)
    ("heterochromatin-associated protein HP1" . SPARSER::PROTEIN)
    ("CCND1 and c- MYC" . SPARSER::COLLECTION)
    ("VEGF , ADM , and ANGPTL4" . SPARSER::COLLECTION)
    ("FGA , FGB , CTSB , and SERPINE2" . SPARSER::COLLECTION)
    ("BCL-xL , BCL-2 , MCL-1 , and BIRC5" . SPARSER::COLLECTION)
    ("FGB" . SPARSER::PROTEIN) ("FGA" . SPARSER::PROTEIN)
    ("kinases (JAKs) or Src kinases" . SPARSER::COLLECTION)
    ("Cytokines or growth factors" . SPARSER::COLLECTION)
    ("Cytokines" . SPARSER::PROTEIN)
    ("proteins, STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6"
     . SPARSER::COLLECTION)
    ("DNA and supports U-STAT3 function" . SPARSER::COLLECTION)
    ("dimers and monomers" . SPARSER::COLLECTION) ("AFM" . SPARSER::PROTEIN)
    ("LEF-1" . SPARSER::PROTEIN) ("α 2 -macroglobulin" . SPARSER::PROTEIN)
    ("nm 3" . SPARSER::DRUG) ("B–F" . SPARSER::PROTEIN)
    ("streptavidin-agarose" . SPARSER::DRUG) ("HP1" . SPARSER::PROTEIN)
    ("BIRC5" . SPARSER::PROTEIN) ("SERPINE2" . SPARSER::PROTEIN)
    ("ANGPTL4" . SPARSER::PROTEIN) ("c- MYC" . SPARSER::PROTEIN)
    ("STAT5B" . SPARSER::PROTEIN) ("STAT2" . SPARSER::PROTEIN)
    ("ATO" . SPARSER::PROTEIN)
    ("non-APL AML only high-AR FLT3/ITD" . SPARSER::COLLECTION)
    ("EFS" . SPARSER::PROTEIN) ("bcr" . SPARSER::PROTEIN)
    ("The microgranular variant" . SPARSER::VARIANT)
    ("the microgranular variant" . SPARSER::VARIANT)
    ("our larger cohort" . SPARSER::MOLECULE) ("CR" . SPARSER::PROTEIN)
    ("ITD-AR" . SPARSER::COLLECTION) ("available DNA" . SPARSER::DNA)
    ("the European cooperative APL Group" . SPARSER::MOLECULE)
    ("MRC" . SPARSER::PROTEIN) ("ITD and FLT3/ALM" . SPARSER::COLLECTION)
    ("pediatric APL" . SPARSER::PROTEIN) ("FLT3/ITD" . SPARSER::COLLECTION)
    ("childhood acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("FLT3/Mut" . SPARSER::COLLECTION)
    ("potential innovative drugs" . SPARSER::DRUG)
    ("integrin-RACK1" . SPARSER::COLLECTION)
    ("Akt ( xref ) and AR ( xref )" . SPARSER::COLLECTION)
    ("FAK/Src" . SPARSER::COLLECTION) ("kinases (PAK)" . SPARSER::PROTEIN)
    ("PAK" . SPARSER::PROTEIN-FAMILY) ("Rac/Rho/Cdc42" . SPARSER::COLLECTION)
    ("FAK and Rho" . SPARSER::COLLECTION)
    ("RACK1 and β1" . SPARSER::COLLECTION)
    ("integrins and Src" . SPARSER::COLLECTION)
    ("β1 integrins ( xref ; xref ; xref ) as well as Src ( xref )"
     . SPARSER::COLLECTION)
    ("β1 and IGF-IR" . SPARSER::COLLECTION)
    ("IGF-IR, RACK1 and β1" . SPARSER::COLLECTION) ("pSrc" . SPARSER::PROTEIN)
    ("either Ca 2+ /Mg 2+ ions (that do not activate β1) or Mn 2+ ions (that do activate β1)"
     . SPARSER::COLLECTION)
    ("namely β1 integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IB" . SPARSER::DRUG) ("DU145 and PC3-1" . SPARSER::COLLECTION)
    ("whose gene" . SPARSER::GENE)
    ("integrin-RACK1-FAK-Src" . SPARSER::COLLECTION)
    ("integrins and RACK1" . SPARSER::COLLECTION)
    ("IGF-I and IGF-IR" . SPARSER::COLLECTION)
    ("FAK and the cAMP-degrading phosphodiesterase PDE4D5"
     . SPARSER::COLLECTION)
    ("Y397F–FAK or A430V-Src" . SPARSER::COLLECTION)
    ("FAK-Src" . SPARSER::COLLECTION)
    ("FAK ( xref ; xref ) and Src ( xref )" . SPARSER::COLLECTION)
    ("activated PKCs ( xref ), FAK ( xref ; xref ) and Src ( xref )"
     . SPARSER::COLLECTION)
    ("FAK and Src" . SPARSER::COLLECTION)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src and the receptor for activated C kinase 1 (RACK1)"
     . SPARSER::COLLECTION)
    ("extracellular signal-regulated kinase (ERK) and myosin light-chain kinase (MLCK)"
     . SPARSER::COLLECTION)
    ("MLCK" . SPARSER::PROTEIN)
    ("integrin-RACK1-Src-FAK" . SPARSER::COLLECTION)
    ("bind RACK1, or IGF-IR's" . SPARSER::COLLECTION)
    ("RACK1, or IGF-IR" . SPARSER::COLLECTION) ("β1" . SPARSER::PROTEIN)
    ("Src and FAK" . SPARSER::COLLECTION) ("β1-RACK1" . SPARSER::COLLECTION)
    ("that Trop-2's" . SPARSER::PROTEIN)
    ("claudin-1 and claudin-7" . SPARSER::COLLECTION)
    ("Trop-1/EpCAM" . SPARSER::COLLECTION) ("EpCAM" . SPARSER::PROTEIN)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("TACSTD2" . SPARSER::PROTEIN) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("calpain inhibitor" . SPARSER::PROTEIN)
    ("envelope glycoprotein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pLP2" . SPARSER::PROTEIN) ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TROP2" . SPARSER::PROTEIN) ("C20" . SPARSER::PROTEIN)
    ("EG7" . SPARSER::PROTEIN)
    ("Insulin-like Growth Factor I" . SPARSER::PROTEIN)
    ("V-Src" . SPARSER::PROTEIN)
    ("receptor for activated C kinase 1" . SPARSER::PROTEIN)
    ("myosin light-chain kinase" . SPARSER::PROTEIN)
    ("IGF-IR" . SPARSER::PROTEIN) ("RACK1" . SPARSER::PROTEIN)
    ("αvβ5" . SPARSER::PROTEIN) ("claudin-7" . SPARSER::PROTEIN)
    ("claudin-1" . SPARSER::PROTEIN) ("Trop-2" . SPARSER::PROTEIN)
    ("allelic variant" . SPARSER::VARIANT)
    ("intronic variants" . SPARSER::VARIANT)
    ("a strong adenoma susceptibility allele" . SPARSER::ALLELE)
    ("ancestral disease variants" . SPARSER::VARIANT)
    ("gene and adenoma" . SPARSER::COLLECTION)
    ("K-ras or B-Rraf" . SPARSER::COLLECTION)
    ("Ras or B-raf" . SPARSER::COLLECTION)
    ("Sprouty and Spred" . SPARSER::COLLECTION)
    ("Spred" . SPARSER::PROTEIN-FAMILY) ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("larger cohorts" . SPARSER::MOLECULE)
    ("hMLh1 and hMSH2" . SPARSER::COLLECTION)
    ("B-raf or K-ras" . SPARSER::COLLECTION)
    ("hMLH1 (available in 44 cases) and hMSH2 (available in 36 cases)"
     . SPARSER::COLLECTION)
    ("ERK, pERK, hMLH1 and hMSH2" . SPARSER::COLLECTION)
    ("intermediary kinases" . SPARSER::KINASE)
    ("ERKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the dual specific MAP kinases MEK1 and MEK2" . SPARSER::COLLECTION)
    ("ERK1 and ERK2" . SPARSER::COLLECTION)
    ("/extracellular signal regulated kinase 1/2" . SPARSER::COLLECTION)
    ("promoters (CIMP)" . SPARSER::PROMOTER)
    ("proto-oncogenes and tumor suppressor genes" . SPARSER::COLLECTION)
    ("tumor suppressor genes as well as genes" . SPARSER::COLLECTION)
    ("primary colon cancer" . SPARSER::PROTEIN)
    ("hMLH1 or hMSH2" . SPARSER::COLLECTION)
    ("total and activated ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("K-ras or B-raf" . SPARSER::COLLECTION) ("pERK" . SPARSER::PROTEIN)
    ("total and activated ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("B-raf and K-ras" . SPARSER::COLLECTION)
    ("hMLH1 and hMSH2" . SPARSER::COLLECTION) ("MMR" . SPARSER::PROTEIN)
    ("Raf/MEK/ERK" . SPARSER::COLLECTION) ("hMLh1" . SPARSER::PROTEIN)
    ("E-4" . SPARSER::PROTEIN) ("aN1" . SPARSER::DRUG)
    ("extracellular signal regulated kinase 1/2" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PMS2" . SPARSER::PROTEIN)
    ("PMS1" . SPARSER::PROTEIN) ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE)
    ("Colon cancer" . SPARSER::PROTEIN) ("B-RAF" . SPARSER::PROTEIN)
    ("hMSH2" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("promoter-" . SPARSER::PROMOTER) ("p110α or p110β" . SPARSER::COLLECTION)
    ("p110α and p110δ" . SPARSER::COLLECTION)
    ("p110δ in synovial fibroblasts and further implicated p110δ"
     . SPARSER::COLLECTION)
    ("further implicated p110δ" . SPARSER::PROTEIN)
    ("selectin" . SPARSER::PROTEIN-FAMILY)
    ("IL-6 or IL-8" . SPARSER::COLLECTION)
    ("IL-6, IL-8 or CCL2" . SPARSER::COLLECTION)
    ("a minor or undetectable fraction" . SPARSER::COMPONENT)
    ("Jurkat and THP-1" . SPARSER::COLLECTION)
    ("exon–exon" . SPARSER::COLLECTION)
    ("The enhancer-associated histone modifications H3K4" . SPARSER::PROTEIN)
    ("active promoters" . SPARSER::PROMOTER)
    ("H3K27Ac and H3K4Me3" . SPARSER::COLLECTION)
    ("previously unidentified PIK3CD" . SPARSER::PROTEIN)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("p110δ protein ( xref C) and mRNA ( xref D)" . SPARSER::COLLECTION)
    ("TNFα and IL-1β" . SPARSER::COLLECTION) ("LICR" . SPARSER::PROTEIN)
    ("CG" . SPARSER::PROTEIN) ("DNase" . SPARSER::PROTEIN)
    ("hg" . SPARSER::MOLECULE)
    ("TNFα (10 ng/ml) or complete medium only (unstimulated control) 24 h"
     . SPARSER::COLLECTION)
    ("pGL3-luc" . SPARSER::PROTEIN-PAIR) ("pRL" . SPARSER::PROTEIN)
    ("pGEM" . SPARSER::MOLECULE) ("RLM-RACE" . SPARSER::COLLECTION)
    ("RACE" . SPARSER::PROTEIN)
    ("eukaryotic 18S rRNA (4310893E) and β-actin (4326315E)"
     . SPARSER::COLLECTION)
    ("eukaryotic 18S rRNA" . SPARSER::PROTEIN)
    ("primary antibodies and HRP (horseradish peroxidase)-conjugated species-specific secondary antibodies"
     . SPARSER::ANTIBODY)
    ("antibodies and HRP" . SPARSER::COLLECTION) ("ray" . SPARSER::PROTEIN)
    ("SDS" . SPARSER::PROTEIN) ("Hepes" . SPARSER::MOLECULE)
    ("RPMI" . SPARSER::PROTEIN) ("hy" . SPARSER::MOLECULE)
    ("Sigma and IKK" . SPARSER::COLLECTION) ("ActD" . SPARSER::MOLECULE)
    ("anti-α-tubulin (B-5-1-2) and anti-vinculin (clone hVIN-1)"
     . SPARSER::COLLECTION)
    ("hVIN-1" . SPARSER::COLLECTION) ("B-5-1-2" . SPARSER::COLLECTION)
    ("Antibodies and reagents" . SPARSER::COLLECTION)
    ("aldosterone" . SPARSER::PROTEIN)
    ("deoxycorticosterone" . SPARSER::MOLECULE) ("−2c" . SPARSER::COLLECTION)
    ("−2b" . SPARSER::COLLECTION) ("c" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN) ("types " . TYPE) ("Pik3cd" . SPARSER::PROTEIN)
    ("Pik" . SPARSER::BIO-COMPLEX)
    ("pro-inflammatory mediators" . SPARSER::PROTEIN)
    ("p110α and p110β" . SPARSER::COLLECTION) ("Key PI3Ks" . SPARSER::PROTEIN)
    ("p110α, p110β and p110δ" . SPARSER::COLLECTION)
    ("B-Raf" . SPARSER::PROTEIN) ("p37" . SPARSER::PROTEIN)
    ("C-C motif" . SPARSER::PROTEIN) ("IκB-α" . SPARSER::PROTEIN)
    ("H3K27Ac" . SPARSER::MOLECULE) ("H3K4Me3" . SPARSER::PROTEIN)
    ("chr1" . SPARSER::PROTEIN) ("pGL2" . SPARSER::PROTEIN)
    ("p85β" . SPARSER::PROTEIN) ("B-5" . SPARSER::PROTEIN)
    ("L -arginine" . SPARSER::MOLECULE) ("2–4 " . SPARSER::PROTEIN)
    ("and −1" . SPARSER::PROTEIN) ("PIK3CD" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("phosphoinositide 3" . SPARSER::PROTEIN) ("rays" . SPARSER::PROTEIN)
    ("a significant skeletal component" . SPARSER::COMPONENT)
    ("ribs" . SPARSER::DRUG) ("fetuses" . SPARSER::PROTEIN)
    ("SD" . SPARSER::PROTEIN) ("perinatal" . SPARSER::PROTEIN)
    ("PTPN11" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("inhibitors and antibodies" . SPARSER::COLLECTION)
    ("anthracyclines and taxanes" . SPARSER::COLLECTION)
    ("HGF/SF/cMET" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("cMET and p-cMET" . SPARSER::COLLECTION)
    ("c-Src and STATs" . SPARSER::COLLECTION)
    ("RAS-MAPK" . SPARSER::COLLECTION) ("-AKT" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("HGF/SF" . SPARSER::COLLECTION)
    ("HGF/cMET" . SPARSER::COLLECTION)
    ("downstream signaling molecules such as Phosphatidylinositol 3-kinase (PI3K/AKT) and Mitogen-activated protein kinase (ERK/MAPK) pathways ( xref , xref )"
     . SPARSER::COLLECTION)
    ("Grb2 (Growth factor receptor-bound protein 2) and Gab1 (GRB2-associated-binding protein 1)"
     . SPARSER::COLLECTION)
    ("ERK/MAPK" . SPARSER::COLLECTION)
    ("an α-chain (50 kDa) and a β-chain (145 kDa)" . SPARSER::COLLECTION)
    ("disulfide" . SPARSER::MOLECULE)
    ("hepatocyte growth factor (HGF) or scatter factor (SF) ( xref - xref )"
     . SPARSER::COLLECTION)
    ("scatter factor (SF)" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cMET (P<0.128) and p-cMET (P<0.088)" . SPARSER::COLLECTION)
    ("receptor (HR)" . SPARSER::RECEPTOR) ("cMET/p-cMET" . SPARSER::COLLECTION)
    ("cMET and p-cMET in 257 breast cancers using reverse phase protein array"
     . SPARSER::COLLECTION)
    ("cMET and phospho-cMET" . SPARSER::COLLECTION)
    ("p-cMET" . SPARSER::COLLECTION) ("cMET" . SPARSER::PROTEIN)
    ("Phospholipase C" . SPARSER::PROTEIN) ("PLC γ" . SPARSER::PROTEIN-FAMILY)
    ("HR 3" . SPARSER::PROTEIN) ("HR 1" . SPARSER::PROTEIN-FAMILY)
    ("HR 2" . SPARSER::PROTEIN) ("c-MET" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("single-pass" . SPARSER::PROTEIN-FAMILY) ("NBD" . SPARSER::PROTEIN)
    ("CARMI/PRMT1" . SPARSER::COLLECTION) ("N1 and Nrf2" . SPARSER::COLLECTION)
    ("Nrf2/ARE" . SPARSER::PROTEIN)
    ("Nrf2/ARE-luciferase" . SPARSER::PROTEIN-PAIR)
    ("transcriptional activator or suppressor" . SPARSER::COLLECTION)
    ("Gal4-Nrf2" . SPARSER::COLLECTION)
    ("SRC-1 and SRC-2" . SPARSER::COLLECTION)
    ("potential regulators" . SPARSER::REGULATOR)
    ("MafF, MafG, and MafK" . SPARSER::COLLECTION)
    ("enzymes and antioxidant" . SPARSER::COLLECTION)
    ("anti-RAC3 (M-397) or anti-Nrf2 (C-20) antibodies" . SPARSER::COLLECTION)
    ("EYFP" . SPARSER::PROTEIN) ("RAC3/Nrf2" . SPARSER::COLLECTION)
    ("EYFP-Nrf2 or EYFP-N2" . SPARSER::COLLECTION)
    ("its fragments (EYFP-N2 and EYFP-N2a) and co-transfected"
     . SPARSER::COLLECTION)
    ("EYFP-N2" . SPARSER::PROTEIN-PAIR) ("EYFP-Nrf2" . SPARSER::COLLECTION)
    ("ECFP-RAC3" . SPARSER::COLLECTION)
    ("cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP)"
     . SPARSER::COLLECTION)
    ("cyan fluorescent protein (CFP)" . SPARSER::PROTEIN)
    ("N1 and N2" . SPARSER::COLLECTION)
    ("The purified His-Nrf2 protein and the differently sized fragments (N1, N2, N2-a, N2-b, N2-c, N3, and N4; xref )"
     . SPARSER::COLLECTION)
    ("GSH-beads" . SPARSER::DRUG) ("N2-c" . SPARSER::PROTEIN-PAIR)
    ("N2-b" . SPARSER::PROTEIN-PAIR) ("GSH" . SPARSER::DRUG)
    ("GST-RAC3" . SPARSER::COLLECTION) ("GFP-Nrf2" . SPARSER::COLLECTION)
    ("DL" . SPARSER::MOLECULE) ("sulforaphane" . SPARSER::PROTEIN)
    ("Nrf2, RAC3, and HO-1" . SPARSER::COLLECTION)
    ("detected using anti-Nrf2 (C-20) and anti-GFP (B-2) or anti-RAC3 (M397) and anti-HA (Zymed) antibodies"
     . SPARSER::COLLECTION)
    ("anti-GFP (B-2) or anti-RAC3 (M397) and anti-HA (Zymed) antibodies"
     . SPARSER::COLLECTION)
    ("anti-RAC3 (M397) and anti-HA (Zymed) antibodies" . SPARSER::COLLECTION)
    ("detected using anti-Nrf2" . SPARSER::ANTIBODY)
    ("Zymed" . SPARSER::PROTEIN) ("pSG5-RAC3" . SPARSER::COLLECTION)
    ("pEGFP-Nrf2" . SPARSER::PROTEIN-PAIR) ("EGFP-Nrf2" . SPARSER::COLLECTION)
    ("both HO-1 and YFP-Nrf2 proteins" . SPARSER::COLLECTION)
    ("YFP-Nrf2" . SPARSER::COLLECTION)
    ("the cytoprotective Nrf2 protein" . SPARSER::PROTEIN)
    ("Nrf2 (1-370) and RAC3" . SPARSER::COLLECTION)
    ("Gal4-luciferase" . SPARSER::COLLECTION)
    ("PRMT1, and CARM1" . SPARSER::COLLECTION)
    ("polyglutamate" . SPARSER::MOLECULE) ("ARNT" . SPARSER::PROTEIN)
    ("p/CAF" . SPARSER::PROTEIN)
    ("progesterone receptor, and thyroid" . SPARSER::COLLECTION)
    ("SRC-1 (NCoA-1) and SRC-2 (TIF2/GRIP1/NCoA2)" . SPARSER::COLLECTION)
    ("TIF2/GRIP1/NCoA2" . SPARSER::COLLECTION) ("NCoA" . SPARSER::PROTEIN)
    ("TRAM" . SPARSER::PROTEIN) ("pCIP" . SPARSER::PROTEIN)
    ("ACTR" . SPARSER::PROTEIN)
    ("the Maf basic leucine zipper (bZIP) transcription regulators"
     . SPARSER::REGULATOR)
    ("MafF, MafK, and MafG" . SPARSER::COLLECTION) ("MafG" . SPARSER::PROTEIN)
    ("MafK" . SPARSER::PROTEIN) ("MafF" . SPARSER::PROTEIN)
    ("Mafs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nrf2-Keap1" . SPARSER::COLLECTION) ("electrophile" . SPARSER::MOLECULE)
    ("Cnc" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HO-1 ( xref ) and γ-glutamylcystein synthetase (γGCS)"
     . SPARSER::COLLECTION)
    ("UDP-glucuronosyltransferase (UGT)" . SPARSER::PROTEIN)
    ("synthetase" . SPARSER::PROTEIN) ("UGT" . SPARSER::PROTEIN)
    ("Nrf2 and RAC3" . SPARSER::COLLECTION)
    ("RAC3 and Nrf2" . SPARSER::COLLECTION)
    ("RAC3/AIB-1/SRC-3" . SPARSER::COLLECTION) ("oxygenase" . SPARSER::PROTEIN)
    ("CCA -3" . SPARSER::PROTEIN) ("acetyl-transferase" . SPARSER::PROTEIN)
    ("N3" . SPARSER::PROTEIN) ("basic helix-loop-helix" . SPARSER::PROTEIN)
    ("CARM1" . SPARSER::PROTEIN)
    ("coactivator-associated arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN)
    ("protein arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN) ("GRIP1" . SPARSER::PROTEIN)
    ("TIF2" . SPARSER::PROTEIN) ("NCoA-1" . SPARSER::PROTEIN)
    ("Receptor-associated coactivator 3" . SPARSER::PROTEIN)
    ("BP-1" . SPARSER::PROTEIN) ("Neh2" . SPARSER::PROTEIN)
    ("Neh1" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("Kelch-like ECH-associated protein 1" . SPARSER::PROTEIN)
    ("nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("MRP1" . SPARSER::PROTEIN)
    ("multidrug-resistance-associated protein 1" . SPARSER::PROTEIN)
    ("UDP-glucuronosyltransferase" . SPARSER::PROTEIN)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("AIB-1" . SPARSER::PROTEIN)
    ("RAC3" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("Nuclear factor erythroid 2-related factor 2" . SPARSER::PROTEIN)
    ("only one non-silent variant" . SPARSER::VARIANT)
    ("NSV" . SPARSER::PROTEIN)
    ("fludarabine, chlorambucil and cyclophosphamide" . SPARSER::COLLECTION)
    ("ATM and IGVH" . SPARSER::COLLECTION)
    ("Only 18 non-silent exonic variants" . SPARSER::VARIANT)
    ("NSVs" . SPARSER::PROTEIN) ("CALGB" . SPARSER::PROTEIN)
    ("ATM-NSV" . SPARSER::COLLECTION) ("Leukemia" . SPARSER::PROTEIN)
    ("cyclophosphamide (FC) [ xref ] or FC" . SPARSER::COLLECTION)
    ("fludarabine [ xref ] or fludarabine" . SPARSER::COLLECTION)
    ("cyclophosphamide (FC)" . SPARSER::DRUG) ("FC" . SPARSER::PROTEIN)
    ("alkylators and nucleoside" . SPARSER::COLLECTION)
    ("p53 and ATM" . SPARSER::COLLECTION) ("Rituximab" . SPARSER::DRUG)
    ("alkylators (chlorambucil, cyclophosphamide) and nucleoside analogs (fludarabine, cladribine, pentostatin)"
     . SPARSER::COLLECTION)
    ("cladribine" . SPARSER::PROTEIN) ("nucleoside" . SPARSER::MOLECULE)
    ("cyclophosphamide" . SPARSER::DRUG) ("alkylators" . SPARSER::MOLECULE)
    ("IGVH" . SPARSER::GENE)
    ("fludarabine and rituximab" . SPARSER::COLLECTION)
    ("rituximab" . SPARSER::DRUG) ("L15" . SPARSER::PROTEIN)
    ("– 2" . SPARSER::PROTEIN) ("key mRNAs" . SPARSER::PROTEIN)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("4EBP1–eIF4E" . SPARSER::COLLECTION)
    ("a comprehensive map" . SPARSER::PROTEIN)
    ("clinically relevant mTOR ATP site inhibitors" . SPARSER::INHIBITOR)
    ("4EBP1 and p70S6K1/2" . SPARSER::COLLECTION)
    ("YB1, MTA1 and CD44" . SPARSER::COLLECTION)
    ("YB1, vimentin, CD44 and MTA1" . SPARSER::COLLECTION)
    ("Pb-cre" . SPARSER::COLLECTION) ("cre" . SPARSER::PROTEIN)
    ("4EBP–eIF4E" . SPARSER::COLLECTION)
    ("4EBP1 and 4EBP2" . SPARSER::COLLECTION)
    ("a doxycycline-inducible dominant-negative mutant" . SPARSER::MUTANT)
    ("4EBP1 and/or p70S6K1/2" . SPARSER::COLLECTION)
    ("the translational regulators downstream mTORC1, 4EBP1 and/or p70S6K1/2"
     . SPARSER::COLLECTION)
    ("the translational regulators downstream mTORC1" . SPARSER::PROTEIN)
    ("mTOR translational effectors" . SPARSER::EFFECTOR)
    ("YB1 and MTA1" . SPARSER::COLLECTION)
    ("YB1 and/or MTA1 ( xref )" . SPARSER::COLLECTION)
    ("MTA1, CD44 , or vimentin" . SPARSER::COLLECTION)
    ("LEF1 and TWIST1" . SPARSER::COLLECTION)
    ("SNAI" . SPARSER::PROTEIN-FAMILY)
    ("PP242 or INK128" . SPARSER::COLLECTION)
    ("YB1, MTA1, vimentin and CD44" . SPARSER::COLLECTION)
    ("pyrazolopyrimidine" . SPARSER::MOLECULE)
    ("Vimentin and CD44" . SPARSER::COLLECTION)
    ("YB1 , vimentin, MTA1 and CD44" . SPARSER::COLLECTION)
    ("MTA1 (metastasis associated 1) and CD44 ( xref )" . SPARSER::COLLECTION)
    ("YB1 (Y-box binding protein 1; also called YBX1), vimentin, MTA1 (metastasis associated 1) and CD44 ( xref )"
     . SPARSER::COLLECTION)
    ("metastasis mRNAs and putative regulators" . SPARSER::COLLECTION)
    ("70 ribosomal proteins" . SPARSER::PROTEIN)
    ("The largest fraction" . SPARSER::COMPONENT) ("uridine" . SPARSER::DRUG)
    ("4EBP1, p70S6K1/2 and AKT" . SPARSER::COLLECTION)
    ("ribosomes" . SPARSER::BIO-COMPLEX) ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("a novel clinically relevant mTOR inhibitor" . SPARSER::INHIBITOR)
    ("4EBP1 (also called EIF4EBP1) and p70S6K1/2 (refs xref , xref )"
     . SPARSER::COLLECTION)
    ("–AKT" . SPARSER::COLLECTION)
    ("phosphatidylinositol-3-OH" . SPARSER::PROTEIN-PAIR)
    ("a clinically relevant ATP site inhibitor" . SPARSER::INHIBITOR)
    ("ribosome" . SPARSER::BIO-COMPLEX) ("HBP1" . SPARSER::PROTEIN)
    ("GDF15" . SPARSER::PROTEIN) ("FOXA1" . SPARSER::PROTEIN)
    ("RND3" . SPARSER::PROTEIN) ("ARID5B" . SPARSER::PROTEIN)
    ("FGFBP1" . SPARSER::PROTEIN) ("CD31" . SPARSER::PROTEIN)
    ("keratin 5" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("P200" . SPARSER::PROTEIN) ("potassium channel" . SPARSER::PROTEIN)
    ("CYP3A4" . SPARSER::PROTEIN) ("CYP1A2" . SPARSER::PROTEIN)
    ("eEF2" . SPARSER::PROTEIN) ("ml –1" . SPARSER::PROTEIN)
    ("CK8" . SPARSER::PROTEIN) ("CK5" . SPARSER::PROTEIN)
    ("4EBP" . SPARSER::PROTEIN) ("BPH-1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("SNAIL1" . SPARSER::PROTEIN)
    ("metastasis associated 1" . SPARSER::PROTEIN) ("MTA1" . SPARSER::PROTEIN)
    ("YBX1" . SPARSER::PROTEIN) ("Y-box binding protein 1" . SPARSER::PROTEIN)
    ("YB1" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("p70S6K1" . SPARSER::PROTEIN) ("EIF4EBP1" . SPARSER::PROTEIN)
    ("PI(3)K" . SPARSER::HUMAN-PROTEIN-FAMILY) ("INK128" . SPARSER::DRUG)
    ("BAP1 or BRAF" . SPARSER::COLLECTION) ("/BAP1" . SPARSER::COLLECTION)
    ("BRAF and HRAS" . SPARSER::COLLECTION)
    ("vesicular chromatin" . SPARSER::PROTEIN)
    ("a significant junctional component" . SPARSER::COMPONENT)
    ("BRAF or HRAS" . SPARSER::COLLECTION) ("GNA11" . SPARSER::PROTEIN)
    ("C-4" . SPARSER::PROTEIN) ("family 2" . SPARSER::PROTEIN)
    ("family 1" . SPARSER::PROTEIN) ("BAP1" . SPARSER::PROTEIN)
    ("TNF-α, and IL-13" . SPARSER::COLLECTION)
    ("many profibrotic cytokines" . SPARSER::PROTEIN)
    ("PDGF-AA, PDGF-BB, PDGF-AB, EGF, IGFBP-2, HGF, MCSFR, and IL-13"
     . SPARSER::COLLECTION)
    ("MCSFR" . SPARSER::PROTEIN)
    ("IL-13 and its receptor" . SPARSER::COLLECTION)
    ("an autoantigen or a co-stimulator" . SPARSER::COLLECTION)
    ("autoantigen" . SPARSER::DRUG)
    ("the major proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CIII" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("collagen and other extracellular matrix proteins" . SPARSER::COLLECTION)
    ("abundant chemotactic chemokine IL-8" . SPARSER::PROTEIN)
    ("IL-4, IL-6, and IL-10" . SPARSER::COLLECTION)
    ("anti-CD3 and anti" . SPARSER::COLLECTION)
    ("latent TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI 3-kinase/Akt" . SPARSER::COLLECTION)
    ("PDGF-AA and EGF" . SPARSER::COLLECTION)
    ("PDGF-BB and IL-13" . SPARSER::COLLECTION)
    ("PDGF-AA, PDGF-BB, IL-13, and EGF" . SPARSER::COLLECTION)
    ("profibrotic cytokines" . SPARSER::PROTEIN)
    ("PDGF-AA, PDGF-BB, IL-13, TNF-α, and EGF" . SPARSER::COLLECTION)
    ("colony stimulating factor receptor (MCSFR)" . SPARSER::PROTEIN)
    ("cytokine or growth factor" . SPARSER::COLLECTION)
    ("cytokines or growth factors" . SPARSER::COLLECTION)
    ("significantly less MMP-1" . SPARSER::PROTEIN)
    ("media and PBMC supernatant" . SPARSER::COLLECTION)
    ("anti-topoisomerase II alpha antibody" . SPARSER::ANTIBODY)
    ("antinuclear antibodies" . SPARSER::ANTIBODY) ("nail" . SPARSER::PROTEIN)
    ("autoantibody" . SPARSER::PROTEIN)
    ("localized scleroderma (LS) variants and systemic sclerosis (SSc)"
     . SPARSER::COLLECTION)
    ("PDGF-BB or IL-13" . SPARSER::COLLECTION)
    ("-AA, PDGF-BB, TNF-α, IL-13, and EGF" . SPARSER::COLLECTION)
    ("-AA" . SPARSER::MOLECULE) ("dc" . SPARSER::MOLECULE)
    ("soluble mediators" . SPARSER::PROTEIN)
    ("collagen (CI)" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("–3 " . SPARSER::PROTEIN) ("CD45 RO" . SPARSER::PROTEIN)
    ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDGF-AA" . SPARSER::PROTEIN) ("interleukin-13" . SPARSER::PROTEIN)
    ("colony stimulating factor receptor" . SPARSER::PROTEIN)
    ("IGFBP-2" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein 2" . SPARSER::PROTEIN)
    ("PDGF-AB" . SPARSER::PROTEIN)
    ("other invadopodia-associated proteins" . SPARSER::PROTEIN)
    ("Gab1 and Met" . SPARSER::COLLECTION)
    ("N-WASP and cortactin" . SPARSER::COLLECTION)
    ("cortactin, N-WASP and Arp2/3" . SPARSER::COLLECTION)
    ("FY" . SPARSER::PROTEIN)
    ("EGFR ( xref ; xref ) and PDGFRα ( xref )" . SPARSER::COLLECTION)
    ("Abl and Arg" . SPARSER::COLLECTION) ("focal ECM" . SPARSER::PROTEIN)
    ("Src, Abl or Met" . SPARSER::COLLECTION)
    ("PP2 or SU6656" . SPARSER::COLLECTION)
    ("Src or Abl" . SPARSER::COLLECTION) ("Imatinib" . SPARSER::DRUG)
    ("receptor and cortactin" . SPARSER::COLLECTION)
    ("Arg and Abl" . SPARSER::COLLECTION)
    ("Nck and actin" . SPARSER::COLLECTION)
    ("GST–cortactin" . SPARSER::COLLECTION)
    ("Gab1-cortactin" . SPARSER::COLLECTION)
    ("Gab1 and cortactin" . SPARSER::COLLECTION)
    ("Nck, N-WASP and Arp2/3" . SPARSER::COLLECTION)
    ("Cortactin" . SPARSER::PROTEIN)
    ("possibly other protein" . SPARSER::PROTEIN)
    ("Gab1ΔP4/5" . SPARSER::PROTEIN) ("GFP-Gab1ΔP4/5" . SPARSER::COLLECTION)
    ("GFP-Gab1" . SPARSER::COLLECTION)
    ("Gab1 and Tpr-Met" . SPARSER::COLLECTION)
    ("receptor, and Gab1" . SPARSER::COLLECTION)
    ("receptor, or Tpr-Met" . SPARSER::COLLECTION)
    ("GFP-fused" . SPARSER::COLLECTION)
    ("fluorescent gelatin matrix" . SPARSER::PROTEIN-FAMILY)
    ("Grb2 and Tpr-Met" . SPARSER::COLLECTION)
    ("proteins, Grb2 and Shc" . SPARSER::COLLECTION)
    ("oncogene and Met" . SPARSER::COLLECTION) ("Shc" . SPARSER::PROTEIN)
    ("Tks5 and cortactin" . SPARSER::COLLECTION)
    ("degraded fluorescent gelatin matrix" . SPARSER::PROTEIN-FAMILY)
    ("FR" . SPARSER::PROTEIN) ("Tpr" . SPARSER::PROTEIN)
    ("Rac and Rap1" . SPARSER::COLLECTION) ("Nck/N-WASP" . SPARSER::COLLECTION)
    ("Ras–MAPK" . SPARSER::COLLECTION) ("PI3K–Akt" . SPARSER::COLLECTION)
    ("PI3K, Shp2 and PLCγ" . SPARSER::COLLECTION) ("Crk" . SPARSER::PROTEIN)
    ("which tethers Gab1" . SPARSER::PROTEIN)
    ("Met and its ligand" . SPARSER::COLLECTION) ("phox" . SPARSER::PROTEIN)
    ("a trimeric complex" . SPARSER::BIO-COMPLEX)
    ("Wiscott" . SPARSER::PROTEIN) ("cofilin" . SPARSER::PROTEIN)
    ("the epidermal growth factor (EGF) as well as platelet derived growth factor (PDGF) receptor tyrosine kinases (RTK)"
     . SPARSER::COLLECTION)
    ("Abl" . SPARSER::PROTEIN)
    ("macrophages and osteoclasts" . SPARSER::COLLECTION)
    ("cortactin and Gab1" . SPARSER::COLLECTION)
    ("Gab1–cortactin" . SPARSER::COLLECTION) ("cortactin" . SPARSER::PROTEIN)
    ("protein-G" . SPARSER::PROTEIN) ("F11" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("PDGFRα" . SPARSER::PROTEIN)
    ("SU6656" . SPARSER::PROTEIN) ("PHA665752" . SPARSER::MOLECULE)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("P85" . SPARSER::PROTEIN)
    ("P  3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tks5" . SPARSER::PROTEIN)
    ("GRB2-associated-binding protein 1" . SPARSER::PROTEIN)
    ("GAF and AAO" . SPARSER::COLLECTION)
    ("ANK3 and CACNA1C" . SPARSER::COLLECTION)
    ("ANK3 and rs1006737" . SPARSER::COLLECTION)
    ("several potential susceptibility genes" . SPARSER::GENE)
    ("NEO-PI" . SPARSER::COLLECTION) ("TPQ" . SPARSER::MOLECULE)
    ("NEO" . SPARSER::PROTEIN)
    ("dysthymic and hyperthymic traits" . SPARSER::PROTEIN)
    ("a highly unstable mixture" . SPARSER::MOLECULE)
    ("an integrator subunit gene ( INTS7 ) and the denticleless homolog gene ( DTL )"
     . SPARSER::COLLECTION)
    ("gene ( DTL )" . SPARSER::GENE)
    ("overconfident lifelong traits" . SPARSER::PROTEIN)
    ("NGL" . SPARSER::PROTEIN) ("INTS7 and DTL" . SPARSER::COLLECTION)
    ("DTL" . SPARSER::PROTEIN) ("APP" . SPARSER::PROTEIN)
    ("Wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MDM1 and FBLN1" . SPARSER::COLLECTION) ("GW" . SPARSER::PROTEIN)
    ("a more severe form" . SPARSER::FORM) ("AAO" . SPARSER::PROTEIN)
    ("state and level" . SPARSER::COLLECTION) ("GAF" . SPARSER::PROTEIN)
    ("state, and illness" . SPARSER::COLLECTION) ("Weaker" . SPARSER::PROTEIN)
    ("antidepressants" . SPARSER::DRUG)
    ("subclinical affective traits" . SPARSER::PROTEIN)
    ("traits" . SPARSER::PROTEIN) ("DSM" . SPARSER::MOLECULE)
    ("Paris" . SPARSER::PROTEIN) ("Pisa" . SPARSER::PROTEIN)
    ("CACNA1C" . SPARSER::PROTEIN) ("ANK3" . SPARSER::PROTEIN)
    ("PDE4D" . SPARSER::PROTEIN) ("SLITRK1" . SPARSER::PROTEIN)
    ("NTNG1" . SPARSER::PROTEIN) ("Netrin-G1" . SPARSER::PROTEIN)
    ("LRRC4" . SPARSER::PROTEIN) ("small nuclear RNAs" . SPARSER::RNA)
    ("INTS7" . SPARSER::PROTEIN) ("A–D" . SPARSER::PROTEIN)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("fibulin 1" . SPARSER::PROTEIN) ("FBLN1" . SPARSER::PROTEIN)
    ("MDM1" . SPARSER::PROTEIN)
    ("its immediate, localized and preferred inhibitor" . SPARSER::INHIBITOR)
    ("mesenchymal states" . SPARSER::BIO-STATE)
    ("MAT and AMT" . SPARSER::COLLECTION)
    ("the mesenchymal state" . SPARSER::BIO-STATE)
    ("uPA∶uPAR" . SPARSER::BIO-COMPLEX)
    ("the cell mesenchymal state" . SPARSER::BIO-STATE)
    ("available matrix-bound PAI-1" . SPARSER::PROTEIN)
    ("the available matrix" . SPARSER::PROTEIN-FAMILY)
    ("the adherent part" . SPARSER::COMPONENT)
    ("an indirect promoter" . SPARSER::PROMOTER)
    ("Flotillin1 and β1" . SPARSER::COLLECTION)
    ("agglutinin" . SPARSER::PROTEIN)
    ("Flotillin1 ( xref , xref ) and β1 Integrin ( xref )"
     . SPARSER::COLLECTION)
    ("PAI-1 ( xref , xref , xref and xref ) and uPA ( xref )"
     . SPARSER::COLLECTION)
    ("PAI-1 and uPA" . SPARSER::COLLECTION)
    ("uPAR, PDK1 or ROCK1" . SPARSER::COLLECTION)
    ("PAI-1 and non-coated" . SPARSER::COLLECTION)
    ("Endo 180 or GP 330" . SPARSER::COLLECTION)
    ("soluble PAI-1" . SPARSER::PROTEIN)
    ("anti-uPA or anti-uPAR" . SPARSER::COLLECTION)
    ("uPA ( xref ) and PAI-1 ( xref )" . SPARSER::COLLECTION)
    ("uPAR∶uPA∶PAI-1" . SPARSER::BIO-COMPLEX)
    ("uPA and uPAR" . SPARSER::COLLECTION)
    ("the illustrative example" . SPARSER::EXAMPLE)
    ("ROCK1 and PDK1" . SPARSER::COLLECTION)
    ("Caspase 3 and RhoA" . SPARSER::COLLECTION) ("Ezrin" . SPARSER::PROTEIN)
    ("uPAR and uPA" . SPARSER::COLLECTION) ("Kinase (FAK)" . SPARSER::KINASE)
    ("Src and Rac" . SPARSER::COLLECTION)
    ("Integrins or Vitronectin" . SPARSER::COLLECTION)
    ("Ras-Mitogen-Activated Protein Kinase" . SPARSER::COLLECTION)
    ("endocytic receptors" . SPARSER::PROTEIN) ("LRP" . SPARSER::PROTEIN)
    ("VN" . SPARSER::PROTEIN) ("Vitronectin" . SPARSER::PROTEIN)
    ("urokinase Plasminogen Activator (uPA) and its receptor (uPAR)"
     . SPARSER::COLLECTION)
    ("PA" . SPARSER::PROTEIN) ("Phosphoinositide" . SPARSER::PROTEIN)
    ("its main effector Rho-associated Coil-containing Protein Kinase"
     . SPARSER::KINASE)
    ("Acto-Myosin" . SPARSER::COLLECTION) ("Myosin" . SPARSER::PROTEIN-FAMILY)
    ("AMT" . SPARSER::PROTEIN) ("MAT" . SPARSER::PROTEIN)
    ("a matricellular protein" . SPARSER::PROTEIN)
    ("matrix-associated PAI-1" . SPARSER::PROTEIN)
    ("PDK1 and ROCK1" . SPARSER::COLLECTION) ("bad" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN)
    ("polyvinylidene fluoride" . SPARSER::DRUG) ("L-15" . SPARSER::PROTEIN)
    ("Flotillin1" . SPARSER::PROTEIN) ("GP 330" . SPARSER::PROTEIN)
    ("Endo 180" . SPARSER::PROTEIN) ("Caspase 3" . SPARSER::PROTEIN)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("low-density Lipoprotein Receptor" . SPARSER::PROTEIN)
    ("its receptor" . SPARSER::PROTEIN)
    ("Myosin Light Chain" . SPARSER::PROTEIN)
    ("Matrix-bound" . SPARSER::PROTEIN) ("matrix-bound" . SPARSER::PROTEIN)
    ("Plasminogen Activator" . SPARSER::PROTEIN)
    ("mTOR and its downstream substrate p70-S6K" . SPARSER::COLLECTION)
    ("AMPK and P-ACC" . SPARSER::COLLECTION)
    ("the AMPK active complex" . SPARSER::BIO-COMPLEX)
    ("SESN2 and AMPKβ1" . SPARSER::COLLECTION)
    ("p53 and AMPK" . SPARSER::COLLECTION) ("LKB1/AMPK" . SPARSER::COLLECTION)
    ("SESN2, P-AMPKα, and P-ACC" . SPARSER::COLLECTION)
    ("LKB1, AMPK, P-AMPKα, and P-ACC" . SPARSER::COLLECTION)
    ("SESN2-AMPK" . SPARSER::COLLECTION)
    ("SESN2 and LKB1" . SPARSER::COLLECTION)
    ("the primary active AMPK heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("stress-inducible genes" . SPARSER::GENE) ("CC" . SPARSER::MOLECULE)
    ("compound C (CC)" . SPARSER::MOLECULE) ("tet" . SPARSER::PROTEIN)
    ("AMPKα and ACC" . SPARSER::COLLECTION) ("ACC" . SPARSER::PROTEIN)
    ("SESN2, LKB1, and AMPKβ1" . SPARSER::COLLECTION)
    ("SESN2, LKB1, and AMPKα1β1γ1" . SPARSER::COLLECTION)
    ("doxycyclin" . SPARSER::MOLECULE)
    ("AMPK and its downstream AMPK substrate" . SPARSER::COLLECTION)
    ("CoA" . SPARSER::MOLECULE) ("Acetyl" . SPARSER::MOLECULE)
    ("subunit and LKB1" . SPARSER::COLLECTION)
    ("AMPK and LKB1" . SPARSER::COLLECTION) ("–1 µ" . SPARSER::PROTEIN)
    ("SESN2 and AMPK" . SPARSER::COLLECTION)
    ("SESN2-Flag" . SPARSER::COLLECTION)
    ("the main AMPK active complex" . SPARSER::BIO-COMPLEX)
    ("the active AMPK heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("the most prominent AMPK heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("smooth muscle" . SPARSER::PROTEIN)
    ("a heterotrimeric enzyme" . SPARSER::ENZYME)
    ("an active complex" . SPARSER::BIO-COMPLEX)
    ("scaffolding protein and form" . SPARSER::COLLECTION)
    ("AMPK and TSC2" . SPARSER::COLLECTION) ("TOR" . SPARSER::PROTEIN)
    ("peroxiredoxins" . SPARSER::PROTEIN)
    ("SESN1 and SESN2" . SPARSER::COLLECTION) ("GADD" . SPARSER::PROTEIN)
    ("stress-sensitive genes" . SPARSER::GENE) ("SESN" . SPARSER::PROTEIN)
    ("Sestrins" . SPARSER::PROTEIN-FAMILY) ("mitogen" . SPARSER::MITOGEN)
    ("LKB1 and AMPKα1β1γ1" . SPARSER::COLLECTION)
    ("LKB1, AMPKα1, and AMPKβ1" . SPARSER::COLLECTION)
    ("AMPKα1 and AMPKβ1" . SPARSER::COLLECTION)
    ("tetracycline" . SPARSER::DRUG) ("sestrins" . SPARSER::PROTEIN-FAMILY)
    ("kinase (AMPK)" . SPARSER::KINASE)
    ("stress-responsive genes" . SPARSER::GENE)
    ("AMPK-mTOR" . SPARSER::COLLECTION) ("SESN1-3" . SPARSER::COLLECTION)
    ("sestrin" . SPARSER::PROTEIN-FAMILY) ("sestrin2" . SPARSER::PROTEIN)
    ("Sestrin2" . SPARSER::PROTEIN) ("AMPK β" . SPARSER::PROTEIN)
    ("AMPK α1" . SPARSER::PROTEIN) ("AMPK α" . SPARSER::PROTEIN-FAMILY)
    ("Akt-mTOR" . SPARSER::PROTEIN) ("1/2" . SPARSER::PROTEIN)
    ("compound C" . SPARSER::MOLECULE) ("p70-S6K" . SPARSER::PROTEIN)
    ("P-ACC" . SPARSER::PROTEIN) ("α1β1" . SPARSER::PROTEIN)
    ("SESN3" . SPARSER::PROTEIN) ("sestrin1" . SPARSER::PROTEIN)
    ("Tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("AMPKα" . SPARSER::PROTEIN-FAMILY) ("AMPKβ" . SPARSER::PROTEIN)
    ("AMPKα1" . SPARSER::PROTEIN) ("SESN2" . SPARSER::PROTEIN)
    ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SESN1" . SPARSER::PROTEIN)
    ("MAPK and phosphatidylinositol-3-OH" . SPARSER::COLLECTION)
    ("kinase/Akt" . SPARSER::COLLECTION)
    ("Ser-9-phosphorylated GSK3β" . SPARSER::PROTEIN)
    ("β-catenin and Snail" . SPARSER::COLLECTION)
    ("LCRMP-1 and CRMP-1" . SPARSER::COLLECTION)
    ("high activity GSK3β and high-level LCRMP-1" . SPARSER::COLLECTION)
    ("LCRMP-1 and Ser-9-phosphorylated" . SPARSER::COLLECTION)
    ("GSK3β and LCRMP-1" . SPARSER::COLLECTION)
    ("CL1-0/LCRMP-1" . SPARSER::COLLECTION)
    ("GFP-LCRMP-1 (WT)" . SPARSER::COLLECTION)
    ("GFP-LCRMP-1" . SPARSER::COLLECTION) ("LCRMP-1 (WT)" . SPARSER::PROTEIN)
    ("GSK3β (CA) and GSK3β (KD)" . SPARSER::COLLECTION)
    ("GSK3β (KD)" . SPARSER::PROTEIN) ("GSK3β (CA)" . SPARSER::PROTEIN)
    ("GSK3β (WT)" . SPARSER::PROTEIN) ("Cdk5 and GSK3β" . SPARSER::COLLECTION)
    ("CRMP-2, CRMP-1, and LCRMP-1" . SPARSER::COLLECTION)
    ("CRMP-1 and CRMP-3" . SPARSER::COLLECTION)
    ("CRMP-3" . SPARSER::COLLECTION) ("CRMP" . SPARSER::PROTEIN)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("glycogen" . SPARSER::PROTEIN)
    ("many master inducers and suppressors" . SPARSER::COLLECTION)
    ("LCRMP-1" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("CL1-5" . SPARSER::PROTEIN) ("CL1-2" . SPARSER::PROTEIN)
    ("CL1-1" . SPARSER::PROTEIN) ("CL1-0" . SPARSER::PROTEIN)
    ("Cdk5" . SPARSER::PROTEIN) ("CRMP-2" . SPARSER::PROTEIN)
    ("Collapsin response mediator protein-1" . SPARSER::PROTEIN)
    ("CRMP-1" . SPARSER::PROTEIN) ("ATF-CRE" . SPARSER::COLLECTION)
    ("CREs" . SPARSER::PROTEIN)
    ("a transcriptional activator or a transcriptional repressor"
     . SPARSER::COLLECTION)
    ("ATF or cAMP" . SPARSER::COLLECTION) ("bZIP" . SPARSER::PROTEIN-FAMILY)
    ("ATF4 and SIRT1" . SPARSER::COLLECTION) ("CDDP-" . SPARSER::DRUG)
    ("SIRT1, ATF4, MDR1, MRP, Bcl-2, and Bax" . SPARSER::COLLECTION)
    ("MRP, Bcl-2, and Bax" . SPARSER::COLLECTION)
    ("the binding site 1 or binding site 2" . SPARSER::COLLECTION)
    ("TESS, and Genomatix" . SPARSER::COLLECTION) ("TESS" . SPARSER::PROTEIN)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("MDR1, MRP, Bcl-2, and Bax" . SPARSER::COLLECTION)
    ("MRP" . SPARSER::PROTEIN)
    ("SIRT1, MDR1, Bcl-2, and Bax" . SPARSER::COLLECTION)
    ("SGC7901-ATF4 and SGC7901/ADR-SCR" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ADR, VCR, CDDP, and 5-FU" . SPARSER::COLLECTION) ("CDDP" . SPARSER::DRUG)
    ("ADR" . SPARSER::PROTEIN)
    ("a potent stress-responsive gene" . SPARSER::GENE)
    ("anoxia/hypoxia" . SPARSER::COLLECTION)
    ("molecules or pathways" . SPARSER::COLLECTION)
    ("Bcl-2/Bax" . SPARSER::COLLECTION) ("Multidrug" . SPARSER::PROTEIN)
    ("T-3" . SPARSER::PROTEIN) ("AT-3" . SPARSER::PROTEIN)
    ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("site 1" . SPARSER::PROTEIN)
    ("5-FU" . SPARSER::PROTEIN) ("MDR1" . SPARSER::PROTEIN)
    ("EX-527" . SPARSER::DRUG)
    ("Activating transcription factor 4" . SPARSER::PROTEIN)
    ("metastasized MCC" . SPARSER::PROTEIN)
    ("AKT and additional components" . SPARSER::COLLECTION)
    ("the viral proteins" . SPARSER::PROTEIN)
    ("the MCV viral T antigens" . SPARSER::MOLECULE)
    ("the presumably oncogenic large and small T antigens" . SPARSER::MOLECULE)
    ("the viral large T antigen" . SPARSER::MOLECULE)
    ("p53 , p73 and CDKN2A" . SPARSER::COLLECTION)
    ("HRAS , KRAS , NRAS , BRAF , C-KIT , and genes" . SPARSER::COLLECTION)
    ("anaplastic thyroid" . SPARSER::PROTEIN) ("BLM" . SPARSER::PROTEIN)
    ("MKI-2" . SPARSER::COLLECTION) ("MKI-1" . SPARSER::COLLECTION)
    ("MKL-1" . SPARSER::COLLECTION) ("MKL" . SPARSER::PROTEIN)
    ("LT" . SPARSER::PROTEIN) ("the western blot" . SPARSER::PROTEIN)
    ("PHD" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase/v-akt" . SPARSER::COLLECTION)
    ("akt" . SPARSER::PROTEIN) ("homologue (PTEN)" . SPARSER::PROTEIN)
    ("light and MCC" . SPARSER::COLLECTION)
    ("a potential new therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("MCCs" . SPARSER::PROTEIN) ("MCC" . SPARSER::PROTEIN)
    ("C-KIT" . SPARSER::PROTEIN) ("PI-3 kinase" . SPARSER::PROTEIN)
    ("T antigen" . SPARSER::MOLECULE) ("KH1" . SPARSER::PROTEIN)
    ("T antigens" . SPARSER::MOLECULE)
    ("MYC, JUN, JUN-B, FOS, HMGA1 and HES1-" . SPARSER::COLLECTION)
    ("HES1-" . SPARSER::PROTEIN)
    ("both ADC and SCC histotypes" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("arm" . SPARSER::PROTEIN)
    ("PIK3CA and AKT1" . SPARSER::COLLECTION)
    ("the type or the position" . SPARSER::COLLECTION)
    ("KRAS or AKT1" . SPARSER::COLLECTION)
    ("AKT1 or AKT2" . SPARSER::COLLECTION) ("ADS" . SPARSER::PROTEIN)
    ("CALU" . SPARSER::PROTEIN) ("ADC-" . SPARSER::PROTEIN)
    ("HMGA1, FOS and MYC" . SPARSER::COLLECTION)
    ("ADCs and SCCs" . SPARSER::COLLECTION)
    ("cytokines (IL1A, IL1B, IL6 and IL8) and chemokines (CXCL2)"
     . SPARSER::COLLECTION)
    ("growth factors (TGFA)" . SPARSER::GROWTH-FACTOR)
    ("IL1A, IL1B, IL6 and IL8" . SPARSER::COLLECTION)
    ("TGFA" . SPARSER::PROTEIN)
    ("CCND1, CCND2, Cdk6 and Cdk" . SPARSER::COLLECTION)
    ("BAG3, IGFBP7, IGFBP3, TRADD and TRIB1" . SPARSER::COLLECTION)
    ("exogenous PI3KCA allele" . SPARSER::ALLELE) ("GGC" . SPARSER::PROTEIN)
    ("TGT" . SPARSER::PROTEIN) ("GGT" . SPARSER::PROTEIN)
    ("AAG" . SPARSER::PROTEIN) ("PIK3CA, AKT1 and AKT2" . SPARSER::COLLECTION)
    ("SCC-4" . SPARSER::PROTEIN)
    ("a representative example" . SPARSER::EXAMPLE)
    ("AKT1, AKT2 and PIK3CA" . SPARSER::COLLECTION)
    ("overexpressed p110α presented significantly activated AKT"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p " . SPARSER::PROTEIN) ("KRAS, PIK3CA and PTEN" . SPARSER::COLLECTION)
    ("SCCs and 30/44" . SPARSER::COLLECTION) ("ADCs" . SPARSER::PROTEIN)
    ("SCCs" . SPARSER::PROTEIN) ("KRAS, PIK3CA or AKT1" . SPARSER::COLLECTION)
    ("phosphatidylinositols" . SPARSER::PROTEIN) ("ADC" . SPARSER::PROTEIN)
    ("MYC, FOS and HMGA1" . SPARSER::COLLECTION)
    ("AKT2 (18/83, 22%) or AKT1 (17/96, 18%)" . SPARSER::COLLECTION)
    ("PTEN, AKT1 and AKT2" . SPARSER::COLLECTION) ("JUN-B" . SPARSER::PROTEIN)
    ("CXCL2" . SPARSER::PROTEIN) ("IL8" . SPARSER::PROTEIN)
    ("IL1B" . SPARSER::PROTEIN) ("IL1A" . SPARSER::PROTEIN)
    ("TRIB1" . SPARSER::PROTEIN) ("IGFBP7" . SPARSER::PROTEIN)
    ("BAG3" . SPARSER::PROTEIN) ("Cdk6" . SPARSER::PROTEIN)
    ("B–H" . SPARSER::PROTEIN) ("glutamic acid" . SPARSER::AMINO-ACID)
    ("p14" . SPARSER::PROTEIN) ("p13" . SPARSER::PROTEIN)
    ("M15" . SPARSER::DRUG) ("RP11" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN) ("PIK3" . SPARSER::PROTEIN)
    ("INO1 , SPS2 , and IME2" . SPARSER::COLLECTION)
    ("CTCF" . SPARSER::PROTEIN) ("Rad51 and Rad52" . SPARSER::COLLECTION)
    ("rad51 or rad52" . SPARSER::COLLECTION)
    ("the shorter alleles" . SPARSER::ALLELE) ("Rpd3-" . SPARSER::PROTEIN)
    ("The relevant yeast HAT" . SPARSER::PROTEIN)
    ("CBP and p300" . SPARSER::COLLECTION) ("HATs" . SPARSER::PROTEIN)
    ("Sae2 and Mre11" . SPARSER::COLLECTION)
    ("sin3 and mre11" . SPARSER::COLLECTION)
    ("Mre11/Rad50/Xrs2" . SPARSER::COLLECTION)
    ("nearby histones" . SPARSER::PROTEIN)
    ("the histone acetyltransferases CREB-binding protein (CBP) and p300 ( xref )"
     . SPARSER::COLLECTION)
    ("CREB-binding protein (CBP)" . SPARSER::PROTEIN)
    ("an HDAC1- and HDAC2-selective inhibitor" . SPARSER::COLLECTION)
    ("HDAC1-" . SPARSER::PROTEIN) ("DMSO-only" . SPARSER::MOLECULE)
    ("Glial" . SPARSER::PROTEIN) ("ataxia" . SPARSER::PROTEIN)
    ("FXN" . SPARSER::PROTEIN) ("Astrocytes" . SPARSER::PROTEIN)
    ("Hos2" . SPARSER::PROTEIN) ("TSA-treated Drosophila" . SPARSER::PROTEIN)
    ("Rpd3 and Hda1" . SPARSER::COLLECTION) ("LYS" . SPARSER::PROTEIN)
    ("sin3 , pho23 , or hda3" . SPARSER::COLLECTION)
    ("hda3" . SPARSER::PROTEIN) ("pho23" . SPARSER::PROTEIN)
    ("pho23 hda3 and sin3 hda3" . SPARSER::PROTEIN)
    ("sin3 , pho23 , and hda3" . SPARSER::COLLECTION)
    ("HDACs and TNR" . SPARSER::COLLECTION)
    ("sin3 and pho23" . SPARSER::COLLECTION)
    ("SIN3 , PHO23 , and HDA3" . SPARSER::COLLECTION)
    ("acetyltransferase (HAT)" . SPARSER::PROTEIN) ("HAT" . SPARSER::PROTEIN)
    ("Sae2 or Mre11" . SPARSER::COLLECTION)
    ("sae2 or mre11" . SPARSER::COLLECTION)
    ("Msh2 or Msh3" . SPARSER::COLLECTION)
    ("Msh2, Msh3, Pms2, Ogg1, and Xpa" . SPARSER::COLLECTION)
    ("Msh2 , Msh3 , Pms2 , Ogg1 , or Xpa" . SPARSER::COLLECTION)
    ("Pms2" . SPARSER::PROTEIN) ("Msh3" . SPARSER::PROTEIN)
    ("Xpa" . SPARSER::PROTEIN) ("TNR" . SPARSER::PROTEIN)
    ("myotonic dystrophy type 1" . SPARSER::PROTEIN)
    ("TNRs" . SPARSER::PROTEIN) ("expansion-associated gene" . SPARSER::GENE)
    ("ALG9" . SPARSER::PROTEIN) ("FAST)" . SPARSER::PROTEIN)
    ("rpd3" . SPARSER::PROTEIN) ("Dnmt1" . SPARSER::PROTEIN)
    ("rad52" . SPARSER::PROTEIN) ("rad51" . SPARSER::PROTEIN)
    ("Rad52" . SPARSER::PROTEIN) ("exo1" . SPARSER::PROTEIN)
    ("Exo1" . SPARSER::PROTEIN) ("MRE11" . SPARSER::PROTEIN)
    ("Xrs2" . SPARSER::PROTEIN) ("IME2" . SPARSER::PROTEIN)
    ("INO1" . SPARSER::PROTEIN) ("Homolog of" . SPARSER::PROTEIN)
    ("Hos1" . SPARSER::PROTEIN) ("URA3" . SPARSER::PROTEIN)
    ("sin3" . SPARSER::PROTEIN) ("SIN3" . SPARSER::PROTEIN)
    ("mre11" . SPARSER::PROTEIN) ("sae2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ogg1" . SPARSER::PROTEIN) ("Msh2" . SPARSER::PROTEIN)
    ("Sae2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HDAC3" . SPARSER::PROTEIN)
    ("Hda1" . SPARSER::PROTEIN) ("Rpd3" . SPARSER::PROTEIN)
    ("PSA and other androgen" . SPARSER::COLLECTION)
    ("androgen and retinoic acid" . SPARSER::COLLECTION)
    ("the distal hTGP promoter" . SPARSER::PROMOTER)
    ("PSA and PSMA" . SPARSER::COLLECTION)
    ("the distal promoter" . SPARSER::PROMOTER)
    ("the ER and both proteins" . SPARSER::COLLECTION)
    ("atRA and RAR" . SPARSER::COLLECTION)
    ("androgen and atRA" . SPARSER::COLLECTION)
    ("the archetypal prostate gene PSA" . SPARSER::PROTEIN)
    ("PSA , PSMA and NKX3.1" . SPARSER::COLLECTION)
    ("AR–RAR" . SPARSER::COLLECTION)
    ("at least one ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("Genes" . SPARSER::GENE) ("BTG1 and SMAD3" . SPARSER::COLLECTION)
    ("Retinoic acid and androgen" . SPARSER::COLLECTION)
    ("CDCA7L, CDK6, BTG1 and SMAD3" . SPARSER::COLLECTION)
    ("AR-target genes and RAR-target genes" . SPARSER::COLLECTION)
    ("retinoic acid and androgen" . SPARSER::COLLECTION)
    ("atRA and R1881" . SPARSER::COLLECTION)
    ("AREs and regions" . SPARSER::COLLECTION)
    ("alongside several deletion mutants" . SPARSER::MUTANT)
    ("RAR-B or RAR-G" . SPARSER::COLLECTION)
    ("RAR-B and RAR-G" . SPARSER::COLLECTION)
    ("malformations and RAR-B" . SPARSER::COLLECTION)
    ("RARs, RAR-B and RAR-G" . SPARSER::COLLECTION)
    ("atRA and bicalutamide" . SPARSER::COLLECTION)
    ("atRA or R1881" . SPARSER::COLLECTION) ("Androgen" . SPARSER::PROTEIN)
    ("atRA and luciferase" . SPARSER::COLLECTION)
    ("promoter and gene" . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("paradoxically no AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("atRA" . SPARSER::DRUG)
    ("both PSA (32 tissues) and TMPRSS2 (39 tissues)" . SPARSER::COLLECTION)
    ("PSA and TMPRSS2" . SPARSER::COLLECTION)
    ("a highly prostate specific gene" . SPARSER::GENE)
    ("AR/RAR" . SPARSER::COLLECTION)
    ("this highly prostate specific gene" . SPARSER::GENE)
    ("androgen–AR" . SPARSER::COLLECTION) ("Promoter" . SPARSER::PROMOTER)
    ("androgen and the AR" . SPARSER::COLLECTION)
    ("Classical prostate specific genes" . SPARSER::GENE)
    ("NKX3.1 and TARP" . SPARSER::COLLECTION) ("TARP" . SPARSER::PROTEIN)
    ("PSMA" . SPARSER::PROTEIN)
    ("retinoic acid receptors (RARs) and retinoid x receptors (RXRs)"
     . SPARSER::COLLECTION)
    ("RXRs" . SPARSER::PROTEIN)
    ("CDCA7L, CDK6, BTG1 and SAMD3" . SPARSER::COLLECTION)
    ("RAR and AR" . SPARSER::COLLECTION)
    ("CDCA7L and CDK6" . SPARSER::COLLECTION)
    ("androgens and RA" . SPARSER::COLLECTION)
    ("AR and RAR" . SPARSER::COLLECTION)
    ("the active ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("RA and androgen" . SPARSER::COLLECTION)
    ("androgen and RA" . SPARSER::COLLECTION) ("vitamin A" . SPARSER::MOLECULE)
    ("ER-A" . SPARSER::PROTEIN) ("RAR-gamma" . SPARSER::PROTEIN)
    ("RAR-alpha" . SPARSER::PROTEIN) ("LT1" . SPARSER::PROTEIN)
    ("RAR-B" . SPARSER::PROTEIN) ("TMPRSS2" . SPARSER::PROTEIN)
    ("penicillin G" . SPARSER::MOLECULE) ("l -Glutamine" . SPARSER::MOLECULE)
    ("NKX3.1" . SPARSER::PROTEIN) ("FOLH1" . SPARSER::PROTEIN)
    ("KLK3" . SPARSER::PROTEIN) ("SAMD3" . SPARSER::PROTEIN)
    ("BTG1" . SPARSER::PROTEIN) ("CDCA7L" . SPARSER::PROTEIN)
    ("retinoic acid receptor gamma" . SPARSER::PROTEIN)
    ("TGM4" . SPARSER::PROTEIN)
    ("the hub miRNAs and hub genes" . SPARSER::COLLECTION)
    ("regulators and clues" . SPARSER::COLLECTION)
    ("NOTCH1/HES1" . SPARSER::COLLECTION)
    ("BCL2L11, PTEN and CYLD" . SPARSER::COLLECTION)
    ("some potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("NF-κB and JNK" . SPARSER::COLLECTION)
    ("HES1 and MYC" . SPARSER::COLLECTION)
    ("PTEN, HOXA, BCL2L11, CYLD and NOTCH1" . SPARSER::COLLECTION)
    ("BCL2L11 (Bim) and NOTCH1" . SPARSER::COLLECTION)
    ("some well-studied T-ALL candidate genes (e.g. NOTCH1, PTEN, FBXW7 and LMO2) and nuclear TFs (e.g. CREB1, MYC, STAT and NF-κB)"
     . SPARSER::COLLECTION)
    ("NOTCH1, PTEN, FBXW7 and LMO2" . SPARSER::COLLECTION)
    ("CREB1, MYC, STAT and NF-κB" . SPARSER::COLLECTION)
    ("miRNAs, genes and modules" . SPARSER::COLLECTION)
    ("miRNA and gene" . SPARSER::COLLECTION)
    ("NOTCH1, PTEN, BCL2L11, HOXA9 and CYLD" . SPARSER::COLLECTION)
    ("REL" . SPARSER::PROTEIN)
    ("the notorious cancer-related miRNA" . SPARSER::PROTEIN)
    ("HOXA9, CYLD, BCL2L11 and RUNX1" . SPARSER::COLLECTION)
    ("NOTCH1, PTEN and BCL2L11" . SPARSER::COLLECTION)
    ("miRNAs or non-thymus" . SPARSER::COLLECTION)
    ("The two notorious tumor-related miRNA" . SPARSER::PROTEIN)
    ("PTEN, CYLD, BCL2L11, MCL1, RUNX1, CDKN1A and JAK1" . SPARSER::COLLECTION)
    ("the two notorious tumor-related miRNA" . SPARSER::PROTEIN)
    ("intergenic miRNAs" . SPARSER::PROTEIN)
    ("the 36 T-ALL-related mature miRNAs" . SPARSER::PROTEIN)
    ("109 miRNAs expressed in thymus (thymus miRNAs) and 113 miRNAs"
     . SPARSER::COLLECTION)
    ("genes and TFs" . SPARSER::COLLECTION)
    ("PITX3 and miR-133b" . SPARSER::COLLECTION)
    ("dopamine" . SPARSER::PROTEIN) ("The mature miRNA" . SPARSER::PROTEIN)
    ("mature miRNA" . SPARSER::PROTEIN)
    ("Long primary miRNAs" . SPARSER::PROTEIN)
    ("DROSHA and DGCR8" . SPARSER::COLLECTION) ("DROSHA" . SPARSER::PROTEIN)
    ("MicroRNAs" . SPARSER::RNA)
    ("TLX1, TLX3, LMO2, LMO1, TAL1 and HOXA" . SPARSER::COLLECTION)
    ("NOTCH1, PTEN and FBXW7" . SPARSER::COLLECTION)
    ("HOXA" . SPARSER::PROTEIN)
    ("pediatric and adult acute lymphoblastic leukemia (ALL)"
     . SPARSER::PROTEIN)
    ("CYLD and NF-κB" . SPARSER::COLLECTION)
    ("CYLD, HOXA9, BCL2L11 and RUNX1" . SPARSER::COLLECTION)
    ("miRNAs and genes" . SPARSER::COLLECTION)
    ("γ-secretase" . SPARSER::PROTEIN) ("HES1" . SPARSER::PROTEIN)
    ("B-ALL" . SPARSER::PROTEIN) ("STAT5A" . SPARSER::PROTEIN)
    ("CREB1" . SPARSER::PROTEIN) ("miR-92a" . SPARSER::MOLECULE)
    ("NFKB1" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("P65" . SPARSER::PROTEIN) ("s 5 " . SPARSER::MOLECULE)
    ("PITX3" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("DICER1" . SPARSER::PROTEIN) ("RNase III" . SPARSER::PROTEIN)
    ("DGCR8" . SPARSER::PROTEIN) ("ABL1" . SPARSER::PROTEIN)
    ("NUP214" . SPARSER::PROTEIN) ("NOTCH1" . SPARSER::PROTEIN)
    ("TAL1" . SPARSER::PROTEIN) ("LMO2" . SPARSER::PROTEIN)
    ("TLX3" . SPARSER::PROTEIN) ("TLX1" . SPARSER::PROTEIN)
    ("HOXA9" . SPARSER::PROTEIN)
    ("Supplementary Figures 1–4 and Supplementary Dataset"
     . SPARSER::COLLECTION)
    ("the HsRad51/dsDNA complex forms stiff and stable filaments"
     . SPARSER::PROTEIN-FAMILY)
    ("ubiquitous modulators" . SPARSER::PROTEIN)
    ("the homologous MvRadA protein" . SPARSER::PROTEIN)
    ("the smaller Mg 2+ ion" . SPARSER::MOLECULE)
    ("more massive cation" . SPARSER::MOLECULE)
    ("a smaller ion" . SPARSER::MOLECULE)
    ("a divalent cation" . SPARSER::MOLECULE)
    ("the two divalent ions" . SPARSER::MOLECULE)
    ("the divalent ions" . SPARSER::MOLECULE)
    ("divalent cations" . SPARSER::MOLECULE)
    ("recombinases" . SPARSER::PROTEIN)
    ("ADP in the presence of Ca 2+ or Mg 2+" . SPARSER::COLLECTION)
    ("homologous proteins" . SPARSER::PROTEIN) ("PDB" . SPARSER::MOLECULE)
    ("the weak ATPase activity" . SPARSER::PROTEIN)
    ("the HsRad51/poly(dT) complex and the HsRad51/poly(dεA) complex"
     . SPARSER::COLLECTION)
    ("HsRad51 and ATP" . SPARSER::COLLECTION)
    ("well-oriented ATP" . SPARSER::ATP) ("chromophore" . SPARSER::MOLECULE)
    ("ethenoadenine" . SPARSER::MOLECULE) ("ATP or DNA" . SPARSER::COLLECTION)
    ("DNA, ATP, and tyrosine and phenylalanine" . SPARSER::COLLECTION)
    ("tyrosine and phenylalanine" . SPARSER::COLLECTION)
    ("divalent cation" . SPARSER::MOLECULE)
    ("ATP in the presence of Mg 2+ or Ca 2+" . SPARSER::COLLECTION)
    ("both ATP and divalent ions" . SPARSER::COLLECTION)
    ("divalent ions" . SPARSER::MOLECULE)
    ("discontinuous short filaments" . SPARSER::PROTEIN-FAMILY)
    ("/ATPγS" . SPARSER::COLLECTION) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a larger ion" . SPARSER::MOLECULE)
    ("an α-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("the divalent cations" . SPARSER::MOLECULE)
    ("cations" . SPARSER::MOLECULE) ("ATP and Ca 2+" . SPARSER::COLLECTION)
    ("chromophores" . SPARSER::MOLECULE)
    ("filamentous molecules or complexes" . SPARSER::COLLECTION)
    ("molecules or complexes" . SPARSER::COLLECTION)
    ("cofactors" . SPARSER::PROTEIN) ("homologous DNA" . SPARSER::DNA)
    ("first cooperatively assembling around single-stranded DNA"
     . SPARSER::DNA)
    ("homologous paternal and maternal DNA" . SPARSER::DNA)
    ("the larger Ca 2+" . SPARSER::CALCIUM-ION)
    ("the divalent cation" . SPARSER::MOLECULE)
    ("nucleobases" . SPARSER::NUCLEOBASE) ("ATP-dependent" . SPARSER::PROTEIN)
    ("exonuclease activity" . SPARSER::PROTEIN) ("ATPγS" . SPARSER::PROTEIN)
    ("TIP3" . SPARSER::PROTEIN) ("PDB2" . SPARSER::PROTEIN)
    ("DOCK6" . SPARSER::PROTEIN) ("f10" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("cm −1" . SPARSER::PROTEIN)
    ("M −1 " . SPARSER::PROTEIN) ("HsRad51" . SPARSER::PROTEIN)
    ("RAD51" . SPARSER::PROTEIN) ("EBP–Brm" . SPARSER::PROTEIN-PAIR)
    ("EBP–cdk2" . SPARSER::PROTEIN-PAIR)
    ("CCND3–cdk4/cdk6" . SPARSER::COLLECTION)
    ("CDK/pRb/E2F" . SPARSER::COLLECTION) ("E1 or E2" . SPARSER::COLLECTION)
    ("CDK4/CDK6" . SPARSER::COLLECTION)
    ("CCND3, CCNE1 and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("RhoC and ROCK2" . SPARSER::COLLECTION) ("RhoC" . SPARSER::PROTEIN)
    ("triphosphatase" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase and Wnt" . SPARSER::COLLECTION)
    ("transforming growth factor-beta and ErbB" . SPARSER::COLLECTION)
    ("HBsAg" . SPARSER::DRUG)
    ("miR-16 ( xref ) and miR-29 ( xref , xref )" . SPARSER::COLLECTION)
    ("many new differentially" . SPARSER::PROTEIN)
    ("tumor-associated proteins GRB2" . SPARSER::PROTEIN)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SNF" . SPARSER::PROTEIN-FAMILY)
    ("SWI" . SPARSER::PROTEIN) ("Brm" . SPARSER::PROTEIN)
    ("the miRNAs and their targets" . SPARSER::COLLECTION)
    ("CCND3 siRNA or control siRNA" . SPARSER::COLLECTION)
    ("CCND3 mRNA and human CCND3" . SPARSER::COLLECTION)
    ("the NC group and the control group ( xref )" . SPARSER::COLLECTION)
    ("miR-138 inhibitor or NC" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase, transforming growth factor-beta and Wnt"
     . SPARSER::COLLECTION)
    ("the representative target genes" . SPARSER::GENE)
    ("GO and KEGG" . SPARSER::COLLECTION)
    ("11 upregulated miRNAs and 12 downregulated miRNAs" . SPARSER::COLLECTION)
    ("oncogenes or tumor suppressor genes" . SPARSER::COLLECTION)
    ("genes and proteins" . SPARSER::COLLECTION)
    ("a potential direct target" . SPARSER::TARGET-PROTEIN)
    ("cdk2" . SPARSER::PROTEIN) ("cdk6" . SPARSER::PROTEIN)
    ("cdk4" . SPARSER::PROTEIN) ("GNAI2" . SPARSER::PROTEIN)
    ("polypeptide 2" . SPARSER::PROTEIN) ("FOSL1" . SPARSER::PROTEIN)
    ("HIF-1a" . SPARSER::PROTEIN)
    ("nerve growth factor receptor" . SPARSER::PROTEIN)
    ("miR-221" . SPARSER::PROTEIN) ("miR-29" . SPARSER::PROTEIN)
    ("miR-21" . SPARSER::PROTEIN) ("GRB2" . SPARSER::PROTEIN)
    ("DDR1" . SPARSER::PROTEIN) ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("messenger RNAs" . SPARSER::RNA) ("CCND3" . SPARSER::PROTEIN)
    ("miR-199a-5p" . SPARSER::MOLECULE) ("HER2/neu/Ki67" . SPARSER::COLLECTION)
    ("highly treatable form" . SPARSER::FORM) ("psoriasin" . SPARSER::PROTEIN)
    ("MIB1" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("p63 as well as the related p73" . SPARSER::COLLECTION)
    ("RARs" . SPARSER::PROTEIN) ("RARα and RARγ" . SPARSER::COLLECTION)
    ("At least one previously unappreciated group" . SPARSER::MOLECULE)
    ("RARα, RARγ and RXR" . SPARSER::COLLECTION) ("RXR" . SPARSER::PROTEIN)
    ("-FGF-R" . SPARSER::COLLECTION)
    ("a master ectodermal regulator" . SPARSER::REGULATOR)
    ("previously identified motifs -NFkB" . SPARSER::COLLECTION)
    ("E2F-" . SPARSER::PROTEIN-FAMILY) ("-NFkB" . SPARSER::COLLECTION)
    ("KLF4, KLF5 and KLF6" . SPARSER::COLLECTION)
    ("Sp1 and KLFs" . SPARSER::COLLECTION)
    ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-Y, E2F and NFkB" . SPARSER::COLLECTION) ("NFkB" . SPARSER::PROTEIN)
    ("p63 and wt" . SPARSER::COLLECTION) ("p63 and p73" . SPARSER::COLLECTION)
    ("p63/p53" . SPARSER::COLLECTION)
    ("a bona fide transcription factor" . SPARSER::PROTEIN)
    ("inactive complexes" . SPARSER::BIO-COMPLEX)
    ("a fully functional ΔNp63α" . SPARSER::PROTEIN)
    ("DNA and RNA" . SPARSER::COLLECTION)
    ("essentially all genes" . SPARSER::GENE)
    ("p57/Kip2" . SPARSER::COLLECTION) ("Chek1" . SPARSER::PROTEIN)
    ("CyclinA" . SPARSER::PROTEIN) ("Topo" . SPARSER::PROTEIN)
    ("previously characterized targets" . SPARSER::TARGET-PROTEIN)
    ("Wnt7a, Wnt9a, Wnt10a- and Retinoic Acids" . SPARSER::COLLECTION)
    ("Receptors, RARα, RARγ and RXRα" . SPARSER::COLLECTION)
    ("Wnt10a-" . SPARSER::PROTEIN) ("Wnt9a" . SPARSER::PROTEIN)
    ("Wnt7a" . SPARSER::PROTEIN) ("-Wnt4" . SPARSER::COLLECTION)
    ("Tyrosine Kinase and GTPase" . SPARSER::COLLECTION)
    ("the larger p63 + cohort" . SPARSER::MOLECULE) ("PHK" . SPARSER::PROTEIN)
    ("p53/p63" . SPARSER::COLLECTION) ("MAX-" . SPARSER::PROTEIN)
    ("MYC-MAX" . SPARSER::COLLECTION) ("ESR" . SPARSER::PROTEIN)
    ("Mycn" . SPARSER::PROTEIN)
    ("KLF4, Notch1, TP63, DLX3/4 and JAG2" . SPARSER::COLLECTION)
    ("the shorter p53 isoforms" . SPARSER::ISOFORM)
    ("Notorious p63" . SPARSER::PROTEIN)
    ("p63 and mutp53" . SPARSER::COLLECTION)
    ("indeed GOF alleles" . SPARSER::ALLELE) ("RM" . SPARSER::MOLECULE)
    ("all possible isoforms" . SPARSER::ISOFORM)
    ("Fos/Jun" . SPARSER::COLLECTION) ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-Y, E2F1, NF-KB and VDR" . SPARSER::COLLECTION)
    ("VDR" . SPARSER::PROTEIN) ("p63/p73" . SPARSER::COLLECTION)
    ("p53/p63/p73" . SPARSER::COLLECTION)
    ("a model whereby mutp53 GOF mutants" . SPARSER::MUTANT)
    ("p63 and mutp53/p63" . SPARSER::COLLECTION) ("GOF" . SPARSER::PROTEIN)
    ("p53 and p63" . SPARSER::COLLECTION) ("C40" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("EGF-R" . SPARSER::PROTEIN)
    ("FGF-R" . SPARSER::PROTEIN) ("KLF6" . SPARSER::PROTEIN)
    ("KLF5" . SPARSER::PROTEIN) ("ΔNp63α" . SPARSER::PROTEIN)
    ("Kip2" . SPARSER::PROTEIN) ("CDC2" . SPARSER::PROTEIN)
    ("CyclinB1" . SPARSER::PROTEIN) ("RXRα" . SPARSER::PROTEIN)
    ("RARγ" . SPARSER::PROTEIN) ("Retinoic Acids" . SPARSER::MOLECULE)
    ("Wnt10a" . SPARSER::PROTEIN) ("Wnt7" . SPARSER::PROTEIN)
    ("Wnt4" . SPARSER::PROTEIN) ("Tyrosine Kinase" . SPARSER::PROTEIN)
    ("NHLH1" . SPARSER::PROTEIN) ("JAG2" . SPARSER::PROTEIN)
    ("DLX3" . SPARSER::PROTEIN) ("TP63" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("KLF4" . SPARSER::PROTEIN)
    ("Caspase 8" . SPARSER::PROTEIN) ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("NF-KB" . SPARSER::PROTEIN) ("ATM and p53" . SPARSER::COLLECTION)
    ("molecule and DNA" . SPARSER::COLLECTION)
    ("ATM, Mdm2 and p53" . SPARSER::COLLECTION)
    ("the SQ/TQ phosphospecific antibodies" . SPARSER::ANTIBODY)
    ("TQ" . SPARSER::DRUG) ("SQ" . SPARSER::MOLECULE)
    ("CK2 and PPM1G" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION) ("form " . SPARSER::FORM)
    ("a commercially available antibody" . SPARSER::PROTEIN)
    ("Regulator" . SPARSER::REGULATOR) ("Isoform" . SPARSER::ISOFORM)
    ("Mdm2 and USP7S" . SPARSER::COLLECTION)
    ("p53, Mdm2 and USP7S" . SPARSER::COLLECTION)
    ("Proteasomal" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("CK2α or CK2α" . SPARSER::COLLECTION)
    ("hydroxyapatite" . SPARSER::MOLECULE)
    ("kinase and phosphatase" . SPARSER::COLLECTION)
    ("Mdm2 and USP7" . SPARSER::COLLECTION)
    ("other chemically active cellular metabolites" . SPARSER::PROTEIN)
    ("mutagens" . SPARSER::MOLECULE) ("USP7/HAUSP" . SPARSER::COLLECTION)
    ("HAUSP" . SPARSER::PROTEIN) ("PPM1D" . SPARSER::PROTEIN)
    ("APE1" . SPARSER::PROTEIN) ("D–6" . SPARSER::PROTEIN)
    ("p53BP1" . SPARSER::PROTEIN) ("Wip1" . SPARSER::PROTEIN)
    ("PP2Cγ" . SPARSER::PROTEIN) ("A–S2" . SPARSER::PROTEIN)
    ("messenger RNA" . SPARSER::RNA) ("S18" . SPARSER::PROTEIN)
    ("CK2α" . SPARSER::PROTEIN) ("PPM1G" . SPARSER::PROTEIN)
    ("Mdm2 " . SPARSER::PROTEIN)
    ("tethering two potential inhibitors" . SPARSER::INHIBITOR)
    ("conformationally-distinct complexes" . SPARSER::BIO-COMPLEX)
    ("our biophysical analysis sheds new light" . SPARSER::PROTEIN)
    ("GTPase and Akt" . SPARSER::COLLECTION) ("linkers" . SPARSER::LINKER)
    ("its three constituent components" . SPARSER::COMPONENT)
    ("Sos1 and Grb2" . SPARSER::COLLECTION) ("MonA" . SPARSER::PROTEIN)
    ("their constituent components" . SPARSER::COMPONENT)
    ("monomers or homodimer" . SPARSER::COLLECTION) ("indole" . SPARSER::DRUG)
    ("guanidine" . SPARSER::MOLECULE)
    ("a left-handed PPII-helical conformation" . SPARSER::BIO-CONFORMATION)
    ("both the monomers ( xref ) and homodimer ( xref )" . SPARSER::COLLECTION)
    ("-PR" . SPARSER::COLLECTION) ("Grb2-PR-Grb2" . SPARSER::COLLECTION)
    ("both enthalpic and entropic components" . SPARSER::COMPONENT)
    ("entropic (TΔΔS c ) components" . SPARSER::COMPONENT)
    ("further shed light" . SPARSER::PROTEIN)
    ("a separate molecule" . SPARSER::MOLECULE) ("ion" . SPARSER::MOLECULE)
    ("polyproline type II (PPII) helical conformations"
     . SPARSER::BIO-CONFORMATION)
    ("well-folded αβ proteins" . SPARSER::PROTEIN)
    ("other structurally-disordered proteins" . SPARSER::PROTEIN)
    ("structurally-disordered proteins" . SPARSER::PROTEIN)
    ("a rigid conformation" . SPARSER::BIO-CONFORMATION)
    ("globular proteins" . SPARSER::PROTEIN)
    ("monomeric and dimeric Grb2" . SPARSER::PROTEIN)
    ("monomer and dimer" . SPARSER::COLLECTION)
    ("both the monomeric and dimeric forms of Grb2 as well as the PR monomers display M w /M n ratio"
     . SPARSER::COLLECTION)
    ("both the monomeric and dimeric forms" . SPARSER::FORM)
    ("ALS" . SPARSER::PROTEIN)
    ("a monomeric conformation" . SPARSER::BIO-CONFORMATION)
    ("a simple binary complex" . SPARSER::BIO-COMPLEX)
    ("a relatively open left-handed polyproline type II (PPII) helical conformation"
     . SPARSER::BIO-CONFORMATION)
    ("type II (PPII)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PPII" . SPARSER::PROTEIN) ("polyproline" . SPARSER::PROTEIN)
    ("valine, leucine or isoleucine" . SPARSER::COLLECTION)
    ("isoleucine" . SPARSER::AMINO-ACID) ("valine" . SPARSER::AMINO-ACID)
    ("the Sos1-Grb2-Gab1 ternary signaling complex" . SPARSER::BIO-COMPLEX)
    ("Sos1-Grb2-Gab1" . SPARSER::COLLECTION)
    ("the Shp2 tyrosine phosphatase and the PI3K kinase" . SPARSER::COLLECTION)
    ("GDP-GTP" . SPARSER::PROTEIN-PAIR)
    ("EGF and PDGF receptors ( xref – xref )" . SPARSER::COLLECTION)
    ("cSH3" . SPARSER::PROTEIN)
    ("effectors and regulators" . SPARSER::COLLECTION)
    ("Ras and Akt" . SPARSER::COLLECTION)
    ("a key macromolecular signaling complex" . SPARSER::BIO-COMPLEX)
    ("our study sheds new light" . SPARSER::PROTEIN) ("hop" . SPARSER::PROTEIN)
    ("Grb2-Sos1" . SPARSER::COLLECTION) ("Sos1" . SPARSER::PROTEIN)
    ("PXR" . SPARSER::PROTEIN) ("_WT" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("Shp2" . SPARSER::PROTEIN)
    ("Gab1" . SPARSER::PROTEIN)
    ("the proximal and distal promoters" . SPARSER::PROMOTER)
    ("SRC1 and SRC3" . SPARSER::COLLECTION)
    ("chromatin looping and interaction with the proximal ERE"
     . SPARSER::COLLECTION)
    ("The two distal EREs" . SPARSER::PROTEIN)
    ("GREB1 (located on chromosome 2) and pS2 (TFF1, located on chromosome 21)"
     . SPARSER::COLLECTION)
    ("distal and proximal GREB1 promoter EREs" . SPARSER::PROTEIN)
    ("estradiol and ICI 182,780" . SPARSER::COLLECTION)
    ("estradiol and an ERα antagonist" . SPARSER::COLLECTION)
    ("LRH-1 and GREB-1" . SPARSER::COLLECTION)
    ("LRH-1 and GREB1" . SPARSER::COLLECTION)
    ("LRH-1 and estradiol" . SPARSER::COLLECTION)
    ("LRH-1, ERα and GREB1" . SPARSER::COLLECTION)
    ("a consensus palindromic ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ERα or LRH-1" . SPARSER::COLLECTION) ("GREB-ERE2" . SPARSER::COLLECTION)
    ("ERE2 and ERE3" . SPARSER::COLLECTION)
    ("LRHRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (LRHRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("GREB1 and pS2" . SPARSER::COLLECTION)
    ("the proximal ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("LRH-1 and the EREs" . SPARSER::COLLECTION)
    ("LRH-1/ERα" . SPARSER::COLLECTION) ("ERα and LRH-1" . SPARSER::COLLECTION)
    ("pyrimidine and R" . SPARSER::COLLECTION) ("purine" . SPARSER::DRUG)
    ("TFF2 or pS2" . SPARSER::COLLECTION)
    ("the most significantly altered genes, caused by modulation of LRH-1 expression"
     . SPARSER::GENE)
    ("dehydrogenase and the Steroidogenic Acute Regulatory protein"
     . SPARSER::COLLECTION)
    ("mitogenic estrogen" . SPARSER::MOLECULE) ("CAFs" . SPARSER::PROTEIN)
    ("NR" . SPARSER::PROTEIN) ("GREB-1" . SPARSER::COLLECTION)
    ("GREB1 and Trefoil Factor 1" . SPARSER::COLLECTION)
    ("LRH-1 and ERα" . SPARSER::COLLECTION)
    ("response elements (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("17 β-estradiol" . SPARSER::PROTEIN) ("βestradiol" . SPARSER::MOLECULE)
    ("SRC3" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("polymerase II" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN) ("FoxA1" . SPARSER::PROTEIN)
    ("ERE2" . SPARSER::PROTEIN) ("LRH- 1" . SPARSER::PROTEIN)
    ("TFF2" . SPARSER::PROTEIN)
    ("Steroidogenic Acute Regulatory protein" . SPARSER::PROTEIN)
    ("P450" . SPARSER::PROTEIN-FAMILY) ("CYP19A1" . SPARSER::PROTEIN)
    ("Aromatase activity" . SPARSER::PROTEIN)
    ("Liver Receptor Homolog-1" . SPARSER::PROTEIN) ("pS2" . SPARSER::PROTEIN)
    ("TFF1" . SPARSER::PROTEIN) ("Trefoil Factor 1" . SPARSER::PROTEIN)
    ("GREB1" . SPARSER::PROTEIN)
    ("Growth Regulation by Estrogen in Breast Cancer 1" . SPARSER::PROTEIN)
    ("aromatase activity" . SPARSER::PROTEIN) ("NR5A2" . SPARSER::PROTEIN)
    ("LRH-1" . SPARSER::PROTEIN) ("Receptor Homolog" . SPARSER::PROTEIN)
    ("TSG-6 or antibodies/antagonists" . SPARSER::COLLECTION)
    ("ischemia" . SPARSER::PROTEIN) ("Rao" . SPARSER::PROTEIN)
    ("retina" . SPARSER::DRUG) ("Cao" . SPARSER::MOLECULE)
    ("IL-1α and IL-1β" . SPARSER::COLLECTION)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("Neuropeptides" . SPARSER::PROTEIN)
    ("corneal opacity" . SPARSER::PROTEIN-FAMILY)
    ("HSPB5 and βB-crystallin" . SPARSER::COLLECTION)
    ("HEK-TLR2" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("macrophage-activating factor" . SPARSER::COLLECTION)
    ("the pro-inflammatory cytokines IL-1α, IL-1β and IL-6"
     . SPARSER::COLLECTION)
    ("IL-1α, IL-1β and IL-6" . SPARSER::COLLECTION)
    ("CD68 and CD11b" . SPARSER::COLLECTION) ("Macrophage" . SPARSER::PROTEIN)
    ("clodronate" . SPARSER::DRUG)
    ("the corneal opacity and neutrophil" . SPARSER::COLLECTION)
    ("opacity and neutrophil" . SPARSER::COLLECTION)
    ("Diltiazem" . SPARSER::DRUG) ("aconitase" . SPARSER::PROTEIN)
    ("HSPB5 or a third Group A gene" . SPARSER::COLLECTION)
    ("crystallin" . SPARSER::PROTEIN)
    ("substance P and calcitonin gene-related peptide" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN) ("CGRP" . SPARSER::PROTEIN)
    ("proteins, HSPB4 and HSPB5" . SPARSER::COLLECTION)
    ("pro-inflammatory chemokines and cytokines" . SPARSER::COLLECTION)
    ("chemokines and cytokines" . SPARSER::COLLECTION)
    ("nerve/neurotransmission-related proteins and structural proteins"
     . SPARSER::COLLECTION)
    ("Group B and 307 genes" . SPARSER::COLLECTION)
    ("myeloperoxidase (MPO)" . SPARSER::PROTEIN) ("MPO" . SPARSER::PROTEIN)
    ("myeloperoxidase" . SPARSER::PROTEIN)
    ("secretoneurin (SN)" . SPARSER::PROTEIN) ("DAMPs" . SPARSER::DAMP)
    ("opacity" . SPARSER::PROTEIN-FAMILY)
    ("activated resident macrophages" . SPARSER::PROTEIN)
    ("TLR2/NF-κB" . SPARSER::COLLECTION)
    ("resident macrophages" . SPARSER::PROTEIN)
    ("secretoneurin" . SPARSER::PROTEIN) ("neuropeptide" . SPARSER::PROTEIN)
    ("sterile" . SPARSER::PROTEIN-FAMILY)
    ("serious chemical" . SPARSER::MOLECULE)
    ("Sterile" . SPARSER::PROTEIN-FAMILY)
    ("neutrophil elastase" . SPARSER::PROTEIN) ("MCP-1" . SPARSER::PROTEIN)
    ("CINC-1" . SPARSER::PROTEIN) ("CXCL1" . SPARSER::PROTEIN)
    ("bis – tris" . SPARSER::MOLECULE) ("g protein" . SPARSER::PROTEIN)
    ("Not1" . SPARSER::PROTEIN) ("Hspb4" . SPARSER::PROTEIN)
    ("HSP60" . SPARSER::PROTEIN) ("activating factor" . SPARSER::PROTEIN)
    ("IL-1α" . SPARSER::PROTEIN) ("CD68" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN)
    ("calcitonin gene-related peptide" . SPARSER::PROTEIN)
    ("substance P" . SPARSER::PROTEIN) ("HSPB5" . SPARSER::PROTEIN)
    ("Group C" . SPARSER::PROTEIN) ("Group B" . SPARSER::PROTEIN)
    ("Group A" . SPARSER::PROTEIN) ("TSG-6" . SPARSER::PROTEIN)
    ("its potential cytotoxic" . SPARSER::PROTEIN)
    ("a taxane-treated cohort" . SPARSER::MOLECULE)
    ("stabilizer" . SPARSER::MOLECULE)
    ("both microtubule stabilizers and destabilizers" . SPARSER::COLLECTION)
    ("Map-tau" . SPARSER::COLLECTION) ("Map" . SPARSER::PROTEIN)
    ("MAP-tau/stathmin" . SPARSER::COLLECTION)
    ("tau/stathmin" . SPARSER::COLLECTION) ("MAP-" . SPARSER::PROTEIN)
    ("PR or HER2" . SPARSER::COLLECTION)
    ("All subsequent AQUA" . SPARSER::MOLECULE)
    ("Normal tissue TMA and an Index TMA" . SPARSER::COLLECTION)
    ("Antibody" . SPARSER::PROTEIN) ("stabilizers" . SPARSER::MOLECULE)
    ("taxane" . SPARSER::DRUG)
    ("a ubiquitous cytosolic phosphoprotein and key regulator"
     . SPARSER::COLLECTION)
    ("a ubiquitous cytosolic phosphoprotein" . SPARSER::PROTEIN)
    ("prosolin" . SPARSER::PROTEIN) ("metablastin" . SPARSER::PROTEIN)
    ("taxanes" . SPARSER::DRUG) ("ER, PR, and HER2" . SPARSER::COLLECTION)
    ("Stathmin" . SPARSER::PROTEIN) ("MAP-tau" . SPARSER::COLLECTION)
    ("MAP" . SPARSER::PROTEIN) ("stathmin" . SPARSER::PROTEIN)
    ("MAPs" . SPARSER::PROTEIN) ("TLE3" . SPARSER::PROTEIN)
    ("op18" . SPARSER::PROTEIN) ("p19" . SPARSER::PROTEIN)
    ("OP18" . SPARSER::PROTEIN) ("stathmin1" . SPARSER::PROTEIN)
    ("K-Ras or MEK" . SPARSER::COLLECTION)
    ("IGF-1R and EGFR" . SPARSER::COLLECTION)
    ("TS and EGFR" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION)
    ("IGF-2 and IGF-1R" . SPARSER::COLLECTION)
    ("the anti-IGF-1R" . SPARSER::ANTIBODY)
    ("small-molecule IGF-1R TKIs and anti-IGF-1R monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("TKIs and anti-IGF-1R" . SPARSER::COLLECTION)
    ("TS and mut" . SPARSER::COLLECTION)
    ("EGFR, and mut" . SPARSER::COLLECTION)
    ("OSI-906 and U0126" . SPARSER::COLLECTION)
    ("representative mut K-Ras" . SPARSER::PROTEIN)
    ("the dominant-negative form" . SPARSER::FORM)
    ("MEK/Erk" . SPARSER::COLLECTION) ("pS6, and pGSK" . SPARSER::COLLECTION)
    ("Ras/MAPK" . SPARSER::COLLECTION) ("GFP or mut" . SPARSER::COLLECTION)
    ("IGF-1R/Akt" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("IGF-1R and Akt" . SPARSER::COLLECTION)
    ("K-Ras mutant and wild type cells" . SPARSER::COLLECTION)
    ("IGF-1R, IR, or pIGF-1R/IR" . SPARSER::COLLECTION)
    ("predictive biomarkers" . SPARSER::MOLECULE)
    ("K-Ras and p53" . SPARSER::COLLECTION)
    ("EGFR and IGF-1R" . SPARSER::COLLECTION)
    ("IGF-1R/IR" . SPARSER::COLLECTION)
    ("potential biomarkers" . SPARSER::MOLECULE)
    ("PQIP and OSI-906" . SPARSER::COLLECTION) ("-1-" . SPARSER::PROTEIN)
    ("-cyclobutyl" . SPARSER::MOLECULE) ("-3-" . SPARSER::PROTEIN)
    ("cyclobutyl" . SPARSER::MOLECULE)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION) ("TS" . SPARSER::PROTEIN)
    ("EGFR and K-Ras" . SPARSER::COLLECTION) ("IGF-TKIs" . SPARSER::COLLECTION)
    ("EGFR and wt" . SPARSER::COLLECTION) ("mut" . SPARSER::PROTEIN)
    ("K-Ras or MAPK/extracellular signal-regulated kinase kinase (MEK)"
     . SPARSER::COLLECTION)
    ("a small-molecular inhibitor" . SPARSER::INHIBITOR)
    ("PQIP or OSI-906" . SPARSER::COLLECTION)
    ("PD98059 or U0126" . SPARSER::COLLECTION)
    ("EGFR or K-Ras" . SPARSER::COLLECTION)
    ("MAPK/extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("PQIP" . SPARSER::MOLECULE)
    ("IGF-1R/insulin receptor" . SPARSER::COLLECTION)
    ("pIGF" . SPARSER::PROTEIN) ("IGF-2" . SPARSER::PROTEIN)
    ("B-K" . SPARSER::PROTEIN) ("Erk1/2" . SPARSER::PROTEIN)
    ("pErk1/2" . SPARSER::PROTEIN) ("OSI-906" . SPARSER::DRUG)
    ("insulin-like growth factor 1 receptor" . SPARSER::PROTEIN)
    ("medicine" . SPARSER::DRUG) ("MSI, and CIMP" . SPARSER::COLLECTION)
    ("this potentially aggressive type" . TYPE)
    ("a prognostic biomarker" . SPARSER::MOLECULE)
    ("PIK3CA, BRAF or KRAS" . SPARSER::COLLECTION)
    ("MSI and CIMP" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA and KRAS" . SPARSER::COLLECTION)
    ("NHS and HPFS" . SPARSER::COLLECTION) ("NHS" . SPARSER::PROTEIN)
    ("PIK3CA and BRAF" . SPARSER::COLLECTION)
    ("BRAF and PIK3CA" . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("BRAF and KRAS" . SPARSER::COLLECTION) ("RUNX3" . SPARSER::PROTEIN)
    ("NEUROG1" . SPARSER::PROTEIN) ("IGF2" . SPARSER::PROTEIN)
    ("CRABP1" . SPARSER::PROTEIN) ("CACNA1G" . SPARSER::PROTEIN)
    ("D5S346" . SPARSER::PROTEIN)
    ("catalytic subunit of PI3K" . SPARSER::PROTEIN)
    ("dNTP" . SPARSER::MOLECULE) ("exonucleases" . SPARSER::PROTEIN)
    ("ATR-Chk1" . SPARSER::COLLECTION) ("NER" . SPARSER::PROTEIN)
    ("IR or HU" . SPARSER::COLLECTION) ("RSK–Chk1" . SPARSER::COLLECTION)
    ("exogenous Chk1" . SPARSER::PROTEIN)
    ("other basophilic kinases" . SPARSER::KINASE)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("–Chk1" . SPARSER::COLLECTION) ("BI-D1870 or DMSO" . SPARSER::COLLECTION)
    ("IR or hydroxyurea" . SPARSER::COLLECTION) ("hydroxyurea" . SPARSER::DRUG)
    ("UV light" . SPARSER::PROTEIN)
    ("Supplemental Figure S2" . SPARSER::MOLECULE)
    ("Myc-Chk1" . SPARSER::COLLECTION)
    ("p90 RSK1 and Akt1" . SPARSER::COLLECTION)
    ("active (CA)" . SPARSER::ACTIVE) ("RSK2 or Akt1" . SPARSER::COLLECTION)
    ("U0126 or BI-D1870" . SPARSER::COLLECTION)
    ("LY294002 or MK-2206" . SPARSER::COLLECTION)
    ("PI3-KxAkt/PKB" . SPARSER::COLLECTION) ("Bad" . SPARSER::PROTEIN)
    ("a phosphomimic mutant (SE)" . SPARSER::MUTANT)
    ("exogenous Chk1 mutant" . SPARSER::MUTANT)
    ("Ala (SA) or Glu (SE)" . SPARSER::COLLECTION)
    ("p-Chk1" . SPARSER::COLLECTION) ("polyacrylamide" . SPARSER::DRUG)
    ("-Phos-tag" . SPARSER::DRUG)
    ("Ser-280–phosphorylated Chk1" . SPARSER::PROTEIN)
    ("kinase (ATR)" . SPARSER::KINASE) ("PI3-K–Akt" . SPARSER::COLLECTION)
    ("PI3-K–Akt/PKB" . SPARSER::COLLECTION) ("PKB" . SPARSER::PROTEIN)
    ("The 90-kDa ribosomal S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("Ras-MAPK" . SPARSER::COLLECTION)
    ("1/2–extracellular signal-regulated kinase" . SPARSER::PROTEIN-PAIR)
    ("Raf–MAPK kinase" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated- and rad3-related" . SPARSER::COLLECTION)
    ("/Chk1" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated-" . SPARSER::PROTEIN)
    ("sentinel" . SPARSER::DRUG) ("UV" . SPARSER::PROTEIN)
    ("Cdc25C" . SPARSER::PROTEIN)
    ("Enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("RSK3" . SPARSER::PROTEIN) ("activated protein kinase" . SPARSER::PROTEIN)
    ("anti–ERK" . SPARSER::PROTEIN)
    ("insulin like growth factor-1" . SPARSER::PROTEIN)
    ("p90 RSK1" . SPARSER::PROTEIN) ("RSK2" . SPARSER::PROTEIN)
    ("p90 RSK 1" . SPARSER::PROTEIN) ("MK-2206" . SPARSER::MOLECULE)
    ("BI-D1870" . SPARSER::MOLECULE) ("Phos-tag" . SPARSER::DRUG)
    ("Cdk1" . SPARSER::PROTEIN) ("h-TERT" . SPARSER::PROTEIN)
    ("Akt/protein" . SPARSER::PROTEIN)
    ("MAPK-activated protein kinase-1" . SPARSER::PROTEIN)
    ("Akt/PKB" . SPARSER::PROTEIN) ("P90 RSK" . SPARSER::PROTEIN-FAMILY)
    ("subfamily—Rnd1, Rnd2, and Rnd3—have" . SPARSER::COLLECTION)
    ("lipids or molecules" . SPARSER::COLLECTION)
    ("the monovalent acidic phosphatidylserine or the more negatively charged phosphatidylinositol-4,5-bisphosphate ( xref )"
     . SPARSER::COLLECTION)
    ("the monovalent acidic phosphatidylserine" . SPARSER::PROTEIN)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("H-Ras and N-Ras" . SPARSER::COLLECTION)
    ("Rnd1, Rnd2, and Rnd3" . SPARSER::COLLECTION)
    ("Rnd2, and Rnd3—which" . SPARSER::COLLECTION)
    ("GST-fused" . SPARSER::COLLECTION) ("-lysine" . SPARSER::COLLECTION)
    ("Rnd1, Rnd3, or Rnd1N/2C" . SPARSER::COLLECTION)
    ("GST-pulldown" . SPARSER::COLLECTION)
    ("proteins—Rnd1" . SPARSER::COLLECTION)
    ("Rnd3 or Rnd1N/2C" . SPARSER::COLLECTION)
    ("GFP-p190 RhoGAP" . SPARSER::COLLECTION)
    ("Rnd1 or Rnd1N/2C" . SPARSER::COLLECTION)
    ("Rnd2 or Rnd1ΔN" . SPARSER::COLLECTION)
    ("GTPases, and RhoA" . SPARSER::COLLECTION)
    ("glutathione S -transferase–fused" . SPARSER::COLLECTION)
    ("rhotekin" . SPARSER::PROTEIN) ("Rnd2 and Rnd3" . SPARSER::COLLECTION)
    ("the last 11 C-terminal amino acids of Rnd2" . SPARSER::PROTEIN)
    ("the last 11 C-terminal amino acids of Rnd1 ( xref )" . SPARSER::PROTEIN)
    ("the last 11 C-terminal amino acids" . SPARSER::AMINO-ACID)
    ("Alanine" . SPARSER::AMINO-ACID)
    ("Rnd1, Rnd1N/2C, and Rnd3" . SPARSER::COLLECTION)
    ("the first six N-terminal amino acids of Rnd2" . SPARSER::PROTEIN)
    ("the first 12 N-terminal amino acids of Rnd1 ( xref )" . SPARSER::PROTEIN)
    ("Rnd1 and caveolin-1" . SPARSER::COLLECTION)
    ("GFP-Rnd1" . SPARSER::COLLECTION)
    ("hemagglutinin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GTPases, RhoA, Rac1, and TC10" . SPARSER::COLLECTION)
    ("TC10" . SPARSER::PROTEIN) ("lipid and protein" . SPARSER::COLLECTION)
    ("subdomains" . SPARSER::PROTEIN)
    ("subfamily—Rnd1, Rnd2, and Rnd3—can" . SPARSER::COLLECTION)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rnd1 or Rnd3" . SPARSER::COLLECTION)
    ("Rnd1 and Rnd2" . SPARSER::COLLECTION) ("GDI" . SPARSER::PROTEIN)
    ("guanine nucleotide-exchange factors (GEFs) and GTPase-activating proteins (GAPs)"
     . SPARSER::COLLECTION)
    ("Rnd1 and Rnd3" . SPARSER::COLLECTION) ("Rnd3/RhoE" . SPARSER::COLLECTION)
    ("RhoE" . SPARSER::PROTEIN) ("CO 3" . SPARSER::PROTEIN)
    ("K +" . SPARSER::MOLECULE) ("Na +" . SPARSER::MOLECULE)
    ("phosphatidylinositol-4,5-bisphosphate" . SPARSER::PIP2)
    ("G protein–coupled receptor" . SPARSER::PROTEIN)
    ("GAP 43" . SPARSER::PROTEIN) ("N-Ras" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("β-cyclodextrin" . SPARSER::MOLECULE)
    ("Gα 13" . SPARSER::PROTEIN) ("Rho-GDI" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("Arg-Arg" . SPARSER::MOLECULE) ("Lys-Glu" . SPARSER::MOLECULE)
    ("p190 RhoGAP" . SPARSER::PROTEIN) ("Rnd3" . SPARSER::PROTEIN)
    ("Rnd2" . SPARSER::PROTEIN) ("Rnd1" . SPARSER::PROTEIN)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Abraxas or RAP80 dominant-negative mutant alleles" . SPARSER::ALLELE)
    ("Abraxas or RAP80" . SPARSER::COLLECTION)
    ("BRCA1 and Abraxas" . SPARSER::COLLECTION)
    ("BRCA2 and PALB2 or BRIP1" . SPARSER::COLLECTION)
    ("PALB2 or BRIP1" . SPARSER::COLLECTION)
    ("Abraxas and RAP80" . SPARSER::COLLECTION)
    ("PALB2, BRCA2, and BRIP1" . SPARSER::COLLECTION)
    ("delE" . SPARSER::PROTEIN)
    ("BRIP1 (FANCJ) and RAP80 ( xref , xref , xref )" . SPARSER::COLLECTION)
    ("FANCJ" . SPARSER::PROTEIN) ("BRCA1, and RAP80" . SPARSER::COLLECTION)
    ("BRCA1 and RAP80" . SPARSER::COLLECTION) ("IRIF" . SPARSER::PROTEIN)
    ("foci (IRIF)" . SPARSER::PROTEIN)
    ("BRCA1 and other core components" . SPARSER::COLLECTION)
    ("cancers often display loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("loss of heterozygosity (LOH)" . SPARSER::PROTEIN)
    ("BRCA1-associated proteins" . SPARSER::PROTEIN)
    ("receptor and HER2" . SPARSER::COLLECTION)
    ("both the estrogen receptor (ER) and the progesterone receptor (PR)"
     . SPARSER::COLLECTION)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("the recurrent Finnish PALB2" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2 , TP53 , CDH1 , and PALB2" . SPARSER::COLLECTION)
    ("Abraxas protein and mRNA" . SPARSER::COLLECTION)
    ("six exonic variants" . SPARSER::VARIANT)
    ("Northern Finnish breast cancer families" . SPARSER::PROTEIN-FAMILY)
    ("MERIT40/NBA1" . SPARSER::COLLECTION)
    ("ABRA1, CCDC98, or FAM175A" . SPARSER::COLLECTION)
    ("PALB2 , BRIP1 , ATM , and CHEK2" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("the recurrent Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("common cancer-associated variants" . SPARSER::VARIANT)
    ("125 Northern Finnish breast cancer families" . SPARSER::PROTEIN-FAMILY)
    ("Abraxas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("γ-tubulin" . SPARSER::PROTEIN)
    ("BRCA1-associated protein" . SPARSER::PROTEIN)
    ("Abraxas protein" . SPARSER::PROTEIN) ("BRCC45" . SPARSER::PROTEIN)
    ("BABAM1" . SPARSER::PROTEIN) ("NBA1" . SPARSER::PROTEIN)
    ("MERIT40" . SPARSER::PROTEIN) ("BRCC36" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("core protein" . SPARSER::PROTEIN)
    ("FAM175A" . SPARSER::PROTEIN) ("CCDC98" . SPARSER::PROTEIN)
    ("ABRA1" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("BRIP1" . SPARSER::PROTEIN) ("ATRA-responses" . SPARSER::DRUG)
    ("farnesyl pyrophosphate (FPP) and geranyl-geranyl pyrophosphate (GGPP) ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("PKCδ and potentially other PKC isoforms" . SPARSER::COLLECTION)
    ("potentially other PKC isoforms" . SPARSER::ISOFORM)
    ("retinoid" . SPARSER::PROTEIN) ("RARα and PKCδ" . SPARSER::COLLECTION)
    ("ATRA and arsenic trioxide" . SPARSER::COLLECTION)
    ("PML and RAR" . SPARSER::COLLECTION) ("RAR" . SPARSER::PROTEIN)
    ("RARα-PML" . SPARSER::COLLECTION) ("PML-RARα" . SPARSER::COLLECTION)
    ("PML" . SPARSER::PROTEIN) ("promyelocytic" . SPARSER::PROTEIN)
    ("acute promyelocytic leukemia (APL)" . SPARSER::PROTEIN)
    ("ATRA or atorvastatin" . SPARSER::COLLECTION)
    ("ATRA and atorvastatin" . SPARSER::COLLECTION)
    ("PKCδ or NB4" . SPARSER::COLLECTION) ("/CCL3" . SPARSER::COLLECTION)
    ("farnesyl pyrophosphate (FPP) and geranyl-geranyl pyrophosphate (GGPP) ( xref )"
     . SPARSER::COLLECTION)
    ("pyrophosphate (GGPP)" . SPARSER::MOLECULE)
    ("pyrophosphate (FPP)" . SPARSER::MOLECULE)
    ("FPP or GGPP" . SPARSER::COLLECTION) ("GGPP" . SPARSER::PROTEIN)
    ("FPP" . SPARSER::PROTEIN) ("pyrophosphate" . SPARSER::MOLECULE)
    ("an exogenous substrate" . SPARSER::SUBSTRATE)
    ("retinoids" . SPARSER::DRUG) ("HMGCoA" . SPARSER::DRUG)
    ("ATRA" . SPARSER::DRUG) ("statin" . SPARSER::MOLECULE)
    ("that atorvastatin and fluvastatin" . SPARSER::COLLECTION)
    ("atorvastatin" . SPARSER::DRUG) ("APL" . SPARSER::PROTEIN)
    ("Statins" . SPARSER::MOLECULE) ("MIP-1" . SPARSER::PROTEIN)
    ("arsenic trioxide" . SPARSER::MOLECULE) ("RARα" . SPARSER::PROTEIN)
    ("MIP-1β" . SPARSER::PROTEIN) ("MIP-1α" . SPARSER::PROTEIN)
    ("macrophage inflammatory protein" . SPARSER::PROTEIN)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("CCL3" . SPARSER::PROTEIN) ("NB4" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG) ("HMG-CoA" . SPARSER::DRUG)
    ("GADD34 and/or CReP" . SPARSER::COLLECTION)
    ("SIRT1 or eIF2α" . SPARSER::COLLECTION)
    ("phosphorylated eIF2α and a sustained shutoff" . SPARSER::COLLECTION)
    ("a translational regulator" . SPARSER::REGULATOR)
    ("GADD34 and CReP" . SPARSER::COLLECTION)
    ("SIRT1, SIRT1H363Y, eIF2α or eIF2αS51A" . SPARSER::COLLECTION)
    ("tryptophan" . SPARSER::AMINO-ACID) ("histidine" . SPARSER::AMINO-ACID)
    ("phosphorylation-mimetic (eIF2αS51D) eIF2α" . SPARSER::PROTEIN)
    ("deacetylase activity or eIF2α" . SPARSER::COLLECTION)
    ("TG" . SPARSER::PROTEIN) ("CHOP/GADD153" . SPARSER::COLLECTION)
    ("SIRT1 null MEFs" . SPARSER::PROTEIN) ("-leucine" . SPARSER::COLLECTION)
    ("tunicamycin" . SPARSER::MOLECULE)
    ("SIRT1 and myc-tagged" . SPARSER::COLLECTION)
    ("anti-SIRT1 or anti-eIF2α" . SPARSER::COLLECTION)
    ("SIRT1 and eIF2α" . SPARSER::COLLECTION) ("Gal4" . SPARSER::PROTEIN)
    ("Gal" . SPARSER::PROTEIN) ("eIF2α, CreP and GADD34" . SPARSER::COLLECTION)
    ("ATF4/CHOP" . SPARSER::COLLECTION) ("ATF4 and CHOP" . SPARSER::COLLECTION)
    ("inactive eIF2α-GDP-eIF2B complex" . SPARSER::BIO-COMPLEX)
    ("tRNA" . SPARSER::PROTEIN) ("HRI" . SPARSER::PROTEIN)
    ("PERK" . SPARSER::PROTEIN)
    ("p73 and the forkhead transcription factors (FOXOs) xref  xref  xref  xref  xref SIRT1"
     . SPARSER::COLLECTION)
    ("NF-κB, Ku70, p53, E2F1, p73 and the forkhead transcription factors (FOXOs) xref  xref  xref  xref  xref SIRT1"
     . SPARSER::COLLECTION)
    ("GADD34 and CreP" . SPARSER::COLLECTION)
    ("CHOP and GADD34" . SPARSER::COLLECTION) ("eIF2" . SPARSER::PROTEIN)
    ("p53 and FOXO" . SPARSER::COLLECTION) ("S-protein" . SPARSER::PROTEIN)
    ("P-40" . SPARSER::PROTEIN) ("GADD153" . SPARSER::PROTEIN)
    ("α at" . SPARSER::PROTEIN) ("myc-tagged" . SPARSER::PROTEIN)
    ("AH109" . SPARSER::DRUG) ("ATF4" . SPARSER::PROTEIN)
    ("GCN2" . SPARSER::PROTEIN) ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GADD34" . SPARSER::PROTEIN)
    ("alpha subunit" . SPARSER::PROTEIN)
    ("LY294002 and NVP-BKM-120" . SPARSER::COLLECTION)
    ("the dual inhibitor" . SPARSER::INHIBITOR)
    ("a novel dual inhibitor" . SPARSER::INHIBITOR)
    ("Dual inhibitors" . SPARSER::INHIBITOR)
    ("a commercially available PI3K inhibitor" . SPARSER::INHIBITOR)
    ("a valuable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("a smaller cohort" . SPARSER::MOLECULE)
    ("p110β, p110δ and p110γ" . SPARSER::COLLECTION)
    ("PiK3r1" . SPARSER::PROTEIN) ("IRS-1 and PTEN" . SPARSER::COLLECTION)
    ("A graphic example" . SPARSER::EXAMPLE) ("Glo" . SPARSER::PROTEIN)
    ("the dual PI3K/mTOR inhibitor NVP-BEZ235 and the EGFR inhibitor erlotinib"
     . SPARSER::COLLECTION)
    ("the dual PI3K/mTOR inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("pAKT, pP70S6K, and pS6" . SPARSER::COLLECTION)
    ("NVP-BKM120, LY294002, and NVP-BEZ235" . SPARSER::COLLECTION)
    ("pAKT, pP70S6K and pS6" . SPARSER::COLLECTION)
    ("LY294002 and rapamycin" . SPARSER::COLLECTION)
    ("p110α and mTOR" . SPARSER::COLLECTION)
    ("rapamycin and NVP-BKM120 and rapamycin and LY294002"
     . SPARSER::COLLECTION)
    ("NVP-BKM120 and rapamycin and LY294002" . SPARSER::COLLECTION)
    ("rapamycin and LY294002" . SPARSER::COLLECTION)
    ("PI3K (p85 or p110α) or total and phosphorylated AKT and sensitivity/resistance"
     . SPARSER::COLLECTION)
    ("total and phosphorylated AKT and sensitivity/resistance"
     . SPARSER::COLLECTION)
    ("p85 or p110α" . SPARSER::COLLECTION)
    ("AKT and sensitivity/resistance" . SPARSER::COLLECTION)
    ("NVP-BKM120 or LY294002" . SPARSER::COLLECTION)
    ("the two PI3K subunits and total and phosphorylated AKT"
     . SPARSER::COLLECTION)
    ("total and phosphorylated AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mere" . SPARSER::PROTEIN-FAMILY) ("HBE" . SPARSER::PROTEIN)
    ("NVP-BKM120 and LY294002" . SPARSER::COLLECTION)
    ("mTOR and p85" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("p85 or p110" . SPARSER::COLLECTION)
    ("continuous AQUA" . SPARSER::MOLECULE)
    ("the p85 subunit and the p110α subunit" . SPARSER::COLLECTION)
    ("both the p85 and the p110α subunits" . SPARSER::COLLECTION)
    ("mask" . SPARSER::PROTEIN) ("p85 and p110" . SPARSER::COLLECTION)
    ("LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("p85 and p110 α" . SPARSER::COLLECTION)
    ("the ribosomal protein S6 kinases (p70 S6K ) and 4E-binding protein (4E-BP)"
     . SPARSER::COLLECTION)
    ("Phosphatidylinositol" . SPARSER::PROTEIN)
    ("/AKT/mTOR" . SPARSER::COLLECTION)
    ("bevacizumab and cetuximab" . SPARSER::COLLECTION)
    ("a valuable drug target" . SPARSER::TARGET-PROTEIN)
    ("Erlotinib" . SPARSER::DRUG) ("pAKT and pP70S6K" . SPARSER::COLLECTION)
    ("LY294002 or NVP-BKM120" . SPARSER::COLLECTION)
    ("a dual PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("LY294002 and NVP-BKM120" . SPARSER::COLLECTION)
    ("p85 and p110α" . SPARSER::COLLECTION) ("BEZ-235" . SPARSER::DRUG)
    ("m-TOR" . SPARSER::PROTEIN) ("p110δ" . SPARSER::PROTEIN)
    ("PiK3r" . SPARSER::PROTEIN-FAMILY) ("caspases-8" . SPARSER::PROTEIN)
    ("BKM-120" . SPARSER::DRUG) ("caspase-2" . SPARSER::PROTEIN)
    ("Ribosomal Protein" . SPARSER::PROTEIN)
    ("PI3-Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SW480" . SPARSER::PROTEIN)
    ("p110 α" . SPARSER::PROTEIN) ("4E-BP" . SPARSER::PROTEIN)
    ("IGF1-R" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NVP-BKM120" . SPARSER::DRUG) ("strabismus" . SPARSER::PROTEIN)
    ("FGFR" . SPARSER::PROTEIN) ("the protein’s" . SPARSER::PROTEIN)
    ("Proline" . SPARSER::AMINO-ACID) ("retinas" . SPARSER::DRUG)
    ("Ig" . SPARSER::MOLECULE)
    ("Fibroblast growth factors (FGFs) and their receptors (FGFRs)"
     . SPARSER::COLLECTION)
    ("FGFs" . SPARSER::PROTEIN) ("FGFRs" . SPARSER::PROTEIN)
    ("ophthalmic" . SPARSER::DRUG) ("S-S" . SPARSER::PROTEIN)
    ("Fibroblast growth factors" . SPARSER::PROTEIN-FAMILY)
    ("fibroblast growth factor receptor" . SPARSER::PROTEIN)
    ("only Han Chinese cohorts" . SPARSER::MOLECULE)
    ("the mature miRNA" . SPARSER::PROTEIN)
    ("latent membrane protein 1 and pro-inﬂammatory" . SPARSER::COLLECTION)
    ("IL-1R-associated kinase (IRAK)" . SPARSER::KINASE)
    ("PRRs" . SPARSER::PROTEIN)
    ("interferon-gamma (IFN-γ) and interleukin 6" . SPARSER::COLLECTION)
    ("the intercellular adhesion molecule 1 ( ICAM-1 ) gene and the interleukin 23 receptor ( IL23R ) gene"
     . SPARSER::COLLECTION)
    ("the cytotoxic T cell antigen ( CTLA ) 4 gene, the intercellular adhesion molecule 1 ( ICAM-1 ) gene and the interleukin 23 receptor ( IL23R ) gene"
     . SPARSER::COLLECTION)
    ("iris" . SPARSER::PROTEIN) ("KP" . SPARSER::PROTEIN)
    ("Han" . SPARSER::PROTEIN) ("FUS" . SPARSER::PROTEIN)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pre-miRNA" . SPARSER::RNA)
    ("latent membrane protein 1" . SPARSER::PROTEIN)
    ("TNF receptor associated factor 6" . SPARSER::PROTEIN)
    ("IL-1R" . SPARSER::PROTEIN) ("interferon-gamma" . SPARSER::PROTEIN)
    ("pre-miRNAs" . SPARSER::RNA) ("IL23R" . SPARSER::PROTEIN)
    ("interleukin 23 receptor" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule 1" . SPARSER::PROTEIN)
    ("ets-1" . SPARSER::PROTEIN) ("the classic variant" . SPARSER::VARIANT)
    ("the clinically more aggressive pleomorphic variant" . SPARSER::VARIANT)
    ("p53 and E-cadherin" . SPARSER::COLLECTION)
    ("the classic and pleomorphic variants" . SPARSER::VARIANT)
    ("the classic ILC" . SPARSER::PROTEIN)
    ("Pleomorphic ILC" . SPARSER::PROTEIN)
    ("ILC and 9 PILC ( p  = 0.157)" . SPARSER::COLLECTION)
    ("the classic and pleomorphic ILC variants" . SPARSER::VARIANT)
    ("22 classic ILC" . SPARSER::PROTEIN)
    ("classic and pleomorphic ILC variants" . SPARSER::VARIANT)
    ("classical ILC" . SPARSER::PROTEIN)
    ("the pleomorphic ILC variant" . SPARSER::VARIANT)
    ("19 pleomorphic subtypes" . SPARSER::PROTEIN)
    ("gross cystic disease fluid protein (GDCFP)" . SPARSER::PROTEIN)
    ("protein (GDCFP)" . SPARSER::PROTEIN) ("progesterone" . SPARSER::PROTEIN)
    ("The pleomorphic variant" . SPARSER::VARIANT)
    ("the pleomorphic variant" . SPARSER::VARIANT) ("alveolar type" . TYPE)
    ("the classic type" . TYPE)
    ("the various different histological types" . TYPE)
    ("classic and pleomorphic ILC" . SPARSER::PROTEIN)
    ("classic ILC" . SPARSER::PROTEIN) ("p  " . SPARSER::PROTEIN)
    ("classic ILC and PILC" . SPARSER::COLLECTION)
    ("ILC and PILC" . SPARSER::COLLECTION) ("PILC" . SPARSER::PROTEIN)
    ("more aggressive pleomorphic variants" . SPARSER::VARIANT)
    ("ILC" . SPARSER::PROTEIN) ("protein can" . SPARSER::PROTEIN)
    ("dual FLT3-Aurora kinase inhibitors" . SPARSER::INHIBITOR)
    ("hERG" . SPARSER::PROTEIN)
    ("dual FLT3-Aurora inhibitors" . SPARSER::INHIBITOR)
    ("doubly-mutated FLT3" . SPARSER::PROTEIN)
    ("The dual FLT3-Aurora kinase inhibitor CCT137690" . SPARSER::DRUG)
    ("AC220 and PKC412" . SPARSER::COLLECTION)
    ("approximately 1-2" . SPARSER::PROTEIN)
    ("ITD and FLT3" . SPARSER::COLLECTION)
    ("ITD and TKD" . SPARSER::COLLECTION)
    ("AC220, Sorafenib, Ponatinib, PLX3397 and DCC2036" . SPARSER::COLLECTION)
    ("DCC" . SPARSER::PROTEIN) ("Ponatinib" . SPARSER::DRUG)
    ("PKC412, Sorafenib and SU5614" . SPARSER::COLLECTION)
    ("-ITD" . SPARSER::COLLECTION) ("ITD" . SPARSER::PROTEIN)
    ("the doubly-mutated FLT3 kinase" . SPARSER::KINASE)
    ("STAT5 and p44/42" . SPARSER::COLLECTION)
    ("MLN518, Sorafenib and AC220" . SPARSER::COLLECTION)
    ("both FLT3 and Aurora kinases" . SPARSER::COLLECTION)
    ("phospho-histone" . SPARSER::PROTEIN) ("FLT3-ITD" . SPARSER::COLLECTION)
    ("FLT3 and STAT5" . SPARSER::COLLECTION)
    ("CCT137690 and MLN518" . SPARSER::COLLECTION)
    ("the dual FLT3-Aurora inhibitor CCT137690" . SPARSER::DRUG)
    ("MLN518 and CCT137690" . SPARSER::COLLECTION)
    ("FLT3 and Aurora kinases" . SPARSER::COLLECTION)
    ("FISH and STR" . SPARSER::COLLECTION) ("STR" . SPARSER::PROTEIN)
    ("a doubly-mutated FLT3 -ITD-D835Y gene" . SPARSER::GENE)
    ("a novel dual FLT3-Aurora kinase inhibitor" . SPARSER::INHIBITOR)
    ("AC220, MLN518 and Sorafenib" . SPARSER::COLLECTION)
    ("Survivin and Borealin" . SPARSER::COLLECTION)
    ("Borealin" . SPARSER::PROTEIN) ("INCENP" . SPARSER::PROTEIN)
    ("CPC" . SPARSER::PROTEIN) ("a heterogeneous class" . CLASS)
    ("the FLT3 wild type allele and duplication of the FLT3 -ITD-D835Y allele"
     . SPARSER::COLLECTION)
    ("AC220 and Sorafenib" . SPARSER::COLLECTION) ("PLX3397" . SPARSER::DRUG)
    ("SU5614" . SPARSER::MOLECULE) ("PKC412" . SPARSER::DRUG)
    ("C-20" . SPARSER::PROTEIN) ("Bis-TRIS" . SPARSER::MOLECULE)
    ("MLN8237" . SPARSER::DRUG) ("AZD1152" . SPARSER::DRUG)
    ("inner centromere protein" . SPARSER::PROTEIN)
    ("fms-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("CCT137690" . SPARSER::DRUG) ("AC220" . SPARSER::DRUG)
    ("MLN518" . SPARSER::DRUG) ("FLT3" . SPARSER::PROTEIN)
    ("Cav-1 and c-Src" . SPARSER::COLLECTION)
    ("Cav-1 and Src" . SPARSER::COLLECTION)
    ("Src, Cav-1 and RhoGD12" . SPARSER::COLLECTION)
    ("Src and RhoGD12" . SPARSER::COLLECTION)
    ("Rho–ROCK" . SPARSER::COLLECTION)
    ("the major coat protein" . SPARSER::PROTEIN)
    ("family (SFK)" . SPARSER::PROTEIN-FAMILY) ("Lyn" . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN) ("Hck" . SPARSER::PROTEIN)
    ("Fyn" . SPARSER::PROTEIN) ("Fgr" . SPARSER::PROTEIN)
    ("Blk" . SPARSER::PROTEIN)
    ("One potential molecular target" . SPARSER::TARGET-PROTEIN)
    ("Cav-1 and RhoGD12" . SPARSER::COLLECTION)
    ("caveolin (Cav-1) and RhoGD12" . SPARSER::COLLECTION)
    ("Src family kinases, focal adhesion kinase (FAK), caveolin (Cav-1) and RhoGD12"
     . SPARSER::COLLECTION)
    ("c-Src kinase" . SPARSER::PROTEIN) ("D4-GDI" . SPARSER::PROTEIN)
    ("Caveolin 1" . SPARSER::PROTEIN)
    ("also more cytotoxic" . SPARSER::PROTEIN)
    ("BCR and CD40 signaling further increase ROS" . SPARSER::PROTEIN)
    ("the secondary lymphoid" . SPARSER::PROTEIN)
    ("BCR and CD40" . SPARSER::COLLECTION)
    ("pS6K, and p4EBP1" . SPARSER::COLLECTION)
    ("PI3Kα and PI3Kβ" . SPARSER::COLLECTION) ("PI3Kβ" . SPARSER::PROTEIN)
    ("PI3Kα" . SPARSER::PROTEIN)
    ("some BCR target genes and incomplete inhibition of the pathway by ON 01910"
     . SPARSER::COLLECTION)
    ("dysfunctional TP53" . SPARSER::PROTEIN)
    ("tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fludarabine" . SPARSER::DRUG)
    ("isothiocyanate (PEITC)" . SPARSER::MOLECULE) ("PEITC" . SPARSER::DRUG)
    ("isothiocyanate" . SPARSER::MOLECULE) ("bortezomib" . SPARSER::DRUG)
    ("a classic ROS" . SPARSER::PROTEIN) ("pSAP/JNK" . SPARSER::COLLECTION)
    ("p110α or p110γ" . SPARSER::COLLECTION) ("SAP/JNK" . SPARSER::COLLECTION)
    ("FDC" . SPARSER::PROTEIN) ("ATF3 or NOXA" . SPARSER::COLLECTION)
    ("NOXA and ATF3" . SPARSER::COLLECTION)
    ("ROS and JNK" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG) ("NAC" . SPARSER::PROTEIN)
    ("antioxidant" . SPARSER::PROTEIN) ("JNK/AP-1" . SPARSER::COLLECTION)
    ("FOS" . SPARSER::PROTEIN) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("HL60" . SPARSER::PROTEIN) ("treated CLL cells GSEA" . SPARSER::PROTEIN)
    ("GEP" . SPARSER::PROTEIN) ("CAL" . SPARSER::PROTEIN)
    ("BAX and BAK" . SPARSER::COLLECTION) ("BAK and BAX" . SPARSER::COLLECTION)
    ("BAX" . SPARSER::PROTEIN) ("BAK" . SPARSER::PROTEIN)
    ("CD19 and CD3" . SPARSER::COLLECTION) ("AnnexinV" . SPARSER::PROTEIN)
    ("MCL" . SPARSER::PROTEIN)
    ("a non-ATP competitive multi-kinase inhibitor" . SPARSER::INHIBITOR)
    ("BTK" . SPARSER::PROTEIN) ("receptor (BCR)" . SPARSER::RECEPTOR)
    ("ZAP70 and CD38" . SPARSER::COLLECTION) ("PB" . SPARSER::PROTEIN)
    ("ATF3 and NOXA" . SPARSER::COLLECTION)
    ("kinase, and ATF3" . SPARSER::COLLECTION)
    ("Annexin V and CD19" . SPARSER::COLLECTION)
    ("BTK inhibitor PCI-32765" . SPARSER::DRUG) ("EBP1" . SPARSER::PROTEIN)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pS6K" . SPARSER::PROTEIN)
    ("LY 294002" . SPARSER::MOLECULE) ("NRF2" . SPARSER::PROTEIN)
    ("p110γ" . SPARSER::PROTEIN) ("BH3-only protein" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG)
    ("AP-1 transcription factor" . SPARSER::PROTEIN)
    ("FOXO4" . SPARSER::PROTEIN) ("forkhead box O4" . SPARSER::PROTEIN)
    ("LY-294002" . SPARSER::PROTEIN) ("S19" . SPARSER::PROTEIN)
    ("MCL-1" . SPARSER::PROTEIN) ("DiOC6" . SPARSER::DRUG)
    ("nM 3" . SPARSER::DRUG) ("MitoTracker Red" . SPARSER::MOLECULE)
    ("beta-2-microglobulin" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("p110β" . SPARSER::PROTEIN)
    ("Ran GTPase-activating protein 1" . SPARSER::PROTEIN)
    ("polo-like" . SPARSER::PROTEIN) ("polo-like kinase 1" . SPARSER::PROTEIN)
    ("anti-mitotic" . SPARSER::MOLECULE) ("IL4" . SPARSER::PROTEIN)
    ("ZAP70" . SPARSER::PROTEIN) ("CD5" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("bank" . SPARSER::PROTEIN) ("labile" . SPARSER::PROTEIN)
    ("the EDRN surgical cohort" . SPARSER::MOLECULE)
    ("activated Src family kinase (SFK) and STAT3" . SPARSER::COLLECTION)
    ("kinase (SFK)" . SPARSER::KINASE) ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("The cetuximab-treated cohort" . SPARSER::MOLECULE)
    ("our surgical cohort" . SPARSER::MOLECULE)
    ("previously described surgical cohorts" . SPARSER::MOLECULE)
    ("type or tumor" . SPARSER::COLLECTION)
    ("a TMA or availability" . SPARSER::COLLECTION)
    ("RPPA and tumor EGFR mRNA (ρ=0.04; p=0.81)" . SPARSER::COLLECTION)
    ("mRNA and EGFRvIII" . SPARSER::COLLECTION)
    ("protein and phosphoprotein" . SPARSER::COLLECTION)
    ("Erbitux" . SPARSER::DRUG)
    ("protein/phosphoprotein" . SPARSER::COLLECTION) ("CRT" . SPARSER::PROTEIN)
    ("EGFR and EGFR" . SPARSER::COLLECTION) ("PY" . SPARSER::MOLECULE)
    ("EGFR and EGFRvIII" . SPARSER::COLLECTION)
    ("beta-glucuronidase" . SPARSER::PROTEIN) ("H11" . SPARSER::PROTEIN)
    ("INK4" . SPARSER::PROTEIN) ("P16" . SPARSER::PROTEIN)
    ("TERT-" . SPARSER::PROTEIN) ("MSI and CIMP+" . SPARSER::COLLECTION)
    ("statins" . SPARSER::DRUG) ("Statin" . SPARSER::MOLECULE)
    ("colon cancer and rs2853668" . SPARSER::COLLECTION)
    ("was run" . SPARSER::PROTEIN-FAMILY) ("San" . SPARSER::PROTEIN)
    ("a Caucasian LD map" . SPARSER::PROTEIN) ("bin" . SPARSER::PROTEIN)
    ("MSI or CIMP" . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase ( TERT )" . SPARSER::PROTEIN)
    ("colon cancer (OR =1.31, 95% CI 1.02,1.69) and TERT-CLPTM1L rs2853668"
     . SPARSER::COLLECTION)
    ("TERT-CLPTM1L" . SPARSER::COLLECTION)
    ("1555 incident colon cancer" . SPARSER::PROTEIN)
    ("KRAS2" . SPARSER::PROTEIN) ("CLPTM1L" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("ON" . SPARSER::PROTEIN) ("nanoparticles" . SPARSER::MOLECULE)
    ("TLR-" . SPARSER::PROTEIN-FAMILY) ("IFNb" . SPARSER::PROTEIN)
    ("locked nucleic acid oligonucleotides" . SPARSER::MOLECULE)
    ("miR155:CK1α" . SPARSER::BIO-COMPLEX)
    ("MDM2, p53, and E2F1" . SPARSER::COLLECTION)
    ("β-catenin and its downstream effector cyclin D1" . SPARSER::COLLECTION)
    ("pre-adipocytes and adipocytes" . SPARSER::COLLECTION)
    ("pre-adipocytes" . SPARSER::PROTEIN)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CK1α and GSK-3β" . SPARSER::COLLECTION)
    ("CK1α, axin, APC, and GSK-3β" . SPARSER::COLLECTION)
    ("dominant mRNA" . SPARSER::PROTEIN)
    ("Meis1, c-MAF, AID, interleukin-1, IKKε, and Ets-1" . SPARSER::COLLECTION)
    ("AID" . SPARSER::PROTEIN) ("RHOA" . SPARSER::PROTEIN)
    ("SHIP and C/EBPβ" . SPARSER::COLLECTION)
    ("suppressor or tumor" . SPARSER::COLLECTION)
    ("papillary thyroid" . SPARSER::PROTEIN)
    ("preadipocytes and adipocytes" . SPARSER::COLLECTION)
    ("preadipocytes" . SPARSER::PROTEIN)
    ("β-catenin/cyclin D1" . SPARSER::COLLECTION)
    ("these potential downstream targets" . SPARSER::TARGET-PROTEIN)
    ("β-catenin and cyclin D1" . SPARSER::COLLECTION)
    ("β-catenin, and cyclin D1" . SPARSER::COLLECTION)
    ("snap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("this potential downstream target" . SPARSER::TARGET-PROTEIN)
    ("CK1α/β-catenin" . SPARSER::COLLECTION)
    ("Foxo3a and SCOS1" . SPARSER::COLLECTION)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("annexin V/PI" . SPARSER::COLLECTION) ("neo" . SPARSER::PROTEIN)
    ("adipocytes" . SPARSER::PROTEIN) ("miR155" . SPARSER::PROTEIN)
    ("MiR" . SPARSER::PROTEIN) ("miR10b and miR126" . SPARSER::COLLECTION)
    ("miR10b" . SPARSER::PROTEIN)
    ("miR-10b, and miR-126" . SPARSER::COLLECTION)
    ("eight frozen human normal fat (NF)" . SPARSER::PROTEIN)
    ("normal fat" . SPARSER::PROTEIN)
    ("suppressors or oncogenes" . SPARSER::COLLECTION) ("avid" . SPARSER::DRUG)
    ("rod" . SPARSER::PROTEIN) ("RCL" . SPARSER::PROTEIN)
    ("this relatively uncommon malignancy cohort" . SPARSER::MOLECULE)
    ("Ets-1" . SPARSER::PROTEIN) ("c-MAF" . SPARSER::PROTEIN)
    ("Meis1" . SPARSER::PROTEIN) ("MSH2" . SPARSER::PROTEIN)
    ("TP53INP1" . SPARSER::PROTEIN) ("C/EBPβ" . SPARSER::PROTEIN)
    ("miR-126" . SPARSER::PROTEIN) ("miR-10b" . SPARSER::MOLECULE)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("beta-catenin" . SPARSER::PROTEIN) ("CK1α" . SPARSER::PROTEIN)
    ("a potential biomarker" . SPARSER::MOLECULE)
    ("p27-Jab1" . SPARSER::COLLECTION) ("cyclin E-Cdk2" . SPARSER::COLLECTION)
    ("siRNA and cisplatin" . SPARSER::COLLECTION)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("Jab1-siRNA" . SPARSER::COLLECTION)
    ("p27/cyclin E/Cdk2" . SPARSER::COLLECTION)
    ("Jab1 siRNA oligonucleotides or control siRNA oligonucleotides"
     . SPARSER::COLLECTION)
    ("GFP-Jab1" . SPARSER::COLLECTION) ("Flag-p27" . SPARSER::COLLECTION)
    ("Myc-Jab1" . SPARSER::COLLECTION) ("Myc-JAB" . SPARSER::COLLECTION)
    ("JAB" . SPARSER::PROTEIN) ("Jab1/p27" . SPARSER::COLLECTION)
    ("a universal cyclin-dependent kinase (Cdk) inhibitor"
     . SPARSER::INHIBITOR)
    ("cyclin-Cdk" . SPARSER::COLLECTION)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("signalosome" . SPARSER::PROTEIN)
    ("the two mainly histologic types" . TYPE)
    ("Jab1 and p27" . SPARSER::COLLECTION) ("Jab1/CSN5" . SPARSER::COLLECTION)
    ("Cdk2" . SPARSER::PROTEIN) ("Lamin A/C" . SPARSER::PROTEIN)
    ("COP9" . SPARSER::PROTEIN) ("CSN5" . SPARSER::PROTEIN)
    ("Jab1" . SPARSER::PROTEIN) ("Pten and Ras" . SPARSER::COLLECTION)
    ("mTOR and MEK" . SPARSER::COLLECTION)
    ("paclitaxel or 5-fluorouracil" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG) ("K-ras and B-raf" . SPARSER::COLLECTION)
    ("the new Pten" . SPARSER::PROTEIN) ("primary Pten" . SPARSER::PROTEIN)
    ("andK-ras" . SPARSER::COLLECTION) ("IL2r" . SPARSER::PROTEIN)
    ("rapamycin and PD325901" . SPARSER::COLLECTION)
    ("P-S6 and P-MAPK" . SPARSER::COLLECTION)
    ("PI3K and RAS" . SPARSER::COLLECTION) ("BLI" . SPARSER::PROTEIN)
    ("IL2rg" . SPARSER::PROTEIN) ("lobe" . SPARSER::PROTEIN)
    ("Ar, Ck8, Ck18, E-cdh and Psca" . SPARSER::COLLECTION)
    ("Vimentin and Zeb2" . SPARSER::COLLECTION) ("Zeb2" . SPARSER::PROTEIN)
    ("/CD24" . SPARSER::COLLECTION) ("Psca" . SPARSER::PROTEIN)
    ("cdh" . SPARSER::PROTEIN) ("Ck" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("previously published RAS signature gene" . SPARSER::GENE)
    ("Rank-Rank" . SPARSER::COLLECTION) ("Rank" . SPARSER::PROTEIN)
    ("PTEN and RAS" . SPARSER::COLLECTION)
    ("Zeb1 ( Zeb1 ) and Foxc2 ( Foxc2 )" . SPARSER::COLLECTION)
    ("Foxc2" . SPARSER::PROTEIN) ("Zeb1" . SPARSER::PROTEIN)
    ("Fn1" . SPARSER::PROTEIN) ("Zeb" . SPARSER::PROTEIN)
    ("EMT-associated genes" . SPARSER::GENE)
    ("epithelial acini" . SPARSER::PROTEIN) ("LacZ" . SPARSER::PROTEIN)
    ("LSL" . SPARSER::PROTEIN) ("Vimentin" . SPARSER::PROTEIN)
    ("synaptophysin" . SPARSER::PROTEIN) ("p53 and p27" . SPARSER::COLLECTION)
    ("acini" . SPARSER::PROTEIN) ("Mme, Msmb and Nkx3.1" . SPARSER::COLLECTION)
    ("Msmb" . SPARSER::PROTEIN) ("Mme" . SPARSER::PROTEIN)
    ("GSEA" . SPARSER::PROTEIN) ("MAPK and PTEN" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN-FAMILY) ("orC" . SPARSER::BIO-COMPLEX)
    ("the dorsal-lateral lobes" . SPARSER::PROTEIN)
    ("lobes" . SPARSER::PROTEIN) ("withK-ras" . SPARSER::COLLECTION)
    ("crossedPb-Cre" . SPARSER::COLLECTION)
    ("theK-ras G12D/W (K-ras L/W ) ( xref ) allele" . SPARSER::ALLELE)
    ("Pb-Cre" . SPARSER::COLLECTION) ("RAS/RAF/MAPK" . SPARSER::COLLECTION)
    ("activatingK-ras" . SPARSER::COLLECTION)
    ("PTEN/PI3K" . SPARSER::COLLECTION) ("PIN" . SPARSER::PROTEIN)
    ("PTEN/PI3K/AKT" . SPARSER::COLLECTION)
    ("gin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("activatableK-ras" . SPARSER::COLLECTION) ("B-raf" . SPARSER::PROTEIN)
    ("Ck14" . SPARSER::PROTEIN) ("UBE2C" . SPARSER::PROTEIN)
    ("FGFR2" . SPARSER::PROTEIN) ("Twist1" . SPARSER::PROTEIN)
    ("Lac-Z" . SPARSER::PROTEIN) ("N-cadherin" . SPARSER::PROTEIN)
    ("Snai1" . SPARSER::PROTEIN) ("N-cad" . SPARSER::PROTEIN)
    ("Mmp2" . SPARSER::PROTEIN) ("RPL13" . SPARSER::PROTEIN)
    ("CD24" . SPARSER::PROTEIN) ("CD49f" . SPARSER::PROTEIN)
    ("p63" . SPARSER::PROTEIN) ("X-gal" . SPARSER::MOLECULE)
    ("Nkx3.1" . SPARSER::PROTEIN) ("PD325901" . SPARSER::DRUG)
    ("One strong candidate regulatory protein" . SPARSER::PROTEIN)
    ("enhancers" . SPARSER::PROTEIN)
    ("clinically relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("kinases and BARD1β" . SPARSER::COLLECTION)
    ("the latter proteins" . SPARSER::PROTEIN)
    ("BARD1 and BARD1β" . SPARSER::COLLECTION) ("MYCN" . SPARSER::PROTEIN)
    ("BARD1/BRCA1" . SPARSER::COLLECTION) ("ser" . SPARSER::AMINO-ACID)
    ("Nb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least one risk allele" . SPARSER::ALLELE)
    ("GT or GG" . SPARSER::COLLECTION)
    ("both the allelic state" . SPARSER::BIO-STATE)
    ("at least one BARD1 exon" . SPARSER::PROTEIN) ("NB" . SPARSER::PROTEIN)
    ("SH-SY5Y" . SPARSER::PROTEIN)
    ("FL BARD1 and 15 unique BARD1 isoforms ( xref )" . SPARSER::COLLECTION)
    ("15 unique BARD1 isoforms" . SPARSER::ISOFORM)
    ("the constitutional DNA" . SPARSER::DNA) ("FOX2" . SPARSER::PROTEIN)
    ("ESR1" . SPARSER::PROTEIN) ("Aurora kinase B" . SPARSER::PROTEIN)
    ("Aurora kinase A" . SPARSER::PROTEIN) ("I-19" . SPARSER::PROTEIN)
    ("p25" . SPARSER::PROTEIN) ("Domain 1" . SPARSER::PROTEIN)
    ("subsequent downstream effector genes" . SPARSER::GENE)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("Cyclin D1 and c-Myc" . SPARSER::COLLECTION)
    ("IL-6 and phospho-Stat3" . SPARSER::COLLECTION)
    ("predominant co-localization MMP-2 and α5β1 integrin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phopsho-Stat3" . SPARSER::COLLECTION)
    ("IL-6, phospho-Stat3, CyclinD1 and c-Myc" . SPARSER::COLLECTION)
    ("phospho-Stat3, CyclinD1 and c-Myc" . SPARSER::COLLECTION)
    ("Nsp-IgG" . SPARSER::COLLECTION)
    ("a potential Stat3 target gene" . SPARSER::GENE)
    ("pIL-6 or pSV+pIL-6" . SPARSER::COLLECTION)
    ("phosho-Stat3" . SPARSER::COLLECTION)
    ("JAK1, phospho-JAK2, JAK2 and phospho-Stat3" . SPARSER::COLLECTION)
    ("phopsho-JAK1" . SPARSER::COLLECTION)
    ("JAK1, JAK2 and Stat3" . SPARSER::COLLECTION)
    ("pM-1 and pM-2" . SPARSER::COLLECTION) ("pSV-2" . SPARSER::COLLECTION)
    ("pM-1" . SPARSER::PROTEIN)
    ("CyclinD1, c-Myc, Bcl-xL, Bcl2 and Survivin" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::PROTEIN)
    ("gp130, phospho-JAK1, JAK1, phospho-JAK2, JAK2 and phospho-Stat3"
     . SPARSER::COLLECTION)
    ("PIAS1, SOCS1, CDKI1A and PP2Aα" . SPARSER::COLLECTION)
    ("CDKI" . SPARSER::DRUG)
    ("JAK2 (Janus kinase 2) and Csf2rb" . SPARSER::COLLECTION)
    ("the essential receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("Csf2rb" . SPARSER::PROTEIN) ("IL1-RA" . SPARSER::COLLECTION)
    ("rb" . SPARSER::PROTEIN)
    ("the possible modulation Stat3 signaling pathway genes" . SPARSER::GENE)
    ("pSV- and pM-" . SPARSER::COLLECTION)
    ("IL-6, IL-8 and IL-10" . SPARSER::COLLECTION) ("BB" . SPARSER::MOLECULE)
    ("GM-CSF, IL-6, IL-8, IL-10, VEGF, and PDGF-BB" . SPARSER::COLLECTION)
    ("pSV and pM" . SPARSER::COLLECTION)
    ("secretory cytokines and growth factors" . SPARSER::COLLECTION)
    ("GM-CSF, IL-6, IL-8, IL-10, TNF-α, Angiogenin, VEGF, and PDGF-BB"
     . SPARSER::COLLECTION)
    ("Angiogenin" . SPARSER::PROTEIN)
    ("anti-MMP-2 and anti-Myc" . SPARSER::COLLECTION)
    ("MMP-2 and α5β1" . SPARSER::COLLECTION)
    ("siRNA and α5β1" . SPARSER::COLLECTION)
    ("gene and blockade" . SPARSER::COLLECTION)
    ("Transducers and Activators" . SPARSER::COLLECTION)
    ("Activators" . SPARSER::ACTIVATOR) ("Transducers" . SPARSER::PROTEIN)
    ("sIL" . SPARSER::PROTEIN) ("MMP-2 and α5" . SPARSER::COLLECTION)
    ("Bcl-2, and NF-κB" . SPARSER::COLLECTION) ("VLA" . SPARSER::MOLECULE)
    ("MMP-2/αVβ3" . SPARSER::COLLECTION) ("endopeptidase" . SPARSER::PROTEIN)
    ("IL-6, phospho-Stat3, CyclinD1, c-Myc, Ki-67 and PCNA"
     . SPARSER::COLLECTION)
    ("MMP-2/α5β1" . SPARSER::COLLECTION) ("IL-6/Stat3" . SPARSER::COLLECTION)
    ("CyclinD1 and c-Myc" . SPARSER::COLLECTION)
    ("integrins and MMP-2" . SPARSER::COLLECTION)
    ("JAK/Stat3" . SPARSER::COLLECTION)
    ("GM-CSF, IL-6, IL-8, IL-10, TNF-α, angiogenin, VEGF and PDGF-BB"
     . SPARSER::COLLECTION)
    ("angiogenin" . SPARSER::PROTEIN) ("pSV-" . SPARSER::PROTEIN)
    ("BrDU" . SPARSER::DRUG) ("pSV" . SPARSER::PROTEIN)
    ("Hema-3" . SPARSER::PROTEIN) ("1 µL" . SPARSER::PROTEIN)
    ("HA5" . SPARSER::PROTEIN) ("Bcl-x" . SPARSER::PROTEIN)
    ("JSM6427" . SPARSER::DRUG) ("pIL-6" . SPARSER::PROTEIN)
    ("PP2Aα" . SPARSER::PROTEIN) ("PIAS1" . SPARSER::PROTEIN)
    ("Bcl-2L1" . SPARSER::PROTEIN) ("beta)" . SPARSER::PROTEIN)
    ("Colony stimulating factor" . SPARSER::PROTEIN)
    ("Csf2" . SPARSER::PROTEIN) ("Tyrosine kinase 2" . SPARSER::PROTEIN)
    ("Interleukin 4 receptor" . SPARSER::PROTEIN) ("alpha)" . SPARSER::PROTEIN)
    ("Interleukin 10" . SPARSER::PROTEIN)
    ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interleukin 2" . SPARSER::PROTEIN) ("IL2RG" . SPARSER::PROTEIN)
    ("IL-6ST" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("Interleukin-6" . SPARSER::PROTEIN) ("αVβ3" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("CyclinD1" . SPARSER::PROTEIN) ("α5β1" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("NCT" . SPARSER::PROTEIN) ("PKCμ and PKCε" . SPARSER::COLLECTION)
    ("the Pax3:Fkhr chimeric transcription factor" . SPARSER::PROTEIN)
    ("Pax3:Fkhr" . SPARSER::BIO-COMPLEX) ("Fkhr" . SPARSER::PROTEIN)
    ("PKCα, PKCδ, PKCθ, and PKCζ" . SPARSER::COLLECTION)
    ("TPA" . SPARSER::PROMOTER) ("a larger cohort" . SPARSER::MOLECULE)
    ("metastatic ARMS" . SPARSER::PROTEIN) ("PAX3-FKHR" . SPARSER::COLLECTION)
    ("FKHR" . SPARSER::PROTEIN) ("group, and VCR" . SPARSER::COLLECTION)
    ("Annexin-V/PI" . SPARSER::COLLECTION)
    ("ATM and/or VCR" . SPARSER::COLLECTION)
    ("β-tubulin and DAPI" . SPARSER::COLLECTION)
    ("phospho-PKCι and Par6" . SPARSER::COLLECTION)
    ("ATM and VCR" . SPARSER::COLLECTION) ("VCR and ATM" . SPARSER::COLLECTION)
    ("VCR" . SPARSER::DRUG) ("PKCι-Par6" . SPARSER::COLLECTION)
    ("total PKCι and its phosphorylated form" . SPARSER::COLLECTION)
    ("ARMS or ERMS" . SPARSER::COLLECTION) ("strong PKCι" . SPARSER::PROTEIN)
    ("normal skeletal muscle" . SPARSER::PROTEIN)
    ("PRKCI and PKCμ" . SPARSER::COLLECTION)
    ("skeletal muscle, ARMS and ERMS" . SPARSER::COLLECTION)
    ("ARMS and ERMS" . SPARSER::COLLECTION) ("PB1" . SPARSER::PROTEIN)
    ("multidrug" . SPARSER::PROTEIN)
    ("virtually all cell and tissue types" . TYPE)
    ("invasive or metastatic ARMS" . SPARSER::PROTEIN)
    ("ARMS" . SPARSER::PROTEIN)
    ("skeletal muscle and non-muscle" . SPARSER::COLLECTION)
    ("ATM and vincristine" . SPARSER::COLLECTION)
    ("vincristine" . SPARSER::DRUG)
    ("aurothiomalate (ATM)" . SPARSER::MOLECULE)
    ("PKCι and Par6" . SPARSER::COLLECTION)
    ("aurothiomalate" . SPARSER::MOLECULE) ("Prkci" . SPARSER::PROTEIN)
    ("PRKCI" . SPARSER::PROTEIN) ("skeletal muscle" . SPARSER::PROTEIN)
    ("anti-Par" . SPARSER::DRUG) ("Pax7" . SPARSER::PROTEIN)
    ("IL-1beta" . SPARSER::PROTEIN) ("Igf-1" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("Pax3" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("Phorbol-13-acetate" . SPARSER::MOLECULE)
    ("PAX3" . SPARSER::PROTEIN) ("heavy chain" . SPARSER::PROTEIN)
    ("PKCμ" . SPARSER::PROTEIN) ("ι/λ" . SPARSER::PROTEIN)
    ("non-muscle" . SPARSER::PROTEIN) ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PKCι" . SPARSER::PROTEIN)
    ("acute myelogenous leukemia (AML)" . SPARSER::PROTEIN)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("RANGTP" . SPARSER::PROTEIN)
    ("Imp" . SPARSER::MOLECULE) ("Rb-E2F" . SPARSER::COLLECTION)
    ("Rb" . SPARSER::PROTEIN) ("Ki67 and TOP2A" . SPARSER::COLLECTION)
    ("BD-" . SPARSER::PROTEIN)
    ("E2F1 and the NuSAP promoter" . SPARSER::COLLECTION)
    ("MYC and NFYA" . SPARSER::COLLECTION)
    ("cMyc or NFYA" . SPARSER::COLLECTION) ("cMyc" . SPARSER::PROTEIN)
    ("NFYA and E2F" . SPARSER::COLLECTION)
    ("NFYA and MYC" . SPARSER::COLLECTION) ("NFYA" . SPARSER::PROTEIN)
    ("log-rank" . SPARSER::PROTEIN)
    ("RanGTP and its regulator RACGAP1" . SPARSER::COLLECTION)
    ("RanGTP" . SPARSER::PROTEIN)
    ("TPX2, RACGAP1 and NuSAP" . SPARSER::COLLECTION)
    ("BCR" . SPARSER::PROTEIN) ("CERK" . SPARSER::PROTEIN)
    ("KIAA0101, TOP2, EZH2, IGFBP3, RAC2, RCSD1, CYP2D6, MCM6, Versican, HGF and ETV5"
     . SPARSER::COLLECTION)
    ("CYP2D6" . SPARSER::PROTEIN) ("Versican" . SPARSER::PROTEIN)
    ("highly variable genes" . SPARSER::GENE)
    ("SAM-survival" . SPARSER::MOLECULE) ("SAM" . SPARSER::MOLECULE)
    ("E2F1 and NuSAP" . SPARSER::COLLECTION) ("CCAAT" . SPARSER::PROTEIN)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("treated, and prognostic biomarkers" . SPARSER::MOLECULE)
    ("Imp 7" . SPARSER::PROTEIN) ("TOP2A" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("APOC1" . SPARSER::PROTEIN)
    ("AK2" . SPARSER::PROTEIN) ("ENO1" . SPARSER::PROTEIN)
    ("CRABP2" . SPARSER::PROTEIN) ("SCUBE2" . SPARSER::PROTEIN)
    ("THBS2" . SPARSER::PROTEIN) ("SIPA1" . SPARSER::PROTEIN)
    ("RACGAP1" . SPARSER::PROTEIN) ("TPX2" . SPARSER::PROTEIN)
    ("ETV5" . SPARSER::PROTEIN) ("MCM6" . SPARSER::PROTEIN)
    ("CYP2" . SPARSER::PROTEIN) ("RCSD1" . SPARSER::PROTEIN)
    ("RAC2" . SPARSER::PROTEIN) ("IGFBP3" . SPARSER::PROTEIN)
    ("TOP2" . SPARSER::PROTEIN) ("KIAA0101" . SPARSER::PROTEIN)
    ("mismatch" . SPARSER::PROTEIN) ("– 1" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE) ("incident CRCs" . SPARSER::PROTEIN)
    ("MSH" . SPARSER::PROTEIN) ("methionine" . SPARSER::AMINO-ACID)
    ("folate" . SPARSER::MOLECULE) ("fat" . SPARSER::PROTEIN)
    ("sporadic CRCs" . SPARSER::PROTEIN)
    ("our group ( xref ) and others ( xref – xref )" . SPARSER::COLLECTION)
    ("507/555 (91%) available CRC" . SPARSER::PROTEIN)
    ("Incident CRCs" . SPARSER::PROTEIN) ("TS2" . SPARSER::PROTEIN)
    ("Exonuclease I" . SPARSER::PROTEIN)
    ("Alkaline Phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("The first identified p53 regulated lincRNA" . SPARSER::RNA)
    ("lincRNA" . SPARSER::RNA)
    ("microRNAs (miRNAs) and large intergenic noncoding RNAs (lincRNAs)"
     . SPARSER::COLLECTION)
    ("large intergenic noncoding RNAs" . SPARSER::RNA)
    ("lincRNAs" . SPARSER::RNA) ("p53/Wnt" . SPARSER::COLLECTION)
    ("MEF or NPC" . SPARSER::COLLECTION) ("mES" . SPARSER::MOLECULE)
    ("new p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("these canonical p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pro-apoptotic gene" . SPARSER::GENE)
    ("Cdkn1a and Mdm2" . SPARSER::COLLECTION)
    ("Cdkn1a and Bbc3" . SPARSER::COLLECTION)
    ("p21 or Waf1" . SPARSER::COLLECTION) ("Cdkn1a" . SPARSER::PROTEIN)
    ("genome-wide chromatin" . SPARSER::PROTEIN)
    ("two well-recognized p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EB-1" . SPARSER::PROTEIN)
    ("there no single p53 target" . SPARSER::TARGET-PROTEIN)
    ("type and strength" . SPARSER::COLLECTION)
    ("a sequence-specific transcription factor" . SPARSER::PROTEIN)
    ("NF-YA" . SPARSER::PROTEIN) ("Bbc3" . SPARSER::PROTEIN)
    ("mitochondria or any other sub-cellular organelles" . SPARSER::COLLECTION)
    ("Mitochondrial-localized EGFR" . SPARSER::PROTEIN)
    ("EGFR and its signaling molecules" . SPARSER::COLLECTION)
    ("The monoclonal anti-EGFR antibody cetuximab and the EGFR tyrosine kinase inhibitor erlotinib"
     . SPARSER::COLLECTION)
    ("The monoclonal anti-EGFR antibody cetuximab" . SPARSER::DRUG)
    ("EGFRvIII" . SPARSER::PROTEIN)
    ("EGFR, FAK and mitochondria" . SPARSER::COLLECTION)
    ("Receptor" . SPARSER::RECEPTOR)
    ("STAT3, MAPK, and AKT" . SPARSER::COLLECTION)
    ("kinases, PlCγ, PKC, and STAT" . SPARSER::COLLECTION)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("RAF1 and PI3k" . SPARSER::COLLECTION)
    ("MEK1 and STAT3" . SPARSER::COLLECTION) ("PI3k" . SPARSER::PROTEIN-FAMILY)
    ("MEK1, RAF1, STAT3 and PI3K" . SPARSER::COLLECTION)
    ("the dual specificity protein kinases MEK1 and MEK2"
     . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("kinases, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("the mitogen-activated protein kinases (MAPK), the phosphatidylinositol 3-kinase–AKT, and signal transducer and activator of transcription proteins (STAT)"
     . SPARSER::COLLECTION)
    ("proteins (STAT)" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases (MAPK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatidylinositol 3-kinase–AKT" . SPARSER::COLLECTION)
    ("p-c-Src" . SPARSER::COLLECTION) ("FAK and c-Src" . SPARSER::COLLECTION)
    ("mitochondria and co-localizes" . SPARSER::COLLECTION)
    ("TMZ" . SPARSER::DRUG) ("Temozolomide" . SPARSER::DRUG)
    ("exogenous EGF" . SPARSER::PROTEIN)
    ("the ubiquitous proliferation marker Ki67" . SPARSER::PROTEIN)
    ("hUCBSC-treated U87" . SPARSER::PROTEIN)
    ("FAK and other molecules" . SPARSER::COLLECTION)
    ("EGFR, FAK and other molecules" . SPARSER::COLLECTION)
    ("EGFR and FAK" . SPARSER::COLLECTION)
    ("FAK and EGFR" . SPARSER::COLLECTION) ("p-Fak" . SPARSER::COLLECTION)
    ("Fak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitochondria and its co-localization" . SPARSER::COLLECTION)
    ("XIAP, FAK and cyclin D1" . SPARSER::COLLECTION)
    ("mitochondrial EGFR" . SPARSER::PROTEIN)
    ("EGFR and/or c-Src" . SPARSER::COLLECTION)
    ("oxidative ATP" . SPARSER::ATP) ("EGFR and c-Src" . SPARSER::COLLECTION)
    ("CoxII" . SPARSER::PROTEIN) ("oxidase" . SPARSER::PROTEIN)
    ("EGFR, FAK and c-Src" . SPARSER::COLLECTION)
    ("EGFR and its co-localization" . SPARSER::COLLECTION)
    ("CD81" . SPARSER::PROTEIN) ("CD29" . SPARSER::PROTEIN)
    ("PlCγ" . SPARSER::PROTEIN-FAMILY) ("ERK1" . SPARSER::PROTEIN)
    ("MEK2" . SPARSER::PROTEIN) ("RAF1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cathepsin-L" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("focal complexes and focal adhesions" . SPARSER::COLLECTION)
    ("integrin-associated molecules" . SPARSER::MOLECULE)
    ("GEF or GAPs" . SPARSER::COLLECTION)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p190RhoGAP and p190RhoGEF" . SPARSER::COLLECTION)
    ("p190RhoGEF" . SPARSER::PROTEIN)
    ("ROCK 1 and ROCK2" . SPARSER::COLLECTION)
    ("one ROCK isoform or use of small molecule inhibitors"
     . SPARSER::COLLECTION)
    ("ROCK1- and ROCK2-" . SPARSER::COLLECTION) ("tip" . SPARSER::PROTEIN)
    ("phosphorylatable" . SPARSER::PROTEIN)
    ("both focal complexes and focal adhesions" . SPARSER::COLLECTION)
    ("complexes and focal adhesions" . SPARSER::COLLECTION)
    ("RFP-paxillin" . SPARSER::COLLECTION)
    ("red fluoresecent protein (RFP)-paxillin" . SPARSER::COLLECTION)
    ("-paxillin" . SPARSER::COLLECTION) ("ROCK2-" . SPARSER::PROTEIN)
    ("only immature focal complexes" . SPARSER::BIO-COMPLEX)
    ("Zyxin" . SPARSER::PROTEIN) ("zyxin" . SPARSER::PROTEIN)
    ("focal adhesion kinase (FAK) and Src" . SPARSER::COLLECTION)
    ("ROCK1-" . SPARSER::PROTEIN) ("Paxillin" . SPARSER::PROTEIN)
    ("actin-" . SPARSER::PROTEIN) ("focal complex" . SPARSER::BIO-COMPLEX)
    ("acto-myosin" . SPARSER::COLLECTION) ("mDia" . SPARSER::PROTEIN)
    ("Focal complexes" . SPARSER::BIO-COMPLEX)
    ("focal complexes" . SPARSER::BIO-COMPLEX)
    ("Rac or Cdc42" . SPARSER::COLLECTION) ("transducers" . SPARSER::PROTEIN)
    ("Integrins" . SPARSER::PROTEIN)
    ("heterodimeric adhesion receptors" . SPARSER::RECEPTOR)
    ("ROCK1 or ROCK2" . SPARSER::COLLECTION)
    ("specifically knockdown ROCK1 and ROCK2" . SPARSER::COLLECTION)
    ("ROCK1 and ROCK2" . SPARSER::COLLECTION) ("ml −1" . SPARSER::PROTEIN)
    ("p190" . SPARSER::PROTEIN) ("p190RhoGAP" . SPARSER::PROTEIN)
    ("neuronal migration" . SPARSER::PROTEIN) ("ROCK 1" . SPARSER::PROTEIN)
    ("myosin light-chain" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("GTP-binding protein" . SPARSER::PROTEIN) ("ROCK2" . SPARSER::PROTEIN)
    ("ROCK1" . SPARSER::PROTEIN)
    ("S6K and its upstream regulator mTOR and IRS-1" . SPARSER::COLLECTION)
    ("mTOR and IRS-1" . SPARSER::COLLECTION) ("orthologs" . SPARSER::PROTEIN)
    ("CBL" . SPARSER::PROTEIN)
    ("at least three differentially" . SPARSER::PROTEIN)
    ("B56γ1, B56γ2, and B56γ3" . SPARSER::COLLECTION)
    ("B56γ" . SPARSER::PROTEIN)
    ("the active PP2A complex" . SPARSER::BIO-COMPLEX)
    ("small T antigen (ST)" . SPARSER::PROTEIN)
    ("PP2A-B56γ" . SPARSER::PROTEIN-PAIR) ("ST" . SPARSER::PROTEIN)
    ("an ABC heterotrimeric holoenzyme" . SPARSER::PROTEIN)
    ("a 65-kDa scaffolding (A) subunit and a 36-kDa catalytic (C) subunit"
     . SPARSER::COLLECTION)
    ("heterotrimeric enzymes" . SPARSER::ENZYME) ("rRNA" . SPARSER::PROTEIN)
    ("IGF" . SPARSER::PROTEIN) ("IRS-1 and Cul7" . SPARSER::COLLECTION)
    ("Grb2 and SOS" . SPARSER::COLLECTION) ("mTOR/S6K" . SPARSER::COLLECTION)
    ("Pei" . SPARSER::MOLECULE) ("TBC1D3 and B56γ" . SPARSER::COLLECTION)
    ("anti-myc or anti-B56γ" . SPARSER::COLLECTION)
    ("S6K-ED 3" . SPARSER::COLLECTION)
    ("FK506 and Calyculin A" . SPARSER::COLLECTION)
    ("a cell permeable inhibitor" . SPARSER::INHIBITOR)
    ("S6K and 4EBP1" . SPARSER::COLLECTION) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("a reliable anti-TBC1D3 antibody" . SPARSER::ANTIBODY)
    ("irrelevant siRNA" . SPARSER::PROTEIN)
    ("myc-TBC1D3" . SPARSER::COLLECTION) ("VA" . SPARSER::MOLECULE)
    ("Type" . TYPE) ("at least two proteins" . SPARSER::PROTEIN)
    ("4E-BP1 and S6K" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("S636/639" . SPARSER::PROTEIN) ("mTOR-S6K-IRS-1" . SPARSER::COLLECTION)
    ("TBC1D3 and PP2A" . SPARSER::COLLECTION)
    ("IRS-1:S636/639" . SPARSER::BIO-COMPLEX) ("I-R" . SPARSER::PROTEIN)
    ("K-R" . SPARSER::PROTEIN) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("Monoclonal antibody" . SPARSER::DRUG)
    ("small T antigen" . SPARSER::PROTEIN)
    ("upstream binding factor 1" . SPARSER::PROTEIN)
    ("Cul7" . SPARSER::PROTEIN) ("ED 3" . SPARSER::PROTEIN)
    ("PPP2R5C" . SPARSER::PROTEIN) ("Calyculin A" . SPARSER::MOLECULE)
    ("eukaryotic initiation factor 4E" . SPARSER::PROTEIN-FAMILY)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("Insulin receptor" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN)
    ("regulatory subunit B" . SPARSER::PROTEIN)
    ("protein phosphatase 2" . SPARSER::PROTEIN)
    ("insulin receptor substrate-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TBC1D3" . SPARSER::PROTEIN)
    ("non-chaperone heat-responsive genes" . SPARSER::GENE)
    ("cytoprotective heat shock proteins" . SPARSER::PROTEIN)
    ("arachidonic acid metabolites" . SPARSER::MOLECULE)
    ("IL-1β, and PGE 2" . SPARSER::COLLECTION)
    ("the accessible state" . SPARSER::BIO-STATE)
    ("classical heat shock genes" . SPARSER::GENE)
    ("monocytes and lymphoblastoid" . SPARSER::COLLECTION)
    ("a distal HSE" . SPARSER::PROTEIN) ("ERB" . SPARSER::PROTEIN)
    ("the heat-regulated factor HSF1" . SPARSER::PROTEIN)
    ("a new putative distal cis" . SPARSER::PROTEIN)
    ("A distal peroxisome proliferator response element (PPRE)"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("PPRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element (SRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response elements (CRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("typical immediate early genes" . SPARSER::GENE)
    ("protein C/EBP" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("SRE" . SPARSER::PROTEIN)
    ("bacterial endotoxin (LPS)" . SPARSER::MOLECULE)
    ("IL-1, IL-2 and TNFα" . SPARSER::COLLECTION)
    ("endotoxin" . SPARSER::MOLECULE) ("mRNA and COX-1" . SPARSER::COLLECTION)
    ("mRNA and COX-2" . SPARSER::COLLECTION)
    ("prostacyclin and different prostaglandins xref" . SPARSER::COLLECTION)
    ("PLA-2" . SPARSER::COLLECTION) ("COX-1 and COX-2" . SPARSER::COLLECTION)
    ("glycoproteins" . SPARSER::PROTEIN)
    ("Cyclooxygenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2 and HSP70" . SPARSER::COLLECTION)
    ("GATA and HSF1" . SPARSER::COLLECTION)
    ("HSE and GATA" . SPARSER::COLLECTION)
    ("HSF1 and GATA1" . SPARSER::COLLECTION) ("Δ-GATA" . SPARSER::COLLECTION)
    ("Δ-HSE" . SPARSER::COLLECTION) ("GATA" . SPARSER::PROTEIN)
    ("Del1, Del2 or Del3" . SPARSER::COLLECTION) ("inducer" . SPARSER::PROTEIN)
    ("response element (PPRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("several potential transcriptional cis" . SPARSER::PROTEIN)
    ("peroxisome" . SPARSER::PROTEIN) ("Ptgs2" . SPARSER::PROTEIN)
    ("COX-2 and β-actin" . SPARSER::COLLECTION)
    ("heat-induced COX-2" . SPARSER::PROTEIN)
    ("NS398 or DMSO" . SPARSER::COLLECTION)
    ("prostacyclin" . SPARSER::MOLECULE)
    ("IL-1β and COX-2" . SPARSER::COLLECTION)
    ("blot, and PGE 2" . SPARSER::COLLECTION)
    ("COX-2, HSP70 and β-actin" . SPARSER::COLLECTION)
    ("COX-2, COX-1, HSP70 and β-actin" . SPARSER::COLLECTION)
    ("PGE" . SPARSER::PROTEIN) ("monocytes and Jurkat" . SPARSER::COLLECTION)
    ("COX-2, COX-1 and β-actin" . SPARSER::COLLECTION)
    ("a distal cis" . SPARSER::PROTEIN) ("prostanoids" . SPARSER::MOLECULE)
    ("HSP27 and other proteins" . SPARSER::COLLECTION)
    ("the HSP70 and HSP90 families, HSP27 and other proteins"
     . SPARSER::COLLECTION)
    ("cytoprotective heat shock genes" . SPARSER::GENE)
    ("HSP70 and HSP90" . SPARSER::COLLECTION) ("chaperones" . SPARSER::PROTEIN)
    ("Functional HSE" . SPARSER::PROTEIN)
    ("nuclear-localized trimers" . SPARSER::TRIMER)
    ("a trimeric state" . SPARSER::BIO-STATE) ("monomers" . SPARSER::MONOMER)
    ("an inert monomer" . SPARSER::MONOMER) ("monomer" . SPARSER::MONOMER)
    ("HSF1, HSF2 and HSF4" . SPARSER::COLLECTION) ("HSFs" . SPARSER::PROTEIN)
    ("cytoprotective heat shock proteins (HSP)" . SPARSER::PROTEIN)
    ("a human non-classical heat-responsive gene" . SPARSER::GENE)
    ("a new distal cis" . SPARSER::PROTEIN)
    ("prostanoid and thromboxane" . SPARSER::COLLECTION)
    ("thromboxane" . SPARSER::MOLECULE) ("prostanoid" . SPARSER::MOLECULE)
    ("cytoprotective heat-shock proteins (HSP)" . SPARSER::PROTEIN)
    ("proteins (HSP)" . SPARSER::PROTEIN) ("HSE" . SPARSER::PROTEIN)
    ("HSF" . SPARSER::PROTEIN) ("DNase I" . SPARSER::PROTEIN)
    ("Gag-Pol" . SPARSER::PROTEIN) ("interleukin 1β" . SPARSER::PROTEIN)
    ("NS-398" . SPARSER::DRUG) ("s 5 A" . SPARSER::PROTEIN)
    ("protein C" . SPARSER::PROTEIN) ("immediate early" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("PGH2" . SPARSER::MOLECULE)
    ("GATA1" . SPARSER::PROTEIN) ("Transcription Factor" . SPARSER::PROTEIN)
    ("Del3" . SPARSER::PROTEIN) ("Del2" . SPARSER::PROTEIN)
    ("Del1" . SPARSER::PROTEIN) ("PGL3" . SPARSER::PROTEIN)
    ("actinomycin D" . SPARSER::MOLECULE) ("NS398" . SPARSER::DRUG)
    ("prostaglandin E 2" . SPARSER::MOLECULE) ("COX-1" . SPARSER::PROTEIN)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("HSP27" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("HSF4" . SPARSER::PROTEIN)
    ("HSF2" . SPARSER::PROTEIN) ("COX-2" . SPARSER::PROTEIN)
    ("HSF1" . SPARSER::PROTEIN) ("BET" . SPARSER::PROTEIN)
    ("EGR1, LEF1, HLF, and STAT6" . SPARSER::COLLECTION)
    ("APC-CDH2" . SPARSER::COLLECTION)
    ("their associated prostate cancer-associated TFAs" . SPARSER::PROTEIN)
    ("hi-c-Myc and Pten" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION)
    ("TFA or gene" . SPARSER::COLLECTION)
    ("NCA and its complementary trimming algorithm" . SPARSER::COLLECTION)
    ("HLF, ELK1, JUN, SMAD1, STAT6 and c-MYC" . SPARSER::COLLECTION)
    ("HLF, JUN, c-MYC, EGR1, SMAD1, and HIF1A" . SPARSER::COLLECTION)
    ("ESR2, MYB, RELA, and USF1" . SPARSER::COLLECTION)
    ("RELA" . SPARSER::PROTEIN) ("MYB" . SPARSER::PROTEIN)
    ("HLF" . SPARSER::PROTEIN) ("shorter DSS" . SPARSER::PROTEIN)
    ("DSS" . SPARSER::PROTEIN) ("separate PTEN" . SPARSER::PROTEIN)
    ("EGR1, ELK1, JUN, and NF-κB1" . SPARSER::COLLECTION)
    ("JUN" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CGH" . SPARSER::PROTEIN)
    ("the epistatic component" . SPARSER::COMPONENT)
    ("PTEN/AKT/mTOR" . SPARSER::COLLECTION)
    ("Ar, Creb1, Hoxc8, Elk1, Smad1, Hif1α, Stat6 and c-Myc"
     . SPARSER::COLLECTION)
    ("Elk1" . SPARSER::PROTEIN) ("Creb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ar" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AKT/mTOR" . SPARSER::COLLECTION)
    ("BCAT1 , CDK4 , EIF4E , and SHMNT1" . SPARSER::COLLECTION)
    ("c-MYC and the promoters" . SPARSER::COLLECTION)
    ("STAT6 and c-JUN" . SPARSER::COLLECTION)
    ("c-MYC and STAT6" . SPARSER::COLLECTION)
    ("c-MYC and LEF1" . SPARSER::COLLECTION)
    ("NF-κB and Hif1α" . SPARSER::COLLECTION)
    ("Egr1 and c-Jun" . SPARSER::COLLECTION) ("Egr1" . SPARSER::PROTEIN)
    ("Relb" . SPARSER::PROTEIN)
    ("NCA and the trimming algorithm" . SPARSER::COLLECTION)
    ("Pten" . SPARSER::PROTEIN) ("CS" . SPARSER::PROTEIN)
    ("NCA" . SPARSER::PROTEIN) ("Component" . SPARSER::COMPONENT)
    ("transcription factor (TFA)" . SPARSER::PROTEIN)
    ("PI3K, AKT and mTOR" . SPARSER::COLLECTION)
    ("PTEN-PI3K-AKT" . SPARSER::COLLECTION)
    ("NF-κB, FOXO, and p53" . SPARSER::COLLECTION)
    ("phosphatase and tensin" . SPARSER::COLLECTION)
    ("tensin" . SPARSER::PROTEIN) ("TFAs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TFA" . SPARSER::PROTEIN) ("protein or gene" . SPARSER::COLLECTION)
    ("Transcription factor" . SPARSER::PROTEIN)
    ("tissue-type" . SPARSER::PROTEIN) ("tissue type" . SPARSER::PROTEIN)
    ("USF1" . SPARSER::PROTEIN) ("ESR2" . SPARSER::PROTEIN)
    ("HIF1A" . SPARSER::PROTEIN) ("ELK1" . SPARSER::PROTEIN)
    ("EGR1" . SPARSER::PROTEIN) ("c - MYC" . SPARSER::PROTEIN)
    ("WISP1" . SPARSER::PROTEIN) ("EIF4E" . SPARSER::PROTEIN)
    ("BCAT1" . SPARSER::PROTEIN) ("c-JUN" . SPARSER::PROTEIN)
    ("LEF1" . SPARSER::PROTEIN) ("Hif1α" . SPARSER::PROTEIN)
    ("P-S6K" . SPARSER::PROTEIN) ("PI3K-AKT" . SPARSER::COLLECTION)
    ("MAGI2" . SPARSER::PROTEIN) ("PI3K-AKT-mTOR" . SPARSER::COLLECTION)
    ("PI3K/PDK1/AKT" . SPARSER::COLLECTION)
    ("p53 and Wnt" . SPARSER::COLLECTION)
    ("the only DUB enzyme" . SPARSER::ENZYME)
    ("alternative proteases" . SPARSER::PROTEIN)
    ("EGF or glucose" . SPARSER::COLLECTION)
    ("USP4 and PDK1" . SPARSER::COLLECTION)
    ("PDK1/Ub-PDK1" . SPARSER::COLLECTION)
    ("the Ubiquitin-Specific Protease 4 (USP4) reproducibly inhibited Ub-PDK1"
     . SPARSER::COLLECTION)
    ("Tagged PDK1 and each individual DUB" . SPARSER::COLLECTION)
    ("DUB" . SPARSER::PROTEIN) ("PDK1 and co-localizes" . SPARSER::COLLECTION)
    ("PDK1:Ub-PDK1" . SPARSER::BIO-COMPLEX)
    ("V5-tagged PDK1" . SPARSER::PROTEIN)
    ("AKT, p53 and Cyclin" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("predicted tryptic peptides" . SPARSER::PEPTIDE)
    ("exogenous ubiquitin" . SPARSER::PROTEIN)
    ("approximately 5–10 kDa" . SPARSER::PROTEIN)
    ("PDK1-ubiquitin" . SPARSER::COLLECTION)
    ("ubiquitin and V5-PDK1" . SPARSER::COLLECTION)
    ("first expressed V5-tagged PDK1" . SPARSER::PROTEIN)
    ("Ub-PDK1" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("the most abundant migrated approximately 5–10 kDa" . SPARSER::PROTEIN)
    ("AKT and PTEN" . SPARSER::COLLECTION) ("DUBs" . SPARSER::PROTEIN)
    ("alternative ubiquitin" . SPARSER::PROTEIN)
    ("kinase (SGK)" . SPARSER::KINASE) ("PIF" . SPARSER::PROTEIN)
    ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY) ("H1.2" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Beta-Mercaptoethanol" . SPARSER::MOLECULE)
    ("N -Ethylmaleimide" . SPARSER::MOLECULE)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("FANCD2" . SPARSER::PROTEIN) ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("MYC-tagged" . SPARSER::PROTEIN) ("USP15" . SPARSER::PROTEIN)
    ("K110" . SPARSER::PROTEIN) ("CRM1" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN)
    ("phosphoinositide-3 kinase" . SPARSER::PROTEIN)
    ("USP4" . SPARSER::PROTEIN) ("phospho-inositide" . SPARSER::MOLECULE)
    ("perfectly or imperfectly palindromic EREs" . SPARSER::PROTEIN)
    ("their respective homodimers" . SPARSER::HOMODIMER)
    ("a widely-utilized FDA-approved breast cancer treatment and prevention drug"
     . SPARSER::DRUG)
    ("endoxifen" . SPARSER::DRUG) ("exogenous ERs" . SPARSER::PROTEIN)
    ("BRET and ERE-luciferase" . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("isoflavones" . SPARSER::MOLECULE)
    ("Biochanin A and formononetin" . SPARSER::COLLECTION)
    ("formononetin" . SPARSER::DRUG) ("isoflavone" . SPARSER::MOLECULE)
    ("CAS" . SPARSER::PROTEIN) ("Isoflavones" . SPARSER::MOLECULE)
    ("pyrone" . SPARSER::MOLECULE) ("secondary HTS BRET" . SPARSER::PROTEIN)
    ("ERβ/β homodimers and ERα/β heterodimers" . SPARSER::COLLECTION)
    ("Liquiritigenin" . SPARSER::DRUG)
    ("phytoestrogens, genistein and liquiritigenin" . SPARSER::COLLECTION)
    ("liquiritigenin" . SPARSER::DRUG)
    ("ERα/α homodimers or ERβ/β homodimers" . SPARSER::COLLECTION)
    ("DAPI and β-actin" . SPARSER::COLLECTION) ("NAT" . SPARSER::PROTEIN)
    ("the quantitative immunofluorescence AQUA" . SPARSER::MOLECULE)
    ("ERα−" . SPARSER::PROTEIN) ("damped" . SPARSER::MOLECULE)
    ("the only ER dimers" . SPARSER::DIMER)
    ("the only functional ER" . SPARSER::PROTEIN)
    ("the pure ER antagonist ICI 182,780 and the ERα selective antagonist MPP dihydrochloride ( xref , middle and right panels)"
     . SPARSER::COLLECTION)
    ("the pure ER antagonist ICI 182,780" . SPARSER::DRUG)
    ("MPP" . SPARSER::PROTEIN) ("that E2's" . SPARSER::MOLECULE)
    ("functional ERs" . SPARSER::PROTEIN)
    ("strong inducers" . SPARSER::MOLECULE) ("matrigel" . SPARSER::PROTEIN)
    ("homodimer- and ERα/β" . SPARSER::COLLECTION)
    ("homodimer-" . SPARSER::HOMODIMER)
    ("ERβ/β homodimers and ERα/β heterodimers ( xref )" . SPARSER::COLLECTION)
    ("both ERβ/β homodimers and ERα/β heterodimers ( xref )"
     . SPARSER::COLLECTION)
    ("two enantiomeric forms" . SPARSER::FORM)
    ("glucoside" . SPARSER::MOLECULE) ("apigenin" . SPARSER::DRUG)
    ("Molecule" . SPARSER::MOLECULE) ("Fulvestrant" . SPARSER::DRUG)
    ("HTS" . SPARSER::PROTEIN) ("BRET" . SPARSER::PROTEIN)
    ("two phytoestrogens that are transcriptionally active and ERα/β"
     . SPARSER::COLLECTION)
    ("ERα∶ERβ" . SPARSER::BIO-COMPLEX) ("HC11" . SPARSER::PROTEIN)
    ("pro-proliferative and anti-apoptotic target genes" . SPARSER::GENE)
    ("homodimers (ERα/ERα or ERβ/ERβ) or heterodimers (ERα/ERβ)"
     . SPARSER::COLLECTION)
    ("ERα or ERβ" . SPARSER::COLLECTION) ("ERα/ERβ" . SPARSER::COLLECTION)
    ("ERβ/ERβ" . SPARSER::COLLECTION) ("ERα/ERα" . SPARSER::COLLECTION)
    ("EREs" . SPARSER::PROTEIN) ("stromal ERα" . SPARSER::PROTEIN)
    ("ERs" . SPARSER::PROTEIN) ("ERα and ERβ" . SPARSER::COLLECTION)
    ("AQUA" . SPARSER::MOLECULE) ("phytoestrogens" . SPARSER::MOLECULE)
    ("receptors, ERα and ERβ" . SPARSER::COLLECTION)
    ("anti-viral" . SPARSER::DRUG) ("Biochanin A" . SPARSER::MOLECULE)
    ("3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("caspases 3" . SPARSER::PROTEIN)
    ("Response Elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("multiple bacterial ligands" . SPARSER::LIGAND)
    ("low level LPS and other bacterial antigens" . SPARSER::COLLECTION)
    ("CD14 and CD16" . SPARSER::COLLECTION)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI3K/PTEN" . SPARSER::COLLECTION)
    ("LPS or other TLR ligands" . SPARSER::COLLECTION)
    ("more proficient sentinels" . SPARSER::DRUG)
    ("RAP1 and p38" . SPARSER::COLLECTION) ("MAPKs" . SPARSER::PROTEIN)
    ("PI3K or p38" . SPARSER::COLLECTION)
    ("PLA2 and PLC" . SPARSER::COLLECTION)
    ("wortmannin or LY294002" . SPARSER::COLLECTION) ("Ib" . SPARSER::DRUG)
    ("MyD88, IRAK, p38, and Rap1" . SPARSER::COLLECTION)
    ("sICAM-1" . SPARSER::COLLECTION) ("VII" . SPARSER::PROTEIN)
    ("ALL1-fused" . SPARSER::COLLECTION) ("/Rap1" . SPARSER::COLLECTION)
    ("RIAM" . SPARSER::PROTEIN) ("AF-6" . SPARSER::PROTEIN)
    ("RapL" . SPARSER::PROTEIN)
    ("LPS and other TLR agonists" . SPARSER::COLLECTION)
    ("the vascular barrier" . SPARSER::PROTEIN)
    ("subsequent chemotaxis" . SPARSER::PROTEIN)
    ("downregulation or degradation CCR2 or other CKRs" . SPARSER::COLLECTION)
    ("chemokine and LPS" . SPARSER::COLLECTION)
    ("CCL2, CXCL12 and fMLF" . SPARSER::COLLECTION)
    ("GGTI-298 and SB203580 or PD98059" . SPARSER::COLLECTION)
    ("SB203580 or PD98059" . SPARSER::COLLECTION)
    ("GGTI and p38" . SPARSER::COLLECTION) ("GGTI" . SPARSER::PROTEIN)
    ("Rap1 and ERK" . SPARSER::COLLECTION)
    ("Rap1 and p38" . SPARSER::COLLECTION)
    ("GGTI-298 and SB203580" . SPARSER::COLLECTION)
    ("both MAPK ( xref ) and Rap1 ( xref )" . SPARSER::COLLECTION)
    ("MAPK or Rap1" . SPARSER::COLLECTION)
    ("p38 and Rap1" . SPARSER::COLLECTION) ("TLR4/MD1" . SPARSER::COLLECTION)
    ("IRAK" . SPARSER::PROTEIN) ("β2-integrin" . SPARSER::COLLECTION)
    ("specifically targets Epac" . SPARSER::PROTEIN)
    ("-methyladenosine-3" . SPARSER::COLLECTION) ("-2-" . SPARSER::PROTEIN)
    ("adenosine" . SPARSER::MOLECULE)
    ("GEF2, Epac1 and C3G" . SPARSER::COLLECTION)
    ("diacyl-glycerol" . SPARSER::COLLECTION)
    ("Ral GDS-RBD (Ral guanine nucleotide dissociation stimulator Ras binding domain) GST (glutathione S -transferase) fusion protein"
     . SPARSER::PROTEIN)
    ("GDS" . SPARSER::PROTEIN) ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Calcein" . SPARSER::MOLECULE)
    ("activated β2 integrin (CD18) and Alexa-488 mAb" . SPARSER::COLLECTION)
    ("activated β2 integrin and the LPS receptor" . SPARSER::COLLECTION)
    ("mAbs" . SPARSER::DRUG) ("CD18 or CD18" . SPARSER::COLLECTION)
    ("LFA-1 or Mac-1" . SPARSER::COLLECTION)
    ("activated LFA-1 ( xref , left) and Mac-1 ( xref , right)"
     . SPARSER::COLLECTION)
    ("LFA-1, Mac-1 and F-actin" . SPARSER::COLLECTION)
    ("LFA-1 (CD11a) or Mac-1 (CD11b)" . SPARSER::COLLECTION)
    ("Integrin" . SPARSER::PROTEIN)
    ("integrins, LFA-1 and Mac-1" . SPARSER::COLLECTION)
    ("PD98059 and SB203580" . SPARSER::COLLECTION)
    ("ERK and p38" . SPARSER::COLLECTION)
    ("MAPK and p44/42" . SPARSER::COLLECTION)
    ("CCR2 and CXCR4" . SPARSER::COLLECTION)
    ("whose monocytes" . SPARSER::PROTEIN)
    ("CCL2 and CXCL12" . SPARSER::COLLECTION) ("PLC" . SPARSER::PROTEIN)
    ("GPCR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cells secreted chemokines" . SPARSER::PROTEIN)
    ("their respective mRNAs" . SPARSER::PROTEIN)
    ("Chemotaxis" . SPARSER::PROTEIN) ("fMLF or CXCL8" . SPARSER::COLLECTION)
    ("Neutrophils" . SPARSER::PROTEIN)
    ("F-actin and PIP 3" . SPARSER::COLLECTION)
    ("fluorescent phalloidin" . SPARSER::MOLECULE) ("mAb" . SPARSER::DRUG)
    ("their respective chemokines, CXCL8 or CCL2" . SPARSER::COLLECTION)
    ("chemokines, CXCL8 or CCL2" . SPARSER::COLLECTION)
    ("Neutrophil" . SPARSER::PROTEIN)
    ("circumferential F-actin" . SPARSER::BIO-COMPLEX)
    ("LPS, MALP-2 and Pam" . SPARSER::COLLECTION)
    ("CCL2 or CXL12" . SPARSER::COLLECTION) ("polymers" . SPARSER::MOLECULE)
    ("TLR2 or TLR4" . SPARSER::COLLECTION)
    ("a recalcitrant state" . SPARSER::BIO-STATE)
    ("LPS or MALP2" . SPARSER::COLLECTION)
    ("CCL2, CXCL12 or fMLF" . SPARSER::COLLECTION)
    ("CCL2 or CXCL12" . SPARSER::COLLECTION)
    ("lipopeptide-2" . SPARSER::COLLECTION) ("dipeptide" . SPARSER::MOLECULE)
    ("muramyl" . SPARSER::MOLECULE) ("ODN" . SPARSER::PROTEIN)
    ("flagellin" . SPARSER::PROTEIN) ("lipopeptide" . SPARSER::PROTEIN)
    ("MALP" . SPARSER::PROTEIN)
    ("LPS and other TLR ligands" . SPARSER::COLLECTION)
    ("CXCL12 ( xref ) or fMLF (not shown)" . SPARSER::COLLECTION)
    ("fMLF" . SPARSER::MOLECULE)
    ("LPS and other TLR2/4 ligands" . SPARSER::COLLECTION)
    ("TLR2" . SPARSER::PROTEIN) ("LFA-1 and Mac-1" . SPARSER::COLLECTION)
    ("pro-inflammatory leukocytes" . SPARSER::PROTEIN)
    ("antigen-1 or integrin" . SPARSER::COLLECTION)
    ("tyrosine kinase, Pyk2 and paxillin" . SPARSER::COLLECTION)
    ("Mac-1" . SPARSER::PROTEIN) ("THP-1" . SPARSER::PROTEIN)
    ("CCR1 and CCR5" . SPARSER::COLLECTION)
    ("CCR1 and CCR2" . SPARSER::COLLECTION) ("CSK" . SPARSER::PROTEIN)
    ("Pam" . SPARSER::PROTEIN) ("septic neutrophils" . SPARSER::PROTEIN)
    ("LPS or LTA" . SPARSER::COLLECTION)
    ("GRK2 and GRK5" . SPARSER::COLLECTION) ("LIX" . SPARSER::PROTEIN)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("usher" . SPARSER::PROTEIN-FAMILY) ("Leukocytes" . SPARSER::PROTEIN)
    ("Monocytes" . SPARSER::PROTEIN)
    ("up robust anti-microbial effector" . SPARSER::EFFECTOR)
    ("the inflammatory foci" . SPARSER::PROTEIN)
    ("the primary sentinels" . SPARSER::DRUG) ("sentinels" . SPARSER::DRUG)
    ("MAPK and Rap1" . SPARSER::COLLECTION)
    ("activated Rap1 (Ras-proximate-1 or Ras-related protein 1) GTPase and Rap1GEF (guanylate exchange factor) Epac1"
     . SPARSER::PROTEIN)
    ("GTPase and Rap1GEF" . SPARSER::COLLECTION) ("Epac1" . SPARSER::PROTEIN)
    ("AMP" . SPARSER::AMP) ("Epac" . SPARSER::PROTEIN)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("polymorphonuclear neutrophils" . SPARSER::PROTEIN)
    ("integrins and PIP 3" . SPARSER::COLLECTION)
    ("CCR2, CXCR4 and FPR" . SPARSER::COLLECTION) ("FPR" . SPARSER::PROTEIN)
    ("RNA or protein" . SPARSER::COLLECTION) ("CKR" . SPARSER::PROTEIN)
    ("proinflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("CS4" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("5–2" . SPARSER::PROTEIN) ("CXCR-1" . SPARSER::PROTEIN)
    ("CCR3" . SPARSER::PROTEIN) ("CDC42" . SPARSER::PROTEIN)
    ("CX 3 CR1" . SPARSER::PROTEIN) ("CD16" . SPARSER::PROTEIN)
    ("IP3" . SPARSER::IP3) ("PIP2" . SPARSER::PIP2)
    ("phospholipase A2" . SPARSER::PROTEIN) ("PLA2" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("PI3Kγ" . SPARSER::PROTEIN)
    ("PI3Kδ" . SPARSER::PROTEIN)
    ("proline-rich tyrosine kinase 2" . SPARSER::PROTEIN)
    ("ALL1" . SPARSER::PROTEIN) ("Krev- 1" . SPARSER::PROTEIN)
    ("KRIT-1" . SPARSER::PROTEIN)
    ("Rap1–GTP-interacting adapter molecule" . SPARSER::PROTEIN)
    ("SKAP1" . SPARSER::PROTEIN) ("RAP1" . SPARSER::PROTEIN)
    ("interleukin-1" . SPARSER::PROTEIN) ("MD1" . SPARSER::PROTEIN)
    ("GGTI-298" . SPARSER::DRUG) ("S5 B" . SPARSER::PROTEIN)
    ("CPT-2" . SPARSER::PROTEIN) ("GEF2" . SPARSER::PROTEIN)
    ("PDZ GEF1" . SPARSER::PROTEIN)
    ("Ral guanine nucleotide dissociation stimulator" . SPARSER::PROTEIN)
    ("Rap-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("VCAM-1" . SPARSER::PROTEIN)
    ("ICAM-1" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("CD11a" . SPARSER::PROTEIN)
    ("SB203580" . SPARSER::DRUG)
    ("extracellular-signal-regulated kinase" . SPARSER::PROTEIN)
    ("IP 3" . SPARSER::IP3) ("CXCL8" . SPARSER::PROTEIN)
    ("nucleotide-binding oligomerization domain" . SPARSER::PROTEIN)
    ("NOD2" . SPARSER::PROTEIN) ("TLR9" . SPARSER::PROTEIN)
    ("TLR7" . SPARSER::PROTEIN) ("TLR5" . SPARSER::PROTEIN)
    ("poly I∶C" . SPARSER::MOLECULE) ("TLR1" . SPARSER::PROTEIN)
    ("CXCL12" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("Pyk2" . SPARSER::PROTEIN) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("αLβ2" . SPARSER::PROTEIN) ("antigen-1" . SPARSER::PROTEIN)
    ("LFA-1" . SPARSER::PROTEIN) ("PI3-K" . SPARSER::PROTEIN)
    ("CCR1" . SPARSER::PROTEIN) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("CXCR1" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase 2" . SPARSER::PROTEIN)
    ("GRK5" . SPARSER::PROTEIN) ("GRK2" . SPARSER::PROTEIN)
    ("CXCR2" . SPARSER::PROTEIN) ("MMP-8" . SPARSER::PROTEIN)
    ("TLR4" . SPARSER::PROTEIN) ("G-protein coupled" . SPARSER::PROTEIN)
    ("anti-microbial" . SPARSER::DRUG)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR)
    ("Ras-related protein" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("G-protein" . SPARSER::PROTEIN) ("CCR2" . SPARSER::PROTEIN)
    ("specifically release IL-18" . SPARSER::PROTEIN)
    ("IFN-γ or IL-12" . SPARSER::COLLECTION)
    ("IL-4 and Stat6" . SPARSER::COLLECTION) ("Stat6" . SPARSER::PROTEIN)
    ("TSLP or IL-33" . SPARSER::COLLECTION)
    ("IL-4, IL-9, IL-13, IL-25, IL-33 or TSLP" . SPARSER::COLLECTION)
    ("Peptide" . SPARSER::PEPTIDE) ("IL-4 and IL-5" . SPARSER::COLLECTION)
    ("plate-bound anti-CD3 and anti-CD28" . SPARSER::COLLECTION)
    ("anti-CD3 and anti-CD28" . SPARSER::COLLECTION) ("ROS" . SPARSER::PROTEIN)
    ("IL-4, IL-13, IL-18, IL-33 and TSLP" . SPARSER::COLLECTION)
    ("rIL" . SPARSER::PROTEIN)
    ("other Th2-associated cytokines" . SPARSER::PROTEIN)
    ("IL-4, IL-9, IL-13, IL-25, IL-33, and TSLP" . SPARSER::COLLECTION)
    ("a unique allergen" . SPARSER::MOLECULE)
    ("TSLP and IL-25" . SPARSER::COLLECTION)
    ("STAT6 and IL-4" . SPARSER::COLLECTION)
    ("IL-25 and IL-33" . SPARSER::COLLECTION) ("Ia" . SPARSER::MOLECULE)
    ("DCs" . SPARSER::MOLECULE)
    ("only one outdoor allergen" . SPARSER::MOLECULE)
    ("perennial ryegrass and Bermuda grass outdoor allergens"
     . SPARSER::MOLECULE)
    ("allergen" . SPARSER::MOLECULE)
    ("allergens and asthma" . SPARSER::COLLECTION)
    ("IL-4 and STAT6" . SPARSER::COLLECTION) ("allergens" . SPARSER::MOLECULE)
    ("IL-4, IL-9, IL-13, IL-25, IL-33, or TSLP" . SPARSER::COLLECTION)
    ("BAL" . SPARSER::PROTEIN) ("IL-25, TSLP and IL-33" . SPARSER::COLLECTION)
    ("TSLP" . SPARSER::PROTEIN) ("D11" . SPARSER::PROTEIN)
    ("4-1" . SPARSER::PROTEIN) ("10 C" . SPARSER::PROTEIN)
    ("5-2" . SPARSER::PROTEIN) ("Annexin-V" . SPARSER::PROTEIN)
    ("Caspase-1" . SPARSER::PROTEIN) ("th2" . SPARSER::PROTEIN)
    ("T-cell Receptor" . SPARSER::PROTEIN) ("NLRP3" . SPARSER::PROTEIN)
    ("PAR2" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("IL-5" . SPARSER::PROTEIN)
    ("IL-4R" . SPARSER::PROTEIN) ("caspase 1" . SPARSER::PROTEIN)
    ("anti-oxidants" . SPARSER::DRUG)
    ("thymic stromal lymphopoietin" . SPARSER::PROTEIN)
    ("NF- κB" . SPARSER::PROTEIN) ("IL-9" . SPARSER::PROTEIN)
    ("IL-18" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("IL-33" . SPARSER::PROTEIN) ("IL-25" . SPARSER::PROTEIN)
    ("other chaperone or binding proteins" . SPARSER::COLLECTION)
    ("Hsp27 or HSPB1" . SPARSER::COLLECTION) ("oxygen" . SPARSER::MOLECULE)
    ("HMGB1 or p53" . SPARSER::COLLECTION)
    ("significantly greater overall total HMGB1 (n=8, paired T-test, p =0.00031) and nuclear HMGB1 (n=8, paired T-test, p =0.023)"
     . SPARSER::COLLECTION)
    ("significantly greater overall total HMGB1" . SPARSER::PROTEIN)
    ("calnexin and CHOP" . SPARSER::COLLECTION)
    ("LC3-II and p62" . SPARSER::COLLECTION) ("CHOP" . SPARSER::PROTEIN)
    ("calnexin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("ADM and ETO" . SPARSER::COLLECTION) ("wortmannin" . SPARSER::PROTEIN)
    ("mitochondria, and caspase-9" . SPARSER::COLLECTION)
    ("ETO" . SPARSER::PROTEIN) ("ADM" . SPARSER::PROTEIN)
    ("adriamycin" . SPARSER::DRUG) ("DRAM and ULK1" . SPARSER::COLLECTION)
    ("DRAM" . SPARSER::PROTEIN) ("EP" . SPARSER::PROTEIN)
    ("HMGB1 and Beclin 1" . SPARSER::COLLECTION)
    ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("HBSS" . SPARSER::MOLECULE) ("the global fit" . SPARSER::PROTEIN-FAMILY)
    ("p53 and HMGB1" . SPARSER::COLLECTION)
    ("IL-2 or bovine serum albumin (BSA, xref )" . SPARSER::COLLECTION)
    ("bovine serum albumin" . SPARSER::PROTEIN)
    ("soluble RAGE" . SPARSER::PROTEIN)
    ("these respective proteins" . SPARSER::PROTEIN)
    ("p53/HMGB1" . SPARSER::COLLECTION) ("TCEP" . SPARSER::MOLECULE)
    ("tris" . SPARSER::MOLECULE) ("amine" . SPARSER::MOLECULE)
    ("p53 −/− HCT116 cells rapidly increase cytosolic HMGB1"
     . SPARSER::PROTEIN)
    ("exogenous HMGB1" . SPARSER::PROTEIN) ("RAGE" . SPARSER::PROTEIN)
    ("proteins and organelles" . SPARSER::COLLECTION)
    ("HMGB1/p53" . SPARSER::COLLECTION)
    ("HMGB1/Beclin 1" . SPARSER::COLLECTION)
    ("HMGB1 and p53" . SPARSER::COLLECTION) ("HSPB1" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN) ("cytochrome c" . SPARSER::PROTEIN)
    ("Unc-51-like kinase 1" . SPARSER::PROTEIN)
    ("Damage-regulated autophagy modulator" . SPARSER::PROTEIN)
    ("DLD-1" . SPARSER::PROTEIN) ("scaffolding protein" . SPARSER::PROTEIN)
    ("LC3-II" . SPARSER::PROTEIN) ("LP2" . SPARSER::PROTEIN)
    ("IgG2a" . SPARSER::PROTEIN) ("ULK1" . SPARSER::PROTEIN)
    ("COX IV" . SPARSER::PROTEIN) ("LC3" . SPARSER::PROTEIN)
    ("light chain 3" . SPARSER::PROTEIN) ("p62" . SPARSER::PROTEIN)
    ("High mobility group box 1" . SPARSER::PROTEIN)
    ("Beclin 1" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("rapidly turnover proteins" . SPARSER::PROTEIN)
    ("API-1and TRAIL" . SPARSER::COLLECTION)
    ("API-1 or API-1" . SPARSER::COLLECTION)
    ("DR4, DR5 and c-FLIP" . SPARSER::COLLECTION)
    ("receptor-" . SPARSER::RECEPTOR) ("Bid" . SPARSER::PROTEIN)
    ("MK2206 and API-2" . SPARSER::COLLECTION)
    ("MK2206 ( xref ) and API-2 ( xref )" . SPARSER::COLLECTION)
    ("flag-FLIP" . SPARSER::COLLECTION) ("flag" . SPARSER::PROTEIN-FAMILY)
    ("DMSO or API-1" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN)
    ("TRAIL and API-1" . SPARSER::COLLECTION)
    ("API-1 (e.g., 5 μM) and TRAIL (e.g., 20 ng/ml)" . SPARSER::COLLECTION)
    ("API-1 and TRAIL" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("DR5 or DR4" . SPARSER::COLLECTION)
    ("c-FLIP, DR4 and DR5" . SPARSER::COLLECTION)
    ("DR4 and DR5" . SPARSER::COLLECTION)
    ("caspase-8, caspase-9, caspase-3 and PARP" . SPARSER::COLLECTION)
    ("FLIP" . SPARSER::PROTEIN) ("FLICE" . SPARSER::PROTEIN)
    ("the adaptor molecule FADD and subsequent caspase-8"
     . SPARSER::COLLECTION)
    ("subsequent caspase-8" . SPARSER::PROTEIN)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("pyrimidines" . SPARSER::DRUG) ("API-2 and MK2206" . SPARSER::COLLECTION)
    ("DR4 or DR5" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("ligand (TRAIL)" . SPARSER::MOLECULE) ("MK2006" . SPARSER::DRUG)
    ("sulforhodamine B" . SPARSER::MOLECULE) ("S -1" . SPARSER::PROTEIN)
    ("long form" . SPARSER::PROTEIN) ("death receptor 4" . SPARSER::PROTEIN)
    ("APO-2L" . SPARSER::PROTEIN) ("API-2" . SPARSER::PROTEIN)
    ("DR5" . SPARSER::PROTEIN) ("DR4" . SPARSER::PROTEIN)
    ("caspase-9" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("API-1" . SPARSER::PROTEIN) ("tobacco and alcohol" . SPARSER::COLLECTION)
    ("E2F1, E2F2 and E2F3" . SPARSER::COLLECTION)
    ("STATx, SRY, and Elk-1" . SPARSER::COLLECTION) ("SRY" . SPARSER::PROTEIN)
    ("STATx" . SPARSER::PROTEIN) ("tobacco or alcohol" . SPARSER::COLLECTION)
    ("E2F1 or E2F2" . SPARSER::COLLECTION)
    ("variants or variant" . SPARSER::COLLECTION)
    ("Rb-E2Fs" . SPARSER::PROTEIN-PAIR)
    ("E2F1 and E2F2 variants or their combination" . SPARSER::COLLECTION)
    ("E2F1 or E2F3" . SPARSER::COLLECTION)
    ("E2F1 , E2F2 and E2F3" . SPARSER::COLLECTION)
    ("E2F1, E2F2 and E2F3a" . SPARSER::COLLECTION)
    ("E2F1 and E2F3" . SPARSER::COLLECTION) ("E2F1-E2F8" . SPARSER::COLLECTION)
    ("Tobacco and alcohol" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("E2F1 and E2F2" . SPARSER::COLLECTION) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("Micro-RNAs" . SPARSER::MICRO-RNA) ("Elk-1" . SPARSER::PROTEIN)
    ("GATA-1" . SPARSER::PROTEIN) ("E2F8" . SPARSER::PROTEIN)
    ("S1P (ranging from 0.1–1 μ M) and EGF (ranging from 0.05–0.5 ng/ml)"
     . SPARSER::COLLECTION)
    ("sphingosine kinase-S1P" . SPARSER::COLLECTION)
    ("Ceramide and sphingosine" . SPARSER::COLLECTION)
    ("Ceramide" . SPARSER::MOLECULE)
    ("S1P (100 nM) and EGF (0.05 ng/ml)" . SPARSER::COLLECTION)
    ("S1P and EGF" . SPARSER::COLLECTION)
    ("S1P (0.1 μ M) and EGF (0.05 ng/ml)" . SPARSER::COLLECTION)
    ("S1P (0.1–1 μ M) or EGF (0.05–0.5 ng/ml)" . SPARSER::COLLECTION)
    ("a competitive antagonist" . SPARSER::MOLECULE)
    ("kinase, NFκB, or PI 3 -kinase" . SPARSER::COLLECTION)
    ("si-S1P 3 specifically knocked-down S1P 3 receptors" . SPARSER::RECEPTOR)
    ("si-S1P 3" . SPARSER::PROTEIN-PAIR) ("S1P-S1P 3" . SPARSER::COLLECTION)
    ("S1P and growth factor" . SPARSER::COLLECTION)
    ("sphingolipid" . SPARSER::MOLECULE)
    ("S1P 1 and S1P 2" . SPARSER::COLLECTION)
    ("S1P 1 and S1P 3" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("-EGFR" . SPARSER::COLLECTION)
    ("S1P/S1P 3" . SPARSER::COLLECTION)
    ("sphingosine kinase 1" . SPARSER::PROTEIN) ("Y-27632" . SPARSER::MOLECULE)
    ("PI 3 -kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SphK1" . SPARSER::PROTEIN) ("EDG-1" . SPARSER::PROTEIN)
    ("S1P 2" . SPARSER::PROTEIN) ("S1P 1" . SPARSER::PROTEIN)
    ("Rho kinase" . SPARSER::PROTEIN) ("S1P 3" . SPARSER::PROTEIN)
    ("Sphingosine-1-phosphate" . SPARSER::DRUG)
    ("BRCA2 and ATR" . SPARSER::COLLECTION) ("RBPs" . SPARSER::PROTEIN)
    ("RHINO" . SPARSER::PROTEIN)
    ("PALB2, BRCA1 and RPA2" . SPARSER::COLLECTION) ("ATR" . SPARSER::PROTEIN)
    ("GFP- and FHA-tagged RBMX mutants ( xref , xref ; see xref )"
     . SPARSER::COLLECTION)
    ("GFP-" . SPARSER::PROTEIN) ("RPA2 or Chk1" . SPARSER::COLLECTION)
    ("IR or camptothecin" . SPARSER::COLLECTION)
    ("ultraviolent light (UV) and tert-butyl hydroperoxide (tBHP)"
     . SPARSER::COLLECTION)
    ("ultraviolent light (UV)" . SPARSER::PROTEIN) ("tBHP" . SPARSER::MOLECULE)
    ("FHA-RBMX" . SPARSER::COLLECTION)
    ("mitomycin C, chlorambucil, oxaliplatin, and carboplatin"
     . SPARSER::COLLECTION)
    ("oxaliplatin" . SPARSER::DRUG) ("chlorambucil" . SPARSER::DRUG)
    ("camptothecin" . SPARSER::DRUG)
    ("two Ambion siRNAs (siRBMX-5 and -6) and three independently selected shRNAs (shRBMX-7, -9 and -10)"
     . SPARSER::COLLECTION)
    ("caused defective HR" . SPARSER::PROTEIN)
    ("BRCA2 and Rad51" . SPARSER::COLLECTION) ("PARG" . SPARSER::PROTEIN)
    ("ionizing radiation-induced foci" . SPARSER::PROTEIN)
    ("GFP-RBMX" . SPARSER::COLLECTION) ("Triton" . SPARSER::MOLECULE)
    ("X-linked RBMX and a Y chromosome-encoded paralog (RBMY)"
     . SPARSER::COLLECTION)
    ("the strong scoring Ambion siRNAs" . SPARSER::PROTEIN)
    ("reagents" . SPARSER::MOLECULE)
    ("our strong scoring Dharmacon siRNAs" . SPARSER::PROTEIN)
    ("CDS" . SPARSER::PROTEIN) ("defective HR" . SPARSER::PROTEIN)
    ("UBN1 and HIRA" . SPARSER::COLLECTION)
    ("seven siRNAs and three shRNAs" . SPARSER::COLLECTION)
    ("HIRA and two additional HIRA-associated proteins (UBN1 and CAIN)"
     . SPARSER::COLLECTION)
    ("two additional HIRA-associated proteins" . SPARSER::PROTEIN)
    ("UBN1 and CAIN" . SPARSER::COLLECTION) ("CAIN" . SPARSER::PROTEIN)
    ("HIRA" . SPARSER::PROTEIN) ("helicase" . SPARSER::PROTEIN)
    ("mediators, HIRIP3 and RBMX" . SPARSER::COLLECTION)
    ("RNA polymerase II (RNAP2) and mediator subunits" . SPARSER::COLLECTION)
    ("RNAP" . SPARSER::PROTEIN) ("I-SceI and GFP" . SPARSER::COLLECTION)
    ("TIP60, RUVBL1, RUVBL2, DMAP1, Brd8, p400, ING3, MRGBP and MRG15"
     . SPARSER::COLLECTION)
    ("Brd8" . SPARSER::PROTEIN) ("MRGBP" . SPARSER::PROTEIN)
    ("DDB1 and the Cul4A ubiquitin ligase" . SPARSER::COLLECTION)
    ("acetylase" . SPARSER::PROTEIN) ("clamp" . SPARSER::PROTEIN-FAMILY)
    ("RFC" . SPARSER::PROTEIN) ("IPA" . SPARSER::MOLECULE)
    ("Strong siRNAs" . SPARSER::PROTEIN)
    ("HR and the DDR" . SPARSER::COLLECTION)
    ("Rad51, BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("4 distinct siRNAs" . SPARSER::PROTEIN) ("DR" . SPARSER::MOLECULE)
    ("spliceosome" . SPARSER::BIO-COMPLEX) ("hnRNP" . SPARSER::PROTEIN)
    ("BRCA2 and the Rad51 paralogs (Rad51B, Rad51C, Rad51D, XRCC2 and XRCC3)"
     . SPARSER::COLLECTION)
    ("Rad51B, Rad51C, Rad51D, XRCC2 and XRCC3" . SPARSER::COLLECTION)
    ("paralogs" . SPARSER::PROTEIN) ("exonuclease" . SPARSER::PROTEIN)
    ("CtIP" . SPARSER::PROTEIN) ("RBMX" . SPARSER::PROTEIN)
    ("a 2 s" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TIAM2" . SPARSER::PROTEIN)
    ("SMAD1" . SPARSER::PROTEIN) ("Reverse Transcriptase" . SPARSER::PROTEIN)
    ("hnRNP-C" . SPARSER::PROTEIN) ("hnRNP-K" . SPARSER::PROTEIN)
    ("KU-55933" . SPARSER::DRUG) ("s 5A" . SPARSER::PROTEIN)
    ("hnRNP A0" . SPARSER::PROTEIN) ("hnRNP K" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("3-1" . SPARSER::PROTEIN)
    ("9-1-1 complex" . SPARSER::|9-1-1|) ("Chk1" . SPARSER::PROTEIN)
    ("RPA2" . SPARSER::PROTEIN)
    ("tert-butyl hydroperoxide" . SPARSER::MOLECULE)
    ("mitomycin C" . SPARSER::DRUG) ("KU0058948" . SPARSER::DRUG)
    ("H2AX" . SPARSER::PROTEIN) ("Y chromosome" . SPARSER::PROTEIN)
    ("X-linked" . SPARSER::PROTEIN) ("RNA binding" . SPARSER::PROTEIN)
    ("EDC3" . SPARSER::PROTEIN) ("BP3" . SPARSER::PROTEIN)
    ("ITGB1" . SPARSER::PROTEIN) ("3-2" . SPARSER::PROTEIN)
    ("UBN1" . SPARSER::PROTEIN) ("RNA-binding protein" . SPARSER::PROTEIN)
    ("DDX17" . SPARSER::PROTEIN) ("HIRIP3" . SPARSER::PROTEIN)
    ("MRG15" . SPARSER::PROTEIN) ("ING3" . SPARSER::PROTEIN)
    ("p400" . SPARSER::PROTEIN) ("DMAP1" . SPARSER::PROTEIN)
    ("RUVBL2" . SPARSER::PROTEIN) ("RUVBL1" . SPARSER::PROTEIN)
    ("Cul4A" . SPARSER::PROTEIN) ("DDB1" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("XRCC3" . SPARSER::PROTEIN)
    ("XRCC2" . SPARSER::PROTEIN) ("Rad51D" . SPARSER::PROTEIN)
    ("Rad51C" . SPARSER::PROTEIN) ("Rad51B" . SPARSER::PROTEIN)
    ("heterogeneous nuclear ribonucleoprotein" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA) ("NFκB, NFAT, and ATF" . SPARSER::COLLECTION)
    ("SREBP" . SPARSER::PROTEIN-FAMILY) ("Sterol" . SPARSER::PROTEIN)
    ("sterol" . SPARSER::PROTEIN)
    ("lysosomal and autophagy genes" . SPARSER::COLLECTION)
    ("GTPase/mTORC1" . SPARSER::COLLECTION)
    ("v-ATPase/Rag" . SPARSER::COLLECTION)
    ("exogenous TFEB–GFP" . SPARSER::COLLECTION)
    ("chloroquine and Torin 1" . SPARSER::COLLECTION)
    ("chloroquine and SalA" . SPARSER::COLLECTION)
    ("serines" . SPARSER::AMINO-ACID)
    ("Torin 1 and Torin 2" . SPARSER::COLLECTION)
    ("U0126 and mTOR" . SPARSER::COLLECTION)
    ("chloroquine or Torin 1" . SPARSER::COLLECTION)
    ("flox/flox" . SPARSER::COLLECTION) ("CRE" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN) ("Chloroquine and SalA" . SPARSER::COLLECTION)
    ("Chloroquine" . SPARSER::PROTEIN)
    ("both TFEB and the Rags DN mutants" . SPARSER::COLLECTION)
    ("FLAG and the Rags CA mutants" . SPARSER::COLLECTION)
    ("FLAG and a control small GTPase (Rap2A)" . SPARSER::COLLECTION)
    ("FLAG and the Rags DN mutants" . SPARSER::COLLECTION)
    ("raptor and mTOR" . SPARSER::COLLECTION)
    ("TFEB-mTORC1" . SPARSER::COLLECTION) ("Rags" . SPARSER::PROTEIN)
    ("mTORC1–TFEB" . SPARSER::COLLECTION) ("‘trap'" . SPARSER::PROTEIN)
    ("clearly discernible intracellular puncta" . SPARSER::PROTEIN)
    ("mTORC1 and TFEB" . SPARSER::COLLECTION) ("Mutants" . SPARSER::MUTANT)
    ("alanines" . SPARSER::AMINO-ACID) ("normal media" . SPARSER::PROTEIN)
    ("Torin 1 or Rapamycin" . SPARSER::COLLECTION)
    ("a phosphospecific antibody" . SPARSER::PROTEIN)
    ("TFEB and mTORC1" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("RagC and RagD" . SPARSER::COLLECTION) ("RagD" . SPARSER::PROTEIN)
    ("RagC" . SPARSER::PROTEIN) ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("Torin 1 (EC50; 147.9 nM) and its analogue Torin 2 (EC50; 1666 nM)"
     . SPARSER::COLLECTION)
    ("U0126, Rapamycin, Torin 1, and Torin 2" . SPARSER::COLLECTION)
    ("ERK and mTOR" . SPARSER::COLLECTION) ("TFEB–GFP" . SPARSER::COLLECTION)
    ("Torin 1 and Torin2" . SPARSER::COLLECTION)
    ("chloroquine or SalA" . SPARSER::COLLECTION) ("SalA" . SPARSER::PROTEIN)
    ("chloroquine" . SPARSER::PROTEIN)
    ("v-ATPase/mTORC1" . SPARSER::COLLECTION)
    ("triphosphatases" . SPARSER::PROTEIN) ("guanosine" . SPARSER::MOLECULE)
    ("both the v-ATPase and the master growth regulator mTOR complex"
     . SPARSER::COLLECTION)
    ("the vacuolar H + -ATPase (v-ATPase) complex" . SPARSER::BIO-COMPLEX)
    ("-ATPase" . SPARSER::COLLECTION) ("LSDs" . SPARSER::DRUG)
    ("TFEB and mTOR" . SPARSER::COLLECTION)
    ("which senses lysosomal amino acids" . SPARSER::AMINO-ACID)
    ("Rag" . SPARSER::PROTEIN)
    ("lysosomal and autophagic genes" . SPARSER::COLLECTION)
    ("autophagic genes" . SPARSER::GENE)
    ("Transcription Factor EB (TFEB)" . SPARSER::PROTEIN)
    ("Nutrient" . SPARSER::MOLECULE) ("mTOR and TFEB" . SPARSER::COLLECTION)
    ("TFEB" . SPARSER::PROTEIN) ("32P" . SPARSER::|32P|)
    ("A –3" . SPARSER::PROTEIN) ("P70S6K" . SPARSER::PROTEIN)
    ("Bis-tris" . SPARSER::MOLECULE) ("pRK5" . SPARSER::PROTEIN)
    ("Trypsin inhibitor" . SPARSER::PROTEIN)
    ("L -glutamine" . SPARSER::MOLECULE)
    ("Element Binding Protein" . SPARSER::PROTEIN) ("p-S6K" . SPARSER::PROTEIN)
    ("Rap2A" . SPARSER::PROTEIN) ("mSin1" . SPARSER::PROTEIN)
    ("Sin1" . SPARSER::PROTEIN) ("Torin 2" . SPARSER::DRUG)
    ("Torin2" . SPARSER::DRUG) ("Torin 1" . SPARSER::DRUG)
    ("amino acid transporter" . SPARSER::PROTEIN)
    ("PAT1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("A ‘" . SPARSER::PROTEIN)
    ("v-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("basic Helix-Loop-Helix" . SPARSER::PROTEIN)
    ("Transcription Factor EB" . SPARSER::PROTEIN)
    ("API2-MALT1" . SPARSER::COLLECTION)
    ("cyclin D2 and p27 kip1" . SPARSER::COLLECTION)
    ("Net1L321E" . SPARSER::PROTEIN)
    ("p38, JNK, and ERK" . SPARSER::COLLECTION) ("IK" . SPARSER::PROTEIN)
    ("BCL10, CARMA3, and CARMA1" . SPARSER::COLLECTION)
    ("LPA, PMA/ionomycin, and IL-1β" . SPARSER::COLLECTION)
    ("LPA" . SPARSER::LPA) ("Net1 and CARMA1" . SPARSER::COLLECTION)
    ("leukocytes" . SPARSER::PROTEIN) ("PMA" . SPARSER::PROTEIN)
    ("anti-Net1 or control antibody (anti-HA)" . SPARSER::COLLECTION)
    ("SAP" . SPARSER::PROTEIN)
    ("The neuroepithelial transforming gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the Ca 2+ -dependent phosphatase calcineurin ( xref ), the serine-threonine protein phosphatase PP2A regulatory subunit Aα ( xref ), the COP9 signalosome subunit 5 ( xref ), the casein kinase 1α ( xref ) and the deubiquitinating protein A20 ( xref )"
     . SPARSER::COLLECTION)
    ("the membrane-associated guanylate kinase (MAGUK) family"
     . SPARSER::PROTEIN-FAMILY)
    ("MAGUK" . SPARSER::PROTEIN-FAMILY)
    ("CARMA3 and BCL10" . SPARSER::COLLECTION)
    ("CARMA3, BCL10, and MALT1" . SPARSER::COLLECTION)
    ("BCL10 and MALT1" . SPARSER::COLLECTION) ("Fc" . SPARSER::PROTEIN)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("-BCL10-MALT1" . SPARSER::COLLECTION)
    ("BCL10 and CARMA" . SPARSER::COLLECTION)
    ("CARMA1 and CARMA3" . SPARSER::COLLECTION)
    ("BCL10, CARMA1, and CARMA3" . SPARSER::COLLECTION)
    ("Net1" . SPARSER::PROTEIN) ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CARMA-BCL10-MALT1" . SPARSER::COLLECTION) ("API2" . SPARSER::PROTEIN)
    ("p27 kip1" . SPARSER::PROTEIN) ("cyclin D2" . SPARSER::PROTEIN)
    ("I-κBα" . SPARSER::PROTEIN) ("subunit I" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endonuclease 1" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN)
    ("lysophosphatidic acid" . SPARSER::LPA)
    ("Interleukin-1β" . SPARSER::PROTEIN) ("anti-CD28" . SPARSER::PROTEIN)
    ("p46" . SPARSER::PROTEIN) ("p54" . SPARSER::PROTEIN)
    ("phospho-JNK" . SPARSER::PROTEIN) ("JNK 1" . SPARSER::PROTEIN)
    ("SAP97" . SPARSER::PROTEIN) ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A20" . SPARSER::PROTEIN) ("deubiquitinating protein" . SPARSER::PROTEIN)
    ("COP9 signalosome subunit 5" . SPARSER::PROTEIN)
    ("G protein-coupled" . SPARSER::PROTEIN) ("CARMA3" . SPARSER::PROTEIN)
    ("CARMA1" . SPARSER::PROTEIN)
    ("Rho guanine nucleotide exchange factor" . SPARSER::PROTEIN)
    ("MALT1" . SPARSER::PROTEIN) ("BCL10" . SPARSER::PROTEIN)
    ("all currently available JAK inhibitors" . SPARSER::INHIBITOR)
    ("p27 KIP1 ( xref ) and RKIP ( xref )" . SPARSER::COLLECTION)
    ("JIP" . SPARSER::PROTEIN) ("RKIP" . SPARSER::PROTEIN)
    ("the only biological kinase inhibitor" . SPARSER::INHIBITOR)
    ("PI-3K/Akt" . SPARSER::COLLECTION) ("Ras/ERK" . SPARSER::COLLECTION)
    ("which lacks GQM" . SPARSER::PROTEIN)
    ("specifically target JAKs" . SPARSER::PROTEIN)
    ("particular cytokines" . SPARSER::PROTEIN)
    ("JAK1, JAK2 or TYK2" . SPARSER::COLLECTION)
    ("such a ternary complex" . SPARSER::BIO-COMPLEX)
    ("an unusual ternary complex" . SPARSER::BIO-COMPLEX)
    ("both JAK and the gp130 receptor" . SPARSER::COLLECTION)
    ("SOCS3 and ADP" . SPARSER::COLLECTION) ("JAK-ADP" . SPARSER::COLLECTION)
    ("ADP and CMP-6" . SPARSER::COLLECTION) ("ATP-competitive" . SPARSER::ATP)
    ("ADP" . SPARSER::PROTEIN) ("substrate and ATP" . SPARSER::COLLECTION)
    ("enzyme and inhibitor" . SPARSER::COLLECTION)
    ("ATP and substrate" . SPARSER::COLLECTION)
    ("ATP (the phosphate donor) and a tyrosine-containing substrate (the phosphate acceptor)"
     . SPARSER::COLLECTION)
    ("Kinases" . SPARSER::KINASE)
    ("this ternary complex" . SPARSER::BIO-COMPLEX)
    ("binding JAK and specific cytokine receptors (which are already associated with JAK)"
     . SPARSER::COLLECTION)
    ("a high affinity ternary complex" . SPARSER::BIO-COMPLEX)
    ("salt" . SPARSER::MOLECULE) ("AV" . SPARSER::MOLECULE)
    ("amides" . SPARSER::MOLECULE) ("SOCS3-JAK2" . SPARSER::COLLECTION)
    ("HMQC" . SPARSER::DRUG) ("JAK2 and cytokine" . SPARSER::COLLECTION)
    ("Socs3" . SPARSER::PROTEIN)
    ("IL-6 and soluble IL-6Rα (Guschin et al., 1995)" . SPARSER::COLLECTION)
    ("DVP" . SPARSER::PROTEIN) ("GQM-DVP" . SPARSER::COLLECTION)
    ("a functional KIR" . SPARSER::PROTEIN)
    ("only SOCS4-7 homologues" . SPARSER::PROTEIN)
    ("homologues" . SPARSER::PROTEIN) ("at least one JAK" . SPARSER::PROTEIN)
    ("SOCS1 or SOCS3" . SPARSER::COLLECTION) ("GQM" . SPARSER::PROTEIN)
    ("GQM-VPA" . SPARSER::PROTEIN-PAIR) ("VPA" . SPARSER::PROTEIN)
    (":SOCS3:gp130" . SPARSER::BIO-COMPLEX)
    ("SOCS4 or SOCS5" . SPARSER::COLLECTION) ("elonginB" . SPARSER::PROTEIN)
    ("SOCS1-SOCS3" . SPARSER::COLLECTION) ("Enzyme" . SPARSER::ENZYME)
    ("Substrate" . SPARSER::SUBSTRATE) ("polymer" . SPARSER::MOLECULE)
    ("any tyrosines that are solvent exposed and not part"
     . SPARSER::COLLECTION)
    ("tyrosines" . SPARSER::AMINO-ACID) ("elonginC" . SPARSER::PROTEIN)
    ("SOCS2, SOCS4, SOCS4-3 and SOCS5-3" . SPARSER::COLLECTION)
    ("SOCS3 and SOCS1-3" . SPARSER::COLLECTION)
    ("SOCS1, SOCS4 or SOCS5" . SPARSER::COLLECTION)
    ("SOCS5-3" . SPARSER::COLLECTION) ("SOCS1-3" . SPARSER::COLLECTION)
    ("substrate (gp130 cytoplasmic domain, gp130 cyt ) and inhibitor (SOCS3)"
     . SPARSER::COLLECTION)
    ("cyt" . SPARSER::MOLECULE) ("JH" . SPARSER::PROTEIN)
    ("a non-competitive tyrosine kinase inhibitor and a new template"
     . SPARSER::COLLECTION)
    ("ATP or substrate" . SPARSER::COLLECTION)
    ("SOCS1 and SOCS3" . SPARSER::COLLECTION) ("KIR" . SPARSER::PROTEIN)
    ("elongins" . SPARSER::PROTEIN) ("CIS" . SPARSER::PROTEIN)
    ("Cytokine" . SPARSER::PROTEIN) ("Suppressors" . SPARSER::SUPPRESSOR)
    ("childhood T- and B-cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("TEL-JAK2" . SPARSER::COLLECTION) ("TEL" . SPARSER::PROTEIN)
    ("Vera" . SPARSER::PROTEIN)
    ("JAK and the cytokine receptor" . SPARSER::COLLECTION)
    ("JAK1, JAK2 and TYK2" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("P81" . SPARSER::PROTEIN) ("A 15" . SPARSER::PROTEIN)
    ("Gly-Ser" . SPARSER::MOLECULE) ("p27 KIP1" . SPARSER::PROTEIN)
    ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATPase activity" . SPARSER::PROTEIN) ("–2" . SPARSER::PROTEIN)
    ("CH 3" . SPARSER::MOLECULE) ("L41" . SPARSER::PROTEIN)
    ("H- 15" . SPARSER::PROTEIN) ("U4" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("SOCS2" . SPARSER::PROTEIN)
    ("SOCS5" . SPARSER::PROTEIN) ("SOCS4" . SPARSER::PROTEIN)
    ("S29" . SPARSER::PROTEIN) ("cytokine-receptor" . SPARSER::PROTEIN)
    ("Cullin5" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("JAK-STAT" . SPARSER::PROTEIN) ("TYK2" . SPARSER::PROTEIN)
    ("Suppressor of Cytokine Signaling-3" . SPARSER::PROTEIN)
    ("K-Ras and mTORC1" . SPARSER::COLLECTION)
    ("TSC2 and RAPTOR" . SPARSER::COLLECTION)
    ("the dual PI3K and mTOR inhibitor NVP-BEZ235" . SPARSER::DRUG)
    ("mTORC1-Grb10" . SPARSER::COLLECTION)
    ("mTORC1-S6K-IRS" . SPARSER::COLLECTION)
    ("a FTase inhibitor [ xref ; xref ] and sorafenib" . SPARSER::COLLECTION)
    ("tipifarnib" . SPARSER::DRUG) ("FTase" . SPARSER::PROTEIN)
    ("isoprenoid" . SPARSER::MOLECULE) ("primary PDAC" . SPARSER::MOLECULE)
    ("Everolimus" . SPARSER::MOLECULE) ("ERK and Akt" . SPARSER::COLLECTION)
    ("Ebi" . SPARSER::PROTEIN) ("FBS and IGF-1" . SPARSER::COLLECTION)
    ("EGF, FGF2, or HGF" . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("IGF-1 or 10% FBS" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("Raf-ERK" . SPARSER::COLLECTION) ("p-EGFP/K-Ras" . SPARSER::COLLECTION)
    ("10 nM everolimus and 10 μM BrdU" . SPARSER::COLLECTION)
    ("sorafenib and everolimus" . SPARSER::COLLECTION)
    ("c-Raf-ERK" . SPARSER::COLLECTION) ("Rasraf-ERK" . SPARSER::COLLECTION)
    ("c-kit and Flt-3" . SPARSER::COLLECTION) ("Flt-3" . SPARSER::PROTEIN)
    ("Sorafenib" . SPARSER::DRUG) ("p-Akt" . SPARSER::COLLECTION)
    ("mt K-Ras and c-Raf protein" . SPARSER::COLLECTION)
    ("mt K-Ras and c-Raf" . SPARSER::COLLECTION)
    ("c-Raf" . SPARSER::COLLECTION) ("p-ERK and p-RSK" . SPARSER::COLLECTION)
    ("p-MEK" . SPARSER::COLLECTION) ("p-c-Raf" . SPARSER::COLLECTION)
    ("c-Raf/Raf-1" . SPARSER::COLLECTION) ("Ras-Raf-ERK" . SPARSER::COLLECTION)
    ("S6K and 4E-BP1" . SPARSER::COLLECTION)
    ("mTORC1 and downstream kinases" . SPARSER::COLLECTION)
    ("p-mTOR" . SPARSER::COLLECTION)
    ("IGF-1-Ras-Raf-ERK" . SPARSER::COLLECTION)
    ("nearly 95% human PDACs" . SPARSER::MOLECULE)
    ("H- Ras or N- Ras" . SPARSER::COLLECTION)
    ("H- Ras , K- Ras and N- Ras" . SPARSER::COLLECTION)
    ("PI3K [ xref ; xref ; xref ; xref ] and ERK" . SPARSER::COLLECTION)
    ("substrate (IRS)" . SPARSER::SUBSTRATE)
    ("growth factor-mTORC1" . SPARSER::COLLECTION) ("IRS" . SPARSER::PROTEIN)
    ("the mTORC1 inhibitor TSC2 [ xref ; xref ] and ERK" . SPARSER::COLLECTION)
    ("ERK and RSK" . SPARSER::COLLECTION)
    ("p90 ribosomal S6 kinase (RSK)" . SPARSER::PROTEIN-FAMILY)
    ("ERK and ERK" . SPARSER::COLLECTION)
    ("Ras GTPase and the protein kinases Raf" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase (MAPK)/ERK kinase (MEK) and ERK"
     . SPARSER::COLLECTION)
    ("kinase (MEK)" . SPARSER::KINASE) ("/ERK" . SPARSER::COLLECTION)
    ("Ras-ERK" . SPARSER::COLLECTION) ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ras-extracellular signal-regulated kinase" . SPARSER::COLLECTION)
    ("its substrates tuberous sclerosis 2 (TSC2) and proline-rich Akt substrate 40 kDa (PRAS40)"
     . SPARSER::COLLECTION)
    ("PI3K and Akt" . SPARSER::COLLECTION)
    ("everolimus and temsirolimus" . SPARSER::COLLECTION)
    ("temsirolimus (CCI-779) and ridaforolimus (AP23573)"
     . SPARSER::COLLECTION)
    ("The rapamycin analogs everolimus (RAD001), temsirolimus (CCI-779) and ridaforolimus (AP23573)"
     . SPARSER::COLLECTION)
    ("ridaforolimus" . SPARSER::DRUG) ("temsirolimus" . SPARSER::DRUG)
    ("macrolide" . SPARSER::MOLECULE)
    ("regulatory-associated protein of mTOR (RAPTOR)" . SPARSER::PROTEIN)
    ("RAPTOR" . SPARSER::PROTEIN)
    ("p70S6 ribosomal kinase (p70S6K) and eukaryotic translational initiation factor 4E (eIF4E) binding protein (4E-BP1)"
     . SPARSER::COLLECTION)
    ("eukaryotic translational initiation factor 4E (eIF4E) binding protein"
     . SPARSER::PROTEIN)
    ("p70S6 ribosomal kinase" . SPARSER::KINASE)
    ("mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)"
     . SPARSER::COLLECTION)
    ("everolimus" . SPARSER::DRUG) ("PDACs" . SPARSER::MOLECULE)
    ("NVP-BEZ235" . SPARSER::DRUG)
    ("fibroblast growth factor 2" . SPARSER::PROTEIN)
    ("c-kit" . SPARSER::PROTEIN) ("PDGFR-β" . SPARSER::PROTEIN)
    ("VEGFR-1" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor-1" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("triton x-100" . SPARSER::MOLECULE) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("p-nitrophenyl" . SPARSER::MOLECULE) ("p-RSK" . SPARSER::PROTEIN)
    ("p-MEK1" . SPARSER::PROTEIN) ("NVP-AEW541" . SPARSER::DRUG)
    ("IGF-1-" . SPARSER::PROTEIN) ("K-Ras" . SPARSER::PROTEIN)
    ("N- Ras" . SPARSER::PROTEIN) ("H- Ras" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 10" . SPARSER::PROTEIN)
    ("tuberous sclerosis 2" . SPARSER::PROTEIN)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("AP23573" . SPARSER::DRUG)
    ("CCI-779" . SPARSER::DRUG) ("RAD001" . SPARSER::DRUG)
    ("regulatory-associated protein of mTOR" . SPARSER::PROTEIN)
    ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("initiation factor 4E" . SPARSER::PROTEIN) ("IGF-1" . SPARSER::PROTEIN)
    ("insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("K- Ras" . SPARSER::PROTEIN)
    ("Mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("NSAIDs and tyrosine kinase" . SPARSER::COLLECTION)
    ("Sp1 or Stat3" . SPARSER::COLLECTION)
    ("VEGF and bFGF" . SPARSER::COLLECTION)
    ("potential regulator" . SPARSER::REGULATOR)
    ("bFGF, hypoxia inducible factor-1α, and VEGF" . SPARSER::COLLECTION)
    ("prolactin" . SPARSER::PROTEIN) ("Sp1-Stat3" . SPARSER::COLLECTION)
    ("nuclear factor-κB, hypoxia-inducible factor-1α, and other factors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("Stat3-Sp1" . SPARSER::COLLECTION)
    ("Stats" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homodimer" . SPARSER::HOMODIMER)
    ("Stat3- and/or Sp1-regulated genes" . SPARSER::COLLECTION)
    ("Stat3-" . SPARSER::PROTEIN) ("Stat1 and Stat3" . SPARSER::COLLECTION)
    ("Stat1" . SPARSER::PROTEIN) ("Stat3 and Sp1" . SPARSER::COLLECTION)
    ("at least 3000 different gene promoters" . SPARSER::PROMOTER)
    ("proproliferative, antiapoptotic, proangiogenic, and prometastatic genes"
     . SPARSER::GENE)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("Sp1 and Stat" . SPARSER::COLLECTION) ("Stat" . SPARSER::PROTEIN)
    ("recently developed two novel small-molecule Stat3 inhibitors"
     . SPARSER::INHIBITOR)
    ("FLLL31 and FLLL32" . SPARSER::COLLECTION) ("LLL" . SPARSER::MOLECULE)
    ("AUH" . SPARSER::PROTEIN) ("cyclin D1 and Bcl-xL" . SPARSER::COLLECTION)
    ("VEGF and MMP-2" . SPARSER::COLLECTION) ("LV" . SPARSER::MOLECULE)
    ("MMP-2, VEGF, cyclin D1, and Bcl-xL" . SPARSER::COLLECTION)
    ("Stat3 and its related genes" . SPARSER::COLLECTION)
    ("Bcl-2, cyclin D1, and c-Myc" . SPARSER::COLLECTION)
    ("Cucurbitacin" . SPARSER::MOLECULE)
    ("AG-490 and IL-12" . SPARSER::COLLECTION)
    ("AG-490 and cucurbitacin" . SPARSER::COLLECTION)
    ("cucurbitacin" . SPARSER::MOLECULE)
    ("Stat3 and receptor" . SPARSER::COLLECTION)
    ("antisense" . SPARSER::PROTEIN) ("Snail" . SPARSER::PROTEIN)
    ("transforming growth factor-β–mediated EMT" . SPARSER::PROTEIN)
    ("Further implicating Stat3" . SPARSER::PROTEIN)
    ("MMP-2 and VEGF" . SPARSER::COLLECTION)
    ("kinase and paxillin" . SPARSER::COLLECTION)
    ("MMP-1 and MMP-10" . SPARSER::COLLECTION)
    ("numerous cytokines, growth factors, and oncogenic proteins"
     . SPARSER::COLLECTION)
    ("genes, and growth factors" . SPARSER::COLLECTION)
    ("dominant-negative Stat3" . SPARSER::PROTEIN)
    ("STAT3C" . SPARSER::PROTEIN)
    ("the known angiogenic mitogens" . SPARSER::MITOGEN)
    ("regulators and oncogenes" . SPARSER::COLLECTION)
    ("survivin and BCL-xL" . SPARSER::COLLECTION)
    ("survivin or BCL-xL" . SPARSER::COLLECTION)
    ("the cyclin D1 promoter and subsequently affecting cell-cycle progression"
     . SPARSER::COLLECTION)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("curcumin" . SPARSER::DRUG)
    ("Bcl-xL, Bcl-2, Fas, MCL1, survivin, and cyclin D1" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::PROTEIN) ("bevacizumab" . SPARSER::DRUG)
    ("a naturally occurring pentacyclic triterpene" . SPARSER::MOLECULE)
    ("triterpene" . SPARSER::MOLECULE)
    ("the angiogenic molecule Sp1" . SPARSER::PROTEIN)
    ("Sp1 and its downstream molecules VEGF, platelet-derived growth factor, and epidermal growth factor"
     . SPARSER::COLLECTION)
    ("VEGF, platelet-derived growth factor, and epidermal growth factor"
     . SPARSER::COLLECTION)
    ("mithramycin" . SPARSER::DRUG)
    ("Sp1, Sp3, Sp4, and VEGF" . SPARSER::COLLECTION)
    ("NSAIDs and cyclooxygenase" . SPARSER::COLLECTION)
    ("biaryl" . SPARSER::MOLECULE)
    ("nonsteroidal anti-inflammatory drugs" . SPARSER::DRUG)
    ("NSAIDs" . SPARSER::DRUG) ("IIB" . SPARSER::PROTEIN)
    ("Biomarkers" . SPARSER::MOLECULE) ("PNA" . SPARSER::PROTEIN)
    ("VEGFR2 mRNA as well as Sp1, Sp3, and Sp4 proteins" . SPARSER::COLLECTION)
    ("Sp1, Sp3, and Sp4" . SPARSER::COLLECTION)
    ("VEGFR2/KDR" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("Sp1 and Sp3" . SPARSER::COLLECTION) ("Sp3 and Sp4" . SPARSER::COLLECTION)
    ("celecoxib" . SPARSER::DRUG) ("Sp1 and VEGF" . SPARSER::COLLECTION)
    ("Sp1, and Sp1" . SPARSER::COLLECTION)
    ("a key angiogenic molecule" . SPARSER::MOLECULE)
    ("placental growth factor, and angiopoietins" . SPARSER::COLLECTION)
    ("growth factor, and angiopoietins" . SPARSER::COLLECTION)
    ("endothelial growth factor, and interleukins" . SPARSER::COLLECTION)
    ("interleukins" . SPARSER::PROTEIN)
    ("TP53, and SMAD4" . SPARSER::COLLECTION)
    ("p16/CDKN2A" . SPARSER::COLLECTION) ("SMAD4/DPC4" . SPARSER::COLLECTION)
    ("Oncogenes" . SPARSER::ONCOGENE)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("an essential transcription factor" . SPARSER::PROTEIN)
    ("GC" . SPARSER::PROTEIN) ("Sp1 and Stat3" . SPARSER::COLLECTION)
    ("Specificity Protein 1 (Sp1) and signal transducer and activator of transcription 3 (Stat3)"
     . SPARSER::COLLECTION)
    ("D-glucose" . SPARSER::MOLECULE)
    ("hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("SOCS1" . SPARSER::PROTEIN)
    ("Sp2" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling" . SPARSER::PROTEIN)
    ("factor-κB" . SPARSER::PROTEIN)
    ("intercellular adhesion molecule-1" . SPARSER::PROTEIN)
    ("M1" . SPARSER::MOLECULE) ("Jak3" . SPARSER::PROTEIN)
    ("S100" . SPARSER::PROTEIN) ("FLLL32" . SPARSER::DRUG)
    ("FLLL31" . SPARSER::DRUG) ("STA-21" . SPARSER::DRUG)
    ("IS3" . SPARSER::PROTEIN) ("cucurbitacin I" . SPARSER::DRUG)
    ("IL-12" . SPARSER::PROTEIN) ("Janus kinase 2" . SPARSER::PROTEIN)
    ("AG-490" . SPARSER::DRUG) ("MMP-10" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("hypoxia-inducible factor-1" . SPARSER::PROTEIN)
    ("BCL-xL" . SPARSER::PROTEIN) ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("BCL-XL" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("proliferation-associated" . SPARSER::PROTEIN)
    ("VEGFR2" . SPARSER::PROTEIN)
    ("vascular endothelial growth factor receptor 2" . SPARSER::PROTEIN)
    ("Sp4" . SPARSER::PROTEIN) ("Sp3" . SPARSER::PROTEIN)
    ("Vascular endothelial" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("endothelial growth factor" . SPARSER::PROTEIN)
    ("DPC4" . SPARSER::PROTEIN)
    ("Signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("Sp1" . SPARSER::PROTEIN)
    ("Protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("trimers" . SPARSER::TRIMER)
    ("vGPCR" . SPARSER::PROTEIN) ("LFS" . SPARSER::PROTEIN)
    ("neither TRAF6 nor TRADD" . SPARSER::COLLECTION)
    ("IL-1β-" . SPARSER::PROTEIN) ("dimers" . SPARSER::DIMER)
    ("viral RNA" . SPARSER::RNA) ("rev" . SPARSER::PROTEIN-FAMILY)
    ("GST-gp41" . SPARSER::COLLECTION)
    ("the dominant-negative TAK1 mutant K63W" . SPARSER::PROTEIN)
    ("K63W" . SPARSER::PROTEIN) ("substantially more RelA" . SPARSER::PROTEIN)
    ("CD8-stop" . SPARSER::COLLECTION) ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TAK1 and NEMO" . SPARSER::COLLECTION)
    ("NEMO or IKKγ" . SPARSER::COLLECTION) ("IKBKG" . SPARSER::PROTEIN)
    ("Components" . SPARSER::COMPONENT) ("phenylalanine" . SPARSER::AMINO-ACID)
    ("YSPL" . SPARSER::PROTEIN)
    ("mutated several amino acids" . SPARSER::AMINO-ACID)
    ("Maps" . SPARSER::PROTEIN) ("CD8-gp41" . SPARSER::COLLECTION)
    ("NF-AT-luciferase" . SPARSER::COLLECTION) ("AP-1-" . SPARSER::PROTEIN)
    ("Env" . SPARSER::PROTEIN) ("p100/p52" . SPARSER::COLLECTION)
    ("p105/p50" . SPARSER::COLLECTION) ("RelB" . SPARSER::PROTEIN)
    ("p115-RhoGEF" . SPARSER::COLLECTION) ("luman" . SPARSER::PROTEIN)
    ("RhoGEF" . SPARSER::PROTEIN)
    ("the viral envelope complex" . SPARSER::BIO-COMPLEX)
    ("only 30–40 amino acids" . SPARSER::AMINO-ACID)
    ("typically 150–200 amino acids" . SPARSER::AMINO-ACID)
    ("lentiviral TM" . SPARSER::PROTEIN)
    ("transmembrane envelope glycoproteins (TM)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("signal peptide" . SPARSER::PROTEIN) ("interleukin-2" . SPARSER::PROTEIN)
    ("TRIM5" . SPARSER::PROTEIN) ("IKKβ" . SPARSER::PROTEIN)
    ("interleukin-1β" . SPARSER::PROTEIN) ("CSNK1A1" . SPARSER::PROTEIN)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("IKKγ" . SPARSER::PROTEIN) ("CARD11" . SPARSER::PROTEIN)
    ("NL4" . SPARSER::PROTEIN) ("NF-AT" . SPARSER::PROTEIN)
    ("CD8" . SPARSER::PROTEIN) ("NF-κB2" . SPARSER::PROTEIN)
    ("p52" . SPARSER::PROTEIN) ("p100" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("prohibitin 1" . SPARSER::PROTEIN) ("PRA1" . SPARSER::PROTEIN)
    ("p115" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("α-catenin" . SPARSER::PROTEIN)
    ("envelope glycoproteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD-" . SPARSER::PROTEIN) ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("actin cytoskeletal-associated components" . SPARSER::COMPONENT)
    ("NF-κB and type I" . SPARSER::COLLECTION) ("PAMP" . SPARSER::PROTEIN)
    ("innate immune-associated components" . SPARSER::COMPONENT)
    ("PAMPs" . SPARSER::PROTEIN)
    ("cytoskeletal components" . SPARSER::COMPONENT)
    ("NF-κB and IRF3" . SPARSER::COLLECTION)
    ("detergent-insoluble fractions" . SPARSER::COMPONENT)
    ("prion" . SPARSER::PROTEIN-FAMILY)
    ("dominant-negative inhibitors" . SPARSER::INHIBITOR)
    ("two dominant-negative fragments" . SPARSER::FRAGMENT)
    ("IFNs" . SPARSER::DRUG) ("FAK-" . SPARSER::PROTEIN)
    ("phosphotyrosine (pTyr)-containing proteins concentrated at FAs ( xref ) and potently inhibited cell migration ( xref )"
     . SPARSER::COLLECTION)
    ("Polypeptide" . SPARSER::PROTEIN) ("Fragment" . SPARSER::FRAGMENT)
    ("EGFP-fused" . SPARSER::COLLECTION) ("Fragments" . SPARSER::FRAGMENT)
    ("glutamine-glycine" . SPARSER::COLLECTION)
    ("glycine" . SPARSER::AMINO-ACID) ("HA-" . SPARSER::MOLECULE)
    ("100 kD and a much smaller Flag-positive fragment" . SPARSER::COLLECTION)
    ("vinculin or other FA-associated components [( xref ) and not shown]"
     . SPARSER::COLLECTION)
    ("many FA-associated components" . SPARSER::COMPONENT)
    ("other FA-associated components" . SPARSER::COMPONENT)
    ("paxillin, talin, or vinculin" . SPARSER::COLLECTION)
    ("FA" . SPARSER::PROTEIN)
    ("Viruses commonly target central components" . SPARSER::COMPONENT)
    ("VSV ( xref ) or SeV ( xref )" . SPARSER::COLLECTION)
    ("EGFP-MAVS" . SPARSER::COLLECTION) ("FAK and MAVS" . SPARSER::COLLECTION)
    ("Flag-MAVS" . SPARSER::COLLECTION)
    ("another RLR-associated adaptor molecule" . SPARSER::MOLECULE)
    ("FAK and RIG-I or STING" . SPARSER::COLLECTION)
    ("RIG-I or STING" . SPARSER::COLLECTION) ("TRIF" . SPARSER::PROTEIN)
    ("STING" . SPARSER::PROTEIN) ("MAVS and components" . SPARSER::COLLECTION)
    ("RIP1 and TRAF3" . SPARSER::COLLECTION)
    ("overexpressed MAVS upregulated NF-κB and IFNβ activation"
     . SPARSER::COLLECTION)
    ("Mitochondria" . SPARSER::PROTEIN)
    ("RIG-I (RIG-I ΔC) or wild-type MAVS" . SPARSER::COLLECTION)
    ("RIG-I and MAVS" . SPARSER::COLLECTION)
    ("NF-κB or IFNβ" . SPARSER::COLLECTION)
    ("NF-κB and IFNβ activation" . SPARSER::COLLECTION)
    ("SeV and VSV" . SPARSER::COLLECTION) ("SeV" . SPARSER::PROTEIN)
    ("VSV" . SPARSER::PROTEIN) ("NF-κB and IFNβ" . SPARSER::COLLECTION)
    ("a dominant-negative inhibitor" . SPARSER::INHIBITOR)
    ("FRNK" . SPARSER::PROTEIN) ("RIG-I-" . SPARSER::PROTEIN)
    ("RLR" . SPARSER::PROTEIN)
    ("band 4.1, ezrin, radixin, and moesin" . SPARSER::COLLECTION)
    ("paxillin, talin, and vinculin" . SPARSER::COLLECTION)
    ("talin" . SPARSER::PROTEIN) ("paxillin" . SPARSER::PROTEIN)
    ("FAT" . SPARSER::PROTEIN) ("moesin" . SPARSER::PROTEIN)
    ("radixin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("FAs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF-κB-" . SPARSER::PROTEIN)
    ("RIG-I and MDA5" . SPARSER::COLLECTION)
    ("VISA/IPS-1/Cardif" . SPARSER::COLLECTION) ("IFN" . SPARSER::DRUG)
    ("Cardif" . SPARSER::PROTEIN) ("VISA" . SPARSER::PROTEIN)
    ("intracellular viral recognition molecules" . SPARSER::MOLECULE)
    ("dsRNA" . SPARSER::RNA)
    ("a RIG-I-like receptor antiviral signaling component"
     . SPARSER::COMPONENT)
    ("MAVS" . SPARSER::PROTEIN) ("NH 4 Cl" . SPARSER::MOLECULE)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("scaffolding molecule" . SPARSER::PROTEIN) ("TNFα" . SPARSER::PROTEIN)
    ("100 kD" . SPARSER::PROTEIN) ("TLR3" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("ISG60" . SPARSER::PROTEIN)
    ("IFNβ" . SPARSER::PROTEIN) ("band 4.1" . SPARSER::PROTEIN)
    ("IPS-1" . SPARSER::PROTEIN) ("MDA5" . SPARSER::PROTEIN)
    ("RIG-I" . SPARSER::PROTEIN) ("Retinoic acid" . SPARSER::MOLECULE)
    ("RIG-I-like receptor" . SPARSER::PROTEIN)
    ("the bacterial GEF SopE" . SPARSER::PROTEIN)
    ("Arf and Rac" . SPARSER::COLLECTION)
    ("Arfs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLAG or CFP" . SPARSER::COLLECTION)
    ("Cdc42/N-WASP" . SPARSER::COLLECTION)
    ("Rho and Arf" . SPARSER::COLLECTION)
    ("ARNO and ARNO" . SPARSER::COLLECTION)
    ("ARNO or ARNO" . SPARSER::COLLECTION)
    ("ARNO and SopE" . SPARSER::COLLECTION)
    ("Arf1 and Rac1" . SPARSER::COLLECTION)
    ("Pathogen SopE and Host ARNO" . SPARSER::COLLECTION)
    ("either SopE (samples from xref A) or ARNO ( xref C)"
     . SPARSER::COLLECTION)
    ("Rho or Arf" . SPARSER::COLLECTION)
    ("Cdc42, Rac1, Arf1, and Arf6" . SPARSER::COLLECTION)
    ("Cyfip, Nap1, WAVE, and Abi, and Rho" . SPARSER::COLLECTION)
    ("Abi, and Rho" . SPARSER::COLLECTION)
    ("Arf1, actin, and HSPC300" . SPARSER::COLLECTION)
    ("either CFP ARNO ( xref D) or the WRC component CFP HSPC300 ( xref E)"
     . SPARSER::COLLECTION)
    ("ARNO and HSPC300" . SPARSER::COLLECTION)
    ("ARNO or CFP" . SPARSER::COLLECTION) ("sopB" . SPARSER::PROTEIN)
    ("derivative" . SPARSER::DERIVATIVE)
    ("phosphoinositide " . SPARSER::PROTEIN) ("ARNO (ARNO)" . SPARSER::PROTEIN)
    ("Arf4 and Arf5" . SPARSER::COLLECTION)
    ("Arf1, Arf3, and Arf6" . SPARSER::COLLECTION) ("Arf5" . SPARSER::PROTEIN)
    ("Arf4" . SPARSER::PROTEIN)
    ("Arf3, Arf4, Arf5, and Arf6" . SPARSER::COLLECTION)
    ("SopE or ARNO" . SPARSER::COLLECTION)
    ("both ARNO ( xref C) and SopE" . SPARSER::COLLECTION)
    ("enriched-actin" . SPARSER::PROTEIN)
    ("GBF1, Big1, and Big2" . SPARSER::COLLECTION)
    ("Big1 and Big2" . SPARSER::COLLECTION) ("Big2" . SPARSER::PROTEIN)
    ("Big1" . SPARSER::PROTEIN) ("a pivotal regulator" . SPARSER::REGULATOR)
    ("SopE and Arf1" . SPARSER::COLLECTION) ("SipC" . SPARSER::PROTEIN)
    ("a distinct bacterial effector" . SPARSER::EFFECTOR)
    ("sopE and its close homolog sopE2 ( ΔE/E2 )" . SPARSER::COLLECTION)
    ("sopE" . SPARSER::PROTEIN) ("Rac1/Cdc42" . SPARSER::COLLECTION)
    ("GGA" . SPARSER::MOLECULE) ("GAT" . SPARSER::PROTEIN)
    ("SopE and Active" . SPARSER::COLLECTION) ("Active" . SPARSER::ACTIVE)
    ("GTPases and N-WASP" . SPARSER::COLLECTION) ("N-WASP-" . SPARSER::PROTEIN)
    ("the smaller WRC constituent HSPC300" . SPARSER::PROTEIN)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("Cdc42 and Rac" . SPARSER::COLLECTION)
    ("N-WASP and WAVE" . SPARSER::COLLECTION)
    ("Cyfip, Nap1, and Abi" . SPARSER::COLLECTION)
    ("phosphatidylcholine and phosphatidylinositol" . SPARSER::COLLECTION)
    ("phosphatidylcholine" . SPARSER::MOLECULE) ("PL" . SPARSER::PROTEIN)
    ("functionally mimics host GEFs" . SPARSER::GEF)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("Abi, Cyfip, Nap1, and HSPC300" . SPARSER::COLLECTION)
    ("Cyfip" . SPARSER::PROTEIN-FAMILY) ("Abi" . SPARSER::PROTEIN-FAMILY)
    ("The best-characterized NPFs N-WASP ( n eural W iskott- A ldrich s yndrome p rotein) and WAVE"
     . SPARSER::COLLECTION)
    ("WA" . SPARSER::MOLECULE)
    ("the ubiquitous Arp2/3 complex" . SPARSER::BIO-COMPLEX)
    ("Cdc42 and Rac1" . SPARSER::COLLECTION) ("GTPases" . SPARSER::GTPASE)
    ("Arf6 and effector" . SPARSER::COLLECTION)
    ("SopE and ARNO" . SPARSER::COLLECTION) ("SopB" . SPARSER::PROTEIN)
    ("ARNO" . SPARSER::PROTEIN) ("GEFs" . SPARSER::PROTEIN)
    ("Arf3 and Arf6" . SPARSER::COLLECTION) ("Arf1" . SPARSER::PROTEIN)
    ("SopE" . SPARSER::PROTEIN) ("GEF" . SPARSER::GEF)
    ("complex (WRC)" . SPARSER::BIO-COMPLEX) ("WAVE" . SPARSER::PROTEIN)
    ("GAT 1" . SPARSER::PROTEIN) ("GGA3" . SPARSER::PROTEIN)
    ("mM 3" . SPARSER::PROTEIN) ("SecinH3" . SPARSER::DRUG)
    ("GBF1" . SPARSER::PROTEIN) ("sopE2" . SPARSER::PROTEIN)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("membrane-bound" . SPARSER::PROTEIN) ("GTPγS" . SPARSER::PROTEIN)
    ("Arf family" . SPARSER::PROTEIN) ("HSPC300" . SPARSER::PROTEIN)
    ("Nap1" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("N-WASP" . SPARSER::PROTEIN) ("Arp2/3" . SPARSER::PROTEIN)
    ("Cdc42" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("Arf3" . SPARSER::PROTEIN)
    ("Rho GTPase" . SPARSER::PROTEIN) ("a specific histological type" . TYPE)
    ("the most recalcitrant form" . SPARSER::FORM)
    ("GGH, BMP7, BAMBI, MBOAT2, HSPA12A, FYN, NAV2, RGL1, SYK and RUNX1"
     . SPARSER::COLLECTION)
    ("SYK" . SPARSER::PROTEIN) ("GGH" . SPARSER::PROTEIN)
    ("TAK1/β-catenin" . SPARSER::COLLECTION) ("elegans" . SPARSER::PROTEIN)
    ("KRAS-TAK1" . SPARSER::COLLECTION) ("Wnt and KRAS" . SPARSER::COLLECTION)
    ("TAK1 and Wnt" . SPARSER::COLLECTION)
    ("other oncogenic stress-induced states" . SPARSER::BIO-STATE)
    ("states" . SPARSER::BIO-STATE) ("KRAS and APC" . SPARSER::COLLECTION)
    ("BMP/TAK1" . SPARSER::COLLECTION)
    ("caspase-3 and PARP" . SPARSER::COLLECTION)
    ("a constitutively-activated (CA) variant" . SPARSER::VARIANT)
    ("BMP7, BMPR1A and TAK1" . SPARSER::COLLECTION)
    ("ER-KRAS" . SPARSER::COLLECTION)
    ("-estrogen receptor" . SPARSER::COLLECTION)
    ("Alk-3" . SPARSER::COLLECTION) ("40kD and 75kD" . SPARSER::COLLECTION)
    ("Smad1, and TAK1" . SPARSER::COLLECTION)
    ("BMP7, BAMBI and INHBB" . SPARSER::COLLECTION)
    ("TGF-β/BMP" . SPARSER::COLLECTION) ("INHBB" . SPARSER::PROTEIN)
    ("a constitutively-activated mutant" . SPARSER::MUTANT)
    ("GSK-3 and TAK1" . SPARSER::COLLECTION)
    ("phosphoglycerate" . SPARSER::MOLECULE)
    ("mutant APC and wild-type KRAS" . SPARSER::COLLECTION)
    ("TCF/LEF" . SPARSER::COLLECTION) ("LEF" . SPARSER::PROTEIN)
    ("KRAS/Wnt" . SPARSER::COLLECTION) ("β-catenin/TCF" . SPARSER::COLLECTION)
    ("KRAS and TAK1" . SPARSER::COLLECTION)
    ("MYC and TCF7" . SPARSER::COLLECTION) ("FLASH" . SPARSER::PROTEIN)
    ("BAMBI, PROX1 and NAV2" . SPARSER::COLLECTION)
    ("BAMBI" . SPARSER::PROTEIN) ("caspase-3 or PARP" . SPARSER::COLLECTION)
    ("p-AMPK" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION)
    ("isoform 2 and CHUK" . SPARSER::COLLECTION) ("CHUK" . SPARSER::PROTEIN)
    ("protein, lipid and nucleotide" . SPARSER::COLLECTION)
    ("a KRAS dependency-associated kinase" . SPARSER::KINASE)
    ("weak KRAS" . SPARSER::PROTEIN) ("Erk and Akt" . SPARSER::COLLECTION)
    ("caspase-3 and polyADP" . SPARSER::COLLECTION)
    ("particular KRAS" . SPARSER::PROTEIN) ("APC/KRAS" . SPARSER::COLLECTION)
    ("KRAS-" . SPARSER::PROTEIN) ("Wnt and TGF-β" . SPARSER::COLLECTION)
    ("several genome-wide shRNA" . SPARSER::PROTEIN)
    ("Mutationally-activated KRAS proteins" . SPARSER::PROTEIN)
    ("KRAS and Wnt" . SPARSER::COLLECTION)
    ("APC and KRAS" . SPARSER::COLLECTION) ("BMP" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("RGL1" . SPARSER::PROTEIN)
    ("HSPA12A" . SPARSER::PROTEIN) ("MBOAT2" . SPARSER::PROTEIN)
    ("GSK3" . SPARSER::PROTEIN) ("Smad2" . SPARSER::PROTEIN)
    ("1A" . SPARSER::PROTEIN) ("receptor type" . SPARSER::PROTEIN)
    ("BMPR1A" . SPARSER::PROTEIN) ("75kD" . SPARSER::PROTEIN)
    ("40kD" . SPARSER::PROTEIN) ("Smad1" . SPARSER::PROTEIN)
    ("BMP7" . SPARSER::PROTEIN) ("Axin 2" . SPARSER::PROTEIN)
    ("TCF7" . SPARSER::PROTEIN) ("PROX1" . SPARSER::PROTEIN)
    ("TCF4" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("5Z-7-oxozeaenol" . SPARSER::DRUG) ("I-κB" . SPARSER::PROTEIN)
    ("isoform 2" . SPARSER::PROTEIN) ("VRK2" . SPARSER::PROTEIN)
    ("Bone Morphogenetic Protein" . SPARSER::PROTEIN)
    ("BMP-7" . SPARSER::PROTEIN) ("MAP3K7" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN)
    ("a therapeutic target and/or biomarker" . SPARSER::COLLECTION)
    ("the targets and upstream regulators" . SPARSER::COLLECTION)
    ("NHERF1, Scribble, and FKBP51" . SPARSER::COLLECTION)
    ("PHLPP and PTEN" . SPARSER::COLLECTION)
    ("the lipid phosphatases PTEN [ xref ] and SHIP" . SPARSER::COLLECTION)
    ("PP2A and PHLPP" . SPARSER::COLLECTION)
    ("substrate and Hippo" . SPARSER::COLLECTION) ("SHIP" . SPARSER::PROTEIN)
    ("receptors and PI3K" . SPARSER::COLLECTION)
    ("Phosphatases" . SPARSER::PHOSPHATASE)
    ("Akt and its downstream substrates" . SPARSER::COLLECTION)
    ("ions" . SPARSER::MOLECULE) ("Homology" . SPARSER::PROTEIN)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("new PHLPP" . SPARSER::PROTEIN)
    ("USPs" . SPARSER::PROTEIN) ("deubiquitinases" . SPARSER::DEUBIQUITINASE)
    ("forskolin" . SPARSER::PROTEIN)
    ("androgen and PI3K" . SPARSER::COLLECTION)
    ("FKBP51 not only scaffolds PHLPP" . SPARSER::PROTEIN)
    ("PHLPP, PTEN, and calcineurin" . SPARSER::COLLECTION)
    ("calcineurin" . SPARSER::PROTEIN)
    ("PHLPP1 (via Scribble's LRR region) and Akt" . SPARSER::COLLECTION)
    ("Scribble" . SPARSER::PROTEIN)
    ("PHLPP1, PTEN, and NHERF" . SPARSER::COLLECTION)
    ("PHLPP1, PHLPP2, and PTEN" . SPARSER::COLLECTION)
    ("scaffolds" . SPARSER::SCAFFOLD) ("Scaffolds" . SPARSER::SCAFFOLD)
    ("hydrolase" . SPARSER::PROTEIN) ("kinase-" . SPARSER::KINASE)
    ("transducin" . SPARSER::PROTEIN) ("PHLPP and Akt" . SPARSER::COLLECTION)
    ("disease-associated alleles" . SPARSER::ALLELE)
    ("huntingtin" . SPARSER::PROTEIN)
    ("possible regulators" . SPARSER::REGULATOR)
    ("PTEN and p53" . SPARSER::COLLECTION)
    ("grade 2 breast tumours often display loss of heterozygosity"
     . SPARSER::PROTEIN)
    ("PHLPP1 and PTEN" . SPARSER::COLLECTION)
    ("“PTEN/PHLPP1" . SPARSER::COLLECTION) ("PHLPP1-" . SPARSER::PROTEIN)
    ("the circadian clock" . SPARSER::PROTEIN) ("clock" . SPARSER::PROTEIN)
    ("a pro-apoptotic kinase" . SPARSER::KINASE)
    ("kinases, Akt and PKC" . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("p38 and c-Jun" . SPARSER::COLLECTION)
    ("Akt, ERK, or PKC" . SPARSER::COLLECTION)
    ("oligonucleotides, and CD40" . SPARSER::COLLECTION)
    ("oligonucleotides" . SPARSER::MOLECULE)
    ("the kinase and the PP2C" . SPARSER::COLLECTION)
    ("detergent" . SPARSER::MOLECULE) ("Akt2 and Akt3" . SPARSER::COLLECTION)
    ("Akt1 and Akt3" . SPARSER::COLLECTION)
    ("p27, and TSC2" . SPARSER::COLLECTION) ("/tuberin" . SPARSER::COLLECTION)
    ("FoxO" . SPARSER::PROTEIN-FAMILY) ("tuberin" . SPARSER::PROTEIN)
    ("GSK" . SPARSER::PROTEIN)
    ("PKC [ xref , xref ] and S6 kinase [ xref ]" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN)
    ("PHLPP1 (DTPL) and PHLPP2 (DTAL)" . SPARSER::COLLECTION)
    ("NHERF" . SPARSER::PROTEIN) ("phosphoinositide" . SPARSER::PROTEIN)
    ("synaptic density protein" . SPARSER::PROTEIN)
    ("zo-1" . SPARSER::COLLECTION) ("zonula" . SPARSER::PROTEIN)
    ("disc" . SPARSER::BIO-COMPLEX) ("LRR" . SPARSER::PROTEIN)
    ("Mg 2+ or Mn 2+" . SPARSER::COLLECTION)
    ("PHLPP1 and PHLPP2" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE) ("/Akt" . SPARSER::COLLECTION)
    ("the pro-apoptotic kinase Mst1" . SPARSER::PROTEIN)
    ("Mst1" . SPARSER::PROTEIN)
    ("Akt, protein kinase C (PKC), and S6 kinase" . SPARSER::COLLECTION)
    ("PHLPP" . SPARSER::PROTEIN) ("Leucine" . SPARSER::AMINO-ACID)
    ("Grb10" . SPARSER::PROTEIN) ("PP2Cα" . SPARSER::PROTEIN)
    ("two domains" . SPARSER::PROTEIN)
    ("purinergic receptor" . SPARSER::PROTEIN) ("FK506" . SPARSER::DRUG)
    ("FKBP51" . SPARSER::PROTEIN) ("NHERF1" . SPARSER::PROTEIN)
    ("UCH-L1" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("NF-Y" . SPARSER::PROTEIN)
    ("nuclear transcription factor Y" . SPARSER::PROTEIN)
    ("IRS-1" . SPARSER::PROTEIN)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("S6K1" . SPARSER::PROTEIN) ("Akt3" . SPARSER::PROTEIN)
    ("Akt2" . SPARSER::PROTEIN) ("TSC2" . SPARSER::PROTEIN)
    ("double minute 2" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("PDK-1" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("Na + /H +" . SPARSER::PROTEIN) ("X-R" . SPARSER::PROTEIN)
    ("large tumor suppressor" . SPARSER::PROTEIN) ("Mg 2+" . SPARSER::MOLECULE)
    ("PP2C" . SPARSER::PROTEIN) ("PHLPP2" . SPARSER::PROTEIN)
    ("PHLPP1" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY)
    ("Protein Phosphatase" . SPARSER::PROTEIN)
    ("pleckstrin homology" . SPARSER::PROTEIN) ("LSCs" . SPARSER::PROTEIN)
    ("MDM2 and MDMX" . SPARSER::COLLECTION) ("MDMX" . SPARSER::PROTEIN)
    ("FoxOs and E2F1" . SPARSER::COLLECTION)
    ("an important pro-apoptotic gene" . SPARSER::GENE)
    ("Necdin and Gfi-1" . SPARSER::COLLECTION)
    ("Bax , Necdin and Gfi-1" . SPARSER::COLLECTION)
    ("an acetylation-defective p53 mutant" . SPARSER::MUTANT)
    ("shRNA and RFP" . SPARSER::COLLECTION)
    ("shRNA and GFP" . SPARSER::COLLECTION)
    ("RFP and GFP" . SPARSER::COLLECTION)
    ("Gfi-1 , Ndn , and Bax" . SPARSER::COLLECTION) ("BP" . SPARSER::PROTEIN)
    ("Puma and Bax" . SPARSER::COLLECTION) ("Necdin" . SPARSER::PROTEIN)
    ("CrkL" . SPARSER::PROTEIN) ("shRNA or TV-6" . SPARSER::COLLECTION)
    ("classical HDACis" . SPARSER::MOLECULE) ("HDACis" . SPARSER::MOLECULE)
    ("EdU and DAPI" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("granulocytic-macrophage" . SPARSER::PROTEIN) ("GMP" . SPARSER::GMP)
    ("macrophage" . SPARSER::PROTEIN) ("CMP" . SPARSER::CMP)
    ("LSK" . SPARSER::PROTEIN)
    ("engrafted cells expressed BCR-ABL" . SPARSER::PROTEIN)
    ("wereBCR-ABL" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("NOD" . SPARSER::PROTEIN)
    ("MEF" . SPARSER::PROTEIN) ("TF-1/BCR-ABL" . SPARSER::COLLECTION)
    ("TF-1-BCR-ABL" . SPARSER::COLLECTION) ("TF-1" . SPARSER::PROTEIN)
    ("methylcellulose" . SPARSER::DRUG) ("Trypan" . SPARSER::DRUG)
    ("ester (CFSE)" . SPARSER::MOLECULE)
    ("SIRT1 or control shRNAs" . SPARSER::COLLECTION)
    ("RFP" . SPARSER::PROTEIN)
    ("anti-SIRT1 antibody and flow cytometry ( xref )" . SPARSER::COLLECTION)
    ("CB" . SPARSER::PROTEIN)
    ("the specific cell or tumor type and the presence or absence of p53 ( xref )"
     . SPARSER::COLLECTION)
    ("p53 and FoxOs" . SPARSER::COLLECTION)
    ("Ku70 and FoxOs" . SPARSER::COLLECTION)
    ("FoxOs" . SPARSER::PROTEIN-FAMILY) ("NAD" . SPARSER::MOLECULE)
    ("Sirtuins" . SPARSER::PROTEIN-FAMILY) ("imatinib (IM)" . SPARSER::DRUG)
    ("nilotinib and dasatinib" . SPARSER::COLLECTION)
    ("nilotinib" . SPARSER::DRUG)
    ("Chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("imatinib" . SPARSER::DRUG) ("SIRT1 or SIRT1" . SPARSER::COLLECTION)
    ("chronic myelogenous leukemia (CML)" . SPARSER::PROTEIN)
    ("Bcr-Abl" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("IL2" . SPARSER::PROTEIN) ("CD235a" . SPARSER::PROTEIN)
    ("CD19" . SPARSER::PROTEIN) ("CD11B" . SPARSER::PROTEIN)
    ("CD10" . SPARSER::PROTEIN) ("CD7" . SPARSER::PROTEIN)
    ("CD2" . SPARSER::PROTEIN) ("HIC1" . SPARSER::PROTEIN)
    ("Gfi-1" . SPARSER::PROTEIN) ("α-tubulin" . SPARSER::PROTEIN)
    ("Nutlin-3" . SPARSER::DRUG) ("CD48" . SPARSER::PROTEIN)
    ("CD150" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("CD33" . SPARSER::PROTEIN)
    ("interleukin-2 receptor" . SPARSER::PROTEIN)
    ("Caspase-3" . SPARSER::PROTEIN) ("1-1" . SPARSER::PROTEIN)
    ("SIRT2" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sirtuin 1" . SPARSER::PROTEIN)
    ("the pro-apoptotic protein Bim" . SPARSER::PROTEIN)
    ("BEZ235 and ABT737" . SPARSER::COLLECTION)
    ("IGF1R, EGFR and HER2" . SPARSER::COLLECTION)
    ("HER2/EGFR" . SPARSER::COLLECTION) ("Tamoxifen" . SPARSER::MOLECULE)
    ("proteins, RTKs and anti-apoptotic" . SPARSER::COLLECTION)
    ("glucose and amino acid" . SPARSER::COLLECTION)
    ("XIAP and Bcl-xL" . SPARSER::COLLECTION)
    ("4E-BP1 or a selective PI3K inhibitor" . SPARSER::COLLECTION)
    ("HER2 or AKT" . SPARSER::COLLECTION)
    ("a specific integrin or downstream component" . SPARSER::COLLECTION)
    ("dominant-negative c-Jun" . SPARSER::PROTEIN)
    ("c-Jun and STAT3" . SPARSER::COLLECTION) ("TM" . SPARSER::PROTEIN)
    ("inducers" . SPARSER::MOLECULE)
    ("BEZ235 and ABT-263" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, and IGF1Rβ" . SPARSER::COLLECTION)
    ("GNE" . SPARSER::PROTEIN) ("BEZ235 and ABT-737" . SPARSER::COLLECTION)
    ("p-BAD" . SPARSER::COLLECTION) ("EGFR-ERK" . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN)
    ("RTKs (Her3, IGF1Rb, Her2, EGFR) and Bcl-2 and Bcl-xL ( xref )"
     . SPARSER::COLLECTION)
    ("the ternary translation initiation complex" . SPARSER::BIO-COMPLEX)
    ("eIF2α" . SPARSER::PROTEIN) ("eIF" . SPARSER::PROTEIN)
    ("BEZ235 or Torin1" . SPARSER::COLLECTION)
    ("rapamycin or 250nM" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL, IGF1R, XIAP, c-Jun and p53" . SPARSER::COLLECTION)
    ("essential cell survival proteins" . SPARSER::PROTEIN)
    ("efficiently as 1μM Torin or 1μM GDC0941" . SPARSER::COLLECTION)
    ("efficiently as 1μM Torin" . SPARSER::PROTEIN)
    ("4E-BP1 and AKT" . SPARSER::COLLECTION) ("Torin" . SPARSER::PROTEIN)
    ("BEZ235, Torin1 or GDC0941" . SPARSER::COLLECTION)
    ("rapamycin (allosteric mTOR inhibitor selective for mTORC1) and Torin1 (mTORC1/2 catalytic inhibitor)"
     . SPARSER::COLLECTION)
    ("PI3K or TORC1/2" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("PI3K and mTORC1/2" . SPARSER::COLLECTION)
    ("FOXO1 or FOXO3" . SPARSER::COLLECTION)
    ("Bcl-2 and IGF1Rβ" . SPARSER::COLLECTION)
    ("ERBB3, EGFR and IGF1R" . SPARSER::COLLECTION)
    ("TSC1, IRS2 and FOXO1/3" . SPARSER::COLLECTION)
    ("IGF1R, EGFR, BCL2, IRS1 and SMAD3" . SPARSER::COLLECTION)
    ("Bcl2, EGFR, and IGF-1R" . SPARSER::COLLECTION)
    ("MEK, PKC, PKA, Jak or IKK" . SPARSER::COLLECTION)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PD168393 or Gefitinib" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG) ("EGFR and IGF1R" . SPARSER::COLLECTION)
    ("ABT-737 and BEZ235" . SPARSER::COLLECTION)
    ("which targets Bcl-2, Bcl-xL and Bcl-w" . SPARSER::COLLECTION)
    ("Bcl-2, Bcl-xL and Bcl-w" . SPARSER::COLLECTION)
    ("Bcl-2, IGF1R or EGFR" . SPARSER::COLLECTION)
    ("FAK, or ILK" . SPARSER::COLLECTION)
    ("Bcl-2 or IGF1R" . SPARSER::COLLECTION) ("ILK" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION) ("IGF1Rβ" . SPARSER::PROTEIN)
    ("p-EGFR" . SPARSER::COLLECTION) ("p-IGF1Rβ" . SPARSER::PROTEIN-PAIR)
    ("p-Erk" . SPARSER::COLLECTION) ("p-HER2" . SPARSER::COLLECTION)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR, HER2, c-Kit and IGF1R" . SPARSER::COLLECTION)
    ("p-SMAD3" . SPARSER::COLLECTION) ("p-c-Jun" . SPARSER::COLLECTION)
    ("p-STAT6" . SPARSER::COLLECTION) ("p-STAT3" . SPARSER::COLLECTION)
    ("p-p90RSK" . SPARSER::COLLECTION) ("RSK" . SPARSER::PROTEIN)
    ("p-4E-BP1" . SPARSER::COLLECTION) ("PCNA" . SPARSER::PROTEIN)
    ("proteins and phospho-proteins" . SPARSER::COLLECTION)
    ("PI3K or mTOR" . SPARSER::COLLECTION) ("PIK" . SPARSER::BIO-COMPLEX)
    ("Rapamycin" . SPARSER::DRUG)
    ("a dual specificity PI3K/mTOR inhibitor" . SPARSER::INHIBITOR)
    ("Matrigel" . SPARSER::PROTEIN)
    ("IGF1R, PI3K, and AKT" . SPARSER::COLLECTION)
    ("specifically rapamycin analogs" . SPARSER::ANALOG)
    ("rapamycin" . SPARSER::DRUG)
    ("3D as well as the filled alveoli" . SPARSER::COLLECTION)
    ("Bcl-2, EGFR, or IGF1R" . SPARSER::COLLECTION)
    ("PI3K/mTOR" . SPARSER::COLLECTION) ("ABT737" . SPARSER::DRUG)
    ("insulin receptor" . SPARSER::PROTEIN) ("NFκB" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("ABT-737-" . SPARSER::DRUG)
    ("IGF1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 2" . SPARSER::PROTEIN)
    ("Torin1" . SPARSER::DRUG) ("TORC1" . SPARSER::PROTEIN)
    ("FOXO3" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN) ("p27Kip1" . SPARSER::PROTEIN)
    ("CDKN1B" . SPARSER::PROTEIN) ("IGF-1R" . SPARSER::PROTEIN)
    ("Bcl2" . SPARSER::PROTEIN) ("PD168393" . SPARSER::DRUG)
    ("Bcl-w" . SPARSER::PROTEIN) ("ABT-737" . SPARSER::DRUG)
    ("β4-integrin" . SPARSER::PROTEIN) ("β1-integrin" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("SMAD3" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("p90" . SPARSER::PROTEIN) ("cyclinE1" . SPARSER::PROTEIN)
    ("cyclinB1" . SPARSER::PROTEIN) ("4E-BP1" . SPARSER::PROTEIN)
    ("GDC0941" . SPARSER::DRUG) ("BEZ235" . SPARSER::DRUG)
    ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S6K" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("IGF1R" . SPARSER::PROTEIN)
    ("Aurora-A-p73" . SPARSER::COLLECTION)
    ("MAD1 or CDC20" . SPARSER::COLLECTION)
    ("phosphor-mimetic mutant p73" . SPARSER::PROTEIN)
    ("the soluble MAD2-CDC20 complex" . SPARSER::BIO-COMPLEX)
    ("BubR1-CDC20" . SPARSER::COLLECTION)
    ("form separate inactive complexes" . SPARSER::BIO-COMPLEX)
    ("MAD2 and BubR1" . SPARSER::COLLECTION) ("Mitotic SAC" . SPARSER::PROTEIN)
    ("phosphor-mimetic p73 mutants" . SPARSER::MUTANT)
    ("large macromolecular complexes" . SPARSER::BIO-COMPLEX)
    ("the inhibitory mitotic checkpoint complex" . SPARSER::BIO-COMPLEX)
    ("Mad2 and CDC20" . SPARSER::COLLECTION)
    ("Mad2-CDC20" . SPARSER::COLLECTION)
    ("WWOX and/or pro-apoptotic mitochondria proteins" . SPARSER::COLLECTION)
    ("pro-apoptotic mitochondria proteins" . SPARSER::PROTEIN)
    ("WWOX" . SPARSER::PROTEIN) ("mortalin and p53" . SPARSER::COLLECTION)
    ("mortalin-p53" . SPARSER::COLLECTION)
    ("p53 and p73" . SPARSER::COLLECTION)
    ("after cisplatin and irradiation treatment" . SPARSER::COLLECTION)
    ("cisplatin and irradiation treatment" . SPARSER::COLLECTION)
    ("chemotherapeutic drug" . SPARSER::DRUG)
    ("DNA and spindle" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs and irradiation ( xref , xref , xref )"
     . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG)
    ("strong cytoplasmic p73" . SPARSER::PROTEIN)
    ("Aurora-A phosphor mimetic p53-S215D mutant" . SPARSER::MUTANT)
    ("PDAC" . SPARSER::MOLECULE)
    ("this complex releases p73 and the inhibitory complex"
     . SPARSER::COLLECTION)
    ("a cytoplasmic ternary complex" . SPARSER::BIO-COMPLEX)
    ("MAD2 and CDC20" . SPARSER::COLLECTION)
    ("BubR1 and MAD2" . SPARSER::COLLECTION)
    ("nocodazole and MG132" . SPARSER::COLLECTION)
    ("anti-p73 and anti-CDC20" . SPARSER::COLLECTION)
    ("Mad2, CDC20, and Aurora-A" . SPARSER::COLLECTION)
    ("MCF-10A and Cos-1" . SPARSER::COLLECTION) ("Nocodazole" . SPARSER::DRUG)
    ("mCherry" . SPARSER::PROTEIN) ("pro-apoptotic genes" . SPARSER::GENE)
    ("phosphor-mimetic p73" . SPARSER::PROTEIN)
    ("p73 and p53" . SPARSER::COLLECTION)
    ("full-length mortalin’s" . SPARSER::PROTEIN)
    ("anti-p73 and mortalin" . SPARSER::COLLECTION)
    ("mega" . SPARSER::MOLECULE) ("p73 and mortalin" . SPARSER::COLLECTION)
    ("Mortalin" . SPARSER::PROTEIN) ("Inhibitor" . SPARSER::INHIBITOR)
    ("the tetrameric form" . SPARSER::FORM) ("tetramer" . SPARSER::TETRAMER)
    ("glutaraldehyde" . SPARSER::MOLECULE)
    ("conformations" . SPARSER::BIO-CONFORMATION)
    ("the phosphor-mimetic mutant" . SPARSER::MUTANT)
    ("PUMA" . SPARSER::PROTEIN) ("Puma, Bax, and Noxa" . SPARSER::COLLECTION)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY) ("thymidine" . SPARSER::PROTEIN)
    ("p73 and Aurora-A" . SPARSER::COLLECTION)
    ("Aurora-A and p73" . SPARSER::COLLECTION)
    ("GFP-p73" . SPARSER::COLLECTION) ("Flag-Aurora-A" . SPARSER::COLLECTION)
    ("phosphor-mimetic (S235D) mutant" . SPARSER::MUTANT)
    ("anti-phosphor" . SPARSER::PROTEIN) ("Aurora-A-KD" . SPARSER::COLLECTION)
    ("anti-phosphor-PKA" . SPARSER::COLLECTION) ("PPase" . SPARSER::PROTEIN)
    ("nocodazole and taxol" . SPARSER::COLLECTION)
    ("Bub1, Bub3, and BubR1" . SPARSER::COLLECTION)
    ("poisons" . SPARSER::MOLECULE) ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitotic SAC" . SPARSER::PROTEIN) ("taxol" . SPARSER::DRUG)
    ("phosphor-mimetic mutant" . SPARSER::MUTANT)
    ("MAD2-CDC20" . SPARSER::COLLECTION) ("mortalin" . SPARSER::PROTEIN)
    ("SAC" . SPARSER::PROTEIN) ("H2B" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("dual-luciferase" . SPARSER::PROTEIN)
    ("MAD1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cyclin B1" . SPARSER::PROTEIN)
    ("cyclin B1" . SPARSER::PROTEIN)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hsp70" . SPARSER::PROTEIN) ("80 kD" . SPARSER::PROTEIN)
    ("leptomycin B" . SPARSER::MOLECULE) ("Aurora-B" . SPARSER::PROTEIN)
    ("MLN8054" . SPARSER::DRUG) ("Cos-1" . SPARSER::PROTEIN)
    ("CDC20" . SPARSER::PROTEIN) ("MAD2" . SPARSER::PROTEIN)
    ("p73" . SPARSER::PROTEIN) ("Aurora-A" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("LTQ" . SPARSER::MOLECULE)
    ("BSA" . SPARSER::PROTEIN) ("IgM or IgA" . SPARSER::COLLECTION)
    ("citrullinated synovial proteins" . SPARSER::PROTEIN)
    ("fibrinogen (α-fibrinogen-27-43: FLAEGGGVCitGPRVVERH; β-fibrinogen-36-52: NEEGFFSACitGHRPLDKK) and one peptide"
     . SPARSER::COLLECTION)
    ("vimentin, fibrinogen and α-enolase" . SPARSER::COLLECTION)
    ("the two adjacent citrullines" . SPARSER::MOLECULE)
    ("inflammatory SF" . SPARSER::PROTEIN) ("neutrophil" . SPARSER::PROTEIN)
    ("TLR" . SPARSER::PROTEIN-FAMILY) ("EDA and EDB" . SPARSER::COLLECTION)
    ("EDB" . SPARSER::PROTEIN) ("two adjacent citrullines" . SPARSER::MOLECULE)
    ("citrullines" . SPARSER::MOLECULE)
    ("anti-citrullinated fibronectin antibodies and two additional HLA-DRB1 alleles"
     . SPARSER::COLLECTION)
    ("IgM and IgA" . SPARSER::COLLECTION) ("IgM-" . SPARSER::PROTEIN)
    ("the reactive sera" . SPARSER::PROTEIN)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("isotype-specific (IgG, IgM and IgA) secondary antibody"
     . SPARSER::PROTEIN)
    ("IgG, IgM and IgA" . SPARSER::COLLECTION)
    ("anti-FN-Cit" . SPARSER::COLLECTION) ("IgM" . SPARSER::PROTEIN)
    ("EAC" . SPARSER::PROTEIN) ("Autoantibodies" . SPARSER::PROTEIN)
    ("anti" . SPARSER::PROTEIN)
    ("their sera and the CCP2" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus (SLE)" . SPARSER::PROTEIN)
    ("larger cohort" . SPARSER::MOLECULE) ("EDA" . SPARSER::PROTEIN)
    ("at least 15 different isoforms" . SPARSER::ISOFORM)
    ("glutamine or asparagine" . SPARSER::COLLECTION)
    ("asparagine" . SPARSER::AMINO-ACID) ("Matrix" . SPARSER::PROTEIN-FAMILY)
    ("the smallest polypeptides" . SPARSER::PEPTIDE)
    ("the largest polypeptides" . SPARSER::PEPTIDE)
    ("One supernatant fraction and one pellet fraction" . SPARSER::COLLECTION)
    ("cytokines and metalloproteinases" . SPARSER::COLLECTION)
    ("SF" . SPARSER::PROTEIN) ("linking (citrullinated) FN" . SPARSER::PROTEIN)
    ("fibronectin (FN)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("citrullinated autoantigenic proteins" . SPARSER::PROTEIN)
    ("particularly using synthetic peptides [ xref , xref ] or material"
     . SPARSER::COLLECTION)
    ("ACR" . SPARSER::PROTEIN) ("enolase" . SPARSER::PROTEIN)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("PADI4, STAT4, IRF5 and CTLA-4" . SPARSER::COLLECTION)
    ("SE" . SPARSER::PROTEIN) ("ACPA" . SPARSER::PROTEIN)
    ("Anti-FN-Cit" . SPARSER::COLLECTION) ("FN-Cit" . SPARSER::COLLECTION)
    ("Cit" . SPARSER::PROTEIN) ("FN" . SPARSER::PROTEIN)
    ("citrulline" . SPARSER::MOLECULE) ("sera and sera" . SPARSER::COLLECTION)
    ("sera" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("fibronectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fibronectin" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("isoform 1" . SPARSER::PROTEIN) ("a polypeptide" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("HCO 3" . SPARSER::MOLECULE)
    ("1D" . SPARSER::PROTEIN) ("IRF5" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN) ("PADI4" . SPARSER::PROTEIN)
    ("TRAF1" . SPARSER::PROTEIN) ("PTPN22" . SPARSER::PROTEIN)
    ("HLA-DRB1" . SPARSER::PROTEIN)
    ("XRCC1 194 T allele or XRCC1 399 G allele" . SPARSER::COLLECTION)
    ("type and cancer" . SPARSER::COLLECTION) ("FPRP" . SPARSER::PROTEIN)
    ("more reliable prognostic or predictive biomarkers" . SPARSER::MOLECULE)
    ("either prognostic or predictive biomarkers" . SPARSER::MOLECULE)
    ("DNA and protein" . SPARSER::COLLECTION) ("Variant" . SPARSER::VARIANT)
    ("polymerase and DNA" . SPARSER::COLLECTION) ("EM9" . SPARSER::PROTEIN)
    ("Platinum" . SPARSER::MOLECULE) ("Stata" . SPARSER::PROTEIN)
    ("cross-complementing" . SPARSER::PROTEIN)
    ("complementing" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN)
    ("both pro- and anti-inflammatory function [ xref ]" . SPARSER::COLLECTION)
    ("the angiogenic factor VEGF" . SPARSER::PROTEIN)
    ("IL-1a and either IL-6 (in the presence of its soluble receptor) or OSM [ xref ]"
     . SPARSER::COLLECTION)
    ("either IL-6 (in the presence of its soluble receptor) or OSM [ xref ]"
     . SPARSER::COLLECTION)
    ("IL-6 and OSM" . SPARSER::COLLECTION)
    ("aggrecan and biglycan" . SPARSER::COLLECTION)
    ("decorin" . SPARSER::PROTEIN) ("biglycan" . SPARSER::PROTEIN)
    ("aggrecan" . SPARSER::PROTEIN) ("GAG" . SPARSER::PROTEIN)
    ("OSM, LIF and CNTF" . SPARSER::COLLECTION)
    ("proteoglycan" . SPARSER::PROTEIN) ("proteoglycans" . SPARSER::PROTEIN)
    ("OSM and LIF" . SPARSER::COLLECTION)
    ("the painful PTT" . SPARSER::MOLECULE)
    ("IL-6 and COX2" . SPARSER::COLLECTION)
    ("VEGF, COX2, OSM, LIF and IL-6" . SPARSER::COLLECTION)
    ("COX2 and IL-6" . SPARSER::COLLECTION) ("normal PTT" . SPARSER::MOLECULE)
    ("COL1A1 and CNTF" . SPARSER::COLLECTION)
    ("COX2 and other genes" . SPARSER::COLLECTION)
    ("ciliary neurotrophic factor (CNTF) and cardiotrophin-1"
     . SPARSER::COLLECTION)
    ("CNTF" . SPARSER::PROTEIN) ("LIF" . SPARSER::PROTEIN)
    ("OSM" . SPARSER::PROTEIN) ("pro-inflammatory PGs" . SPARSER::PROTEIN)
    ("PGs" . SPARSER::PROTEIN)
    ("inflammatory cytokines and mediators" . SPARSER::COLLECTION)
    ("cytokines and mediators" . SPARSER::COLLECTION)
    ("cyclooxygenase-1 and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("painful PTT" . SPARSER::MOLECULE)
    ("both painful PTT and AT" . SPARSER::COLLECTION)
    ("both painful PTT" . SPARSER::MOLECULE) ("Collagen" . SPARSER::PROTEIN)
    ("PTT" . SPARSER::MOLECULE) ("IL-1a" . SPARSER::PROTEIN)
    ("EIF4A2" . SPARSER::PROTEIN)
    ("eukaryotic initiation factor 4A-II" . SPARSER::PROTEIN)
    ("cardiotrophin-1" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("oncostatin M" . SPARSER::PROTEIN) ("synthase 2" . SPARSER::PROTEIN)
    ("cyclooxygenase-1" . SPARSER::PROTEIN) ("oncostatin-M" . SPARSER::PROTEIN)
    ("COX2" . SPARSER::PROTEIN) ("cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("COL1A1" . SPARSER::PROTEIN) ("α-chain" . SPARSER::PROTEIN)
    ("The latter proteins" . SPARSER::PROTEIN)
    ("c-Myc and 14-3-3" . SPARSER::COLLECTION)
    ("Akt and PKCζ" . SPARSER::COLLECTION)
    ("synemin/PP2A" . SPARSER::COLLECTION)
    ("protein and PP2A" . SPARSER::COLLECTION) ("tau" . SPARSER::PROTEIN)
    ("cytoskeletal microtubules" . SPARSER::PROTEIN)
    ("Several viral proteins" . SPARSER::PROTEIN) ("trimer" . SPARSER::TRIMER)
    ("Akt and Rb" . SPARSER::COLLECTION)
    ("PDPK1, mTORc2, PI3K, and PTEN" . SPARSER::COLLECTION)
    ("PI3K and PTEN" . SPARSER::COLLECTION)
    ("PDPK1 and Akt" . SPARSER::COLLECTION)
    ("shRNAs and vehicle" . SPARSER::COLLECTION)
    ("antibodies and PLA" . SPARSER::COLLECTION) ("PLA" . SPARSER::PROTEIN)
    ("PP2A and synemin" . SPARSER::COLLECTION)
    ("Synemin and PP2A" . SPARSER::COLLECTION)
    ("synemin antibodies or control IgGs" . SPARSER::COLLECTION)
    ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble protein complexes" . SPARSER::BIO-COMPLEX)
    ("Antibodies" . SPARSER::ANTIBODY)
    ("a structural A subunit, a regulatory B subunit, and a catalytic C subunit ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("a regulatory B subunit" . SPARSER::PROTEIN)
    ("holoenzyme" . SPARSER::PROTEIN)
    ("PDPK1 or pS241-PDPK1" . SPARSER::COLLECTION)
    ("mTORc2 and PDPK1" . SPARSER::COLLECTION)
    ("phosphatidylinositol (3,4,5)-triphosphate (PIP3)–dependent protein kinase"
     . SPARSER::KINASE)
    ("iodide" . SPARSER::PROTEIN) ("propidium" . SPARSER::MOLECULE)
    ("PPC-1" . SPARSER::PROTEIN) ("Axl" . SPARSER::PROTEIN)
    ("keratins" . SPARSER::PROTEIN) ("polymerized actin" . SPARSER::PROTEIN)
    ("plasma membrane junctional complexes" . SPARSER::BIO-COMPLEX)
    ("α-actinin and vinculin" . SPARSER::COLLECTION) ("IFs" . SPARSER::PROTEIN)
    ("desmin" . SPARSER::PROTEIN) ("reactive astrocytes" . SPARSER::PROTEIN)
    ("actin-associated proteins" . SPARSER::PROTEIN) ("IF" . SPARSER::PROTEIN)
    ("pAkt and pRb" . SPARSER::COLLECTION)
    ("synemin and PP2A" . SPARSER::COLLECTION)
    ("PP2A and Akt" . SPARSER::COLLECTION) ("PLAs" . SPARSER::PROTEIN)
    ("PDPK1 and mTOR" . SPARSER::COLLECTION)
    ("p21 Cip1 and p27 Kip1" . SPARSER::COLLECTION)
    ("mature astrocytes" . SPARSER::PROTEIN) ("astrocytes" . SPARSER::PROTEIN)
    ("PDPK1 and mTORc2" . SPARSER::COLLECTION) ("synemin" . SPARSER::PROTEIN)
    ("Synemin" . SPARSER::PROTEIN) ("PI3" . SPARSER::PROTEIN)
    ("anti-S" . SPARSER::ANTIBODY) ("annexin V" . SPARSER::PROTEIN)
    ("K18" . SPARSER::PROTEIN) ("PKCζ" . SPARSER::PROTEIN)
    ("K10" . SPARSER::PROTEIN) ("Keratin 10" . SPARSER::PROTEIN)
    ("NF-L" . SPARSER::PROTEIN) ("B55" . SPARSER::PROTEIN)
    ("B subunit" . SPARSER::PROTEIN) ("PIP3" . SPARSER::PIP3)
    ("Rictor-mTOR" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("E2F" . SPARSER::PROTEIN-FAMILY) ("keratin 17" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 5" . SPARSER::PROTEIN) ("p35" . SPARSER::PROTEIN)
    ("α-actinin" . SPARSER::PROTEIN) ("type 2" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("mTORc2" . SPARSER::PROTEIN) ("PDPK1" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN)
    ("intermediate filament protein" . SPARSER::PROTEIN)
    ("The phosphorylation-defective LRRK1(Y944F) mutant" . SPARSER::MUTANT)
    ("LRRK1 and EGFR" . SPARSER::COLLECTION)
    ("a cargo-specific regulator" . SPARSER::REGULATOR)
    ("lysosomal-associated membrane protein" . SPARSER::PROTEIN)
    ("LBPA" . SPARSER::MOLECULE) ("EGF and Alexa" . SPARSER::COLLECTION)
    ("transferrin" . SPARSER::PROTEIN) ("gold" . SPARSER::MOLECULE)
    ("EEA1 and CI-MPR" . SPARSER::COLLECTION) ("cation" . SPARSER::MOLECULE)
    ("weak punctate" . SPARSER::PROTEIN) ("Rh" . SPARSER::MOLECULE)
    ("EGF/EGFR" . SPARSER::COLLECTION) ("fluorescent EGF" . SPARSER::PROTEIN)
    ("GDP" . SPARSER::NUCLEOTIDE)
    ("GTP-agarose ( xref , lane 5)" . SPARSER::NUCLEOTIDE)
    ("GTP-agarose" . SPARSER::NUCLEOTIDE)
    ("the phosphomimic mutations LRRK1(Y944E) and LRRK1(Y944D)"
     . SPARSER::COLLECTION)
    ("the phosphomimic mutations LRRK1" . SPARSER::PROTEIN)
    ("GTP" . SPARSER::NUCLEOTIDE) ("GTPase and kinase" . SPARSER::COLLECTION)
    ("vanadate" . SPARSER::MOLECULE) ("GFP-LRRK1" . SPARSER::COLLECTION)
    ("EGFR or an EGFR-associated tyrosine kinase" . SPARSER::COLLECTION)
    ("an EGFR-associated tyrosine kinase" . SPARSER::PROTEIN)
    ("LRRK1-N2" . SPARSER::COLLECTION) ("-N2" . SPARSER::COLLECTION)
    ("LRRK1-N1" . SPARSER::COLLECTION) ("pY" . SPARSER::PROTEIN)
    ("LRRK1/EGFR" . SPARSER::COLLECTION)
    ("EGFR, and LRRK1" . SPARSER::COLLECTION)
    ("protein–protein" . SPARSER::COLLECTION) ("MAPKKK" . SPARSER::PROTEIN)
    ("COR" . SPARSER::PROTEIN-FAMILY) ("ROCO" . SPARSER::PROTEIN-FAMILY)
    ("receptor (EGFR)" . SPARSER::RECEPTOR)
    ("many membrane-associated proteins" . SPARSER::PROTEIN)
    ("H4A" . SPARSER::PROTEIN) ("G10" . SPARSER::PROTEIN)
    ("p230" . SPARSER::PROTEIN) ("LAMP1" . SPARSER::PROTEIN)
    ("membrane protein" . SPARSER::PROTEIN) ("S6D" . SPARSER::PROTEIN)
    ("S5B" . SPARSER::PROTEIN) ("CI-MPR" . SPARSER::PROTEIN)
    ("mannose 6-phosphate receptor" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("anti-EGFR" . SPARSER::PROTEIN) ("A–C" . SPARSER::PROTEIN)
    ("Tyr-Phe" . SPARSER::MOLECULE) ("Glu-Glu-Glu" . SPARSER::MOLECULE)
    ("leucine-rich repeat" . SPARSER::PROTEIN) ("LRRK1" . SPARSER::PROTEIN)
    ("traditional pathway CRCs" . SPARSER::PROTEIN)
    ("exogenous estrogens and/or progestins" . SPARSER::COLLECTION)
    ("exogenous estrogens" . SPARSER::MOLECULE) ("serrated" . SPARSER::PROTEIN)
    ("progestins" . SPARSER::DRUG) ("MSS" . SPARSER::PROTEIN)
    ("BRAF or KRAS" . SPARSER::COLLECTION) ("MSI" . SPARSER::PROTEIN)
    ("RRs" . SPARSER::MOLECULE) ("incident CRC" . SPARSER::PROTEIN)
    ("myoblasts" . SPARSER::PROTEIN) ("pRB" . SPARSER::PROTEIN)
    ("pRb" . SPARSER::PROTEIN) ("radical" . SPARSER::MOLECULE)
    ("1.068 - 2.222" . SPARSER::PROTEIN) ("SP4" . SPARSER::PROTEIN)
    ("hydrogen peroxide" . SPARSER::MOLECULE) ("of 45" . SPARSER::PROTEIN)
    ("CCND1" . SPARSER::PROTEIN) ("- 2" . SPARSER::PROTEIN)
    ("miRNA/mRNA" . SPARSER::COLLECTION)
    ("NF-κB and STAT1α" . SPARSER::COLLECTION)
    ("TLRs" . SPARSER::PROTEIN-FAMILY)
    ("acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("CDK6/RB" . SPARSER::COLLECTION) ("RB" . SPARSER::PROTEIN)
    ("EGFR network proteins (e.g., AKT2, STAT3, p38 and JNK1) as well as Cyclin D1"
     . SPARSER::COLLECTION)
    ("AKT2, STAT3, p38 and JNK1" . SPARSER::COLLECTION)
    ("AKT1 and ERK2" . SPARSER::COLLECTION)
    ("RB1 and CDK4" . SPARSER::COLLECTION)
    ("Cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("miRNAs and proteins" . SPARSER::COLLECTION)
    ("potential tumor suppressors" . SPARSER::SUPPRESSOR)
    ("AKT2 and Cyclin D1" . SPARSER::COLLECTION)
    ("CDK4, CDK2 and SHC1" . SPARSER::COLLECTION)
    ("potential direct targets" . SPARSER::TARGET-PROTEIN)
    ("MAPK and STAT3" . SPARSER::COLLECTION) ("parts" . SPARSER::COMPONENT)
    ("AAD" . SPARSER::MOLECULE) ("CDK4 and Cyclin D1" . SPARSER::COLLECTION)
    ("CDK4 and RB1" . SPARSER::COLLECTION) ("MiRNAs" . SPARSER::PROTEIN)
    ("retinoblastoma protein RB1 (for PIK3CA and AKT2) and CDK4 (for PLCG1)"
     . SPARSER::COLLECTION)
    ("PIK3CA, AKT2 and PLCG1" . SPARSER::COLLECTION)
    ("PIK3CA and AKT2" . SPARSER::COLLECTION)
    ("p27/Kip1" . SPARSER::COLLECTION) ("given miRNAs" . SPARSER::PROTEIN)
    ("all proteins and their significantly regulating miRNAs"
     . SPARSER::COLLECTION)
    ("new miRNA" . SPARSER::PROTEIN) ("MiRNA" . SPARSER::PROTEIN)
    ("miR-7/EGFR" . SPARSER::COLLECTION)
    ("miRNA/protein" . SPARSER::COLLECTION)
    ("241 miRNAs and 25 genes (PIK3CB was not a predicted miRNA target)"
     . SPARSER::COLLECTION)
    ("gene's" . SPARSER::GENE) ("mer" . SPARSER::PROTEIN)
    ("miRNA-mRNA" . SPARSER::COLLECTION) ("miRNome" . SPARSER::PROTEIN)
    ("miRNome–protein" . SPARSER::PROTEIN-PAIR)
    ("si-EGFR" . SPARSER::COLLECTION) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("810 mature miRNAs" . SPARSER::PROTEIN)
    ("miRNA–protein" . SPARSER::COLLECTION)
    ("miR-122-regulated genes" . SPARSER::GENE) ("shotgun" . SPARSER::PROTEIN)
    ("miRNA and target mRNAs" . SPARSER::COLLECTION)
    ("RISC" . SPARSER::PROTEIN)
    ("co-target EGFR-driven cell-cycle network proteins" . SPARSER::PROTEIN)
    ("miR" . SPARSER::PROTEIN)
    ("miRNAs simultaneously co-regulate several proteins" . SPARSER::PROTEIN)
    ("microRNAs" . SPARSER::RNA) ("new miRNAs" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::PROTEIN) ("miRNA" . SPARSER::PROTEIN)
    ("microRNA" . SPARSER::RNA) ("Delta-" . SPARSER::PROTEIN)
    ("c-Kit" . SPARSER::PROTEIN) ("CDK6" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("SHC1" . SPARSER::PROTEIN)
    ("CDK2" . SPARSER::PROTEIN) ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MIG-6" . SPARSER::PROTEIN)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PIK3CB" . SPARSER::PROTEIN)
    ("PLCG1" . SPARSER::PROTEIN) ("Ago2" . SPARSER::PROTEIN)
    ("Cyclin D1" . SPARSER::PROTEIN) ("miR-16" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("miR-7" . SPARSER::PROTEIN)
    ("affordable gene" . SPARSER::GENE) ("refs" . SPARSER::PROTEIN)
    ("UK" . SPARSER::PROTEIN)
    ("progesterone receptor (PR) and human epidermal growth factor receptor (HER2)"
     . SPARSER::COLLECTION)
    ("oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2)"
     . SPARSER::COLLECTION)
    ("receptor (ER)" . SPARSER::RECEPTOR) ("TN" . SPARSER::PROTEIN)
    ("trans -resveratrol and resveratrol-glucuronide" . SPARSER::COLLECTION)
    ("NSAIDS" . SPARSER::DRUG)
    ("the glucuronide and sulfate metabolites" . SPARSER::COLLECTION)
    ("sulfatases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Both free resveratrol and the metabolites" . SPARSER::COLLECTION)
    ("free resveratrol and the metabolites" . SPARSER::COLLECTION)
    ("trans -resveratrol and the glucuronide metabolite" . SPARSER::COLLECTION)
    ("RASSF1a" . SPARSER::PROTEIN) ("APC, p16, or CCND2" . SPARSER::COLLECTION)
    ("COX" . SPARSER::PROTEIN) ("cyclooxygenase" . SPARSER::PROTEIN)
    ("both total trans -resveratrol and its glucuronide metabolite (metabolite data not shown)"
     . SPARSER::COLLECTION)
    ("glucuronide and most sulfate metabolites" . SPARSER::COLLECTION)
    ("NAF and serum PGE 2" . SPARSER::COLLECTION)
    ("p16, CCND2, APC, and RASSF-1a" . SPARSER::COLLECTION)
    ("total resveratrol and total sulfate metabolites" . SPARSER::COLLECTION)
    ("sulfate" . SPARSER::MOLECULE) ("Cis" . SPARSER::PROTEIN)
    ("-resveratrol" . SPARSER::COLLECTION) ("Resveratrol" . SPARSER::PROTEIN)
    ("NAF" . SPARSER::PROTEIN) ("PGE 2 or resveratrol" . SPARSER::COLLECTION)
    ("NSAID" . SPARSER::PROTEIN)
    ("approximately 14 mg/day resveratrol" . SPARSER::PROTEIN)
    ("more aggressive forms" . SPARSER::FORM)
    ("at least some resveratrol derivatives" . SPARSER::DERIVATIVE)
    ("albumin and low density lipoproteins (LDLs)" . SPARSER::COLLECTION)
    ("LDLs" . SPARSER::PROTEIN)
    ("DNMT1, DNMT3a, and DNMT3b" . SPARSER::COLLECTION)
    ("DNMTs" . SPARSER::PROTEIN)
    ("genistein and daidzein" . SPARSER::COLLECTION)
    ("daidzein" . SPARSER::DRUG) ("genistein" . SPARSER::PROTEIN)
    ("DMBA" . SPARSER::MOLECULE)
    ("trans -resveratrol and glucuronide" . SPARSER::COLLECTION)
    ("glucuronide" . SPARSER::MOLECULE) ("RASSF" . SPARSER::PROTEIN-FAMILY)
    ("PG" . SPARSER::PROTEIN) ("prostaglandin" . SPARSER::PROTEIN)
    ("methyltransferases" . SPARSER::PROTEIN) ("wine" . SPARSER::MOLECULE)
    ("RASSF1" . SPARSER::PROTEIN) ("trans-resveratrol" . SPARSER::MOLECULE)
    ("pH 3" . SPARSER::MOLECULE) ("DNA methyltransferase 1" . SPARSER::PROTEIN)
    ("DNMT3b" . SPARSER::PROTEIN) ("DNMT3a" . SPARSER::PROTEIN)
    ("DNMT1" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("E 2" . SPARSER::MOLECULE) ("trans -resveratrol" . SPARSER::MOLECULE)
    ("Trans -resveratrol" . SPARSER::MOLECULE) ("bipartite" . SPARSER::PROTEIN)
    ("Mad1–Mad2" . SPARSER::COLLECTION) ("Mad2" . SPARSER::PROTEIN)
    ("Mad1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("dynein" . SPARSER::PROTEIN)
    ("BubR1–Bub3" . SPARSER::COLLECTION)
    ("Bub1 and Bub3" . SPARSER::COLLECTION)
    ("currently unknown targets" . SPARSER::TARGET-PROTEIN)
    ("BubR1(1–203) or BubR1(1–363)" . SPARSER::COLLECTION)
    ("Bub1(WT) and the Bub1(4A) mutant" . SPARSER::COLLECTION)
    ("FRAP" . SPARSER::PROTEIN)
    ("Bub1(227–270) and Bub1(227–270-EK)" . SPARSER::COLLECTION)
    ("at least two kinetochore subunits, Knl1 and Hec1" . SPARSER::COLLECTION)
    ("subunits, Knl1 and Hec1" . SPARSER::COLLECTION)
    ("the resulting anti-GFP" . SPARSER::ANTIBODY) ("EK" . SPARSER::PROTEIN)
    ("Bub1(209–270) and Bub1(227–270)" . SPARSER::COLLECTION)
    ("Bub1–Bub3" . SPARSER::COLLECTION)
    ("Bub1(4A) and Bub1(Δ189)" . SPARSER::COLLECTION)
    ("EGFP-Bub1" . SPARSER::COLLECTION)
    ("Bub1(3A) or Bub1(4A)" . SPARSER::COLLECTION)
    ("KI1 or KI2" . SPARSER::COLLECTION) ("Met" . SPARSER::AMINO-ACID)
    ("Asp" . SPARSER::AMINO-ACID) ("Trp" . SPARSER::AMINO-ACID)
    ("KI1–Bub1" . SPARSER::COLLECTION)
    ("a helical conformation" . SPARSER::BIO-CONFORMATION)
    ("Bank" . SPARSER::PROTEIN)
    ("Knl1(150–250) or Knl1 (150–200)" . SPARSER::COLLECTION)
    ("a synthetic fluorescent peptide" . SPARSER::PEPTIDE)
    ("Mis12 and Ndc80" . SPARSER::COLLECTION)
    ("Knl1, Hec1, and Mis12" . SPARSER::COLLECTION)
    ("EGFP-tagged wild-type Bub1 and a mutant" . SPARSER::COLLECTION)
    ("the Bub1(1–150)–Knl1(150–250) complex" . SPARSER::BIO-COMPLEX)
    ("Bub1–Knl1" . SPARSER::COLLECTION) ("van" . SPARSER::PROTEIN)
    ("a fluorescent synthetic peptide" . SPARSER::PEPTIDE)
    ("solvent" . SPARSER::MOLECULE) ("polypeptide" . SPARSER::PROTEIN)
    ("helical hairpins" . SPARSER::PROTEIN-FAMILY)
    ("form helical hairpins" . SPARSER::PROTEIN-FAMILY)
    ("hairpins" . SPARSER::PROTEIN-FAMILY)
    ("The four Bub1(1–150)–Knl1(150–200) complexes" . SPARSER::BIO-COMPLEX)
    ("the Bub1(1–150)–Knl1(150–200) complex" . SPARSER::BIO-COMPLEX)
    ("–Knl1" . SPARSER::COLLECTION)
    ("The latter bound Knl1" . SPARSER::PROTEIN)
    ("stoichiometric complexes" . SPARSER::BIO-COMPLEX)
    ("macromolecules" . SPARSER::MOLECULE) ("KI2" . SPARSER::PROTEIN)
    ("Bub1(1–150) and BubR1(1–204)" . SPARSER::COLLECTION)
    ("BubR1(Δ204) or BubR1(Δ328)" . SPARSER::COLLECTION)
    ("Bub1(Δ150) or Bub1(Δ189)" . SPARSER::COLLECTION)
    ("Bub1(1–150) or Bub1(1–190)" . SPARSER::COLLECTION)
    ("EGFP" . SPARSER::PROTEIN) ("Knl1 and Bub3" . SPARSER::COLLECTION)
    ("BubR1–KI2" . SPARSER::COLLECTION) ("KI1 and KI2" . SPARSER::COLLECTION)
    ("Ndc80 and Knl1" . SPARSER::COLLECTION)
    ("Knl1 and Zwint-1" . SPARSER::COLLECTION)
    ("Nuf2, Spc24, and Spc25" . SPARSER::COLLECTION)
    ("Spc25" . SPARSER::PROTEIN) ("Spc24" . SPARSER::PROTEIN)
    ("Ndc80/Hec1" . SPARSER::COLLECTION) ("Nsl1" . SPARSER::PROTEIN)
    ("Dsn1" . SPARSER::PROTEIN)
    ("Blinkin, CASC5, and AF15q14" . SPARSER::COLLECTION)
    ("Saccharomyces" . SPARSER::PROTEIN) ("Blinkin" . SPARSER::PROTEIN)
    ("Bub1 or BubR1" . SPARSER::COLLECTION) ("BD" . SPARSER::PROTEIN)
    ("Further deletion mapping" . SPARSER::PROTEIN)
    ("Bub3-BD" . SPARSER::COLLECTION) ("BubR1/Mad3" . SPARSER::COLLECTION)
    ("propeller" . SPARSER::PROTEIN-FAMILY)
    ("the so-called mitotic checkpoint complex" . SPARSER::BIO-COMPLEX)
    ("Bub3, Mad2, and Cdc20" . SPARSER::COLLECTION)
    ("anaphase-promoting complex/cyclosome" . SPARSER::COLLECTION)
    ("Mad3/BubR1" . SPARSER::COLLECTION) ("Mad" . SPARSER::PROTEIN)
    ("benzimidazole" . SPARSER::DRUG) ("Knl1" . SPARSER::PROTEIN)
    ("TPRs" . SPARSER::PROTEIN)
    ("the essential checkpoint kinases Bub1 and BubR1" . SPARSER::COLLECTION)
    ("Bub1 and BubR1" . SPARSER::COLLECTION) ("EH1" . SPARSER::PROTEIN)
    ("P-2" . SPARSER::PROTEIN) ("sodium chloride" . SPARSER::DRUG)
    ("Full-length" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("B-2" . SPARSER::PROTEIN) ("wt/wt" . SPARSER::PROTEIN)
    ("T-REx" . SPARSER::PROTEIN-FAMILY) ("l -glutamine" . SPARSER::MOLECULE)
    ("BUB1" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fis1" . SPARSER::PROTEIN) ("histone 3" . SPARSER::PROTEIN)
    ("OH-" . SPARSER::MOLECULE) ("M 2" . SPARSER::MOLECULE)
    ("C–E" . SPARSER::PROTEIN) ("1 D" . SPARSER::PROTEIN)
    ("1 C" . SPARSER::PROTEIN) ("KI1" . SPARSER::PROTEIN)
    ("Nuf2" . SPARSER::PROTEIN) ("Hec1" . SPARSER::PROTEIN)
    ("Ndc80" . SPARSER::PROTEIN) ("NDC80" . SPARSER::PROTEIN)
    ("Mis12" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MIS12" . SPARSER::PROTEIN)
    ("Zwint-1" . SPARSER::PROTEIN) ("KNL1" . SPARSER::PROTEIN)
    ("Spc7" . SPARSER::PROTEIN) ("Spc105" . SPARSER::PROTEIN)
    ("AF15q14" . SPARSER::PROTEIN) ("CASC5" . SPARSER::PROTEIN)
    ("Rae1" . SPARSER::PROTEIN) ("Gle2" . SPARSER::PROTEIN)
    ("anaphase-promoting complex" . SPARSER::PROTEIN)
    ("Sgo1" . SPARSER::PROTEIN) ("histone 2" . SPARSER::PROTEIN)
    ("Mad3" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("Bub3" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("Bub1" . SPARSER::PROTEIN) ("neural marker genes" . SPARSER::GENE)
    ("NCAM1, NEUROG3 and GFAP" . SPARSER::COLLECTION)
    ("MAPT and TUBB3" . SPARSER::COLLECTION)
    ("TUBB3 and GFAP" . SPARSER::COLLECTION)
    ("CDH1, CLDN4, SST, PDX1,GCG and HLXB9" . SPARSER::COLLECTION)
    ("uPAR-uPA-integrin-PAI-1" . SPARSER::COLLECTION)
    ("uPAR" . SPARSER::PROTEIN) ("Plasmin" . SPARSER::PROTEIN)
    ("uPA" . SPARSER::PROTEIN) ("E-cadherin and forms" . SPARSER::COLLECTION)
    ("infected-PANC-1 and PD-PANC-1s" . SPARSER::COLLECTION)
    ("ATC" . SPARSER::DRUG) ("prostatic" . SPARSER::PROTEIN)
    ("PAI" . SPARSER::PROTEIN) ("vimentin" . SPARSER::PROTEIN)
    ("CDH1 and NCAM1" . SPARSER::COLLECTION)
    ("four mesenchymal marker mRNAs, THY1, VIM, NES and MMP2"
     . SPARSER::COLLECTION)
    ("three neural marker mRNAs, NCAM1, NEUROG3 and GFAP"
     . SPARSER::COLLECTION)
    ("mRNAs, CDH1, PDX1, HLXB9, CLDN4 and SST" . SPARSER::COLLECTION)
    ("mRNAs, NCAM1, NEUROG3 and GFAP" . SPARSER::COLLECTION)
    ("mRNAs, THY1, VIM, NES and MMP2" . SPARSER::COLLECTION)
    ("SNAI1, SNAI2, THY1, CTNNB1, ACTA2, VIM, NES, P4HA1 and MMP2"
     . SPARSER::COLLECTION)
    ("CDH1, PDX1, HLXB9, PTF1A, MAFA, CLDN3, CLDN4, OCLN, PNLIP, CPA1, INS, GCG and SST"
     . SPARSER::COLLECTION)
    ("NCAM1, CDH2, NEUROG3, POU3F2, OLIG1, MAPT, GFAP and TUBB3"
     . SPARSER::COLLECTION)
    ("GFAP" . SPARSER::PROTEIN) ("MAPT" . SPARSER::PROTEIN)
    ("SST" . SPARSER::PROTEIN) ("GCG" . SPARSER::PROTEIN)
    ("INS" . SPARSER::PROTEIN) ("PNLIP" . SPARSER::PROTEIN)
    ("OCLN" . SPARSER::PROTEIN) ("MAFA" . SPARSER::PROTEIN)
    ("NES" . SPARSER::PROTEIN) ("VIM" . SPARSER::PROTEIN)
    ("vitronectin" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("plasmin" . SPARSER::PROTEIN) ("plasminogen" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN) ("exogenous PAI-1" . SPARSER::PROTEIN)
    ("PAI-1 and E-cadherin" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("mesenchymal marker RNAs" . SPARSER::RNA) ("mRNAs" . SPARSER::PROTEIN)
    ("the parental PANC-1" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("TUBB3" . SPARSER::PROTEIN) ("OLIG1" . SPARSER::PROTEIN)
    ("POU3F2" . SPARSER::PROTEIN) ("NEUROG3" . SPARSER::PROTEIN)
    ("CDH2" . SPARSER::PROTEIN) ("NCAM1" . SPARSER::PROTEIN)
    ("CLDN4" . SPARSER::PROTEIN) ("CLDN3" . SPARSER::PROTEIN)
    ("PTF1A" . SPARSER::PROTEIN) ("HLXB9" . SPARSER::PROTEIN)
    ("PDX1" . SPARSER::PROTEIN) ("MMP2" . SPARSER::PROTEIN)
    ("P4HA1" . SPARSER::PROTEIN) ("ACTA2" . SPARSER::PROTEIN)
    ("THY1" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("SNAI1" . SPARSER::PROTEIN) ("–3µ" . SPARSER::PROTEIN)
    ("β-tubulin" . SPARSER::PROTEIN) ("ML-1" . SPARSER::PROTEIN)
    ("CC1" . SPARSER::PROTEIN)
    ("Plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::PROTEIN)
    ("E-cadherin" . SPARSER::PROTEIN) ("PANC-1" . SPARSER::PROTEIN)
    ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("YB-1, YY1, or RelA" . SPARSER::COLLECTION)
    ("p53 and DNA" . SPARSER::COLLECTION) ("theK-ras" . SPARSER::COLLECTION)
    ("nucleoplasmic p53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arf , and p19 Arf" . SPARSER::COLLECTION)
    ("genotoxic drug" . SPARSER::DRUG) ("Cip1 and bbc3" . SPARSER::COLLECTION)
    ("Cip1" . SPARSER::PROTEIN) ("p21 Cip1 and bbc3" . SPARSER::COLLECTION)
    ("Dmp1 (wild-type and M11 mutant) and p53" . SPARSER::COLLECTION)
    ("bbc3" . SPARSER::PROTEIN) ("puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and Dmp1" . SPARSER::COLLECTION)
    ("Dmp1 ( xref ) suggesting that Dmp1’s" . SPARSER::PROTEIN)
    ("a general/non-specific inhibitor of Hdm2’s" . SPARSER::INHIBITOR)
    ("Hdm2 and Dmp1" . SPARSER::COLLECTION)
    ("polyubiquitination" . SPARSER::PROTEIN) ("NTA" . SPARSER::MOLECULE)
    ("p53 and p53" . SPARSER::COLLECTION)
    ("full-length or carboxyl-terminal" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION)
    ("p53-bindig" . SPARSER::PROTEIN-PAIR) ("Mapping" . SPARSER::PROTEIN)
    ("p19 Arf or Mdm2" . SPARSER::COLLECTION)
    ("Mdm2 and p53" . SPARSER::COLLECTION)
    ("Dmp1 and Mdm2" . SPARSER::COLLECTION) ("Flag-Dmp1" . SPARSER::COLLECTION)
    ("DNA-damage" . SPARSER::DNA) ("RAX" . SPARSER::PROTEIN)
    ("etoposide" . SPARSER::DRUG) ("topoisomerase" . SPARSER::PROTEIN)
    ("c-Myc, E2F2, or E2F3" . SPARSER::COLLECTION)
    ("Mdm2-p53" . SPARSER::COLLECTION)
    ("p53, Mdm2, p19 Arf , or c-Myb" . SPARSER::COLLECTION)
    ("Arf-Mdm2-p53" . SPARSER::COLLECTION) ("Dmp1:ER" . SPARSER::BIO-COMPLEX)
    ("ARF" . SPARSER::PROTEIN) ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Arf-p53" . SPARSER::COLLECTION) ("-Myc" . SPARSER::COLLECTION)
    ("LA" . SPARSER::PROTEIN) ("Arf-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogens" . SPARSER::MITOGEN) ("E2Fs and Dmp1" . SPARSER::COLLECTION)
    ("Pokemon" . SPARSER::PROTEIN) ("Tbx" . SPARSER::PROTEIN-FAMILY)
    ("Ink4a/Arf" . SPARSER::COLLECTION) ("hypoxia" . SPARSER::PROTEIN)
    ("inp53" . SPARSER::PROTEIN) ("Dmp1-p53" . SPARSER::COLLECTION)
    ("Dmp1 and p53" . SPARSER::COLLECTION)
    ("a Ras/HER2-activated haplo-insufficient tumor suppressor"
     . SPARSER::SUPPRESSOR)
    ("Arf/p53" . SPARSER::COLLECTION) ("Dmp1" . SPARSER::PROTEIN)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("YB-1" . SPARSER::PROTEIN)
    ("ARF-BP1" . SPARSER::PROTEIN) ("– 3" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("DMP1" . SPARSER::PROTEIN)
    ("E2F3" . SPARSER::PROTEIN) ("E2F2" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("Waf1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("caspase 3" . SPARSER::PROTEIN) ("cyclin D" . SPARSER::PROTEIN)
    ("Bmi1" . SPARSER::PROTEIN) ("E2Fs" . SPARSER::PROTEIN-FAMILY)
    ("p16 Ink4a" . SPARSER::PROTEIN) ("Ink4a" . SPARSER::PROTEIN)
    ("alternative reading frame" . SPARSER::PROTEIN)
    ("p14 ARF" . SPARSER::PROTEIN) ("p19 Arf" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("reverse transcriptase-polymerase" . SPARSER::COLLECTION)
    ("albumin" . SPARSER::PROTEIN) ("ALB" . SPARSER::PROTEIN)
    ("biomarkers" . SPARSER::MOLECULE)
    ("ERBB2, mTOR, or PI3K" . SPARSER::COLLECTION)
    ("mammalian target of rapamycin (mTOR) or PI3K inhibitors [ xref ]"
     . SPARSER::COLLECTION)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("lapatinib" . SPARSER::DRUG) ("trastuzumab" . SPARSER::DRUG)
    ("ERα, PR, and ERBB2" . SPARSER::COLLECTION) ("adjuvant" . SPARSER::DRUG)
    ("/PR" . SPARSER::COLLECTION) ("/ERBB2" . SPARSER::COLLECTION)
    ("the last C-terminal amino acid" . SPARSER::AMINO-ACID)
    ("Exon" . SPARSER::PROTEIN) ("ERα, PR , and ERBB2" . SPARSER::COLLECTION)
    ("estrogen receptor-alpha-" . SPARSER::COLLECTION)
    ("HRAS" . SPARSER::PROTEIN) ("a heterodimeric enzyme" . SPARSER::ENZYME)
    ("-phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("TKR" . SPARSER::PROTEIN) ("ERBB2-" . SPARSER::PROTEIN)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ER-" . SPARSER::PROTEIN)
    ("GC-C" . SPARSER::PROTEIN) ("anti-ERBB2" . SPARSER::DRUG)
    ("alpha-" . SPARSER::PROTEIN) ("P110α" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN)
    ("Phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("CXCL13/CXCR5" . SPARSER::COLLECTION)
    ("NFATc3 and RANKL" . SPARSER::COLLECTION)
    ("NFAT and c-Myc" . SPARSER::COLLECTION) ("NFAT" . SPARSER::PROTEIN)
    ("soluble RANKL" . SPARSER::PROTEIN)
    ("osteotropic cytokines" . SPARSER::PROTEIN)
    ("IL-1β and prostaglandin E2" . SPARSER::COLLECTION)
    ("PTH" . SPARSER::PROTEIN) ("c-Myc and RANKL" . SPARSER::COLLECTION)
    ("RANKL-RANK" . SPARSER::COLLECTION) ("RANK" . SPARSER::PROTEIN)
    ("anti-p-c-Myc" . SPARSER::COLLECTION)
    ("NFATc3 or c-Myc" . SPARSER::COLLECTION) ("ALP" . SPARSER::PROTEIN)
    ("luciferin" . SPARSER::MOLECULE)
    ("c-Myc, NFATc3 and RANKL" . SPARSER::COLLECTION)
    ("hRANKL" . SPARSER::PROTEIN) ("hRANKL-luciferase" . SPARSER::COLLECTION)
    ("pg" . SPARSER::MOLECULE) ("media (CM)" . SPARSER::PROTEIN)
    ("CCR7 and CXCR5" . SPARSER::COLLECTION) ("chemotaxis" . SPARSER::PROTEIN)
    ("amino acid and play" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN) ("Chemokines" . SPARSER::PROTEIN)
    ("RANKL and osteoprotegerin" . SPARSER::COLLECTION)
    ("OPG" . SPARSER::PROTEIN) ("osteoprotegerin" . SPARSER::PROTEIN)
    ("ligand (RANKL)" . SPARSER::MOLECULE) ("osteoclasts" . SPARSER::PROTEIN)
    ("MMP-1 and MMP-9" . SPARSER::COLLECTION) ("kappaB" . SPARSER::PROTEIN)
    ("a potential therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("CXCL13-CXCR5" . SPARSER::COLLECTION) ("Chromatin" . SPARSER::PROTEIN)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("RANKL and NFATc3" . SPARSER::COLLECTION)
    ("p-c-Myc" . SPARSER::COLLECTION)
    ("c-Myc and NFATc3" . SPARSER::COLLECTION) ("RANKL" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("A-3" . SPARSER::PROTEIN)
    ("RNase A" . SPARSER::PROTEIN) ("NaHCO 3" . SPARSER::DRUG)
    ("A 20" . SPARSER::PROTEIN) ("AC -3" . SPARSER::PROTEIN)
    ("murine leukemia virus" . SPARSER::PROTEIN) ("1–2" . SPARSER::PROTEIN)
    ("p-ERK" . SPARSER::PROTEIN) ("NFATc1" . SPARSER::PROTEIN)
    ("cathepsin G" . SPARSER::PROTEIN) ("PGE2" . SPARSER::DRUG)
    ("prostaglandin E2" . SPARSER::MOLECULE)
    ("parathyroid hormone" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pERK1/2" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("SCC-1" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("seven-transmembrane" . SPARSER::PROTEIN)
    ("MMP-7" . SPARSER::PROTEIN)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("p-ERK1" . SPARSER::PROTEIN) ("NFATc3" . SPARSER::PROTEIN)
    ("CXCR5" . SPARSER::PROTEIN) ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("CXCL13" . SPARSER::PROTEIN)
    ("STAT3 and nicotine/NNK-induced IKBKE" . SPARSER::COLLECTION)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and NF-κB" . SPARSER::COLLECTION)
    ("IL6, IL-1β and interferon-γ" . SPARSER::COLLECTION)
    ("LPS" . SPARSER::PROTEIN) ("interferon-γ" . SPARSER::PROTEIN)
    ("nicotinic acetylcholine receptor nicotinic acetylcholine receptor"
     . SPARSER::PROTEIN)
    ("kinase/STAT3" . SPARSER::COLLECTION) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("K-ras , p53 or p16" . SPARSER::COLLECTION)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("STAT3 and nicotine" . SPARSER::COLLECTION)
    ("shRNA-IKBKE" . SPARSER::COLLECTION) ("gemcitabine-" . SPARSER::DRUG)
    ("cisplatin-" . SPARSER::DRUG) ("doxorubicin" . SPARSER::PROTEIN)
    ("that nicotine and NNK-stimulated IKBKE promoter activity in a dose-dependent manner"
     . SPARSER::COLLECTION)
    ("nicotine (1 μM) or NNK (1 μM)" . SPARSER::COLLECTION)
    ("janus" . SPARSER::PROTEIN-FAMILY) ("Tobacco" . SPARSER::DRUG)
    ("Nicotine" . SPARSER::DRUG) ("IKBKE and pSTAT3" . SPARSER::COLLECTION)
    ("an irrelevant actin antibody" . SPARSER::ANTIBODY)
    ("a particular transcription factor" . SPARSER::PROTEIN)
    ("pGL3-IKBKE" . SPARSER::COLLECTION)
    ("dominant-negative STAT3" . SPARSER::PROTEIN)
    ("STAT3 and v-Src" . SPARSER::COLLECTION) ("-STAT3" . SPARSER::COLLECTION)
    ("Mcl-1 and c-myc" . SPARSER::COLLECTION) ("BMX" . SPARSER::PROTEIN)
    ("ETK" . SPARSER::PROTEIN) ("oncoproteins" . SPARSER::PROTEIN)
    ("IKKε and IKK" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION)
    ("serine/threonine" . SPARSER::COLLECTION) ("NEMO" . SPARSER::PROTEIN)
    ("deubiquitinase" . SPARSER::DEUBIQUITINASE) ("CYLD" . SPARSER::PROTEIN)
    ("STAT3-" . SPARSER::PROTEIN) ("protein and mRNA" . SPARSER::COLLECTION)
    ("NNK" . SPARSER::MOLECULE)
    ("nicotine and nicotine-derived nitrosamine ketone (NNK)"
     . SPARSER::COLLECTION)
    ("ketone (NNK)" . SPARSER::MOLECULE) ("ketone" . SPARSER::MOLECULE)
    ("nitrosamine" . SPARSER::MOLECULE) ("nicotine" . SPARSER::DRUG)
    ("cigarette" . SPARSER::DRUG) ("mRNA and protein" . SPARSER::COLLECTION)
    ("Serine/threonine" . SPARSER::COLLECTION) ("IKBKE" . SPARSER::PROTEIN)
    ("Serine" . SPARSER::AMINO-ACID) ("caspase3" . SPARSER::PROTEIN)
    ("ChIP-1" . SPARSER::PROTEIN) ("β-gal" . SPARSER::PROTEIN)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p50" . SPARSER::PROTEIN)
    ("IL-1β" . SPARSER::PROTEIN) ("acetylcholine receptor" . SPARSER::PROTEIN)
    ("p16" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("interleukin 6" . SPARSER::PROTEIN)
    ("IL6" . SPARSER::PROTEIN) ("JSI-124" . SPARSER::DRUG)
    ("mTORC2" . SPARSER::PROTEIN) ("TRAF6" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("STAT1" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 1" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("multiple representative examples" . SPARSER::EXAMPLE)
    ("the larger cohort" . SPARSER::MOLECULE)
    ("RAF and RB1" . SPARSER::COLLECTION) ("KRAS/BRAF" . SPARSER::COLLECTION)
    ("RAS/RAF/MEK1" . SPARSER::COLLECTION)
    ("the TP53 and/or BRCA1/2 genes" . SPARSER::COLLECTION)
    ("RPPA" . SPARSER::PROTEIN) ("−1" . SPARSER::PROTEIN)
    ("KRAS and BRAF" . SPARSER::COLLECTION)
    ("PD901 and MK2206" . SPARSER::COLLECTION) ("p70S6K" . SPARSER::PROTEIN)
    ("ERK and AKT" . SPARSER::COLLECTION)
    ("RAS and PI3K" . SPARSER::COLLECTION)
    ("MEK and AKT" . SPARSER::COLLECTION)
    ("AKT2 or AKT3" . SPARSER::COLLECTION)
    ("the respective AKT isoforms" . SPARSER::ISOFORM)
    ("AKT1, AKT2, or AKT3" . SPARSER::COLLECTION)
    ("BG-1 ( PIK3CA E545K mutant) and SKOV-6 ( PTEN / RB1- null)"
     . SPARSER::COLLECTION)
    ("RB1-" . SPARSER::PROTEIN) ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("EC" . SPARSER::PROTEIN) ("AKTi" . SPARSER::PROTEIN)
    ("PH" . SPARSER::PROTEIN)
    ("selective pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("AKT1, -2 and -3" . SPARSER::COLLECTION)
    ("PRAS40, GSK3β and FOXO" . SPARSER::COLLECTION)
    ("p-AKT" . SPARSER::COLLECTION) ("cohorts" . SPARSER::MOLECULE)
    ("OV" . SPARSER::MOLECULE) ("concurrent BRAF V600E" . SPARSER::PROTEIN)
    ("RAS/RAF" . SPARSER::COLLECTION) ("ERBB2 and AKT2" . SPARSER::COLLECTION)
    ("PI3K-" . SPARSER::PROTEIN-FAMILY) ("RAS or RAF" . SPARSER::COLLECTION)
    ("PIK3CA and AKT1/2/3" . SPARSER::COLLECTION)
    ("receptor and integrin" . SPARSER::COLLECTION)
    ("AKT1/2/3" . SPARSER::COLLECTION) ("PI3 kinase/AKT" . SPARSER::COLLECTION)
    ("Anti-ERBB2" . SPARSER::DRUG) ("Anti–" . SPARSER::ANTIBODY)
    ("RPM1" . SPARSER::PROTEIN) ("RAS-GTP" . SPARSER::PROTEIN)
    ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Type 1" . SPARSER::PROTEIN)
    ("ZVAD-FMK" . SPARSER::DRUG) ("p70S6" . SPARSER::PROTEIN)
    ("PD901" . SPARSER::DRUG) ("PD0325901" . SPARSER::DRUG)
    ("4EBP1" . SPARSER::PROTEIN) ("cyclin D3" . SPARSER::PROTEIN)
    ("BG-1" . SPARSER::PROTEIN) ("MK2206" . SPARSER::DRUG)
    ("AKT-1" . SPARSER::PROTEIN) ("GSK3β" . SPARSER::PROTEIN)
    ("PRAS40" . SPARSER::PROTEIN) ("MEK1" . SPARSER::PROTEIN)
    ("AKT2" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("AKT3" . SPARSER::PROTEIN) ("AKT1" . SPARSER::PROTEIN)
    ("PI3 kinase" . SPARSER::PROTEIN) ("food" . SPARSER::MOLECULE)
    ("β-catenin and TCF" . SPARSER::COLLECTION)
    ("tankyrase" . SPARSER::PROTEIN) ("β-catenin/c-myc" . SPARSER::COLLECTION)
    ("particular Wnt-10b" . SPARSER::PROTEIN) ("Ctnnb1" . SPARSER::PROTEIN)
    ("hydroxyproline" . SPARSER::MOLECULE)
    ("a classical target gene" . SPARSER::GENE)
    ("Wnt-1, Wnt-4 and Wnt-10b" . SPARSER::COLLECTION)
    ("Wnt-1 and Wnt-4" . SPARSER::COLLECTION)
    ("Wnt-2, Wnt-9a, Wnt-9b and Wnt-16" . SPARSER::COLLECTION)
    ("Wnt-3a, Wnt-6, Wnt-7a, Wnt-7b and Wnt-8a" . SPARSER::COLLECTION)
    ("potential Wnt ligands" . SPARSER::LIGAND) ("casein" . SPARSER::PROTEIN)
    ("axin" . SPARSER::PROTEIN) ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TCF" . SPARSER::PROTEIN) ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin/Wnt" . SPARSER::COLLECTION) ("bleomycin" . SPARSER::DRUG)
    ("Wnt-1 and Wnt-10b" . SPARSER::COLLECTION) ("Wnt-10b" . SPARSER::PROTEIN)
    ("prolyl" . SPARSER::PROTEIN) ("non-selective" . SPARSER::PROTEIN)
    ("S33" . SPARSER::PROTEIN) ("as 2" . SPARSER::PROTEIN)
    ("Wnt-16" . SPARSER::PROTEIN) ("Wnt-9b" . SPARSER::PROTEIN)
    ("Wnt-9a" . SPARSER::PROTEIN) ("Wnt-2" . SPARSER::PROTEIN)
    ("Wnt-8" . SPARSER::PROTEIN) ("Wnt-7" . SPARSER::PROTEIN)
    ("Wnt-6" . SPARSER::PROTEIN) ("Wnt-3a" . SPARSER::PROTEIN)
    ("Wnt-2b" . SPARSER::PROTEIN) ("a2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Messenger RNA" . SPARSER::RNA) ("Wnt-4" . SPARSER::PROTEIN)
    ("axin-2" . SPARSER::PROTEIN) ("GSK-3β" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("Wnt-10" . SPARSER::PROTEIN) ("Wnt-1" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN)
    ("P53 ( xref ), FOXO ( xref ), PGC1-α ( xref ) and HIF-2α ( xref )"
     . SPARSER::COLLECTION)
    ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("a SIRT1 activator (resveratrol) and an inhibitor (NAM)"
     . SPARSER::COLLECTION)
    ("inhibitor (NAM)" . SPARSER::INHIBITOR) ("globin" . SPARSER::PROTEIN)
    ("SIRT1 and ε-globin" . SPARSER::COLLECTION)
    ("ACF and the NURD chromatin" . SPARSER::COLLECTION)
    ("HDAC1 and HDAC2" . SPARSER::COLLECTION) ("ACF" . SPARSER::PROTEIN)
    ("CHRAC" . SPARSER::BIO-COMPLEX) ("nucleosome" . SPARSER::BIO-COMPLEX)
    ("that SATB1’s" . SPARSER::PROTEIN) ("umbilical HSCs" . SPARSER::PROTEIN)
    ("mock and wild-type SATB1" . SPARSER::PROTEIN)
    ("SATB1 or K136AK175A" . SPARSER::COLLECTION)
    ("activator or inhibitor" . SPARSER::COLLECTION)
    ("human primary HSCs" . SPARSER::PROTEIN)
    ("SIRT1 or luciferase" . SPARSER::COLLECTION) ("puromycin" . SPARSER::DRUG)
    ("Epo" . SPARSER::PROTEIN) ("erythropoietin" . SPARSER::PROTEIN)
    ("HSCs" . SPARSER::PROTEIN) ("resveratrol" . SPARSER::PROTEIN)
    ("SIRT1 and NAD +" . SPARSER::COLLECTION)
    ("Myc-SATB1" . SPARSER::COLLECTION) ("A western blot" . SPARSER::PROTEIN)
    ("coenzyme" . SPARSER::MOLECULE) ("acetyl" . SPARSER::MOLECULE)
    ("Dlg" . SPARSER::PROTEIN) ("TSA and NAM" . SPARSER::COLLECTION)
    ("SIRT1 inhibitor Nicotinamide (NAM) (5 mM) or both" . SPARSER::COLLECTION)
    ("Nicotinamide (NAM)" . SPARSER::MOLECULE)
    ("NAM" . SPARSER::PROTEIN-FAMILY) ("Nicotinamide" . SPARSER::PROTEIN)
    ("inhibitor or activator" . SPARSER::COLLECTION)
    ("SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("GFP-SATB1" . SPARSER::COLLECTION) ("KD-SIRT1" . SPARSER::COLLECTION)
    ("SIRT1 and SATB1" . SPARSER::COLLECTION)
    ("SATB1 and non-tagged" . SPARSER::COLLECTION)
    ("SIRT1, or Myc-tagged" . SPARSER::COLLECTION)
    ("SIRT1 and non-tagged" . SPARSER::COLLECTION) ("Myc" . SPARSER::PROTEIN)
    ("SATB1 and SIRT1" . SPARSER::COLLECTION) ("Myo" . SPARSER::PROTEIN)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY) ("hemin" . SPARSER::MOLECULE)
    ("PCAF" . SPARSER::PROTEIN) ("protein (CBP)" . SPARSER::PROTEIN)
    ("hypersensitive site 2" . SPARSER::PROTEIN)
    ("complexes and histone modifiers ( xref )" . SPARSER::COLLECTION)
    ("a well-studied matrix binding protein" . SPARSER::PROTEIN)
    ("modifiers" . SPARSER::MOLECULE)
    ("associated genes and gene" . SPARSER::COLLECTION)
    ("different potential MARs" . SPARSER::PROTEIN)
    ("genes and gene" . SPARSER::COLLECTION) ("MARs" . SPARSER::PROTEIN)
    ("Conformation" . SPARSER::BIO-CONFORMATION)
    ("erythroid" . SPARSER::PROTEIN)
    ("cytokine, MHC-I and β-globin" . SPARSER::COLLECTION)
    ("HS4" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("P53" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("γ-globin" . SPARSER::PROTEIN) ("HDAC2" . SPARSER::PROTEIN)
    ("HDAC1" . SPARSER::PROTEIN) ("A 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SATB-1" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("SIRT7" . SPARSER::PROTEIN)
    ("SIRT6" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("acetyl-CoA" . SPARSER::MOLECULE) ("Nonidet P-40" . SPARSER::DRUG)
    ("CD34" . SPARSER::PROTEIN) ("PGC1" . SPARSER::PROTEIN)
    ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p300/CBP-associated factor" . SPARSER::PROTEIN)
    ("cAMP Response Element-Binding Protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("site 2" . SPARSER::PROTEIN) ("Hi-C" . SPARSER::PROTEIN)
    ("ε-globin" . SPARSER::PROTEIN) ("HS2" . SPARSER::PROTEIN)
    ("β-globin" . SPARSER::PROTEIN) ("SATB1" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN) ("S. cerevisiae" . SPARSER::PROTEIN)
    ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("allele and genetic heterogeneity" . SPARSER::COLLECTION)
    ("around LMO1" . SPARSER::PROTEIN) ("the gene's" . SPARSER::GENE)
    ("2–4 and exons" . SPARSER::COLLECTION)
    ("the web-based software SNAP" . SPARSER::PROTEIN)
    ("SNAP" . SPARSER::PROTEIN) ("GIF" . SPARSER::PROTEIN)
    ("MDS" . SPARSER::PROTEIN) ("AAs" . SPARSER::MOLECULE)
    ("AA" . SPARSER::MOLECULE) ("the more severe form" . SPARSER::FORM)
    ("EMP2" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("HSD17B12" . SPARSER::PROTEIN) ("IL31RA" . SPARSER::PROTEIN)
    ("DDX4" . SPARSER::PROTEIN) ("LMO1" . SPARSER::PROTEIN)
    ("minimal DNA" . SPARSER::DNA) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("Sunitinib" . SPARSER::DRUG)
    ("sunitinib, sorafenib and vandetanib" . SPARSER::COLLECTION)
    ("vandetanib" . SPARSER::DRUG) ("sorafenib" . SPARSER::DRUG)
    ("Thyroid" . SPARSER::PROTEIN)
    ("EGFR , ERBB2 , BRAF or KRAS" . SPARSER::COLLECTION)
    ("intense RET" . SPARSER::PROTEIN) ("PTC-RET" . SPARSER::COLLECTION)
    ("PTC" . SPARSER::PROTEIN) ("KIF5B-ALK" . SPARSER::COLLECTION)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the last KIF5B and first RET exons" . SPARSER::COLLECTION)
    ("the last KIF5B" . SPARSER::PROTEIN)
    ("PI3K and MEK" . SPARSER::COLLECTION)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("CDKN2A, CCNE1 and CDK4" . SPARSER::COLLECTION)
    ("PI3K and mTOR" . SPARSER::COLLECTION) ("v-raf" . SPARSER::COLLECTION)
    ("nutlin" . SPARSER::DRUG) ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("vemurafenib" . SPARSER::DRUG) ("raf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("APC , CCNE1, CDK4 , MLH1, MSH6 , NF1, RB1, RET , and TSC1"
     . SPARSER::COLLECTION)
    ("MLH1" . SPARSER::PROTEIN)
    ("PIK3CA (2) and ATM (2)" . SPARSER::COLLECTION)
    ("KRAS (10), TP53 (7), STK11 (4), LRP1B (3), JAK2 (3), EGFR (2), BRAF (2), CDKN2A (2), CTNNB1 (2), MDM2 (2), PIK3CA (2) and ATM (2)"
     . SPARSER::COLLECTION)
    ("crizotinib or other ALK inhibitors" . SPARSER::COLLECTION)
    ("KRAS and BR AF (cetuximab xref , xref or panitumumab resistance  xref  )"
     . SPARSER::COLLECTION)
    ("GNAS (MEK or ERK inhibitor trials  xref  ) and PIK3CA"
     . SPARSER::COLLECTION)
    ("MEK or ERK" . SPARSER::COLLECTION) ("panitumumab" . SPARSER::DRUG)
    ("cetuximab" . SPARSER::DRUG) ("AF" . SPARSER::PROTEIN)
    ("Examples" . SPARSER::EXAMPLE)
    ("ALK , CDK8 , LRP1B , MYC , MSH6 , RICTOR , SMAD2 and STK11"
     . SPARSER::COLLECTION)
    ("RICTOR" . SPARSER::PROTEIN)
    ("PIK3CA (2) and SMAD4 (2)" . SPARSER::COLLECTION)
    ("KRAS (10), BRAF (6), FBXW7 (5), ATM (2), BCL2L1 (2), BRCA2 (2), CDH1 (2), ERBB3 (2), GNAS (2), PIK3CA (2) and SMAD4 (2)"
     . SPARSER::COLLECTION)
    ("GNAS" . SPARSER::PROTEIN) ("TP53 and APC" . SPARSER::COLLECTION)
    ("at least two classes" . CLASS) ("classes" . CLASS)
    ("CRCs" . SPARSER::PROTEIN) ("solution" . SPARSER::MOLECULE)
    ("CRC" . SPARSER::PROTEIN) ("145 cancer-relevant genes" . SPARSER::GENE)
    ("KIF5B-RET" . SPARSER::COLLECTION) ("RET" . SPARSER::PROTEIN)
    ("orf" . SPARSER::PROTEIN) ("formalin" . SPARSER::MOLECULE)
    ("IL-3" . SPARSER::PROTEIN) ("interleukin-3" . SPARSER::PROTEIN)
    ("K16" . SPARSER::PROTEIN) ("ROS1" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase 4" . SPARSER::PROTEIN)
    ("GSK 2118436" . SPARSER::DRUG) ("TSC1" . SPARSER::PROTEIN)
    ("NF1" . SPARSER::PROTEIN) ("CDK4" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("CDKN2A" . SPARSER::PROTEIN)
    ("mechanistic target of rapamycin" . SPARSER::PROTEIN)
    ("alpha polypeptide" . SPARSER::PROTEIN)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("STK11" . SPARSER::PROTEIN) ("SMAD2" . SPARSER::PROTEIN)
    ("MSH6" . SPARSER::PROTEIN) ("LRP1B" . SPARSER::PROTEIN)
    ("CDK8" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("ERBB3" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("FBXW7" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("very weak AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Medicine" . SPARSER::DRUG) ("hematoxylin" . SPARSER::MOLECULE)
    ("chromogen" . SPARSER::MOLECULE)
    ("a monoclonal anti-AR antibody" . SPARSER::ANTIBODY)
    ("Dako High-pH Target Retrieval Solution" . SPARSER::MOLECULE)
    ("Solution" . SPARSER::MOLECULE) ("Target" . SPARSER::TARGET-PROTEIN)
    ("ethanol" . SPARSER::MOLECULE) ("xylene" . SPARSER::MOLECULE)
    ("ARs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Estrogen" . SPARSER::MOLECULE)
    ("MLL and JunD" . SPARSER::COLLECTION)
    ("the aggressive leukemia" . SPARSER::PROTEIN)
    ("a menin-MLL1-LEDGF ternary complex" . SPARSER::BIO-COMPLEX)
    ("menin-MLL1-LEDGF" . SPARSER::COLLECTION)
    ("CBP/p300" . SPARSER::COLLECTION) ("anisomycin" . SPARSER::DRUG)
    ("GST-JunD" . SPARSER::COLLECTION)
    ("basic amino acids" . SPARSER::AMINO-ACID)
    ("menin-MLL2-LEDGF" . SPARSER::COLLECTION)
    ("a ternary complex" . SPARSER::BIO-COMPLEX) ("anchor" . SPARSER::ANCHOR)
    ("MLL1 and α4" . SPARSER::COLLECTION) ("leucine" . SPARSER::AMINO-ACID)
    ("-LEDGF" . SPARSER::COLLECTION)
    ("menin and an N-terminal fragment" . SPARSER::COLLECTION)
    ("neither menin nor MLL1 MBM-LBM" . SPARSER::COLLECTION)
    ("IBD" . SPARSER::PROTEIN) ("MLL1 and menin" . SPARSER::COLLECTION)
    ("Hoxc6 or Hoxc8" . SPARSER::COLLECTION)
    ("Hoxc8 and Hoxc6" . SPARSER::COLLECTION)
    ("complemented" . SPARSER::PROTEIN) ("menin-MLL" . SPARSER::COLLECTION)
    ("Hoxc6 and Hoxc8" . SPARSER::COLLECTION) ("Hoxc8" . SPARSER::PROTEIN)
    ("Hoxc6" . SPARSER::PROTEIN)
    ("yielded insoluble proteins" . SPARSER::PROTEIN)
    ("menin-MLL1" . SPARSER::COLLECTION) ("RR" . SPARSER::MOLECULE)
    ("TPR" . SPARSER::PROTEIN)
    ("a rectangular-shaped conformation" . SPARSER::BIO-CONFORMATION)
    ("palm" . SPARSER::PROTEIN) ("MLL1 and MLL2" . SPARSER::COLLECTION)
    ("MLL" . SPARSER::PROTEIN)
    ("the internal non-conserved polyglycine" . SPARSER::MOLECULE)
    ("polyglycine" . SPARSER::MOLECULE) ("mapping" . SPARSER::PROTEIN)
    ("JNK" . SPARSER::PROTEIN) ("MLL1 or JunD" . SPARSER::COLLECTION)
    ("MLL1-LEDGF" . SPARSER::COLLECTION) ("LEDGF" . SPARSER::PROTEIN)
    ("protein (MFP)" . SPARSER::PROTEIN) ("MFP" . SPARSER::PROTEIN)
    ("HOX" . SPARSER::PROTEIN) ("cofactor" . SPARSER::MOLECULE)
    ("methyltransferase" . SPARSER::PROTEIN)
    ("menin-JunD" . SPARSER::COLLECTION) ("menin" . SPARSER::PROTEIN)
    ("JunD" . SPARSER::PROTEIN) ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("endocrine" . SPARSER::PROTEIN) ("Menin" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("JNK3" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("β-galactosidase" . SPARSER::PROTEIN)
    ("L40" . SPARSER::PROTEIN) ("CCP4" . SPARSER::PROTEIN)
    ("SO 4" . SPARSER::PROTEIN) ("p-1" . SPARSER::PROTEIN)
    ("Ulp1" . SPARSER::PROTEIN) ("c-Jun" . SPARSER::PROTEIN)
    ("A-P" . SPARSER::PROTEIN) ("F-P" . SPARSER::PROTEIN)
    ("MLL 1" . SPARSER::PROTEIN) ("Men1" . SPARSER::PROTEIN)
    ("MLL2" . SPARSER::PROTEIN) ("H3K4" . SPARSER::PROTEIN)
    ("MLL1" . SPARSER::PROTEIN) ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("autosomal dominant" . SPARSER::PROTEIN) ("MEN1" . SPARSER::PROTEIN)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("a ligand’s" . SPARSER::MOLECULE) ("pure antiestrogens" . SPARSER::DRUG)
    ("weaker" . SPARSER::PROTEIN) ("LBDs" . SPARSER::PROTEIN)
    ("CBP or SRC-1" . SPARSER::COLLECTION) ("raloxifene" . SPARSER::PROTEIN)
    ("the terminal polar hydroxyl group" . SPARSER::MOLECULE)
    ("SRC-1 or CBP" . SPARSER::COLLECTION) ("LBD" . SPARSER::PROTEIN)
    ("LBD-NID" . SPARSER::PROTEIN-PAIR) ("Estradiol" . SPARSER::PROTEIN)
    ("E2, and C14" . SPARSER::COLLECTION)
    ("AF-1 and AF-2" . SPARSER::COLLECTION)
    ("the agonist and antagonist properties" . SPARSER::COLLECTION)
    ("the receptor’s" . SPARSER::RECEPTOR)
    ("The ICI pure antiestrogens" . SPARSER::DRUG)
    ("luciferase and co-IP" . SPARSER::COLLECTION)
    ("ERα-SRC-3" . SPARSER::COLLECTION) ("E2 and C14" . SPARSER::COLLECTION)
    ("the potential agonist" . SPARSER::AGONIST)
    ("ERE-luciferase" . SPARSER::PROTEIN-PAIR)
    ("SRC-1 and CBP" . SPARSER::COLLECTION)
    ("CBP and ERα" . SPARSER::COLLECTION) ("GAL-CBP" . SPARSER::COLLECTION)
    ("a weak ER agonist" . SPARSER::AGONIST)
    ("GAL-SRC-1" . SPARSER::COLLECTION) ("GAL" . SPARSER::PROTEIN)
    ("p300 and the p160 SRC family" . SPARSER::COLLECTION)
    ("CBP, p300 and the p160 SRC family" . SPARSER::COLLECTION)
    ("Ligand" . SPARSER::LIGAND) ("ERE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("cellular ERα" . SPARSER::PROTEIN) ("exogenous ERα" . SPARSER::PROTEIN)
    ("partial agonist and antagonist properties" . SPARSER::COLLECTION)
    ("the pure antiestrogen ICI" . SPARSER::DRUG)
    ("response element (ERE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("FBS, and ligand" . SPARSER::COLLECTION) ("EGTA" . SPARSER::MOLECULE)
    ("Complete Mini protease inhibitor" . SPARSER::INHIBITOR)
    ("10% charcoal stripped FBS" . SPARSER::PROTEIN) ("HC" . SPARSER::PROTEIN)
    ("using HRP-conjugated ECL IgG secondary antibodies" . SPARSER::ANTIBODY)
    ("HRP" . SPARSER::PROTEIN) ("Water" . SPARSER::MOLECULE)
    ("nitrocellulose" . SPARSER::MOLECULE) ("Sarkosyl" . SPARSER::DRUG)
    ("2.5 Western blot" . SPARSER::PROTEIN)
    ("CH3 and NID" . SPARSER::COLLECTION) ("NID" . SPARSER::PROTEIN)
    ("Reagent" . SPARSER::MOLECULE) ("Luciferase" . SPARSER::PROTEIN)
    ("EDTA and 150mM" . SPARSER::COLLECTION) ("NaCl" . SPARSER::PROTEIN)
    ("EDTA" . SPARSER::MOLECULE) ("Tris" . SPARSER::MOLECULE)
    ("Trans" . SPARSER::PROTEIN-FAMILY)
    ("5% charcoal-stripped FBS" . SPARSER::PROTEIN) ("Dr" . SPARSER::MOLECULE)
    ("17β-Estradiol and 4-hydroxytamoxifen" . SPARSER::COLLECTION)
    ("Chemical" . SPARSER::MOLECULE) ("Sigma" . SPARSER::PROTEIN-FAMILY)
    ("Chemicals" . SPARSER::MOLECULE)
    ("the pure antiestrogens" . SPARSER::DRUG)
    ("-17β-estradiol" . SPARSER::COLLECTION)
    ("CBP and agonist-bound nuclear receptors [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("CBP" . SPARSER::PROTEIN) ("NCoR" . SPARSER::PROTEIN)
    ("ICI" . SPARSER::DRUG) ("Antiestrogen" . SPARSER::DRUG)
    ("two pure antiestrogens" . SPARSER::DRUG) ("Partial" . SPARSER::PROTEIN)
    ("partial" . SPARSER::PROTEIN) ("Antiestrogens" . SPARSER::DRUG)
    ("coactivators" . SPARSER::PROTEIN) ("SERM" . SPARSER::DRUG)
    ("the pure antiestrogen ICI 182,780" . SPARSER::DRUG)
    ("antiestrogen" . SPARSER::DRUG)
    ("known pure antiestrogens" . SPARSER::DRUG)
    ("Two novel 7α-substituted E2 derivatives" . SPARSER::DERIVATIVE)
    ("derivatives" . SPARSER::DERIVATIVE) ("estradiol" . SPARSER::PROTEIN)
    ("SERMs" . SPARSER::DRUG) ("Pure antiestrogens" . SPARSER::DRUG)
    ("antiestrogens" . SPARSER::DRUG) ("ERβ" . SPARSER::PROTEIN)
    ("AF1" . SPARSER::PROTEIN) ("AF2" . SPARSER::PROTEIN)
    ("transcriptional coactivator" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("p160" . SPARSER::PROTEIN)
    ("1-2" . SPARSER::PROTEIN) ("Reducing Agent" . SPARSER::MOLECULE)
    ("pG5" . SPARSER::PROTEIN) ("VP16" . SPARSER::DRUG)
    ("SRC-1" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("17β-Estradiol" . SPARSER::PROTEIN)
    ("cAMP response element-binding protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CH3" . SPARSER::MOLECULE) ("SRC-3" . SPARSER::PROTEIN)
    ("H12" . SPARSER::PROTEIN) ("AF-2" . SPARSER::PROTEIN)
    ("AF-1" . SPARSER::PROTEIN) ("17β-estradiol" . SPARSER::PROTEIN)
    ("Steroid hormone" . SPARSER::MOLECULE) ("ICI 182,780" . SPARSER::DRUG)
    ("C-7" . SPARSER::PROTEIN) ("exogenous glutamine" . SPARSER::AMINO-ACID)
    ("lactate and glutamine" . SPARSER::COLLECTION)
    ("redox" . SPARSER::PROTEIN) ("pyruvate and NADH" . SPARSER::COLLECTION)
    ("NADH" . SPARSER::MOLECULE) ("Gls1 and Glul" . SPARSER::COLLECTION)
    ("glucocorticoids" . SPARSER::PROTEIN)
    ("Hk2, Ldha and Gls1" . SPARSER::COLLECTION) ("analogs" . SPARSER::ANALOG)
    ("a valuable biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE)
    ("ectopically-expressed MYC" . SPARSER::PROTEIN)
    ("analog and inhibitor" . SPARSER::COLLECTION)
    ("diazo" . SPARSER::MOLECULE) ("OHT" . SPARSER::DRUG)
    ("GLS1, bis-2-(5-phenylacetoamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) ( xref ), and its water-soluble analog"
     . SPARSER::COLLECTION)
    ("its water-soluble analog" . SPARSER::ANALOG)
    ("water" . SPARSER::MOLECULE) ("GLS2 and GLUL" . SPARSER::COLLECTION)
    ("GLUL" . SPARSER::PROTEIN) ("4-hydroxytamoxifen (OHT)" . SPARSER::DRUG)
    ("Glutaminase" . SPARSER::PROTEIN)
    ("protein and glutamine" . SPARSER::COLLECTION)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Hk2 and Ldha" . SPARSER::COLLECTION)
    ("malate and citrate" . SPARSER::COLLECTION) ("malate" . SPARSER::MOLECULE)
    ("-glutamine" . SPARSER::COLLECTION) ("Slc1a5" . SPARSER::PROTEIN)
    ("transporter" . SPARSER::PROTEIN)
    ("adult periportal hepatocytes" . SPARSER::PROTEIN)
    ("ammonia" . SPARSER::MOLECULE) ("Glutamine" . SPARSER::AMINO-ACID)
    ("phosphofructokinase" . SPARSER::PROTEIN)
    ("hexokinase" . SPARSER::PROTEIN) ("Hexokinase" . SPARSER::PROTEIN)
    ("glucokinase" . SPARSER::PROTEIN) ("hepatocytes" . SPARSER::PROTEIN)
    ("FDG" . SPARSER::PROTEIN) ("Ldha" . SPARSER::PROTEIN)
    ("dehydrogenase (LDH)" . SPARSER::PROTEIN) ("LDH" . SPARSER::PROTEIN)
    ("dehydrogenase" . SPARSER::PROTEIN) ("pyruvate" . SPARSER::PROTEIN)
    ("Lactate" . SPARSER::LACTATE) ("-glucose" . SPARSER::COLLECTION)
    ("lactate" . SPARSER::LACTATE) ("Glucose" . SPARSER::PROTEIN)
    ("MYC and use glutamine" . SPARSER::COLLECTION)
    ("MYC or MET" . SPARSER::COLLECTION)
    ("either human MYC ( xref ) or MET ( xref )" . SPARSER::COLLECTION)
    ("transporters and glutaminase" . SPARSER::COLLECTION)
    ("RAS/MAPK" . SPARSER::COLLECTION)
    ("/scatter factor" . SPARSER::COLLECTION)
    ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HGF" . SPARSER::PROTEIN)
    ("transporters" . SPARSER::PROTEIN) ("Gls1" . SPARSER::PROTEIN)
    ("Gls2" . SPARSER::PROTEIN) ("glutaminase" . SPARSER::PROTEIN)
    ("Gls" . SPARSER::PROTEIN) ("glucose and glutamine" . SPARSER::COLLECTION)
    ("catabolism" . SPARSER::PROTEIN) ("glutamine" . SPARSER::AMINO-ACID)
    ("glucose" . SPARSER::PROTEIN) ("mTORC1" . SPARSER::PROTEIN)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("H-RAS" . SPARSER::PROTEIN) ("L-norleucine" . SPARSER::MOLECULE)
    ("GLS2" . SPARSER::PROTEIN) ("GLS1" . SPARSER::PROTEIN)
    ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("glutaminase activity" . SPARSER::PROTEIN) ("Hk2" . SPARSER::PROTEIN)
    ("glucose-6-phosphatase" . SPARSER::PROTEIN)
    ("β-catenin" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("scatter factor" . SPARSER::PROTEIN) ("proto-oncogene" . SPARSER::PROTEIN)
    ("glutamine synthetase" . SPARSER::PROTEIN)
    ("Plk1 and PARP" . SPARSER::COLLECTION)
    ("PARP and Plk1" . SPARSER::COLLECTION) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("IR and Olaparib" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("Rad51 and Nbs1" . SPARSER::COLLECTION)
    ("phospho-mimetic aspartate" . SPARSER::PROTEIN)
    ("either nonphosphorylatable alanine" . SPARSER::AMINO-ACID)
    ("CK2 or Plk1" . SPARSER::COLLECTION) ("endonucleases" . SPARSER::PROTEIN)
    ("meiotic" . SPARSER::DRUG) ("nucleoprotein" . SPARSER::PROTEIN)
    ("Plk1-" . SPARSER::PROTEIN)
    ("damage-responsive proteins" . SPARSER::PROTEIN)
    ("accurate HR" . SPARSER::PROTEIN) ("PPAR" . SPARSER::PROTEIN)
    ("nuclease (ZFN)" . SPARSER::PROTEIN)
    ("functional BRCA2 " . SPARSER::PROTEIN)
    ("Tr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CK2 and Plk1" . SPARSER::COLLECTION)
    ("the phospho-mimetic S14D Rad51 variant" . SPARSER::VARIANT)
    ("polymerase (PARP)" . SPARSER::PROTEIN) ("PARP" . SPARSER::PROTEIN)
    ("polymerase" . SPARSER::PROTEIN) ("Rad51 or BRCA2" . SPARSER::COLLECTION)
    ("exogenous WT Rad51" . SPARSER::PROTEIN)
    ("characteristic Rad51 foci" . SPARSER::PROTEIN)
    ("Plk1 and/or CK2" . SPARSER::COLLECTION)
    ("BRCA2 and PALB2" . SPARSER::COLLECTION)
    ("Rad51-BRCA2-PALB2" . SPARSER::COLLECTION)
    ("kinase and ATP" . SPARSER::COLLECTION) ("glutathione" . SPARSER::DRUG)
    ("an acidophilic kinase" . SPARSER::KINASE)
    ("full-length Rad51 and the NTD fragment" . SPARSER::COLLECTION)
    ("Plk1 and CK2" . SPARSER::COLLECTION) ("nocodazole" . SPARSER::DRUG)
    ("N-terminally FLAG-tagged Rad51 and its S14 variants"
     . SPARSER::COLLECTION)
    ("aspartate" . SPARSER::PROTEIN) ("ATPase" . SPARSER::PROTEIN)
    ("pS" . SPARSER::PROTEIN) ("Recombinase" . SPARSER::PROTEIN)
    ("Nbs1 and Rad51" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("Mdc1 and BRCA2" . SPARSER::COLLECTION)
    ("an essential cell-cycle regulator" . SPARSER::REGULATOR)
    ("CDKs" . SPARSER::PROTEIN) ("RPA" . SPARSER::PROTEIN)
    ("Mre11-Rad50-Nbs1" . SPARSER::COLLECTION)
    ("Mre11 and Rad50" . SPARSER::COLLECTION)
    ("prone" . SPARSER::PROTEIN-FAMILY) ("IR" . SPARSER::PROTEIN)
    ("the essential Rad51 recombinase" . SPARSER::PROTEIN)
    ("recombinase" . SPARSER::PROTEIN) ("broken DNA" . SPARSER::DNA)
    ("1L" . SPARSER::PROTEIN) ("AZD 2281" . SPARSER::DRUG)
    ("PARP1" . SPARSER::PROTEIN) ("NP40" . SPARSER::MOLECULE)
    ("BI-2536" . SPARSER::DRUG) ("Cdc5" . SPARSER::PROTEIN)
    ("PPP1R12C" . SPARSER::PROTEIN) ("BRCA2 " . SPARSER::PROTEIN)
    ("I-SceI" . SPARSER::PROTEIN) ("ADP-ribose" . SPARSER::MOLECULE)
    ("γ−H2AX" . SPARSER::PROTEIN) ("S3B" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("CDK1" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("serine residue" . SPARSER::MOLECULE)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA2" . SPARSER::PROTEIN) ("cancer 2" . SPARSER::PROTEIN)
    ("single-strand binding protein" . SPARSER::PROTEIN)
    ("mediator of DNA damage checkpoint 1" . SPARSER::PROTEIN)
    ("Mdc1" . SPARSER::PROTEIN) ("Rad50" . SPARSER::PROTEIN)
    ("Mre11" . SPARSER::PROTEIN) ("NBS1" . SPARSER::PROTEIN)
    ("autosomal recessive" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("casein kinase 2" . SPARSER::PROTEIN) ("S14" . SPARSER::PROTEIN)
    ("Rad51" . SPARSER::PROTEIN) ("Plk1" . SPARSER::PROTEIN)
    ("Polo-like kinase" . SPARSER::PROTEIN) ("dimer" . SPARSER::DIMER)
    ("PRC1.4, RYBP and YAF2" . SPARSER::COLLECTION)
    ("CBX, PHC, and SCM" . SPARSER::COLLECTION)
    ("RYBP/YAF2 forms stable ternary complexes" . SPARSER::BIO-COMPLEX)
    ("a unique type" . TYPE)
    ("sequence-specific DNA binding proteins" . SPARSER::PROTEIN)
    ("here lack polypeptides" . SPARSER::PROTEIN)
    ("HOXD11 and HOXD12" . SPARSER::COLLECTION)
    ("RYBP/YAF2-YY1" . SPARSER::COLLECTION)
    ("MAX and MGA" . SPARSER::COLLECTION) ("MAX" . SPARSER::PROTEIN)
    ("which cases CBX2" . SPARSER::PROTEIN)
    ("H3K27me3 and PRC1" . SPARSER::COLLECTION)
    ("fits" . SPARSER::PROTEIN-FAMILY)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EB" . SPARSER::PROTEIN-FAMILY) ("Fgf5 and Nestin" . SPARSER::COLLECTION)
    ("Fgf5" . SPARSER::PROTEIN) ("Nestin" . SPARSER::PROTEIN)
    ("the pluripotent state" . SPARSER::BIO-STATE)
    ("Gata4 , Gata6 , Mixl1 , and Brachyury" . SPARSER::COLLECTION)
    ("EBs" . SPARSER::PROTEIN) ("heterodimer" . SPARSER::HETERODIMER)
    ("those containing PHC2 and either CBX2 or CBX8 ( xref )"
     . SPARSER::COLLECTION)
    ("CBX2 or CBX8" . SPARSER::COLLECTION)
    ("RING1B-PCGF4" . SPARSER::COLLECTION)
    ("RHO and SYN1" . SPARSER::COLLECTION)
    ("RHO" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nuclease" . SPARSER::PROTEIN)
    ("CBX/PHC/SCMs" . SPARSER::COLLECTION) ("EM" . SPARSER::PROTEIN)
    ("Electron" . SPARSER::MOLECULE) ("histones" . SPARSER::PROTEIN)
    ("RYBP, CBX2 and PHC3" . SPARSER::COLLECTION)
    ("sucrose" . SPARSER::MOLECULE) ("CBX/PHC" . SPARSER::COLLECTION)
    ("CBX/PHC/SCM" . SPARSER::COLLECTION) ("Fractions" . SPARSER::COMPONENT)
    ("RYBP- and CBX/PHC-containing PRC1 complexes" . SPARSER::COLLECTION)
    ("CBX7 (one of the PRC1-related CBX proteins) and RYBP"
     . SPARSER::COLLECTION)
    ("RYBP and PHC3" . SPARSER::COLLECTION)
    ("RYBP/YAF2 and CBX4/CBX8 form separate yet stable complexes"
     . SPARSER::BIO-COMPLEX)
    ("RING1B and PCGF4" . SPARSER::COLLECTION)
    ("CBX4/CBX8" . SPARSER::COLLECTION)
    ("RING1B and other PCGFs" . SPARSER::COLLECTION)
    ("many promoters RYBP- and CBX-containing PRC1 complexes ( xref top) co-exist"
     . SPARSER::COLLECTION)
    ("RYBP-" . SPARSER::PROTEIN) ("PCGF4-" . SPARSER::PROTEIN)
    ("PCGF2-" . SPARSER::PROTEIN) ("RING1B-" . SPARSER::PROTEIN)
    ("target and genome-wide" . SPARSER::COLLECTION)
    ("RYBP and CBX2" . SPARSER::COLLECTION)
    ("RYBP or CBXs" . SPARSER::COLLECTION)
    ("RYBP and CBX" . SPARSER::COLLECTION)
    ("RYBP and H2AK119ub1" . SPARSER::COLLECTION)
    ("CBX2 or other CBX proteins" . SPARSER::COLLECTION)
    ("RING1B and each PCGF" . SPARSER::COLLECTION)
    ("PRC1.1, PRC1.5, and PRC1" . SPARSER::COLLECTION)
    ("PRC1 components and a preferential association" . SPARSER::COLLECTION)
    ("RING1B and H3K27me3" . SPARSER::COLLECTION)
    ("CBX2-containing PRC1.2 and PRC1" . SPARSER::COLLECTION)
    ("RING1B, RYBP, PCGF4 and CBX2" . SPARSER::COLLECTION)
    ("GO" . SPARSER::PROTEIN) ("at most (58%–74%) genes" . SPARSER::GENE)
    ("RING1B and PCGFs" . SPARSER::COLLECTION)
    ("SERs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RING1B and RYBP" . SPARSER::COLLECTION)
    ("H3K27me3 and H2AK119ub1" . SPARSER::COLLECTION)
    ("-PCGF6" . SPARSER::COLLECTION) ("-PCGF5" . SPARSER::COLLECTION)
    ("-PCGF4" . SPARSER::COLLECTION) ("-PCGF2" . SPARSER::COLLECTION)
    ("-PCGF1" . SPARSER::COLLECTION) ("-RYBP" . SPARSER::COLLECTION)
    ("This variety of complexes and their heterogeneous composition"
     . SPARSER::COLLECTION)
    ("NFH-PCGF1" . SPARSER::COLLECTION) ("NFH-RING1B" . SPARSER::COLLECTION)
    ("glycerol" . SPARSER::PROTEIN)
    ("YAF2 and vice versa ( xref , lane 14 and 15)" . SPARSER::COLLECTION)
    ("RYBP and YAF2" . SPARSER::COLLECTION)
    ("RYBP or YAF2" . SPARSER::COLLECTION)
    ("RING1A, RING1B, RYBP, PCGF1, PCGF2, PCGF4, and PCGF6"
     . SPARSER::COLLECTION)
    ("PRC1.1, PRC1.2, PRC1.3, PRC1.4, PRC1.5, or PRC1" . SPARSER::COLLECTION)
    ("-PHC1–3" . SPARSER::COLLECTION) ("-YAF2" . SPARSER::COLLECTION)
    ("NFH-RYBP" . SPARSER::COLLECTION) ("TAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PCGF2 and PCGF4" . SPARSER::COLLECTION)
    ("sequential N-terminal FLAG and HA" . SPARSER::COLLECTION)
    ("FLAG and HA" . SPARSER::COLLECTION) ("MEL18/PCGF2" . SPARSER::COLLECTION)
    ("NFH" . SPARSER::PROTEIN) ("TAP" . SPARSER::PROTEIN)
    ("SCMs" . SPARSER::PROTEIN-FAMILY) ("PHCs" . SPARSER::PROTEIN)
    ("RYBP/YAF2" . SPARSER::COLLECTION)
    ("RING1/YY1-binding protein (RYBP) and its homolog YAF2 ( xref )"
     . SPARSER::COLLECTION)
    ("protein (RYBP)" . SPARSER::PROTEIN)
    ("even more such complexes" . SPARSER::BIO-COMPLEX)
    ("the BcoR complex and L3MBTL2 complex" . SPARSER::COLLECTION)
    ("PRCs" . SPARSER::PROTEIN) ("promoters" . SPARSER::PROMOTER)
    ("the canonical PRC1" . SPARSER::PROTEIN)
    ("L3MBTL2-associated polypeptides" . SPARSER::PEPTIDE)
    ("MBLR/PCGF6" . SPARSER::COLLECTION) ("NSPC1/PCGF1" . SPARSER::COLLECTION)
    ("MBLR" . SPARSER::PROTEIN) ("proteins (CBX)" . SPARSER::PROTEIN)
    ("RING1A and RING1B" . SPARSER::COLLECTION)
    ("BMI1/PCGF4" . SPARSER::COLLECTION) ("PHC1–3" . SPARSER::COLLECTION)
    ("Scm" . SPARSER::PROTEIN-FAMILY) ("Polyhomeotic" . SPARSER::PROTEIN)
    ("PRC1 and PRC2" . SPARSER::COLLECTION) ("Complex" . SPARSER::BIO-COMPLEX)
    ("developmental regulators" . SPARSER::REGULATOR)
    ("Hox" . SPARSER::PROTEIN) ("PcG" . SPARSER::PROTEIN-FAMILY)
    ("Group" . SPARSER::MOLECULE) ("Polycomb" . SPARSER::PROTEIN)
    ("CBX/PHC/SCM-containing complexes compact chromatin"
     . SPARSER::BIO-COMPLEX)
    ("AK" . SPARSER::PROTEIN)
    ("RYBP or its homolog YAF2" . SPARSER::COLLECTION)
    ("CBX, PHC and SCM" . SPARSER::COLLECTION)
    ("SCM" . SPARSER::PROTEIN-FAMILY) ("PHC" . SPARSER::PROTEIN)
    ("CBX" . SPARSER::PROTEIN) ("RYBP" . SPARSER::PROTEIN)
    ("associated polypeptides" . SPARSER::PEPTIDE)
    ("polypeptides" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("HOXD12" . SPARSER::PROTEIN) ("HOXD11" . SPARSER::PROTEIN)
    ("BCL6" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("E2F6" . SPARSER::PROTEIN) ("homolog of" . SPARSER::PROTEIN)
    ("Mixl1" . SPARSER::PROTEIN) ("Gata6" . SPARSER::PROTEIN)
    ("Gata4" . SPARSER::PROTEIN) ("PHC2" . SPARSER::PROTEIN)
    ("SYN1" . SPARSER::PROTEIN) ("CBX7" . SPARSER::PROTEIN)
    ("PHC3" . SPARSER::PROTEIN) ("CBX8" . SPARSER::PROTEIN)
    ("CBX4" . SPARSER::PROTEIN) ("a 15" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("CCND2" . SPARSER::PROTEIN)
    ("1–1" . SPARSER::PROTEIN) ("CBX2" . SPARSER::PROTEIN)
    ("PCGF5" . SPARSER::PROTEIN) ("PCGF2" . SPARSER::PROTEIN)
    ("MEL18" . SPARSER::PROTEIN) ("YY1" . SPARSER::PROTEIN)
    ("RING1" . SPARSER::PROTEIN) ("PCGF6" . SPARSER::PROTEIN)
    ("PCGF1" . SPARSER::PROTEIN) ("NSPC1" . SPARSER::PROTEIN)
    ("L3MBTL2" . SPARSER::PROTEIN) ("SCMH1" . SPARSER::PROTEIN)
    ("PCGF4" . SPARSER::PROTEIN) ("BMI1" . SPARSER::PROTEIN)
    ("PHC1" . SPARSER::PROTEIN) ("PRC2" . SPARSER::PROTEIN)
    ("YAF2" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::PROTEIN)
    ("RING1A" . SPARSER::PROTEIN) ("PRC1" . SPARSER::PROTEIN)
    ("the viral protein" . SPARSER::PROTEIN)
    ("this viral adaptor protein" . SPARSER::PROTEIN)
    ("viral proteins" . SPARSER::PROTEIN)
    ("multimolecular protein complexes" . SPARSER::BIO-COMPLEX)
    ("an essential scaffold" . SPARSER::SCAFFOLD)
    ("monocytes/macrophages" . SPARSER::COLLECTION) ("APCs" . SPARSER::PROTEIN)
    ("macrophages" . SPARSER::PROTEIN) ("monocytes" . SPARSER::PROTEIN)
    ("Tec" . SPARSER::PROTEIN) ("ITK and Zap-70" . SPARSER::COLLECTION)
    ("NCK and the p85 subunit" . SPARSER::COLLECTION)
    ("NCK" . SPARSER::PROTEIN) ("multi-protein" . SPARSER::COLLECTION)
    ("Vav1, Nck1 and Pak2" . SPARSER::COLLECTION) ("ASW" . SPARSER::PROTEIN)
    ("viral components" . SPARSER::COMPONENT)
    ("a multimeric complex" . SPARSER::BIO-COMPLEX)
    ("Vav1, Pak2 and Nck1" . SPARSER::COLLECTION)
    ("Nck1, Pak2 and Vav1" . SPARSER::COLLECTION)
    ("PAK2 and Nck1" . SPARSER::COLLECTION)
    ("PAK2, Vav1 and Nck1" . SPARSER::COLLECTION) ("Nck1" . SPARSER::PROTEIN)
    ("Vav and Nck" . SPARSER::COLLECTION)
    ("an important accessory protein" . SPARSER::PROTEIN)
    ("ing" . SPARSER::PROTEIN-FAMILY) ("extracellular p24" . SPARSER::PROTEIN)
    ("SLP-76 +/+ and SLP-76 −/− cells using a HIV-1 virus entry assay"
     . SPARSER::COLLECTION)
    ("CD4 or CXCR4" . SPARSER::COLLECTION)
    ("the viral envelope protein" . SPARSER::PROTEIN)
    ("receptor, CD4 and co-receptors, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("co-receptors, CXCR4 or CCR5" . SPARSER::COLLECTION)
    ("BaL" . SPARSER::PROTEIN) ("siRNA and SLP-76" . SPARSER::COLLECTION)
    ("trypan" . SPARSER::DRUG)
    ("the lab-adapted X4-tropic virus HIV-1 IIIB" . SPARSER::DRUG)
    ("IIIB" . SPARSER::DRUG) ("CXCR4, and CD4" . SPARSER::COLLECTION)
    ("receptor, CD4 and co-receptor" . SPARSER::COLLECTION)
    ("chemokine" . SPARSER::PROTEIN) ("myristoylated" . SPARSER::PROTEIN)
    ("Actin" . SPARSER::PROTEIN)
    ("Nck ( xref ) and ITK ( xref )" . SPARSER::COLLECTION)
    ("Vav ( xref , xref ), Nck ( xref ) and ITK ( xref )"
     . SPARSER::COLLECTION)
    ("ITK" . SPARSER::PROTEIN) ("Nck" . SPARSER::PROTEIN)
    ("Vav" . SPARSER::PROTEIN) ("proline" . SPARSER::AMINO-ACID)
    ("viral Nef protein and multiple signaling molecules"
     . SPARSER::COLLECTION)
    ("viral Nef protein" . SPARSER::PROTEIN)
    ("a key adaptor protein" . SPARSER::PROTEIN) ("Zap-70" . SPARSER::PROTEIN)
    ("ZAP-70" . SPARSER::PROTEIN) ("Pak2" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("envelope protein" . SPARSER::PROTEIN)
    ("NH2" . SPARSER::MOLECULE) ("CD38" . SPARSER::PROTEIN)
    ("T- cell" . SPARSER::PROTEIN) ("SLP -76" . SPARSER::PROTEIN)
    ("SLP76" . SPARSER::PROTEIN) ("SiRNA-mediated" . SPARSER::PROTEIN)
    ("F-Actin" . SPARSER::BIO-COMPLEX) ("P24" . SPARSER::PROTEIN)
    ("PAK2" . SPARSER::PROTEIN) ("NCK1" . SPARSER::PROTEIN)
    ("Vav1" . SPARSER::PROTEIN)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("p24" . SPARSER::PROTEIN) ("CCR5" . SPARSER::PROTEIN)
    ("CXCR4" . SPARSER::PROTEIN) ("MT-4" . SPARSER::PROTEIN)
    ("F-actin" . SPARSER::BIO-COMPLEX) ("MT4" . SPARSER::PROTEIN)
    ("SLP-76" . SPARSER::PROTEIN) ("ER and mitochondria" . SPARSER::COLLECTION)
    ("Drosophila" . SPARSER::PROTEIN)
    ("cAMP-responsive element-binding protein (CREB)" . SPARSER::PROTEIN)
    ("kinase or mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("CREB-binding protein/p300" . SPARSER::COLLECTION)
    ("calmodulin" . SPARSER::PROTEIN) ("cAMP" . SPARSER::CAMP)
    ("family—Bax and Bak—have" . SPARSER::COLLECTION)
    ("chelators" . SPARSER::MOLECULE) ("inositol" . SPARSER::PROTEIN)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the internal cues" . SPARSER::PROTEIN-FAMILY)
    ("Bcl-XL or GFP" . SPARSER::COLLECTION) ("/GFP" . SPARSER::COLLECTION)
    ("Bcl-XL and ATP" . SPARSER::COLLECTION)
    ("ATP and Bcl-XL" . SPARSER::COLLECTION) ("–1" . SPARSER::PROTEIN)
    ("chelator" . SPARSER::MOLECULE) ("thapsigargin" . SPARSER::MOLECULE)
    ("-tetraacetic acid tetra" . SPARSER::MOLECULE)
    ("ethane-" . SPARSER::MOLECULE) ("BAPTA" . SPARSER::MOLECULE)
    ("tetra" . SPARSER::MOLECULE) ("ethane" . SPARSER::MOLECULE)
    ("bis" . SPARSER::PROTEIN) ("Ins" . SPARSER::PROTEIN)
    ("S2, B and C" . SPARSER::COLLECTION) ("S2, D and E" . SPARSER::COLLECTION)
    ("family—p57, p27 and p21—which" . SPARSER::COLLECTION)
    ("Cip" . SPARSER::PROTEIN) ("Insm1 and Ngn2" . SPARSER::COLLECTION)
    ("bromo" . SPARSER::MOLECULE) ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("run" . SPARSER::PROTEIN-FAMILY) ("proliferative IPs" . SPARSER::PROTEIN)
    ("neurogenic progenitor BTG family member 2" . SPARSER::PROTEIN)
    ("Tis21" . SPARSER::PROTEIN) ("bHLH" . SPARSER::PROTEIN)
    ("hNS" . SPARSER::MOLECULE)
    ("Bax and Bak, or BH3-only" . SPARSER::COLLECTION)
    ("Bak, or BH3-only" . SPARSER::COLLECTION)
    ("Bak or Bax" . SPARSER::COLLECTION) ("Bax" . SPARSER::PROTEIN)
    ("Bak" . SPARSER::PROTEIN) ("many external cues" . SPARSER::PROTEIN-FAMILY)
    ("severe brain malformations" . SPARSER::PROTEIN)
    ("malformations" . SPARSER::PROTEIN) ("NPCs" . SPARSER::MOLECULE)
    ("/BTG family member 2" . SPARSER::COLLECTION) ("Insm1" . SPARSER::PROTEIN)
    ("IPs" . SPARSER::PROTEIN) ("p53–p21" . SPARSER::COLLECTION)
    ("ATP" . SPARSER::ATP) ("Calcium" . SPARSER::CALCIUM)
    ("Tween 20" . SPARSER::MOLECULE)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("m1" . SPARSER::MOLECULE) ("pMD2" . SPARSER::MOLECULE)
    ("pST1" . SPARSER::PROTEIN) ("FGF2" . SPARSER::PROTEIN)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("recombinant human epidermal growth factor" . SPARSER::DRUG)
    ("v-myc" . SPARSER::PROTEIN) ("AMP-activated" . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN) ("Id1" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("P19" . SPARSER::PROTEIN) ("Hes5" . SPARSER::PROTEIN)
    ("p57" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("NeuroD1" . SPARSER::PROTEIN) ("Pax6" . SPARSER::PROTEIN)
    ("paired box 6" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("Mcl-1" . SPARSER::PROTEIN) ("Bcl-2" . SPARSER::PROTEIN)
    ("Ngn2" . SPARSER::PROTEIN) ("neurogenin 2" . SPARSER::PROTEIN)
    ("Btg2" . SPARSER::PROTEIN) ("BTG family member 2" . SPARSER::PROTEIN)
    ("insulinoma-associated 1" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("Csk" . SPARSER::PROTEIN)
    ("the total membrane fraction (containing virtually 100% of the total eNOS and Cav-1 protein) instead of membrane-enriched fractions"
     . SPARSER::COLLECTION)
    ("CaM or Cav-1" . SPARSER::COLLECTION) ("heme" . SPARSER::PROTEIN)
    ("CaM (amino acids [aa] 491–510; xref ) and Cav-1 (aa 348–356; xref )"
     . SPARSER::COLLECTION)
    ("Cav-CSD" . SPARSER::COLLECTION) ("Cav" . SPARSER::PROTEIN)
    ("Cav-1 or Cav-1" . SPARSER::COLLECTION)
    ("the most favorable conformation" . SPARSER::BIO-CONFORMATION)
    ("phosphodefective Cav-1 mutant" . SPARSER::MUTANT)
    ("Cav-1-Y14F" . SPARSER::PROTEIN-PAIR)
    ("phosphodefective eNOS" . SPARSER::PROTEIN)
    ("phosphodefective eNOS mutants" . SPARSER::MUTANT)
    ("Cav-1-Y14D" . SPARSER::PROTEIN-PAIR) ("VEGF-" . SPARSER::PROTEIN)
    ("the primary coat protein" . SPARSER::PROTEIN)
    ("a well-established signaling molecule and key regulator of cardiovascular function ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("a favorable conformation" . SPARSER::BIO-CONFORMATION)
    ("Cav1-YFP" . SPARSER::COLLECTION)
    ("Y14F phosphodefective mutant" . SPARSER::MUTANT)
    ("phosphodefective Cav-1 and eNOS mutants" . SPARSER::MUTANT)
    ("l -NAME and Src" . SPARSER::COLLECTION)
    ("phospho-Cav-1 and eNOS" . SPARSER::COLLECTION)
    ("thrombin, or VEGF" . SPARSER::COLLECTION)
    ("a flexible linker" . SPARSER::LINKER) ("linker" . SPARSER::LINKER)
    ("pTyr" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("NONOate" . SPARSER::MOLECULE) ("DEA" . SPARSER::MOLECULE)
    ("nNOS" . SPARSER::PROTEIN) ("p" . SPARSER::PROTEIN)
    ("HEK/eNOS" . SPARSER::COLLECTION) ("Nitrite" . SPARSER::MOLECULE)
    ("Western blot" . SPARSER::PROTEIN) ("HEK" . SPARSER::PROTEIN)
    ("p-eNOS (Ser-1177) and p-Cav-1 (Tyr-14)" . SPARSER::COLLECTION)
    ("p-Cav-1" . SPARSER::PROTEIN-PAIR) ("p-eNOS" . SPARSER::PROTEIN-PAIR)
    ("pSer" . SPARSER::PROTEIN) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("Akt, PKA, AMPK, and CaMKII" . SPARSER::COLLECTION)
    ("CaMKII" . SPARSER::PROTEIN) ("AMPK" . SPARSER::PROTEIN)
    ("PKA" . SPARSER::PROTEIN) ("l -NAME and PP2" . SPARSER::COLLECTION)
    ("PP2 or l -NAME" . SPARSER::COLLECTION)
    ("Src and Cav-1" . SPARSER::COLLECTION)
    ("eNOS, Src, and Cav-1" . SPARSER::COLLECTION)
    ("fractions" . SPARSER::COMPONENT) ("eNOS–Cav-1" . SPARSER::COLLECTION)
    ("growth factor (VEGF)" . SPARSER::GROWTH-FACTOR)
    ("DA" . SPARSER::MOLECULE) ("diacetate" . SPARSER::MOLECULE)
    ("VEGF" . SPARSER::PROTEIN)
    ("Src (Tyr-418) and Cav-1 (Tyr-14)" . SPARSER::COLLECTION)
    ("Cav-1/eNOS" . SPARSER::COLLECTION)
    ("the expressed fluorescent Cav-1 and eNOS proteins" . SPARSER::PROTEIN)
    ("Cav-1 and eNOS" . SPARSER::COLLECTION) ("eNOS–CFP" . SPARSER::COLLECTION)
    ("eNOS-CFP" . SPARSER::COLLECTION) ("Cav-1–YFP" . SPARSER::COLLECTION)
    ("Cav-1–eNOS" . SPARSER::COLLECTION)
    ("eNOS–cyan fluorescent protein" . SPARSER::PROTEIN)
    ("Cav-1–yellow fluorescent protein" . SPARSER::COLLECTION)
    ("acceptor" . SPARSER::MOLECULE) ("YFP" . SPARSER::PROTEIN)
    ("CFP" . SPARSER::PROTEIN) ("fluorescent protein" . SPARSER::PROTEIN)
    ("Quiescent eNOS" . SPARSER::PROTEIN) ("-CaM" . SPARSER::COLLECTION)
    ("CaM" . SPARSER::PROTEIN)
    ("alanine scanning of the CSD" . SPARSER::PROTEIN)
    ("Phe" . SPARSER::AMINO-ACID) ("Thr" . SPARSER::AMINO-ACID)
    ("alanine" . SPARSER::AMINO-ACID) ("scaffold" . SPARSER::SCAFFOLD)
    ("eNOS/Cav-1" . SPARSER::COLLECTION) ("pyrimidine" . SPARSER::DRUG)
    ("hydrochloride" . SPARSER::MOLECULE) ("ester" . SPARSER::MOLECULE)
    ("eNOS and Cav-1" . SPARSER::COLLECTION)
    ("growth factor, and Ca 2+" . SPARSER::COLLECTION)
    ("ionophore" . SPARSER::MOLECULE) ("thrombin" . SPARSER::PROTEIN)
    ("Src" . SPARSER::PROTEIN) ("eNOS" . SPARSER::PROTEIN)
    ("Membrane-bound" . SPARSER::PROTEIN) ("protein A" . SPARSER::PROTEIN)
    ("l -arginine" . SPARSER::MOLECULE) ("MgSO 4" . SPARSER::DRUG)
    ("A-F" . SPARSER::PROTEIN) ("A-R" . SPARSER::PROTEIN)
    ("D-F" . SPARSER::PROTEIN) ("TG-3" . SPARSER::PROTEIN)
    ("D-R" . SPARSER::PROTEIN) ("caveolin 1" . SPARSER::PROTEIN)
    ("N1" . SPARSER::PROTEIN) ("AC-3" . SPARSER::PROTEIN)
    ("F-12" . SPARSER::PROTEIN) ("coat protein" . SPARSER::PROTEIN)
    ("p-Src" . SPARSER::PROTEIN) ("NO 2" . SPARSER::MOLECULE)
    ("STO-609" . SPARSER::DRUG) ("PP2" . SPARSER::DRUG)
    ("l -NAME" . SPARSER::MOLECULE) ("S1B" . SPARSER::PROTEIN)
    ("DAF-2" . SPARSER::PROTEIN)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("Ca 2+ -calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("NOS3" . SPARSER::PROTEIN) ("nitric oxide" . SPARSER::MOLECULE)
    ("Y14" . SPARSER::PROTEIN) ("t -butyl" . SPARSER::MOLECULE)
    ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN)
    ("Src kinase" . SPARSER::PROTEIN) ("KD" . SPARSER::PROTEIN)
    ("Eps15, auxilin, amphiphysin, AP180, synaptojanin, and HIP1"
     . SPARSER::COLLECTION)
    ("synaptojanin" . SPARSER::PROTEIN) ("auxilin" . SPARSER::PROTEIN)
    ("DPF" . SPARSER::PROTEIN) ("Dab2-DPF" . SPARSER::PROTEIN-PAIR)
    ("Dab2 and a DPF-interacting protein" . SPARSER::COLLECTION)
    ("FCHO1 or FCHO2" . SPARSER::COLLECTION)
    ("FCHO1 and FCHO2" . SPARSER::COLLECTION)
    ("the endocytic adaptor Dab2" . SPARSER::PROTEIN)
    ("Dab2 or ARH-AP2" . SPARSER::COLLECTION)
    ("FCHO2 and FCHO1" . SPARSER::COLLECTION)
    ("canonical CCPs" . SPARSER::PROTEIN)
    ("LDLR and TfnR" . SPARSER::COLLECTION)
    ("Dab2 and other adaptor proteins" . SPARSER::COLLECTION)
    ("TfnR or LDLR" . SPARSER::COLLECTION)
    ("FCHO2 and CHC" . SPARSER::COLLECTION) ("FCHO2-" . SPARSER::PROTEIN)
    ("CCS" . SPARSER::PROTEIN) ("LCa-GFP" . SPARSER::COLLECTION)
    ("light chain-GFP" . SPARSER::COLLECTION) ("LCa" . SPARSER::PROTEIN)
    ("available antibodies" . SPARSER::ANTIBODY)
    ("Dab2 and ARH" . SPARSER::COLLECTION)
    ("Dab2 and ARH-AP2" . SPARSER::COLLECTION)
    ("FCHO2-Dab2" . SPARSER::COLLECTION)
    ("four endocytic EH-domain proteins" . SPARSER::PROTEIN)
    ("Eps15, Eps15R, ITSN1, and ITSN2" . SPARSER::COLLECTION)
    ("Eps15 and the additional EH-domain protein intersectin (ITSN; Teckchandani and Cooper, unpublished results)"
     . SPARSER::COLLECTION)
    ("Eps15 or ITSN" . SPARSER::COLLECTION) ("intersectin" . SPARSER::PROTEIN)
    ("FCHO2 and the other known μHD-containing proteins SGIPα, Syp1p, and FCHO1"
     . SPARSER::COLLECTION)
    ("fused" . SPARSER::PROTEIN) ("NPFs" . SPARSER::PROTEIN)
    ("T7-tagged Dab2" . SPARSER::PROTEIN)
    ("p67 and p96-" . SPARSER::COLLECTION) ("NPF" . SPARSER::PROTEIN)
    ("puncta" . SPARSER::PROTEIN) ("GFP-FCHO2" . SPARSER::COLLECTION)
    ("Dab2 and FCHO2" . SPARSER::COLLECTION)
    ("FCHO2 and Dab2" . SPARSER::COLLECTION) ("HBT" . SPARSER::PROTEIN)
    ("nickel and streptavidin" . SPARSER::COLLECTION)
    ("HBT-Dab2" . SPARSER::PROTEIN-PAIR) ("streptavidin" . SPARSER::PROTEIN)
    ("nickel" . SPARSER::MOLECULE)
    ("FCHO2 and its close relative FCHO1" . SPARSER::COLLECTION)
    ("its close relative FCHO1" . SPARSER::PROTEIN)
    ("the same accessory proteins" . SPARSER::PROTEIN)
    ("Dab2 or ARH" . SPARSER::COLLECTION)
    ("the low-density lipoprotein receptor (LDLR; xref ; xref ; xref ; xref ; xref ) and integrin β1 ( xref ; xref ; xref )"
     . SPARSER::COLLECTION)
    ("ARH and Numb" . SPARSER::COLLECTION) ("Numb" . SPARSER::PROTEIN)
    ("ARH" . SPARSER::PROTEIN) ("PTB" . SPARSER::PROTEIN)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("CCPs" . SPARSER::PROTEIN)
    ("clathrin-associated sorting proteins" . SPARSER::PROTEIN)
    ("Eps15 and ITSN" . SPARSER::COLLECTION) ("amphiphysin" . SPARSER::PROTEIN)
    ("ITSN" . SPARSER::PROTEIN) ("a functional CCP" . SPARSER::PROTEIN)
    ("PtdIns" . SPARSER::PROTEIN) ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("TfnR" . SPARSER::PROTEIN)
    ("the large GTPase dynamin and other accessory proteins"
     . SPARSER::COLLECTION)
    ("other accessory proteins" . SPARSER::PROTEIN)
    ("dynamin" . SPARSER::PROTEIN) ("GTPase" . SPARSER::GTPASE)
    ("accessory proteins" . SPARSER::PROTEIN) ("CCP" . SPARSER::PROTEIN)
    ("clathrin and membrane phospholipids" . SPARSER::COLLECTION)
    ("endocytic adaptor proteins" . SPARSER::PROTEIN)
    ("phospholipids" . SPARSER::PHOSPHOLIPID) ("Receptors" . SPARSER::PROTEIN)
    ("LDLR and transferrin receptor" . SPARSER::COLLECTION)
    ("Dab2-FCHO2" . SPARSER::COLLECTION) ("HD" . SPARSER::PROTEIN)
    ("homology" . SPARSER::PROTEIN)
    ("one such accessory protein" . SPARSER::PROTEIN)
    ("the accessory proteins" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor (LDLR)" . SPARSER::PROTEIN)
    ("LDLR" . SPARSER::PROTEIN)
    ("Clathrin and endocytic accessory proteins" . SPARSER::COLLECTION)
    ("endocytic accessory proteins" . SPARSER::PROTEIN)
    ("Clathrin" . SPARSER::PROTEIN) ("FCH" . SPARSER::PROTEIN-FAMILY)
    ("a 37" . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("anti-ERK" . SPARSER::PROTEIN) ("α-adaptin" . SPARSER::PROTEIN)
    ("anti–" . SPARSER::ANTIBODY) ("HIP1" . SPARSER::PROTEIN)
    ("AP180" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("B–D" . SPARSER::PROTEIN) ("S5" . SPARSER::MOLECULE)
    ("S4" . SPARSER::PROTEIN-FAMILY) ("ITSN2" . SPARSER::PROTEIN)
    ("ITSN1" . SPARSER::PROTEIN) ("Eps15R" . SPARSER::PROTEIN)
    ("Syp1" . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("AP2 α" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("p67" . SPARSER::PROTEIN) ("green fluorescent protein" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN) ("FCHO1" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN) ("hsc70" . SPARSER::PROTEIN)
    ("Eps15" . SPARSER::PROTEIN) ("transferrin receptor" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN)
    ("low-density lipoprotein receptor" . SPARSER::PROTEIN)
    ("FCHO2" . SPARSER::PROTEIN) ("Dab2" . SPARSER::PROTEIN)
    ("carboplatin" . SPARSER::DRUG) ("cisplatin" . SPARSER::DRUG)
    ("rank" . SPARSER::PROTEIN) ("IIb" . SPARSER::DRUG)
    ("p-ATM and p-53BP1" . SPARSER::COLLECTION)
    ("ATM or 53BP1" . SPARSER::COLLECTION)
    ("KU55933 and irradiation ( xref  f and Supporting Information xref )"
     . SPARSER::COLLECTION)
    ("RPE" . SPARSER::PROTEIN) ("MDM2 and p21" . SPARSER::COLLECTION)
    ("sharp" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("53BP1 and γ-H2AX" . SPARSER::COLLECTION) ("foci" . SPARSER::PROTEIN)
    ("ATM-" . SPARSER::PROTEIN) ("ATM and 53BP1" . SPARSER::COLLECTION)
    ("platinum" . SPARSER::MOLECULE) ("HR" . SPARSER::PROTEIN)
    ("ATM" . SPARSER::PROTEIN)
    ("potential therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("DDR" . SPARSER::PROTEIN) ("kinase activity" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BP1" . SPARSER::PROTEIN) ("p-53" . SPARSER::PROTEIN)
    ("S25" . SPARSER::PROTEIN) ("HistoneH3" . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN) ("6.3" . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("acridine orange" . SPARSER::MOLECULE) ("KU55933" . SPARSER::DRUG)
    ("γ-H2AX" . SPARSER::PROTEIN) ("MDM-2" . SPARSER::PROTEIN)
    ("Tween20" . SPARSER::MOLECULE) ("Polyvinylidene fluoride" . SPARSER::DRUG)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TP53BP1" . SPARSER::PROTEIN)
    ("Chk2" . SPARSER::PROTEIN)
    ("ataxia telangiectasia-mutated" . SPARSER::PROTEIN)
    ("p-ATM" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("protein-1" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("extracellular cathepsin B" . SPARSER::PROTEIN)
    ("Extracellular cathepsin B" . SPARSER::PROTEIN)
    ("cathepsin B and procathepsin" . SPARSER::COLLECTION)
    ("LNCaP and PC-3" . SPARSER::COLLECTION) ("PC-3" . SPARSER::PROTEIN)
    ("complement" . SPARSER::PROTEIN) ("chromatin" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("transiently transduced cells overexpressed cathepsin B"
     . SPARSER::PROTEIN)
    ("AC and S1P" . SPARSER::COLLECTION)
    ("the pro-apoptotic lipid ceramide" . SPARSER::MOLECULE)
    ("bioactive sphingolipids" . SPARSER::MOLECULE)
    ("AC and CatB" . SPARSER::COLLECTION)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cathepsin B and AC" . SPARSER::COLLECTION)
    ("Acid ceramidase and cathepsin B" . SPARSER::COLLECTION)
    ("an artificial collagen matrix" . SPARSER::PROTEIN-FAMILY)
    ("trypsin or non-proteolytic" . SPARSER::COLLECTION)
    ("trypsin" . SPARSER::PROTEIN)
    ("a fluorogenic cathepsin B substrate" . SPARSER::SUBSTRATE)
    ("strong cathepsin B" . SPARSER::PROTEIN)
    ("antagonists" . SPARSER::MOLECULE)
    ("S1PR-associated G-proteins" . SPARSER::PROTEIN)
    ("toxin (PTX)" . SPARSER::MOLECULE) ("exogenous S1P" . SPARSER::PROTEIN)
    ("Sphingosine" . SPARSER::SPHINGOSINE)
    ("a fatty acid and sphingosine" . SPARSER::COLLECTION)
    ("cis" . SPARSER::PROTEIN) ("CTSB" . SPARSER::PROTEIN)
    ("cathepsins" . SPARSER::PROTEIN) ("cysteine" . SPARSER::AMINO-ACID)
    ("States" . SPARSER::BIO-STATE)
    ("AC and cathepsin B" . SPARSER::COLLECTION)
    ("acid ceramidase (AC)" . SPARSER::PROTEIN) ("AC" . SPARSER::PROTEIN)
    ("ceramide" . SPARSER::MOLECULE)
    ("hepatocyte growth factor" . SPARSER::PROTEIN) ("JTE013" . SPARSER::DRUG)
    ("S1PR1" . SPARSER::PROTEIN) ("G-proteins" . SPARSER::PROTEIN)
    ("S1PR" . SPARSER::PROTEIN-FAMILY)
    ("sphingosine kinase" . SPARSER::PROTEIN)
    ("fatty acid" . SPARSER::MOLECULE)
    ("Sphingosine 1-phosphate" . SPARSER::DRUG) ("ASAH1" . SPARSER::PROTEIN)
    ("Acid ceramidase" . SPARSER::PROTEIN) ("CA -3" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("serum albumin" . SPARSER::PROTEIN)
    ("Bis-Tris" . SPARSER::MOLECULE) ("SEW 2871" . SPARSER::DRUG)
    ("Cathepsin B" . SPARSER::PROTEIN) ("cathepsin B" . SPARSER::PROTEIN)
    ("Ets1" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("acid ceramidase" . SPARSER::PROTEIN) ("TBP" . SPARSER::PROTEIN)
    ("citrate" . SPARSER::PROTEIN) ("PVDF" . SPARSER::DRUG)
    ("GAPDH" . SPARSER::PROTEIN) ("phenylindole" . SPARSER::MOLECULE)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("MEK and AR" . SPARSER::COLLECTION)
    ("PIK3CA and AR" . SPARSER::COLLECTION)
    ("EGFR or AR" . SPARSER::COLLECTION)
    ("a potential breast cancer target" . SPARSER::TARGET-PROTEIN)
    ("AIs and selective estrogen receptor modulators" . SPARSER::COLLECTION)
    ("modulators" . SPARSER::PROTEIN) ("EGFR and AR" . SPARSER::COLLECTION)
    ("functional p21" . SPARSER::PROTEIN) ("cyclin/CDK" . SPARSER::COLLECTION)
    ("complexes" . SPARSER::BIO-COMPLEX)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("no functional p21" . SPARSER::PROTEIN)
    ("AR-1 and p21" . SPARSER::COLLECTION) ("biologic" . SPARSER::DRUG)
    ("cyclin E and cyclin D1" . SPARSER::COLLECTION)
    ("RAS and RAF" . SPARSER::COLLECTION)
    ("no exogenous growth factors" . SPARSER::GROWTH-FACTOR)
    ("glucocorticoid receptor (GR)" . SPARSER::PROTEIN)
    ("GR" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase (ERK)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MCF-10A or ARIBE" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("bicalutamide" . SPARSER::DRUG)
    ("p21, FKBP5 and NSDHL" . SPARSER::COLLECTION)
    ("FKBP5 [ xref ] and NSDHL [ xref ]" . SPARSER::COLLECTION)
    ("IGFR-1 [ xref , xref ], p21 [ xref ], FKBP5 [ xref ] and NSDHL [ xref ]"
     . SPARSER::COLLECTION)
    ("NSDHL" . SPARSER::PROTEIN) ("cellular mRNA" . SPARSER::PROTEIN)
    ("PSA" . SPARSER::PROTEIN)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("ETOH" . SPARSER::MOLECULE) ("EtOH" . SPARSER::MOLECULE)
    ("testosterone" . SPARSER::MOLECULE) ("analog" . SPARSER::ANALOG)
    ("AR (androgen-response element; ARE) or a mutated ARE"
     . SPARSER::COLLECTION)
    ("a mutated ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("LNCaP" . SPARSER::PROTEIN) ("antibiotic" . SPARSER::DRUG)
    ("ARIBE-2" . SPARSER::COLLECTION) ("neomycin" . SPARSER::DRUG)
    ("FISH" . SPARSER::PROTEIN) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fulvestrant" . SPARSER::DRUG) ("agonist" . SPARSER::AGONIST)
    ("medroxyprogesterone" . SPARSER::DRUG)
    ("AR and ERα" . SPARSER::COLLECTION) ("ERα and PR" . SPARSER::COLLECTION)
    ("tamoxifen or aromatase" . SPARSER::COLLECTION) ("AIs" . SPARSER::PROTEIN)
    ("aromatase" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::MOLECULE)
    ("androgen" . SPARSER::PROTEIN) ("agonists" . SPARSER::AGONIST)
    ("androgen receptor (AR)" . SPARSER::PROTEIN) ("Androgens" . SPARSER::DRUG)
    ("progesterone receptor (PR)" . SPARSER::PROTEIN)
    ("these therapies directly target ERα" . SPARSER::PROTEIN)
    ("estrogens" . SPARSER::MOLECULE) ("ERα/PR" . SPARSER::COLLECTION)
    ("AR and epidermal growth factor receptor" . SPARSER::COLLECTION)
    ("AR or EGFR" . SPARSER::COLLECTION) ("transgene" . SPARSER::PROTEIN)
    ("MCF-10A" . SPARSER::PROTEIN) ("androgens" . SPARSER::DRUG)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("glyceraldehyde 3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("dimethyl sulfoxide" . SPARSER::MOLECULE) ("8B" . SPARSER::PROTEIN)
    ("AR-1" . SPARSER::PROTEIN) ("cyclin D1" . SPARSER::PROTEIN)
    ("cyclin E" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Prostate-specific antigen" . SPARSER::PROTEIN)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Androgen receptor" . SPARSER::PROTEIN) ("IGFR-1" . SPARSER::PROTEIN)
    ("FKBP5" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("DNAse I" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN)
    ("p42 MAPK" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("MAPK kinase" . SPARSER::PROTEIN) ("Androgen Receptor" . SPARSER::PROTEIN)
    ("epidermal growth factor" . SPARSER::PROTEIN) ("G418" . SPARSER::MOLECULE)
    ("phenol red" . SPARSER::DRUG)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti-androgen" . SPARSER::DRUG) ("ERα" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("full-length" . SPARSER::PROTEIN) ("steroid hormone" . SPARSER::MOLECULE)
    ("androgen receptor" . SPARSER::PROTEIN) ("alcohol" . SPARSER::DRUG)
    ("chemical" . SPARSER::MOLECULE)
    ("a particular genotoxin" . SPARSER::MOLECULE)
    ("chemicals" . SPARSER::MOLECULE) ("Only three mutants" . SPARSER::MUTANT)
    ("Asn" . SPARSER::AMINO-ACID) ("Leu" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("Gln" . SPARSER::AMINO-ACID) ("His" . SPARSER::AMINO-ACID)
    ("Arg" . SPARSER::AMINO-ACID) ("maps" . SPARSER::PROTEIN)
    ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("acetaldehyde and AFB 1" . SPARSER::COLLECTION)
    ("smoke" . SPARSER::MOLECULE) ("Pol" . SPARSER::PROTEIN)
    ("polymerases" . SPARSER::PROTEIN) ("LacI" . SPARSER::PROTEIN)
    ("fragments" . SPARSER::FRAGMENT) ("guanines" . SPARSER::NUCLEOBASE)
    ("endonuclease" . SPARSER::PROTEIN) ("Guanines" . SPARSER::NUCLEOBASE)
    ("-dA" . SPARSER::MOLECULE) ("-quinones" . SPARSER::MOLECULE)
    ("dA" . SPARSER::MOLECULE) ("quinones" . SPARSER::MOLECULE)
    ("Catechols" . SPARSER::DRUG) ("AKR1A1 and 1C1-4" . SPARSER::COLLECTION)
    ("catechols" . SPARSER::DRUG)
    ("CYP1A, CYP1B, CYP3A and epoxide" . SPARSER::COLLECTION)
    ("adenine" . SPARSER::NUCLEOBASE) ("hydrolases" . SPARSER::PROTEIN)
    ("epoxide" . SPARSER::MOLECULE)
    ("Many genotoxic metabolites" . SPARSER::PROTEIN)
    ("metabolites" . SPARSER::PROTEIN)
    ("a given genotoxin" . SPARSER::MOLECULE) ("Hot" . SPARSER::PROTEIN)
    ("AGT" . SPARSER::PROTEIN) ("pSS" . SPARSER::PROTEIN-FAMILY)
    ("RAL" . SPARSER::PROTEIN) ("metabolite" . SPARSER::MOLECULE)
    ("BPDE" . SPARSER::DRUG)
    ("exogenous metabolization fraction" . SPARSER::COMPONENT)
    ("Acetaldehyde" . SPARSER::MOLECULE) ("AG" . SPARSER::PROTEIN)
    ("guanine" . SPARSER::PROTEIN)
    ("acetaldehyde and aflatoxin" . SPARSER::COLLECTION)
    ("inactive" . SPARSER::INACTIVE) ("genotoxins" . SPARSER::MOLECULE)
    ("acetaldehyde" . SPARSER::MOLECULE) ("pyrene" . SPARSER::PROTEIN)
    ("Alleles" . SPARSER::ALLELE) ("genotoxin" . SPARSER::MOLECULE)
    ("aflatoxin" . SPARSER::MOLECULE) ("N 2" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("AKR1A1" . SPARSER::PROTEIN)
    ("N2" . SPARSER::PROTEIN) ("CYP3A" . SPARSER::PROTEIN)
    ("CYP1" . SPARSER::PROTEIN) ("CYP1A" . SPARSER::PROTEIN)
    ("DNA polymerase" . SPARSER::PROTEIN) ("AG-3" . SPARSER::PROTEIN)
    ("GAG-3" . SPARSER::PROTEIN) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-3" . SPARSER::PROTEIN) ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C-3" . SPARSER::PROTEIN) ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P-7" . SPARSER::PROTEIN) ("RNAse A" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("receptor and JAK" . SPARSER::COLLECTION)
    ("soluble IL-6" . SPARSER::PROTEIN)
    ("MEK, EGFR, MET, or PDGFRA" . SPARSER::COLLECTION)
    ("mutated growth factor receptors or inflammatory cytokines"
     . SPARSER::COLLECTION)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("the Janus kinase (JAK) and SRC family" . SPARSER::COLLECTION)
    ("kinase (JAK)" . SPARSER::KINASE) ("PTPRD" . SPARSER::PROTEIN)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("myeloid" . SPARSER::PROTEIN)
    ("PBS" . SPARSER::PROTEIN) ("HCC" . SPARSER::PROTEIN)
    ("U0126, erlotinib or sunitinib" . SPARSER::COLLECTION)
    ("JAK2, PI3K, MEK and mTOR" . SPARSER::COLLECTION)
    ("ruxolitinib and the targeted kinase inhibitors" . SPARSER::COLLECTION)
    ("pro-inflammatory cytokines" . SPARSER::PROTEIN)
    ("EGFR or KRAS" . SPARSER::COLLECTION) ("Cisplatin" . SPARSER::DRUG)
    ("Adjuvant" . SPARSER::DRUG) ("KRAS or EGFR" . SPARSER::COLLECTION)
    ("RFS" . SPARSER::PROTEIN) ("KRAS/EGFR" . SPARSER::COLLECTION)
    ("STAT3 (94%) and JAK2 (79%)" . SPARSER::COLLECTION)
    ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("JAK2, STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("lentiviral shRNAs" . SPARSER::RNA) ("shRNAs" . SPARSER::RNA)
    ("JAK/STAT" . SPARSER::COLLECTION)
    ("selectively targets both JAK1 and JAK2" . SPARSER::COLLECTION)
    ("JAK1 and JAK2" . SPARSER::COLLECTION)
    ("JAK1, JAK2, JAK3 and Tyk2" . SPARSER::COLLECTION)
    ("Inflammatory cytokines" . SPARSER::PROTEIN) ("CNTFR" . SPARSER::PROTEIN)
    ("soluble ligand" . SPARSER::LIGAND)
    ("IL-6 and several other inflammatory cytokines" . SPARSER::COLLECTION)
    ("several other inflammatory cytokines" . SPARSER::PROTEIN)
    ("media" . SPARSER::PROTEIN) ("Ligands" . SPARSER::LIGAND)
    ("Family" . SPARSER::PROTEIN-FAMILY) ("FBS" . SPARSER::PROTEIN)
    ("neither sunitinib nor crizotinib" . SPARSER::COLLECTION)
    ("sunitinib and MET" . SPARSER::COLLECTION)
    ("PI3K, RAS and mTOR" . SPARSER::COLLECTION) ("sunitinib" . SPARSER::DRUG)
    ("the tyrosine kinases PDGFRA (NCI-H1703) and MET (NCI-H1993)"
     . SPARSER::COLLECTION)
    ("PDGFRA" . SPARSER::PROTEIN) ("MAPK" . SPARSER::PROTEIN)
    ("mTOR and ERK—are" . SPARSER::COLLECTION) ("mTOR" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR) ("phosphoprotein" . SPARSER::PROTEIN)
    ("Inhibitors" . SPARSER::INHIBITOR) ("Kinase" . SPARSER::KINASE)
    ("SRC and JAK" . SPARSER::COLLECTION)
    ("families" . SPARSER::PROTEIN-FAMILY)
    ("T-antigen, and EGFR" . SPARSER::COLLECTION)
    ("cues" . SPARSER::PROTEIN-FAMILY)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("RTKs" . SPARSER::PROTEIN)
    ("TKI" . SPARSER::PROTEIN) ("receptor (PDGFR)" . SPARSER::RECEPTOR)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinases (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HGFR/MET" . SPARSER::COLLECTION) ("HGFR" . SPARSER::PROTEIN)
    ("PDGFR" . SPARSER::PROTEIN) ("RTK" . SPARSER::PROTEIN)
    ("JAK2/STAT3" . SPARSER::COLLECTION) ("ruxolitinib" . SPARSER::DRUG)
    ("gp130/JAK2" . SPARSER::COLLECTION)
    ("KRAS or tyrosine kinase" . SPARSER::COLLECTION)
    ("per 1" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("NNT1" . SPARSER::PROTEIN) ("Phospho-protein" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("pS6" . SPARSER::PROTEIN)
    ("CRLF1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SOCS3" . SPARSER::PROTEIN)
    ("Negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("INCB018424" . SPARSER::DRUG) ("Tyk2" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor receptor" . SPARSER::PROTEIN)
    ("CLCF1" . SPARSER::PROTEIN)
    ("cardiotrophin-like cytokine factor 1" . SPARSER::PROTEIN)
    ("interleukin-6" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI-3-kinase" . SPARSER::PROTEIN) ("T-antigen" . SPARSER::PROTEIN)
    ("v-Src" . SPARSER::PROTEIN)
    ("hepatocyte growth factor receptor" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("JAK1" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("PDGFD" . SPARSER::PROTEIN) ("PPAP2B and ADAMTS7" . SPARSER::COLLECTION)
    ("LTA" . SPARSER::PROTEIN) ("leukotriene" . SPARSER::MOLECULE)
    ("TA" . SPARSER::PROTEIN) ("lipoprotein" . SPARSER::PROTEIN)
    ("max" . SPARSER::PROTEIN) ("HLA-B and HLA-C" . SPARSER::COLLECTION)
    ("HLA-A , HLA-B and HLA-C" . SPARSER::COLLECTION)
    ("IMP" . SPARSER::PROTEIN) ("the top 10 PC’s" . SPARSER::PROTEIN)
    ("the first two PC’s" . SPARSER::PROTEIN) ("PC" . SPARSER::PROTEIN)
    ("PC1" . SPARSER::PROTEIN) ("HLA-C and HLA-B" . SPARSER::COLLECTION)
    ("systemic lupus erythematosus and type 1" . SPARSER::COLLECTION)
    ("thyroid" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("nucleotide" . SPARSER::NUCLEOTIDE)
    ("the causative allele" . SPARSER::ALLELE)
    ("statistically imputed common HLA alleles" . SPARSER::ALLELE)
    ("HLA" . SPARSER::PROTEIN) ("alleles" . SPARSER::ALLELE)
    ("major histocompatibility complex (MHC)" . SPARSER::PROTEIN)
    ("ADAMTS7" . SPARSER::PROTEIN) ("PPAP2B" . SPARSER::PROTEIN)
    ("MHC class II transactivator" . SPARSER::PROTEIN)
    ("type 1" . SPARSER::PROTEIN) ("−3" . SPARSER::PROTEIN)
    ("HLA-B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Class I" . SPARSER::PROTEIN)
    ("dominant and recessive" . SPARSER::PROTEIN)
    ("HLA-C" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("a potential anti-glioma target" . SPARSER::TARGET-PROTEIN)
    ("CK2 and SIRT1" . SPARSER::COLLECTION) ("Sirtinol–" . SPARSER::DRUG)
    ("light" . SPARSER::PROTEIN) ("Sirtinol" . SPARSER::DRUG)
    ("Gene" . SPARSER::GENE) ("caspases" . SPARSER::PROTEIN)
    ("p21, NOXA and GADD45" . SPARSER::COLLECTION) ("NOXA" . SPARSER::PROTEIN)
    ("xref  neither DRB nor Apigenin" . SPARSER::COLLECTION)
    ("Fas or FADD" . SPARSER::COLLECTION) ("MDM2–p53" . SPARSER::COLLECTION)
    ("CHX" . SPARSER::PROTEIN) ("Cycloheximide" . SPARSER::PROTEIN)
    ("XIAP, BIRC6, NOL3 and TRAF4" . SPARSER::COLLECTION)
    ("four pro-apoptotic genes" . SPARSER::GENE)
    ("CASP10, CASP14, CASP5 and CIDEA" . SPARSER::COLLECTION)
    ("TNF α and NF- κ B" . SPARSER::COLLECTION)
    ("BIRC3, TNFRSF9, RIPK2, BCL2A1, PYCARD, CFLAR, TRADD, TRAF2, TRAF3 and CARD6"
     . SPARSER::COLLECTION)
    ("CFLAR" . SPARSER::PROTEIN)
    ("BCL2L1, BCL2L10, PYCARD, APAF1, GADD45A, CIDEA, TNFRSF10A, CASP10, CASP14 and CASP5"
     . SPARSER::COLLECTION)
    ("CIDEA" . SPARSER::PROTEIN) ("PYCARD" . SPARSER::PROTEIN)
    ("TNFRSF9, TNFSF10, BIRC3, CD40, TNFRSF11B, RIPK2, BCL2L11, BID, BIK, XIAP, BNIP3, NOD1, CARD8, TNFRSF1A, CD70, TRADD, TRAF2, TRAF3, BCL2 and BCLAF1"
     . SPARSER::COLLECTION)
    ("TRADD" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("BIK" . SPARSER::PROTEIN) ("BID" . SPARSER::PROTEIN)
    ("TNF α or Apigenin" . SPARSER::COLLECTION)
    ("TNF α and CK2-Is" . SPARSER::COLLECTION)
    ("p53-p21" . SPARSER::COLLECTION) ("p53 and p21" . SPARSER::COLLECTION)
    ("Noxa and GADD45" . SPARSER::COLLECTION)
    ("p21, Noxa and GADD45" . SPARSER::COLLECTION)
    ("p21and GADD45" . SPARSER::COLLECTION) ("Noxa" . SPARSER::PROTEIN)
    ("TNF α- and CK2-I-mediated" . SPARSER::COLLECTION)
    ("TNF α-" . SPARSER::PROTEIN)
    ("TNF α and CK2-I-mediated" . SPARSER::COLLECTION)
    ("TNF α and DRB" . SPARSER::COLLECTION) ("Pifithrin-" . SPARSER::DRUG)
    ("Pifithrin" . SPARSER::DRUG) ("Lys" . SPARSER::AMINO-ACID)
    ("TNF α and CK2-I" . SPARSER::COLLECTION)
    ("FADD and caspase-8" . SPARSER::COLLECTION)
    ("FAS or FADD" . SPARSER::COLLECTION) ("FAS" . SPARSER::PROTEIN)
    ("caspase-8 and caspase-3" . SPARSER::COLLECTION)
    ("FADD" . SPARSER::PROTEIN) ("Fas" . SPARSER::PROTEIN)
    ("subunits" . SPARSER::FRAGMENT) ("siRNAs" . SPARSER::PROTEIN)
    ("RNAs" . SPARSER::RNA) ("DRB or Apigenin" . SPARSER::COLLECTION)
    ("NF- κ B, p53 and SIRT1" . SPARSER::COLLECTION)
    ("TRAIL" . SPARSER::PROTEIN) ("caspase" . SPARSER::PROTEIN)
    ("MDM2-p53" . SPARSER::COLLECTION) ("p53 and TNF α" . SPARSER::COLLECTION)
    ("DRB and Apigenin" . SPARSER::COLLECTION) ("Apigenin" . SPARSER::DRUG)
    ("DRB" . SPARSER::PROTEIN) ("Casein" . SPARSER::PROTEIN)
    ("A-12" . SPARSER::PROTEIN) ("RPL13A" . SPARSER::PROTEIN)
    ("HPRT1" . SPARSER::PROTEIN) ("B2M" . SPARSER::PROTEIN)
    ("Deacetylase activity" . SPARSER::PROTEIN) ("β -gal" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("caspases-3" . SPARSER::PROTEIN)
    ("anti- β" . SPARSER::PROTEIN) ("SIRT-1" . SPARSER::PROTEIN)
    ("receptor-interacting protein 1" . SPARSER::PROTEIN)
    ("Ubiquitin ligase" . SPARSER::PROTEIN) ("TRAF4" . SPARSER::PROTEIN)
    ("NOL3" . SPARSER::PROTEIN) ("BIRC6" . SPARSER::PROTEIN)
    ("BCL2A1" . SPARSER::PROTEIN) ("CASP5" . SPARSER::PROTEIN)
    ("CASP14" . SPARSER::PROTEIN) ("CASP10" . SPARSER::PROTEIN)
    ("TNFRSF10A" . SPARSER::PROTEIN) ("GADD45A" . SPARSER::PROTEIN)
    ("APAF1" . SPARSER::PROTEIN) ("BCL2L10" . SPARSER::PROTEIN)
    ("BCL2L1" . SPARSER::PROTEIN) ("BCLAF1" . SPARSER::PROTEIN)
    ("BCL2" . SPARSER::PROTEIN) ("TRAF2" . SPARSER::PROTEIN)
    ("CD70" . SPARSER::PROTEIN) ("TNFRSF1A" . SPARSER::PROTEIN)
    ("CARD8" . SPARSER::PROTEIN) ("NOD1" . SPARSER::PROTEIN)
    ("BNIP3" . SPARSER::PROTEIN) ("BCL2L11" . SPARSER::PROTEIN)
    ("RIPK2" . SPARSER::PROTEIN) ("TNFRSF11B" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("BIRC3" . SPARSER::PROTEIN)
    ("TNFSF10" . SPARSER::PROTEIN) ("TNFRSF9" . SPARSER::PROTEIN)
    ("β -galactosidase" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("G2/M" . SPARSER::PROTEIN) ("2–4" . SPARSER::PROTEIN)
    ("I κ B α" . SPARSER::PROTEIN) ("procaspase-8" . SPARSER::PROTEIN)
    ("caspase-8" . SPARSER::PROTEIN) ("U87MG" . SPARSER::PROTEIN)
    ("caspase-3" . SPARSER::PROTEIN) ("siRNA-mediated" . SPARSER::PROTEIN)
    ("CK2 α" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("NAD+" . SPARSER::MOLECULE) ("Apo2L" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("NF- κ B" . SPARSER::PROTEIN)
    ("TNF α" . SPARSER::PROTEIN)
    ("a nonmucinous BAC component" . SPARSER::COMPONENT)
    ("HER2/neu" . SPARSER::COLLECTION) ("neu" . SPARSER::PROTEIN)
    ("estrogen" . SPARSER::MOLECULE) ("Estrogens" . SPARSER::MOLECULE)
    ("male" . SPARSER::MOLECULE)
    ("especially histological subtypes" . SPARSER::PROTEIN)
    ("EGFR, HER2 , and KRAS" . SPARSER::COLLECTION) ("TNM" . SPARSER::MOLECULE)
    ("KRAS or BRAF" . SPARSER::COLLECTION) ("EML-ALK" . SPARSER::COLLECTION)
    ("ins" . SPARSER::PROTEIN) ("MIA" . SPARSER::PROTEIN)
    ("Other invasive types" . TYPE) ("enteric" . SPARSER::PROTEIN)
    ("met" . SPARSER::AMINO-ACID) ("just 4 genes" . SPARSER::GENE)
    ("EGFR and HER2" . SPARSER::COLLECTION)
    ("adenocarcinoma histological subtypes" . SPARSER::PROTEIN)
    ("crizotinib" . SPARSER::DRUG)
    ("KRAS, HER2, ALK , and BRAF" . SPARSER::COLLECTION)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("erlotinib" . SPARSER::DRUG) ("gefitinib" . SPARSER::DRUG)
    ("TKIs" . SPARSER::PROTEIN) ("cigarettes" . SPARSER::DRUG)
    ("tobacco" . SPARSER::DRUG) ("EML4-ALK" . SPARSER::COLLECTION)
    ("histological subtypes" . SPARSER::PROTEIN)
    ("EGFR, KRAS, ALK, HER2 , and BRAF" . SPARSER::COLLECTION)
    ("just four genes" . SPARSER::GENE)
    ("EGFR, ALK, HER2 , and KRAS" . SPARSER::COLLECTION)
    ("KRAS" . SPARSER::PROTEIN) ("ALK" . SPARSER::PROTEIN)
    ("–3" . SPARSER::PROTEIN) ("PLX4032" . SPARSER::DRUG)
    ("BIBW 2992" . SPARSER::DRUG)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EML4" . SPARSER::PROTEIN)
    ("a potential telomerase inhibitor" . SPARSER::INHIBITOR)
    ("telomerase activity, and NPC" . SPARSER::COLLECTION)
    ("a potential inhibitor" . SPARSER::INHIBITOR) ("Chen" . SPARSER::PROTEIN)
    ("nucleolin" . SPARSER::PROTEIN) ("deoxycytidine" . SPARSER::PROTEIN)
    ("AGC/TGC" . SPARSER::COLLECTION) ("TGC" . SPARSER::PROTEIN)
    ("PinX1, hTERT and hTR" . SPARSER::COLLECTION)
    ("hTERT and hTR" . SPARSER::COLLECTION)
    ("PinX1-siRNA" . SPARSER::COLLECTION) ("hTR" . SPARSER::RNA)
    ("TID" . SPARSER::PROTEIN) ("Wang" . SPARSER::PROTEIN)
    ("Cai" . SPARSER::DRUG) ("inhibitor and tumor" . SPARSER::COLLECTION)
    ("p22" . SPARSER::PROTEIN) ("LPTS/PinX1" . SPARSER::COLLECTION)
    ("a special reverse transcriptase" . SPARSER::PROTEIN)
    ("RNA and protein" . SPARSER::COLLECTION) ("AI" . SPARSER::PROTEIN)
    ("/PI" . SPARSER::COLLECTION) ("Annexin V/PI" . SPARSER::COLLECTION)
    ("PI" . SPARSER::PROTEIN) ("NC" . SPARSER::PROTEIN)
    ("fragment" . SPARSER::FRAGMENT) ("XhoI" . SPARSER::PROTEIN-FAMILY)
    ("leukemia" . SPARSER::PROTEIN)
    ("suppressor and telomerase" . SPARSER::COLLECTION)
    ("Pin2/TRF1" . SPARSER::COLLECTION)
    ("NPC and its stem cells in vitro" . SPARSER::COLLECTION)
    ("TK and CD" . SPARSER::COLLECTION) ("TK" . SPARSER::PROTEIN)
    ("Antisense" . SPARSER::PROTEIN) ("TERT" . SPARSER::PROTEIN)
    ("group" . SPARSER::MOLECULE) ("MTT" . SPARSER::MOLECULE)
    ("human PinX1 (pEGFP-C3-PinX1) and its small interfering RNA (PinX1-FAM-siRNA)"
     . SPARSER::COLLECTION)
    ("PinX1-FAM-siRNA" . SPARSER::COLLECTION) ("NPC" . SPARSER::MOLECULE)
    ("FAM" . SPARSER::PROTEIN) ("N-2" . SPARSER::PROTEIN)
    ("colon cancer" . SPARSER::PROTEIN)
    ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("Annexin V" . SPARSER::PROTEIN) ("MnCl 2" . SPARSER::DRUG)
    ("Telomerase activity" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("Pin2" . SPARSER::PROTEIN)
    ("telomerase catalytic subunit" . SPARSER::PROTEIN)
    ("telomerase activity" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("PinX1" . SPARSER::PROTEIN)
    ("Cav1-associated signaling molecules and Cav1 regulation"
     . SPARSER::COLLECTION)
    ("Cav1-associated signaling molecules" . SPARSER::MOLECULE)
    ("filamin" . SPARSER::PROTEIN-FAMILY)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CTxB and shiga" . SPARSER::COLLECTION) ("toxins" . SPARSER::MOLECULE)
    ("Sphingolipid" . SPARSER::MOLECULE) ("fungi" . SPARSER::PROTEIN)
    ("Cav1 and PKCα" . SPARSER::COLLECTION)
    ("PKCα and Cav1" . SPARSER::COLLECTION) ("a special type" . TYPE)
    ("sphingolipids and raft proteins" . SPARSER::COLLECTION)
    ("sphingolipids" . SPARSER::MOLECULE) ("Lipid" . SPARSER::LIPID)
    ("the fungal hyaluronic acid" . SPARSER::MOLECULE)
    ("monolayers" . SPARSER::PROTEIN) ("electron" . SPARSER::MOLECULE)
    ("peroxidase" . SPARSER::PROTEIN)
    ("tubulin and Pi-Cav1" . SPARSER::COLLECTION)
    ("β-actin and Pi-cav1" . SPARSER::COLLECTION)
    ("phalloidin" . SPARSER::MOLECULE)
    ("β-actin and Pi-Cav1" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN) ("tubulin" . SPARSER::PROTEIN)
    ("Filipin" . SPARSER::MOLECULE)
    ("oligonucleotide and Cav1" . SPARSER::COLLECTION)
    ("oligonucleotide" . SPARSER::MOLECULE) ("-FITC" . SPARSER::MOLECULE)
    ("FITC" . SPARSER::MOLECULE) ("CTxB" . SPARSER::PROTEIN)
    ("toxin" . SPARSER::MOLECULE) ("rhodamine" . SPARSER::PROTEIN)
    ("Cav-1-GFP" . SPARSER::COLLECTION) ("bright" . SPARSER::PROTEIN)
    ("CHO" . SPARSER::PROTEIN) ("DAPI" . SPARSER::DRUG)
    ("Cav1 and CD44" . SPARSER::COLLECTION)
    ("CD44 and Cav1" . SPARSER::COLLECTION) ("Cav1-GFP" . SPARSER::COLLECTION)
    ("part" . SPARSER::COMPONENT) ("Cys" . SPARSER::AMINO-ACID)
    ("At least 37 proteins" . SPARSER::PROTEIN)
    ("Caveolins" . SPARSER::PROTEIN-FAMILY) ("CSD" . SPARSER::PROTEIN)
    ("VIP" . SPARSER::PROTEIN) ("oligomers" . SPARSER::PROTEIN)
    ("caveolin-1, -2, and -3" . SPARSER::COLLECTION)
    ("caveolins" . SPARSER::PROTEIN-FAMILY)
    ("dynamic caveolin" . SPARSER::PROTEIN) ("caveolin" . SPARSER::PROTEIN)
    ("CD44, Cav1, and actin" . SPARSER::COLLECTION)
    ("clathrin" . SPARSER::PROTEIN) ("ganglioside" . SPARSER::PROTEIN)
    ("lipids or rafts" . SPARSER::COLLECTION) ("lipids" . SPARSER::PROTEIN)
    ("reagent" . SPARSER::MOLECULE) ("filament" . SPARSER::PROTEIN-FAMILY)
    ("fraction" . SPARSER::COMPONENT) ("PKC" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN) ("HA and HBMEC" . SPARSER::COLLECTION)
    ("HA" . SPARSER::MOLECULE) ("synthase" . SPARSER::PROTEIN)
    ("A special type" . TYPE) ("BBB" . SPARSER::PROTEIN)
    ("barrier (BBB)" . SPARSER::PROTEIN)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("filipin" . SPARSER::MOLECULE)
    ("lipid" . SPARSER::LIPID) ("cav1" . SPARSER::PROTEIN)
    ("β-Actin" . SPARSER::PROTEIN) ("HA-CD44" . SPARSER::PROTEIN)
    ("cps1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tight junction" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("subunit B" . SPARSER::PROTEIN) ("monoclonal antibody" . SPARSER::DRUG)
    ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY) ("F12" . SPARSER::PROTEIN)
    ("GRB7" . SPARSER::PROTEIN) ("tyrosine kinase" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("membrane Protein" . SPARSER::PROTEIN)
    ("muscle specific" . SPARSER::PROTEIN) ("M-caveolin" . SPARSER::PROTEIN)
    ("Caveolin-3" . SPARSER::PROTEIN) ("Caveolin-2" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN)
    ("cytochalasin D" . SPARSER::DRUG) ("PKCα" . SPARSER::PROTEIN)
    ("CPS1" . SPARSER::PROTEIN) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("brain)" . SPARSER::PROTEIN) ("m 2" . SPARSER::MOLECULE)
    ("Cav1" . SPARSER::PROTEIN) ("caveolin-1" . SPARSER::PROTEIN)
    ("the variable histologic subtypes" . SPARSER::PROTEIN)
    ("both luminal and basal markers" . SPARSER::COLLECTION)
    ("-mutant" . SPARSER::MUTANT)
    ("MYC (using short-hairpin RNA knockdown) and MET (using a kinase inhibitor)"
     . SPARSER::COLLECTION)
    ("RNA" . SPARSER::RNA) ("PI3K/AKT" . SPARSER::COLLECTION)
    ("MMTV-" . SPARSER::PROTEIN) ("Neu" . SPARSER::PROTEIN)
    ("the WAP promoter (which is active in alveolar progenitor and differentiated secretory luminal epithelial cells) or the MMTV promoter (which is active in differentiated luminal mammary epithelial cells)"
     . SPARSER::COLLECTION)
    ("histologic subtypes" . SPARSER::PROTEIN) ("MMTV" . SPARSER::PROTEIN)
    ("WAP" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("PIK3CA-" . SPARSER::PROTEIN) ("p110α and p85" . SPARSER::COLLECTION)
    ("hot" . SPARSER::PROTEIN) ("p85/p55" . SPARSER::COLLECTION)
    ("isoforms" . SPARSER::ISOFORM) ("IA" . SPARSER::MOLECULE)
    ("Class" . CLASS) ("AKT, PDK1, and SGK" . SPARSER::COLLECTION)
    ("SGK" . SPARSER::PROTEIN) ("phosphatidylinositol" . SPARSER::PROTEIN)
    ("MYC and MET" . SPARSER::COLLECTION) ("MET" . SPARSER::PROTEIN)
    ("MYC" . SPARSER::PROTEIN) ("oncogenes" . SPARSER::ONCOGENE)
    ("oncogene" . SPARSER::ONCOGENE) ("luminal" . SPARSER::DRUG)
    ("exon" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GDC-0941" . SPARSER::DRUG) ("P-S6" . SPARSER::PROTEIN)
    ("Ras-GTP" . SPARSER::PROTEIN) ("p110α" . SPARSER::PROTEIN)
    ("p55" . SPARSER::PROTEIN) ("p85" . SPARSER::PROTEIN)
    ("catalytic subunit" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("PI3Ks" . SPARSER::PROTEIN) ("PDK1" . SPARSER::PROTEIN)
    ("PIP 3" . SPARSER::PIP3) ("PIP 2" . SPARSER::PIP2)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PIK3CA" . SPARSER::PROTEIN) ("self-ubiquitin" . SPARSER::PROTEIN)
    ("a target or interacting protein" . SPARSER::COLLECTION)
    ("the interacting E3's" . SPARSER::MOLECULE)
    ("LMP-1 and TRAF3" . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER) ("example" . SPARSER::EXAMPLE)
    ("-1" . SPARSER::PROTEIN) ("RING1B and histone" . SPARSER::COLLECTION)
    ("multi-" . SPARSER::PROTEIN)
    ("E3s or their substrates in the context of cancer therapeutics and prognostics"
     . SPARSER::COLLECTION)
    ("therapeutics and prognostics" . SPARSER::COLLECTION)
    ("BCA2 or hHR23a" . SPARSER::COLLECTION)
    ("make attractive and optimal components" . SPARSER::COMPONENT)
    ("Velcade" . SPARSER::DRUG) ("Bortezomib" . SPARSER::DRUG)
    ("therapeutics" . SPARSER::THERAPEUTICS) ("lysosomal" . SPARSER::PROTEIN)
    ("ubiquitin and substrate" . SPARSER::COLLECTION)
    ("homologue" . SPARSER::PROTEIN) ("HOS" . SPARSER::PROTEIN)
    ("apt" . SPARSER::PROTEIN) ("RP" . SPARSER::PROTEIN)
    ("SS" . SPARSER::PROTEIN) ("multi" . SPARSER::PROTEIN)
    ("UBA" . SPARSER::PROTEIN) ("UBL" . SPARSER::PROTEIN)
    ("elongation and de-ubiquitinase" . SPARSER::COLLECTION)
    ("ubiquitinase" . SPARSER::UBIQUITINASE) ("other E2's" . SPARSER::MOLECULE)
    ("UbcH3" . SPARSER::PROTEIN) ("hHR23a and ER" . SPARSER::COLLECTION)
    ("Both the wild-type BCA2 protein and the RING mutant"
     . SPARSER::COLLECTION)
    ("the RING-mutant and BZF mutant" . SPARSER::COLLECTION)
    ("ubiquitin and UBC9" . SPARSER::COLLECTION)
    ("GST-pulldowns" . SPARSER::PROTEIN-PAIR)
    ("cognate substrate(s) and/or binding proteins" . SPARSER::COLLECTION)
    ("Xpress-14-3-3σ" . SPARSER::COLLECTION)
    ("AKT or a kinase-dead AKT mutant" . SPARSER::COLLECTION)
    ("variant" . SPARSER::VARIANT)
    ("conformation and stability" . SPARSER::COLLECTION)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("western blot" . SPARSER::PROTEIN)
    ("hHR23a and BCA2 and protein" . SPARSER::COLLECTION)
    ("BCA2 and protein" . SPARSER::COLLECTION) ("hHR23A" . SPARSER::PROTEIN)
    ("BCA2 or BCA2" . SPARSER::COLLECTION)
    ("multi-ubiquitin" . SPARSER::COLLECTION)
    ("hHR23a and/or UbcH5b" . SPARSER::COLLECTION)
    ("BCA2 and Ubiquitin" . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::PROTEIN)
    ("BCA2 and RING" . SPARSER::COLLECTION)
    ("UbcH5a, UbcH5b, UbcH5c, or Ubc3" . SPARSER::COLLECTION)
    ("GST-BCA2" . SPARSER::COLLECTION) ("Ubc3" . SPARSER::PROTEIN)
    ("Ubc" . SPARSER::PROTEIN) ("ER and PR" . SPARSER::COLLECTION)
    ("estrogen receptor or progesterone receptor" . SPARSER::COLLECTION)
    ("versa" . SPARSER::PROTEIN) ("BCA2 and 14-3-3σ" . SPARSER::COLLECTION)
    ("examples" . SPARSER::EXAMPLE)
    ("BCA2, hHR23a and 14-3-3σ" . SPARSER::COLLECTION)
    ("DAB" . SPARSER::MOLECULE) ("TMA" . SPARSER::MOLECULE)
    ("BCA2 and either hHR23a or 14-3-3σ" . SPARSER::COLLECTION)
    ("hHR23a or 14-3-3σ" . SPARSER::COLLECTION)
    ("14-3-3σ and BCA2" . SPARSER::COLLECTION) ("punctate" . SPARSER::PROTEIN)
    ("BCA2, 14-3-3σ and hHR23a" . SPARSER::COLLECTION) ("MDA" . SPARSER::DRUG)
    ("MCF7" . SPARSER::PROTEIN) ("ER" . SPARSER::PROTEIN)
    ("hHR23a, 14-3-3σ and BCA2" . SPARSER::COLLECTION)
    ("14-3-3σ and hHR23a" . SPARSER::COLLECTION)
    ("potential substrates" . SPARSER::SUBSTRATE)
    ("BCA2 and BCA2" . SPARSER::COLLECTION) ("14-3-3σ" . SPARSER::PROTEIN)
    ("GST-14-3-3σ" . SPARSER::PROTEIN-PAIR) ("Flag-BCA2" . SPARSER::COLLECTION)
    ("sepharose" . SPARSER::MOLECULE) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("BCA2 as well as wild-type protein (lanes 1-4, top panel)"
     . SPARSER::COLLECTION)
    ("myc" . SPARSER::PROTEIN) ("mutants" . SPARSER::MUTANT)
    ("GST" . SPARSER::PROTEIN) ("ha-c-Ras" . SPARSER::COLLECTION)
    ("component" . SPARSER::COMPONENT) ("pSOS" . SPARSER::PROTEIN)
    ("pBT" . SPARSER::PROTEIN)
    ("BCA2 and partner proteins" . SPARSER::COLLECTION)
    ("chaperone" . SPARSER::PROTEIN) ("Ten new BCA2" . SPARSER::PROTEIN)
    ("hHR23a and 14-3-3σ" . SPARSER::COLLECTION)
    ("Proteins" . SPARSER::PROTEIN) ("variants" . SPARSER::VARIANT)
    ("HECT" . SPARSER::PROTEIN) ("enzymes" . SPARSER::ENZYME)
    ("Ubiquitin" . SPARSER::PROTEIN)
    ("which targets proteins" . SPARSER::PROTEIN)
    ("proteasomal" . SPARSER::PROTEIN) ("MDM2 and SIAH1" . SPARSER::COLLECTION)
    ("carboxy" . SPARSER::MOLECULE) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BRCA1/BARD1" . SPARSER::COLLECTION) ("cCbl" . SPARSER::PROTEIN)
    ("ligases" . SPARSER::LIGASE)
    ("differentially expressed genes" . SPARSER::GENE)
    ("BCA2 and hHR23a" . SPARSER::COLLECTION)
    ("proteins and BCA2" . SPARSER::COLLECTION) ("nodal" . SPARSER::PROTEIN)
    ("hHR23a and BCA2" . SPARSER::COLLECTION)
    ("Ten unique BCA2" . SPARSER::PROTEIN)
    ("hHR23a and 14-3-3sigma" . SPARSER::COLLECTION)
    ("hHR23a" . SPARSER::PROTEIN) ("TMAs" . SPARSER::MOLECULE)
    ("Rab7, tetherin, ubiquitin and UBC9" . SPARSER::COLLECTION)
    ("ubiquitin" . SPARSER::PROTEIN)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY) ("hormone" . SPARSER::MOLECULE)
    ("poly-ubiquitin" . SPARSER::PROTEIN) ("UBA52" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("LMP-1" . SPARSER::PROTEIN)
    ("USP7" . SPARSER::PROTEIN) ("ICP0" . SPARSER::PROTEIN)
    ("H2A" . SPARSER::PROTEIN) ("RING1B" . SPARSER::PROTEIN)
    ("E3s" . SPARSER::MOLECULE) ("c-Cbl" . SPARSER::PROTEIN)
    ("Cdc4" . SPARSER::PROTEIN) ("Cdc 4" . SPARSER::PROTEIN)
    ("IκBα" . SPARSER::PROTEIN) ("K26" . SPARSER::PROTEIN)
    ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("LY294002" . SPARSER::MOLECULE) ("β-Tubulin" . SPARSER::PROTEIN)
    ("g-2" . SPARSER::PROTEIN) ("UbcH5c" . SPARSER::PROTEIN)
    ("UbcH5a" . SPARSER::PROTEIN) ("UbcH5b" . SPARSER::PROTEIN)
    ("UbcH5" . SPARSER::PROTEIN) ("E2s" . SPARSER::MOLECULE)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("estrogen receptor" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("g-3" . SPARSER::PROTEIN) ("1-4" . SPARSER::PROTEIN)
    ("H 2 O 2" . SPARSER::DRUG) ("de-" . SPARSER::MOLECULE)
    ("Protein A" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("X-Gal" . SPARSER::MOLECULE) ("pSG5" . SPARSER::PROTEIN)
    ("c-Myc" . SPARSER::PROTEIN) ("AD1" . SPARSER::PROTEIN)
    ("GST-2" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::PROTEIN)
    ("SIAH1" . SPARSER::PROTEIN) ("three domains" . SPARSER::PROTEIN)
    ("BARD1" . SPARSER::PROTEIN) ("BRCA1" . SPARSER::PROTEIN)
    ("MDM2" . SPARSER::PROTEIN) ("amino acid" . SPARSER::AMINO-ACID)
    ("gene 2" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("14-3-3sigma" . SPARSER::PROTEIN) ("UBC9" . SPARSER::PROTEIN)
    ("BCA2" . SPARSER::PROTEIN)
    ("the Gram-positive specific bactericidal lectin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nutrient" . SPARSER::MOLECULE)
    ("counteractive CagA-dependent SHP2-(Ras)-ERK" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN)
    ("IL-8 , IL-6 and IRF1" . SPARSER::COLLECTION)
    ("barrier" . SPARSER::PROTEIN) ("SHP2-ERK" . SPARSER::COLLECTION)
    ("IL-11 and STAT3" . SPARSER::COLLECTION)
    ("SHP-2 and MAP-kinase" . SPARSER::COLLECTION)
    ("gp130/SHP2/ERK" . SPARSER::COLLECTION)
    ("the principal H. pylori cytotoxin" . SPARSER::PROTEIN)
    ("SHP-2/ERK" . SPARSER::COLLECTION)
    ("the mucosal immune regulators" . SPARSER::REGULATOR)
    ("IL-6 , IL-8 and IRF1" . SPARSER::COLLECTION)
    ("antagonist" . SPARSER::MOLECULE)
    ("STAT3 and mediators" . SPARSER::COLLECTION)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("STAT3 and IL-11" . SPARSER::COLLECTION)
    ("JAK/STAT3" . SPARSER::COLLECTION)
    ("exogenous recombinant human (rh)IL-11 or IL-6 peptide"
     . SPARSER::PEPTIDE)
    ("IL-11 or IL-6" . SPARSER::COLLECTION) ("rh" . SPARSER::MOLECULE)
    ("IL-11 and IL-6" . SPARSER::COLLECTION)
    ("cytokines, IL-11 and IL-6" . SPARSER::COLLECTION)
    ("homodimers" . SPARSER::HOMODIMER) ("activators" . SPARSER::ACTIVATOR)
    ("gastric epithelial cells IL-11" . SPARSER::PROTEIN)
    ("PR-CagA" . SPARSER::COLLECTION) ("-CagA" . SPARSER::COLLECTION)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("doxycycline" . SPARSER::MOLECULE)
    ("Tet" . SPARSER::PROTEIN) ("aims" . SPARSER::PROTEIN)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("the bactericidal C-type lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("differentially" . SPARSER::PROTEIN)
    ("pro-inflammatory STAT3" . SPARSER::PROTEIN)
    ("lectins, Reg3β and Reg3γ" . SPARSER::COLLECTION)
    ("an isolated bacterial cytotoxin" . SPARSER::PROTEIN)
    ("SHP2/ERK" . SPARSER::COLLECTION) ("cohort" . SPARSER::MOLECULE)
    ("directly antibacterial C-type lectin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("carbohydrate" . SPARSER::MOLECULE) ("kDa" . SPARSER::PROTEIN)
    ("lectins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-6/IL-11" . SPARSER::COLLECTION) ("ligand" . SPARSER::LIGAND)
    ("Interleukin" . SPARSER::PROTEIN)
    ("gp130/JAK/STAT3" . SPARSER::COLLECTION) ("JAK" . SPARSER::PROTEIN)
    ("Janus" . SPARSER::PROTEIN-FAMILY) ("glycoprotein" . SPARSER::PROTEIN)
    ("a bacterial oncoprotein" . SPARSER::PROTEIN)
    ("oncoprotein" . SPARSER::PROTEIN)
    ("simian virus (SV)40 large T-antigen" . SPARSER::PROTEIN)
    ("hTERT" . SPARSER::PROTEIN) ("SV" . SPARSER::MOLECULE)
    ("EMT" . SPARSER::PROTEIN) ("elongation" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase (SHP)" . SPARSER::PROTEIN)
    ("SHP" . SPARSER::PROTEIN) ("Glu-Pro-Ile-Tyr-Ala" . SPARSER::COLLECTION)
    ("Ala" . SPARSER::AMINO-ACID) ("Tyr" . SPARSER::AMINO-ACID)
    ("Ile" . SPARSER::AMINO-ACID) ("Pro" . SPARSER::AMINO-ACID)
    ("Glu" . SPARSER::AMINO-ACID) ("IV" . SPARSER::PROTEIN)
    ("molecules" . SPARSER::MOLECULE)
    ("IL-11/gp130/STAT3" . SPARSER::COLLECTION)
    ("mucosal innate immune regulators" . SPARSER::REGULATOR)
    ("IL-6, IL-8 and interferon-response" . SPARSER::COLLECTION)
    ("-ERK" . SPARSER::COLLECTION) ("SHP2-" . SPARSER::PROTEIN)
    ("IRF" . SPARSER::PROTEIN) ("interferon" . SPARSER::PROTEIN)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-11/STAT3" . SPARSER::COLLECTION) ("siRNA" . SPARSER::PROTEIN)
    ("Exogenous IL-11" . SPARSER::PROTEIN)
    ("interleukin(IL)" . SPARSER::PROTEIN) ("IL" . SPARSER::PROTEIN)
    ("interleukin" . SPARSER::PROTEIN) ("ligands" . SPARSER::LIGAND)
    ("STAT" . SPARSER::PROTEIN) ("activator" . SPARSER::ACTIVATOR)
    ("cytokine" . SPARSER::PROTEIN) ("tyrosine" . SPARSER::AMINO-ACID)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("type" . TYPE)
    ("REG" . SPARSER::PROTEIN) ("CagA" . SPARSER::PROTEIN)
    ("cytotoxin" . SPARSER::PROTEIN) ("β-actin" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("retinoblastoma protein" . SPARSER::PROTEIN)
    ("−2" . SPARSER::PROTEIN) ("reverse transcriptase" . SPARSER::PROTEIN)
    ("or 2" . SPARSER::MOLECULE) ("REGγ" . SPARSER::PROTEIN)
    ("SHP-2" . SPARSER::PROTEIN) ("pRB1" . SPARSER::PROTEIN)
    ("P21" . SPARSER::PROTEIN) ("CyclinE1" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN) ("IRF1" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("C-type-lectin" . SPARSER::PROTEIN) ("cell membrane" . SPARSER::PROTEIN)
    ("IL-6R" . SPARSER::PROTEIN) ("IL6Rα" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN)
    ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("large T-antigen" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("Src-homology" . SPARSER::PROTEIN) ("T4SS" . SPARSER::PROTEIN-FAMILY)
    ("virulence factor" . SPARSER::PROTEIN-FAMILY) ("IL-8" . SPARSER::PROTEIN)
    ("SHP2" . SPARSER::PROTEIN) ("STAT3" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("co-receptor" . SPARSER::PROTEIN) ("gp130" . SPARSER::PROTEIN)
    ("natural TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein or Ex-Tregs" . SPARSER::COLLECTION)
    ("IL-2 and IL-10" . SPARSER::COLLECTION)
    ("Foxo, or Smad3" . SPARSER::COLLECTION) ("p65/RelA" . SPARSER::COLLECTION)
    ("subunit" . SPARSER::FRAGMENT) ("RelA" . SPARSER::PROTEIN)
    ("retinoic acid (RA)" . SPARSER::MOLECULE) ("RA" . SPARSER::PROTEIN)
    ("trans" . SPARSER::PROTEIN-FAMILY) ("molecule" . SPARSER::MOLECULE)
    ("fit" . SPARSER::PROTEIN-FAMILY) ("GFP-Foxp3" . SPARSER::COLLECTION)
    ("MFI" . SPARSER::PROTEIN) ("allele" . SPARSER::ALLELE)
    ("either Ex-527 or carrier control" . SPARSER::COLLECTION)
    ("Foxp3 and GFP" . SPARSER::COLLECTION) ("Foxp3-GFP" . SPARSER::COLLECTION)
    ("exogenous TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CFSE" . SPARSER::DRUG) ("IL-2 and IL-13" . SPARSER::COLLECTION)
    ("esters and ionomycin" . SPARSER::COLLECTION)
    ("ionomycin" . SPARSER::DRUG) ("esters" . SPARSER::MOLECULE)
    ("phorbol" . SPARSER::DRUG) ("CD25 and CTLA-4" . SPARSER::COLLECTION)
    ("t" . SPARSER::PROTEIN) ("cytometry" . SPARSER::PROTEIN)
    ("PER2, BAML1, and Tau" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("Protein" . SPARSER::PROTEIN) ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antibodies and TGF-β" . SPARSER::COLLECTION) ("aa" . SPARSER::MOLECULE)
    ("p300 and SIRT1" . SPARSER::COLLECTION)
    ("p300 and Tip60" . SPARSER::COLLECTION)
    ("wildtype Foxp3 or a mutant protein" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID) ("antiserum" . SPARSER::PROTEIN)
    ("Ex-527 or nicotinamide" . SPARSER::COLLECTION)
    ("TSA, nicotinamide or Ex-527" . SPARSER::COLLECTION)
    ("FLAG-Foxp3" . SPARSER::COLLECTION) ("blot" . SPARSER::PROTEIN)
    ("lysines" . SPARSER::AMINO-ACID) ("Peptides" . SPARSER::PEPTIDE)
    ("peptides" . SPARSER::PEPTIDE) ("agarose" . SPARSER::MOLECULE)
    ("TSA and nicotinamide" . SPARSER::COLLECTION)
    ("nicotinamide" . SPARSER::PROTEIN) ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("map" . SPARSER::PROTEIN) ("lysine" . SPARSER::AMINO-ACID)
    ("AP-1" . SPARSER::PROTEIN) ("the viral Tat protein" . SPARSER::PROTEIN)
    ("protein:protein" . SPARSER::BIO-COMPLEX)
    ("NF-κB, p53, and Foxo" . SPARSER::COLLECTION)
    ("targets" . SPARSER::TARGET-PROTEIN) ("seven" . SPARSER::PROTEIN)
    ("the p300 acetyltransferase and the class III HDAC SIRT1"
     . SPARSER::COLLECTION)
    ("HDAC" . SPARSER::PROTEIN) ("class" . CLASS) ("Jurkat" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN) ("HDACs" . SPARSER::PROTEIN)
    ("histone" . SPARSER::PROTEIN) ("TSA" . SPARSER::PROTEIN)
    ("trichostatin" . SPARSER::MOLECULE)
    ("Various cellular acetyltransferases and deacetylases"
     . SPARSER::COLLECTION)
    ("acetyltransferases and deacetylases" . SPARSER::COLLECTION)
    ("deacetylases" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("lymphoid" . SPARSER::PROTEIN)
    ("CD28 and CD25" . SPARSER::COLLECTION) ("peptide" . SPARSER::PEPTIDE)
    ("MHC" . SPARSER::PROTEIN) ("exogenous IL-2" . SPARSER::PROTEIN)
    ("Foxp3 and CD25" . SPARSER::COLLECTION)
    ("IL-10 as well as cell-surface-associated" . SPARSER::COLLECTION)
    ("the cytotoxic T cell-associated antigen-4" . SPARSER::PROTEIN)
    ("IL-2, IFN-γ, and IL-4" . SPARSER::COLLECTION) ("GITR" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("glucocorticoid" . SPARSER::PROTEIN)
    ("cytokines" . SPARSER::PROTEIN) ("forkhead" . SPARSER::PROTEIN)
    ("KR" . SPARSER::PROTEIN-FAMILY) ("arginine" . SPARSER::AMINO-ACID)
    ("Mutant" . SPARSER::MUTANT) ("Smad3" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("retinoic acid" . SPARSER::MOLECULE) ("PER2" . SPARSER::PROTEIN)
    ("amino acids" . SPARSER::AMINO-ACID) ("1–4" . SPARSER::PROTEIN)
    ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD44" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-13" . SPARSER::PROTEIN) ("brefeldin A" . SPARSER::MOLECULE)
    ("CD4" . SPARSER::PROTEIN) ("CD3" . SPARSER::PROTEIN)
    ("U6" . SPARSER::PROTEIN) ("EF-1α" . SPARSER::PROTEIN)
    ("Thy1" . SPARSER::PROTEIN) ("Runx1" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("CO2" . SPARSER::PROTEIN)
    ("β-mercaptoethanol" . SPARSER::MOLECULE)
    ("deacetylase activity" . SPARSER::PROTEIN) ("T-cell" . SPARSER::PROTEIN)
    ("p53" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NF-κB" . SPARSER::PROTEIN)
    ("histone deacetylase" . SPARSER::PROTEIN) ("sir2" . SPARSER::PROTEIN)
    ("p300" . SPARSER::PROTEIN) ("HDAC7" . SPARSER::PROTEIN)
    ("Tip60" . SPARSER::PROTEIN) ("HDAC9" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor-beta" . SPARSER::PROTEIN)
    ("CD28" . SPARSER::PROTEIN) ("T-cell receptor" . SPARSER::PROTEIN)
    ("CTLA-4" . SPARSER::PROTEIN) ("antigen-4" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("IL-2 receptor" . SPARSER::PROTEIN)
    ("IL-10" . SPARSER::PROTEIN) ("IL-4" . SPARSER::PROTEIN)
    ("IFN-γ" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("SIRT1" . SPARSER::PROTEIN) ("NAD +" . SPARSER::MOLECULE)
    ("Ex-527" . SPARSER::DRUG) ("FoxP3" . SPARSER::PROTEIN)
    ("dasatinib or saracatinib" . SPARSER::COLLECTION)
    ("gemcitabine, paclitaxel or EGFR" . SPARSER::COLLECTION)
    ("EGFR" . SPARSER::PROTEIN) ("paclitaxel" . SPARSER::DRUG)
    ("gemcitabine" . SPARSER::DRUG) ("cytotoxic" . SPARSER::PROTEIN)
    ("a dual specific SRC/BCR-ABL inhibitor" . SPARSER::INHIBITOR)
    ("SRC/BCR-ABL" . SPARSER::COLLECTION) ("Dasatinib" . SPARSER::DRUG)
    ("fish" . SPARSER::PROTEIN)
    ("the crucial regulators of cell migration and invasion"
     . SPARSER::COLLECTION)
    ("enzyme" . SPARSER::ENZYME) ("ATF/CREB" . SPARSER::COLLECTION)
    ("CREB" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATF" . SPARSER::PROTEIN)
    ("the MMP-1 promoter ( xref ) and MMP-13 expression ( xref )"
     . SPARSER::COLLECTION)
    ("MMP-9 , MMP-1 or MMP-13" . SPARSER::COLLECTION)
    ("components" . SPARSER::COMPONENT) ("calpain" . SPARSER::PROTEIN)
    ("calcium" . SPARSER::CALCIUM) ("isoform" . SPARSER::ISOFORM)
    ("MEK/ERK" . SPARSER::COLLECTION)
    ("either directly phosphorylating and activating MLC kinase ( xref ) or phosphorylating and inhibiting RhoGAP ( xref )"
     . SPARSER::COLLECTION)
    ("RhoGAP" . SPARSER::PROTEIN) ("ERK/MAP-kinase" . SPARSER::COLLECTION)
    ("receptor" . SPARSER::RECEPTOR) ("EtBr" . SPARSER::PROTEIN)
    ("DMSO" . SPARSER::MOLECULE) ("dermal collagen" . SPARSER::PROTEIN)
    ("selumetinib and saracatinib" . SPARSER::COLLECTION)
    ("dasatinib" . SPARSER::DRUG) ("antibodies" . SPARSER::ANTIBODY)
    ("3D-collagen" . SPARSER::COLLECTION) ("vinculin" . SPARSER::PROTEIN)
    ("bFGF, SCF and TPA" . SPARSER::COLLECTION) ("bFGF" . SPARSER::PROTEIN)
    ("PAN-SRC" . SPARSER::COLLECTION)
    ("Further important regulators" . SPARSER::REGULATOR)
    ("FYN" . SPARSER::PROTEIN) ("kinase (FAK)" . SPARSER::KINASE)
    ("FAK" . SPARSER::PROTEIN) ("antibody" . SPARSER::PROTEIN)
    ("mediators" . SPARSER::PROTEIN) ("receptors" . SPARSER::PROTEIN)
    ("beta1-integrin" . SPARSER::COLLECTION)
    ("selumetinib or PD184352" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::AMINO-ACID) ("pro" . SPARSER::AMINO-ACID)
    ("collagenase" . SPARSER::PROTEIN)
    ("MMP-1 or MMP-13" . SPARSER::COLLECTION)
    ("matrix-metalloproteinases" . SPARSER::COLLECTION)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("myosin-light chain" . SPARSER::COLLECTION)
    ("actin-myosin" . SPARSER::COLLECTION) ("myosin" . SPARSER::PROTEIN-FAMILY)
    ("3D fibrillar collagen" . SPARSER::PROTEIN)
    ("Selumetinib" . SPARSER::DRUG) ("fibrillar collagen" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::PROTEIN) ("regulator" . SPARSER::REGULATOR)
    ("a potent orally available SRC inhibitor" . SPARSER::INHIBITOR)
    ("Saracatinib" . SPARSER::DRUG) ("MMP/protease" . SPARSER::COLLECTION)
    ("MMP" . SPARSER::PROTEIN) ("mixture" . SPARSER::MOLECULE)
    ("state" . SPARSER::BIO-STATE)
    ("proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Rho/ROCK" . SPARSER::COLLECTION)
    ("matrix-metalloproteases" . SPARSER::COLLECTION)
    ("ROCK" . SPARSER::PROTEIN-FAMILY) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMPs" . SPARSER::PROTEIN) ("metalloproteases" . SPARSER::PROTEIN)
    ("matrix" . SPARSER::PROTEIN-FAMILY) ("ECM" . SPARSER::PROTEIN)
    ("II" . SPARSER::PROTEIN) ("active" . SPARSER::ACTIVE)
    ("NRAS and BRAF" . SPARSER::COLLECTION) ("effector" . SPARSER::EFFECTOR)
    ("serine-threonine" . SPARSER::COLLECTION) ("NRAS" . SPARSER::PROTEIN)
    ("BRAF" . SPARSER::PROTEIN) ("threonine" . SPARSER::AMINO-ACID)
    ("serine" . SPARSER::AMINO-ACID)
    ("saracatinib and selumetinib" . SPARSER::COLLECTION)
    ("MEK and SRC" . SPARSER::COLLECTION)
    ("ERK/MAP kinase" . SPARSER::COLLECTION) ("saracatinib" . SPARSER::DRUG)
    ("regulators" . SPARSER::REGULATOR) ("SRC" . SPARSER::PROTEIN)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP-2 and MT1-MMP" . SPARSER::COLLECTION) ("integrin" . SPARSER::PROTEIN)
    ("actin" . SPARSER::PROTEIN)
    ("selumetinib (AZD6244, ARRY-142886) or PD184352" . SPARSER::COLLECTION)
    ("selumetinib" . SPARSER::DRUG) ("drug" . SPARSER::DRUG)
    ("drugs" . SPARSER::DRUG) ("inhibitors" . SPARSER::INHIBITOR)
    ("RAS-RAF-MEK-ERK" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GM6001" . SPARSER::DRUG)
    ("CO 2" . SPARSER::PROTEIN) ("MLC2" . SPARSER::PROTEIN)
    ("SRC-2" . SPARSER::PROTEIN) ("C-14" . SPARSER::PROTEIN)
    ("ERK2" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("BMS-354825" . SPARSER::DRUG)
    ("ATF3" . SPARSER::PROTEIN) ("IGF-I" . SPARSER::PROTEIN)
    ("calpain2" . SPARSER::PROTEIN) ("beta-1" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::GROWTH-FACTOR)
    ("MAP-kinase" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta1" . SPARSER::PROTEIN) ("MMP-9" . SPARSER::PROTEIN)
    ("MMP-13" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::PROTEIN)
    ("light chain" . SPARSER::PROTEIN) ("CI-1040" . SPARSER::DRUG)
    ("3D" . SPARSER::PROTEIN-FAMILY)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXO3a" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("a 3D" . SPARSER::PROTEIN)
    ("AZD0530" . SPARSER::DRUG) ("SRC kinase" . SPARSER::PROTEIN)
    ("MT1-MMP" . SPARSER::PROTEIN) ("MMP-2" . SPARSER::PROTEIN)
    ("PD184352" . SPARSER::DRUG) ("ARRY-142886" . SPARSER::DRUG)
    ("AZD6244" . SPARSER::DRUG) ("substrate" . SPARSER::SUBSTRATE)
    ("Foxo3a/Skp2" . SPARSER::COLLECTION)
    ("Skp2 and Skp1" . SPARSER::COLLECTION)
    ("Skp2 SCF complex and its E3 ligase activity" . SPARSER::COLLECTION)
    ("Ser" . SPARSER::AMINO-ACID) ("PI3K/Akt" . SPARSER::COLLECTION)
    ("Skp1 and Skp2" . SPARSER::COLLECTION) ("Cand1" . SPARSER::PROTEIN)
    ("PTEN/Akt" . SPARSER::COLLECTION) ("PTEN" . SPARSER::PROTEIN)
    ("repressors" . SPARSER::REPRESSOR) ("GABP" . SPARSER::PROTEIN)
    ("SP1" . SPARSER::PROTEIN) ("p27 and p21" . SPARSER::COLLECTION)
    ("Bim, FasL and GADD45" . SPARSER::COLLECTION)
    ("Foxo1, Foxo3, and Foxo4" . SPARSER::COLLECTION)
    ("suppressors" . SPARSER::SUPPRESSOR) ("BrdU" . SPARSER::DRUG)
    ("ligase" . SPARSER::LIGASE) ("Skp1 and Cul-1" . SPARSER::COLLECTION)
    ("Foxo1 and target" . SPARSER::COLLECTION)
    ("Skp1, Cul-1 and Rbx1" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("Myr" . SPARSER::MOLECULE) ("mRNA" . SPARSER::PROTEIN)
    ("Foxo" . SPARSER::PROTEIN-FAMILY) ("Foxo3a-DBM" . SPARSER::COLLECTION)
    ("form" . SPARSER::FORM) ("DBM" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT) ("luciferase" . SPARSER::PROTEIN)
    ("suppressor" . SPARSER::SUPPRESSOR) ("DQ" . SPARSER::MOLECULE)
    ("Akt, IKK, and ERK" . SPARSER::COLLECTION) ("trigger" . SPARSER::PROTEIN)
    ("kinases" . SPARSER::KINASE) ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IKK" . SPARSER::PROTEIN) ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("foxo3a" . SPARSER::PROTEIN) ("types" . TYPE)
    ("p27, Bim, FasL, and Gadd45" . SPARSER::COLLECTION)
    ("FasL" . SPARSER::PROTEIN) ("Bim" . SPARSER::PROTEIN)
    ("genes" . SPARSER::GENE) ("DNA" . SPARSER::DNA)
    ("Forkhead" . SPARSER::PROTEIN) ("Cdh1" . SPARSER::PROTEIN)
    ("APC" . SPARSER::PROTEIN) ("cyclosome" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN) ("variety" . SPARSER::VARIETY)
    ("MEFs" . SPARSER::PROTEIN) ("target" . SPARSER::TARGET-PROTEIN)
    ("inhibitor" . SPARSER::INHIBITOR) ("proteins" . SPARSER::PROTEIN)
    ("forms" . SPARSER::FORM) ("family" . SPARSER::PROTEIN-FAMILY)
    ("kinase" . SPARSER::KINASE) ("promoter" . SPARSER::PROMOTER)
    ("gene" . SPARSER::GENE) ("repressor" . SPARSER::REPRESSOR)
    ("Skp2 and Skp2" . SPARSER::COLLECTION) ("substrates" . SPARSER::SUBSTRATE)
    ("Skp2" . SPARSER::PROTEIN) ("protein" . SPARSER::PROTEIN)
    ("complex" . SPARSER::BIO-COMPLEX) ("SCF" . SPARSER::PROTEIN)
    ("Skp" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("MgCl 2" . SPARSER::MOLECULE) ("E2" . SPARSER::MOLECULE)
    ("E1" . SPARSER::MOLECULE) ("MG132" . SPARSER::PROTEIN)
    ("M2" . SPARSER::MOLECULE) ("anti-β" . SPARSER::PROTEIN)
    ("NP-40" . SPARSER::DRUG) ("-2" . SPARSER::PROTEIN)
    ("-3" . SPARSER::PROTEIN) ("RNA polymerase II" . SPARSER::PROTEIN)
    ("anti-" . SPARSER::ANTIBODY) ("Anti-" . SPARSER::ANTIBODY)
    ("DU145" . SPARSER::PROTEIN) ("PI3K" . SPARSER::PROTEIN-FAMILY)
    ("Foxp3" . SPARSER::PROTEIN) ("growth factors" . SPARSER::GROWTH-FACTOR)
    ("FoxM1" . SPARSER::PROTEIN) ("CBF1" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN) ("NF-kB" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("GADD45" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("Foxo4" . SPARSER::PROTEIN)
    ("Foxo3" . SPARSER::PROTEIN) ("Foxo1" . SPARSER::PROTEIN)
    ("foxo3" . SPARSER::PROTEIN) ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul-1" . SPARSER::PROTEIN) ("Cullin1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("protein-2" . SPARSER::PROTEIN)
    ("p27" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("transcription factor" . SPARSER::PROTEIN) ("Foxo3a" . SPARSER::PROTEIN)
    ("ligase activity" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)))